Citrus Sinensis ID: 041350

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340----
Protein Sequence
MEMLPSSCTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA
Secondary Structure (PSIPRED)
ccccccccEEEEEEccccccccccccccEEEEEEEccccccccccccEEccccccccEEEEEccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccccccccccEEEEEEccccccccccccccccccccccccccccHHHHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccEEEEcccccccccccccEEEEEEEEEccccccccccccccccccccccccccccccccccccHEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccHHccccHHHHHHccccccccEEcHHHHHHHHHccHHcccccccccEEEcEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEcccHccEEEcccccccHcHccHHHHccccccEEEEEEEEcccccccHHHHHHcccccccccHHHHHHHEEEHHHccccccccc
Coil and Loop (DISEMBL)
memlpssctisqtveisaemtpnDAILRATLgwealggchhceksghycgynvtsssticvkqnrglgplsISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDyrtvnptryTYKELKKITSKFkhrlgqggygsvfrgklfngIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYefmpngslekfifsktnssshrplswEKLKKIAFGVARGVEYLHQGcnqrilhfdikphnilldhnfqpkisdfglaklcskdisIVSLTAargtagyiapelfsrnfgevsyksdVYSYGMMLLEMVgcrknkdpa
Flexible Loop (DISEMBL)
memlpsscTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKsresekeketqlkvekfledyrtvnptrytykELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKtnssshrplswEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTagyiapelfsrnfgevsYKSDVYSYGMMLLEmvgcrknkdpa
Low Complexity Region (SEG)
MEMLPSSCTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPlsislistgtsiggiVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA
Disordered region (IsUnstruct)
*******************MTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYK************KVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT*****RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC*******
Disordered Region (DISOPRED)
*EMLPSSCTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKE*********FLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG*RKN****
Disordered Region (DISEMBL)
*********ISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRE********LKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK********LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA
Disordered Region (DISPRO)
*EMLPSSCTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQ***LGPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEK*TQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEMLPSSCTISQTVEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	344	2.2.26 [Sep-21-2011]
Q9FID6	813	Probable receptor-like pr	no	no	0.752	0.318	0.511	2e-72
Q3ECH2	892	Probable receptor-like pr	no	no	0.918	0.354	0.445	4e-72
Q9FID5	806	Probable receptor-like pr	no	no	0.706	0.301	0.511	4e-69
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.723	0.303	0.492	1e-61
Q9XID3	829	G-type lectin S-receptor-	no	no	0.651	0.270	0.493	1e-58
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.735	0.290	0.456	2e-58
O64477	828	G-type lectin S-receptor-	no	no	0.625	0.259	0.493	3e-54
Q39202	832	G-type lectin S-receptor-	no	no	0.607	0.251	0.497	6e-53
O65238	872	G-type lectin S-receptor-	no	no	0.616	0.243	0.481	5e-52
Q39203	797	G-type lectin S-receptor-	no	no	0.904	0.390	0.4	6e-52

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  272 bits (696), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 138/270 (51%), Positives = 186/270 (68%), Gaps = 11/270 (4%)

Query: 70  LSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKE 129
           L I LI  G+ IG      +++ LI + +  + +KE  + + K L         +Y Y E
Sbjct: 438 LVIILIVVGSVIGLATFIVIIMLLIRQMKRKKNKKENSVIMFKLLL-------KQYIYAE 490

Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH 189
           LKKIT  F H +G+GG+G+V+RG L NG  VAVK+L+ LKGNG +FINEV ++ +  H +
Sbjct: 491 LKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVN 550

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           IV LLGFC EG++RA++ EF+ +GSL++FI   + + S  P +   L  IA G+ARG+EY
Sbjct: 551 IVSLLGFCYEGSKRAIISEFLEHGSLDQFI---SRNKSLTP-NVTTLYGIALGIARGLEY 606

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           LH GC  RI+HFDIKP NILLD NF PK++DFGLAKLC K  SI+SL   RGT GYIAPE
Sbjct: 607 LHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPE 666

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           + SR +G +S+KSDVYSYGM++L+M+G R 
Sbjct: 667 VVSRMYGGISHKSDVYSYGMLVLDMIGARN 696

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  271 bits (694), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 154/346 (44%), Positives = 213/346 (61%), Gaps = 30/346 (8%)

Query: 19  EMTPNDAILRATL--GWEAL--GGCHHCEKSGHYCGYNVTSSSTICVKQNRGLG------ 68
           +  PN   L+  L  G+  L    C  C  SG  CGYN TSS   C  ++   G      
Sbjct: 421 QTRPNQDNLKMALDQGFRMLITSDCERCRGSGGACGYNQTSSGFGCYCKDGKCGYEYDDG 480

Query: 69  -----------PLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDY 117
                       +  + I+ G   G +++F +++   ++ +   K K +    E  L+  
Sbjct: 481 FFRRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSD---EVRLQKL 537

Query: 118 RTVNPTR-YTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-NGQEF 175
           + + P + YTY E+KK+T  F   +G+GG+G V+ G L +   VAVK+L+  KG +G++F
Sbjct: 538 KALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDF 597

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           INEVA++ +  H +IV LLGFC EG+RRA++YEF+ NGSL+KFI  K++ +    L  + 
Sbjct: 598 INEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVN----LDLKT 653

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+SDFGLAKLC K  SI+S
Sbjct: 654 LYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILS 713

Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK 341
           L   RGT GYIAPE+ SR +G VS+KSDVYSYGM++LEM+G RK +
Sbjct: 714 LLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKE 759

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  261 bits (668), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 132/258 (51%), Positives = 183/258 (70%), Gaps = 15/258 (5%)

Query: 83  GIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLG 142
           G+  F +V+ L  +  + +  KE ++ + K L +        YTY ELKKIT  F + +G
Sbjct: 453 GLATFVVVLMLWMRQMKRKNRKEERVVMFKKLLN-------MYTYAELKKITKSFSYIIG 505

Query: 143 QGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR 202
           +GG+G+V+ G L NG  VAVK+L+ LKG+ ++FINEVA++ +  H +IV LLGFC EG++
Sbjct: 506 KGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSK 565

Query: 203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE--KLKKIAFGVARGVEYLHQGCNQRILH 260
           RA+VYEF+ NGSL++F+      S ++ L+ +   L  IA G+ARG+EYLH GC  RI+H
Sbjct: 566 RAIVYEFLENGSLDQFM------SRNKSLTQDVTTLYGIALGIARGLEYLHYGCKTRIVH 619

Query: 261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY 320
           FDIKP NILLD N  PK+SDFGLAKLC K  S++SL   RGT GYIAPE+FSR +G VS+
Sbjct: 620 FDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSH 679

Query: 321 KSDVYSYGMMLLEMVGCR 338
           KSDVYS+GM++++M+G R
Sbjct: 680 KSDVYSFGMLVIDMIGAR 697

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  237 bits (604), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 127/258 (49%), Positives = 172/258 (66%), Gaps = 9/258 (3%)

Query: 89  LVIFLIYKSRES--EKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGY 146
            V F I+K ++   E  +E+  + + FLE+   + P R+ YK+L+  T+ F  +LGQGG+
Sbjct: 447 FVAFRIHKRKKMILEAPQESS-EEDNFLENLSGM-PIRFAYKDLQSATNNFSVKLGQGGF 504

Query: 147 GSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV 206
           GSV+ G L +G  +AVK LE +    +EF  EV+ IG IHH H+VRL GFC+EG  R L 
Sbjct: 505 GSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLA 564

Query: 207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH 266
           YEF+  GSLE++IF K +      L W+    IA G A+G+ YLH+ C+ RI+H DIKP 
Sbjct: 565 YEFLSKGSLERWIFRKKDGDVL--LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPE 622

Query: 267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS 326
           NILLD NF  K+SDFGLAKL +++ S V  T  RGT GY+APE  + N+  +S KSDVYS
Sbjct: 623 NILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYLAPEWIT-NYA-ISEKSDVYS 679

Query: 327 YGMMLLEMVGCRKNKDPA 344
           YGM+LLE++G RKN DP+
Sbjct: 680 YGMVLLELIGGRKNYDPS 697

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  227 bits (578), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 113/229 (49%), Positives = 157/229 (68%), Gaps = 5/229 (2%)

Query: 114 LEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ 173
           L +Y +  P ++TYKEL++ T  FK +LG GG+G+V+RG L N   VAVK LE ++   +
Sbjct: 463 LLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEK 522

Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
           +F  EVATI   HH ++VRL+GFCS+G  R LVYEFM NGSL+ F+F+   + S + L+W
Sbjct: 523 QFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFT---TDSAKFLTW 579

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
           E    IA G A+G+ YLH+ C   I+H DIKP NIL+D NF  K+SDFGLAKL +   + 
Sbjct: 580 EYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR 639

Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
            ++++ RGT GY+APE  +     ++ KSDVYSYGM+LLE+V  ++N D
Sbjct: 640 YNMSSVRGTRGYLAPEWLAN--LPITSKSDVYSYGMVLLELVSGKRNFD 686

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  226 bits (576), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 120/263 (45%), Positives = 171/263 (65%), Gaps = 10/263 (3%)

Query: 81  IGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHR 140
           +G +VL AL+  L+Y + + ++  +   K    L D    +P  +TY++L+  T+ F   
Sbjct: 480 VGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCD----SPVSFTYRDLQNCTNNFSQL 535

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCSE 199
           LG GG+G+V++G +     VAVK L+    +G+ EFI EV TIG +HH ++VRL G+CSE
Sbjct: 536 LGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSE 595

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
            + R LVYE+M NGSL+K+IFS   +++   L W    +IA   A+G+ Y H+ C  RI+
Sbjct: 596 DSHRLLVYEYMINGSLDKWIFSSEQTANL--LDWRTRFEIAVATAQGIAYFHEQCRNRII 653

Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVS 319
           H DIKP NILLD NF PK+SDFGLAK+  ++ S V +T  RGT GY+APE  S     ++
Sbjct: 654 HCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRGTRGYLAPEWVSNR--PIT 710

Query: 320 YKSDVYSYGMMLLEMVGCRKNKD 342
            K+DVYSYGM+LLE+VG R+N D
Sbjct: 711 VKADVYSYGMLLLEIVGGRRNLD 733

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  212 bits (540), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 109/221 (49%), Positives = 146/221 (66%), Gaps = 6/221 (2%)

Query: 123 TRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATI 182
           + ++Y+EL+  T  F  +LG GG+GSVF+G L +   +AVK LE +    ++F  EV TI
Sbjct: 481 SAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTI 540

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHR-PLSWEKLKKIAF 241
           G I H ++VRL GFCSEG+++ LVY++MPNGSL+  +F   N    +  L W+   +IA 
Sbjct: 541 GTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLF--LNQVEEKIVLGWKLRFQIAL 598

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
           G ARG+ YLH  C   I+H DIKP NILLD  F PK++DFGLAKL  +D S V LT  RG
Sbjct: 599 GTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRG 657

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           T GY+APE  S     ++ K+DVYSYGMML E+V  R+N +
Sbjct: 658 TRGYLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTE 696

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  208 bits (529), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 111/223 (49%), Positives = 149/223 (66%), Gaps = 14/223 (6%)

Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK-GNGQEFINEV 179
           +TY EL + T  F   LG+G +G V++G L     + + VAVK L+ L   N +EF NEV
Sbjct: 521 FTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEV 580

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
             IG+IHH ++VRL+GFC+EG  + +VYEF+P G+L  F+F +      RP SWE  K I
Sbjct: 581 KVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRP-----RP-SWEDRKNI 634

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A  +ARG+ YLH+ C+++I+H DIKP NILLD  + P+ISDFGLAKL   +    +LT  
Sbjct: 635 AVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMN-QTYTLTNI 693

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           RGT GY+APE F RN   ++ K DVYSYG+MLLE+V C+K  D
Sbjct: 694 RGTKGYVAPEWF-RN-SPITSKVDVYSYGVMLLEIVCCKKAVD 734

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  204 bits (520), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 106/220 (48%), Positives = 150/220 (68%), Gaps = 8/220 (3%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-QEFINEVA 180
           P ++ ++EL++ T  FK ++G GG+GSV++G L +   +AVK + +   +G QEF  E+A
Sbjct: 502 PQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIA 561

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            IG I H ++V+L GFC+ G +  LVYE+M +GSLEK +FS         L W++   IA
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPV----LEWQERFDIA 617

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
            G ARG+ YLH GC+Q+I+H D+KP NILL  +FQPKISDFGL+KL +++ S +  T  R
Sbjct: 618 LGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMR 676

Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN 340
           GT GY+APE  +     +S K+DVYSYGM+LLE+V  RKN
Sbjct: 677 GTRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKN 714

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  204 bits (520), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 132/330 (40%), Positives = 194/330 (58%), Gaps = 19/330 (5%)

Query: 14  VEISAEMTPNDAILRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSIS 73
           V++S       +  +  LG  +  G +H EKS + C   + S + +  K ++G   +S S
Sbjct: 347 VKMSRLQVSKSSCAKTCLGNSSCVGFYHKEKS-NLCKILLESPNNL--KNSKG--NISKS 401

Query: 74  LISTGTSIGGIVL--FALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELK 131
           +I   + +G I +  F L++ LI   R  +++K  +   + F      +N   +++KEL+
Sbjct: 402 IIILCSVVGSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFA----VLNLKVFSFKELQ 457

Query: 132 KITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI 190
             T+ F  ++G GG+G+VF+G L  +   VAVK LE       EF  EV TIG I H ++
Sbjct: 458 SATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIGNIQHVNL 517

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           VRL GFCSE   R LVY++MP GSL  ++    + +S + LSWE   +IA G A+G+ YL
Sbjct: 518 VRLRGFCSENLHRLLVYDYMPQGSLSSYL----SRTSPKLLSWETRFRIALGTAKGIAYL 573

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H+GC   I+H DIKP NILLD ++  K+SDFGLAKL  +D S V L   RGT GY+APE 
Sbjct: 574 HEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRV-LATMRGTWGYVAPEW 632

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMVGCRKN 340
            S     ++ K+DVYS+GM LLE++G R+N
Sbjct: 633 ISGL--PITTKADVYSFGMTLLELIGGRRN 660

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
3341747	616	receptor-like protein kinase [Oryza sati	0.906	0.506	0.588	1e-106
359472653	439	PREDICTED: probable receptor-like protei	0.784	0.615	0.607	1e-106
11072000	635	putative rust resistance kinase Lr10 [Or	0.901	0.488	0.591	1e-106
222617637	651	hypothetical protein OsJ_00156 [Oryza sa	0.950	0.502	0.575	1e-106
115434192	636	Os01g0117700 [Oryza sativa Japonica Grou	0.950	0.514	0.575	1e-106
115434180	663	Os01g0117100 [Oryza sativa Japonica Grou	0.872	0.452	0.615	1e-106
115434188	641	Os01g0117500 [Oryza sativa Japonica Grou	0.901	0.483	0.591	1e-106
115434120	617	Os01g0113200 [Oryza sativa Japonica Grou	0.906	0.505	0.589	1e-106
125568758	598	hypothetical protein OsJ_00108 [Oryza sa	0.906	0.521	0.589	1e-106
218187382	598	hypothetical protein OsI_00116 [Oryza sa	0.906	0.521	0.589	1e-106

>gi|3341747|gb|AAC27489.1| receptor-like protein kinase [Oryza sativa Indica Group]

 Score =  392 bits (1007), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 187/318 (58%), Positives = 242/318 (76%), Gaps = 6/318 (1%)

Query: 30  TLGWE---ALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVL 86
           T  W+   +L     CE+    CG++    +  C K +    P  + +++   S+  IV+
Sbjct: 218 TFTWQLLISLMFASDCERQQRLCGFSSQRRTAFC-KPHGSKSPAKVIIVAV--SVPTIVV 274

Query: 87  FALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGY 146
             LV   +Y S +++ + E QLKVE FL+ Y T  PTRYT+ E+K+IT +FKH+LG GG+
Sbjct: 275 LTLVASALYLSLKTKNDDEIQLKVEMFLKTYGTSKPTRYTFSEVKRITRRFKHKLGTGGF 334

Query: 147 GSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV 206
           GSV++G+L  G+PVAVKMLE+ KG G+EFINEVATIGRIHH ++VRLLGFCSEGTR AL+
Sbjct: 335 GSVYKGELSKGVPVAVKMLENSKGEGEEFINEVATIGRIHHVNVVRLLGFCSEGTRHALI 394

Query: 207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH 266
           YEFMPN SLEK+IFS+   SS   L  +K+ KIA G+A+G+EYLHQGC+QRILHFDIKPH
Sbjct: 395 YEFMPNNSLEKYIFSRDYISSQEVLVPDKMLKIALGIAQGIEYLHQGCSQRILHFDIKPH 454

Query: 267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS 326
           NILLDH+F PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFG VSYKSDV+S
Sbjct: 455 NILLDHSFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAVSYKSDVFS 514

Query: 327 YGMMLLEMVGCRKNKDPA 344
           +GM++LEM+  ++N DP+
Sbjct: 515 FGMLVLEMLSGKRNSDPS 532

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472653|ref|XP_002280038.2| PREDICTED: probable receptor-like protein kinase At5g39020-like [Vitis vinifera]

 Score =  392 bits (1007), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 190/313 (60%), Positives = 232/313 (74%), Gaps = 43/313 (13%)

Query: 31  LGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALV 90
           L WE L GC+ CE SG++CG+N T ++TIC          S S +  GTSIGG    ALV
Sbjct: 79  LAWEGLDGCYECENSGNFCGFNSTRNATICSTSR---PKRSHSAVILGTSIGGTAFLALV 135

Query: 91  IFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVF 150
           + ++Y+ R S+ EKETQLKVE+FL +Y+T+NP+RY+Y +LKKIT KF+H++GQGGYG+V 
Sbjct: 136 VLVLYRFRRSDSEKETQLKVERFLANYKTLNPSRYSYSDLKKITGKFRHKVGQGGYGTV- 194

Query: 151 RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM 210
                                                 ++VRLLGFC+EGTRRALVYEFM
Sbjct: 195 --------------------------------------NVVRLLGFCAEGTRRALVYEFM 216

Query: 211 PNGSLEKFIFSKTNSSS-HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           PN SLEKFIFS  +S + +RP SWEKL++IA G+ARG+EYLHQGCNQRILHFDIKPHNIL
Sbjct: 217 PNESLEKFIFSSKDSKTRNRPFSWEKLQQIAMGIARGMEYLHQGCNQRILHFDIKPHNIL 276

Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM 329
           LDHNFQPKISDFGLAKLCSK+ S+VS+TAARGTAGYIAPELFSRNFG VS+KSDV+S+GM
Sbjct: 277 LDHNFQPKISDFGLAKLCSKERSVVSMTAARGTAGYIAPELFSRNFGAVSHKSDVFSFGM 336

Query: 330 MLLEMVGCRKNKD 342
           +LLE+VGCR+N D
Sbjct: 337 LLLEIVGCRRNID 349

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|11072000|dbj|BAB17345.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|14090206|dbj|BAB55467.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group]

 Score =  391 bits (1005), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 187/316 (59%), Positives = 239/316 (75%), Gaps = 6/316 (1%)

Query: 30  TLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGG-IVLFA 88
           T  W     C  CE+ G  C ++   + T C+++        + +I+  +S+   +VL  
Sbjct: 237 TTVWWYRYDCPQCEQLGGRCAFSSQRNQTFCMRRGS-----HVKVIAATSSVAAFVVLLL 291

Query: 89  LVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGS 148
           +V   +Y S ++   +E  LKVE FL+ Y T  PTRYT+ E+KKI  +FK ++GQGG+GS
Sbjct: 292 MVATALYLSLKTRYNEEIHLKVEMFLKTYGTSKPTRYTFSEVKKIARRFKVKVGQGGFGS 351

Query: 149 VFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE 208
           V+RG+L NG+PVAVKMLE+ +G G EFINEVATIGRIHH +IVRLLGFCSEGTRRAL+YE
Sbjct: 352 VYRGELPNGVPVAVKMLENSEGEGDEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYE 411

Query: 209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 268
           +MPN SLEK++FS  + +S   L   K+  IA G+ARG+EYLHQGCNQRILHFDIKP+NI
Sbjct: 412 YMPNDSLEKYVFSHDSDTSQEVLVPSKMLDIAIGIARGMEYLHQGCNQRILHFDIKPNNI 471

Query: 269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYG 328
           LLD+NF PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFGE+SYKSDVYS+G
Sbjct: 472 LLDYNFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGEISYKSDVYSFG 531

Query: 329 MMLLEMVGCRKNKDPA 344
           M++LEMV  R+N DP+
Sbjct: 532 MLVLEMVSGRRNSDPS 547

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|222617637|gb|EEE53769.1| hypothetical protein OsJ_00156 [Oryza sativa Japonica Group]

 Score =  391 bits (1005), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/337 (57%), Positives = 247/337 (73%), Gaps = 10/337 (2%)

Query: 11  SQTVEISAEMTPNDAILRATLGWEALGGCHH---CEKSGHYCGYNVTSSSTICVKQNRGL 67
           S T   SAE   N      T  W     C H   CE+ G  C ++   + T C++     
Sbjct: 225 SSTFRKSAERILN---FSDTTIWWFNDDCSHPAQCEEQGGRCAFSSQRNQTFCMRP---- 277

Query: 68  GPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTY 127
           G  +  + +T +    +VL  +V   +Y S +++  +E  LKVE FL+ Y T  PTRYT+
Sbjct: 278 GSHAKVIAATSSVAAFVVLLLMVATALYLSLKTKYNEEIHLKVEMFLKTYGTSKPTRYTF 337

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
            E+KKI+ +FK ++GQGG+GSV+RG+L NG+PVAVKMLE+ +G G EFINEVATIGRIHH
Sbjct: 338 SEVKKISRRFKVKVGQGGFGSVYRGELPNGVPVAVKMLENSEGEGDEFINEVATIGRIHH 397

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +IVRLLGFCSEGTRRAL+YE+MPN SLEK+IFS+ + +S   L   K+  IA G+ARG+
Sbjct: 398 ANIVRLLGFCSEGTRRALIYEYMPNDSLEKYIFSQDSDTSQELLVPSKMLDIALGIARGM 457

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYLHQGCNQRILHFDIKP+NILLD+NF PKISDFGLAKLC++D SI++LTAARGT GYIA
Sbjct: 458 EYLHQGCNQRILHFDIKPNNILLDYNFSPKISDFGLAKLCARDQSIITLTAARGTMGYIA 517

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           PEL+SRNFGE+SYKSDVYS+GM++LEMV  R+N DP+
Sbjct: 518 PELYSRNFGEISYKSDVYSFGMLVLEMVSGRRNSDPS 554

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434192|ref|NP_001041854.1| Os01g0117700 [Oryza sativa Japonica Group] gi|11072003|dbj|BAB17348.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|14090209|dbj|BAB55470.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531385|dbj|BAF03768.1| Os01g0117700 [Oryza sativa Japonica Group]

 Score =  391 bits (1005), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 194/337 (57%), Positives = 247/337 (73%), Gaps = 10/337 (2%)

Query: 11  SQTVEISAEMTPNDAILRATLGWEALGGCHH---CEKSGHYCGYNVTSSSTICVKQNRGL 67
           S T   SAE   N      T  W     C H   CE+ G  C ++   + T C++     
Sbjct: 210 SSTFRKSAERILN---FSDTTIWWFNDDCSHPAQCEEQGGRCAFSSQRNQTFCMRP---- 262

Query: 68  GPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTY 127
           G  +  + +T +    +VL  +V   +Y S +++  +E  LKVE FL+ Y T  PTRYT+
Sbjct: 263 GSHAKVIAATSSVAAFVVLLLMVATALYLSLKTKYNEEIHLKVEMFLKTYGTSKPTRYTF 322

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
            E+KKI+ +FK ++GQGG+GSV+RG+L NG+PVAVKMLE+ +G G EFINEVATIGRIHH
Sbjct: 323 SEVKKISRRFKVKVGQGGFGSVYRGELPNGVPVAVKMLENSEGEGDEFINEVATIGRIHH 382

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +IVRLLGFCSEGTRRAL+YE+MPN SLEK+IFS+ + +S   L   K+  IA G+ARG+
Sbjct: 383 ANIVRLLGFCSEGTRRALIYEYMPNDSLEKYIFSQDSDTSQELLVPSKMLDIALGIARGM 442

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYLHQGCNQRILHFDIKP+NILLD+NF PKISDFGLAKLC++D SI++LTAARGT GYIA
Sbjct: 443 EYLHQGCNQRILHFDIKPNNILLDYNFSPKISDFGLAKLCARDQSIITLTAARGTMGYIA 502

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           PEL+SRNFGE+SYKSDVYS+GM++LEMV  R+N DP+
Sbjct: 503 PELYSRNFGEISYKSDVYSFGMLVLEMVSGRRNSDPS 539

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434180|ref|NP_001041848.1| Os01g0117100 [Oryza sativa Japonica Group] gi|53791461|dbj|BAD52513.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531379|dbj|BAF03762.1| Os01g0117100 [Oryza sativa Japonica Group] gi|125568799|gb|EAZ10314.1| hypothetical protein OsJ_00150 [Oryza sativa Japonica Group]

 Score =  391 bits (1004), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 187/304 (61%), Positives = 232/304 (76%), Gaps = 4/304 (1%)

Query: 41  HCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRES 100
           HCE+ G  C ++   + T C+    G G     + +T +    ++L  +V   +Y S  +
Sbjct: 276 HCEQQGRRCAFSSQRNQTFCM----GRGSHVKVIAATSSVAAFVILLLMVATALYLSLRT 331

Query: 101 EKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPV 160
              +E  LKVE FL+ Y T  PTRYT+ E+KKI S+FK ++GQGG+GSV+RG+L NG+PV
Sbjct: 332 RYNEEIHLKVEMFLKTYGTSKPTRYTFSEVKKIASRFKVKVGQGGFGSVYRGELPNGVPV 391

Query: 161 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
            VKMLE+ KG G EFINEVATIGRIHH +IVRLLGFC EGTRRAL+YE+MPN SLEK+IF
Sbjct: 392 VVKMLENSKGEGDEFINEVATIGRIHHANIVRLLGFCLEGTRRALIYEYMPNDSLEKYIF 451

Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           S  + +S   L   K+  IA G+ARG+EYLHQGCNQRILHFDIKPHNILLD+NF PKISD
Sbjct: 452 SHDSDTSQEVLVPNKMLDIALGIARGMEYLHQGCNQRILHFDIKPHNILLDYNFSPKISD 511

Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN 340
           FGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFGE+SYKSDVYS+GM++LEMV  R+N
Sbjct: 512 FGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGEISYKSDVYSFGMLVLEMVSGRRN 571

Query: 341 KDPA 344
            DP+
Sbjct: 572 SDPS 575

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434188|ref|NP_001041852.1| Os01g0117500 [Oryza sativa Japonica Group] gi|113531383|dbj|BAF03766.1| Os01g0117500 [Oryza sativa Japonica Group] gi|125568801|gb|EAZ10316.1| hypothetical protein OsJ_00152 [Oryza sativa Japonica Group]

 Score =  391 bits (1004), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 187/316 (59%), Positives = 239/316 (75%), Gaps = 6/316 (1%)

Query: 30  TLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGG-IVLFA 88
           T  W     C  CE+ G  C ++   + T C+++        + +I+  +S+   +VL  
Sbjct: 243 TTVWWYRYDCPQCEQLGGRCAFSSQRNQTFCMRRGS-----HVKVIAATSSVAAFVVLLL 297

Query: 89  LVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGS 148
           +V   +Y S ++   +E  LKVE FL+ Y T  PTRYT+ E+KKI  +FK ++GQGG+GS
Sbjct: 298 MVATALYLSLKTRYNEEIHLKVEMFLKTYGTSKPTRYTFSEVKKIARRFKVKVGQGGFGS 357

Query: 149 VFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE 208
           V+RG+L NG+PVAVKMLE+ +G G EFINEVATIGRIHH +IVRLLGFCSEGTRRAL+YE
Sbjct: 358 VYRGELPNGVPVAVKMLENSEGEGDEFINEVATIGRIHHANIVRLLGFCSEGTRRALIYE 417

Query: 209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 268
           +MPN SLEK++FS  + +S   L   K+  IA G+ARG+EYLHQGCNQRILHFDIKP+NI
Sbjct: 418 YMPNDSLEKYVFSHDSDTSQEVLVPSKMLDIAIGIARGMEYLHQGCNQRILHFDIKPNNI 477

Query: 269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYG 328
           LLD+NF PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFGE+SYKSDVYS+G
Sbjct: 478 LLDYNFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGEISYKSDVYSFG 537

Query: 329 MMLLEMVGCRKNKDPA 344
           M++LEMV  R+N DP+
Sbjct: 538 MLVLEMVSGRRNSDPS 553

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115434120|ref|NP_001041818.1| Os01g0113200 [Oryza sativa Japonica Group] gi|14587270|dbj|BAB61188.1| putative rust resistance kinase Lr10 [Oryza sativa Japonica Group] gi|113531349|dbj|BAF03732.1| Os01g0113200 [Oryza sativa Japonica Group]

 Score =  390 bits (1003), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 188/319 (58%), Positives = 242/319 (75%), Gaps = 7/319 (2%)

Query: 30  TLGWEA---LGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVL 86
           T  W A      C  CE+    CG++    +  C K +    P  + +++   S+  IV+
Sbjct: 218 TFTWSAPNITDVCIDCERQQRLCGFSSQRRTAFC-KPHGSKSPAKVIIVAV--SVPTIVV 274

Query: 87  FALVIF-LIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGG 145
             LV+   +Y S +++ + E QLKVE FL+ Y T  PTRYT+ E+K+IT +FKH+LG GG
Sbjct: 275 LTLVVASALYLSLKTKNDDEIQLKVEMFLKTYGTSKPTRYTFSEVKRITRRFKHKLGTGG 334

Query: 146 YGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL 205
           +GSV++G+L  G+PVAVKMLE+ KG G+EFINEVATIGRIHH ++VRLLGFCSEGTR AL
Sbjct: 335 FGSVYKGELSKGVPVAVKMLENSKGEGEEFINEVATIGRIHHVNVVRLLGFCSEGTRHAL 394

Query: 206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP 265
           +YEFMPN SLEK+IFS+   SS   L  +K+ KIA G+A+G+EYLHQGC+QRILHFDIKP
Sbjct: 395 IYEFMPNNSLEKYIFSRDYISSQEVLVPDKMLKIALGIAQGIEYLHQGCSQRILHFDIKP 454

Query: 266 HNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
           HNILLDH+F PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFG VSYKSDV+
Sbjct: 455 HNILLDHSFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAVSYKSDVF 514

Query: 326 SYGMMLLEMVGCRKNKDPA 344
           S+GM++LEM+  ++N DP+
Sbjct: 515 SFGMLVLEMLSGKRNSDPS 533

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|125568758|gb|EAZ10273.1| hypothetical protein OsJ_00108 [Oryza sativa Japonica Group]

 Score =  390 bits (1003), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 188/319 (58%), Positives = 242/319 (75%), Gaps = 7/319 (2%)

Query: 30  TLGWEA---LGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVL 86
           T  W A      C  CE+    CG++    +  C K +    P  + +++   S+  IV+
Sbjct: 199 TFTWSAPNITDVCIDCERQQRLCGFSSQRRTAFC-KPHGSKSPAKVIIVAV--SVPTIVV 255

Query: 87  FALVIF-LIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGG 145
             LV+   +Y S +++ + E QLKVE FL+ Y T  PTRYT+ E+K+IT +FKH+LG GG
Sbjct: 256 LTLVVASALYLSLKTKNDDEIQLKVEMFLKTYGTSKPTRYTFSEVKRITRRFKHKLGTGG 315

Query: 146 YGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL 205
           +GSV++G+L  G+PVAVKMLE+ KG G+EFINEVATIGRIHH ++VRLLGFCSEGTR AL
Sbjct: 316 FGSVYKGELSKGVPVAVKMLENSKGEGEEFINEVATIGRIHHVNVVRLLGFCSEGTRHAL 375

Query: 206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP 265
           +YEFMPN SLEK+IFS+   SS   L  +K+ KIA G+A+G+EYLHQGC+QRILHFDIKP
Sbjct: 376 IYEFMPNNSLEKYIFSRDYISSQEVLVPDKMLKIALGIAQGIEYLHQGCSQRILHFDIKP 435

Query: 266 HNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
           HNILLDH+F PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFG VSYKSDV+
Sbjct: 436 HNILLDHSFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAVSYKSDVF 495

Query: 326 SYGMMLLEMVGCRKNKDPA 344
           S+GM++LEM+  ++N DP+
Sbjct: 496 SFGMLVLEMLSGKRNSDPS 514

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218187382|gb|EEC69809.1| hypothetical protein OsI_00116 [Oryza sativa Indica Group]

 Score =  390 bits (1002), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 188/319 (58%), Positives = 242/319 (75%), Gaps = 7/319 (2%)

Query: 30  TLGWEA---LGGCHHCEKSGHYCGYNVTSSSTICVKQNRGLGPLSISLISTGTSIGGIVL 86
           T  W A      C  CE+    CG++    +  C K +    P  + +++   S+  IV+
Sbjct: 199 TFTWSAPNITDVCIDCERQQRLCGFSSQRRTAFC-KPHGSKSPAKVIIVAV--SVPTIVV 255

Query: 87  FALVIF-LIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGG 145
             LV+   +Y S +++ + E QLKVE FL+ Y T  PTRYT+ E+K+IT +FKH+LG GG
Sbjct: 256 LTLVVASALYLSLKTKNDDEIQLKVEMFLKTYGTSKPTRYTFSEVKRITRRFKHKLGTGG 315

Query: 146 YGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL 205
           +GSV++G+L  G+PVAVKMLE+ KG G+EFINEVATIGRIHH ++VRLLGFCSEGTR AL
Sbjct: 316 FGSVYKGELSKGVPVAVKMLENSKGEGEEFINEVATIGRIHHVNVVRLLGFCSEGTRHAL 375

Query: 206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP 265
           +YEFMPN SLEK+IFS+   SS   L  +K+ KIA G+A+G+EYLHQGC+QRILHFDIKP
Sbjct: 376 IYEFMPNNSLEKYIFSRDYISSQEVLVPDKMLKIALGIAQGIEYLHQGCSQRILHFDIKP 435

Query: 266 HNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
           HNILLDH+F PKISDFGLAKLC++D SIV+LTAARGT GYIAPEL+SRNFG VSYKSDV+
Sbjct: 436 HNILLDHSFSPKISDFGLAKLCARDQSIVTLTAARGTMGYIAPELYSRNFGAVSYKSDVF 495

Query: 326 SYGMMLLEMVGCRKNKDPA 344
           S+GM++LEM+  ++N DP+
Sbjct: 496 SFGMLVLEMLSGKRNSDPS 514

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.962	0.496	0.446	3.3e-70
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.723	0.291	0.509	1.9e-67
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.648	0.330	0.558	6.8e-67
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.953	0.514	0.436	3.6e-66
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.909	0.350	0.454	7.4e-66
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.889	0.460	0.436	7.4e-66
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.706	0.298	0.531	1.4e-64
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.709	0.302	0.521	3.7e-64
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.718	0.309	0.517	6e-64
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.555	0.324	0.584	2.6e-59

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 711 (255.3 bits), Expect = 3.3e-70, P = 3.3e-70
 Identities = 158/354 (44%), Positives = 217/354 (61%)

Query:     5 PSSCTISQTVEISAEMTPNDAI-LRATLGWEALGGCHHCEKSGHYCGYNVTSSSTICVKQ 63
             P+S T   T+E S   T N  I L      E    C  C  S   CG++ TSS  +C  +
Sbjct:   202 PASRTALNTLE-STPSTDNLKIALEDGFALEVNSDCRTCIDSKGACGFSQTSSRFVCYYR 260

Query:    64 NRGLGPXXXXXXXXXXXXXXXVL------FAL--VIF-------LIYKSRESEKEKETQL 108
                  P               VL      FA+  VI        LI + R++  +   + 
Sbjct:   261 QEPQNPTRNKVILKLFFIVIYVLGIGAASFAMMGVILVVTCLNCLIRRQRKTLNDPRMRT 320

Query:   109 KVEKFLEDYRTVNPTR-YTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEH 167
               +   ++ + + P + Y+Y ++  IT  F   +G+GG+G+V+RG L++G  VAVK+L+ 
Sbjct:   321 SDDSRQQNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKE 380

Query:   168 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSS 227
              +GNG++FINEVA++ +  H +IV LLGFCSEG +RA++YEFM NGSL+KFI SK +S+ 
Sbjct:   381 SQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSST- 439

Query:   228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
                + W +L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+SDFGLAKLC
Sbjct:   440 ---MDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLC 496

Query:   288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK 341
              +  SI+SL   RGT GYIAPE+FSR +G VS+KSDVYSYGM++L+++G R NK
Sbjct:   497 ERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGAR-NK 549

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 133/261 (50%), Positives = 194/261 (74%)

Query:    85 VLFALVIF-LIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQ 143
             VL ++V+  L+ ++R ++++ E     ++ +E    V   RY+++++KK+T+ F H +G+
Sbjct:   473 VLISIVVIALVVRARHAKRKSELN---DENIE--AVVMLKRYSFEKVKKMTNSFDHVIGK 527

Query:   144 GGYGSVFRGKL--FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT 201
             GG+G+V++GKL   +G  +A+K+L+  KGNG+EFINE+ ++ R  H +IV L GFC EG+
Sbjct:   528 GGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGS 587

Query:   202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHF 261
             +RA++YEFMPNGSL+KFI S+  S+    + W+ L  IA GVARG+EYLH  C  +I+HF
Sbjct:   588 QRAIIYEFMPNGSLDKFI-SENMSTK---IEWKTLYNIAVGVARGLEYLHNSCVSKIVHF 643

Query:   262 DIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYK 321
             DIKP NIL+D +  PKISDFGLAKLC K  SI+S+  ARGT GYIAPE+FS+N+G VS+K
Sbjct:   644 DIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHK 703

Query:   322 SDVYSYGMMLLEMVGCRKNKD 342
             SDVYSYGM++LEM+G  K ++
Sbjct:   704 SDVYSYGMVVLEMIGATKREE 724

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 650 (233.9 bits), Expect = 6.8e-67, Sum P(2) = 6.8e-67
 Identities = 128/229 (55%), Positives = 166/229 (72%)

Query:   115 EDYRTVNPTR-YTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ 173
             E  + + P + YTY ++K++T  F   +G+GG+G V+RG L +G  VAVK+L+  KGN  
Sbjct:   325 EKLKALIPLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNS 384

Query:   174 E-FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
             E FINEV+++ +  H +IV LLGFCSEG+RRA++YEF+ NGSL+KFI  KT+      L 
Sbjct:   385 EDFINEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVI----LD 440

Query:   233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
                L  IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+SDFGLAKLC K  S
Sbjct:   441 LTALYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKES 500

Query:   293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK 341
             ++SL   RGT GYIAPE+ SR +G VS+KSDVYSYGM++ EM+G RK +
Sbjct:   501 VMSLMDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKE 549

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 673 (242.0 bits), Expect = 3.6e-66, P = 3.6e-66
 Identities = 157/360 (43%), Positives = 217/360 (60%)

Query:     1 MEMLPSSCTISQTVEISA---EMTPNDAILRAT-----LGWEALG---GCHHCEKSGHYC 49
             ++ L +SC  +  + +S    E T  +  L A      +G+E LG    C  C  S   C
Sbjct:   178 LDGLSASCERNVDIPVSRSAMETTATNQSLEAIKKVLDVGFE-LGFNSDCSLCVASKGAC 236

Query:    50 GYNVTSSSTICVKQNRG----LGPXXXXXXXXXXXXXXXVL-FALVIFLIYKSRESE--K 102
             G+N +S + +C  ++       G                ++   L+ F   K R S   +
Sbjct:   237 GFNQSSKAFVCYCKDEPHEHTCGKMGIGIGLGCGFLGATLITVCLLCFFFQKRRTSHHLR 296

Query:   103 EKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAV 162
              ++  LK          V   +Y+Y E++KIT  F H LG+GG+G+V+ G L +G  VAV
Sbjct:   297 PRDNNLK--------GLVQLKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAV 348

Query:   163 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK 222
             K+L+  K NG++FINEVA++ +  H +IV LLGFC EG++RA+VYEF+ NGSL++F+  K
Sbjct:   349 KILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEK 408

Query:   223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
              + +    L    L +IA GVARG++YLH GC  RI+HFDIKP NILLD  F PK+SDFG
Sbjct:   409 KSLN----LDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFG 464

Query:   283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
             LAKLC K  SI+SL  ARGT GYIAPE+FS  +G VS+KSDVYSYGM++LEM+G  KNK+
Sbjct:   465 LAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGA-KNKE 523

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
 Identities = 156/343 (45%), Positives = 207/343 (60%)

Query:    22 PNDAILRATL--GWEAL--GGCHHCEKSGHYCGYNVTSSSTICV-KQNR-------GLGP 69
             PN   L+  L  G+  L    C  C  SG  CGYN TSS   C  K  +       G   
Sbjct:   424 PNQDNLKMALDQGFRMLITSDCERCRGSGGACGYNQTSSGFGCYCKDGKCGYEYDDGFFR 483

Query:    70 XXXXXXXXXXXXXXXVLFAL----VIFLI-----YKSRESEKEKETQLKVEKFLEDYRTV 120
                             L AL    ++FL+     ++ +   K K +    E  L+  + +
Sbjct:   484 RHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSD---EVRLQKLKAL 540

Query:   121 NPTR-YTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-NGQEFINE 178
              P + YTY E+KK+T  F   +G+GG+G V+ G L +   VAVK+L+  KG +G++FINE
Sbjct:   541 IPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINE 600

Query:   179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
             VA++ +  H +IV LLGFC EG+RRA++YEF+ NGSL+KFI  K++ +    L  + L  
Sbjct:   601 VASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVN----LDLKTLYG 656

Query:   239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
             IA GVARG+EYLH GC  RI+HFDIKP N+LLD N  PK+SDFGLAKLC K  SI+SL  
Sbjct:   657 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLD 716

Query:   299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK 341
              RGT GYIAPE+ SR +G VS+KSDVYSYGM++LEM+G RK +
Sbjct:   717 TRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKE 759

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 670 (240.9 bits), Expect = 7.4e-66, P = 7.4e-66
 Identities = 141/323 (43%), Positives = 199/323 (61%)

Query:    23 NDAILRATLGWEALGGCHHCEKSGHY----CGYNVTSSSTICVKQNRGLGPXXX--XXXX 76
             N+  L  +  ++       C  S +Y    C  +++S S    + N G            
Sbjct:   219 NECPLAYSYAYDNENNTFRCSNSPNYVITFCPNDISSMSQPSKETNGGTKQKSSWKLKLI 278

Query:    77 XXXXXXXXVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSK 136
                     ++  +V+ +I +++     +     VE            RY+Y  +KK+T+ 
Sbjct:   279 VGVSAALTLMILIVVVIIVRTKNMRNSEWNDQNVEA------VAMLKRYSYTRVKKMTNS 332

Query:   137 FKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
             F H LG+GG+G+V++GKL + G  VAVK+L+  +GNG+EFINEVA++ R  H +IV LLG
Sbjct:   333 FAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEVASMSRTSHVNIVSLLG 392

Query:   196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             FC E  +RA++YEFMPNGSL+K+I    N S+   + WE+L  +A G++RG+EYLH  C 
Sbjct:   393 FCYEKNKRAIIYEFMPNGSLDKYI--SANMSTK--MEWERLYDVAVGISRGLEYLHNRCV 448

Query:   256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
              RI+HFDIKP NIL+D N  PKISDFGLAKLC    SI+S+   RGT GYIAPE+FS+NF
Sbjct:   449 TRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNF 508

Query:   316 GEVSYKSDVYSYGMMLLEMVGCR 338
             G VS+KSDVYSYGM++LEM+G +
Sbjct:   509 GAVSHKSDVYSYGMVVLEMIGAK 531

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 136/256 (53%), Positives = 183/256 (71%)

Query:    87 FALVIFLIYKSRESEK-EKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGG 145
             F ++I L+ +  + +K +KE  + + K L         +Y Y ELKKIT  F H +G+GG
Sbjct:   454 FIVIIMLLIRQMKRKKNKKENSVIMFKLLLK-------QYIYAELKKITKSFSHTVGKGG 506

Query:   146 YGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL 205
             +G+V+RG L NG  VAVK+L+ LKGNG +FINEV ++ +  H +IV LLGFC EG++RA+
Sbjct:   507 FGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSMSQTSHVNIVSLLGFCYEGSKRAI 566

Query:   206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP 265
             + EF+ +GSL++FI S+  S +  P +   L  IA G+ARG+EYLH GC  RI+HFDIKP
Sbjct:   567 ISEFLEHGSLDQFI-SRNKSLT--P-NVTTLYGIALGIARGLEYLHYGCKTRIVHFDIKP 622

Query:   266 HNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
              NILLD NF PK++DFGLAKLC K  SI+SL   RGT GYIAPE+ SR +G +S+KSDVY
Sbjct:   623 QNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTIGYIAPEVVSRMYGGISHKSDVY 682

Query:   326 SYGMMLLEMVGCRKNK 341
             SYGM++L+M+G R NK
Sbjct:   683 SYGMLVLDMIGAR-NK 697

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 654 (235.3 bits), Expect = 3.7e-64, P = 3.7e-64
 Identities = 133/255 (52%), Positives = 184/255 (72%)

Query:    87 FALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGY 146
             F +V+ L  +  + +  KE ++ + K L     +N   YTY ELKKIT  F + +G+GG+
Sbjct:   457 FVVVLMLWMRQMKRKNRKEERVVMFKKL-----LN--MYTYAELKKITKSFSYIIGKGGF 509

Query:   147 GSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV 206
             G+V+ G L NG  VAVK+L+ LKG+ ++FINEVA++ +  H +IV LLGFC EG++RA+V
Sbjct:   510 GTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQTSHVNIVSLLGFCFEGSKRAIV 569

Query:   207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH 266
             YEF+ NGSL++F+ S+ N S  + ++   L  IA G+ARG+EYLH GC  RI+HFDIKP 
Sbjct:   570 YEFLENGSLDQFM-SR-NKSLTQDVT--TLYGIALGIARGLEYLHYGCKTRIVHFDIKPQ 625

Query:   267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS 326
             NILLD N  PK+SDFGLAKLC K  S++SL   RGT GYIAPE+FSR +G VS+KSDVYS
Sbjct:   626 NILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYIAPEVFSRMYGRVSHKSDVYS 685

Query:   327 YGMMLLEMVGCRKNK 341
             +GM++++M+G R  +
Sbjct:   686 FGMLVIDMIGARSKE 700

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
 Identities = 132/255 (51%), Positives = 184/255 (72%)

Query:    85 VLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQG 144
             VL  ++I +I     +   +++ L  EK +E    V   R++Y ++KK+T  F++ LG+G
Sbjct:   412 VLATMIIIVIVGKVRANNMRKSDLN-EKNME--AVVMLKRFSYVQVKKMTKSFENVLGKG 468

Query:   145 GYGSVFRGKLFNGI-PVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR 203
             G+G+V++GKL +G   VAVK+L+    +G++FINE+A++ R  H +IV LLGFC EG ++
Sbjct:   469 GFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIASMSRTSHANIVSLLGFCYEGRKK 528

Query:   204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI 263
             A++YE MPNGSL+KFI SK  S+    + W+ L  IA GV+ G+EYLH  C  RI+HFDI
Sbjct:   529 AIIYELMPNGSLDKFI-SKNMSAK---MEWKTLYNIAVGVSHGLEYLHSHCVSRIVHFDI 584

Query:   264 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSD 323
             KP NIL+D +  PKISDFGLAKLC  + SI+S+  ARGT GYIAPE+FS+NFG VS+KSD
Sbjct:   585 KPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSD 644

Query:   324 VYSYGMMLLEMVGCR 338
             VYSYGM++LEM+G R
Sbjct:   645 VYSYGMVVLEMIGAR 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 584 (210.6 bits), Expect = 2.6e-59, Sum P(2) = 2.6e-59
 Identities = 118/202 (58%), Positives = 153/202 (75%)

Query:   141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG 200
             +G+GG+G+V++G L +G  VAVK+L+   GN ++FINEVA+I +  H +IV LLGFC E 
Sbjct:   287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346

Query:   201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILH 260
             ++RA+VYEF+ NGSL++        SS+  +S   L  IA GVARG+EYLH GC +RI+H
Sbjct:   347 SKRAIVYEFLENGSLDQ--------SSNLDVS--TLYGIALGVARGIEYLHFGCKKRIVH 396

Query:   261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY 320
             FDIKP N+LLD N +PK++DFGLAKLC K  SI+SL   RGT GYIAPELFSR +G VS+
Sbjct:   397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456

Query:   321 KSDVYSYGMMLLEMVGCRKNKD 342
             KSDVYSYGM++LEM G R NK+
Sbjct:   457 KSDVYSYGMLVLEMTGAR-NKE 477

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00030420001 SubName- Full=Chromosome chr1 scaffold_5, whole genome shotgun sequence; (474 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	344
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-54
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-31
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-30
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-25
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-24
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-19
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-16
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-15
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-13
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  176 bits (449), Expect = 4e-54
 Identities = 71/214 (33%), Positives = 114/214 (53%), Gaps = 21/214 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
           LG+GG+G+V+  +    G  VA+K++  E      +E + E+  + +++H +IV+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            +     LV E+   GSL+  +           LS +++ +I   +  G+EYLH      
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN-----EGKLSEDEILRILLQILEGLEYLHS---NG 112

Query: 258 ILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           I+H D+KP NILLD  N + K++DFGL+KL + D S+  L    GT  Y+APE+     G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGK-G 169

Query: 317 EVSYKSDVYSYGMMLLEMVGCRK------NKDPA 344
             S KSD++S G++L E+   +        KDP 
Sbjct: 170 YYSEKSDIWSLGVILYELPELKDLIRKMLQKDPE 203

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (430), Expect = 9e-51
 Identities = 77/204 (37%), Positives = 109/204 (53%), Gaps = 16/204 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIV 191
           +   +LG G +G+V++ K    G  VAVK+L+         Q    E+  + R+ H +IV
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           RL+    +     LV E+   G L  ++      S   PLS ++ KKIA  + RG+EYLH
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
              +  I+H D+KP NILLD N   KI+DFGLAK   K  S  SLT   GT  Y+APE+ 
Sbjct: 116 ---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVL 170

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
               G    K DV+S G++L E++
Sbjct: 171 LGGNG-YGPKVDVWSLGVILYELL 193

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  161 bits (410), Expect = 7e-48
 Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHF 188
               +LG+G +G V++GKL        + VAVK L  +  +   +EF+ E   + ++ H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           ++V+LLG C+E     +V E+M  G L  ++       +   LS   L   A  +ARG+E
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-----RKNRPKLSLSDLLSFALQIARGME 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL     +  +H D+   N L+  N   KISDFGL++    D         +    ++AP
Sbjct: 117 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAP 172

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E  S   G+ + KSDV+S+G++L E+
Sbjct: 173 E--SLKEGKFTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  158 bits (403), Expect = 9e-47
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 17/206 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG-----IPVAVKML--EHLKGNGQEFINEVATIGRIHHF 188
               +LG+G +G V++G L        + VAVK L  +  +   +EF+ E   + ++ H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +IV+LLG C+E     +V E+MP G L  ++      +  + LS   L   A  +ARG+E
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGME 117

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL     +  +H D+   N L+  N   KISDFGL++    D     +   +    ++AP
Sbjct: 118 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYKVKGGKLPIRWMAP 173

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E  S   G+ + KSDV+S+G++L E+
Sbjct: 174 E--SLKEGKFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  153 bits (390), Expect = 8e-45
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 17/206 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHF 188
           +   +LG+G +G V++G L          VAVK L+      +  EF+ E + + ++ H 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +IVRLLG C++G    +V E+MP G L  F+           L+ + L ++A  +A+G+E
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-----EKLTLKDLLQMALQIAKGME 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL    ++  +H D+   N L+  N   KISDFGL++   +D         +    ++AP
Sbjct: 117 YLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E      G+ + KSDV+S+G++L E+
Sbjct: 174 ESL--KDGKFTSKSDVWSFGVLLWEI 197

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  152 bits (387), Expect = 2e-44
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)

Query: 141 LGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+G +G V++GKL         VAVK L  +  +   ++F+ E   + ++ H ++VRLL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFI---FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           G C+E     LV E+M  G L  ++        S     LS + L   A  +A+G+EYL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-L 310
               ++ +H D+   N L+  +   KISDFGL++    D      T  +    ++APE L
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
               F   + KSDV+S+G++L E+ 
Sbjct: 180 KDGIF---TSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (383), Expect = 7e-44
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
           +   +LG+G +G V+  +    G  VA+K++  + +K + +  + E+  + ++ H +IVR
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L     +  +  LV E+   G L   +           LS ++ +     +   +EYLH 
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLL------KKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
              + I+H D+KP NILLD +   K++DFGLA+          LT   GT  Y+APE+  
Sbjct: 116 ---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFVGTPEYMAPEVLL 169

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
                     D++S G++L E++
Sbjct: 170 GK--GYGKAVDIWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (312), Expect = 2e-33
 Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 15/202 (7%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRL 193
           +   ++G+GG+G V++ +    G  VA+K+++      +E I NE+  + +  H +IV+ 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G   +     +V EF   GSL+  +      S+++ L+  ++  +   + +G+EYLH  
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLL-----KSTNQTLTESQIAYVCKELLKGLEYLH-- 115

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            +  I+H DIK  NILL  + + K+ DFGL+   S   +  ++    GT  ++APE+ + 
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171

Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                 YK+D++S G+  +E+ 
Sbjct: 172 --KPYDYKADIWSLGITAIELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  123 bits (310), Expect = 4e-33
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRL 193
             LG+G +GSV+       G  +AVK +E L G+ +E +     E+  +  + H +IVR 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 194 LGFC-SEGTRRALVY-EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
            G    E      ++ E++  GSL   +           L    ++K    +  G+ YLH
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLL------KKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
              +  I+H DIK  NIL+D +   K++DFG AK      +     + RGT  ++APE+ 
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 312 SRNFGEVSYKSDVYSYGMMLLEM 334
                E    +D++S G  ++EM
Sbjct: 176 RG--EEYGRAADIWSLGCTVIEM 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (305), Expect = 2e-32
 Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 12/197 (6%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEH-LKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +LG G +G V+ G   N + VA+K+L+       Q+F  EV  + R+ H H++ L   CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
            G    ++ E M  GSL  F+     S   + L    L  +A  VA G+ YL +   Q  
Sbjct: 73  VGEPVYIITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMAYLEE---QNS 125

Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEV 318
           +H D+   NIL+  +   K++DFGLA+L  +D+ + S    +    + APE  + + G  
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK--KIPYKWTAPE--AASHGTF 181

Query: 319 SYKSDVYSYGMMLLEMV 335
           S KSDV+S+G++L EM 
Sbjct: 182 STKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 25/221 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHF 188
           KF  +LG+G +G V   +        G  VAVK L H        +F  E+  +  + H 
Sbjct: 7   KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 189 HIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVAR 245
           +IV+  G C +   R+  L+ E++P+GSL  ++        HR  ++ ++L   +  + +
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL------QRHRDQINLKRLLLFSSQICK 120

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT-AG 304
           G++YL    +QR +H D+   NIL++     KISDFGLAK+  +D     +     +   
Sbjct: 121 GMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 305 YIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
           + APE L +  F   S  SDV+S+G+ L E+      ++ P
Sbjct: 178 WYAPECLRTSKF---SSASDVWSFGVTLYELFTYGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 1e-31
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 139 HRLGQGGYGSVFRGKLF--NG--IPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
             LG G +GSV +G     +G  + VAVK L  EH+    +EF+ E + + ++ H  IVR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L+G C +G    LV E  P G L K++  +             LK++A  VA G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVS------DLKELAHQVAMGMAYLES 113

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELF 311
              +  +H D+   N+LL +  Q KISDFG+++ L +      + TA R    + APE  
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
             N+G+ S KSDV+SYG+ L E  
Sbjct: 171 --NYGKFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKML----EHLKGNGQEFINEVATIGRI-HHFHIVRLLG 195
           LG+G +G V+  +  +   VA+K+L    E      + F+ E+  +  + H  +IV+L  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E++  GSLE  +          PLS  +   I   +   +EYLH    
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLL---KKIGRKGPLSESEALFILAQILSALEYLHS--- 119

Query: 256 QRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVS----LTAARGTAGYIAPEL 310
           + I+H DIKP NILLD +    K+ DFGLAKL     S  S     + + GT GY+APE+
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 311 FSR-NFGEVSYKSDVYSYGMMLLEM 334
               +    S  SD++S G+ L E+
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYEL 204

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 9e-30
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 10/207 (4%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K + +LG G +G V+ G       VAVK L+    + + F+ E   + ++ H 
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHD 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L   CSE     +V E+M  GSL  F+  K+       L   +L  +A  +A G+ 
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL--KSGEGKKLRL--PQLVDMAAQIAEGMA 117

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL     +  +H D+   NIL+  N   KI+DFGLA+L   D        A+    + AP
Sbjct: 118 YLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAP 173

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  + N+G  + KSDV+S+G++L E+V
Sbjct: 174 E--AANYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (288), Expect = 9e-30
 Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 29/226 (12%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG--QEFINEVA 180
            +++ T   K  LG+G +G VF G+ ++  P      VAVK L+    N   ++F  E  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI--------FSKTNSSSHRPLS 232
            +    H +IV+  G C+EG    +V+E+M +G L KF+        F K+  S    L+
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             +L +IA  +A G+ YL    +Q  +H D+   N L+ ++   KI DFG+    S+D+ 
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM----SRDVY 173

Query: 293 IVSLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                   G       ++ PE  S  + + + +SDV+S+G++L E+
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (270), Expect = 3e-27
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 33/208 (15%)

Query: 139 HRLGQGGYGSVFRG--KLFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRL 193
             LGQG  G V++   K   G   A+K + H+ G+    ++ + E+ T+      ++V+ 
Sbjct: 7   KVLGQGSSGVVYKVRHKP-TGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 194 LG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            G F  EG    +V E+M  GSL   +           +    L  IA  + +G++YLH 
Sbjct: 65  YGAFYKEGEIS-IVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGYIA 307
              + I+H DIKP N+L++   + KI+DFG++K       ++  T  +     GT  Y++
Sbjct: 118 --KRHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTFVGTVTYMS 168

Query: 308 PELFSRNFGEV-SYKSDVYSYGMMLLEM 334
           PE      GE  SY +D++S G+ LLE 
Sbjct: 169 PERIQ---GESYSYAADIWSLGLTLLEC 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 20/204 (9%)

Query: 138 KHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLK-GNGQEFINEVATIGRIHHFHIVRL 193
             +LG+G YG V++ +    G  VA+K   L++ + G     + E++ +  + H +IV+L
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           L       +  LV+E+     L+K++          PLS   +K I + + RG+ Y H  
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHS- 116

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              RILH D+KP NIL++ +   K++DFGLA+     I + + T    T  Y APE+   
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFG--IPLRTYTHEVVTLWYRAPEIL-- 170

Query: 314 NFGEVSYKS--DVYSYGMMLLEMV 335
             G   Y +  D++S G +  EM+
Sbjct: 171 -LGSKHYSTAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 9e-27
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 10/207 (4%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + +   +LG G +G V+ G   N  PVAVK L+    + ++F+ E   + ++ H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +++L   C+      +V E M  GSL +++       + R L   +L  +A  VA G+ 
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYL----QGGAGRALKLPQLIDMAAQVASGMA 117

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL     Q  +H D+   N+L+  N   K++DFGLA++  +DI   +   A+    + AP
Sbjct: 118 YLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAP 173

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +   S KSDV+S+G++L E+V
Sbjct: 174 E--AALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 1e-26
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRG-----KLFNGIPVAVKMLEHLKG--NGQEFINEVAT 181
           EL+KI       LG G +G+V++G          IPVA+K+L         +E ++E   
Sbjct: 8   ELEKIKV-----LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSWEKLKKIA 240
           +  + H H+VRLLG C   ++  L+ + MP G L  ++ + K N  S   L+W       
Sbjct: 63  MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------C 115

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A+G+ YL +   +R++H D+   N+L+      KI+DFGLAKL   D         +
Sbjct: 116 VQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               ++A E  S      ++KSDV+SYG+ + E+
Sbjct: 173 VPIKWMALE--SILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (256), Expect = 2e-25
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEF-INEVATI 182
           Y+ +K+I        G+G +G V+  +   +G    +K   L ++    +E  +NEV  +
Sbjct: 2   YEIIKQI--------GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKIL 53

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
            +++H +I++      E  +  +V E+   G L + I  K      +P   E++      
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQ 111

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +   ++YLH    ++ILH DIKP NI L  N   K+ DFG++K+ S     ++ T   GT
Sbjct: 112 LCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKTVV-GT 166

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             Y++PEL        +YKSD++S G +L E+
Sbjct: 167 PYYLSPELCQNK--PYNYKSDIWSLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (255), Expect = 2e-25
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
                +G G +G V+ G       VA+K +     + ++FI E   + ++ H  +V+L G
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C+E +   LV+EFM +G L  ++ ++         S E L  +   V  G+ YL     
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDVCEGMAYLESSN- 120

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD-QYTSSTGTKFPVKWSSPEVFS--F 175

Query: 316 GEVSYKSDVYSYGMMLLEM 334
            + S KSDV+S+G+++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 3e-25
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK L+      Q F+ E + +  + H ++V+LLG
Sbjct: 9   KLGATIGKGEFGDVMLG-DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              +G    +V E+M  GSL  ++ S+  +     ++  +    A  V  G+EYL +   
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLEE--- 120

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +  +H D+   N+L+  +   K+SDFGLAK  S+        + +    + APE      
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-----GQDSGKLPVKWTAPEALRE-- 173

Query: 316 GEVSYKSDVYSYGMMLLEM 334
            + S KSDV+S+G++L E+
Sbjct: 174 KKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (252), Expect = 1e-24
 Identities = 65/225 (28%), Positives = 111/225 (49%), Gaps = 42/225 (18%)

Query: 139 HRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE-----FINEVATIGRI- 185
             LG+G +G V + +   G+        VAVKML   K +  E      ++E+  +  I 
Sbjct: 18  KPLGEGAFGQVVKAEAV-GLDNPNETSTVAVKML---KDDATEKDLSDLVSEMEMMKMIG 73

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI---------FSKTNSSSHRP-LSWEK 235
            H +I+ LLG C++     +V E+  +G+L  F+          S  +       L+ + 
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L   A+ VARG+E+L     ++ +H D+   N+L+  +   KI+DFGLA    +DI  + 
Sbjct: 134 LVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHHID 186

Query: 296 L----TAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                T  R    ++APE LF R +   +++SDV+S+G++L E+ 
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  100 bits (252), Expect = 1e-24
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLL 194
           R+G+G +G VF+ K    G  VA+K +  L+    G   + + E+  +    H ++V+LL
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                G+   LV E+MP   L + +         RPL   ++K     + +GV Y+H   
Sbjct: 66  DVFPHGSGFVLVMEYMP-SDLSEVL-----RDEERPLPEAQVKSYMRMLLKGVAYMHA-- 117

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
              I+H D+KP N+L+  +   KI+DFGLA+L S++      +    T  Y APEL    
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELL--- 172

Query: 315 FGEVSYKS--DVYSYGMMLLEMVGCR 338
           +G   Y    D+++ G +  E++   
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.2 bits (247), Expect = 3e-24
 Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 13/208 (6%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRG--KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH 186
           E+++     KH+LG G YG V+ G  K ++   VAVK L+      +EF+ E A +  I 
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEEFLKEAAVMKEIK 60

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H ++V+LLG C+      ++ EFM  G+L  ++  + N      +    L  +A  ++  
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVV---LLYMATQISSA 116

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +EYL +   +  +H D+   N L+  N   K++DFGL++L + D    +   A+    + 
Sbjct: 117 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWT 172

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE  S  + + S KSDV+++G++L E+
Sbjct: 173 APE--SLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 5e-24
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVK-----MLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           ++G+G +G V++G L     VAVK     +   LK   ++F+ E   + +  H +IV+L+
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK---RKFLQEAEILKQYDHPNIVKLI 58

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G C +     +V E +P GSL  F+  K N      L+ +KL +++   A G+EYL    
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLESKN 113

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
               +H D+   N L+  N   KISDFG+++     I  VS    +    + APE  + N
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE--ALN 168

Query: 315 FGEVSYKSDVYSYGMMLLE 333
           +G  + +SDV+SYG++L E
Sbjct: 169 YGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 9e-24
 Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 28/205 (13%)

Query: 141 LGQGGYGSVFRGKL-FNG---IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLL 194
           +G G +G V RG+L   G   I VA+K L+    + Q  +F+ E + +G+  H +I+RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  ++     ++ E+M NGSL+KF+            +  +L  +  G+A G++YL +  
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIASGMKYLSEMN 126

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG------YIAP 308
               +H D+   NIL++ N   K+SDFGL++       +    A   T G      + AP
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRR------LEDSEATYTTKGGKIPIRWTAP 177

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLE 333
           E  +  + + +  SDV+S+G+++ E
Sbjct: 178 EAIA--YRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.6 bits (244), Expect = 2e-23
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 37/228 (16%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLE--HL-KGNGQEFIN-EVATIGRIHHF-H 189
           KF   +G+G + +V   K        A+K+L+   L K    +++  E   + R++    
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 190 IVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           I++L   F  E      V E+ PNG L ++I  +   S    L  +  +  A  +   +E
Sbjct: 64  IIKLYYTFQDE-ENLYFVLEYAPNGELLQYI--RKYGS----LDEKCTRFYAAEILLALE 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAAR------- 300
           YLH   ++ I+H D+KP NILLD +   KI+DFG AK L        +   A        
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 301 ----------GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
                     GTA Y++PEL +         SD+++ G ++ +M+  +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           K   ++G+G  G V++      G  VA+K +   K N +  INE+  +    H +IV   
Sbjct: 22  KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAF---GVARGVEY 249
                G    +V E+M  GSL   I       +             IA+    V +G+EY
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ----------IAYVCREVLQGLEY 131

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA----KLCSKDISIVSLTAARGTAGY 305
           LH    Q ++H DIK  NILL  +   K++DFG A    K  SK  S+V      GT  +
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYW 182

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +APE+  R   +   K D++S G+M +EM 
Sbjct: 183 MAPEVIKRK--DYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 3e-23
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 140 RLGQGGYGSVFRGK----LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRL 193
           +LG G +G V RG+        IPVAVK L  + L     +F+ E A +  + H +++RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G         +V E  P GSL   +  + ++  H  +S   L   A  +A G+ YL   
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRL--RKDALGHFLIS--TLCDYAVQIANGMRYLES- 115

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFS 312
             +R +H D+   NILL  + + KI DFGL + L   +   V     +    + APE  S
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--S 171

Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
                 S+ SDV+ +G+ L EM
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 5e-23
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 11/203 (5%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK    I VA+KM+     +  +FI E   + ++ H ++V+L G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     +V E+M NG L  ++         + L  E L  +   V   +EYL      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYL----RERKGK-LGTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
             +H D+   N L+  +   K+SDFGLA+    D    S    +    +  PE+F  ++ 
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQGTKFPVKWAPPEVF--DYS 176

Query: 317 EVSYKSDVYSYGMMLLEMVGCRK 339
             S KSDV+S+G+++ E+    K
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 96.2 bits (239), Expect = 6e-23
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 25/215 (11%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNG--QEFINEVAT 181
           EL+K+       LG G +G+V +G          IPVA+K ++   G    QE  + +  
Sbjct: 8   ELRKLKL-----LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNS-SSHRPLSWEKLKKIA 240
           +G + H +IVRLLG C  G    LV +  P GSL   +    +S    R L+W       
Sbjct: 63  MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------C 115

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A+G+ YL +    R++H ++   NILL  +   +I+DFG+A L   D      +  +
Sbjct: 116 VQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               ++A E  S  FG  +++SDV+SYG+ + EM+
Sbjct: 173 TPIKWMALE--SILFGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.7 bits (238), Expect = 6e-23
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 15/209 (7%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   +LG G +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61

Query: 189 HIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            +VRL       T+    ++ E+M NGSL  F+  KT       ++  KL  +A  +A G
Sbjct: 62  RLVRLYAVV---TQEPIYIITEYMENGSLVDFL--KTPEGIKLTIN--KLIDMAAQIAEG 114

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           + ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + 
Sbjct: 115 MAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWT 170

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE    N+G  + KSDV+S+G++L E+V
Sbjct: 171 APEAI--NYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.0 bits (236), Expect = 1e-22
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 19/196 (9%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCS 198
            +G+G +G+V +G+ + G  VAVK ++      Q F+ E A + ++HH ++VRLLG    
Sbjct: 13  IIGEGEFGAVLQGE-YTGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
            G    +V E M  G+L  F+ ++  +         +L + +  VA G+EYL    ++++
Sbjct: 71  NGLY--IVMELMSKGNLVNFLRTRGRALVSVI----QLLQFSLDVAEGMEYLE---SKKL 121

Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEV 318
           +H D+   NIL+  +   K+SDFGLA++ S       +  ++    + APE       + 
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEALKHK--KF 174

Query: 319 SYKSDVYSYGMMLLEM 334
           S KSDV+SYG++L E+
Sbjct: 175 SSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 31/228 (13%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKML--EHLKGNGQEFINEVA 180
           E+     +F   LG+G +G V++G+L       +   VA+K L         QEF  E  
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI----------FSKTNSSSHRP 230
            +  + H +IV LLG C++     +++E++ +G L +F+              + +    
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC-SK 289
           L       IA  +A G+EYL    +   +H D+   N L+      KISDFGL++   S 
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 290 DISIV---SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           D   V   SL   R    ++ PE  +  +G+ + +SD++S+G++L E+
Sbjct: 178 DYYRVQSKSLLPVR----WMPPE--AILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 3e-22
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 15/198 (7%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGF 196
           LG+G YGSV++ K L +    A+K ++    + +E    +NE+  +  ++H +I+     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             +G +  +V E+ P G L K I         + +  +++ +I   + RG++ LH+   Q
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---Q 122

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +ILH D+K  NILL  N   KI D G++K+  K+++   +    GT  Y+APE++     
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR-- 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
             SYKSD++S G +L EM
Sbjct: 177 PYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 93.6 bits (232), Expect = 3e-22
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 10/207 (4%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K   +LG G +G V+ G   N   VAVK L+    + Q F+ E   +  + H 
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M  GSL  F+ S        P    KL   +  +A G+ 
Sbjct: 62  KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMA 117

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +   +  +H D++  N+L+  +   KI+DFGLA++  +D    +   A+    + AP
Sbjct: 118 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAP 173

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KSDV+S+G++L E+V
Sbjct: 174 EAI--NFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 20/200 (10%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF---INEVATIGRIHHFHIVRLLGF 196
           LG G  G V +      G  +AVK +  L+ N       + E+  + + +  +IV   G 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                  ++  E+M  GSL+K +           +    L KIA  V +G+ YLH+    
Sbjct: 68  FYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTYLHE--KH 120

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +I+H D+KP NIL++   Q K+ DFG++    + ++ ++ T   GT+ Y+APE   R  G
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-GTSSYMAPE---RIQG 173

Query: 317 EV-SYKSDVYSYGMMLLEMV 335
              S KSD++S G+ L+E+ 
Sbjct: 174 NDYSVKSDIWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 94.4 bits (234), Expect = 4e-22
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 20/214 (9%)

Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKG--NGQEFINEVATI 182
           LK+   K    LG G +G+V++G          IPVA+K+L    G     EF++E   +
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSWEKLKKIAF 241
             + H H+VRLLG C   T + LV + MP+G L  ++   K N  S   L+W        
Sbjct: 64  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CV 116

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
            +A+G+ YL +   +R++H D+   N+L+      KI+DFGLA+L   D    +    + 
Sbjct: 117 QIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              ++A E    ++ + +++SDV+SYG+ + E++
Sbjct: 174 PIKWMALECI--HYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 58/183 (31%), Positives = 96/183 (52%), Gaps = 27/183 (14%)

Query: 160 VAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF 218
           VAVK ++  K   +E + NEV  +    H +IV +      G    +V EF+  G+L   
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL--- 103

Query: 219 IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 278
               T+  +H  ++ E++  +   V + + +LH    Q ++H DIK  +ILL  + + K+
Sbjct: 104 ----TDIVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKL 156

Query: 279 SDFGLAKLCSKDI----SIVSLTAARGTAGYIAPELFSRN-FG-EVSYKSDVYSYGMMLL 332
           SDFG     SK++    S+V      GT  ++APE+ SR  +G EV    D++S G+M++
Sbjct: 157 SDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLPYGTEV----DIWSLGIMVI 206

Query: 333 EMV 335
           EMV
Sbjct: 207 EMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 22/219 (10%)

Query: 136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLKGNGQE-FINEVATIGRIHHFH 189
           KF  +LG+G +GSV   +        G  VAVK L+H        F  E+  +  + H +
Sbjct: 7   KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66

Query: 190 IVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           IV+  G C    RR   LV E++P GSL  ++        HR     KL   A  + +G+
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-----KLLLYASQICKGM 121

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSKDISIVSLTAARGTAGY 305
           EYL     +R +H D+   NIL++   + KI DFGL K+    K+   V          Y
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
            APE  + +  + S  SDV+S+G++L E+     K+  P
Sbjct: 179 -APESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSP 214

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 6e-21
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLE--HLKGNGQE--FINEVATIGRIHHFHI 190
           LG+G +G V        GKL+     A+K+L+   +    +    + E   + RI+H  I
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 191 VRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L    +  T   L  V E+ P G L   +      S     S E+ +  A  +   +E
Sbjct: 56  VKL--HYAFQTEEKLYLVLEYAPGGELFSHL------SKEGRFSEERARFYAAEIVLALE 107

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIA 307
           YLH   +  I++ D+KP NILLD +   K++DFGLAK L S+     +     GT  Y+A
Sbjct: 108 YLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---GTPEYLA 161

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
           PE+            D +S G++L EM
Sbjct: 162 PEVLLG--KGYGKAVDWWSLGVLLYEM 186

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 8e-21
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATI 182
           Y++L KI        G+G YG V++ +    G  VA+K +      +G  +  + E+  +
Sbjct: 1   YQKLGKI--------GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLL 52

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             ++H +I++LL          LV+EFM +  L K I  K      R L    +K   + 
Sbjct: 53  KELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQ---RGLPESLIKSYLYQ 106

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           + +G+ + H      ILH D+KP N+L++     K++DFGLA+     +     T    T
Sbjct: 107 LLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP--YTHYVVT 161

Query: 303 AGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             Y APEL     G+  Y +  D++S G +  E++
Sbjct: 162 RWYRAPELL---LGDKGYSTPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.2 bits (224), Expect = 9e-21
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 26/209 (12%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLG- 195
           RLG+G  GSV + +L N   +          N    ++ + E+         +IV+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 196 FCSEGTRR-ALVYEFMPNGSLE---KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           F  E +    +  E+   GSL+   K +  +      + L      KIA  V +G+ YLH
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH 122

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR--GTAGYIAPE 309
               ++I+H DIKP NILL    Q K+ DFG++        +V+  A    GT+ Y+APE
Sbjct: 123 S---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG------ELVNSLAGTFTGTSFYMAPE 173

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
                    S  SDV+S G+ LLE+   R
Sbjct: 174 RIQG--KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 9e-21
 Identities = 60/209 (28%), Positives = 113/209 (54%), Gaps = 19/209 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFH 189
           K +  +G G +G V RG+L       I VA+K L+  + +   ++F++E + +G+  H +
Sbjct: 7   KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           I+ L G  ++     ++ EFM NG+L+ F+  + N      +   +L  +  G+A G++Y
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVI---QLVGMLRGIAAGMKY 121

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG---TAGYI 306
           L +      +H D+   NIL++ N   K+SDFGL++    D S  + T++ G      + 
Sbjct: 122 LSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE  +  + + +  SDV+SYG+++ E++
Sbjct: 179 APEAIA--YRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.8 bits (223), Expect = 9e-21
 Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 20/202 (9%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVK--MLEHLKGNGQEFIN----EVATIGRIHHFHIVRL 193
           LG G +GSV+ G  L +G   AVK   L      GQE +     E+A + ++ H +IV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           LG   E     +  E +P GSL K +        +       ++     +  G+EYLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLEYLH-- 119

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            ++  +H DIK  NIL+D N   K++DFG+AK   +     S    +G+  ++APE+ ++
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQ 175

Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
             G     +D++S G  +LEM 
Sbjct: 176 Q-GGYGLAADIWSLGCTVLEMA 196

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +G V++G  L  G  VA+K +   K      +  + E+  +  + H +IV+ +G 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   ++ E+  NGSL + I          P     +    + V +G+ YLH+   Q
Sbjct: 68  IETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLHE---Q 118

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            ++H DIK  NIL   +   K++DFG+A KL        S+    GT  ++APE+     
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV---GTPYWMAPEVI--EM 173

Query: 316 GEVSYKSDVYSYGMMLLEM 334
              S  SD++S G  ++E+
Sbjct: 174 SGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 11/207 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + +   +LG G +G V+ G       VAVK L+    + + F+ E   + ++ H 
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+         R L    L  +A  VA G+ 
Sbjct: 62  KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 117 YIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAP 172

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+V
Sbjct: 173 E--AALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 66/217 (30%), Positives = 117/217 (53%), Gaps = 26/217 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG---IPVAVKMLEHL--KGNGQEFINEVATIGRI-HHFH 189
           KF+  +G+G +G V + ++      +  A+K ++    K + ++F  E+  + ++ HH +
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFI-----------FSKTNSSSHRPLSWEKLKK 238
           I+ LLG C       L  E+ P+G+L  F+           F+  NS++   LS ++L  
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA-STLSSQQLLH 128

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
            A  VARG++YL Q   ++ +H D+   NIL+  N+  KI+DFGL++   +++  V  T 
Sbjct: 129 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV-YVKKTM 182

Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            R    ++A E  S N+   +  SDV+SYG++L E+V
Sbjct: 183 GRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 11/206 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 62  KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 172

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E  +  +G  + KSDV+S+G++L E+
Sbjct: 173 E--AALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 24/200 (12%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
           LG+G YGSV++      G  VA+K++  ++ + QE I E++ + +    +IV+  G   +
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
            T   +V E+   GS+   +       +++ L+ E++  I +   +G+EYLH   + + +
Sbjct: 70  NTDLWIVMEYCGAGSVSDIM-----KITNKTLTEEEIAAILYQTLKGLEYLH---SNKKI 121

Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGYIAPELFSRN 314
           H DIK  NILL+   Q K++DFG++         ++ T A+     GT  ++APE+    
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 315 FGEVSYKSDVYSYGMMLLEM 334
               + K+D++S G+  +EM
Sbjct: 175 --GYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 57/203 (28%), Positives = 111/203 (54%), Gaps = 19/203 (9%)

Query: 141 LGQGGYGSVFRGKL----FNGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +G G +G VFRG L       + VA+K L+  + +   Q+F++E + +G+  H +I+RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  ++     ++ E+M NG+L+K++  + +          +L  +  G+A G++YL    
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYL--RDHDGEFSSY---QLVGMLRGIAAGMKYL---S 124

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAGYIAPELFS- 312
           +   +H D+   NIL++ N + K+SDFGL+++   D     + +  +    + APE  + 
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
           R F   +  SDV+S+G+++ E++
Sbjct: 185 RKF---TSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.0 bits (215), Expect = 8e-20
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 9   KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 196 -FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E+M  GSL  ++ S+  S     L  + L K +  V   +EYL    
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLE--- 119

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSR 313
               +H D+   N+L+  +   K+SDFGL K  S      +    +    + APE L  +
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREK 174

Query: 314 NFGEVSYKSDVYSYGMMLLEM 334
            F   S KSDV+S+G++L E+
Sbjct: 175 KF---STKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 8e-20
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 11/198 (5%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   + ++ H  +V+L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     +V E+M NG L  ++         +     +L ++   V  G+ YL    ++
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL-----REHGKRFQPSQLLEMCKDVCEGMAYLE---SK 119

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + +H D+   N L+D     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVL--LYS 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSDV+++G+++ E+
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.9 bits (218), Expect = 8e-20
 Identities = 70/244 (28%), Positives = 116/244 (47%), Gaps = 23/244 (9%)

Query: 105 ETQLKVEKFLED--YRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN--- 156
           E + KV + +    Y  ++PT+  Y    E  +    F   LG G +G V     +    
Sbjct: 2   EVRWKVIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSK 61

Query: 157 ---GIPVAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFM 210
               + VAVKML+        +  ++E+  +  + +H +IV LLG C+ G    ++ E+ 
Sbjct: 62  SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121

Query: 211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 270
             G L  F+  K        L+ E L   ++ VA+G+ +L    ++  +H D+   N+LL
Sbjct: 122 CYGDLLNFLRRK----RESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLL 174

Query: 271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            H    KI DFGLA+    D + V    AR    ++APE  S      +++SDV+SYG++
Sbjct: 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIL 232

Query: 331 LLEM 334
           L E+
Sbjct: 233 LWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.0 bits (215), Expect = 8e-20
 Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 15/196 (7%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKML-EHLKGNGQ-EFINEVATIGRIHHFHIVRLLGFCS 198
           LG+G +G VF+G L +  PVAVK   E L    + +F++E   + +  H +IV+L+G C+
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +     +V E +P G    F+  K +      L  ++L K A   A G+ YL    ++  
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDE-----LKTKQLVKFALDAAAGMAYLE---SKNC 114

Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA-GYIAPELFSRNFGE 317
           +H D+   N L+  N   KISDFG+++   +D  I S +  +     + APE  + N+G 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPE--ALNYGR 170

Query: 318 VSYKSDVYSYGMMLLE 333
            S +SDV+SYG++L E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 8e-20
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 141 LGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G             VA+K +       +  EF+NE + +   +  H+VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSK----TNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S G    +V E M  G L+ ++ S+     N+    P + +K  ++A  +A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI--------SIVSLTAAR 300
           YL     ++ +H D+   N ++  +   KI DFG+ +    DI            L   R
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186

Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               ++APE  S   G  + KSDV+S+G++L EM 
Sbjct: 187 ----WMAPE--SLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK    I VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     +V EFM NG L  ++  +        LS + L  +   V  G+EYL +    
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEGMEYLER---N 119

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
             +H D+   N L+      K+SDFG+ +    D    S + A+    +  PE+F  NF 
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-EYTSSSGAKFPVKWSPPEVF--NFS 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSDV+S+G+++ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 68/212 (32%), Positives = 115/212 (54%), Gaps = 35/212 (16%)

Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLL 194
           +G+G +G V+ G L       I  AVK L  +    +  +F+ E   +    H +++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 195 GFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARGVEYL 250
           G C  SEG+   +V  +M +G L  FI S+T++ + + L       I FG  VA+G+EYL
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDL-------IGFGLQVAKGMEYL 114

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI------SIVSLTAARGTAG 304
               +++ +H D+   N +LD +F  K++DFGLA    +DI      S+ + T A+    
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLA----RDIYDKEYYSVHNHTGAKLPVK 167

Query: 305 YIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E L ++ F   + KSDV+S+G++L E++
Sbjct: 168 WMALESLQTQKF---TTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 29/209 (13%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNG--QEFINEVATIGRIHHF---HIVR 192
            +G+G YG+V++ + L  G  VA+K +   L   G     + E+A + ++  F   +IVR
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 193 LLGFC-----SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           LL  C         +  LV+E + +  L  ++ SK        L  E +K +   + RGV
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPG---LPPETIKDLMRQLLRGV 120

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           ++LH   + RI+H D+KP NIL+  + Q KI+DFGLA++ S ++++ S+     T  Y A
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV---TLWYRA 174

Query: 308 PELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           PE+  +     SY +  D++S G +  E+
Sbjct: 175 PEVLLQ----SSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.5 bits (211), Expect = 3e-19
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + +   +LGQG +G V+ G       VA+K L+      + F+ E   + ++ H 
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V L    SE     +V EFM  GSL  F+  K     +  L   +L  +A  +A G+ 
Sbjct: 62  KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFL--KEGDGKY--LKLPQLVDMAAQIADGMA 116

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAP 172

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+V
Sbjct: 173 E--AALYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 31/218 (14%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHL---KGNGQEFINEV 179
           E KKI       LG G +G+V++G L+        IPVA+K L      K N +E ++E 
Sbjct: 8   EFKKIKV-----LGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKAN-KEILDEA 60

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKK 238
             +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+W     
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW----- 114

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
               +A+G+ YL +   +R++H D+   N+L+      KI+DFGLAKL   D        
Sbjct: 115 -CVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 299 ARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 171 GKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 141 LGQGGYGSVFRGKLFNGI-------PVAVKMLEHLKGNGQE--FINEVATIGRIHHFHIV 191
           LG G +G V+ G L+ G         VAVK L        E  F+ E   + + +H +IV
Sbjct: 14  LGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH-RPLSWEKLKKIAFGVARGVEYL 250
           RL+G   E   R ++ E M  G L+ F+            L+ + L   A  VA+G +YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA--- 303
            +      +H DI   N LL     P    KI+DFG+A    +DI   S     G A   
Sbjct: 133 EE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMA----RDIYRASYYRKGGRAMLP 184

Query: 304 -GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             ++ PE F    G  + K+DV+S+G++L E+
Sbjct: 185 IKWMPPEAFLD--GIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 85.7 bits (212), Expect = 4e-19
 Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 37/222 (16%)

Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQ-EFINEVATIGRIHHFHIVR 192
           +GQG +G VF+ +    +P      VAVKML E    + Q +F  E A +    H +IV+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSK----TNSSSHR------------PLSWEKL 236
           LLG C+ G    L++E+M  G L +F+  +      S SH             PLS  + 
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
             IA  VA G+ YL +   ++ +H D+   N L+  N   KI+DFGL    S++I     
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL----SRNIYSADY 185

Query: 297 TAARGTAG----YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             A         ++ PE  S  +   + +SDV++YG++L E+
Sbjct: 186 YKASENDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 31/211 (14%)

Query: 136 KFKHRLGQGGYGSVF--RGKLFNGIPVAVKML------EHLKGNGQEFINEVATIGRIHH 187
           +    +G+G YG V   R K    I VA+K        E +K   +  + EV  + ++ H
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVK---KTALREVKVLRQLRH 59

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +IV L        R  LV+E++    LE    S         L  + ++   + + + +
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG------LPPDAVRSYIWQLLQAI 113

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSKDISIVSLTAARGTAGY 305
            Y H      I+H DIKP NIL+  +   K+ DFG A+         +    A R    Y
Sbjct: 114 AYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---WY 167

Query: 306 IAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
            APEL     G+ +Y    DV++ G ++ E+
Sbjct: 168 RAPELL---VGDTNYGKPVDVWAIGCIMAEL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.1 bits (210), Expect = 4e-19
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 15/209 (7%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K + +LG G +G V+         VAVK ++    + + F+ E   +  + H 
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61

Query: 189 HIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            +V+L       T+    ++ EFM  GSL  F+  K++  S +PL   KL   +  +A G
Sbjct: 62  KLVKLHAVV---TKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLP--KLIDFSAQIAEG 114

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           + ++ Q   +  +H D++  NIL+  +   KI+DFGLA++  +D    +   A+    + 
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWT 170

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE    NFG  + KSDV+S+G++L+E+V
Sbjct: 171 APEAI--NFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.0 bits (210), Expect = 6e-19
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG-QEFINEVATIGRIHHFH 189
            K  LG+G +G VF  +  N +P      VAVK L+    +  Q+F  E   +  + H H
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSHRPLSWEKLKKIA 240
           IVR  G C+EG    +V+E+M +G L +F         I +     +   L+  ++  IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A G+ YL    +   +H D+   N L+      KI DFG+    S+DI         
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDYYRVG 181

Query: 301 GTA----GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           G       ++ PE +  R F   + +SD++S+G++L E+
Sbjct: 182 GRTMLPIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.9 bits (210), Expect = 6e-19
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 18/207 (8%)

Query: 141 LGQGGYGSVFRGKLF--NGIP--VAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRL 193
           LG+G +GSV  G+L   +G    VAVK ++   H     +EF++E A +    H ++++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 194 LGFCSEGTRRA------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           +G C E +         ++  FM +G L  F+           L  + L K    +A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL    N+  +H D+   N +L  +    ++DFGL+K             A+    +IA
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
            E  +      + KSDV+++G+ + E+
Sbjct: 184 IESLADRV--YTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.8 bits (210), Expect = 7e-19
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 141 LGQGGYGSVFRGKLFNGI-------PVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIV 191
           LG+G +G VF  K   GI        V VK L+  K      EF  E+    ++ H ++V
Sbjct: 13  LGRGEFGEVFLAKA-KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIF---SKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           RLLG C E     ++ E+   G L++F+    SK       PLS ++   +   +A G++
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           +L    N R +H D+   N L+    + K+S   L+K          L  A     ++AP
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAP 187

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E    +  + S KSDV+S+G+++ E+
Sbjct: 188 EAVQED--DFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.8 bits (210), Expect = 7e-19
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLL 194
           ++G+G +  V++   L +G  VA+K ++          Q+ + E+  + ++ H ++++ L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E    G L + I  K      R +    + K    +   +E++H   
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIWKYFVQLCSALEHMHS-- 124

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFSR 313
            +RI+H DIKP N+ +      K+ D GL +   SK  +  SL    GT  Y++PE    
Sbjct: 125 -KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 180

Query: 314 NFGEVSYKSDVYSYGMMLLEM 334
           N    ++KSD++S G +L EM
Sbjct: 181 N--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 65/232 (28%), Positives = 113/232 (48%), Gaps = 37/232 (15%)

Query: 141 LGQGGYGSVFRGKLFN--GIP----VAVKMLEHLKGNGQ----EFINEVATIGRIHHFHI 190
           LG+G +G V +   F   G      VAVKML+  +        + ++E   + +++H H+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK--ENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI-------------FSKTNSSS-----HRPLS 232
           ++L G CS+     L+ E+   GSL  F+                 NSS       R L+
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
              L   A+ ++RG++YL +    +++H D+   N+L+    + KISDFGL++   ++ S
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
            V  +  R    ++A E LF   +   + +SDV+S+G++L E+V    N  P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYP 231

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.9 bits (211), Expect = 7e-19
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 45/213 (21%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFIN-----EVATIGRIHHFHIVR 192
           LG+G Y  V++ +    G  VA+K   L   K   ++ IN     E+  +  + H +I+ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERK-EAKDGINFTALREIKLLQELKHPNIIG 66

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA-------- 244
           LL      +   LV+EFM    LEK I               K K I    A        
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDLEKVI---------------KDKSIVLTPADIKSYMLM 110

Query: 245 --RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
             RG+EYLH   +  ILH D+KP+N+L+  +   K++DFGLA+          +T    T
Sbjct: 111 TLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVT 165

Query: 303 AGYIAPELFSRNFGEVSYKS--DVYSYGMMLLE 333
             Y APEL    FG   Y    D++S G +  E
Sbjct: 166 RWYRAPELL---FGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 9e-19
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLE---HLKGNGQEFI--------NEVATIGRIHHF 188
           +G+G YG V+    +  G  +AVK +E    + G              +E+ T+  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +IV+ LGF +     ++  E++P GS+   +       ++     + ++     V  G+ 
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL------RTYGRFEEQLVRFFTEQVLEGLA 122

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAGYIA 307
           YLH   ++ ILH D+K  N+L+D +   KISDFG++K  S DI       + +G+  ++A
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMA 178

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           PE+        S K D++S G ++LEM   R+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 1e-18
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 27/207 (13%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLE------HLKGNGQEFINEVATIGRIHHFHIVRL 193
           LGQG +G V+    +  G  +AVK +         K        E+  +  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G   +    ++  E+MP GS++  +       ++  L+    +K    +  GVEYLH  
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQL------KAYGALTETVTRKYTRQILEGVEYLH-- 121

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDISIVSLTAARGTAGYIAPE 309
            +  I+H DIK  NIL D     K+ DFG +K    +CS    + S+T   GT  +++PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSPE 177

Query: 310 LFSRNFGE-VSYKSDVYSYGMMLLEMV 335
           + S   GE    K+DV+S G  ++EM+
Sbjct: 178 VIS---GEGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 36/220 (16%)

Query: 141 LGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKGNGQE-----FINEVATIGRI-H 186
           LG+G +G V R + +          + VAVKML   K N  +      I+E+  +  I  
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML---KDNATDKDLADLISEMELMKLIGK 76

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKL 236
           H +I+ LLG C++     ++ E+   G+L +F+ ++                  LS++ L
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
              A+ VARG+EYL    ++R +H D+   N+L+  +   KI+DFGLA+    DI     
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GVHDIDYYKK 192

Query: 297 TA-ARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           T+  R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
            ++G+G YG V++ +    G  VA+K +    +  G     I E+  + ++ H +IVRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 195 GFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
              +   + +  +V+E+M +  L   + S          +  ++K     +  G++YLH 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLH- 117

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
             +  ILH DIK  NIL++++   K++DFGLA+  +K  S    T    T  Y  PEL  
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELL- 173

Query: 313 RNFGEVSYKS--DVYSYGMMLLEM 334
              G   Y    D++S G +L E+
Sbjct: 174 --LGATRYGPEVDMWSVGCILAEL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 69/279 (24%), Positives = 133/279 (47%), Gaps = 46/279 (16%)

Query: 80  SIGGIVLFALVIF---LIYKSRESEKEK--------ETQLKVEKFLEDYRTVNPTRYTYK 128
           ++G  ++ ALV F    I      E ++        E Q    K  +   T+N    + K
Sbjct: 635 TLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI-TINDILSSLK 693

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFI--NEVATIGRI 185
           E        ++ + +G  G+ ++GK   NG+   VK     + N    I  +E+A +G++
Sbjct: 694 E--------ENVISRGKKGASYKGKSIKNGMQFVVK-----EINDVNSIPSSEIADMGKL 740

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
            H +IV+L+G C       L++E++   +L + +         R LSWE+ +KIA G+A+
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---------RNLSWERRRKIAIGIAK 791

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
            + +LH  C+  ++  ++ P  I++D   +P +       LC+     +S       + Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFIS-------SAY 844

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           +APE  +R   +++ KSD+Y +G++L+E++  +   D  
Sbjct: 845 VAPE--TRETKDITEKSDIYGFGLILIELLTGKSPADAE 881

Length = 968

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.7 bits (204), Expect = 3e-18
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-------QEFINEVATIGRIHHFHIVRL 193
           LG+G YG+V+ G    G  +AVK +E    N        ++   EV  +  + H +IV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           LG C +    ++  EF+P GS+   +      +   PL      K    +  GV YLH  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL------NRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS--------LTAARGTAGY 305
           C   ++H DIK +N++L  N   K+ DFG    C++ ++ V         L +  GT  +
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFG----CARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 306 IAPELFSRNFGEVSY--KSDVYSYGMMLLEM 334
           +APE+ +    E  Y  KSD++S G  + EM
Sbjct: 175 MAPEVIN----ESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 27/215 (12%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL---KGNGQEFINEVATI 182
           +K+L+K        LG+G Y +V++G+    G  VA+K + HL   +G     I E++ +
Sbjct: 2   FKQLEK--------LGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLM 52

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             + H +IVRL        +  LV+E+M +  L+K++ +         L    +K   + 
Sbjct: 53  KELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGV---RGALDPNTVKSFTYQ 108

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           + +G+ + H+    R+LH D+KP N+L++   + K++DFGLA+  +  I + + +    T
Sbjct: 109 LLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVT 163

Query: 303 AGYIAPE--LFSRNFGEVSYKSDVYSYGMMLLEMV 335
             Y AP+  L SR +   S   D++S G ++ EM+
Sbjct: 164 LWYRAPDVLLGSRTY---STSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 27/207 (13%)

Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +G G +G V  G+L       IPVA+K L+  + +   ++F++E + +G+  H +I+ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  ++     +V E+M NGSL+ F+  + +      +   +L  +  G+A G++YL    
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVI---QLVGMLRGIASGMKYL---S 123

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG------YIAP 308
           +   +H D+   NIL++ N   K+SDFGL+++   D       AA  T G      + AP
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-----AAYTTRGGKIPIRWTAP 178

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  + + +  SDV+SYG+++ E++
Sbjct: 179 EAIA--YRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.3 bits (203), Expect = 5e-18
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 17/213 (7%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLKGNGQE--FINEVATI 182
           EL   + K +  LG G +G + RG L       +PVA+  L     + Q   F+ E  T+
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
           G+  H +IVRL G  + G    +V E+M NG+L+ F+           L   +L  +  G
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPG 115

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +A G++YL +      +H  +  H +L++ +   KIS F   +   K  +I +  + +  
Sbjct: 116 LASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSP 171

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             + APE     +   S  SDV+S+G+++ E++
Sbjct: 172 VLWAAPEAI--QYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 81.8 bits (202), Expect = 6e-18
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 17/202 (8%)

Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRL 193
            +++G+G +G VF+  +  +    A+K ++  K N    +E I+E   + ++   +I+R 
Sbjct: 5   LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                +  +  +V E+  NG L K +         RPL  +++ +    +  G+ +LH  
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLL----KMQRGRPLPEDQVWRFFIQILLGLAHLH-- 118

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS- 312
            +++ILH DIK  N+ LD     KI D G+AKL S D +  + T   GT  Y++PEL   
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIV-GTPYYLSPELCED 175

Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
           + + E   KSDV++ G++L E 
Sbjct: 176 KPYNE---KSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.4 bits (203), Expect = 6e-18
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 27/223 (12%)

Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG-QEFINEVATI 182
           +K+     K  LG+G +G VF  + +N  P      VAVK L+    N  ++F  E   +
Sbjct: 2   IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRPLSWEK 235
             + H HIV+  G C EG    +V+E+M +G L KF+ +           +    L+  +
Sbjct: 62  TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           +  IA  +A G+ YL    +Q  +H D+   N L+  N   KI DFG+    S+D+    
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGM----SRDVYSTD 174

Query: 296 LTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                G       ++ PE  S  + + + +SDV+S G++L E+
Sbjct: 175 YYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 8e-18
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 30/219 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN--EVATIG 183
           YK +K        +LG G +GSV+  +    G  VA+K ++    + +E +N  EV ++ 
Sbjct: 1   YKVIK--------QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLR 52

Query: 184 RI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
           ++  H +IV+L     E      V+E+M  G+L + +  +      +P S   ++ I + 
Sbjct: 53  KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQ 107

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARG 301
           + +G+ ++H+       H D+KP N+L+      KI+DFGLA+ + S+       T    
Sbjct: 108 ILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTDYVS 160

Query: 302 TAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCR 338
           T  Y APE+  R+    SY S  D+++ G ++ E+   R
Sbjct: 161 TRWYRAPEILLRS---TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 9e-18
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 34/219 (15%)

Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKMLEHLKGNGQE-----FINEVATIGRI-H 186
           LG+G +G V         + K    + VAVKML   K +  E      ++E+  +  I  
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 79

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKL 236
           H +I+ LLG C++     ++ E+   G+L +++ ++                  ++++ L
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
               + VARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 297 TAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           T  R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 197 TNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.0 bits (202), Expect = 9e-18
 Identities = 63/217 (29%), Positives = 114/217 (52%), Gaps = 26/217 (11%)

Query: 136 KFKHRLGQGGYGSVFRG---KLFNGIPVAVKMLEHL--KGNGQEFINEVATIGRI-HHFH 189
           KF+  +G+G +G V R    K    +  A+KML+    + + ++F  E+  + ++ HH +
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFI-----------FSKTNSSSHRPLSWEKLKK 238
           I+ LLG C       +  E+ P G+L  F+           F+K + ++   L+ ++L +
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA-STLTSQQLLQ 123

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
            A  VA G++YL +   ++ +H D+   N+L+  N   KI+DFGL++    +   V  T 
Sbjct: 124 FASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTM 177

Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            R    ++A E  S N+   + KSDV+S+G++L E+V
Sbjct: 178 GRLPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 80.8 bits (200), Expect = 1e-17
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)

Query: 139 HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLL 194
           +++G G +G V+    L  G  +AVK +          +E  +E+  +  + H ++V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 195 GFCSEGTRRALVYEFMP---NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           G       R  VY FM     G+LE+ +         R L    ++     +  G+ YLH
Sbjct: 66  GVEVH---REKVYIFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLH 116

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR------GTAGY 305
                 I+H DIKP NI LDHN   K+ DFG    C+  +   + T         GT  Y
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFG----CAVKLKNNTTTMGEEVQSLAGTPAY 169

Query: 306 IAPELFSRNFGEVSYKS-DVYSYGMMLLEMV 335
           +APE+ +   G+   ++ D++S G ++LEM 
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 30/223 (13%)

Query: 136 KFKHRLGQGGYGSV----------FRGK---LFNGIP--VAVKML--EHLKGNGQEFINE 178
           + K +LG+G +G V          F G+    F+G P  VAVKML  +  K    +F+ E
Sbjct: 8   RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67

Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF-----IFSKTNSSSHRP-LS 232
           +  + R+ + +I+RLLG C       ++ E+M NG L +F     I S    +++ P +S
Sbjct: 68  IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI 291
              L  +A  +A G++YL    +   +H D+   N L+ +++  KI+DFG+++ L S D 
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             +   A      ++A E  S   G+ +  SDV+++G+ L EM
Sbjct: 185 YRIQGRAVLPIR-WMAWE--SILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLK-GNGQEFINEVATI 182
           Y++++KI        G+G YG V++ +    G  VA+K   LE    G     I E++ +
Sbjct: 1   YQKVEKI--------GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLL 52

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             ++H +IVRLL       +  LV+EF+ +  L+K++    +SS    L    +K   + 
Sbjct: 53  KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM----DSSPLTGLDPPLIKSYLYQ 107

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           + +G+ Y H     R+LH D+KP N+L+D     K++DFGLA+  +  + + + T    T
Sbjct: 108 LLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVT 162

Query: 303 AGYIAPE--LFSRNFGEVSYKSDVYSYGMMLLEMV 335
             Y APE  L SR +   S   D++S G +  EMV
Sbjct: 163 LWYRAPEILLGSRQY---STPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 32/220 (14%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFH 189
            K  LG+G +G VF  + +N  P   KML  +K          ++F  E   +  + H H
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS----------SHRPLSWEKLKKI 239
           IV+  G C +G    +V+E+M +G L KF+ +    +          +   L   ++  I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A  +A G+ YL    +Q  +H D+   N L+  N   KI DFG+    S+D+        
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM----SRDVYSTDYYRV 181

Query: 300 RGTA----GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            G       ++ PE +  R F   + +SDV+S+G++L E+
Sbjct: 182 GGHTMLPIRWMPPESIMYRKF---TTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 140 RLGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +   G  VAVK ++  K   +E + NEV  +   HH ++V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V R + YLH   NQ 
Sbjct: 89  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQG 138

Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL  + + K+SDFG     SK++      +  GT  ++APE+ SR  +G
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYG 196

Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EM+
Sbjct: 197 T---EVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 141 LGQGGYGSVFRG--KLFNG-IPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG G +G V +G  K+    I VA+K+L  E+ K    E + E   + ++ + +IVR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C E     LV E    G L KF+  K +      ++   + ++   V+ G++YL     
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDE-----ITVSNVVELMHQVSMGMKYLEG--- 113

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +  +H D+   N+LL +    KISDFGL+K L + D    + +A +    + APE    N
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--N 171

Query: 315 FGEVSYKSDVYSYGMMLLE 333
           F + S +SDV+SYG+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 40/216 (18%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVK-----------------MLEHLKGNGQEFINEVATI 182
           +G G +GSV+ G    +G  +AVK                 ML+ L         E+A +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAR-------EIALL 60

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             + H +IV+ LG   +     +  E++P GS+   +      +    L    +++I   
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQIL-- 116

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-- 300
             +G+ YLH   N+ I+H DIK  NIL+D+    KISDFG++K    +        AR  
Sbjct: 117 --KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 301 --GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             G+  ++APE+  +     + K+D++S G +++EM
Sbjct: 172 LQGSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 31/205 (15%)

Query: 141 LGQGGYGSVFRGKLF-NGIPVAVKMLE-----HLKGNGQE--FINEVATIGRIHHFHIVR 192
           LG G +G V   +   +G   A+K+L       LK   Q    +NE   +  I H  +V 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK---QVEHVLNEKRILQSIRHPFLVN 65

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L G   + +   LV E++P G L    FS    S   P    +    A  V   +EYLH 
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARF--YAAQVVLALEYLH- 118

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF- 311
             +  I++ D+KP N+LLD +   KI+DFG AK        +      GT  Y+APE+  
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEIIL 171

Query: 312 SRNFGEVSYKS-DVYSYGMMLLEMV 335
           S+ +G    K+ D ++ G+++ EM+
Sbjct: 172 SKGYG----KAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.3 bits (195), Expect = 5e-17
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVK-----MLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           R+G+G +G VF G+L  +  PVAVK     +   LK    +F+ E   + +  H +IVRL
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 58

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G C++     +V E +  G    F+           L  ++L ++    A G+EYL   
Sbjct: 59  IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGPR--LKVKELIQMVENAAAGMEYLESK 113

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
                +H D+   N L+      KISDFG+++     +   +    +    + APE  + 
Sbjct: 114 H---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE--AL 168

Query: 314 NFGEVSYKSDVYSYGMMLLE 333
           N+G  S +SDV+S+G++L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 29/217 (13%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLF-NG----IPVAVKMLEH---LKGNGQEFINEVA 180
           ELKK+       LG G +G+V++G    +G    IPVA+K+L      K N +E ++E  
Sbjct: 8   ELKKVKV-----LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAY 61

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKI 239
            +  +   ++ RLLG C   T + LV + MP G L  ++  +K    S   L+W      
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------ 114

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
              +A+G+ YL +    R++H D+   N+L+      KI+DFGLA+L   D +       
Sbjct: 115 CVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171

Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +    ++A E +  R F   +++SDV+SYG+ + E++
Sbjct: 172 KVPIKWMALESILHRRF---THQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 79.3 bits (195), Expect = 7e-17
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 18/199 (9%)

Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 87  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLKALSVLHA---QG 136

Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++      +  GT  ++APEL SR  +G
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYG 194

Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 195 P---EVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 26/203 (12%)

Query: 140 RLGQGGYGSV--FRGKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGF 196
           ++G+G  G V   R K  +G  VAVKM++  K   +E + NEV  +    H ++V +   
Sbjct: 28  KIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
              G    ++ EF+  G+L       T+  S   L+ E++  +   V + + YLH   +Q
Sbjct: 87  YLVGEELWVLMEFLQGGAL-------TDIVSQTRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI----SIVSLTAARGTAGYIAPELFS 312
            ++H DIK  +ILL  + + K+SDFG     SKD+    S+V      GT  ++APE+ S
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS 190

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
           R       + D++S G+M++EMV
Sbjct: 191 RT--PYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 9e-17
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 23/207 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRL 193
           +   R+G G YG V++ + +  G  VA+K+++   G+  E I  E++ +    H +IV  
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G      +  +V E+   GSL+  I+  T      PLS  ++  +     +G+ YLH+ 
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQD-IYQVTR----GPLSELQIAYVCRETLKGLAYLHE- 119

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPE 309
                +H DIK  NILL  +   K++DFG++   +  I+       R    GT  ++APE
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA------KRKSFIGTPYWMAPE 171

Query: 310 LFSRNFGEVSY--KSDVYSYGMMLLEM 334
           + +    +  Y  K D+++ G+  +E+
Sbjct: 172 VAAVE-RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-------QEFINEVATIGRIHHFHIVR 192
           LG G + S ++ + +  G  +AVK + +++          +    E+  + R++H HI+R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           +LG   E +   L  E+M  GS+   +      S +       +      + RG+ YLH+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL------SKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAAR--GTAGYIAPE 309
               +I+H D+K  N+L+D   Q  +I+DFG A   +   +       +  GT  ++APE
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 310 -LFSRNFGEVSYKSDVYSYGMMLLEM 334
            L    +G      DV+S G +++EM
Sbjct: 179 VLRGEQYGR---SCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 28/216 (12%)

Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +    +  + ++E+  +  I  H +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++          T       L+++ L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +Q+ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 65/212 (30%), Positives = 114/212 (53%), Gaps = 26/212 (12%)

Query: 141 LGQGGYGSVFRGKLF-NGIPV--AVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLL 194
           +G+G +G V + ++  +G+ +  A+K ++    K + ++F  E+  + ++ HH +I+ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFI-----------FSKTNSSSHRPLSWEKLKKIAFGV 243
           G C       L  E+ P+G+L  F+           F+  NS++   LS ++L   A  V
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA-STLSSQQLLHFAADV 121

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           ARG++YL Q   ++ +H D+   NIL+  N+  KI+DFGL++        V  T  R   
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            ++A E  S N+   +  SDV+SYG++L E+V
Sbjct: 176 RWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 29/221 (13%)

Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGI-------PVAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 6   EKIT--MSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S +K+ 
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 123 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 175

Query: 298 AARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 176 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 30/206 (14%)

Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-----EVATIGRIHHFHIVRLL 194
           +G+G YG V + K    G  VA+K    L+    + +      E+  + ++ H ++V L+
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP--LSWEKLKKIAFGVARGVEYLHQ 252
                  R  LV+EF+ +  L+             P  L   +++K  F + RG+E+ H 
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDL--------EKYPNGLDESRVRKYLFQILRGIEFCH- 117

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELF 311
             +  I+H DIKP NIL+  +   K+ DFG A+ L +         A R    Y APEL 
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELL 172

Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
               G+  Y    D+++ G ++ EM+
Sbjct: 173 ---VGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 19/200 (9%)

Query: 141 LGQGGYGSVFRG--KLFNGI-PVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLL 194
           LG G +G+V +G  K+      VAVK+L++   +     E + E   + ++ + +IVR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G C E     LV E    G L KF+    + +         + ++   V+ G++YL +  
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK------NITELVHQVSMGMKYLEE-- 113

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTAGYIAPELFSR 313
               +H D+   N+LL      KISDFGL+K    D +   + T  +    + APE    
Sbjct: 114 -TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-- 170

Query: 314 NFGEVSYKSDVYSYGMMLLE 333
           N+ + S KSDV+S+G+++ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 77.2 bits (190), Expect = 3e-16
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 141 LGQGGYGSVFRGKLFN-------GIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFH 189
           LG G +G V+ G   +        I VAVK L   KG      +EF+ E   +   +H +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARGVE 248
           IV+LLG C     + ++ E M  G L  ++          P L+ ++L  I   VA+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 249 YLHQGCNQRILHFDIKPHNILL-----DHNFQPKISDFGLAKLCSKDISIVSLTAARG-- 301
           YL Q      +H D+   N L+     D +   KI DFGLA    +DI         G  
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RDIYKSDYYRKEGEG 173

Query: 302 --TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                ++APE  S   G+ + +SDV+S+G+++ E++
Sbjct: 174 LLPVRWMAPE--SLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 14/204 (6%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G V  G++ +G   A  +++ L+ +       +F+ E      + H ++++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C+E T   LV EF P G L+ ++ S   +    P     L+++A  +A G+ +LH+   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK--- 118

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
              +H D+   N LL  +   KI D+GL+    K+   V+         +IAPEL     
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 316 GEV-----SYKSDVYSYGMMLLEM 334
           G +     + +S+V+S G+ + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 19/202 (9%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+    ++S    +    +K   F + +G+ + H   +
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFM----DASPLSGIPLPLIKSYLFQLLQGLAFCH---S 118

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 173

Query: 316 GEVSYKS--DVYSYGMMLLEMV 335
           G   Y +  D++S G +  EMV
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 31/218 (14%)

Query: 130 LKKITSKFKHRLGQGGYGSV--FRGKLFN---GIPVAVKMLEHLKGNGQE----FINEVA 180
           LKKI       LG+G +G V  +     N   G  VAVK L+  +  GQ+    +  E+ 
Sbjct: 6   LKKI-----RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK--RECGQQNTSGWKKEIN 58

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
            +  ++H +IV+  G CSE   +   L+ E++P GSL  ++           L+  +L  
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------PKHKLNLAQLLL 111

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
            A  +  G+ YLH   +Q  +H D+   N+LLD++   KI DFGLAK   +      +  
Sbjct: 112 FAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168

Query: 299 -ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  + A E    N  + SY SDV+S+G+ L E++
Sbjct: 169 DGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 61/228 (26%), Positives = 92/228 (40%), Gaps = 46/228 (20%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFR------GKLFNGIPVAVK------MLEHLKGNGQE 174
           Y+ L+ I        G+G +G+V +      GK+        K      M E  K   Q+
Sbjct: 2   YEVLETI--------GKGSFGTVRKVRRKSDGKIL-----VWKEIDYGNMTEKEK---QQ 45

Query: 175 FINEVATIGRIHHFHIVRLLG--FCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRP 230
            ++EV  +  + H +IVR              +V E+   G L + I    K        
Sbjct: 46  LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE 105

Query: 231 LSWEKLKKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             W    +I   +   +   H        +LH D+KP NI LD N   K+ DFGLAK+  
Sbjct: 106 FIW----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEM 334
            D S        GT  Y++PE  +      SY  KSD++S G ++ E+
Sbjct: 162 HDSSFAKTYV--GTPYYMSPEQLNHM----SYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 35/230 (15%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEV 179
           EL     +F   LG+  +G +++G L+  +P       VA+K L+ +    Q  EF  E 
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLY--LPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-----------SKTNSSSH 228
           + +  +HH +IV LLG  ++     +++E++  G L +F+            S  + +  
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LC 287
             L       IA  +A G+EYL    +   +H D+   NIL+      KISD GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 288 SKDISIV---SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S D   V   SL   R    ++ PE     +G+ S  SD++S+G++L E+
Sbjct: 176 SADYYRVQPKSLLPIR----WMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 66/236 (27%), Positives = 113/236 (47%), Gaps = 46/236 (19%)

Query: 137 FKHRLGQGGYGSV---------------FRGKLFNGIP--VAVKML-----EHLKGNGQE 174
           F  +LG+G +G V               F        P  VAVK+L     ++ +   ++
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR---ED 65

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS---KTNSSSH--R 229
           F+ EV  + R+   +I RLLG C+      ++ E+M NG L +F+     +T+  +   +
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCS 288
            LS+  L  +A  +A G+ YL        +H D+   N L+  N+  KI+DFG+++ L S
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 289 KDISIVSLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRK 339
            D   V     +G A     ++A E      G+ + KSDV+++G+ L E++  CR+
Sbjct: 183 SDYYRV-----QGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 64/220 (29%), Positives = 116/220 (52%), Gaps = 36/220 (16%)

Query: 141 LGQGGYGSVFRGKLF-------NGI-PVAVKMLEH--LKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V   +         N +  VAVKML+    + +  + I+E+  +  I  H +
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++         + +  P   LS++ L   
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--- 296
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA    +DI  +     
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHIDYYKK 198

Query: 297 -TAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            T  R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 199 TTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 25/210 (11%)

Query: 141 LGQGGYGSVFRG---KLFNGIP---VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G    +  G     VAVK +       +  EF+NE + +      H+VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA----G 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKGLLPVR 186

Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 187 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 75.3 bits (185), Expect = 1e-15
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 27/205 (13%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           LG+G YG V+  + L   + +A+K + E      Q    E+A    + H +IV+ LG  S
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK----IAF---GVARGVEYLH 251
           E     +  E +P GSL   + SK          W  LK     I F    +  G++YLH
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSK----------WGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 252 QGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE 309
                +I+H DIK  N+L++ ++   KISDFG +K L   +    + T   GT  Y+APE
Sbjct: 126 D---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 179

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEM 334
           +  +        +D++S G  ++EM
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 24/205 (11%)

Query: 140 RLGQGGYGSVFRG--KLFNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           ++G+G YG V++   ++ N   +A+K +   +  +G     I E++ +  + H +IVRL 
Sbjct: 9   KIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTN-SSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                  R  LV+E++ +  L+K + S  + + + R      +K   + + RG+ Y H  
Sbjct: 68  DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPR-----LIKTYLYQILRGIAYCH-- 119

Query: 254 CNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF- 311
            + R+LH D+KP N+L+D      K++DFGLA+  +  I + + T    T  Y APE+  
Sbjct: 120 -SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 312 -SRNFGEVSYKSDVYSYGMMLLEMV 335
            SR++   S   D++S G +  EMV
Sbjct: 177 GSRHY---STPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 141 LGQGGYGSVFRGKLFNG---IPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+G +GSV  G+L      + VAVK ++     +   ++F++E   +    H +++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 195 GFCSEGTRR------ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           G C +           ++  FM +G L  F+         + L  + L K    +A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL    ++  +H D+   N +L+ N    ++DFGL+K             A+    +IA 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 309 E-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           E L  R +   + KSDV+S+G+ + E+
Sbjct: 184 ESLADRVY---TTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.2 bits (182), Expect = 3e-15
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLK--GNGQE---FINEVATIGRIHHFHIVRLLG 195
           +G G +G V  G+   G+  A  +++ L+      E   F+ EV     ++H ++++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C E     LV EF P G L+ ++ S     +      + L+++A  VA G+ +LHQ   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQA-- 119

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL---FS 312
              +H D+   N  L  +   KI D+GLA     +   ++         ++APEL     
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 313 RNF--GEVSYKSDVYSYGMMLLEM 334
           ++    + + KS+++S G+ + E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 41/231 (17%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-----MLEHLKGNGQEFINEVA 180
           Y++L+KI        G+G YG V++ +    G  VA+K     M E  +G     + E++
Sbjct: 3   YEKLEKI--------GEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREIS 52

Query: 181 TIGRIHH-FHIVRLLGFCSEGTRRA-------LVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
            +  +    +IVRLL    E            LV+E++ +  L+KF+ S       RPL 
Sbjct: 53  LLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDS-NGRGPGRPLP 108

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDI 291
            + +K   + + +GV + H+     ++H D+KP N+L+D      KI+D GL +  S  I
Sbjct: 109 AKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--I 163

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCRKN 340
            + S T    T  Y APE+     G   Y +  D++S G +  EM   RK 
Sbjct: 164 PVKSYTHEIVTLWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEMS--RKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 33/210 (15%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-----FINEVATIGRIHHF---HIV 191
           +G G YG+V++ +   +G  VA+K +       ++      + EVA + R+  F   +IV
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 192 RLLGFCS-----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           RL+  C+       T+  LV+E + +  L  ++  K        L  E +K +     RG
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPG---LPAETIKDLMRQFLRG 120

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +++LH  C   I+H D+KP NIL+    Q K++DFGLA++ S  +   +LT    T  Y 
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYR 174

Query: 307 APELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           APE+  ++    +Y +  D++S G +  EM
Sbjct: 175 APEVLLQS----TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 74/271 (27%), Positives = 114/271 (42%), Gaps = 84/271 (30%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGI-------PVAVKML-------EHLKGNGQEFINEVAT 181
           K    LG+G +G V +   F GI        VAVKML       E+     +  + E+  
Sbjct: 10  KLGKPLGRGAFGKVIQASAF-GIEKSASCRTVAVKMLKEGATASEY-----KALMTELKI 63

Query: 182 IGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSL--------EKFIFSKTNSSSHR-- 229
           +  I HH ++V LLG C++ G    ++ E+   G+L        E F   +  S+  R  
Sbjct: 64  LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123

Query: 230 ---------------------------------------------PLSWEKLKKIAFGVA 244
                                                        PL+ E L   +F VA
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           RG+E+L    +++ +H D+   NILL  N   KI DFGLA+   KD   V    AR    
Sbjct: 184 RGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 305 YIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE +F + +   + +SDV+S+G++L E+
Sbjct: 241 WMAPESIFDKVY---TTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 36/223 (16%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFR------GKLFNGIPVAVKML--EHLKGNGQ 173
               +  EL+++     +R+G G  G+V++      G+L+     A+K++   H     +
Sbjct: 68  SAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLY-----ALKVIYGNHEDTVRR 117

Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
           +   E+  +  ++H ++V+            ++ EFM  GSLE                 
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----------GTHIADE 167

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
           + L  +A  +  G+ YLH+   + I+H DIKP N+L++     KI+DFG++++ ++ +  
Sbjct: 168 QFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223

Query: 294 VSLTAARGTAGYIAPELFSR--NFGEVS-YKSDVYSYGMMLLE 333
               ++ GT  Y++PE  +   N G    Y  D++S G+ +LE
Sbjct: 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 21/199 (10%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLG- 195
           LG G  GSV + K +  G  +A K++ H+       ++ + E+  +      +IV   G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F +E     +  EFM  GSL++ I+ K       P+  E L KIA  V  G+ YL+    
Sbjct: 72  FLNENNI-CMCMEFMDCGSLDR-IYKKGG-----PIPVEILGKIAVAVVEGLTYLYN--V 122

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            RI+H DIKP NIL++   Q K+ DFG++    + I+ ++ T   GT+ Y++PE      
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFV-GTSTYMSPERIQG-- 176

Query: 316 GEVSYKSDVYSYGMMLLEM 334
           G+ + KSDV+S G+ ++E+
Sbjct: 177 GKYTVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           + +G YG VF   K   G   A+K+++      K    + + E   + +    ++V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 196 FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           + S   ++ L  V E++P G L   +     S     L  +  +     +   +EYLH  
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDL-ASLLENVGS-----LDEDVARIYIAEIVLALEYLHS- 111

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKL------CSKDISIVSLTAARGTAGYIA 307
               I+H D+KP NIL+D N   K++DFGL+K+       + +          GT  YIA
Sbjct: 112 NG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLE-MVGC 337
           PE+     G  S   D +S G +L E +VG 
Sbjct: 170 PEVI-LGQGH-SKTVDWWSLGCILYEFLVGI 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 27/203 (13%)

Query: 140 RLGQGGYGSVFRG-KLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
            +G+G +G V++         VA+K+  LE  +   ++   E+  + +    +I +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             +G++  ++ E+   GS    +           L    +  I   V  G+EYLH    +
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLH---EE 117

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGYIAPELF 311
             +H DIK  NILL      K++DFG++         ++ T ++     GT  ++APE+ 
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 312 SRNFGEVSYKSDVYSYGMMLLEM 334
            +       K+D++S G+  +E+
Sbjct: 171 KQ--SGYDEKADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 31/232 (13%)

Query: 111 EKFLEDYRTV----NPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKML 165
           E+ LE  RT+    +P +  Y   +KI        GQG  G+V+    +  G  VA+K +
Sbjct: 2   EEILEKLRTIVSVGDPKK-KYTRFEKI--------GQGASGTVYTAIDVATGQEVAIKQM 52

Query: 166 EHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
              +   +E I NE+  +    H +IV  L     G    +V E++  GSL       T+
Sbjct: 53  NLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TD 105

Query: 225 SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
             +   +   ++  +     + +E+LH   NQ ++H DIK  NILL  +   K++DFG  
Sbjct: 106 VVTETCMDEGQIAAVCRECLQALEFLHS--NQ-VIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
              + + S    +   GT  ++APE+ +R  +G    K D++S G+M +EMV
Sbjct: 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 43/114 (37%), Positives = 64/114 (56%), Gaps = 9/114 (7%)

Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
           S +PLS + +K   + + RG++YLH      ILH DIKP N+L++ N   KI DFGLA++
Sbjct: 96  SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Query: 287 CSKDISIVSLTAARGTAGYIAPELF--SRNFGEVSYKSDVYSYGMMLLEMVGCR 338
              D S   +T    T  Y APE+   SR++       D++S G +  E++G R
Sbjct: 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 21/205 (10%)

Query: 140 RLGQGGYGSVFRG--KLFNGIPVAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           +LG+G Y +VF+G  KL   + VA+K   LEH +G     I EV+ +  + H +IV L  
Sbjct: 12  KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV+E++ +  L++++ +  N      +S   +K   F + RG+ Y H+   
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNL-----MSMHNVKIFMFQLLRGLSYCHK--- 121

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ILH D+KP N+L++   + K++DFGLA+  +K +   + +    T  Y  P++     
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVL---L 176

Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++  G +L EM   R
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V        G+ VA+K +   +     Q  + E+  + R  H +I+ +L   
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII 72

Query: 198 SEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
              +  +     +V E M    L K I ++        LS + ++   + + RG++Y+H 
Sbjct: 73  RPPSFESFNDVYIVQELMET-DLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIH- 123

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD-ISIVSLTAARGTAGYIAPELF 311
             N  +LH D+KP N+LL+ N   KI DFGLA++   +      LT    T  Y APE+ 
Sbjct: 124 SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             N    +   D++S G +L EM+  R
Sbjct: 182 -LNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG---QEFINEV 179
           E+   T +F   LG+  +G V++G LF   P      VA+K L+  K  G   +EF +E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEA 59

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK- 238
               R+ H +IV LLG  ++    ++++ +  +  L +F+  ++  S       +K  K 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 239 ---------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCS 288
                    I   +A G+E+L    +  ++H D+   N+L+      KISD GL + + +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 289 KDISIV---SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
            D   +   SL   R    +++PE     +G+ S  SD++SYG++L E+
Sbjct: 177 ADYYKLMGNSLLPIR----WMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 18/202 (8%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LE-HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++G+    G  VA+K   LE   +G     I E++ +  + H +IV L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + +R  L++EF+ +  L+K++ S       + +  E +K   + + +G+ + H    
Sbjct: 67  VLMQESRLYLIFEFL-SMDLKKYLDS---LPKGQYMDAELVKSYLYQILQGILFCHS--- 119

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R+LH D+KP N+L+D+    K++DFGLA+  +  I +   T    T  Y APE+     
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVL---L 174

Query: 316 GEVSYKS--DVYSYGMMLLEMV 335
           G   Y +  D++S G +  EM 
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 70.8 bits (174), Expect = 4e-14
 Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 16/167 (9%)

Query: 169 KGNGQEFINEVATIGRIHHFHIVRL-LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSS 227
           KG+ +  +NE   +  ++H  +V L   F  E     LV + +  G L   +      S 
Sbjct: 41  KGSVRNVLNERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHL------SQ 93

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
               S E++K     +   +EYLH   ++ I+H DIKP NILLD      I+DF +A   
Sbjct: 94  KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150

Query: 288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           + D    S +   GT GY+APE+  R     S   D +S G+   E 
Sbjct: 151 TPDTLTTSTS---GTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYEC 192

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 31/223 (13%)

Query: 137 FKHRLGQGGYGSV----------FRGKLFNGIP-------VAVKML--EHLKGNGQEFIN 177
           FK +LG+G +G V          F  K F+          VAVKML  +  K    +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-----SKTNSSSHRPLS 232
           E+  + R+   +I+RLL  C       ++ E+M NG L +F+           +    +S
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI 291
           +  L  +A  +A G++YL    +   +H D+   N L+  N+  KI+DFG+++ L S D 
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             +   A      +++ E  S   G+ +  SDV+++G+ L E+
Sbjct: 186 YRIQGRAVLPIR-WMSWE--SILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 140 RLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF--INEVATIGRIHHFHIVRLLGF 196
           +LG+G Y +V++G    NG  VA+K++      G  F  I E + +  + H +IV L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP--LSWEKLKKIAFGVARGVEYLHQGC 254
                    V+E+M +  L +++          P  L    ++   F + RG+ Y+H   
Sbjct: 72  IHTKETLTFVFEYM-HTDLAQYM-------IQHPGGLHPYNVRLFMFQLLRGLAYIHG-- 121

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
            Q ILH D+KP N+L+ +  + K++DFGLA+  +K I   + ++   T  Y  P++    
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL--- 175

Query: 315 FGEVSYKS--DVYSYGMMLLEMV 335
            G   Y S  D++  G + +EM+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 38/215 (17%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G V        GKL+    +  K L+  KG  +  + E   + ++H   IV L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY-EGAMVEKRILAKVHSRFIVSLA 59

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNS----SSHRPLSWEKLKKIAFGVARGVEYL 250
                 T   LV   M  G L   I++           R   +         +  G+E+L
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY------TAQIISGLEHL 113

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTA 303
           HQ   +RI++ D+KP N+LLD++   +ISD GLA         V L   +       GT 
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLA---------VELKDGQSKTKGYAGTP 161

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           G++APEL      E  +  D ++ G+ L EM+  R
Sbjct: 162 GFMAPELLQGE--EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.0 bits (174), Expect = 5e-14
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 29/209 (13%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHI 190
           LG+GG+G V        GK++     A K L+      +   Q  +NE   + ++    I
Sbjct: 1   LGKGGFGEVCACQVKATGKMY-----ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           V L           LV   M  G L+  I++             +    A  +  G+E+L
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLKYHIYN----VGEPGFPEARAIFYAAQIICGLEHL 111

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPE 309
           HQ   +RI++ D+KP N+LLD +   +ISD GLA     ++        R GT GY+APE
Sbjct: 112 HQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA----VELKGGKKIKGRAGTPGYMAPE 164

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +         +  D ++ G  L EM+  R
Sbjct: 165 VLQG--EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 28/189 (14%)

Query: 160 VAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLL--GFCSEGTRRALVYEFMPNG 213
           VA+K+L       +     F  E A   R++H +IV LL  G    G   A V+E++P  
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPGR 64

Query: 214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--- 270
           +L + +      ++   L   +  ++   V   +   H   NQ I+H D+KP NI++   
Sbjct: 65  TLREVL------AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 271 DHNFQPKISDFGLAKLCS--KDISIVSLTAAR---GTAGYIAPELFSRNFGE-VSYKSDV 324
                 K+ DFG+  L    +D  + +LT      GT  Y APE      GE V+  SD+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR---GEPVTPNSDL 172

Query: 325 YSYGMMLLE 333
           Y++G++ LE
Sbjct: 173 YAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 21/205 (10%)

Query: 140 RLGQGGYGSVFRG--KLFNGIPVAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           +LG+G Y +V++G  KL + + VA+K   LEH +G     I EV+ +  + H +IV L  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV+E++ +  L++++    NS     ++   +K   F + RG+ Y H+   
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNS-----INMHNVKLFLFQLLRGLNYCHR--- 122

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +++LH D+KP N+L++   + K++DFGLA+  +K I   + +    T  Y  P++     
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDIL---L 177

Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++  G +  EM   R
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.0 bits (175), Expect = 7e-14
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 24/215 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML----EHLKGNGQEFINEVATIGRIHHFHI 190
           +    +G G YG V        G  VA+K +    + L  + +  + E+  +  + H +I
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI-DAKRILREIKLLRHLRHENI 61

Query: 191 VRLLG-FCSEGTRR----ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           + LL               +V E M    L K I       S +PL+ + ++   + + R
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI------KSPQPLTDDHIQYFLYQILR 114

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAG 304
           G++YLH   N  ++H D+KP NIL++ N   KI DFGLA+    D      LT    T  
Sbjct: 115 GLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           Y APEL   +    +   D++S G +  E++  RK
Sbjct: 172 YRAPELLL-SSSRYTKAIDIWSVGCIFAELLT-RK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVR 192
           +    +G G    V+    L N   VA+K   LE  + +  E   EV  + + +H ++V+
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF---GVARGVEY 249
                  G    LV  ++  GSL   + S            E +  IA     V +G+EY
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD----EAI--IATVLKEVLKGLEY 117

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSLTAARGTAGYIA 307
           LH   N +I H DIK  NILL  +   KI+DFG++   +   D +        GT  ++A
Sbjct: 118 LHS--NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
           PE+  +  G   +K+D++S+G+  +E+
Sbjct: 175 PEVMEQVHG-YDFKADIWSFGITAIEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 17/203 (8%)

Query: 140 RLGQGGYGSVFRG--KLFNGIPVAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           +LG+G Y +VF+G  KL   + VA+K   LEH +G     I EV+ +  + H +IV L  
Sbjct: 13  KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV+E++ +  L++++    N      +S   +K   + + RG+ Y H+   
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNI-----MSMHNVKIFLYQILRGLAYCHR--- 122

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +++LH D+KP N+L++   + K++DFGLA+  +K +   + +    T  Y  P++   + 
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGS- 179

Query: 316 GEVSYKSDVYSYGMMLLEMVGCR 338
            E S + D++  G +  EM   R
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 30/209 (14%)

Query: 141 LGQGGYGSVFRGK-LFNGIP-VAVKMLE---HLKGNGQEFINEVATIGRIHHF---HIVR 192
           +G+G YG VF+ + L NG   VA+K +      +G     I EVA +  +  F   ++VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 193 LLGFCS-----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           L   C+       T+  LV+E      +++ + +  +      +  E +K + F + RG+
Sbjct: 69  LFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           ++LH   + R++H D+KP NIL+  + Q K++DFGLA++ S  +++ S+     T  Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRA 177

Query: 308 PELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           PE+  ++    SY +  D++S G +  EM
Sbjct: 178 PEVLLQS----SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 141 LGQGGYGSVFR-------GKLFNGIPVAVKMLEHLKGNGQ------EFINEVATIG-RIH 186
           LG G +G V++         L     + V      K   +      + ++EV  I  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSL-EKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           H +IVR      E  R  +V + +    L E F   K      +  + E++  I   +  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVL 124

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
            + YLH+   +RI+H D+ P+NI+L  + +  I+DFGLAK    +     LT+  GT  Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE---SKLTSVVGTILY 179

Query: 306 IAPELF-SRNFGEVSYKSDVYSYGMMLLEMV 335
             PE+  +  +GE   K+DV+++G +L +M 
Sbjct: 180 SCPEIVKNEPYGE---KADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLG-FC 197
           LG G +G V++ K    G   A K++E       ++++ E+  +   +H +IV+LLG F 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            +G +  ++ EF P G+++  +         R L+  +++ I   +   ++YLH   + +
Sbjct: 80  WDG-KLWIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH---SMK 130

Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLA----KLCSKDISIVSLTAARGTAGYIAPELF-- 311
           I+H D+K  N+LL  +   K++DFG++    K   +  S +      GT  ++APE+   
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMC 184

Query: 312 -SRNFGEVSYKSDVYSYGMMLLEM 334
            +       YK+D++S G+ L+EM
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRL 193
           LG+G +GSV   +L     +   VAVKML+       + +EF+ E A +    H ++++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 194 LGFCSEGTRRA--------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           +G       RA        ++  FM +G L  F+           L  + L +    +A 
Sbjct: 67  IGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           G+EYL    ++  +H D+   N +L+ N    ++DFGL+K            A++    +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +A E  + N       SDV+++G+ + E++
Sbjct: 182 LALESLADNVYTT--HSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 64/232 (27%), Positives = 109/232 (46%), Gaps = 39/232 (16%)

Query: 137 FKHRLGQGGYGSV---------------FRGKLFNGIP--VAVKML--EHLKGNGQEFIN 177
           FK +LG+G +G V               F   +  G P  VAVK+L  +  K    +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT------NSSSHRP- 230
           EV  + R+   +I+RLLG C +     ++ E+M NG L +F+ S        N +   P 
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 231 ------LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
                 +S+  L  +A  +A G++YL    +   +H D+   N L+  N   KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 285 K-LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           + L + D   +   A      ++A E      G+ +  SDV+++G+ L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR-WMAWECIL--MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKML---EHLKGNGQEFINEVATI 182
           Y++L+KI        G+G YG+VF+ K       VA+K +   +  +G     + E+  +
Sbjct: 2   YEKLEKI--------GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL 53

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             + H +IVRL        +  LV+E+  +  L+K+ F   N      +    +K   F 
Sbjct: 54  KELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEI----VKSFMFQ 107

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           + +G+ + H      +LH D+KP N+L++ N + K++DFGLA+  +  I +   +A   T
Sbjct: 108 LLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162

Query: 303 AGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
             Y  P++    FG   Y +  D++S G +  E+
Sbjct: 163 LWYRPPDVL---FGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGR-IHHFHIVRLLG 195
           LG+G YG V + + +  G  +AVK +     N QE    + ++    R +   + V   G
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 196 --FCSEGTRRALVYEFMP--NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
             F     R   V+  M   + SL+KF     +     P   + L KIA  + + +EYLH
Sbjct: 68  ALF-----REGDVWICMEVMDTSLDKFYKKVYDKGLTIP--EDILGKIAVSIVKALEYLH 120

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                 ++H D+KP N+L++ N Q K+ DFG++      +  V+ T   G   Y+APE  
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAKTIDAGCKPYMAPERI 175

Query: 312 S--RNFGEVSYKSDVYSYGMMLLEM 334
           +   N      KSDV+S G+ ++E+
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)

Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V++G   +     I VAVK           ++F+ E   + +  H HIV+L+
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     +V E  P G L  ++  + N  S   L    L   ++ ++  + YL    
Sbjct: 74  GVITENP-VWIVMELAPLGELRSYL--QVNKYS---LDLASLILYSYQLSTALAYLE--- 124

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+      K+ DFGL++    D S    +  +    ++APE  S N
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPE--SIN 181

Query: 315 FGEVSYKSDVYSYGMMLLE--MVGCR-----KNKD 342
           F   +  SDV+ +G+ + E  M+G +     KN D
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVK---MLEHLKGNG-QEFINEVATIGRIHHFHI 190
           + + ++G+G +  V+R   L +  PVA+K   + E +     Q+ + E+  + +++H ++
Sbjct: 5   QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           ++ L    E     +V E    G L + I  K      R +    + K    +   VE++
Sbjct: 65  IKYLDSFIEDNELNIVLELADAGDLSQMI--KYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR---GTAGYIA 307
           H   ++R++H DIKP N+ +      K+ D GL +  S        TAA    GT  Y++
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-----TAAHSLVGTPYYMS 174

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
           PE    N    ++KSD++S G +L EM
Sbjct: 175 PERIHEN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.0 bits (168), Expect = 3e-13
 Identities = 64/228 (28%), Positives = 114/228 (50%), Gaps = 23/228 (10%)

Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK 169
           E+ +E  RT+     +  + KK  ++++ ++GQG  G+VF    +  G  VA+K +   K
Sbjct: 2   EEIMEKLRTI----VSIGDPKKKYTRYE-KIGQGASGTVFTAIDVATGQEVAIKQINLQK 56

Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +  + + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 57  QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL-------TDVVTE 109

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   NQ ++H DIK  N+LL  +   K++DFG     +
Sbjct: 110 TCMDEAQIAAVCRECLQALEFLH--ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166

Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EMV
Sbjct: 167 PEQSKRSTMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)

Query: 141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLG-F 196
           +G+G YG V++ +    G  VA+K++  +  + +E I E   I R +  H  I    G F
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 197 CSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
             +          LV E    GS+   +  K      + L  E +  I     RG+ YLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCS----KDISIVSLTAARGTAGYI 306
                +++H DIK  NILL  N + K+ DFG+ A+L S    ++  I       GT  ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-------GTPYWM 180

Query: 307 APELFSRNFG-EVSY--KSDVYSYGMMLLEM 334
           APE+ + +   + SY  +SDV+S G+  +E+
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 4e-13
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEF--INEVATIGRIHHFHIVRLLGF 196
           +LG+G Y +V++GK   NG  VA+K++   +  G  F  I E + +  + H +IV L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV+E++     +   +   +     P   E +K   F + RG+ Y+HQ   +
Sbjct: 72  IHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHP---ENVKLFLFQLLRGLSYIHQ---R 122

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ILH D+KP N+L+    + K++DFGLA+  +K +   + +    T  Y  P++     G
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL---LG 177

Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++  G + +EM+
Sbjct: 178 STEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 47/136 (34%), Positives = 73/136 (53%), Gaps = 7/136 (5%)

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
           G    L   F P+ S       +T+     PL+ E L   +F VARG+E+L    +++ +
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196

Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEV 318
           H D+   NILL  N   KI DFGLA+   KD   V   +AR    ++APE +F + +   
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY--- 253

Query: 319 SYKSDVYSYGMMLLEM 334
           + +SDV+S+G++L E+
Sbjct: 254 TTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 33/220 (15%)

Query: 130 LKKITSKFKHRLGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFIN----EV 179
           LK+I       LG+G +G V        G    G  VAVK L+    +G   I     E+
Sbjct: 6   LKRIRD-----LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLK--PESGGNHIADLKKEI 57

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             +  ++H +IV+  G C+E       L+ EF+P+GSL++++    N      ++ ++  
Sbjct: 58  EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-----INLKQQL 112

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           K A  + +G++YL  G  Q + H D+   N+L++   Q KI DFGL K    D    ++ 
Sbjct: 113 KYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169

Query: 298 AARGTAGY-IAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
               +  +  APE L    F      SDV+S+G+ L E++
Sbjct: 170 DDLDSPVFWYAPECLIQSKF---YIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.4 bits (164), Expect = 8e-13
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHI 190
           + + ++G+G +  V+R   L +G+PVA+K ++           + I E+  + +++H ++
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 64

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           ++      E     +V E    G L + I  K      R +  + + K    +   +E++
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE 309
           H   ++R++H DIKP N+ +      K+ D GL +   SK  +  SL    GT  Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPE 176

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEM 334
               N    ++KSD++S G +L EM
Sbjct: 177 RIHEN--GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 33/213 (15%)

Query: 141 LGQGGYGSVFRGKLFN---GIPVAVK----MLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           LG+G YGSV+  K+ +   G+ +A+K     L+  K N    I E+  + +    +IV  
Sbjct: 9   LGKGNYGSVY--KVLHRPTGVTMAMKEIRLELDESKFNQ--IIMELDILHKAVSPYIVDF 64

Query: 194 LG-FCSEGTRRALVY---EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
            G F  EG     VY   E+M  GSL+K         +   +  + L++I + V +G+++
Sbjct: 65  YGAFFIEGA----VYMCMEYMDAGSLDKLY---AGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           L +  N  I+H D+KP N+L++ N Q K+ DFG++      ++  ++    G   Y+APE
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPE 171

Query: 310 LFS----RNFGEVSYKSDVYSYGMMLLEM-VGC 337
                        + +SDV+S G+ +LEM +G 
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 20/163 (12%)

Query: 126 TYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATI 182
           TYK+L K        LG+G Y +V++G+    G  VA+K   LEH +G     I E + +
Sbjct: 6   TYKKLDK--------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLL 57

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             + H +IV L           LV+E++ +  L++++           LS   ++   F 
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYM-----DDCGGGLSMHNVRLFLFQ 111

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           + RG+ Y HQ   +R+LH D+KP N+L+    + K++DFGLA+
Sbjct: 112 LLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 89/308 (28%)

Query: 116 DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFR------GKLFNGIPVAVKMLE 166
           +Y  ++PT+  Y    E  +   +F   LG G +G V        GK  N + VAVKML 
Sbjct: 18  NYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML- 76

Query: 167 HLKGNG-----QEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSL----- 215
             K +      +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L     
Sbjct: 77  --KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134

Query: 216 -----------------------------EKFI-----FSKTNSSSH------------- 228
                                        +K+I     FS   S ++             
Sbjct: 135 KKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194

Query: 229 ------------RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 276
                        PL  + L + +  VA+G+++L    ++  +H D+   N+LL      
Sbjct: 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVA 251

Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           KI DFGLA+    D + V    AR    ++APE +F   +   + +SDV+SYG++L E+ 
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIF 308

Query: 336 GCRKNKDP 343
              K+  P
Sbjct: 309 SLGKSPYP 316

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 55/201 (27%), Positives = 85/201 (42%), Gaps = 27/201 (13%)

Query: 143 QGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF-----HIVRLLGF 196
           +G +GSV+   K   G   A+K+L+      +  +  V     I        ++ +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E++  G     I  KT       L  +  K+    V  GVE LHQ   +
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI--KTLG----GLPEDWAKQYIAEVVLGVEDLHQ---R 116

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTAARGTAGYIAPELFSRN 314
            I+H DIKP N+L+D     K++DFGL++  L +K           GT  Y+APE     
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--------GTPDYLAPETILGV 168

Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
             +    SD +S G ++ E +
Sbjct: 169 GDDKM--SDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 80/267 (29%)

Query: 141 LGQGGYGSVFRGKLFNGI-------PVAVKMLEHLKGNGQE--FINEVATIGRI-HHFHI 190
           LG+G +G V     F GI        VAVKML+    + +    ++E+  +  I HH ++
Sbjct: 15  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 73

Query: 191 VRLLG--------------FCSEGTR----RALVYEFMPNGS------------------ 214
           V LLG              FC  G      R+   EF+P  +                  
Sbjct: 74  VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISED 133

Query: 215 ----LEKFIFSKTNSSS----------------------HRPLSWEKLKKIAFGVARGVE 248
               L+    S++++SS                       + L+ E L   +F VA+G+E
Sbjct: 134 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           +L    +++ +H D+   NILL  N   KI DFGLA+   KD   V    AR    ++AP
Sbjct: 194 FL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 250

Query: 309 E-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           E +F R +   + +SDV+S+G++L E+
Sbjct: 251 ETIFDRVY---TIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 61/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)

Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA+K +   +
Sbjct: 2   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ 56

Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 57  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 109

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +++LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 110 TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166

Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EMV
Sbjct: 167 PEQSKRSTMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 17/142 (11%)

Query: 209 FMPNGSLEK---FIFSKTNSSSHR------PLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
             P G+  K    +     S  H       PL+ E ++   + + RG++Y+H      ++
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VI 129

Query: 260 HFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVS-LTAARGTAGYIAPEL-FSRNFG 316
           H D+KP N+L++ + + +I DFG+A+ L S        +T    T  Y APEL  S    
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS--LP 187

Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
           E +   D++S G +  EM+G R
Sbjct: 188 EYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 136 KFKHRLGQGGYGSVFRG-KLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVR 192
           +++  LG G  G+V++   L     +AVK+  L+      ++ ++E+  + +    +I+ 
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
             G      R ++  EFM  GSL+ +          R +    L +IA  V +G+ YL  
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL-- 111

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
             + +ILH D+KP N+L++   Q K+ DFG++      I+        GT  Y+APE  S
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGTNAYMAPERIS 166

Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
               +    SDV+S G+  +E+
Sbjct: 167 GE--QYGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 5e-12
 Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 17/198 (8%)

Query: 140 RLGQGGYGSVFRG-KLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           R+G+G +G V++G        VA+K+  LE  +   ++   E+  + +    +I R  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             +GT+  ++ E++  GS    +          PL    +  I   + +G++YLH   ++
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLH---SE 120

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           R +H DIK  N+LL      K++DFG+A   + D  I   T   GT  ++APE+  ++  
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFV-GTPFWMAPEVIKQS-- 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
              +K+D++S G+  +E+
Sbjct: 177 AYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 25/204 (12%)

Query: 139 HRLGQGGYGSVF--RGKLFNGIPVAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVR 192
             +G G +G+V+  R    N + VA+K + +      E     I EV  + ++ H + + 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHR-PLSWEKLKKIAFGVARGVEYLH 251
             G         LV E+   GS    +        H+ PL   ++  I  G  +G+ YLH
Sbjct: 80  YKGCYLREHTAWLVMEYCL-GSASDIL------EVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-L 310
              +   +H DIK  NILL      K++DFG A L S   S V      GT  ++APE +
Sbjct: 133 ---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVI 183

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEM 334
            + + G+   K DV+S G+  +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 18/204 (8%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVA---VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +R+G+G YG V+R +   +G  VA   V+M     G     + E+  +  + H +IV L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                   + L   F+     E+ + S  ++    P S  ++K +   + RG++YLH+  
Sbjct: 73  EVV---VGKHLDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
              I+H D+K  N+LL      KI+DFGLA+     +    +T    T  Y APEL    
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTPKVVTLWYRAPELL--- 180

Query: 315 FGEVSYKS--DVYSYGMMLLEMVG 336
            G  +Y +  D+++ G +L E++ 
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 33/231 (14%)

Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-----VAVKMLEHLKGNGQ 173
            ++  R T  +L          L +G +G +F G L +  P     V VK +   K +  
Sbjct: 2   AISRDRVTLSDL----------LQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHAS 48

Query: 174 E-----FINEVATIGRIHHFHIVRLLGFCSEGTRRALV-YEFMPNGSLEKFIFSKTNSS- 226
           E      + E   +  + H +I+ +L  C E      V Y +M  G+L+ F+        
Sbjct: 49  EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA 108

Query: 227 -SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
            + + LS ++L  +A  +A G+ YLH    + ++H DI   N ++D   Q KI+D  L++
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165

Query: 286 -LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            L   D   +     R    ++A E         S  SDV+S+G++L E++
Sbjct: 166 DLFPMDYHCLGDNENRPVK-WMALESLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.5 bits (157), Expect = 6e-12
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 141 LGQGGYGSVF--RGK------LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVR 192
           +G+G +G V   R K      +   IPV  +M +  +   Q   NE   +  + H +I+ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVE-QMTKDERLAAQ---NECQVLKLLSHPNIIE 63

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
                 E     +V E+ P G+L ++I  + NS     L  + +      +   + ++H 
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL----LDEDTILHFFVQILLALHHVHT 119

Query: 253 GCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLC---SKDISIVSLTAARGTAGYIAP 308
              + ILH D+K  NILLD H    KI DFG++K+    SK  ++V      GT  YI+P
Sbjct: 120 ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV------GTPCYISP 170

Query: 309 ELF-SRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           EL   + + +   KSD+++ G +L E+   ++  + A
Sbjct: 171 ELCEGKPYNQ---KSDIWALGCVLYELASLKRAFEAA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG-FC 197
           +G G YG V++G+ +  G   A+K+++      +E   E+  + +  HH +I    G F 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 198 SEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +       +  LV EF   GS+   I     ++    L  E +  I   + RG+ +LHQ
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
               +++H DIK  N+LL  N + K+ DFG++     D ++       GT  ++APE+ +
Sbjct: 130 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 313 RNF---GEVSYKSDVYSYGMMLLEM 334
            +        +KSD++S G+  +EM
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)

Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57

Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 110

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167

Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 168 PEQSKRSTMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 50/200 (25%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCS 198
           LG G +G V++ +    G+  A K+++       E F+ E+  +    H +IV L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
              +  ++ EF   G+L+  +         R L+  +++ +   +   + +LH   + ++
Sbjct: 73  YENKLWILIEFCDGGALDSIMLE-----LERGLTEPQIRYVCRQMLEALNFLH---SHKV 124

Query: 259 LHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPELFS-RNFG 316
           +H D+K  NILL  +   K++DFG+ AK  S      +     GT  ++APE+ +   F 
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFK 181

Query: 317 EVSY--KSDVYSYGMMLLEM 334
           +  Y  K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 53/236 (22%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVK-MLEHLKGNGQEF----INEVA 180
           Y+ L K        LG+G +G V++  ++  G  VA+K +L H + +G  F    + E+ 
Sbjct: 10  YEILGK--------LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG--FPITALREIK 59

Query: 181 TIGRIHHFHIVRLLGFCSE-----GTRRALVYEFMP------NGSLEKFIFSKTNSSSHR 229
            + ++ H ++V L+    E       +R  VY   P      +G LE       N S   
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-------NPSVK- 111

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
            L+  ++K     +  G+ YLH+     ILH DIK  NIL+D+    KI+DFGLA+    
Sbjct: 112 -LTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 290 DISIVSLTAARGTAGYI---------APELFSRNFGEVSYKS--DVYSYGMMLLEM 334
                      GT  Y           PEL     GE  Y +  D++  G +  EM
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELL---LGERRYTTAVDIWGIGCVFAEM 220

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 25/204 (12%)

Query: 141 LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G V        GK++    +  K ++  KG     +NE   + +++   +V L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSRFVVSLA 66

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR---GVEYLH 251
                     LV   M  G L+  I+    +            +  F  A    G+E LH
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-------RAVFYAAEICCGLEDLH 119

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
           Q   +RI++ D+KP NILLD +   +ISD GLA    +  +I       GT GY+APE+ 
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVGYMAPEVV 173

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                  ++  D ++ G +L EM+
Sbjct: 174 KNE--RYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 52/200 (26%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLL-GFC 197
           LG G +G V++ +    G+  A K+++   +   ++++ E+  +    H +IV+LL  F 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            E     L+ EF   G+++  +         RPL+  +++ +       + YLH+    +
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHE---NK 123

Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF---SRN 314
           I+H D+K  NIL   +   K++DFG++   ++  +I    +  GT  ++APE+    +  
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 315 FGEVSYKSDVYSYGMMLLEM 334
                YK+DV+S G+ L+EM
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 139 HRLGQGGYGSV-FRGKLFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRL 193
           H +G G +G+V F         VAVK + +         Q+ I EV  + ++ H + +  
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G   +     LV E+    + +     K      +PL   ++  I  G  +G+ YLH  
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH 140

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFS 312
               ++H DIK  NILL    Q K++DFG A   S   S V      GT  ++APE + +
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILA 191

Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
            + G+   K DV+S G+  +E+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.8 bits (153), Expect = 2e-11
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 141 LGQGGYGS--VFRGKLFNGIPV--AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           LG+G +G   ++R    + + V   V +    +   ++ +NE+  +  + H +I+     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 197 CSEGTRRALVYEFMPNGSL-EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             +     +  E+   G+L +K +  K        + W       F +   V Y+H+   
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHK--- 119

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ILH DIK  NI L      K+ DFG++K+   + S+       GT  Y++PEL     
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV--GTPYYMSPELCQGV- 176

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
            + ++KSD+++ G +L E++  ++
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQEFINEVATIGRI----HHFH 189
           K   ++G+G +  V + +    G   A+K + +H K   Q  +N +  I  +     H +
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPN 59

Query: 190 IVRLLG--FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+RL+   F  +  R ALV+E M + +L + I  +      RPL  +++K   + + + +
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGR-----KRPLPEKRVKSYMYQLLKSL 113

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
           +++H+     I H DIKP NIL+  +   K++DFG  + + SK       T    T  Y 
Sbjct: 114 DHMHR---NGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKP----PYTEYISTRWYR 165

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE    + G    K D+++ G +  E++
Sbjct: 166 APECLLTD-GYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 40/228 (17%)

Query: 131 KKITSKF--KHRLGQGGYGSVFRG--KLFNGIPVAVKMLEHLKGN---GQEFINEVATIG 183
           K I  K+    +LG+G YG V++   +    + VA+K +     N    Q    E+  + 
Sbjct: 3   KHILRKYEILQKLGKGAYGIVWKAIDRRTKEV-VALKKIFDAFRNATDAQRTFREIMFLQ 61

Query: 184 RI-HHFHIVRLLGFCSEGTRRA-------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
            +  H +IV+LL        +A       LV+E+M    L   I +      H+      
Sbjct: 62  ELGDHPNIVKLLN-----VIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHK------ 109

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIV 294
            + I + + + ++Y+H G    ++H D+KP NILL+ + + K++DFGLA+ L   + +  
Sbjct: 110 -RYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 295 S--LTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCR 338
           +  LT    T  Y APE+     G   Y    D++S G +L EM+  +
Sbjct: 166 NPVLTDYVATRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLE--HLKGNGQEFIN--EVATIGRIHHFHIVRLLG 195
           LG+GG+G V   ++ N G   A K L+   LK    E +   E   + +++   IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                T   LV   M  G L+  I++       R L  E++   +  +  G+ +LH    
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSAQITCGILHLHS--- 113

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             I++ D+KP N+LLD     ++SD GLA       +I   T   GT GY+APE+     
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEE- 169

Query: 316 GEVSYKSDVYSYGMMLLEMVGCR 338
              SY  D ++ G  + EMV  R
Sbjct: 170 -PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 40/227 (17%)

Query: 126 TYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-F----INEV 179
            Y++L KI        GQG +G VF+ +       VA+K +  L  N +E F    + E+
Sbjct: 13  KYEKLAKI--------GQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREI 62

Query: 180 ATIGRIHHFHIVRLLGFC-SEGTR----RA---LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
             +  + H ++V L+  C ++ T     +    LV+EF  +  L   +     S+ +   
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-----SNKNVKF 116

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--K 289
           +  ++KK+   +  G+ Y+H+    +ILH D+K  NIL+  +   K++DFGLA+  S  K
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173

Query: 290 DISIVSLTAARGTAGYIAPELF--SRNFGEVSYKSDVYSYGMMLLEM 334
           +      T    T  Y  PEL    R++G      D++  G ++ EM
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 29/219 (13%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLG 195
           LG G  G+V   K + +G P AVK+++ ++G  +   N    EV  +     F IV+   
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95

Query: 196 FCSEGTRR------------ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            C E   +            ALV ++   G L + I  K+ + ++R     +   +   V
Sbjct: 96  -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI--KSRAKTNRTFREHEAGLLFIQV 152

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
              V ++H   ++ ++H DIK  NILL  N   K+ DFG +K+ +  +S        GT 
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
            Y+APE++ R     S K+D++S G++L E++  ++  D
Sbjct: 210 YYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 31/210 (14%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATI-------GRIHHFHIVR 192
           LGQG +G V+       G  +AVK ++       E   EV  +         + H  IV+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 193 LLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
             G   +   R L    E MP GS+      K    S+  L+    +K    +  GV YL
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDISIVSLTAARGTAGYI 306
           H   +  I+H DIK  NIL D     K+ DFG +K    +C     + S+T   GT  ++
Sbjct: 123 H---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWM 176

Query: 307 APELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
           +PE+ S   +G    K+D++S G  ++EM+
Sbjct: 177 SPEVISGEGYGR---KADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 75/254 (29%), Positives = 113/254 (44%), Gaps = 47/254 (18%)

Query: 94  IYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK 153
           ++K ++S+  KE + K +   ED+                   F   LG G +G V    
Sbjct: 9   LHKKKDSDSTKEPKRKNKMKYEDF------------------NFIRTLGTGSFGRVILAT 50

Query: 154 LFNG--IPVAVKMLEHLKGNGQEFINEVAT----IGRIHHFHIVRLLGFCSEGTRRALVY 207
             N    PVA+K  E  K   Q+ ++ V +    +  I+H   V L G   + +   LV 
Sbjct: 51  YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110

Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV---EYLHQGCNQRILHFDIK 264
           EF+  G  E F F + N      +         F  A+ V   EYL Q  N  I++ D+K
Sbjct: 111 EFVIGG--EFFTFLRRNKRFPNDVG-------CFYAAQIVLIFEYL-QSLN--IVYRDLK 158

Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDV 324
           P N+LLD +   K++DFG AK+   D    +L    GT  YIAPE+   N G     +D 
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVV--DTRTYTLC---GTPEYIAPEIL-LNVGH-GKAADW 211

Query: 325 YSYGMMLLEM-VGC 337
           ++ G+ + E+ VGC
Sbjct: 212 WTLGIFIYEILVGC 225

Length = 340

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 46/198 (23%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 140 RLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           R+G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             +GT+  ++ E++  GS    + +        P    ++  +   + +G++YLH   ++
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLH---SE 120

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + +H DIK  N+LL      K++DFG+A   + D  I   T   GT  ++APE+  ++  
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFV-GTPFWMAPEVIQQS-- 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
               K+D++S G+  +E+
Sbjct: 177 AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 8e-11
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 141 LGQGGYGSVFRGKLFNG-----------IPVAVKMLEHLKGNGQEFINEVATIGRIHHFH 189
           LGQG + ++++G L              + V +K+L     +   F    + + ++ H H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           +V+L G C       +V E++  G L+ F+  + N   +  L W KL  +A  +A  + Y
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN---NVSLHW-KL-DVAKQLASALHY 116

Query: 250 LHQGCNQRILHFDIKPHNILL-----DHNFQP--KISDFGLAKLCSKDISIVSLTAARGT 302
           L    +++++H ++   NIL+     +  + P  K+SD G+       I+++S       
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP------ITVLSREERVER 167

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
             +IAPE        ++  +D +S+G  LLE+  C   ++P
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI--CSNGEEP 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G+V F   +     VA+K + +         Q+ I EV  + RI H + +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV E+    + +     K      +PL   ++  I  G  +G+ YLH   +
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLH---S 143

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRN 314
             ++H DIK  NILL    Q K++DFG A + S   S V      GT  ++APE + + +
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMD 197

Query: 315 FGEVSYKSDVYSYGMMLLEM 334
            G+   K DV+S G+  +E+
Sbjct: 198 EGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 41/112 (36%), Positives = 64/112 (57%), Gaps = 12/112 (10%)

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S H   S  +++  A  +  G+E++H   N+ +++ D+KP NILLD +   +ISD GLA 
Sbjct: 89  SQHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA- 144

Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            C  D S     A+ GT GY+APE+  +    V+Y S  D +S G ML +++
Sbjct: 145 -C--DFSKKKPHASVGTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 35/209 (16%)

Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKML-------EHLKGNGQEFINEVATIGRIHHFHIVR 192
           +G G YG V        G  VA+K L        H K        E+  +  + H +++ 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT----YRELRLLKHMDHENVIG 78

Query: 193 LLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LL  F    +        LV   M    L   +         + LS + ++ + + + RG
Sbjct: 79  LLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV-------KCQKLSDDHIQFLVYQILRG 130

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           ++Y+H      I+H D+KP NI ++ + + KI DFGLA+    +     +T    T  Y 
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 182

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE+   N+   +   D++S G ++ E++
Sbjct: 183 APEIM-LNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 27/187 (14%)

Query: 142 GQGGYGSVFRGKLFNGIP---VAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           G+G YG V++ K  NG      A+K  +       G  Q    E+A +  + H ++V L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 195 GFCSEGTRRA--LVYEFMPNGSLE--KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
               E   ++  L++++  +   +  KF       S    +    +K + + +  GV YL
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM----VKSLLWQILNGVHYL 124

Query: 251 HQGCNQRILHFDIKPHNILL--DHNFQP--KISDFGLAKLCSKDISIVSLTAARG---TA 303
           H      +LH D+KP NIL+  +   +   KI D GLA+L +    +  L        T 
Sbjct: 125 HS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA--PLKPLADLDPVVVTI 179

Query: 304 GYIAPEL 310
            Y APEL
Sbjct: 180 WYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G+V+  + + N   VA+K + +         Q+ I EV  + ++ H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV E+    + +     K      +PL   ++  +  G  +G+ YLH   +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---S 133

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRN 314
             ++H D+K  NILL      K+ DFG A + +     V      GT  ++APE + + +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 187

Query: 315 FGEVSYKSDVYSYGMMLLEM 334
            G+   K DV+S G+  +E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)

Query: 110 VEKFLEDYR-TVNPTRYTYKELKKITSKFKHRLGQGGYGSV--FRGKLFNGIPVAVKML- 165
           ++ FL  Y+ T+N  R     +K    +    +G+G +G V   R K    +  A+K+L 
Sbjct: 21  IDNFLNRYKDTINKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-YAMKLLS 77

Query: 166 --EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA-LVYEFMPNGSLEKFIFSK 222
             E +K +   F  E   I    +   V  L +  +  R   +V E+MP G L   +   
Sbjct: 78  KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--- 134

Query: 223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
             S+   P  W +     F  A  V  L    +   +H D+KP N+LLD +   K++DFG
Sbjct: 135 --SNYDVPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMV 335
                +K+  +V    A GT  YI+PE+     G+  Y  + D +S G+ L EM+
Sbjct: 188 TCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 40/212 (18%)

Query: 141 LGQGGYGSVF---------RGKLFNGIPVAVKMLEH--LK-GNGQEFINEVATIGRIHHF 188
           LGQG +G VF          G+L+     A+K+L+   LK  +      E   +  ++H 
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLY-----AMKVLKKATLKVRDRVRTKMERDILAEVNHP 58

Query: 189 HIVRL-LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            IV+L   F +EG +  L+ +F+  G L    F  T  S     + E +K     +A  +
Sbjct: 59  FIVKLHYAFQTEG-KLYLILDFLRGGDL----F--TRLSKEVMFTEEDVKFYLAELALAL 111

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC----SKDISIVSLTAARGTA 303
           ++LH   +  I++ D+KP NILLD     K++DFGL+K       K  S        GT 
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTV 162

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            Y+APE+ +R  G  +  +D +S+G+++ EM+
Sbjct: 163 EYMAPEVVNRR-GH-TQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 47/135 (34%), Positives = 70/135 (51%), Gaps = 14/135 (10%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +VYE M +  L + I       S + LS +  +   + + RG++Y+H      +LH D+K
Sbjct: 86  IVYELM-DTDLHQII------RSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLK 135

Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDV 324
           P N+LL+ N   KI DFGLA+  S+      +T    T  Y APEL   N  E +   DV
Sbjct: 136 PSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELL-LNCSEYTTAIDV 192

Query: 325 YSYGMMLLEMVGCRK 339
           +S G +  E++G RK
Sbjct: 193 WSVGCIFAELLG-RK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 46/233 (19%)

Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRG--KLFNGIPVA---VKMLEHLKGNGQEFINEV 179
             Y++L +I         +G YG V+R   K    I VA   +KM +  +G     + E+
Sbjct: 5   DEYEKLNRIE--------EGTYGVVYRARDKKTGEI-VALKKLKMEKEKEGFPITSLREI 55

Query: 180 ATIGRIHHFHIVRL----LGFCSEGTRRALVYEFMPN---GSLEKFIFSKTNSSSHRPLS 232
             + ++ H +IV +    +G  S   +  +V E++ +     +E            +P  
Sbjct: 56  NILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETM---------KQPFL 104

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             ++K +   +  GV +LH      ILH D+K  N+LL++    KI DFGLA+     + 
Sbjct: 105 QSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 293 IVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMVGCRKNKDP 343
               T    T  Y APEL     G   Y    D++S G +  E++     K P
Sbjct: 162 --PYTQLVVTLWYRAPELL---LGAKEYSTAIDMWSVGCIFAELL----TKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 43/198 (21%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 140 RLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   ++
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---SE 120

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + +H DIK  N+LL  + + K++DFG+A   +   + +      GT  ++APE+  ++  
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS-- 176

Query: 317 EVSYKSDVYSYGMMLLEM 334
               K+D++S G+  +E+
Sbjct: 177 AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 54/199 (27%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEV---ATIGR------------- 184
           LG+GGYG VF+ +   G              G+ F  +V   ATI R             
Sbjct: 4   LGKGGYGKVFQVRKVTG-----------ADTGKIFAMKVLKKATIVRNQKDTAHTKAERN 52

Query: 185 ----IHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEK 235
               + H  IV L+     G +  L+ E++  G L      + IF +  +  +       
Sbjct: 53  ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY------- 105

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L +I+  +    E+LHQ   Q I++ D+KP NILLD     K++DFG   LC + I   +
Sbjct: 106 LSEISLAL----EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFG---LCKESIHEGT 155

Query: 296 LTAAR-GTAGYIAPELFSR 313
           +T    GT  Y+APE+  R
Sbjct: 156 VTHTFCGTIEYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 141 LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G V        GK++    +  K ++  KG     +NE   + +++   +V L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQFVVNLA 66

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                     LV   M  G L+  I++  N         E+    A  +  G+E LH+  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLEDLHR-- 120

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSLTAARGTAGYIAPELFSR 313
            +  ++ D+KP NILLD     +ISD GLA K+   +    S+    GT GY+APE+ + 
Sbjct: 121 -ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNN 175

Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                +   D +  G ++ EM+
Sbjct: 176 Q--RYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 14/152 (9%)

Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            ++H  ++R+      G    +V   +P+ S + + +    S   RPL  ++   I   +
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRS---RPLPIDQALIIEKQI 166

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
             G+ YLH    QRI+H D+K  NI ++   Q  I D G A+      + + L    GT 
Sbjct: 167 LEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA---GTV 220

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              APE+ +R+  + + K+D++S G++L EM+
Sbjct: 221 ETNAPEVLARD--KYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 27/205 (13%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHF---HIVRLL 194
           +G+G YG+V+RGK +  G  VA+K+  L+    +  +   EVA + ++      +I +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G   +G R  ++ E+   GS+              P++ + +  I   V   ++Y+H+  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTL-------MKAGPIAEKYISVIIREVLVALKYIHK-- 119

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL----CSKDISIVSLTAARGTAGYIAPEL 310
              ++H DIK  NIL+ +    K+ DFG+A L     SK  + V      GT  ++APE+
Sbjct: 120 -VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV------GTPYWMAPEV 172

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
                     K+D++S G+ + EM 
Sbjct: 173 I-TEGKYYDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 19/198 (9%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLG-F 196
           LG G  G V + +      +  + L HL+       + I E+  +   +  +IV   G F
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            S+G   ++  E M  GSL++ +         + +  E L K++  V RG+ YL +    
Sbjct: 73  YSDG-EISICMEHMDGGSLDQVL------KEAKRIPEEILGKVSIAVLRGLAYLRE--KH 123

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  Y++PE       
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT-- 177

Query: 317 EVSYKSDVYSYGMMLLEM 334
             S +SD++S G+ L+E+
Sbjct: 178 HYSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG-FC 197
           +G G YG V++G+ +  G   A+K+++  +   +E   E+  + +  HH +I    G F 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 198 SEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +       +  LV EF   GS+   +   T  ++   L  + +  I   + RG+ +LH 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNA---LKEDWIAYICREILRGLAHLHA 139

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
               +++H DIK  N+LL  N + K+ DFG++     D ++       GT  ++APE+ +
Sbjct: 140 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIA 194

Query: 313 RNFGEVS---YKSDVYSYGMMLLEM 334
            +    +   Y+SD++S G+  +EM
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKM--LEHLK-GNGQEFINEVATIGRIHHFHIVRL--- 193
           +G+G YG V++ +    G  VA+K   L++ K G     I E+  + +++H +IV L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 194 -------LGFCSEGTRRALVYEFMPN---GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
                  L F  +     LV+E+M +   G LE    S     S      + +K     +
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE----SGLVHFSE-----DHIKSFMKQL 125

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
             G+ Y H    +  LH DIK  NILL++  Q K++DFGLA+L + +      T    T 
Sbjct: 126 LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-ESRPYTNKVITL 181

Query: 304 GYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
            Y  PEL     GE  Y    DV+S G +L E+
Sbjct: 182 WYRPPELL---LGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           E+  +  + H  IV+  G   +   + L    E+MP GS+      K    ++  L+   
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENV 107

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDI 291
            ++    + +GV YLH   +  I+H DIK  NIL D     K+ DFG +K    +C    
Sbjct: 108 TRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164

Query: 292 SIVSLTAARGTAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
            I S+T   GT  +++PE+ S   +G    K+DV+S    ++EM+
Sbjct: 165 GIKSVT---GTPYWMSPEVISGEGYGR---KADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 68/242 (28%), Positives = 108/242 (44%), Gaps = 37/242 (15%)

Query: 110 VEKFLEDYRTVNPTRYTYKELKKITSKFKHR-----LGQGGYGSV--FRGKLFNGIPVAV 162
           ++ FL  Y  +       ++++K+  K +       +G+G +G V   R K    +  A+
Sbjct: 21  IDNFLNRYEKI------VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV-YAM 73

Query: 163 KML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEK 217
           K+L   E +K +   F  E   I    +   V  L FC+    + L  V E+MP G L  
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVN 132

Query: 218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 277
            +     S+   P  W K     F  A  V  L    +  ++H D+KP N+LLD +   K
Sbjct: 133 LM-----SNYDVPEKWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK 182

Query: 278 ISDFGLAKLCSK--DISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLE 333
           ++DFG    C K  +  +V    A GT  YI+PE+     G+  Y  + D +S G+ L E
Sbjct: 183 LADFG---TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239

Query: 334 MV 335
           M+
Sbjct: 240 ML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 137 FKHR--LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           F+H   LG+GG+G V        GK++    +  K ++  KG     +NE   + +++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSR 60

Query: 189 HIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            +V L  +  E T+ AL  V   M  G L+  I++  N         ++    A  +  G
Sbjct: 61  FVVSL-AYAYE-TKDALCLVLTIMNGGDLKFHIYNMGNPG----FDEQRAIFYAAELCCG 114

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +E L +   +RI++ D+KP NILLD     +ISD GLA    +  ++       GT GY+
Sbjct: 115 LEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV---RGRVGTVGYM 168

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE+ +    + ++  D +  G ++ EM+
Sbjct: 169 APEVINNE--KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 41/126 (32%), Positives = 64/126 (50%), Gaps = 15/126 (11%)

Query: 214 SLEKF---IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 270
           SL+KF   ++    S     +  E L KIA    + + YL +    +I+H D+KP NILL
Sbjct: 88  SLDKFYKYVYEVLKSV----IPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILL 141

Query: 271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYG 328
           D N   K+ DFG   +  + +  ++ T   G   Y+APE    +  +  Y  +SDV+S G
Sbjct: 142 DRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSARD-GYDVRSDVWSLG 197

Query: 329 MMLLEM 334
           + L E+
Sbjct: 198 ITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIG 183
           Y++LK I S       QG   + F   L  GI VAVK L     N    +    E+  + 
Sbjct: 23  YQQLKPIGSG-----AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLK 75

Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSHRPLSWE 234
            ++H +I+ LL              F P  SLE+F         + +      H  L  E
Sbjct: 76  CVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE 123

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           ++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+    +  + 
Sbjct: 124 RMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 180

Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
                R    Y APE+     G + YK   D++S G ++ E+V
Sbjct: 181 PYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 23/200 (11%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLG-F 196
           LG G  G V +     +G+ +A K+  LE       + I E+  +   +  +IV   G F
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            S+G   ++  E M  GSL++ +           +    L KI+  V RG+ YL +    
Sbjct: 69  YSDG-EISICMEHMDGGSLDQVL------KKAGRIPENILGKISIAVLRGLTYLRE--KH 119

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +I+H D+KP NIL++   + K+ DFG++   + S   S V      GT  Y++PE     
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 173

Query: 315 FGEVSYKSDVYSYGMMLLEM 334
               + +SD++S G+ L+EM
Sbjct: 174 --HYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 40/212 (18%)

Query: 141 LGQGGYGSVF------RGKLF-----NGIPVAVKMLEHLKGNGQEFINEVAT------IG 183
           +G+GG+G V+       GK++     +   + +K  E L  N +  ++ V+T      + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
             + FH    L F         + + M  G L   +      S H   S ++++  A  +
Sbjct: 62  MTYAFHTPDKLCF---------ILDLMNGGDLHYHL------SQHGVFSEKEMRFYATEI 106

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
             G+E++H   N+ +++ D+KP NILLD +   +ISD GLA  C  D S     A+ GT 
Sbjct: 107 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASVGTH 159

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           GY+APE+  +     S  +D +S G ML +++
Sbjct: 160 GYMAPEVLQKGTAYDS-SADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.5 bits (141), Expect = 8e-10
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 22/165 (13%)

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALV--YEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           E+  +  + H  IV+  G   +   + L    E+MP GS+      K    ++  L+   
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESV 107

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK----LCSKDI 291
            +K    +  G+ YLH   +  I+H DIK  NIL D     K+ DFG +K    +C    
Sbjct: 108 TRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164

Query: 292 SIVSLTAARGTAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
            I S+T   GT  +++PE+ S   +G    K+DV+S G  ++EM+
Sbjct: 165 GIRSVT---GTPYWMSPEVISGEGYGR---KADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 137 FKHR--LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           F+H   LG+GG+G V        GK++    +  K ++  KG     +NE   + +++  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60

Query: 189 HIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            +V L  +  E T+ AL  V   M  G L+  I++  N         E+    A  +  G
Sbjct: 61  FVVSL-AYAYE-TKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCG 114

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGY 305
           +E LH+   +RI++ D+KP NILLD     +ISD GLA     +I        R GT GY
Sbjct: 115 LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGY 167

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +APE+        ++  D +  G ++ EM+
Sbjct: 168 MAPEVVKNE--RYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK-MLE-----HLKGNGQEFINEVATIGRIHHFHIVR 192
           ++G+G YG VF+ +    G  VA+K  +E      +K   +  + E+  + ++ H ++V 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIALREIRMLKQLKHPNLVN 64

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L+       +  LV+E+  +  L +         + R +    +KKI +   + V + H+
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNEL------EKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS-KDISIVSLTAARGTAGYIAPELF 311
                 +H D+KP NIL+    Q K+ DFG A++ +          A R    Y APEL 
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WYRAPELL 172

Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
               G+  Y    DV++ G +  E++
Sbjct: 173 ---VGDTQYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVK-MLEHLK--GNGQEFINEVATIGRIHHFHIVRLLG- 195
           +G G +G V   +    G  VA+K +++        +    E+  +  + H +I+ L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F S       V E +    L + + S       RPL  + ++   + + RG++Y+H    
Sbjct: 78  FISPLEDIYFVTELLGT-DLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSA-- 127

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE--LFSR 313
             ++H D+KP NIL++ N   KI DFGLA+     I    +T    T  Y APE  L  +
Sbjct: 128 -GVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVSTRYYRAPEIMLTWQ 181

Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
            +     + D++S G +  EM+
Sbjct: 182 KYDV---EVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 32/223 (14%)

Query: 124 RYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK----MLEHLKGNGQEFINE 178
           RY  +E+          +G+G YG V        G  VA+K    + EH+  +    + E
Sbjct: 1   RYKIQEV----------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILRE 49

Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
           +  +  + H  IV +       +RR      +V+E M    L + I  K N      L+ 
Sbjct: 50  IKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI--KANDD----LTP 102

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-S 292
           E  +   + + R ++Y+H      + H D+KP NIL + + + KI DFGLA++   D  +
Sbjct: 103 EHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159

Query: 293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +  T    T  Y APEL    F + +   D++S G +  E++
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLG-F 196
           ++G+G YG V++ K  +G       L+ ++G G       E+A +  + H +++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 197 CSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK--LKKIAFGVARGVEYLHQG 253
            S   R+  L++++  +       F + + ++ +P+   +  +K + + +  G+ YLH  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 126

Query: 254 CNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDIS-IVSLTAARGTAGYIAP 308
               +LH D+KP NIL+        + KI+D G A+L +  +  +  L     T  Y AP
Sbjct: 127 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 309 ELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           EL     G   Y    D+++ G +  E++
Sbjct: 185 ELL---LGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 1e-09
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 17/210 (8%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G V   +++    VA  +++ LK N       EF+ +      + H +I++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE-KLKKIAFGVARGVEYLHQGC 254
            C E     LV+E+   G L+ ++   +    HR  S    L+++A  +A GV ++H+  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-- 117

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
               LH D+   N  L  +   K+ D+G+     K+  I +         ++APEL    
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 315 FG-----EVSYKSDVYSYGMMLLEMVGCRK 339
            G     E +  S+V++ G+ L E+     
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAA 206

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 7/159 (4%)

Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
           +E+  +    HF IV+         +  L+ E+   G L K I  K     H P    ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYEV 171

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
             + + +   ++ +H   +++++H D+K  NI L      K+ DFG +K  S  +S+   
Sbjct: 172 GLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++  GT  Y+APEL+ R     S K+D++S G++L E++
Sbjct: 229 SSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLG-F 196
           ++G+G YG V++ K  +G       L+ ++G G       E+A +  + H +++ L   F
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 197 CSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK--LKKIAFGVARGVEYLHQG 253
            S   R+  L++++  +       F + + ++ +P+   +  +K + + +  G+ YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA- 126

Query: 254 CNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDIS-IVSLTAARGTAGYIAP 308
               +LH D+KP NIL+        + KI+D G A+L +  +  +  L     T  Y AP
Sbjct: 127 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 309 ELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           EL     G   Y    D+++ G +  E++
Sbjct: 185 ELL---LGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 37/105 (35%), Positives = 60/105 (57%), Gaps = 7/105 (6%)

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L  E L   ++ VA+G+ +L    ++  +H D+   NILL H    KI DFGLA+    D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 291 ISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            + V    AR    ++APE +F+  +   +++SDV+SYG++L E+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRLLGF 196
            R+G G YG V++ +  N G   A+K+++   G     +  E+  +    H +IV   G 
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                +  +  EF   GSL+  I+  T      PLS  ++  ++    +G+ YLH   ++
Sbjct: 75  YLRRDKLWICMEFCGGGSLQD-IYHVTG-----PLSESQIAYVSRETLQGLYYLH---SK 125

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RNF 315
             +H DIK  NILL  N   K++DFG++   +   +I    +  GT  ++APE+ +    
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 316 GEVSYKSDVYSYGMMLLEM 334
           G  +   D+++ G+  +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLG-F 196
           LG G  G VF+        +  + L HL+       + I E+  +   +  +IV   G F
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            S+G   ++  E M  GSL++ +  K        +  + L K++  V +G+ YL +    
Sbjct: 73  YSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVIKGLTYLRE--KH 123

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  Y++PE       
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT-- 177

Query: 317 EVSYKSDVYSYGMMLLEM 334
             S +SD++S G+ L+EM
Sbjct: 178 HYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 22/202 (10%)

Query: 141 LGQGGYGSVF--RGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
           +G+G +G ++  + K  +   V +K ++  K   +E      EV  + ++ H +IV    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNS--SSHRPLSWEKLKKIAFGVARGVEYLHQG 253
              E  R  +V E+   G L K I  +     S  + LSW         ++ G++++H  
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH-- 118

Query: 254 CNQRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
            +++ILH DIK  NI L  N    K+ DFG+A+  +  + +       GT  Y++PE+  
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV--GTPYYLSPEICQ 175

Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
                 + K+D++S G +L E+
Sbjct: 176 NR--PYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 7/102 (6%)

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L K+   + + + YL +     ++H D+KP NILLD +   K+ DFG++    + +   +
Sbjct: 116 LGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS---GRLVDSKA 170

Query: 296 LTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMV 335
            T + G A Y+APE          Y  ++DV+S G+ L+E+ 
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 44/234 (18%)

Query: 131 KKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN----------GQEFIN-- 177
           ++   K  H LG+G YG V +      G  VA+K ++ ++ +          G   I+  
Sbjct: 8   ERYIQKGAH-LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66

Query: 178 ---EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
              E+  +  I H +I+ L+    EG    LV + M    L+K +  K        L+  
Sbjct: 67  TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR------LTES 119

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--------- 285
           ++K I   +  G+  LH       +H D+ P NI ++     KI+DFGLA+         
Sbjct: 120 QVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 286 LCSKDISIVS---LTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
             SKD ++     +T+   T  Y APEL     G   Y    D++S G +  E+
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAEL 227

Length = 335

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 28/185 (15%)

Query: 163 KMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI 219
           K  EH+    G       E   +  I+H  I++L G  +      L+   +P    + + 
Sbjct: 115 KTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYC 171

Query: 220 FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 279
           +     ++ R ++   +  I   V R ++YLH     RI+H DIK  NI ++H     + 
Sbjct: 172 YL----AAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLG 224

Query: 280 DFGLAKLCSKDISIVSLTAAR--GTAGYIA---PELFSRN-FGEVSYKSDVYSYGMMLLE 333
           DFG A  C      V + A +  G AG IA   PEL +R+ +G      D++S G++L E
Sbjct: 225 DFGAA--CFP----VDINANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFE 275

Query: 334 MVGCR 338
           M  C 
Sbjct: 276 MATCH 280

Length = 391

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 139 HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRLLGF 196
            R+G G YG V++   L  G   AVK+++   G+    I  E+  +    H +IV   G 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                +  +  E+   GSL+  I+  T      PLS  ++  +     +G+ YLH   ++
Sbjct: 75  YLSREKLWICMEYCGGGSLQD-IYHVTG-----PLSELQIAYVCRETLQGLAYLH---SK 125

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELFS 312
             +H DIK  NILL  N   K++DFG+A        I +  A R    GT  ++APE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAA------KITATIAKRKSFIGTPYWMAPEVAA 179

Query: 313 -RNFGEVSYKSDVYSYGMMLLEM 334
               G  +   D+++ G+  +E+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 41/133 (30%), Positives = 62/133 (46%), Gaps = 13/133 (9%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V E+MP G L   +     S+   P  W +     F  A  V  L    +   +H D+K
Sbjct: 120 MVMEYMPGGDLVNLM-----SNYDIPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVK 169

Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KS 322
           P N+LLD +   K++DFG       +  +   TA  GT  YI+PE+     G+  Y  + 
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228

Query: 323 DVYSYGMMLLEMV 335
           D +S G+ L EM+
Sbjct: 229 DWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 140 RLGQGGYGSVFRGKLFN-GIPVAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           ++GQGGYG VF  K  + G  VA+K ++          +  + E   +       +V+LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ-G 253
               +     L  E++P G     +    N      LS +  +     +   V+ LH+ G
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGV---LSEDHARFYMAEMFEAVDALHELG 121

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE-LF 311
                +H D+KP N L+D +   K++DFGL+K + +   S+V      G+  Y+APE L 
Sbjct: 122 ----YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVLR 171

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
            + +    +  D +S G ML E +
Sbjct: 172 GKGYD---FTVDYWSLGCMLYEFL 192

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 25/217 (11%)

Query: 141 LGQGGYGSVFRGK---LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF----HIVRL 193
           LGQG YG V   +         VA+K + ++          +  +  + HF    +I  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 194 LGF---CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
                          +YE +    L + I       S +PL+    +   + +  G++Y+
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQII------RSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS--LTAARGTAGYIAP 308
           H      +LH D+KP N+L++ + + KI DFGLA+  S++    +  +T    T  Y AP
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVGCR---KNKD 342
           E+   +F   +   DV+S G +L E++G +   K KD
Sbjct: 179 EIM-LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 139 HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF----INEVATIGRIHHFHIVRL 193
            ++G G YGSV        G  VA+K L       + F      E+  +  + H +++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 194 LG-FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           L  F S  +       Y  MP      ++ +        PLS +K++ + + +  G++Y+
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYI 133

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H      I+H D+KP N+ ++ + + KI DFGLA+    D  +      R    Y APE+
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTR---WYRAPEV 185

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMVGCR---KNKD 342
              N+   +   D++S G ++ EM+  +   K KD
Sbjct: 186 I-LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 138 KHRLGQGGYGSVF-----------RGKLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRI 185
           + RLG+G +G+V+           R K+   IPV       L  N     N E   + ++
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG-----ELNPNETVQANQEAQLLSKL 59

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGV 243
            H  IV+      E     ++ E+     L+  +     T  +       E   ++    
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL-- 117

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--SKDISIVSLTAARG 301
             GV Y+HQ   +RILH D+K  NI L +N   KI DFG+++L   S D++    T   G
Sbjct: 118 --GVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA----TTFTG 167

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           T  Y++PE           KSD++S G +L EM
Sbjct: 168 TPYYMSPEALKHQ--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 49/189 (25%)

Query: 160 VAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEK 217
           + +K  +H+        NE   +  + H  I+RL  F +E  +R L  + E++P G L  
Sbjct: 40  IRLKQEQHVH-------NEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFS 90

Query: 218 FIFS--KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
           ++ +  + ++S+    + E        +   +EYLH   ++ I++ D+KP NILLD    
Sbjct: 91  YLRNSGRFSNSTGLFYASE--------IVCALEYLH---SKEIVYRDLKPENILLDKEGH 139

Query: 276 PKISDFGLAK--------LCSKDISIVSLTAARGTAGYIAPELF-SRNFGEVSYKSDVYS 326
            K++DFG AK        LC             GT  Y+APE+  S+   +     D ++
Sbjct: 140 IKLTDFGFAKKLRDRTWTLC-------------GTPEYLAPEVIQSKGHNKA---VDWWA 183

Query: 327 YGMMLLEMV 335
            G+++ EM+
Sbjct: 184 LGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFI 176
           +T+      Y++LK++        G G YG+V        G  VA+K L +     + F 
Sbjct: 8   KTIWEVPDRYRDLKQV--------GSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFA 58

Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-------FSKTNSSS-- 227
                      +  +RLL          L+  F P+ SL++F        F  T+     
Sbjct: 59  KRA--------YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM 110

Query: 228 -HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
            H  LS ++++ + + + +G++Y+H      I+H D+KP N+ ++ + + KI DFGLA+ 
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167

Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              +     +T    T  Y APE+   N+   +   D++S G ++ EM+
Sbjct: 168 TDSE-----MTGYVVTRWYRAPEVI-LNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 39/209 (18%)

Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKML---EHLKGNGQEFINEVATI-GRIHHFHIVRLLG 195
           LG G +G V   K    G   A+K L   E LK    + + +  +I   + H  IV ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              +  R   + EF+  G L    F+    +   P    K       +A   EYLH   +
Sbjct: 86  SFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLA--FEYLH---S 136

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK--------LCSKDISIVSLTAARGTAGYIA 307
           + I++ D+KP N+LLD+    K++DFG AK        LC             GT  Y+A
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-------------GTPEYLA 183

Query: 308 PELF-SRNFGEVSYKSDVYSYGMMLLEMV 335
           PE+  S+  G+     D ++ G++L E +
Sbjct: 184 PEVIQSKGHGKA---VDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 31/211 (14%)

Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCS 198
           +G+G YG V++     +G   AVK+L+ +    +E   E   +  + +H ++V+  G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 199 E-----GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +     G +  LV E    GS+ + +  K      + L    +  I +G   G+++LH  
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELV--KGLLICGQRLDEAMISYILYGALLGLQHLH-- 145

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTAGYI 306
            N RI+H D+K +NILL      K+ DFG++           LT+ R       GT  ++
Sbjct: 146 -NNRIIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRNTSVGTPFWM 195

Query: 307 APELFS-RNFGEVSY--KSDVYSYGMMLLEM 334
           APE+ +     + SY  + DV+S G+  +E+
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 42/199 (21%), Positives = 91/199 (45%), Gaps = 30/199 (15%)

Query: 148 SVFRGKLFNGIPVAVKMLEHLKGNGQ----EFINEVATIGRIHHFHIVRLLGF----CSE 199
           S+++G  FN   V ++  +      +       NE+  + RI   +I+++ GF      +
Sbjct: 35  SIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
             R +L+ E+   G L + +         + LS++    +A    +G+  L++  N+   
Sbjct: 94  LPRLSLILEYCTRGYLREVL------DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-- 145

Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCS----KDISIVSLTAARGTAGYIAPELFSRNF 315
           + ++   + L+  N++ KI   GL K+ S    K+++ +          Y + ++ +  F
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV---------YFSYKMLNDIF 196

Query: 316 GEVSYKSDVYSYGMMLLEM 334
            E + K D+YS G++L E+
Sbjct: 197 SEYTIKDDIYSLGVVLWEI 215

Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 33/211 (15%)

Query: 141 LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
           +G G YGSV   F  K   G+ VAVK L       Q  I+   T      +  +RLL   
Sbjct: 25  VGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PFQSIIHAKRT------YRELRLLKHM 73

Query: 198 SEGTRRALVYEFMPNGSLEKF--IFSKT--------NSSSHRPLSWEKLKKIAFGVARGV 247
                  L+  F P  SLE+F  ++  T        N    + L+ + ++ + + + RG+
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           +Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +     +T    T  Y A
Sbjct: 134 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRA 185

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           PE+   N+   +   D++S G ++ E++  R
Sbjct: 186 PEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 7/92 (7%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +A  ++YLH+   + ILH D+K  N+ L      K+ D G+A++      + S     GT
Sbjct: 111 IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI--GT 165

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             Y++PELFS      +YKSDV++ G  + EM
Sbjct: 166 PYYMSPELFSNK--PYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 15/93 (16%)

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS---KDISIVSLTAARGTAG 304
           EYLH   N+ I++ D+KP N+LLD N   K+ DFG AK      K  +        GT  
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPE 157

Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLE-MVG 336
           Y+APE+   N G   +  D +S G++L E + G
Sbjct: 158 YVAPEIIL-NKGY-DFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 37/224 (16%)

Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKML-EHLKGNG---QEFINEVATIGRIHHFHIVRLLG 195
           +G+GG G V+          VA+K + E L  N    + F+ E      + H  IV +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 196 FCSEGTRRALVYEFMP--NG----SLEKFIFSKTNSSS--HRPLSWEKLKKIAFGVARGV 247
            CS+G     VY  MP   G    SL K ++ K + S       S      I   +   +
Sbjct: 70  ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--------SKDISIVSLTAA 299
           EY+H   ++ +LH D+KP NILL    +  I D+G A             D+   ++  +
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 300 R--------GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                    GT  Y+APE         S  +D+Y+ G++L +M+
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 4/98 (4%)

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
           F +A  V  +H       +H DIKP N+LLD N   +++DFG     ++D ++ S + A 
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS-SVAV 164

Query: 301 GTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMV 335
           GT  YI+PE+        G+   + D +S G+ + EM+
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKMLEH---LKGNGQEFI---NEVATIGRIHHFHIVRL 193
           LG+G +G V   +L  +G   AVK+L+    L+ +  E       + ++ R H F  +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF--LTQ 60

Query: 194 LGFCSEGTRRAL-VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L  C +   R   V EF+  G L  F   K+     R     + +  A  +   + +LH 
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL-MFHIQKS-----RRFDEARARFYAAEITSALMFLH- 113

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELF 311
             ++ I++ D+K  N+LLDH    K++DFG   +C + I     T+   GT  YIAPE+ 
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 312 SRNFGEVSYKSDV--YSYGMMLLEMV 335
                E+ Y   V  ++ G++L EM+
Sbjct: 169 Q----EMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 11/91 (12%)

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           GV+++H+   +R+LH DIK  NI L  N + K+ DFG A+L +   +        GT  Y
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYY 166

Query: 306 IAPELFSRNFGEVSY--KSDVYSYGMMLLEM 334
           + PE++      + Y  KSD++S G +L E+
Sbjct: 167 VPPEIWE----NMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 13/135 (9%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           LV E+ P G L   +      + +     E +    F +A  V  +H       +H DIK
Sbjct: 78  LVMEYQPGGDLLSLL------NRYEDQFDEDM--AQFYLAELVLAIHSVHQMGYVHRDIK 129

Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS--RNFGEVSY-- 320
           P N+L+D     K++DFG A   + +  + S     GT  YIAPE+ +     G+ +Y  
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGV 188

Query: 321 KSDVYSYGMMLLEMV 335
           + D +S G++  EM+
Sbjct: 189 ECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 39/164 (23%)

Query: 196 FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           FCS  T+R L  V E++  G     +       +   L  +  +         +EYLH  
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETVLALEYLH-- 118

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA----------AR--- 300
            N  I+H D+KP N+L+      K++DFGL+K     I ++SLT            R   
Sbjct: 119 -NYGIVHRDLKPDNLLITSMGHIKLTDFGLSK-----IGLMSLTTNLYEGHIEKDTREFL 172

Query: 301 -----GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLE-MVGC 337
                GT  YIAPE +  + +G+     D ++ G++L E +VGC
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGC 213

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L+   L    + VARG+E+L    ++  +H D+   N+LL      KI DFGLA+    D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
            + VS  +      ++APE    N    +  SDV+SYG++L E+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 59/239 (24%), Positives = 89/239 (37%), Gaps = 67/239 (28%)

Query: 140 RLGQGGYGSVF--RGKLFNGIPVAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRL 193
            +G+G +G V+  R K   G   A+K+L       +        E   +       IV+L
Sbjct: 8   VIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66

Query: 194 LGFCSEGTRRAL--VYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEKLKKIAFGVAR- 245
             + S      L  V E+MP G L      K +F         P    +     F +A  
Sbjct: 67  --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF---------PEETAR-----FYIAEL 110

Query: 246 --GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK------------------ 285
              ++ +H+      +H DIKP NIL+D +   K++DFGL K                  
Sbjct: 111 VLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 286 --LCSKDISIVSLTAAR-------GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
               +  +        R       GT  YIAPE L    +G    + D +S G++L EM
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 17/165 (10%)

Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EVA +  + H +IV+      E     +V ++   G L    + K N+       
Sbjct: 44  EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFP 99

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
            +++      +   ++++H   +++ILH DIK  NI L  +   K+ DFG+A++ +   S
Sbjct: 100 EDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---S 153

Query: 293 IVSLTAAR---GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
            V L  AR   GT  Y++PE+        + KSD+++ G +L EM
Sbjct: 154 TVEL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 75/229 (32%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFI---------------------NEV 179
           LG+G +G VF              L  LKG  Q F                        V
Sbjct: 3   LGKGSFGKVF--------------LAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRV 48

Query: 180 ATIGRIHHF--HIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
            ++   H F  H+     +C+  T+  L  V E++  G L   I      S H+      
Sbjct: 49  LSLAWEHPFLTHL-----YCTFQTKENLFFVMEYLNGGDLMFHI-----QSCHK----FD 94

Query: 236 LKKIAFGVAR---GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           L +  F  A    G+++LH   ++ I++ D+K  NILLD +   KI+DFG   +C +++ 
Sbjct: 95  LPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFG---MCKENM- 147

Query: 293 IVSLTAAR-----GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
              L  A+     GT  YIAPE L  + +       D +S+G++L EM+
Sbjct: 148 ---LGDAKTCTFCGTPDYIAPEILLGQKYN---TSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 39/227 (17%)

Query: 128 KELKKITSKFKHRL------GQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQEFINE 178
           +EL K   +   R       G G YGSV   +  +L     VAVK L       Q  I+ 
Sbjct: 4   QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKLSR---PFQSLIHA 58

Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKTNSSSH-------- 228
             T      +  +RLL          L+  F P  S+E F  ++  TN            
Sbjct: 59  RRT------YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC 112

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
           + LS E ++ + + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +     +T    T  Y APE+   N+   +   D++S G ++ E++
Sbjct: 170 DE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 23/146 (15%)

Query: 196 FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           FC+  T+  L  V E++  G L   I      SS R     + +  A  +  G+++LH+ 
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGR-FDEARARFYAAEIICGLQFLHK- 114

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR---GTAGYIAPEL 310
             + I++ D+K  N+LLD +   KI+DFG+ K      ++     A    GT  YIAPE+
Sbjct: 115 --KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-----NMNGEGKASTFCGTPDYIAPEI 167

Query: 311 FSRNFGEVSYKS-DVYSYGMMLLEMV 335
                G+   +S D +S+G++L EM+
Sbjct: 168 LK---GQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 141 LGQGGYGSVFRGKL--------FNGIPVAVKMLEHLKGNGQEFINEVATI-GRIHHFHIV 191
           LGQG +  +F+G           +   V +K+L+    N  E   E A++  ++ H H+V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
              G C  G    +V E++  GSL+ ++  K N +    +SW KL ++A  +A  + +L 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNL-INISW-KL-EVAKQLAWALHFLE 117

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA--GYIAPE 309
              ++ + H ++   N+LL      K  +    KL    ISI  L          ++ PE
Sbjct: 118 ---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEM 334
               N   +S  +D +S+G  L E+
Sbjct: 175 CI-ENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 52/217 (23%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFI---NEVA----------T 181
           LG+G +G V        G+L+     A+K L+      +  I   +EV           T
Sbjct: 7   LGRGHFGKVLLAEYKKTGELY-----AIKALK------KGDIIARDEVESLMCEKRIFET 55

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI-A 240
                H  +V L            V E+   G L   I        H  +  E      A
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI--------HTDVFSEPRAVFYA 107

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             V  G++YLH+    +I++ D+K  N+LLD     KI+DFG   LC + +     T+  
Sbjct: 108 ACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTF 161

Query: 301 -GTAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
            GT  ++APE+ +    E SY   V  +  G+++ EM
Sbjct: 162 CGTPEFLAPEVLT----ETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 49.6 bits (118), Expect = 7e-07
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 28/204 (13%)

Query: 141 LGQGGYGSVF--RGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLG 195
           +G+G YG V   R K    I VA+K  +  + N    +  + E+  +  +   +IV L  
Sbjct: 9   VGEGAYGVVLKCRHKETKEI-VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65

Query: 196 FCSEGTRRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
              E  RR     LV+E++    LE     +   +   P   EK++   + + + + + H
Sbjct: 66  --KEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPP---EKVRSYIYQLIKAIHWCH 117

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
           +     I+H DIKP N+L+ HN   K+ DFG A+  S+  S  + T    T  Y +PEL 
Sbjct: 118 K---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELL 173

Query: 312 SRNFGEVSYKS-DVYSYGMMLLEM 334
               G    K+ D++S G +L E+
Sbjct: 174 ---LGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 15/96 (15%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTAAR 300
           +  G+++LH+   + I++ D+K  N+LLD     KI+DFG+ K  +     +    +   
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFC 157

Query: 301 GTAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
           GT  YIAPE+ S       Y   V  ++ G++L EM
Sbjct: 158 GTPDYIAPEILS----YQPYGPAVDWWALGVLLYEM 189

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC + I     T+   G
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCG 158

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+  +         D +  G +L EM+
Sbjct: 159 TPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 10/112 (8%)

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKL 286
             PLS E  +   + + RG++Y+H      +LH D+KP N+ ++  +   KI DFGLA++
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Query: 287 CSKDISIVS-LTAARGTAGYIAPELF--SRNFGEVSYKSDVYSYGMMLLEMV 335
                S    L+    T  Y +P L     N+ +     D+++ G +  EM+
Sbjct: 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  S ++ +     +   ++YLH G   +I++ D+K  N++LD +   KI+DFGL K
Sbjct: 87  SRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
               D +  ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 144 EGITDAA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 70/245 (28%), Positives = 99/245 (40%), Gaps = 56/245 (22%)

Query: 128 KELKKITSKFKHRLGQGGYGSVF------RGKLFNGIPVAVKMLEH---LKGNGQEFI-N 177
           K  KKI    K  LG+G  G VF       GKLF     A+K+L+    +K N  + +  
Sbjct: 1   KHFKKI----KL-LGKGDVGRVFLVRLKGTGKLF-----ALKVLDKKEMIKRNKVKRVLT 50

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E   +  + H  +  L       T   LV ++ P G L    F        + LS E  +
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVAR 106

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--------- 288
             A  V   +EYLH      I++ D+KP NILL  +    +SDF L+K            
Sbjct: 107 FYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 289 --------KDISIVSLTAAR----------GTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
                      SI S T +           GT  YIAPE+ S + G      D ++ G++
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GH-GSAVDWWTLGIL 221

Query: 331 LLEMV 335
           L EM+
Sbjct: 222 LYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGY 305
           +E+LH+     I++ D+KP NILLD      + DFGL+K    +++    T    GT  Y
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEY 162

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           +APE+     G  +   D +S G+++ EM
Sbjct: 163 LAPEVLLDEKG-YTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 37/139 (26%), Positives = 67/139 (48%), Gaps = 15/139 (10%)

Query: 201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILH 260
           +R   V EF+  G L   +F   +    R L  E  +  +  ++  + +LH+     I++
Sbjct: 69  SRLFFVIEFVSGGDL---MF---HMQRQRKLPEEHARFYSAEISLALNFLHER---GIIY 119

Query: 261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVS 319
            D+K  N+LLD     K++D+G   +C + I     T+   GT  YIAPE+      +  
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGE--DYG 174

Query: 320 YKSDVYSYGMMLLEMVGCR 338
           +  D ++ G+++ EM+  R
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 5/104 (4%)

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           LS+  L   ++ VA G+E+L    ++  +H D+   N+L+      KI DFGLA+   +D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
            + +S  +      ++APE    N    +  SDV+S+G++L E+
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGF-- 196
           +G+G YG VF+     NG   AVK+L+ +    +E   E   +  +  H ++V+  G   
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85

Query: 197 ---CSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
                 G +  LV E    GS+   +  F K       P+    +  I      G+++LH
Sbjct: 86  KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI----IAYILHEALMGLQHLH 141

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPEL 310
                + +H D+K +NILL      K+ DFG+ A+L S   + +    + GT  ++APE+
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS---TRLRRNTSVGTPFWMAPEV 195

Query: 311 FS-RNFGEVSY--KSDVYSYGMMLLEM 334
            +     + +Y  + DV+S G+  +E+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)

Query: 141 LGQGGYGSVFRGKLFNGIPV-AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLL 194
           +G+G Y  V   +L     + A+K+++    N  E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                 +R   V E++  G L   +F   +    R L  E  +  +  ++  + YLH+  
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MF---HMQRQRKLPEEHARFYSAEISLALNYLHE-- 114

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF-SR 313
            + I++ D+K  N+LLD     K++D+G+ K   +     S     GT  YIAPE+    
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC--GTPNYIAPEILRGE 171

Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           ++G   +  D ++ G+++ EM+  R   D
Sbjct: 172 DYG---FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 23/101 (22%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-- 300
           +A G+ +LH   ++ I++ D+K  N++LD     KI+DFG+ K      +I      R  
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-----NIFGGKTTRTF 161

Query: 301 -GTAGYIAPELFSRNFGEVSY----KS-DVYSYGMMLLEMV 335
            GT  YIAPE+       ++Y    KS D +++G++L EM+
Sbjct: 162 CGTPDYIAPEI-------IAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 51/237 (21%)

Query: 119 TVNPTRYT----YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLE------- 166
            V  + +T    Y+ LK I        G G  G V        G  VA+K L        
Sbjct: 6   EVGDSTFTVLKRYQNLKPI--------GSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT 57

Query: 167 HLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIF 220
           H K   +E +     +  ++H +I+ LL  F  + +        LV E M + +L + I 
Sbjct: 58  HAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI- 111

Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
                     L  E++  + + +  G+++LH   +  I+H D+KP NI++  +   KI D
Sbjct: 112 -------QMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161

Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           FGLA+       +      R    Y APE+     G + YK   D++S G ++ EM+
Sbjct: 162 FGLARTAGTSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 42/134 (31%), Positives = 69/134 (51%), Gaps = 15/134 (11%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V EF+P  ++ K++     ++   PL   KL   ++ + R + Y+H   ++ I H D+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL--YSYQLCRALAYIH---SKFICHRDLK 197

Query: 265 PHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS- 322
           P N+L+D N    K+ DFG AK        VS   +R    Y APEL     G  +Y + 
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPELM---LGATNYTTH 251

Query: 323 -DVYSYGMMLLEMV 335
            D++S G ++ EM+
Sbjct: 252 IDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 7/91 (7%)

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           ++ +HQ      +H DIKP N+LLD N   +++DFG       D ++ S  A  GT  YI
Sbjct: 115 IDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYI 170

Query: 307 APE-LFSRNFGEVSY--KSDVYSYGMMLLEM 334
           +PE L +   G+  Y  + D +S G+ + EM
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 15/143 (10%)

Query: 201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILH 260
           +R  LV E++  G L   +F   +    R L  E  +  A  +   + +LH+   + I++
Sbjct: 69  SRLFLVIEYVNGGDL---MF---HMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119

Query: 261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVS 319
            D+K  N+LLD +   K++D+G   +C + +     T+   GT  YIAPE+      E  
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTSTFCGTPNYIAPEILRGE--EYG 174

Query: 320 YKSDVYSYGMMLLEMVGCRKNKD 342
           +  D ++ G+++ EM+  R   D
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 44/216 (20%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFI---NEVATIGRIHHFHIV 191
           LG+G +G V        GK +     A+K+L+      +E I   +EVA     H     
Sbjct: 3   LGKGTFGKVILVREKATGKYY-----AMKILK------KEVIIAKDEVA-----HTLTES 46

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNS-------SSHRPLSWEKLKKIAFGVA 244
           R+L         AL Y F  +  L  F+    N        S  R  S ++ +     + 
Sbjct: 47  RVLQNTRHPFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 105

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTA 303
             + YLH      +++ D+K  N++LD +   KI+DFG   LC + IS  +      GT 
Sbjct: 106 SALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTP 159

Query: 304 GYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCR 338
            Y+APE+   N +G      D +  G+++ EM+  R
Sbjct: 160 EYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 44/166 (26%), Positives = 65/166 (39%), Gaps = 48/166 (28%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           L+ EF+P G +   +  K        LS E  +         ++ +HQ      +H DIK
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT------LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIK 128

Query: 265 PHNILLDHNFQPKISDFGLAKLCSK----------------DISIVSLTAAR-------- 300
           P N+LLD     K+SDFGL     K                D S  ++ + R        
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 301 ---------GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
                    GT  YIAPE+F     +  Y    D +S G+++ EM+
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 43/169 (25%), Positives = 83/169 (49%), Gaps = 28/169 (16%)

Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG----SLEKFIFSKTNSSSHRPLS 232
           NE+  +GR++H +I+++     E   R+    +M        L  F++ +      RPL 
Sbjct: 212 NEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
            +  + I   +   VEY+H   +++++H DIK  NI L+ + +  + DFG A    K+  
Sbjct: 267 KQT-RAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE-- 320

Query: 293 IVSLTAAR-----GTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
                 A      GT    +PE+ + + + E+   +D++S G++LL+M+
Sbjct: 321 ----REAFDYGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 6e-06
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 44/246 (17%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGK------LFNGIPVAVKMLEHLKGNGQEF 175
           P +Y   E +    +   ++G G +G VF  K       F    ++ + L+  + +  + 
Sbjct: 2   PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS--QL 59

Query: 176 INEVATIGRIHHFHIVRLLG-FCSEGTRRA-LVYEFMPNGSLEKFI------FSKTNSSS 227
           + EV  +  + H +IVR +  F ++  ++  ++ EF   G L + I      F K    +
Sbjct: 60  VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCN-QRILHFDIKPHNILL---------------D 271
              ++ + L  +A+        L  G N +R+LH D+KP NI L               +
Sbjct: 120 IVDITRQLLHALAY-----CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 272 HNFQP--KISDFGLAKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYG 328
            N +P  KI DFGL    SK+I I S+  +  GT  Y +PEL          KSD+++ G
Sbjct: 175 LNGRPIAKIGDFGL----SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230

Query: 329 MMLLEM 334
            ++ E+
Sbjct: 231 CIIYEL 236

Length = 1021

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 6/113 (5%)

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  S ++ +     +   ++YLH    + +++ D+K  N++LD +   KI+DFGL K
Sbjct: 87  SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
              KD +  ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 145 EGIKDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 87  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 140

Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 141 LCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 17/143 (11%)

Query: 196 FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +C+  T+  L  V EF+  G L   I  K     +R   +      A  +  G+++LH  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY------AAEIVCGLQFLH-- 113

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFS 312
            ++ I++ D+K  N++LD +   KI+DFG   +C +++   +  +   GT  YIAPE+  
Sbjct: 114 -SKGIIYRDLKLDNVMLDRDGHIKIADFG---MCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
               + ++  D +S+G++L EM+
Sbjct: 170 GL--KYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 4/80 (5%)

Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR---NF 315
           +H DIKP NIL+D N   +++DFG      +D ++ S + A GT  YI+PE+        
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEDGK 182

Query: 316 GEVSYKSDVYSYGMMLLEMV 335
           G+   + D +S G+ + EM+
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 42/166 (25%), Positives = 66/166 (39%), Gaps = 48/166 (28%)

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           L+ EF+P G +   +  K        L+ E+ +         ++ +HQ      +H DIK
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT------LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIK 128

Query: 265 PHNILLDHNFQPKISDFGLAKLCSK----------------DISIVSLTAAR-------- 300
           P N+LLD     K+SDFGL     K                D +  ++ + R        
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 301 ---------GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
                    GT  YIAPE+F +      Y    D +S G+++ EM+
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 7/94 (7%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           ++ G+ +LH+   + I++ D+K  N++LD     KI+DFG+ K     +  V+     GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
             YIAPE+ +  +       D ++YG++L EM+ 
Sbjct: 165 PDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC + I+    T    G
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFG---LCKEGIAQSDTTTTFCG 158

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+  +         D +  G +L EM+
Sbjct: 159 TPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +E LH+     +++ D+KP NILLD+     + DFGL KL  KD    +     GT  Y+
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC--GTPEYL 160

Query: 307 APELFSRNFGEVSYKS-DVYSYGMMLLEMV 335
           APEL     G    K+ D ++ G++L EM+
Sbjct: 161 APELLL---GHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 27/167 (16%)

Query: 178 EVATIGR-IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
           E A++ R + H HIV L G C       +V EF+  G L+ F+  K++      L+    
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWK 107

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-----DHNFQP--KISDFGLAKLCSK 289
            K+A  +A  + YL    ++ ++H ++   NILL     D    P  K+SD G+      
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP----- 159

Query: 290 DISIVSLTAARGTAGYIAPELF--SRNFGEVSYKSDVYSYGMMLLEM 334
            I+++S         +IAPE    S+N   +S  +D +S+G  L E+
Sbjct: 160 -ITVLSRQECVERIPWIAPECVEDSKN---LSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEH-------LKGNGQEFINEVATIGRIH- 186
           +G GG+G V+         + N     ++ LE+       L  N    I+++A    IH 
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 187 --HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK--LKKIAFG 242
             H  I +  G C    R  + Y F+    LEK + + T     R     K  +K I   
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVEN-TKEIFKRIKCKNKKLIKNIMKD 134

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK---LCSKDI--SIVSLT 297
           +   +EY+H+     I H DIKP NI++D N +  I D+G+A    +  K I  S     
Sbjct: 135 MLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191

Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
             RGT  Y    L + N   V+ + D+ S G  +L+  G
Sbjct: 192 LHRGTLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAG 228

Length = 294

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 33/107 (30%), Positives = 54/107 (50%), Gaps = 12/107 (11%)

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+     
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 173 FMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 13/96 (13%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           V   + +LH+     +++ D+K  NILLD     K++DFG   +C + I     T    G
Sbjct: 105 VTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCG 158

Query: 302 TAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEMV 335
           T  YIAPE+      E+ Y   V  ++ G+++ EM+
Sbjct: 159 TPDYIAPEILQ----ELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 30/114 (26%), Positives = 45/114 (39%), Gaps = 40/114 (35%)

Query: 259 LHFDIKPHNILLDHNFQPKISDFGL-------------------AKLCSKDISIVSLTAA 299
           +H DIKP N+LLD     K+SDFGL                         D     +++ 
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 300 R-----------------GTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
           R                 GT  YIAPE+F +  + +     D +S G+++ EM+
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 49/222 (22%)

Query: 141 LGQGGYGSVF---------RGKLF-------NGIPVAVKMLEHLKGNGQ--EFINEVATI 182
           LG G YG VF          GKL+         I    K  EH +   Q  E +     +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             +H+        F ++ T+  L+ +++  G L   ++ + + +           ++   
Sbjct: 68  VTLHY-------AFQTD-TKLHLILDYVNGGELFTHLYQREHFTESE-------VRVYIA 112

Query: 243 -VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR- 300
            +   +++LHQ     I++ DIK  NILLD      ++DFGL+K        ++    R 
Sbjct: 113 EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE------FLAEEEERA 163

Query: 301 ----GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
               GT  Y+APE+     G      D +S G++  E++ G 
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 9/94 (9%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           VA  + YLH   +  I++ D+KP NILLD      ++DFG   LC + +     T+   G
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFG---LCKEGVEPEETTSTFCG 158

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+  +         D +  G +L EM+
Sbjct: 159 TPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 21/143 (14%)

Query: 204 ALVYEFMPNGSLEKF----IFSKTNSSS-----HRPLSWEKLKKIAFGVARGVEYLHQGC 254
            L+  F P  SLE+F    I  +   ++        L  E++  + + +  G+++LH   
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA- 145

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
              I+H D+KP NI++  +   KI DFGLA+       +      R    Y APE+    
Sbjct: 146 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVI--- 197

Query: 315 FGEVSYKS--DVYSYGMMLLEMV 335
            G + YK   D++S G ++ EM+
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 6e-05
 Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 22/167 (13%)

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
           F    + + ++ H H+  + G C  G+   +V EF+ +G L+  +          P++W+
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL---RKEKGRVPVAWK 119

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-----LDHNFQP--KISDFGLAKLC 287
               +A  +A  + YL    ++ ++H ++   NIL     L     P  K+SD G++   
Sbjct: 120 IT--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--- 171

Query: 288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               + +S         +IAPE        +S  +D +S+G  LLE+
Sbjct: 172 ---FTALSREERVERIPWIAPECV-PGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 43.8 bits (103), Expect = 6e-05
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A  + YLH   +  I++ D+KP NILLD      ++DFG   LC ++I     T+   G
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFG---LCKENIEHNGTTSTFCG 158

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+  +         D +  G +L EM+
Sbjct: 159 TPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 29/95 (30%), Positives = 54/95 (56%), Gaps = 9/95 (9%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSLTAARG 301
           +A G+ +LH   ++ I++ D+K  N++LD     KI+DFG   +C +++   V+     G
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCG 163

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           T  YIAPE+ +  +       D +++G++L EM+ 
Sbjct: 164 TPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLA 196

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 51/226 (22%), Positives = 85/226 (37%), Gaps = 56/226 (24%)

Query: 128 KELKKITSKFKHRLGQGGYGSVF----------------RGKLFNGIPVAVKMLEHLKGN 171
           + LK      K +L  G +G V                 + K FN I   V     L  +
Sbjct: 11  QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMV---HQLMKD 67

Query: 172 GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHR 229
              FI        +++             T +   L+ +++ +G L  F   K       
Sbjct: 68  NPNFIK-------LYYSV----------TTLKGHVLIMDYIKDGDL--FDLLKKE----G 104

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCS 288
            LS  ++KKI   +   +  LH      I+H DIK  N+L D    +  + D+GL K   
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--- 158

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               I + +   GT  Y +PE    +  +VS+  D ++ G++  E+
Sbjct: 159 ---IIGTPSCYDGTLDYFSPEKIKGHNYDVSF--DWWAVGVLTYEL 199

Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 141 LGQGGYGSVF---------RGKLFN-------GIPVAVKMLEHLKGNGQ--EFINEVATI 182
           LG G YG VF          GKL+         I    K  EH +   Q  E I +   +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             +H+        F ++ T+  L+ +++  G L       T+ S       ++++  +  
Sbjct: 68  VTLHY-------AFQTD-TKLHLILDYINGGEL------FTHLSQRERFKEQEVQIYSGE 113

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +   +E+LH+     I++ DIK  NILLD N    ++DFGL+K   +D    + +   GT
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GT 169

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             Y+AP++     G      D +S G+++ E++
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 22/162 (13%)

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E+  +  I H  I+ L+      +   +V   MP    + F +   +     PL  E+  
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSG----PLPLEQAI 188

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
            I   +   + YLH    + I+H D+K  NI LD      + DFG A  C  D    +  
Sbjct: 189 TIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDT-P 242

Query: 298 AARGTAGYI---APELFSRNFGEVSY--KSDVYSYGMMLLEM 334
              G +G +   +PEL + +     Y  K+D++S G++L EM
Sbjct: 243 QCYGWSGTLETNSPELLALD----PYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 18/44 (40%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
           VA  ++YLH+     I+H D+KP N+L+ +    K++DFGL+K+
Sbjct: 113 VALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 50/132 (37%)

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL----------------------- 283
           +E +H       +H DIKP NIL+D +   K++DFGL                       
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 284 -------AKLCSKDISIVSLTAAR-----------GTAGYIAPELFSRNFGEVSYKS--D 323
                  +++    +  +     R           GT  YIAPE+  R      Y    D
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR----TGYTQLCD 226

Query: 324 VYSYGMMLLEMV 335
            +S G++L EM+
Sbjct: 227 WWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 43/216 (19%)

Query: 141 LGQGGYGSVF---------RGKLFN-------GIPVAVKMLEHLKGNGQ--EFINEVATI 182
           LG G YG VF          GKL+         +    K +EH +      E + +   +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             +H+        F +E  +  L+ +++  G +   ++ + N S       E   +   G
Sbjct: 68  VTLHY-------AFQTE-AKLHLILDYVSGGEMFTHLYQRDNFS-------EDEVRFYSG 112

Query: 243 -VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTAA 299
            +   +E+LH+     I++ DIK  NILLD      ++DFGL+K  L  +     S    
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-- 167

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            GT  Y+APE+  R  G      D +S G+++ E++
Sbjct: 168 -GTIEYMAPEII-RGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.5 bits (90), Expect = 0.002
 Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 20/108 (18%)

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
           RPL+ E++  +       +  LH+           K  NILL  +        GL KL  
Sbjct: 12  RPLNEEEIWAVCLQCLGALRELHRQ---------AKSGNILLTWD--------GLLKL-D 53

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
             ++  +   +R    ++APE+        + K+D+YS G+ L E + 
Sbjct: 54  GSVAFKTPEQSRPDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALD 99

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 16/136 (11%)

Query: 105 ETQLKVEKFLE--DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLF---- 155
           E Q KV + +   +Y  ++PT+  Y    E  +    F   LG G +G V     +    
Sbjct: 2   EIQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFK 61

Query: 156 --NGIPVAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF 209
               + VAVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    ++ E+
Sbjct: 62  SDAAMTVAVKMLKPSAHLT-EREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEY 120

Query: 210 MPNGSLEKFIFSKTNS 225
              G L  F+  K +S
Sbjct: 121 CCYGDLLNFLRRKRDS 136

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 15/26 (57%), Positives = 19/26 (73%)

Query: 259 LHFDIKPHNILLDHNFQPKISDFGLA 284
           +H DIKP NIL+D     K+SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	344
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.53
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.16
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.08
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
PRK09902	216	hypothetical protein; Provisional	98.87
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.84
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.82
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.77
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.56
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.51
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.44
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.44
PRK10593	297	hypothetical protein; Provisional	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.33
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.26
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.16
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.03
PF14380	94	WAK_assoc: Wall-associated receptor kinase C-termi	97.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.73
PRK05231	319	homoserine kinase; Provisional	97.68
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.64
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.58
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.46
PLN02236	344	choline kinase	97.42
KOG2270	520	consensus Serine/threonine protein kinase involved	97.35
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.33
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.25
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.22
COG2334	331	Putative homoserine kinase type II (protein kinase	97.22
PLN02756	418	S-methyl-5-thioribose kinase	97.16
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.06
PRK11768	325	serine/threonine protein kinase; Provisional	97.06
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.04
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.03
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.02
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.82
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.77
PRK12396	409	5-methylribose kinase; Reviewed	96.7
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.7
PRK06148	1013	hypothetical protein; Provisional	96.67
PTZ00384	383	choline kinase; Provisional	96.4
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.04
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.94
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.93

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-54  Score=391.17  Aligned_cols=214  Identities=50%  Similarity=0.891  Sum_probs=192.7

Q ss_pred             CCcccCHHHHHHHHHhhc--ccccccCcEEEEEEEEeCCceEEEEEeeccccc-hHHHHHHHHHHhhhcccceeeEeeEE
Q 041350          121 NPTRYTYKELKKITSKFK--HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN-GQEFINEVATIGRIHHFHIVRLLGFC  197 (344)
Q Consensus       121 ~~~~~~~~~l~~~~~~~~--~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~  197 (344)
                      ....|++.++..+|++|.  +.||+|+||+||+|.+.+|..||||++...... .++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999997  689999999999999999999999998876554 67799999999999999999999999


Q ss_pred             EcCC-eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          198 SEGT-RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       198 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                      .+.+ +.+||||||++|+|.++|+.....    +++|..|++||.++|+||+|||+.+.++|+||||||+|||||+++++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999 599999999999999999875531    79999999999999999999999888899999999999999999999


Q ss_pred             EEeecCCcccccC-Cccceeeecc-cCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          277 KISDFGLAKLCSK-DISIVSLTAA-RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       277 kl~Dfgla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ||+|||+|+..+. .....   .. .||.+|+|||++..  +..+.|+|||||||+|+||+|||+|.|.
T Consensus       217 KlsDFGLa~~~~~~~~~~~---~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVS---TTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             EccCccCcccCCcccccee---eecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCC
Confidence            9999999977655 32221   12 79999999999875  4889999999999999999999999885

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-49  Score=345.31  Aligned_cols=193  Identities=27%  Similarity=0.466  Sum_probs=171.4

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.++||.|+||+||+|++ .++..||||.+...+   ...+....|+.+|+.++|||||++++++.+++..+||||||.+
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            345699999999999985 457899999997542   3446678999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC------CceEEeecCCccc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN------FQPKISDFGLAKL  286 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~------~~~kl~Dfgla~~  286 (344)
                      |||.+|++...      .+++..++.++.|+|.||++||+   ++||||||||.||||+.+      -.+||+|||+|+.
T Consensus        94 GDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   94 GDLSDYIRRRG------RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999996543      69999999999999999999999   999999999999999764      4689999999999


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.+..-   ....+|+|-|||||++...  .|+.|+|+||+|+++|++++|+.||+.
T Consensus       165 L~~~~~---a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  165 LQPGSM---AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             CCchhH---HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccc
Confidence            886533   2467899999999999654  899999999999999999999999984

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=344.80  Aligned_cols=196  Identities=35%  Similarity=0.602  Sum_probs=170.4

Q ss_pred             cccccccCcEEEEEEEEeCCce-EEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCC-eEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIP-VAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGT-RRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~-vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  212 (344)
                      .+.||+|+||+||+|. ..|.. ||||++......   .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus        46 ~~~iG~G~~g~V~~~~-~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGK-WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhcccCCceeEEEEE-eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            3559999999999998 45555 999999864322   458999999999999999999999999988 79999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCceEEcCCC-ceEEeecCCcccccCC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR-ILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~  290 (344)
                      |+|.++++..    ....+++..+++++.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       125 GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  125 GSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999774    22579999999999999999999999   67 99999999999999997 9999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ...+...||+.|||||++.+....++.|+||||||+++|||+||+.||..
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~  248 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED  248 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence            2  22344679999999999984223799999999999999999999999964

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=329.39  Aligned_cols=195  Identities=27%  Similarity=0.380  Sum_probs=174.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||.++. .+++.+|+|++++..    .+.+...+|..+|.+++||.||++...|++.+++|+|+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            3568899999999999974 558899999997532    34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      .||.|..+|.+.      ..+++..+..++..|+.||.|||+   .+||||||||+|||||++|+++|+|||+++..-.+
T Consensus       108 ~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  108 NGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             CCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999543      469999999999999999999999   99999999999999999999999999999965444


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+||+.|||||++.+.  .++..+|+||+|+++|||++|.+||..
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~  227 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYA  227 (357)
T ss_pred             CC--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcC
Confidence            22  23457899999999999886  899999999999999999999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=344.42  Aligned_cols=197  Identities=27%  Similarity=0.453  Sum_probs=178.6

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeec----cccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ++...+.||+|||++||+++. .+|..||+|++.+    .....+...+|+++.++|+|||||+++++|.+.++.|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            444567899999999999986 7899999999976    34556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      +|++++|..++.      .+.++++.+++.+.+||+.||.|||+   ++|+|||||..|+||+++.++||+|||||..+.
T Consensus        99 LC~~~sL~el~K------rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   99 LCHRGSLMELLK------RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             ecCCccHHHHHH------hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence            999999999995      23579999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .+..  +..+.+|||.|+|||++.+.  ..+..+||||+||+||.||.|++||+.
T Consensus       170 ~~~E--rk~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFet  220 (592)
T KOG0575|consen  170 YDGE--RKKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFET  220 (592)
T ss_pred             Cccc--ccceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCccc
Confidence            6533  23567899999999999865  789999999999999999999999974

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-46  Score=323.71  Aligned_cols=201  Identities=29%  Similarity=0.449  Sum_probs=177.1

Q ss_pred             ccCHHHHHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeec--cccchHHHHHHHHHHhhhcccceeeEeeEEEcC
Q 041350          124 RYTYKELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG  200 (344)
Q Consensus       124 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  200 (344)
                      ..+..|++..     +.||+|..|+|||+.+ .+++.+|+|++..  .....+++.+|++++++.+||+||.++|.|..+
T Consensus        75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            4566666543     6799999999999985 4688999999953  334457899999999999999999999999998


Q ss_pred             C-eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          201 T-RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       201 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      . ...++||||++|||++++...      +.+++..+-.++.++++||.|||+  .++||||||||+|||++..|++||+
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEec
Confidence            8 599999999999999999543      459999999999999999999995  3899999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||.++.+.+..    .....||..|||||.+.+.  .|+.++||||||+.++|+.+||-|+-+
T Consensus       222 DFGVS~~lvnS~----a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  222 DFGVSGILVNSI----ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPP  279 (364)
T ss_pred             cccccHHhhhhh----cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCC
Confidence            999999776552    2567899999999999886  899999999999999999999999876

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=338.23  Aligned_cols=206  Identities=31%  Similarity=0.508  Sum_probs=180.0

Q ss_pred             CHHHHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          126 TYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       126 ~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .-.++......+.++||+|-||+||.|.......||+|.++......++|.+|+++|++|+|+|||+++|+|..+..++|
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            34556666667789999999999999997777799999999877777999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      |||||+.|+|.+||....    +..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||||+
T Consensus       279 VtE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999997622    3568899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNK  341 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~  341 (344)
                      ...++. +.......-+..|.|||.+..  +.++.|||||||||+||||+| |+.|+
T Consensus       352 ~~~d~~-Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py  405 (468)
T KOG0197|consen  352 LIGDDE-YTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPY  405 (468)
T ss_pred             ccCCCc-eeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCC
Confidence            554443 333345567889999999965  489999999999999999996 44443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=332.44  Aligned_cols=194  Identities=31%  Similarity=0.512  Sum_probs=165.6

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHh--hhcccceeeEeeEEEcCC----eEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIG--RIHHFHIVRLLGFCSEGT----RRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e~~  210 (344)
                      +.+.||+|+||+||||++ +++.||||++..  .+.+.|.+|-++.+  .++|+||+++++.-..++    .++||++|.
T Consensus       214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hHHHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            456799999999999986 458999999975  45567777766655  458999999999876665    899999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ------GCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~------~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +.|+|.+||..       ..++|....+|+..+++||+|||+      +.+++|+|||||++||||.+|++..|+|||+|
T Consensus       291 ~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  291 PKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             cCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999954       458999999999999999999998      34578999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCC-----cccchHhHHHHHHHHHcCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVS-----YKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ..+............+||.+|||||++.+.. ++.     .+.||||+|.|||||+++=.-.
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            9998776666666788999999999998753 222     3689999999999999865544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=328.46  Aligned_cols=199  Identities=29%  Similarity=0.421  Sum_probs=170.3

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeecccc--------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG--------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      .+-+.+.||+|+||.|-+|. ..+|+.||||++++.+.        ......+|+++|++|+|||||++++++......|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            34456889999999999996 46799999999975321        1234579999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEeec
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDF  281 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Df  281 (344)
                      |||||++||+|.+.+-.+      ..+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+||
T Consensus       253 mVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999544      457888889999999999999999   999999999999999765   78999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCC-CcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEV-SYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      |+|+......   .+.+.+|||.|.|||++.+..-.+ ..+.|+||+||+||-+|+|-.||..+
T Consensus       324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9999876432   346788999999999997642233 34889999999999999999999753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-47  Score=316.95  Aligned_cols=203  Identities=26%  Similarity=0.417  Sum_probs=175.7

Q ss_pred             HhhcccccccCcEEEEEEE-EeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEee-EEEcCCe-EEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTR-RALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e  208 (344)
                      +.+.++||.|.||+|||+. +.+|..||.|.++-.   ....++...|+.+|++|+|||||++++ -+.++.+ ++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3456789999999999996 788999999998732   234578899999999999999999999 4555555 899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      |+.+|||...+...+.  .++.+++..++++..|++.||..+|...+. -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus       101 ~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             hhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999976553  346799999999999999999999973322 3999999999999999999999999999998


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.....  ....+|||.||+||.+..+  .|+.+|||||+||++|||..-+.||..
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g  230 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYG  230 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCccc
Confidence            876443  3567899999999999886  899999999999999999999999964

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=304.57  Aligned_cols=212  Identities=26%  Similarity=0.406  Sum_probs=183.2

Q ss_pred             HHhhhhcccCCcccCHHHHHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhc
Q 041350          112 KFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIH  186 (344)
Q Consensus       112 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~  186 (344)
                      .+...+.......+++.+.+     +.+.||.|+||.|.+++. .+|..+|+|+++..+    .+.+...+|..+|+.+.
T Consensus        28 ~~~~~~~~~~~~~~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~  102 (355)
T KOG0616|consen   28 DFPKKWANTPQNPYSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS  102 (355)
T ss_pred             hhhhhhcCCCCCCcchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc
Confidence            34444444444447777764     447899999999999974 458899999998643    33466789999999999


Q ss_pred             ccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041350          187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH  266 (344)
Q Consensus       187 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~  266 (344)
                      ||.++++.+.+.+.+.++|||||.+||.|..+++..      +.+++..++.+|.||+.||+|||+   .+|++||+||+
T Consensus       103 ~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPE  173 (355)
T KOG0616|consen  103 HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPE  173 (355)
T ss_pred             CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChH
Confidence            999999999999999999999999999999999543      469999999999999999999999   99999999999


Q ss_pred             ceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       267 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      |||||.+|.+||+|||+|+.....     .-..+|||.|+|||++...  .+...+|.|||||++|||+.|..||..+
T Consensus       174 NiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  174 NLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             HeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            999999999999999999987654     3467899999999999876  7888999999999999999999999753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8e-45  Score=344.75  Aligned_cols=209  Identities=32%  Similarity=0.520  Sum_probs=175.4

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcC
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEG  200 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~  200 (344)
                      ++......+.++||+|+||+||+|....      ...||||.++...+.  .++|.+|+++++.++|||||+|+|+|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            4444444567889999999999997533      457999999875544  57999999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCC----C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSS----S----HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~----~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      +.+++|+|||..|||.+||.......    .    ..+|+..+.+.||.|||.||+||-+   +.+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence            99999999999999999997543211    1    3349999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      +..+||+||||++.......+.......-+++|||||.+.-  +.+|.+||||||||+|||++ .|+.|+.
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~  707 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYY  707 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCccc
Confidence            99999999999996544333322223446889999999865  59999999999999999999 5777764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-43  Score=315.24  Aligned_cols=194  Identities=29%  Similarity=0.411  Sum_probs=170.2

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEeccC
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEFMP  211 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  211 (344)
                      .++||+|.||.||||+ ..+|+.||+|++....   +...-..+|+.+|++|+||||++|.+...+.  ..+|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            3679999999999997 5679999999997543   2335678999999999999999999988776  68999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      + ||.-++...     ...+++.++..++.|++.||+|+|.   .+|+|||||.+|||||.+|.+||+|||||+++....
T Consensus       202 h-DL~GLl~~p-----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  202 H-DLSGLLSSP-----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             c-hhhhhhcCC-----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            6 888887433     2469999999999999999999999   999999999999999999999999999999887664


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .. ..+..+-|++|.|||++.+. ..|+...|+||.||||.||+.|++.+-
T Consensus       273 ~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  273 SA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             Cc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcC
Confidence            33 25677789999999999887 589999999999999999999998874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8e-43  Score=315.28  Aligned_cols=196  Identities=24%  Similarity=0.338  Sum_probs=169.9

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ...||+|+||.||+++ ..+|..+|+|+++++.    .+.+....|-.+|...++|+||+++..|++...+||||||+||
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            3679999999999997 4569999999998643    4557788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC--
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD--  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~--  290 (344)
                      ||+..+|...      ..|+++.++.++.+++.|++.||+   .|+|||||||+|+|||..|++||+||||+.-+...  
T Consensus       226 GD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  226 GDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             ccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            9999999543      579999999999999999999999   99999999999999999999999999998533110  


Q ss_pred             ---------------------cc----cee------------------eecccCCcccccccccccccCCCCcccchHhH
Q 041350          291 ---------------------IS----IVS------------------LTAARGTAGYIAPELFSRNFGEVSYKSDVYSY  327 (344)
Q Consensus       291 ---------------------~~----~~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~  327 (344)
                                           ..    ...                  ....+|||.|||||++.+.  .|+..+|+||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSL  374 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSL  374 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHH
Confidence                                 00    000                  0123599999999999987  68999999999


Q ss_pred             HHHHHHHHcCCCCCCCC
Q 041350          328 GMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       328 Gvvl~ell~g~~p~~~~  344 (344)
                      |||+||||.|-+||..+
T Consensus       375 G~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             HHHHHHHHhCCCCCCCC
Confidence            99999999999999754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=317.31  Aligned_cols=197  Identities=30%  Similarity=0.427  Sum_probs=171.6

Q ss_pred             hhcccccccCcEEEEEEE-EeCCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .|.+.||+|+|++|++|+ ..+++.+|||++.+..    ...+-...|-++|.+| .||.|++|+..|++...+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            467889999999999997 4568999999997521    2224466788999999 899999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.++|...      +.+++.-.+.++.+|+.||+|||+   +|||||||||+|||||.|++++|+|||.|+.++.
T Consensus       156 A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  156 APNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            9999999999543      469999999999999999999999   9999999999999999999999999999998764


Q ss_pred             Cccc---------ee--eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISI---------VS--LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....         ..  ...++||..|.+||++...  ..+..+|+|+|||+||.|+.|.+||..
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCcc
Confidence            3221         11  1457899999999999875  788899999999999999999999965

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-43  Score=318.78  Aligned_cols=193  Identities=31%  Similarity=0.483  Sum_probs=173.4

Q ss_pred             hcccccccCcEEEEEEE-EeCCceEEEEEeeccccch---HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||+|+||+||||+ ..+.+.||+|.+.+.....   +...+|++++++++||||+.++++|....++++|+||+.|
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            44679999999999996 5668899999998655444   5678999999999999999999999999999999999966


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                       +|..+|...      ..++++.+..++.|+..||.|||+   ++|+|||+||.|||++.++++|++|||+|+....+..
T Consensus        86 -~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   86 -DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             -hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence             999999544      469999999999999999999999   9999999999999999999999999999998876543


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ..+...|||-|||||++.+.  .|+..+|+||+||++||+++|++||..
T Consensus       156 --vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  156 --VLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             --eeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchH
Confidence              34677899999999999875  899999999999999999999999953

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=314.16  Aligned_cols=199  Identities=31%  Similarity=0.463  Sum_probs=171.9

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeecc----cc--chHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL----KG--NGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+|+.|. ..++..||+|++...    ..  ..+...+|+.++++++ ||||++++.++....+.++
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            34456789999999999996 456899999977653    11  2345668999999999 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLA  284 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla  284 (344)
                      ||||+.+|+|.+++..      ..++.+..+..+++|+++|++|+|+   ++|+||||||+|||++.+ +++||+|||++
T Consensus        98 vmEy~~gGdL~~~i~~------~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVN------KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEecCCccHHHHHHH------cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999965      2468999999999999999999999   999999999999999999 99999999999


Q ss_pred             cccc-CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          285 KLCS-KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       285 ~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      .... .+   ......+||+.|+|||++.+.......++||||+||+||.|++|+.||+++
T Consensus       169 ~~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~  226 (370)
T KOG0583|consen  169 AISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS  226 (370)
T ss_pred             cccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence            9873 32   234678899999999999886212347999999999999999999999863

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=320.24  Aligned_cols=206  Identities=29%  Similarity=0.498  Sum_probs=175.2

Q ss_pred             CHHHHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCe
Q 041350          126 TYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR  202 (344)
Q Consensus       126 ~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  202 (344)
                      .++|+.-....+.+.||+|.||+||+|.. .| .||||+++..   .+..+.|.+|+..+++-+|.||+-+.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW-HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccc-cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            34555555555678999999999999974 34 6999999753   3455889999999999999999999999998887


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                       +||+.+|+|-+|..+|+..+     ..++..+.+.||.|||+||.|||.   ++|||||||+.||++.+++++||+|||
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             -eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence             99999999999999998654     468899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++..-.............|...|||||++.. ...+|+.++||||||+|+|||++|..|+.
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            9875544322233344558899999999853 23589999999999999999999999985

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=306.95  Aligned_cols=190  Identities=28%  Similarity=0.498  Sum_probs=157.0

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhh--hcccceeeEeeEEEcC----CeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSEG----TRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~lv~e~~  210 (344)
                      +.+.||+|.||+||+|. +.|+.||||++...  +.+.+++|.++.+.  |+|+||+.+++.-..+    +++|||++|.
T Consensus       215 L~e~IGkGRyGEVwrG~-wrGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGR-WRGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeecc-ccCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            45789999999999997 78999999999864  44566676666655  5999999999875443    4789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ-----GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ++|||.|||..       .+++.+..++++..+|.||++||.     ..++.|.|||||++|||+..+++..|+|+|||.
T Consensus       292 e~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  292 EHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999954       469999999999999999999996     345789999999999999999999999999998


Q ss_pred             cccCCccc--eeeecccCCcccccccccccccC----CCCcccchHhHHHHHHHHHc
Q 041350          286 LCSKDISI--VSLTAARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMVG  336 (344)
Q Consensus       286 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Dv~s~Gvvl~ell~  336 (344)
                      ....+...  ...+..+||.+|||||++....+    ..-..+||||||.|+||+.-
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            87655322  23456789999999999965321    11236899999999999873

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=309.50  Aligned_cols=197  Identities=28%  Similarity=0.425  Sum_probs=173.6

Q ss_pred             HHHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHH--HHHHHHHhhhc-ccceeeEeeEEEcCC-eEEEEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF--INEVATIGRIH-HFHIVRLLGFCSEGT-RRALVY  207 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~  207 (344)
                      .+|...++||.|.||+||+|+ ..+|..||||+++..-...++.  ++|++.|++|+ ||||+++.+++.+.. .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            355667889999999999997 5678999999998654444444  68999999998 999999999999888 999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||| ..+|.+++..+.     ..+++..++.|+.||++||+|+|+   +|++|||+||+|||+..+..+||+|||+||..
T Consensus        90 E~M-d~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             Hhh-hhhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence            999 569999996553     679999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....   .+..+.|.+|.|||++.+. +.|+.+.||||+||+++|+.+-|+-|-
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFP  211 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFP  211 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCC
Confidence            65544   3567789999999999876 689999999999999999999888763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-42  Score=292.36  Aligned_cols=191  Identities=24%  Similarity=0.386  Sum_probs=165.7

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccccch---HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .++|+|+||.|||++. .+|+.||||++..+.++.   +-.++|+++|++++|+|+|.++.+|.....++||+||++..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            4689999999999985 459999999998765543   456899999999999999999999999999999999997755


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+ |....     ..++.+....++.|++.|+.|+|+   ++++||||||+||||+.++.+||+|||+|+.+.....  
T Consensus        88 L~e-Le~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--  156 (396)
T KOG0593|consen   88 LHE-LERYP-----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--  156 (396)
T ss_pred             HHH-HHhcc-----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence            544 43322     358899999999999999999999   9999999999999999999999999999998874322  


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ..+..+.|.+|.|||.+.+. ..|....||||+||++.||++|.+-+
T Consensus       157 ~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~  202 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLW  202 (396)
T ss_pred             hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCC
Confidence            23566789999999999886 48899999999999999999998866

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=311.61  Aligned_cols=190  Identities=29%  Similarity=0.469  Sum_probs=172.4

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeeccccch-HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ++||+|+-|.||.+. ..+++.||||++....... +-.++|+.+|+..+|+|||++++.+..++++|+|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            568999999999996 5568899999998766555 45689999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +.+..       ..+++.++..|++++++||+|||.   ++|+|||||++|||++.++.+||+|||++..+.....  ..
T Consensus       359 DvVt~-------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR  426 (550)
T KOG0578|consen  359 DVVTK-------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR  426 (550)
T ss_pred             hhhhc-------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence            99843       348999999999999999999999   9999999999999999999999999999998877654  33


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...+|||.|||||++.+.  .|.++.||||||++++||+-|.+||-
T Consensus       427 ~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYl  470 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYL  470 (550)
T ss_pred             ccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCcc
Confidence            567899999999999886  89999999999999999999999984

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-41  Score=280.74  Aligned_cols=193  Identities=30%  Similarity=0.431  Sum_probs=168.2

Q ss_pred             hcccccccCcEEEEEEE-EeCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      -.++||+|.||.||+|+ ..+|+.||||+++..+.   -....++|++.|+.++|+||+.+++.|...+.+.||+|||+ 
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-   84 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-   84 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-
Confidence            34679999999999997 46799999999985432   24678999999999999999999999999999999999995 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      .+|...+....     ..++..++..++.++++|++|||+   +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        85 tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   85 TDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            59999995443     579999999999999999999999   9999999999999999999999999999998876543


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ..  +..+-|..|.|||.+-+. ..|+...||||.||++.||+-|.+-+
T Consensus       157 ~~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  157 IQ--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             cc--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCC
Confidence            32  334679999999999876 57899999999999999999776544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=310.29  Aligned_cols=206  Identities=27%  Similarity=0.428  Sum_probs=178.4

Q ss_pred             HHHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       128 ~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .|+.+....|.++||+|-||+|..+....+..||||+++..  +....+|.+|+++|.+++||||++++|+|..++.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            45666666788999999999999999888899999999853  3345799999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      |+|||++|+|..|+......    .+......+|+.|||+||+||.+   .++|||||.++|+|++.++++||+|||+++
T Consensus       613 I~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence            99999999999999765321    24556677899999999999999   999999999999999999999999999999


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH--cCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV--GCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell--~g~~p~~  342 (344)
                      -+.....+......+-+++|||||.+..  ++++.++|||+||+++||++  +..+|+.
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence            6655555544456667899999998876  48999999999999999986  6777764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=326.00  Aligned_cols=208  Identities=28%  Similarity=0.504  Sum_probs=179.1

Q ss_pred             ccCHHHHHHHHHhh-----------cccccccCcEEEEEEEEeC----CceEEEEEeecc--ccchHHHHHHHHHHhhhc
Q 041350          124 RYTYKELKKITSKF-----------KHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHL--KGNGQEFINEVATIGRIH  186 (344)
Q Consensus       124 ~~~~~~l~~~~~~~-----------~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~  186 (344)
                      .++|+|--++..+|           .+.||.|.||+|++|.+.-    ...||||.++..  ..+..+|+.|+.+|.+++
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            45666655555544           3569999999999998643    357999999964  455679999999999999


Q ss_pred             ccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041350          187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH  266 (344)
Q Consensus       187 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~  266 (344)
                      ||||++|.|+........||+|||+||+|+.||..+.     ..+++.++..+.++||.||+||.+   .++|||||.++
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR  760 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR  760 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence            9999999999999999999999999999999997665     358999999999999999999998   99999999999


Q ss_pred             ceEEcCCCceEEeecCCcccccCCc-cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCC
Q 041350          267 NILLDHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNK  341 (344)
Q Consensus       267 Nill~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~  341 (344)
                      |||++.+...|++|||+++.++++. .........-+++|.|||.+.-.  .++..|||||||+||||.+ .|.+|+
T Consensus       761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCcc
Confidence            9999999999999999999887664 22333445567899999999654  8999999999999999988 688887

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=316.55  Aligned_cols=204  Identities=30%  Similarity=0.496  Sum_probs=171.2

Q ss_pred             HHHHHHHHhhcccccccCcEEEEEEEEeCC-----ceEEEEEeec----cccchHHHHHHHHHHhhhcccceeeEeeEEE
Q 041350          128 KELKKITSKFKHRLGQGGYGSVFRGKLFNG-----IPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLGFCS  198 (344)
Q Consensus       128 ~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~-----~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  198 (344)
                      +++....-.+.++||+|+||+||+|++..+     ..||||..+.    .+....+|++|+++|++++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344444444568899999999999986442     2389999874    2445579999999999999999999999999


Q ss_pred             cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEE
Q 041350          199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  278 (344)
Q Consensus       199 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl  278 (344)
                      ....+++|||+|+||+|.+||....     ..++..+...++.+.|.||+|||+   .+++||||.++|+|++.++.+||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKI  303 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKI  303 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEe
Confidence            9999999999999999999996544     258999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +|||+++....-  ........-+.+|+|||.+...  .++.++|||||||++||+++ |..|+.+
T Consensus       304 SDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g  365 (474)
T KOG0194|consen  304 SDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPG  365 (474)
T ss_pred             CccccccCCcce--eeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCC
Confidence            999998865411  1111123467899999999764  89999999999999999996 7877754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=296.82  Aligned_cols=197  Identities=31%  Similarity=0.461  Sum_probs=165.2

Q ss_pred             hcccccccCcEEEEEEEEeC-CceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--eEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--RRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~  212 (344)
                      ..+.||+|+||+||++...+ |...|||...... ...+.+.+|+.+|.+++|||||+.+|......  .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            45679999999999998544 8999999987542 12467899999999999999999999754444  68999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCC-
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKD-  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~-  290 (344)
                      |+|.+++....     ..+++..++.+++||++||+|||+   ++|+|+||||+|||++. ++.+||+|||+++..... 
T Consensus       101 GsL~~~~~~~g-----~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen  101 GSLSDLIKRYG-----GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             CcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            99999996543     159999999999999999999999   99999999999999999 799999999999877631 


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..........||+.|||||++... .....++||||+||++.||+||..|+.
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             ccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcch
Confidence            111223457799999999999752 123359999999999999999998875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=332.02  Aligned_cols=210  Identities=29%  Similarity=0.488  Sum_probs=175.8

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEeC--Cc----eEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCC
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLFN--GI----PVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT  201 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  201 (344)
                      +......+.+.||+|+||.||+|...+  |.    .||||.++..  ..+..+|++|..+|++++|||||+++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            334444556789999999999998543  33    4899999865  344578999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSS-SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      ..++++|||++|||..||.+.+... ....++..+++.++.|||+|+.||++   +++|||||..+|+||+....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcc
Confidence            9999999999999999998753322 23568999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      ||+|+.......+.......-+..|||||.+..  +.++.|+|||||||++||++|...+++++
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~  907 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPS  907 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCC
Confidence            999995544433333233456789999999986  48999999999999999999877776653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=294.62  Aligned_cols=203  Identities=25%  Similarity=0.344  Sum_probs=176.2

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+++.+.||.|..++||+|. ...+..||||++...+.  ..+.+.+|+..|+.++||||++.+..|..+..+|+||.||
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM  106 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM  106 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence            34566889999999999997 56789999999985433  3468899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      .+||+.+.+...-.    ..+++..+..|.+++++||.|||+   +|.||||||+.||||+++|.+||+|||.+..+...
T Consensus       107 a~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             cCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999976432    348999999999999999999999   99999999999999999999999999987655433


Q ss_pred             ccc-e-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISI-V-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~-~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... . +.....||+.|||||++..+...|+.|+||||||++..||.+|..||..
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k  234 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK  234 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence            221 1 1145689999999999777667899999999999999999999999953

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-40  Score=304.92  Aligned_cols=206  Identities=32%  Similarity=0.466  Sum_probs=167.9

Q ss_pred             HHHhhcccccccCcEEEEEEEE------eCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcC-Ce
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEG-TR  202 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~  202 (344)
                      ..+.+.++||+|+||.||+|..      .++..||+|+++...  ...+.+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            3456678899999999999963      235689999997532  2335789999999999 899999999988764 45


Q ss_pred             EEEEEeccCCCCHHHHHhccCCC--------------------------------------------------------C
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNS--------------------------------------------------------S  226 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~  226 (344)
                      .+++|||+++|+|.+++......                                                        .
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            79999999999999999753210                                                        0


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccc
Q 041350          227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI  306 (344)
Q Consensus       227 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  306 (344)
                      ...++++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++...............+++.|+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  243 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM  243 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence            02358899999999999999999999   999999999999999999999999999998654433222223345678999


Q ss_pred             cccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          307 APELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       307 aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       244 aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~  279 (338)
T cd05102         244 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPG  279 (338)
T ss_pred             CcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence            99998764  78999999999999999996 9888853

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-40  Score=307.76  Aligned_cols=197  Identities=25%  Similarity=0.335  Sum_probs=168.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++.. .+++.||+|+++...    ...+.+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            3457899999999999974 458899999997532    22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        84 ~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          84 PGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999543      458999999999999999999999   99999999999999999999999999998754321


Q ss_pred             ccc---------------------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcC
Q 041350          291 ISI---------------------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       291 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                      ...                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhC
Confidence            100                                 001234699999999999764  788999999999999999999


Q ss_pred             CCCCCC
Q 041350          338 RKNKDP  343 (344)
Q Consensus       338 ~~p~~~  343 (344)
                      +.||..
T Consensus       233 ~~Pf~~  238 (363)
T cd05628         233 YPPFCS  238 (363)
T ss_pred             CCCCCC
Confidence            999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=308.22  Aligned_cols=191  Identities=31%  Similarity=0.551  Sum_probs=168.6

Q ss_pred             CHHHHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          126 TYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       126 ~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .|++|.+.     +=||+|+.|.||+|++ .++.||||+++..+      ..+++.|++|+|+||+.|.|+|.....++|
T Consensus       122 PFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI  189 (904)
T KOG4721|consen  122 PFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI  189 (904)
T ss_pred             CHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence            45555433     4589999999999985 56789999887543      357999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      |||||..|.|...|..      +++++......+..+||.||.|||.   +.|||||||+-||||..+..+||+|||-++
T Consensus       190 iMEfCa~GqL~~VLka------~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKA------GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             eeeccccccHHHHHhc------cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchH
Confidence            9999999999999943      4578999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......   ...+.||..|||||++.+.  +.+.|+|||||||||||||||.-|+-
T Consensus       261 e~~~~ST---kMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  261 ELSDKST---KMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hhhhhhh---hhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCcc
Confidence            8766533   2457899999999999875  88999999999999999999999974

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-40  Score=294.95  Aligned_cols=196  Identities=27%  Similarity=0.403  Sum_probs=168.9

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ...+.||+|+||+||++.. .+|+.||+|.+....    .....+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            3457899999999999974 568999999986432    22246789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.++|+|||++......
T Consensus        83 ~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          83 NGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             CCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999988854321    358999999999999999999999   99999999999999999999999999999875433


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       156 ~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         156 ET---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             Ce---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCC
Confidence            22   2345689999999999764  788999999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-40  Score=301.49  Aligned_cols=192  Identities=24%  Similarity=0.332  Sum_probs=166.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||.||+++. .+|+.||+|+++...    .....+.+|+.++++++||||+++++.+.+++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3589999999999975 468899999997532    23356789999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-  150 (323)
T cd05571          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence            999998542      358999999999999999999999   9999999999999999999999999999875432211 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~  197 (323)
T cd05571         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             -cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCC
Confidence             12345689999999999764  788999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-40  Score=301.79  Aligned_cols=193  Identities=25%  Similarity=0.347  Sum_probs=169.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+.. +++.||+|+++...    ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            356688999999999999854 58899999997532    2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       100 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263        100 VVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             CCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999543      357899999999999999999999   9999999999999999999999999999987644


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCC
Confidence            32     234689999999999765  678899999999999999999999854

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=297.44  Aligned_cols=192  Identities=25%  Similarity=0.321  Sum_probs=168.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|... +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            45678999999999999854 58899999997432    23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   ++++||||||+|||+++++.+||+|||+++.....
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          84 PGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999543      358899999999999999999999   99999999999999999999999999999866432


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1     234689999999998765  678899999999999999999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-40  Score=307.21  Aligned_cols=196  Identities=22%  Similarity=0.283  Sum_probs=166.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||+|+||+||+|+. .+++.||+|++....    ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            457899999999999974 457899999997532    233568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++.+....
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          85 GGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999998543      358899999999999999999999   999999999999999999999999999986432100


Q ss_pred             cc---------------------------------------------eeeecccCCcccccccccccccCCCCcccchHh
Q 041350          292 SI---------------------------------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS  326 (344)
Q Consensus       292 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s  326 (344)
                      ..                                             .......||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                             001234699999999998764  6889999999


Q ss_pred             HHHHHHHHHcCCCCCCC
Q 041350          327 YGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       327 ~Gvvl~ell~g~~p~~~  343 (344)
                      |||++|||++|+.||..
T Consensus       234 lG~il~elltG~~Pf~~  250 (381)
T cd05626         234 VGVILFEMLVGQPPFLA  250 (381)
T ss_pred             hhhHHHHHHhCCCCCcC
Confidence            99999999999999953

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.6e-40  Score=301.80  Aligned_cols=194  Identities=27%  Similarity=0.353  Sum_probs=169.0

Q ss_pred             HHhhcccccccCcEEEEEEEEeC--CceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN--GIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.+.||+|+||.||+|+..+  +..||+|.+...    ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            34567889999999999997543  368999998643    233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++..
T Consensus       111 Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        111 EFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999543      358999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....     ....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       182 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        182 DTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             CCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCC
Confidence            4321     245689999999999764  678899999999999999999999864

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=297.53  Aligned_cols=190  Identities=24%  Similarity=0.326  Sum_probs=165.3

Q ss_pred             ccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||+||+++.. +++.||+|+++..    ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999854 5789999999742    23345678999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++.......  .
T Consensus        81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  149 (312)
T cd05585          81 FHHLQRE------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K  149 (312)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence            9999542      358999999999999999999999   9999999999999999999999999999986433221  1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       150 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCC
Confidence            2345689999999999764  788999999999999999999999853

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-39  Score=283.23  Aligned_cols=197  Identities=30%  Similarity=0.432  Sum_probs=169.0

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeecccc---chHHHHHHHHHHhhhcccc-eeeEeeEEEcCC------eEEEE
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFH-IVRLLGFCSEGT------RRALV  206 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~lv  206 (344)
                      .++||+|+||+||+|+ ..+|+.||+|+++...+   ......+|+.++++++|+| |+++++++.+.+      .+++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            3669999999999997 45689999999986543   3356789999999999999 999999998877      88999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||+ .-+|..++.......  ..++...++.+++||+.||+|||+   ++|+||||||.||||+++|.+||+|||+|+.
T Consensus        96 fe~~-d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   96 FEFL-DRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             EEee-cccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            9999 569999997654321  356778999999999999999999   9999999999999999999999999999996


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.-+..  ..+..++|..|.|||++.+. ..|+...||||+||++.||+++++-|..
T Consensus       170 ~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG  223 (323)
T KOG0594|consen  170 FSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPG  223 (323)
T ss_pred             hcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence            653322  23556789999999999886 4689999999999999999999888753

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.6e-40  Score=298.29  Aligned_cols=192  Identities=26%  Similarity=0.357  Sum_probs=165.5

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||.||++.. .+|..||+|+++..    ......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3589999999999974 46899999999753    223356788999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  150 (323)
T cd05595          81 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence            999988532      358999999999999999999999   9999999999999999999999999999875432211 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             -ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCC
Confidence             12345689999999998764  788999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-40  Score=282.35  Aligned_cols=193  Identities=27%  Similarity=0.368  Sum_probs=167.4

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeeccccch---HHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEEeccC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEFMP  211 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  211 (344)
                      .++|++|+||.||+|+. .+++.||+|+++..++..   -.-++|+.+|.+++|||||.+-.+...  -+..|+|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            36799999999999974 458899999998654222   345899999999999999999987644  457999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      . ||..++....     +++...+...+..|+++|++|||.   +-|+|||||++|+|+++.|.+||+|||+|+.+....
T Consensus       161 h-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  161 H-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             h-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            6 9999997654     578999999999999999999999   999999999999999999999999999999887663


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .  ..+..+-|.+|.|||++.+. ..|+...|+||+||++.||+++++.|.
T Consensus       232 k--~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~  279 (419)
T KOG0663|consen  232 K--PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFP  279 (419)
T ss_pred             c--cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCC
Confidence            3  34566789999999999886 589999999999999999999988763

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.9e-40  Score=298.04  Aligned_cols=192  Identities=26%  Similarity=0.368  Sum_probs=166.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||.||++.. .+++.||+|++...    ......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3589999999999974 46899999999753    223457889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-  150 (328)
T cd05593          81 ELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-  150 (328)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence            999988532      358999999999999999999999   9999999999999999999999999999875432211 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             -ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCC
Confidence             12345689999999998764  688999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-40  Score=306.14  Aligned_cols=197  Identities=24%  Similarity=0.298  Sum_probs=166.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++.. .+++.||||++....    ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            3457899999999999974 468899999986432    22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        84 ~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          84 PGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999543      358899999999999999999999   99999999999999999999999999999643211


Q ss_pred             ccc------------e---------------------------------eeecccCCcccccccccccccCCCCcccchH
Q 041350          291 ISI------------V---------------------------------SLTAARGTAGYIAPELFSRNFGEVSYKSDVY  325 (344)
Q Consensus       291 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~  325 (344)
                      ...            .                                 ......||+.|+|||++.+.  .++.++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Diw  232 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeE
Confidence            000            0                                 00124589999999998764  788999999


Q ss_pred             hHHHHHHHHHcCCCCCCC
Q 041350          326 SYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       326 s~Gvvl~ell~g~~p~~~  343 (344)
                      ||||++|||++|+.||..
T Consensus       233 SlGvil~elltG~~Pf~~  250 (377)
T cd05629         233 SLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             ecchhhhhhhcCCCCCCC
Confidence            999999999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-40  Score=300.19  Aligned_cols=192  Identities=26%  Similarity=0.384  Sum_probs=169.3

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||+|+.. +++.||+|+++...    ...+.+.+|+.++..++||||+++++++.++...++||||+
T Consensus         4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   83 (333)
T cd05600           4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence            45678999999999999865 58899999997532    23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~  154 (333)
T cd05600          84 PGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY  154 (333)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc
Confidence            999999999543      358899999999999999999999   99999999999999999999999999999865431


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~  200 (333)
T cd05600         155 -----ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             -----cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCC
Confidence                 2345689999999999765  788999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=304.59  Aligned_cols=197  Identities=24%  Similarity=0.321  Sum_probs=167.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +++.||||++....    .....+.+|+.++..++||||+++++++.++...++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34578999999999999854 58899999997532    23356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++.....
T Consensus        84 ~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          84 PGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999543      358999999999999999999999   99999999999999999999999999998754321


Q ss_pred             ccce------------------------------------eeecccCCcccccccccccccCCCCcccchHhHHHHHHHH
Q 041350          291 ISIV------------------------------------SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       291 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~el  334 (344)
                      ....                                    ......||+.|+|||++.+.  .++.++|||||||++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el  232 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHh
Confidence            1000                                    00123589999999998764  788999999999999999


Q ss_pred             HcCCCCCCC
Q 041350          335 VGCRKNKDP  343 (344)
Q Consensus       335 l~g~~p~~~  343 (344)
                      ++|+.||..
T Consensus       233 ~~G~~Pf~~  241 (364)
T cd05599         233 LVGYPPFCS  241 (364)
T ss_pred             hcCCCCCCC
Confidence            999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-40  Score=305.70  Aligned_cols=196  Identities=23%  Similarity=0.299  Sum_probs=166.0

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||+|+||+||+|+. .+++.+|+|++....    ...+.+.+|+.++++++|+||+++++.+.++...++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            457899999999999974 457899999997532    233578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..+....
T Consensus        85 gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          85 GGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999998543      358899999999999999999999   999999999999999999999999999975331100


Q ss_pred             c---------------------------------------------ceeeecccCCcccccccccccccCCCCcccchHh
Q 041350          292 S---------------------------------------------IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS  326 (344)
Q Consensus       292 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s  326 (344)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001124689999999999765  7889999999


Q ss_pred             HHHHHHHHHcCCCCCCC
Q 041350          327 YGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       327 ~Gvvl~ell~g~~p~~~  343 (344)
                      +||++|||++|+.||..
T Consensus       234 lGvil~elltG~~Pf~~  250 (382)
T cd05625         234 VGVILYEMLVGQPPFLA  250 (382)
T ss_pred             chHHHHHHHhCCCCCCC
Confidence            99999999999999963

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=305.65  Aligned_cols=193  Identities=25%  Similarity=0.360  Sum_probs=168.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .|.+.||+|.||+|+++... +++.+|||++++.    .++.+..+.|..++... +||.+++++..|+..+++++||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45688999999999999754 5789999999863    35557778888888777 499999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +.||++..+.+       ...+++..+..++..++.||+|||+   ++||+||||.+|||||.+|++||+|||+++..-.
T Consensus       451 ~~Ggdm~~~~~-------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  451 VAGGDLMHHIH-------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             cCCCcEEEEEe-------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999443331       2469999999999999999999999   9999999999999999999999999999996542


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...  +..+.+|||.|||||++.+.  .|+...|+|||||+|||||.|..||.
T Consensus       521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFP  569 (694)
T ss_pred             CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCC
Confidence            222  35678999999999999886  89999999999999999999999996

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=289.91  Aligned_cols=198  Identities=27%  Similarity=0.393  Sum_probs=175.5

Q ss_pred             HHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc-h---HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN-G---QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~-~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      -++.|.+.||+|.||.|-+|.. ..|+.||||.+++.+-. .   -.+.+|+++|+.|+||||++++.+|...+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            3556678899999999999974 67999999999864322 2   34678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||..+|.|.+|+...      +.|++.+++.+.+||.+|+.|+|.   ++++|||||.+|||+|+++++||+|||++..+
T Consensus       133 EYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  133 EYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhh
Confidence            999999999999543      569999999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....   ...++|+|-|.+||++.+. ..-.+..|-||+||+||.|+.|..|||.
T Consensus       204 ~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  204 ADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             ccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCC
Confidence            76643   3568899999999999876 3346789999999999999999999984

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8e-40  Score=302.78  Aligned_cols=199  Identities=24%  Similarity=0.327  Sum_probs=168.9

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.+.||+|+||.||+++.. +++.+|+|++....    ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3455678999999999999854 57899999986421    233567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       124 y~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         124 YMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999843       247889999999999999999999   999999999999999999999999999998764


Q ss_pred             CCccceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .... .......||+.|+|||++.+..  +.++.++||||+||++|||++|+.||..
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            3321 1123456999999999986531  2377899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-39  Score=295.97  Aligned_cols=192  Identities=28%  Similarity=0.372  Sum_probs=164.9

Q ss_pred             ccccccCcEEEEEEEE----eCCceEEEEEeeccc-----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.||+|+||.||+++.    .+++.||+|+++...     .....+.+|+.+++.++||||+++++.+.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5699999999999974    357889999997532     2234678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+.+..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            9999999998543      357888999999999999999999   9999999999999999999999999999875432


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         153 EGT--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             CCC--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCC
Confidence            221  12345689999999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.3e-40  Score=304.67  Aligned_cols=197  Identities=22%  Similarity=0.291  Sum_probs=166.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++. .+++.||+|++....    ...+.+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            3457899999999999974 458899999996422    23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|..+...
T Consensus        84 ~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          84 PGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999542      358899999999999999999999   99999999999999999999999999997533100


Q ss_pred             c-----------------------------------------cceeeecccCCcccccccccccccCCCCcccchHhHHH
Q 041350          291 I-----------------------------------------SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM  329 (344)
Q Consensus       291 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gv  329 (344)
                      .                                         .........||+.|+|||++.+.  .++.++|||||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccc
Confidence            0                                         00001134689999999999765  6889999999999


Q ss_pred             HHHHHHcCCCCCCC
Q 041350          330 MLLEMVGCRKNKDP  343 (344)
Q Consensus       330 vl~ell~g~~p~~~  343 (344)
                      ++|||++|+.||..
T Consensus       233 ilyell~G~~Pf~~  246 (376)
T cd05598         233 ILYEMLVGQPPFLA  246 (376)
T ss_pred             eeeehhhCCCCCCC
Confidence            99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-40  Score=302.83  Aligned_cols=195  Identities=29%  Similarity=0.426  Sum_probs=173.4

Q ss_pred             hcccccccCcEEEEEEE-EeCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||.|+-|.|-.|+ ..+|+.+|||++...    ......+.+|+.+|+-+.|||++++++++.+..++|+|.||++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence            45679999999999998 467999999999754    2234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|-|.+++...      +++++.++.++..||+.|+.|+|.   .+|+|||+||+|+|||..+++||+|||+|..-.++.
T Consensus        96 gGELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   96 GGELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             CchhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999543      579999999999999999999999   999999999999999999999999999998766553


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      -   ..+-+|+|.|.|||++.+. .....++||||.||+||.||+|+.|||+.
T Consensus       167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDd  215 (786)
T KOG0588|consen  167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDD  215 (786)
T ss_pred             c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence            3   2456799999999999886 34567999999999999999999999973

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.5e-39  Score=288.17  Aligned_cols=191  Identities=20%  Similarity=0.330  Sum_probs=164.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEc----CCeEEEEEecc
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSE----GTRRALVYEFM  210 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  210 (344)
                      ..||+|++|.||+|+. +|+.||||.++.....    .+.|.+|+.+|++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            3589999999999985 7899999999764333    3567799999999999999999999876    35789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++.....++.|++.||+|||+  ..+++||||||+|||+++++.+||+|||+++.....
T Consensus       105 ~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        105 TRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            999999999543      358899999999999999999997  247889999999999999999999999999865432


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .     ....+++.|+|||++.+....++.++|||||||++|||++|+.||+.
T Consensus       177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~  224 (283)
T PHA02988        177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN  224 (283)
T ss_pred             c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence            1     23458899999999976445789999999999999999999999864

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.3e-39  Score=293.49  Aligned_cols=192  Identities=25%  Similarity=0.329  Sum_probs=164.4

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+.. +++.||+|+++..    ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35899999999999854 4789999999753    23335677899998876 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          81 GDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            9999988543      358899999999999999999999   9999999999999999999999999999875432221


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         152 --TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             --cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCC
Confidence              12345689999999998764  788999999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.3e-39  Score=290.53  Aligned_cols=204  Identities=27%  Similarity=0.447  Sum_probs=166.2

Q ss_pred             HHhhcccccccCcEEEEEEEEeC-----------------CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN-----------------GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLL  194 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~  194 (344)
                      .+.+.++||+|+||.||++...+                 +..||+|.+....  ....+|.+|+.++.+++||||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34567889999999999997432                 3469999987532  2345789999999999999999999


Q ss_pred             eEEEcCCeEEEEEeccCCCCHHHHHhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 041350          195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNS-------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHF  261 (344)
Q Consensus       195 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~  261 (344)
                      +++.+.+..++||||+++|+|.+++......             .....+++..+..++.|++.||+|||+   .+|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence            9999999999999999999999998653211             112357889999999999999999999   999999


Q ss_pred             CCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc--CCC
Q 041350          262 DIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG--CRK  339 (344)
Q Consensus       262 Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~--g~~  339 (344)
                      ||||+|||+++++.+||+|||+++...............++..|+|||++...  .++.++||||||+++|||++  +..
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999865443222222234467899999998654  78899999999999999986  455


Q ss_pred             CCC
Q 041350          340 NKD  342 (344)
Q Consensus       340 p~~  342 (344)
                      |+.
T Consensus       241 p~~  243 (304)
T cd05096         241 PYG  243 (304)
T ss_pred             CCC
Confidence            553

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-39  Score=299.21  Aligned_cols=200  Identities=23%  Similarity=0.317  Sum_probs=169.2

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      ..+.+.+.||+|+||.||++... +++.+|+|++....    ...+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            34456688999999999999854 57899999986422    22355788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++..
T Consensus       123 Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         123 EYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             cCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999843       247888999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...... ......||+.|+|||++....  +.++.++|||||||++|||++|+.||..
T Consensus       193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            433211 123456999999999986531  2378899999999999999999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.3e-39  Score=298.84  Aligned_cols=199  Identities=23%  Similarity=0.318  Sum_probs=168.5

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.+.||+|+||+||+++.. ++..||+|.++...    ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            3456688999999999999854 58899999997422    233457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       124 y~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         124 YMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999843       247888899999999999999999   999999999999999999999999999998654


Q ss_pred             CCccceeeecccCCcccccccccccc--cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRN--FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..... ......||+.|+|||++.+.  ...++.++|||||||++|||++|+.||..
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  249 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence            33211 12345699999999998643  12478899999999999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-40  Score=307.80  Aligned_cols=196  Identities=31%  Similarity=0.534  Sum_probs=172.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCC----ceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNG----IPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .-.++||+|+||+||||.. ..|    .+||+|++.....  ..+++++|+.+|.+++|||+++++|+|.... .-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            3457899999999999964 333    5799999976443  4689999999999999999999999998877 789999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |||.|+|.+|++..+     ..+..+..+.|..|||+||.|||+   ++++||||..+|||+..-..+|+.|||+|+...
T Consensus       778 ~mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             hcccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            999999999997755     468889999999999999999998   999999999999999999999999999999988


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      .+..........-.+.|||-|.+...  .++.++|||||||.+||++ .|.+|++
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~  902 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYD  902 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccC
Confidence            77665555566678899999998764  8999999999999999999 5778875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-39  Score=295.07  Aligned_cols=193  Identities=26%  Similarity=0.356  Sum_probs=165.2

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||+||++.. .+|..||+|+++..    ......+.+|+++++.++||||+++.+++.+....++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3589999999999974 46889999999753    223356788999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|..++...      ..+++..+..++.|++.||+|||+  ..+|+||||||+|||+++++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  151 (325)
T cd05594          81 ELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-  151 (325)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence            999988432      358999999999999999999996  26999999999999999999999999999875432221 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         152 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             -ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCC
Confidence             12345689999999998764  788999999999999999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.7e-39  Score=291.29  Aligned_cols=192  Identities=25%  Similarity=0.345  Sum_probs=162.6

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+.. +++.||+|.++...    ...+.+..|..++... +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            35899999999999854 57889999997532    2334566677777654 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          81 GDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            9999998543      358999999999999999999999   9999999999999999999999999999986433221


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~  198 (316)
T cd05592         152 --KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCC
Confidence              12345689999999998764  688999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9e-39  Score=285.11  Aligned_cols=194  Identities=29%  Similarity=0.418  Sum_probs=166.0

Q ss_pred             ccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||+||++.. .+++.+|+|.+.....    ..+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999974 4688999999874321    225678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++.....  ....+++..+..++.|++.||+|||+   .+|+||||||+||++++++.++|+|||++.........  
T Consensus        81 ~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--  153 (280)
T cd05608          81 RYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--  153 (280)
T ss_pred             HHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence            988854321  22468999999999999999999999   99999999999999999999999999999765443221  


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~  199 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            2345689999999999764  788999999999999999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-39  Score=294.26  Aligned_cols=196  Identities=23%  Similarity=0.329  Sum_probs=166.7

Q ss_pred             hhcccccccCcEEEEEEEE----eCCceEEEEEeeccc-----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK-----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.||+|+||+||+++.    .+++.||+|++....     ...+.+.+|+.++..+ +|+||+++++++.+....++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            4567899999999999874    357899999997421     2235678899999999 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        83 v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999998543      358999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ........ ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||+
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~  208 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFT  208 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCC
Confidence            65433221 12345689999999998754 346889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.6e-39  Score=291.86  Aligned_cols=192  Identities=26%  Similarity=0.362  Sum_probs=164.5

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+.. +++.||+|+++..    ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            35899999999999854 5789999999742    23345678888888877 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.......
T Consensus        81 g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          81 GDLMFHIQKS------RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             chHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            9999988543      358999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             --cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCC
Confidence              12345689999999998764  788899999999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-39  Score=299.08  Aligned_cols=196  Identities=26%  Similarity=0.332  Sum_probs=167.2

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||+|+||+||++... +++.||+|+++..    ....+.+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4578999999999999754 5889999999742    2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+++++|+|||+++......
T Consensus        85 gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          85 GGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999543      458999999999999999999999   999999999999999999999999999987543211


Q ss_pred             cc---------------------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCC
Q 041350          292 SI---------------------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR  338 (344)
Q Consensus       292 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~  338 (344)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001134689999999998765  7889999999999999999999


Q ss_pred             CCCCC
Q 041350          339 KNKDP  343 (344)
Q Consensus       339 ~p~~~  343 (344)
                      .||..
T Consensus       234 ~Pf~~  238 (360)
T cd05627         234 PPFCS  238 (360)
T ss_pred             CCCCC
Confidence            99864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-39  Score=293.21  Aligned_cols=191  Identities=24%  Similarity=0.364  Sum_probs=164.3

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+++. .+++.||+|+++...    ...+.+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3589999999999975 458899999997532    2235578899999988 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            9999988432      358999999999999999999999   9999999999999999999999999999875322111


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcc
Confidence              12345689999999999764  78889999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.8e-39  Score=297.29  Aligned_cols=207  Identities=30%  Similarity=0.490  Sum_probs=169.7

Q ss_pred             HHHHHhhcccccccCcEEEEEEEE------eCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCC
Q 041350          131 KKITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGT  201 (344)
Q Consensus       131 ~~~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  201 (344)
                      ....+.+.+.||+|+||+||+|+.      .++..||||+++...  ...+.+.+|+.+++.+ +||||+++++++.++.
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            334456778999999999999963      235689999997533  2346788999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCC--------------------------------------------------------
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNS--------------------------------------------------------  225 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  225 (344)
                      ..++||||+++|+|.+++......                                                        
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            999999999999999999653210                                                        


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          226 -------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       226 -------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                                   .....+++..+..++.||++||+|||+   .+++||||||+|||+++++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                         011357899999999999999999999   9999999999999999999999999999986654332


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ........++..|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            2222233456789999998764  78899999999999999997 777774

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.1e-39  Score=286.91  Aligned_cols=197  Identities=28%  Similarity=0.421  Sum_probs=166.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.++||+|+||+||+|... ++..||+|.++...  .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            345678999999999999754 58899999987432  234577899999999999999999999999999999999997


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       ++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        87 -~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          87 -SDLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             -cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence             59999885432     357899999999999999999999   999999999999999999999999999997654322


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+++.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             c--cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  12334579999999988653 3678899999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.7e-39  Score=288.42  Aligned_cols=197  Identities=28%  Similarity=0.424  Sum_probs=166.2

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|+.. +++.||+|+++...  .....+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            345678999999999999854 68899999987533  223567899999999999999999999999999999999995


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       ++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        87 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          87 -TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             -cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence             68888875432     358899999999999999999999   999999999999999999999999999987543221


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+|+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  12345689999999998654 3578899999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=293.06  Aligned_cols=199  Identities=24%  Similarity=0.302  Sum_probs=168.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +++.||+|++...    ....+.+.+|+.++..++|+||+++++++.++...++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (331)
T cd05597           4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY   83 (331)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence            45678999999999999854 5889999999742    223356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999995422     358899999999999999999999   99999999999999999999999999998765433


Q ss_pred             ccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++...   ...++.++|||||||++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            221 11234589999999998631   23577899999999999999999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.3e-39  Score=290.92  Aligned_cols=195  Identities=24%  Similarity=0.300  Sum_probs=165.5

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhccc-ceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHF-HIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||.||+|+.. +++.||+|+++..    ....+.+..|..++..++|+ +|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45678999999999999854 4678999999753    23346788899999999765 688899999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          83 VNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999998543      358899999999999999999999   9999999999999999999999999999875322


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         154 GGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             CCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            211  12345689999999999764  688999999999999999999999863

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.1e-39  Score=291.20  Aligned_cols=195  Identities=24%  Similarity=0.298  Sum_probs=165.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||+||+|+.. +++.||+|.++...    ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            35678999999999999754 57899999997532    2234567788888777 589999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          83 VNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999998543      358899999999999999999999   9999999999999999999999999999975432


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       154 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         154 DGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             CCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCC
Confidence            211  12345689999999999764  789999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.6e-39  Score=293.74  Aligned_cols=199  Identities=23%  Similarity=0.297  Sum_probs=168.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +++.||+|.+....    ...+.+.+|..++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            45678999999999999854 57889999987421    22345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          84 VGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999996532     358899999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++.+.   .+.++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            221 12335699999999988642   13577899999999999999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-38  Score=289.53  Aligned_cols=192  Identities=26%  Similarity=0.340  Sum_probs=163.6

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|... +++.||+|+++..    ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999854 4789999999753    23345667788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            9999998542      358899999999999999999999   9999999999999999999999999999875322211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             --ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence              12345689999999998764  688999999999999999999999853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.2e-39  Score=292.61  Aligned_cols=191  Identities=24%  Similarity=0.368  Sum_probs=163.3

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||++... +++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            35899999999999854 57899999997532    2234577888888777 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          81 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            9999888432      358999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             --ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCc
Confidence              12345689999999999764  78889999999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=297.97  Aligned_cols=197  Identities=26%  Similarity=0.361  Sum_probs=170.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|... +++.||+|+++...    ...+.+.+|++++..++|+||+++++++.++...++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            45678999999999999854 68999999997532    34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          84 PGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999543      358999999999999999999999   99999999999999999999999999999866543


Q ss_pred             c---------------------------cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 I---------------------------SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .                           .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112345689999999999775  788999999999999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.1e-39  Score=305.16  Aligned_cols=202  Identities=23%  Similarity=0.337  Sum_probs=170.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-C-CceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-N-GIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            456788999999999999643 3 5778888765432 233567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++.....  ...++++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus       149 gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        149 GGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999998865321  23568999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .........||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             ccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            22222345699999999998764  788999999999999999999999863

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-38  Score=289.56  Aligned_cols=192  Identities=26%  Similarity=0.352  Sum_probs=163.8

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||.||+|+.. +|..||+|.++..    ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36899999999999854 5889999999753    23345667788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++.......
T Consensus        81 g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          81 GDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            9999998542      358899999999999999999999   9999999999999999999999999999875322211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~  198 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCC
Confidence              12345689999999999764  788999999999999999999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.1e-39  Score=296.26  Aligned_cols=207  Identities=29%  Similarity=0.481  Sum_probs=168.9

Q ss_pred             HHHHHhhcccccccCcEEEEEEEE------eCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCC
Q 041350          131 KKITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGT  201 (344)
Q Consensus       131 ~~~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  201 (344)
                      ....+.+.+.||+|+||.||+|+.      .++..||+|+++...  ...+.+.+|+.+++.+ +|+||+++++++.+..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            344556678999999999999863      234579999997532  2335688999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCC--------------------------------------------------------
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNS--------------------------------------------------------  225 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  225 (344)
                      ..++||||+++|+|.+++......                                                        
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999998643210                                                        


Q ss_pred             --------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeee
Q 041350          226 --------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT  297 (344)
Q Consensus       226 --------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  297 (344)
                              ....++++..+++++.|+++||+|||+   ++|+||||||+|||+++++++||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                    012357889999999999999999999   999999999999999999999999999998654432221112


Q ss_pred             cccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       298 ~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ...+++.|||||++.+.  .++.++||||||+++|||++ |+.||.
T Consensus       273 ~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~  316 (374)
T cd05106         273 NARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYP  316 (374)
T ss_pred             CCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            23456789999998764  78999999999999999997 998875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9e-39  Score=290.66  Aligned_cols=192  Identities=26%  Similarity=0.346  Sum_probs=161.6

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHH-HHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+. .+++.||+|++....    .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3689999999999985 458899999997432    22344555654 57889999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          81 GELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            9999888532      358889999999999999999999   9999999999999999999999999999875322211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         152 --TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             --ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCC
Confidence              12345689999999998764  688899999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-38  Score=291.13  Aligned_cols=199  Identities=24%  Similarity=0.300  Sum_probs=167.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.++||+|+||+||+++.. +++.+|+|++...    ....+.+.+|+.++..++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            45678999999999999854 4678999998642    122345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          84 VGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             CCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999996532     358999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++...   ...++.++|||||||++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            221 12335699999999998631   13578899999999999999999999863

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-39  Score=283.23  Aligned_cols=191  Identities=32%  Similarity=0.439  Sum_probs=158.7

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC-----eEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-----RRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~  212 (344)
                      +.+|.|+||.||+|++. +++.||||+.-..+.-   --+|+++|++++|||||+++.+|....     ...+||||||.
T Consensus        30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~  106 (364)
T KOG0658|consen   30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE  106 (364)
T ss_pred             EEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence            67999999999999854 4689999988543321   136899999999999999999885432     34589999965


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCcccccCCc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~~~~~  291 (344)
                       +|..++.....  .+..++...++-+..||++||+|||+   .+|+||||||.|+|+|.+ +.+||+|||.|+....+.
T Consensus       107 -tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  107 -TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             -HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence             99999875322  22457778889999999999999999   999999999999999976 899999999999887765


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...   ...-|..|.|||.+.+. ..|+.+.||||.|||+.||+-|+.-|-
T Consensus       181 pni---SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFp  227 (364)
T KOG0658|consen  181 PNI---SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFP  227 (364)
T ss_pred             Cce---eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccC
Confidence            543   23357889999999886 589999999999999999999998773

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.6e-39  Score=290.71  Aligned_cols=192  Identities=25%  Similarity=0.356  Sum_probs=162.2

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHH-HHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+.. +|+.||+|++....    ...+++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            35899999999999854 68999999997432    22345556655 56789999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            9999998542      358899999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         152 --TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             --ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCC
Confidence              12345689999999998764  788999999999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-38  Score=290.39  Aligned_cols=191  Identities=25%  Similarity=0.360  Sum_probs=164.3

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+++. .+++.+|+|+++...    ...+.+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3689999999999985 457899999998532    2235678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          81 GDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            9999988532      358999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             --ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCC
Confidence              12345689999999998764  78899999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-38  Score=290.52  Aligned_cols=196  Identities=24%  Similarity=0.310  Sum_probs=166.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +++.+.||+|+||+||++.. .+|+.||+|+++..    ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            34668899999999999974 46889999999753    223356788999998886 5778889999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++...
T Consensus        82 y~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          82 YVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999998543      358999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||+|+++|||++|+.||+.
T Consensus       153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         153 VDGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             CCCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            3211  12345589999999998764  688999999999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.3e-39  Score=294.66  Aligned_cols=199  Identities=24%  Similarity=0.288  Sum_probs=170.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++.. .+++.||+|+++....    ..+.+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (330)
T cd05601           4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ   83 (330)
T ss_pred             eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence            4567899999999999974 4688999999975322    3456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          84 PGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999996542     358999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccc----cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN----FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++...    ...++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  211 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence            322 12345689999999998631    13577899999999999999999999863

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-38  Score=281.95  Aligned_cols=199  Identities=27%  Similarity=0.446  Sum_probs=166.8

Q ss_pred             HHHhhcccccccCcEEEEEEEEe----CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      ..+.+.+.||+|+||.||+|+..    .+..||+|.++...  .....+.+|+..+++++||||++++|++..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34456788999999999999753    35689999998643  2235789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.++++|||.+..
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            99999999999996432     368999999999999999999999   9999999999999999999999999998765


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....... ......++..|+|||.+.+.  .++.++||||||+++||+++ |+.|+.
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         157 DKSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            4322111 11233456789999998764  78899999999999999875 999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-38  Score=290.43  Aligned_cols=195  Identities=27%  Similarity=0.405  Sum_probs=168.2

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||.||+++.. ++..+|+|.+....  ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   86 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence            344578999999999999854 57889999987532  233678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.++|+|||++.......
T Consensus        87 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          87 GGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999543      358899999999999999999997  2469999999999999999999999999997654322


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                1345689999999999764  788999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=286.07  Aligned_cols=199  Identities=29%  Similarity=0.414  Sum_probs=162.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---------------chHHHHHHHHHHhhhcccceeeEeeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---------------NGQEFINEVATIGRIHHFHIVRLLGFCS  198 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~  198 (344)
                      +.+.+.||+|.||.|-+|.. .+++.||||++.+.+.               ..+...+|+.+|++++|||||+|+.+..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            34557899999999999973 4689999999964321               1256789999999999999999999986


Q ss_pred             c--CCeEEEEEeccCCCCHHHHHhccCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc
Q 041350          199 E--GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ  275 (344)
Q Consensus       199 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~  275 (344)
                      +  .+.+|||+|||..|.+...=       ...+ +++.+++.+.+++..||+|||.   ++||||||||+|+||+++|+
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             CcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            5  56899999999988875432       1233 9999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccccCC---ccceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          276 PKISDFGLAKLCSKD---ISIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       276 ~kl~Dfgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +||+|||.+..+...   ..........|||.|+|||...+..  ...+.+.||||+||+||-|+.|+.||-.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            999999999876322   1112233467999999999886521  2345688999999999999999999964

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.6e-38  Score=289.43  Aligned_cols=194  Identities=25%  Similarity=0.331  Sum_probs=163.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHH---hhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATI---GRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|.. .+++.||||+++...    ...+.+.+|..++   +.++||||+++++++.+....++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            3467899999999999975 458899999997432    2234566665554   5678999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|..++..       ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        82 E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          82 EYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             cCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            99999999988742       358999999999999999999999   99999999999999999999999999998753


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         152 MGFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             CCCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            32211  12345689999999998764  788899999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-38  Score=280.97  Aligned_cols=197  Identities=37%  Similarity=0.633  Sum_probs=164.6

Q ss_pred             hcccccccCcEEEEEEEEe-----CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.||.|.||.||+|...     .+..|+||.++....  ..++|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     256899999965332  357899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.++|....    ...+++..+..++.|+++||+|||+   .+++|+||+++|||+++++.+||+|||+++....
T Consensus        83 ~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             -TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            99999999998762    2468999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ...............|+|||.+...  .++.++||||||+++|||++ |+.|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~  207 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFS  207 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred             ccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            3222223344578899999998765  68999999999999999999 677765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=267.35  Aligned_cols=195  Identities=25%  Similarity=0.392  Sum_probs=172.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ++.+.||+|-||.||.|+. .++-.||+|++.++.    ...+++.+|+++-+.|+||||++++++|.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            4678899999999999974 457789999997532    33467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +.|+|...|.....    ..+++.....++.|+|.|+.|+|.   ++++||||||+|+|++.++.+||+|||.+...+.+
T Consensus       105 ~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  105 PRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             CCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            99999999975443    458888899999999999999999   99999999999999999999999999998765422


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          .....+||..|.|||...+.  ..+...|+|++|++.||++.|.+||..
T Consensus       178 ----kR~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes  224 (281)
T KOG0580|consen  178 ----KRKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFES  224 (281)
T ss_pred             ----CceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhh
Confidence                23567899999999999876  788999999999999999999999974

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.4e-39  Score=291.04  Aligned_cols=192  Identities=26%  Similarity=0.354  Sum_probs=162.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHH-HHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+++. .+|+.+|+|++....    .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3589999999999974 468999999997431    22345566655 46778999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.......
T Consensus        81 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          81 GELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            9999988532      458999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         152 --TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             --CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCC
Confidence              12345689999999998764  788899999999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-38  Score=277.93  Aligned_cols=198  Identities=24%  Similarity=0.330  Sum_probs=169.1

Q ss_pred             hcccccccCcEEEEEEEEeC-CceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||+|.-|+||++.+.+ +..+|+|++.+..    ....+...|-+||+.++||.+++|+..+..+...+++||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            34789999999999998655 5889999997532    223566789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC-
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD-  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~-  290 (344)
                      ||+|..+.+.+..    ..++++.++.++..++-||+|||.   .|||.|||||+||||.++|++.|+||.|+...... 
T Consensus       161 GGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  161 GGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             CccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999876553    679999999999999999999999   99999999999999999999999999987533110 


Q ss_pred             ---------------------------------c--------------------cceeeecccCCcccccccccccccCC
Q 041350          291 ---------------------------------I--------------------SIVSLTAARGTAGYIAPELFSRNFGE  317 (344)
Q Consensus       291 ---------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~  317 (344)
                                                       .                    ...+....+||-.|+|||++.+.  .
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--G  311 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--G  311 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--C
Confidence                                             0                    00112345699999999999986  6


Q ss_pred             CCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          318 VSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       318 ~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .+.++|+|+|||++||||.|..||-.
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG  337 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKG  337 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCC
Confidence            78899999999999999999999953

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-39  Score=291.34  Aligned_cols=192  Identities=27%  Similarity=0.362  Sum_probs=166.0

Q ss_pred             ccccccCcEEEEEEEE----eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          139 HRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.||+|+||+||+++.    .+|+.+|+|+++...   .....+.+|++++++++||||+++++++.++...++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999864    357899999997532   233567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            99999998432      358999999999999999999999   999999999999999999999999999998654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       153 ~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~  200 (318)
T cd05582         153 K--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             C--ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCC
Confidence            1  12345689999999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-38  Score=289.31  Aligned_cols=192  Identities=24%  Similarity=0.330  Sum_probs=160.9

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHH-HHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVA-TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+++.. +++.||+|++....    .....+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            35899999999999854 57789999997532    22234455544 56788999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          81 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            9999998543      357888999999999999999999   9999999999999999999999999999975432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         152 --TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             --CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCC
Confidence              12345689999999998764  788999999999999999999999853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-38  Score=289.06  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=169.1

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ..+.+.++||+|+||+||++... ++..+|+|.+....  ...+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34556788999999999999854 57889999887532  2236789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+  ..+++|+||||+|||+++++.+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999542      358899999999999999999997  24799999999999999999999999999876533


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..    .....|++.|+|||++.+.  .++.++|||||||++|||++|+.|+++
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         157 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            21    1234689999999998764  688899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.3e-38  Score=283.29  Aligned_cols=195  Identities=24%  Similarity=0.338  Sum_probs=166.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+++.. +++.||+|+++...   ...+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            45678999999999999864 57889999997532   234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      ++++..+...      ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          84 KNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            8877655421      2358999999999999999999999   999999999999999999999999999998764332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .. ......|++.|+|||++.+.  .++.++||||+||++|||++|+.||.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~  202 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFP  202 (287)
T ss_pred             cc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCC
Confidence            11 12234689999999998764  68889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.3e-38  Score=276.27  Aligned_cols=197  Identities=29%  Similarity=0.485  Sum_probs=169.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||.||++...++..+|+|.+.......+++.+|++++++++||||+++++++.+....+++|||+++|+|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L   86 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL   86 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence            45678999999999999887888999999876555567899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..+..++.|++.||+|||+   ++++||||+|+||++++++.++|+|||+++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          87 LNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            99986432     358899999999999999999999   99999999999999999999999999998865433221 1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |+.|+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence            1233456789999998754  68889999999999999999 8888753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.4e-38  Score=286.27  Aligned_cols=199  Identities=29%  Similarity=0.490  Sum_probs=165.8

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCc----eEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGI----PVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      .+...+.||+|+||+||+|+.. ++.    .||+|.++...  ...+++.+|+.+++.++||||++++|++... ..+++
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v   86 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   86 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence            3445578999999999999743 343    48999987432  3346889999999999999999999999765 46799


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.
T Consensus        87 ~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          87 TQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999996543     358899999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            7654333222333457789999998764  78899999999999999997 9998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=281.77  Aligned_cols=196  Identities=28%  Similarity=0.411  Sum_probs=168.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +..+.||+|+||+||++.. .+++.||+|.+....    .....+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            4457899999999999985 468899999997432    12245788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....    ...+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          83 NGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             CCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999886432    1458999999999999999999999   99999999999999999999999999999875433


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....|++.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCC
Confidence            22   1234689999999998764  788899999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=298.95  Aligned_cols=196  Identities=29%  Similarity=0.462  Sum_probs=170.4

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEEEEe
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRALVYE  208 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  208 (344)
                      .+.||+|+||.||+|+ -.+|+.||||.++..  ....+...+|+++|++++|+|||++++.-.+.      ....++||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            3569999999999998 567999999999863  45567889999999999999999999976443      35689999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc--CCCc--eEEeecCCc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQ--PKISDFGLA  284 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~--~~~~--~kl~Dfgla  284 (344)
                      ||.+|||...|....+   ...|++.+.+.+..+++.||.|||+   ++|+||||||.||++-  .+|+  .||+|||.|
T Consensus        98 yC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999966543   3569999999999999999999999   9999999999999994  3333  599999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +..+.+..   .....||+.|++||++.++ ..++..+|.|||||++||.+||..||.|
T Consensus       172 rel~d~s~---~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNSL---FTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCCe---eeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99887753   4567899999999999853 4789999999999999999999999976

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.4e-38  Score=289.77  Aligned_cols=197  Identities=26%  Similarity=0.412  Sum_probs=163.7

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  206 (344)
                      .+.+.||+|+||.||+|+. .++..||+|+++...   .....+.+|++++++++||||+++++++...     ...++|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            4567899999999999984 468999999987422   2335688999999999999999999987543     357999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||++ ++|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          83 FELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99995 7899988432      358999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...... ........||+.|+|||++.+....++.++|||||||++|||++|+.||.
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~  209 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP  209 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence            533211 11123456899999999986533478889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.7e-38  Score=286.21  Aligned_cols=192  Identities=26%  Similarity=0.349  Sum_probs=164.4

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||++... ++..||+|+++..    ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999854 4789999999753    22345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|..++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||+++.......
T Consensus        81 ~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          81 GDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            9999988543      358999999999999999999999   9999999999999999999999999999875322211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......|++.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       152 --~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         152 --TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             --cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence              11334689999999999764  788999999999999999999999864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-38  Score=301.43  Aligned_cols=203  Identities=28%  Similarity=0.381  Sum_probs=169.3

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--------
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--------  201 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  201 (344)
                      .+.+.+.||+|+||+||+++. .+|+.||||++....   .....+.+|+..+..++|+|++++.+.+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            445678899999999999974 568999999997532   23356788999999999999999988764332        


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+||
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEec
Confidence            36899999999999999965432  23568999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++...............||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999876533222222345699999999999764  789999999999999999999999864

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-38  Score=293.81  Aligned_cols=204  Identities=29%  Similarity=0.456  Sum_probs=167.8

Q ss_pred             HHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||.||+|+...      +..||||+++...  ...+.+.+|+++++++. ||||+++++++.+....+
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY  117 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence            44556889999999999997432      3469999997532  23467899999999996 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCC-----------------------------------------------------------
Q 041350          205 LVYEFMPNGSLEKFIFSKTNS-----------------------------------------------------------  225 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------------  225 (344)
                      +||||+++|+|.+++......                                                           
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (400)
T cd05105         118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA  197 (400)
T ss_pred             EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence            999999999999998753210                                                           


Q ss_pred             -------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC
Q 041350          226 -------------------------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF  274 (344)
Q Consensus       226 -------------------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~  274 (344)
                                                     .....+++..+..++.|+++||+|||+   .+++||||||+|||+++++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCC
Confidence                                           011357889999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            9999999999866443222222334467889999998764  68899999999999999996 888875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-38  Score=279.88  Aligned_cols=205  Identities=29%  Similarity=0.471  Sum_probs=171.3

Q ss_pred             HHHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      .++.+.+.||+|+||.||+|+..+      +..||+|.++.....  .+.+.+|++++++++|+||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            345566889999999999997543      478999999764333  468999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          205 LVYEFMPNGSLEKFIFSKTN--------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                      ++|||+++++|.+++.....        ......+++..+..++.|++.|++|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            99999999999999976432        1223468899999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +|+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            99999999765332221111233457889999998764  78899999999999999998 999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.3e-38  Score=323.80  Aligned_cols=197  Identities=27%  Similarity=0.561  Sum_probs=162.8

Q ss_pred             cCHHHHHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeE
Q 041350          125 YTYKELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       125 ~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  203 (344)
                      ++++++... ....+.||+|+||+||+|+. .++..||||.++.....   ..+|++.+++++||||++++|+|.+....
T Consensus       683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            344444332 22346799999999999985 57899999998754322   23568899999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||||+++|+|.+++.         .++|..+..++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.
T Consensus       759 ~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             EEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            99999999999999993         38899999999999999999996555899999999999999999988876 666


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +......      ....+|+.|+|||++.+.  .++.++|||||||++|||++|+.|+++
T Consensus       829 ~~~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        829 PGLLCTD------TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ccccccC------CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            5433221      223578999999998764  789999999999999999999999864

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-37  Score=277.10  Aligned_cols=190  Identities=29%  Similarity=0.438  Sum_probs=163.8

Q ss_pred             ccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||+||++.. .+|+.+|+|.+....    ...+.+..|++++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999975 458999999986421    1234556799999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........   
T Consensus        81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---  150 (277)
T cd05607          81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---  150 (277)
T ss_pred             HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence            998854332    458899999999999999999999   9999999999999999999999999999887654322   


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....|++.|+|||++.+.  .++.++||||+||++|||++|+.|+.
T Consensus       151 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~  195 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFK  195 (277)
T ss_pred             eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            2335689999999998765  68899999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=276.22  Aligned_cols=203  Identities=31%  Similarity=0.482  Sum_probs=173.3

Q ss_pred             HHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       131 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ....+.+.+.||+|+||.||+|...++..||+|.++......+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            33455677899999999999998777889999999866556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++....    ...+++..+..++.|++.|+.|||+   .+++|+||||+||++++++.++|+|||+++.....
T Consensus        84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999996533    2458999999999999999999999   99999999999999999999999999999876533


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ... .......+..|+|||.+.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         157 IYE-AREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             ccc-ccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            211 11222335689999988764  78899999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.6e-38  Score=280.33  Aligned_cols=196  Identities=31%  Similarity=0.499  Sum_probs=161.7

Q ss_pred             HhhcccccccCcEEEEEEEE--eCCceEEEEEeeccc---cchHHHHHHHHHHhhh---cccceeeEeeEEE-----cCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL--FNGIPVAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCS-----EGT  201 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~  201 (344)
                      +.+.+.||+|+||+||+|+.  .++..||+|.++...   .....+.+|+.+++.+   +||||+++++++.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            34567899999999999975  246789999987432   2234667787777766   6999999999885     345


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+||
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence            6899999996 699999864332    358999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++......   ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~  211 (290)
T cd07862         155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             cceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCC
Confidence            9998654431   12345689999999998764  788899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.8e-38  Score=289.00  Aligned_cols=191  Identities=26%  Similarity=0.428  Sum_probs=160.7

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.++||+|+||+||+|+.. +++.||||++.....  ..+.+.+|+++++.++|+||+++++++.+++..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            3467999999999999854 689999999965332  2367889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|....          ..++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... 
T Consensus       158 ~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        158 SLEGTH----------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cccccc----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            986532          35677888999999999999999   9999999999999999999999999999987643321 


Q ss_pred             eeeecccCCccccccccccccc---CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNF---GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       ......||+.|+|||++....   ...+.++|||||||++|||++|+.||.
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence             113456899999999874321   133568999999999999999999985

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=288.20  Aligned_cols=191  Identities=24%  Similarity=0.402  Sum_probs=171.0

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeec--cccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.||+|.||.||||.. .+++.||+|++..  .+...++..+|+.+|.+++++||.+.+|.+..+..++++|||+.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            6799999999999974 4588999999974  345557889999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+.|..      ...+++..+.-+.+++..|+.|||.   .+.+|||||+.|||+..+|.+||+|||.+.........  
T Consensus        99 ~~lL~~------~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--  167 (467)
T KOG0201|consen   99 LDLLKS------GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--  167 (467)
T ss_pred             hhhhcc------CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence            999943      2345888888899999999999999   99999999999999999999999999999887765432  


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....+|||.|||||++.+.  .|+.|+||||||++.+||++|.+|+.
T Consensus       168 r~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s  212 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHS  212 (467)
T ss_pred             cccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCc
Confidence            2678899999999999864  89999999999999999999999984

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.2e-38  Score=275.47  Aligned_cols=198  Identities=28%  Similarity=0.451  Sum_probs=170.7

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+....+++|||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            44568899999999999998788899999987655556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....    ...+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||+++........ 
T Consensus        88 L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          88 LLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             HHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            999996543    2458889999999999999999999   99999999999999999999999999999876543211 


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ......++..|+|||.+...  .++.++||||||+++|||++ |+.|+.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~  206 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYP  206 (261)
T ss_pred             ccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCC
Confidence            11233457789999998664  68889999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-38  Score=291.42  Aligned_cols=189  Identities=25%  Similarity=0.323  Sum_probs=161.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||.||++.. .+++.||+|...     .+.+.+|++++++++||||+++++++......++|+|++ .+
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~  167 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT  167 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence            44567899999999999974 458899999753     345789999999999999999999999999999999999 47


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|..++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       168 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        168 DLYCYLAAK------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence            898888432      358899999999999999999999   8999999999999999999999999999975432211 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      .......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            112345699999999998764  7899999999999999999999875

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=283.59  Aligned_cols=195  Identities=29%  Similarity=0.389  Sum_probs=172.9

Q ss_pred             HHhhcccccccCcEEEEEEEEeC-CceEEEEEeecccc----chHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKG----NGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.++||+|.||.||+++... |+.+|+|.+.....    ..+.+.+|+.+|+++. ||||+.+.+.+.+....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            44556889999999999998554 99999999975432    3368899999999998 999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC----CceEEeecCC
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKISDFGL  283 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfgl  283 (344)
                      |++.||.|.+.+...       .+++..+..++.|++.|++|||+   .+|+||||||+|+|+...    +.+|++|||+
T Consensus       116 EL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999654       28999999999999999999999   999999999999999643    5799999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |......   ......+||+.|+|||++...  .++..+||||+||++|.|++|..||..
T Consensus       186 a~~~~~~---~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~  240 (382)
T KOG0032|consen  186 AKFIKPG---ERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWG  240 (382)
T ss_pred             ceEccCC---ceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcC
Confidence            9988762   234678899999999999864  799999999999999999999999964

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-37  Score=274.88  Aligned_cols=199  Identities=27%  Similarity=0.412  Sum_probs=160.3

Q ss_pred             cccccCcEEEEEEEEeCC---ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLFNG---IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +||+|+||+||+|+..++   ..+|+|.+....  .....+.+|+..++.++|+||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            589999999999975543   467888775432  223568899999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++..... ......++..+..++.|++.||+|||+   .+|+||||||+|||+++++++||+|||+++.........
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          82 LKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             HHHHHHhccc-cccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999966442 112345788899999999999999999   999999999999999999999999999987543332212


Q ss_pred             eeecccCCcccccccccccc-----cCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRN-----FGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ......+++.|+|||++...     ...++.++||||||+++|||++ |+.|+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP  211 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence            22334467789999987431     1256789999999999999998 677764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=288.11  Aligned_cols=191  Identities=26%  Similarity=0.308  Sum_probs=160.4

Q ss_pred             ccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhh---cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          141 LGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRI---HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       141 lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ||+|+||+||+|+. .+++.||+|++....    .....+..|..++...   +||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999999975 458999999996422    1223456677777666   699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.||++||+|||+   .+|+||||||+|||+++++.++|+|||+++.......
T Consensus        81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            9999998532      358999999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~  199 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             --CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCC
Confidence              12345689999999998653 3478899999999999999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=272.33  Aligned_cols=196  Identities=30%  Similarity=0.489  Sum_probs=168.0

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||.||++...++..+|+|.+........++.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            45678999999999999877777899999876555567899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++........ .
T Consensus        87 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          87 LNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             HHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            99996433     258999999999999999999999   99999999999999999999999999999865432211 1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .....++..|+|||.+.+.  .++.++||||||+++|||++ |+.|++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~  203 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYE  203 (256)
T ss_pred             cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCC
Confidence            1122345689999998764  78889999999999999998 788875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=274.39  Aligned_cols=193  Identities=29%  Similarity=0.437  Sum_probs=167.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEc-----CCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSE-----GTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~  209 (344)
                      +.||+|+||.|..+.. .+|..||||++.+.   ....++-.+|+++|+.++|+||+.+.+.+..     -...|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            5699999999999974 56899999999742   3344778999999999999999999998855     3578999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      | ..+|...+...      +.|+.+....+..|+++||.|+|+   .+|+|||+||+|+|++.+..+||+|||+|+....
T Consensus       108 M-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  108 M-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             H-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccc
Confidence            9 67999999543      459999999999999999999999   9999999999999999999999999999998865


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......++..+-|..|.|||++... ..|+...||||.||++.||++|+.-|-
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFp  229 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFP  229 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCC
Confidence            4223334677789999999998654 689999999999999999999998773

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-37  Score=272.76  Aligned_cols=196  Identities=28%  Similarity=0.467  Sum_probs=168.7

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||+||+|+..++..+|+|.++......+++.+|+.++++++||||+++++++.+....+++|||+++|+|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL   86 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence            45678999999999999876677899999886555567899999999999999999999999998899999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||.++........ .
T Consensus        87 ~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05113          87 LNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S  157 (256)
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence            99995432     258999999999999999999999   99999999999999999999999999998865443221 1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .....++..|+|||.+...  .++.++||||||+++|||++ |..|++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~  203 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYE  203 (256)
T ss_pred             cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            1223456789999998754  68889999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.9e-37  Score=275.56  Aligned_cols=202  Identities=27%  Similarity=0.498  Sum_probs=168.0

Q ss_pred             hhcccccccCcEEEEEEEEeC------CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||.||+|....      ...||+|.++....  ..++|.+|+..+++++||||+++++++.+....+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            456789999999999997543      25799999874332  2357899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceE
Q 041350          208 EFMPNGSLEKFIFSKTNSS----------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  277 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~k  277 (344)
                      ||+++++|.+++.......          ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEE
Confidence            9999999999997543211          11468899999999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.||.
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999865433222222344568899999988764  78899999999999999998 998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.2e-37  Score=276.42  Aligned_cols=203  Identities=26%  Similarity=0.464  Sum_probs=167.5

Q ss_pred             HhhcccccccCcEEEEEEEE-----eCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .++.+.||+|+||+||+|+.     .++..+|+|.+.....  ...++.+|++++++++||||+++++++..+...+++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            35668899999999999974     2457899999974322  2357889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          208 EFMPNGSLEKFIFSKTNS-----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                      ||+++++|.+++......           .....+++..++.++.|++.||+|||+   ++++||||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcE
Confidence            999999999998543210           112358899999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            99999999865433222222334457789999998764  68899999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.4e-37  Score=279.73  Aligned_cols=199  Identities=24%  Similarity=0.386  Sum_probs=161.4

Q ss_pred             cccccccCcEEEEEEEEe---CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  212 (344)
                      .++||+|+||+||+|+..   +++.+|+|.+... .....+.+|+.++++++||||+++++++..  +...+++|||++ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            357999999999999854   4678999998753 234567899999999999999999998854  456799999995 


Q ss_pred             CCHHHHHhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE----cCCCceEEeecCCcc
Q 041350          213 GSLEKFIFSKTNS---SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAK  285 (344)
Q Consensus       213 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfgla~  285 (344)
                      ++|.+++......   .....+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            5888887533211   122468999999999999999999999   999999999999999    456789999999998


Q ss_pred             cccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... ........+|+.|+|||++.+. ..++.++||||+||++|||++|+.||.
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            7654321 1122345689999999998764 357889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.1e-37  Score=275.89  Aligned_cols=195  Identities=28%  Similarity=0.407  Sum_probs=167.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ..+.||+|+||+||++.. .+++.+|+|.+.....    ....+.+|+.++++++|+|++.+++.+.+.+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            457799999999999974 4688999999864321    12457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....    ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        84 g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          84 GGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             CCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999854332    358999999999999999999999   999999999999999999999999999987654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....|++.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            2   1234689999999998764  788999999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.7e-37  Score=271.52  Aligned_cols=202  Identities=29%  Similarity=0.458  Sum_probs=173.0

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +...++++.++||+|+||.||+|...++..||+|.+.......+++.+|+.++++++|+||+++++++. ....+++|||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            445567778999999999999999888899999999876666788999999999999999999999874 4568999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++....    ...+++.++..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        82 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          82 MENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             CCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999986533    2468999999999999999999998   9999999999999999999999999999987653


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .... ......++..|+|||++...  .++.++||||||+++|||++ |+.|+.
T Consensus       155 ~~~~-~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~  205 (260)
T cd05067         155 NEYT-AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYP  205 (260)
T ss_pred             CCcc-cccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCC
Confidence            2211 11233467789999998654  67889999999999999998 998885

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-37  Score=275.07  Aligned_cols=204  Identities=26%  Similarity=0.445  Sum_probs=167.0

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||.||+|...      .+..||+|.+....  ....++.+|+.+++.++||||+++++++.++...++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            3456688999999999998642      24679999986432  234578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ||||+++++|.+++.......    ....+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999996533211    12356889999999999999999999   89999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~  223 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQ  223 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            998865443222222233457889999998764  68899999999999999998 677764

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.8e-37  Score=272.26  Aligned_cols=200  Identities=27%  Similarity=0.392  Sum_probs=162.9

Q ss_pred             ccccccCcEEEEEEEEeC---CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLFN---GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||.||+|+..+   +..+|+|.++....  ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999997543   45799998875432  2347889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++..... .....+++..+..++.|++.||+|||+   .+++|+||||+||+++++++++|+|||+++........
T Consensus        81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          81 DLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             cHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999965432 112356788889999999999999999   99999999999999999999999999999754333222


Q ss_pred             eeeecccCCccccccccccccc-----CCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNF-----GEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .......+++.|+|||++.+..     ..++.++||||||+++|||++ |+.|+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  211 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR  211 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            2222345788899999986431     135789999999999999996 998885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-37  Score=283.32  Aligned_cols=206  Identities=33%  Similarity=0.513  Sum_probs=168.2

Q ss_pred             HHHHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEc-CC
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSE-GT  201 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~  201 (344)
                      ...+++.+.||+|+||.||+|...      +++.||+|+++....  ..+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            335667788999999999999632      347899999975332  235678899999999 89999999998865 45


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCC-------------------------------------------------------C
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNS-------------------------------------------------------S  226 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------~  226 (344)
                      ..++++||+++++|.+++......                                                       .
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999998643211                                                       0


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccc
Q 041350          227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI  306 (344)
Q Consensus       227 ~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  306 (344)
                      ....+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.++|+|||+++...............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            01368999999999999999999999   999999999999999999999999999998765443322233445678899


Q ss_pred             cccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          307 APELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       307 aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |||++.+.  .++.++|||||||++|||++ |..|+.
T Consensus       243 aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~  277 (337)
T cd05054         243 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYP  277 (337)
T ss_pred             CcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCC
Confidence            99998764  78999999999999999997 988874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-37  Score=279.26  Aligned_cols=197  Identities=26%  Similarity=0.425  Sum_probs=165.6

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.++||+|+||+||+|+.. ++..||+|.++...  .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            344578999999999999754 57889999987432  233567899999999999999999999999999999999997


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      + +|.+++....     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        88 ~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          88 K-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             C-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            4 8888875432     357899999999999999999999   999999999999999999999999999997654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+++.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       159 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~  207 (309)
T cd07872         159 KT--YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             cc--cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            11  1234578999999988654 3678899999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-37  Score=272.67  Aligned_cols=198  Identities=30%  Similarity=0.496  Sum_probs=169.2

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      ..+.+.||+|+||.||+|... ++..||+|.++.......++.+|++.+++++|+||+++++++..+...+++|||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            345678999999999999854 5889999999865555678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....    ...+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||++.........
T Consensus        88 ~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          88 NLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             cHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999995433    2458999999999999999999999   99999999999999999999999999999876543221


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                       ......+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~  207 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             -ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence             11122346789999988764  78889999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-38  Score=285.59  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=174.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCe-EEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR-RALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~  210 (344)
                      ...+.+|+|+||.++..+. .++..+++|.+...   ....+...+|+.++++++|||||.+.+.|.+++. .+|||+|+
T Consensus         7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~   86 (426)
T KOG0589|consen    7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYC   86 (426)
T ss_pred             hhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeec
Confidence            3457799999999998863 45778999998743   2334578999999999999999999999998888 89999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +||+|.+.+....    ...++++.+..+..|++.|+.|||+   ..|+|||||+.|||++.+..++|+|||+|+....+
T Consensus        87 eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   87 EGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             CCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999997655    2568999999999999999999998   99999999999999999999999999999998877


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  .....|||.||.||++.+.  +|..|+||||+||++|||++-+++|+.
T Consensus       160 ~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a  208 (426)
T KOG0589|consen  160 DSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKA  208 (426)
T ss_pred             hhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCc
Confidence            532  2457799999999999886  899999999999999999999999975

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.4e-37  Score=274.93  Aligned_cols=195  Identities=28%  Similarity=0.386  Sum_probs=167.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ..+.||+|+||+||+++. .+++.+|+|.+....    .....+.+|++++++++|+|++++.+.+..++..+++|||++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            446799999999999975 468899999987532    122457889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....    ..+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++.......
T Consensus        84 ~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          84 GGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             CccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998864322    358999999999999999999999   999999999999999999999999999987654322


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....|++.|+|||.+.+.  .++.++|+||||+++|||++|..||..
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            1   1234689999999998764  788999999999999999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.1e-37  Score=304.49  Aligned_cols=202  Identities=24%  Similarity=0.313  Sum_probs=168.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.++||+|+||+||+|... +|+.||+|+++...    ...+++.+|++++++++||||+++++++.+++..+++|||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            45678999999999999854 58899999987432    12357899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          211 PNGSLEKFIFSKTNS-----SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ++|+|.+++......     .....+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.++|+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999998643211     112346778889999999999999999   999999999999999999999999999998


Q ss_pred             cccCCcc----------------ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDIS----------------IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......                ........||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            6621100                0011124689999999998764  78899999999999999999999985

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.4e-37  Score=270.01  Aligned_cols=199  Identities=30%  Similarity=0.457  Sum_probs=168.8

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.++||+|+||.||+|...++..+|+|.++......+.+.+|+.++++++|+|++++++++.+ ...+++|||++++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~   85 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKG   85 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCC
Confidence            455678899999999999987788889999998765566789999999999999999999998754 5678999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....    ...+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++.........
T Consensus        86 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          86 SLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999996532    2458999999999999999999999   89999999999999999999999999999876443211


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      . .....++..|+|||.+.+.  .++.++||||||+++|||++ |..|+..
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             c-ccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            1 1223356789999988654  78889999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=272.91  Aligned_cols=195  Identities=27%  Similarity=0.434  Sum_probs=174.8

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .+.++||+|+||.|||+.. ..|..+|||.+.. ..+.+++.+|+.+|++.+.|++|+++|.+..+..+|+|||||..|+
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            4457899999999999964 5699999999875 3567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      ..+.+..++     .+|+++++..+.++.++||+|||.   ..-+|||||..|||++.+|.+||+|||.|..+.....  
T Consensus       115 iSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  115 ISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             HHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            999996544     589999999999999999999998   8999999999999999999999999999987765432  


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..+...|||-|||||++..-  .|..++||||+|+...||.-|++|+.+
T Consensus       185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCccc
Confidence            33567899999999999875  788899999999999999999999854

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-37  Score=270.98  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=165.7

Q ss_pred             hcccccccCcEEEEEEEEeC----CceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCe------E
Q 041350          137 FKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTR------R  203 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~  203 (344)
                      +.+.||+|+||.||+|+...    +..||+|.++....   ....+.+|++.++.++||||+++++++.+...      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45789999999999998643    36799999875322   23578899999999999999999998866554      7


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++++||+++|+|..++...........+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence            9999999999999998664433333568999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~  217 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYP  217 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            9876544322222223356789999998654  78899999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.4e-37  Score=271.54  Aligned_cols=199  Identities=29%  Similarity=0.449  Sum_probs=167.9

Q ss_pred             HHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ..+.+.++||+|+||+||+|+..++..||+|+++......+++.+|++++++++|+||+++++++.+ ...+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence            3456778999999999999987676789999998655556789999999999999999999998754 557899999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.++.......
T Consensus        85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          85 GSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999996432    1357899999999999999999999   9999999999999999999999999999986644322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      . ......++..|+|||+..+.  .++.++||||||+++|||++ |..|+.
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~  205 (262)
T cd05071         158 T-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYP  205 (262)
T ss_pred             c-cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            1 11233467789999988654  78899999999999999999 777774

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.9e-37  Score=268.91  Aligned_cols=194  Identities=28%  Similarity=0.463  Sum_probs=162.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.||+|+||+||+|+. .+++.+|+|.+....  .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4689999999999985 468899999876432  2346789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..++.++.|++.||+|||+   .+++||||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99985432     358899999999999999999998   9999999999999999999999999999876543211111


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ......+..|+|||.+.+.  .++.++||||||+++|||++ |..|++
T Consensus       153 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             CCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            1111235679999998664  68889999999999999997 877774

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.7e-37  Score=286.53  Aligned_cols=195  Identities=30%  Similarity=0.430  Sum_probs=164.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCC-----eEEEEE
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-----RRALVY  207 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~  207 (344)
                      +.+.||+|+||+||++.. .+++.||+|.+....   ...+.+.+|+++++.++|+||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            457899999999999985 468999999986432   23367889999999999999999999998776     789999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++ ++|.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          84 ELMQ-SDLHKIIVS------PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             eccc-cCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9996 688888743      2468999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...... ......+++.|+|||++.+. ..++.++||||+||++|||++|+.||+.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  207 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQA  207 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence            433221 12334578999999998764 3578899999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.5e-37  Score=274.17  Aligned_cols=203  Identities=28%  Similarity=0.463  Sum_probs=167.8

Q ss_pred             HhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.+.||+|+||+||++...      ++..+|+|.+.... ...+.+.+|++++++++||||+++++++..+...+++|
T Consensus         7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (288)
T cd05093           7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   86 (288)
T ss_pred             eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            345678999999999999742      34568999987543 23467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          208 EFMPNGSLEKFIFSKTN-------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      ||+++++|.+++.....       ......+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEecc
Confidence            99999999999965331       1122458999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999865433221112233457889999998764  68889999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.6e-37  Score=272.04  Aligned_cols=201  Identities=26%  Similarity=0.450  Sum_probs=163.5

Q ss_pred             hcccccccCcEEEEEEEEeCC-c--eEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          137 FKHRLGQGGYGSVFRGKLFNG-I--PVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~-~--~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +.+.||+|+||.||+|+..+. .  .+|+|.++..   ....+.+.+|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            457899999999999986543 2  5899988753   23346788999999999999999999987432      2468


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ++|||+++|+|.+++...........+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.++|+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999988543322233568999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~  216 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYP  216 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            876543222111233467789999998764  78899999999999999998 777774

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.2e-37  Score=273.96  Aligned_cols=203  Identities=25%  Similarity=0.437  Sum_probs=167.4

Q ss_pred             HhhcccccccCcEEEEEEEEeC------CceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.+.++||+|+||+||+|+..+      +..||+|+++.....  .+.+.+|+.+++.++||||+++++++.+....+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            4556789999999999997533      478999999754332  35688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          207 YEFMPNGSLEKFIFSKTN----------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                      +||+++++|.+++.....          ......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence            999999999999853211          1112458899999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ||+|||+++...............+++.|+|||.+...  .++.++||||||+++|||++ |..|+.
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            99999998865443222222334567899999998653  68889999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=289.03  Aligned_cols=206  Identities=30%  Similarity=0.477  Sum_probs=178.4

Q ss_pred             CHHHHHHHHHhhcccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          126 TYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       126 ~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      +-+|+++-......+||-|.||.||.|.+.. .-.||||.++......++|++|..+|+.++|||+|+++|+|..+...|
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            4556665555567899999999999998544 668999999988888999999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ||+|||.+|+|.+||.....    ..++.-.++.++.||++||+||..   .++|||||..+|+|+.++..+|++||||+
T Consensus       340 IiTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchh
Confidence            99999999999999976543    457778889999999999999998   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNK  341 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~  341 (344)
                      +++..+... ......-++.|.|||.+.-+  .++.|+|||+|||+|||+.| |..|+
T Consensus       413 RlMtgDTYT-AHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPY  467 (1157)
T KOG4278|consen  413 RLMTGDTYT-AHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPY  467 (1157)
T ss_pred             hhhcCCcee-cccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCC
Confidence            998776331 12234457899999998654  89999999999999999985 55554

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=291.31  Aligned_cols=196  Identities=24%  Similarity=0.338  Sum_probs=158.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcC--------CeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG--------TRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~l  205 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++....   ....+|+.+++.++||||+++++++...        ..+++
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            44567899999999999985 468899999886432   2345799999999999999999886432        24679


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLA  284 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla  284 (344)
                      ||||++ ++|.+++.....  ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+|
T Consensus       145 vmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        145 VMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            999997 477777653221  22468999999999999999999999   9999999999999998654 7999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.......   .....||+.|+|||++.+. ..++.++|||||||++|||++|..||..
T Consensus       219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        219 KNLLAGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             hhccCCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            87654322   1234689999999988653 3688999999999999999999999853

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-37  Score=270.03  Aligned_cols=198  Identities=28%  Similarity=0.489  Sum_probs=167.5

Q ss_pred             HhhcccccccCcEEEEEEEEeC----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|....    ...||+|.++...  ...++|.+|+.++++++||||+++++++.++...+++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            3456789999999999998642    4579999987533  234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++....     ..+++..+..++.|++.||+|||+   .+|+|+||+|+|||+++++.++|+|||+++...
T Consensus        86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          86 YMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             cCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999996433     368999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ............+++.|+|||.+...  .++.++||||||+++|||++ |..|+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCC
Confidence            22222222233456789999998764  78899999999999999997 988874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8e-37  Score=272.37  Aligned_cols=196  Identities=30%  Similarity=0.462  Sum_probs=161.2

Q ss_pred             hcccccccCcEEEEEEEEe-CCc----eEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGI----PVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.||+|+||+||+|+.. ++.    .+++|.+.....  ..+++..|+..+++++||||+++++++.. ...++++||
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~   89 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL   89 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence            4578999999999999853 444    477787754322  23567888889999999999999998764 457889999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        90 ~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          90 SPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             CCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999996433     358999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            3222222334577899999998764  78999999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.3e-36  Score=269.67  Aligned_cols=199  Identities=27%  Similarity=0.441  Sum_probs=167.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcC------CeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG------TRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|... +++.||+|.+.........+.+|+.+++++ +|+||+++++++...      ...+++|
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~   88 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM   88 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence            44567999999999999754 578999999987666667889999999999 699999999998653      4689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++...
T Consensus        89 e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          89 EFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999986532    2468999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  ......|++.|+|||++...   ...++.++|||||||++|||++|+.|+++
T Consensus       162 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         162 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             ccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            43221  12345689999999998532   23578899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.3e-37  Score=284.99  Aligned_cols=209  Identities=27%  Similarity=0.456  Sum_probs=170.0

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhc-ccceeeEeeEEEc
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIH-HFHIVRLLGFCSE  199 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  199 (344)
                      ++......+.+.||+|+||.||+|+..      .+..||+|+++....  ..+.+.+|+.++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            444444556688999999999999743      346899999975422  2357889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhccCCC------------------------------------------------------
Q 041350          200 GTRRALVYEFMPNGSLEKFIFSKTNS------------------------------------------------------  225 (344)
Q Consensus       200 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  225 (344)
                      ....++||||+++|+|.++++.....                                                      
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            99999999999999999999754210                                                      


Q ss_pred             --------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 041350          226 --------------------------------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN  267 (344)
Q Consensus       226 --------------------------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~N  267 (344)
                                                            .....+++..++.++.|++.||+|||+   .+++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence                                                  011347888899999999999999998   999999999999


Q ss_pred             eEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       268 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ||+++++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999865433221112234567899999998764  68889999999999999997 888874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-36  Score=270.96  Aligned_cols=188  Identities=28%  Similarity=0.436  Sum_probs=164.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||.||+|.. .++..||+|.+....  ...+++.+|++++++++||||+++++++......++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            3457899999999999974 568899999986532  2346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|..+.          .+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.++|+|||++....... 
T Consensus        84 ~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          84 GSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CChHHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9997653          46888999999999999999999   999999999999999999999999999997654321 


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.||+
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~  194 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYP  194 (279)
T ss_pred             ---ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCch
Confidence               2345689999999998765  68899999999999999999999985

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=278.45  Aligned_cols=193  Identities=30%  Similarity=0.431  Sum_probs=172.1

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      -+.||+||||.||-++. .+|+.+|.|.+.+.    +....-.++|-.+|.+++.+.||.+-..+.+.+.+++|+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            36799999999999874 56899999998642    12234568999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |||.-+|.+..+    ..++++.++.++.+|+.||++||+   .+||.||+||+|||||++|+++|+|+|||..+.....
T Consensus       270 GDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  270 GDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             CceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999977654    469999999999999999999999   9999999999999999999999999999998887655


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .   ...+||.+|||||++.+.  .|+...|.||+||++|||+.|+.||.
T Consensus       343 ~---~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr  387 (591)
T KOG0986|consen  343 I---RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFR  387 (591)
T ss_pred             c---ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchh
Confidence            3   345899999999999875  79999999999999999999999985

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-37  Score=287.61  Aligned_cols=195  Identities=24%  Similarity=0.265  Sum_probs=166.2

Q ss_pred             HHHHhhcccccccCcEEEEEEEEe---CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ...+.+.+.||+|+||.||++...   .+..||+|.+...    ....+|++++++++||||+++++++......+++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            345667788999999999999643   3578999988643    345689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ++. ++|.+++..      ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++...
T Consensus       167 ~~~-~~l~~~l~~------~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        167 KYK-CDLFTYVDR------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             hcC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            995 789888832      2468999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ............||+.|+|||++...  .++.++|||||||++|||++|+.||.
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~  288 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLF  288 (392)
T ss_pred             cccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            44332222345699999999999764  78899999999999999999999984

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-36  Score=275.68  Aligned_cols=198  Identities=23%  Similarity=0.366  Sum_probs=160.4

Q ss_pred             ccccccCcEEEEEEEEe---CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g  213 (344)
                      .+||+|+||+||+|+..   ++..||+|.+.... ....+.+|+.++++++||||+++++++..  +...++++||++ +
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence            57999999999999854   35789999987532 34567899999999999999999998853  567899999986 5


Q ss_pred             CHHHHHhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE----cCCCceEEeecCCccc
Q 041350          214 SLEKFIFSKTN---SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKL  286 (344)
Q Consensus       214 sL~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfgla~~  286 (344)
                      +|.+++.....   ......+++..+..++.|++.||+|||+   .+|+||||||+|||+    ++++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            88887753221   1122468999999999999999999999   999999999999999    5678999999999987


Q ss_pred             ccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... .......+|+.|+|||++.+. ..++.++||||||+++|||++|+.||+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            6443211 122345689999999998653 357889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.6e-37  Score=268.89  Aligned_cols=199  Identities=33%  Similarity=0.519  Sum_probs=171.8

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.++||+|+||+||+|...++..+|+|.+..... ..+++.+|+.+++.++|+||+++++++.+....+++|||+++
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK   86 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence            3456688999999999999987899999999986543 457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........
T Consensus        87 ~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          87 GSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             CCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999996533    2468999999999999999999999   9999999999999999999999999999987644322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .  .....++..|+|||.+.+.  .++.++||||||+++|+|++ |+.|+..
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~  207 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPG  207 (261)
T ss_pred             c--ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence            1  1234467889999998764  78889999999999999998 7888753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-37  Score=288.92  Aligned_cols=190  Identities=23%  Similarity=0.306  Sum_probs=160.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .+.+.||+|+||.||++... .++.||||...     ...+.+|++++++++|+||+++++++..++..++|||++ .++
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~  245 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSD  245 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCC
Confidence            34567999999999999854 47889999642     234678999999999999999999999999999999999 579


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||+++.........
T Consensus       246 L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        246 LYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            998885432     368999999999999999999999   999999999999999999999999999998764432221


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ......||+.|+|||++.+.  .++.++|||||||++|||++|..|+
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCc
Confidence            12245699999999999765  7899999999999999999887654

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-36  Score=270.65  Aligned_cols=198  Identities=28%  Similarity=0.477  Sum_probs=163.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCc----eEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGI----PVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      ..+.+.||+|+||+||+|+. .++.    .||+|.++...  ...+++.+|+.+++.++|+||+++++++... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence            34567899999999999973 3454    48999987432  2346788999999999999999999998754 467999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        88 ~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          88 QLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999986432     358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .............+++.|+|||.+.+.  .++.++||||||+++|||++ |..|++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            543322222233456789999998664  78899999999999999998 8888764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=267.67  Aligned_cols=201  Identities=32%  Similarity=0.494  Sum_probs=172.4

Q ss_pred             HHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ...+.+.+.||+|+||+||+|...++..+|+|.+.......+++.+|+.++++++|+||+++++++.+....+++|||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            33445678899999999999987778899999998766667889999999999999999999999999889999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....    ..+++..+..++.|++.|++|||+   ++++|+||+|+||++++++.++|+|||+++......
T Consensus        85 ~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          85 KGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999965331    358999999999999999999999   899999999999999999999999999998765322


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ... .....++..|+|||.+.+.  ..+.++||||+|+++|||++ |+.|+.
T Consensus       158 ~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~  206 (261)
T cd05034         158 YTA-REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYP  206 (261)
T ss_pred             hhh-hhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            111 1222356789999998764  68889999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-37  Score=304.80  Aligned_cols=209  Identities=23%  Similarity=0.318  Sum_probs=168.2

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeE
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRR  203 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  203 (344)
                      .....+.+.+.||+|+||+||+++.. ++..+|+|.+....   .....+..|+.++++++||||+++++++.+  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            33334556788999999999999854 47789999987432   234678899999999999999999998854  4568


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeeecCCCCCceEEcCC------
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC----NQRILHFDIKPHNILLDHN------  273 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~----~~~ivH~Dik~~Nill~~~------  273 (344)
                      ++||||+++|+|.++|.....  ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.+      
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            999999999999999965321  1246999999999999999999999822    1459999999999999643      


Q ss_pred             -----------CceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          274 -----------FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       274 -----------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                                 ..+||+|||+++.......   .....||+.|+|||++.+....++.++|||||||++|||++|+.||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       3489999999986643321   13456899999999986543468889999999999999999999996


Q ss_pred             C
Q 041350          343 P  343 (344)
Q Consensus       343 ~  343 (344)
                      .
T Consensus       245 ~  245 (1021)
T PTZ00266        245 K  245 (1021)
T ss_pred             c
Confidence            3

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.4e-36  Score=264.60  Aligned_cols=193  Identities=31%  Similarity=0.479  Sum_probs=164.2

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.||+|+||.||+|...++..+|+|.+.....  ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999875432  2356889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +++....     ..+++..+..++.|++.||.|||+   ++++|+||+|+||++++++.++|+|||++......... ..
T Consensus        81 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~  151 (250)
T cd05085          81 SFLRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS  151 (250)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence            9985432     357899999999999999999999   99999999999999999999999999998754332211 11


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....+++.|+|||++...  .++.++||||||+++|||++ |..|+.
T Consensus       152 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~  196 (250)
T cd05085         152 GLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYP  196 (250)
T ss_pred             CCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence            122346789999998653  68889999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-36  Score=265.63  Aligned_cols=193  Identities=30%  Similarity=0.489  Sum_probs=160.1

Q ss_pred             cccccCcEEEEEEEEe---CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .||+|+||.||+|+..   ++..||+|++.....  ..+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   355799999875432  2357899999999999999999999875 456799999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.........
T Consensus        81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999986432     368999999999999999999999   899999999999999999999999999998654432211


Q ss_pred             -eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          295 -SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       295 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                       ......+++.|+|||.+...  .++.++||||||+++|||++ |..|+..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~  201 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKK  201 (257)
T ss_pred             eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence             11223346789999998654  67889999999999999996 9999853

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.3e-36  Score=265.47  Aligned_cols=197  Identities=28%  Similarity=0.444  Sum_probs=170.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|++|.||+++. .++..|++|.+...   ....+++.+|++++++++||||+++++++.+....++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            3557899999999999985 46889999998743   2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++....    ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++......
T Consensus        83 ~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          83 NGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999997542    2468999999999999999999998   999999999999999999999999999988665432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+++.|+|||++.+.  .++.++|+||||+++|||++|+.|++.
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  203 (256)
T cd08529         156 NF--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDA  203 (256)
T ss_pred             ch--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            21  1234578999999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.9e-36  Score=267.09  Aligned_cols=199  Identities=30%  Similarity=0.445  Sum_probs=167.5

Q ss_pred             HHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ..+.+.+.||+|+||.||++....+..+|+|.+.......+.+.+|+.++++++|+|++++++++.. ...+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            3455678899999999999987777789999987655556789999999999999999999998754 567899999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          85 GSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999996532    2358899999999999999999999   8999999999999999999999999999986543321


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      . ......++..|+|||.+.+.  ..+.++||||||+++|||++ |+.|+.
T Consensus       158 ~-~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~  205 (260)
T cd05069         158 T-ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             c-ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1 11223467789999988654  78899999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-38  Score=288.52  Aligned_cols=192  Identities=27%  Similarity=0.456  Sum_probs=164.0

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEee-----ccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCe--EEEEEe
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLE-----HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR--RALVYE  208 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e  208 (344)
                      |.++||+|+|-+||||.. .+|..||--.++     ......+.|..|+.+|+.|+||||++++.+|.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            456799999999999964 347778743332     223344889999999999999999999999987665  788999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfgla~~~  287 (344)
                      .+..|+|..|+...      +.++.+.+..|++||++||.|||+. +++|+|||||-.||+|+ ..|.+||+|+|||...
T Consensus       124 L~TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             cccCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            99999999999543      4588899999999999999999984 57999999999999997 5689999999999987


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....    ....|||.|||||++..   .|....||||||+.++||+|+..|+.
T Consensus       197 r~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  197 RKSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             hcccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChh
Confidence            66533    34679999999999986   68889999999999999999999974

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=303.98  Aligned_cols=199  Identities=26%  Similarity=0.329  Sum_probs=174.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeec---c-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEH---L-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~---~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||.|..++. .+++.+|+|++++   . .....-|..|-.+|..-+.+-|++++..|+++.++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            34557899999999999985 4578899999986   2 23445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      |+||||-.++.      ...+++++.++.++..|..||.-||+   .|+|||||||+|||||..|++||+|||.+-.+..
T Consensus       157 ~pGGDlltLlS------k~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLS------KFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHh------hcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999993      33469999999999999999999999   9999999999999999999999999999988776


Q ss_pred             CccceeeecccCCccccccccccc--cc-CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSR--NF-GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~--~~-~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +....+ ...+|||.|++||++..  .. +.|...+|+||+||++|||+.|..||+.
T Consensus       228 dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  228 DGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            655443 56789999999999853  22 5789999999999999999999999974

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-36  Score=271.97  Aligned_cols=202  Identities=28%  Similarity=0.486  Sum_probs=166.6

Q ss_pred             hcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          137 FKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.||+|+||+||+|+..      ....+|+|.+.....  ..+++.+|+.+++.++||||+++++.+...+..++++|
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE   83 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence            4578999999999999743      235689998875332  23678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          209 FMPNGSLEKFIFSKTNS------------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      |+++++|.+++......                  .....+++..++.++.|++.||+|||+   .+++||||||+|||+
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill  160 (290)
T cd05045          84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLV  160 (290)
T ss_pred             ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEE
Confidence            99999999998653211                  112458899999999999999999998   999999999999999


Q ss_pred             cCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++++.++|+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            99999999999999865443322222334567889999988664  68899999999999999998 8888753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.7e-36  Score=271.95  Aligned_cols=202  Identities=27%  Similarity=0.466  Sum_probs=167.5

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.||+|+||.||+++..      ++..+++|.++.... ..+.+.+|++++++++|+||+++++++..+...++|||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE   87 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence            34578999999999999743      345689999875433 23678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEE
Q 041350          209 FMPNGSLEKFIFSKTN----------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  278 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl  278 (344)
                      |+++++|.+++.....          ......+++..++.++.|++.||+|||+   ++++||||||+|||+++++.++|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEE
Confidence            9999999999965431          1122458999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +|||++................+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999765443221112234467889999988764  68889999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=262.95  Aligned_cols=195  Identities=25%  Similarity=0.369  Sum_probs=169.5

Q ss_pred             HhhcccccccCcEEEEEEE-EeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.+.||+|.|+.||++. ..+|+.+|+|++...   ....+++.+|+.+.+.|+||||+++.+...+....++|+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            4455779999999999985 467899999988642   235578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLC  287 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~  287 (344)
                      .|++|-.-+-.+      ..+++..+-..++||++||.|+|.   ++|||||+||+|+|+..   .--+||+|||+|...
T Consensus        93 ~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   93 TGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999998877443      357888899999999999999999   99999999999999953   345899999999988


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +...   ......|||+|||||++.+.  +++..+|||+.||+||-||.|+.||..
T Consensus       164 ~~g~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  164 NDGE---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             CCcc---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            7332   23567899999999999885  899999999999999999999999975

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=280.53  Aligned_cols=191  Identities=27%  Similarity=0.361  Sum_probs=160.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +.+.+.||+|+||.||++.. .+|..||+|.+...   ......+.+|+.+++.++||||+++++++...      ...+
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            44567899999999999975 45889999999643   22346788999999999999999999988644      3579


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++ +|...+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       103 lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         103 LVMELMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             EEEeCCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            99999965 6666652        247889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.......   .....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||.
T Consensus       171 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~  223 (359)
T cd07876         171 RTACTNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQ  223 (359)
T ss_pred             cccccCcc---CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            76433221   2345689999999999764  78899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.5e-36  Score=274.39  Aligned_cols=206  Identities=28%  Similarity=0.437  Sum_probs=167.9

Q ss_pred             HHHHhhcccccccCcEEEEEEEEe--------CCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcC
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEG  200 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  200 (344)
                      ...+.+.+.||+|+||.||++...        ++..+|+|.++...  ...+++.+|+++++++ +|+||+++++++.+.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            345667789999999999999642        23469999997532  2335788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      ...++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||+   .+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            9999999999999999999754321          112358999999999999999999998   999999999999999


Q ss_pred             cCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++++.++|+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..|++
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999998765432211112223356789999988764  68899999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-36  Score=271.34  Aligned_cols=205  Identities=26%  Similarity=0.460  Sum_probs=166.7

Q ss_pred             HHHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      ..+.+.+.||+|+||.||+|...      .+..||+|.++....  ....+.+|+..++.++||||+++++++.++...+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            34556788999999999999643      245799999875432  2346889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          205 LVYEFMPNGSLEKFIFSKTNS----SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      +||||+++|+|.+++......    .....+++..+..++.|++.||+|||+   ++++||||||+||++++++.++|+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence            999999999999999753221    112456788899999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~  223 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQ  223 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999865433222212223457789999998764  68899999999999999998 677764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-37  Score=260.05  Aligned_cols=193  Identities=31%  Similarity=0.427  Sum_probs=168.0

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeeccc-----cch----HHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEE
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK-----GNG----QEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~-----~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  206 (344)
                      ++.||.|..++|.++. ..+|...|+|++....     .+.    +.-..|+.+|+++ .||+|+++.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            3568999999998885 4568899999986421     122    3346799999999 599999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +|.|+.|.|.+||.      +...++++..++|++|+.+|+.|||.   .+|+||||||+|||++++.+++|+|||+|..
T Consensus       102 Fdl~prGELFDyLt------s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen  102 FDLMPRGELFDYLT------SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhcccchHHHHhh------hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence            99999999999994      34579999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCccceeeecccCCccccccccccc----ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSR----NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .++...   ....+|||+|+|||.+..    +...|+...|+||.||++|.||.|-+||-
T Consensus       173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            877643   456789999999998854    23568889999999999999999999984

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.3e-36  Score=266.98  Aligned_cols=189  Identities=26%  Similarity=0.382  Sum_probs=157.8

Q ss_pred             ccccccCcEEEEEEEEeC-------------CceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          139 HRLGQGGYGSVFRGKLFN-------------GIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      +.||+|+||.||+|+..+             ...||+|.+.... .....+.+|+.+++.++||||+++++++.+....+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997432             2358899886543 23357889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc-------eE
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-------PK  277 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~-------~k  277 (344)
                      ++|||+++|+|..++....     ..+++..++.++.|+++||+|||+   .+++||||||+|||++.++.       ++
T Consensus        81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999885432     458999999999999999999999   99999999999999987664       89


Q ss_pred             EeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      ++|||++......      ....+++.|+|||.+... ..++.++||||||+++|||+ +|+.|+.
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLK  211 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999998755322      234578899999988633 36888999999999999998 6777764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-36  Score=265.43  Aligned_cols=192  Identities=29%  Similarity=0.484  Sum_probs=160.3

Q ss_pred             cccccCcEEEEEEEE---eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          140 RLGQGGYGSVFRGKL---FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +||+|+||+||+|..   .++..+|+|+++....   ..+++.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   3578899999874332   23678999999999999999999998854 4678999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++...      ..+++..+..++.|++.||+|||+   ++++||||||.||++++++.+||+|||+++........
T Consensus        81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            999999432      358999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             e-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 V-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      . ......+++.|+|||.+...  .++.++||||||+++|||++ |+.||+.
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~  201 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKG  201 (257)
T ss_pred             eeecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            1 11223346799999988653  67889999999999999997 9999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-36  Score=278.51  Aligned_cols=207  Identities=32%  Similarity=0.483  Sum_probs=166.6

Q ss_pred             HHHHHhhcccccccCcEEEEEEEE------eCCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEc-C
Q 041350          131 KKITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSE-G  200 (344)
Q Consensus       131 ~~~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~  200 (344)
                      ....+.+.+.||+|+||+||+|..      .+++.||||+++....  ..+.+.+|+.++.++ +|+||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            344566788999999999999962      3568899999975332  235788999999999 68999999998865 4


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCC------------------------------------------------------
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSS------------------------------------------------------  226 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------  226 (344)
                      ...+++|||+++|+|.+++.......                                                      
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999999986532100                                                      


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecc
Q 041350          227 -------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA  299 (344)
Q Consensus       227 -------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  299 (344)
                             ....+++..+..++.|+++||+|||+   .+|+||||||+|||+++++++||+|||+++..............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   01247888999999999999999999   99999999999999999999999999999865433222222233


Q ss_pred             cCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       300 ~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       242 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~  283 (343)
T cd05103         242 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYP  283 (343)
T ss_pred             CCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            467789999998664  78899999999999999996 887764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=269.55  Aligned_cols=204  Identities=27%  Similarity=0.455  Sum_probs=169.0

Q ss_pred             HHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||.||+|...+      +..||+|.+....  .....+.+|+.+++.++|+||+++++++..+...++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            44556889999999999997542      3689999987433  223578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ||||+++|+|.+++.......    ....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence            999999999999996543211    12457899999999999999999998   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |+++...............++..|+|||.+...  .++.++||||||+++|||++ |..|+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~  223 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQ  223 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCc
Confidence            999865443322222334567899999998654  68889999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-36  Score=267.63  Aligned_cols=195  Identities=34%  Similarity=0.591  Sum_probs=168.1

Q ss_pred             hhcccccccCcEEEEEEEEeC-CceEEEEEeeccccchH---HHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ++.+.||+|+||+||+++... ++.+|+|.+........   ...+|+.++++++||||+++++++.+....+++|||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            456789999999999998554 56899999987544332   34569999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|+++||++||+   .+++|+||||+||++++++.++|+|||.+.......
T Consensus        82 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   82 GGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             ccccccccccc------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999622      458999999999999999999999   999999999999999999999999999997642221


Q ss_pred             cceeeecccCCcccccccccc-cccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .......+++.|+|||++. +  ...+.++||||+|+++|+|++|+.|+..
T Consensus       153 --~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~  201 (260)
T PF00069_consen  153 --ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEE  201 (260)
T ss_dssp             --SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred             --ccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence              2234566899999999987 3  3788999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.3e-36  Score=272.51  Aligned_cols=200  Identities=31%  Similarity=0.501  Sum_probs=167.5

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||.||+++..      ++..||+|+++...  ...+.+.+|+.+++++ +||||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            4456788999999999999742      24579999987543  2335789999999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ++|||+++|+|.+++.....    ..+++.++..++.|++.||+|||+   ++++|+||||+|||+++++.++|+|||++
T Consensus       116 lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999964332    348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +...............+++.|+|||.+.+.  .++.++||||+|+++|||++ |..|+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~  245 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYP  245 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence            866543222112233467889999988764  68889999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=282.48  Aligned_cols=202  Identities=28%  Similarity=0.521  Sum_probs=172.8

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEeC---C--ceEEEEEeec--cccchHHHHHHHHHHhhhcccceeeEeeEEEcCC
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLFN---G--IPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT  201 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~~---~--~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  201 (344)
                      ++.+....+.++||.|-||.||+|+..+   |  ..||||.-+.  ..++.+.|+.|..+|++++||||++++|+|.+. 
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            3334444456789999999999997433   2  3589999875  345678999999999999999999999999876 


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..|+|||.++.|.|..||..+..     .|+...+..++.||..||+|||+   .+.|||||..+|||+.....+||+||
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeeccc
Confidence            47999999999999999987663     58889999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      |+++..+.+..+.. +...-++.|||||.+  ++..++.++|||.|||.+||++ -|.+||-
T Consensus       536 GLSR~~ed~~yYka-S~~kLPIKWmaPESI--NfRrFTtASDVWMFgVCmWEIl~lGvkPfq  594 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKA-SRGKLPIKWMAPESI--NFRRFTTASDVWMFGVCMWEILSLGVKPFQ  594 (974)
T ss_pred             chhhhccccchhhc-cccccceeecCcccc--chhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence            99998877654433 455678899999988  4458999999999999999998 6888884

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3e-36  Score=266.69  Aligned_cols=197  Identities=25%  Similarity=0.383  Sum_probs=167.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++++++||||+++++.+......++||||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            44567899999999999985 568899999997543 3345678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||+|+||++++++.++|+|||++........
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          91 GSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999998532      358999999999999999999999   9999999999999999999999999999986643221


Q ss_pred             ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||.+... ...++.++||||||+++|||++|+.|+.
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~  210 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence              11334588999999987431 2357789999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-36  Score=267.71  Aligned_cols=198  Identities=25%  Similarity=0.448  Sum_probs=168.3

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||+|+. .++..||||.++...    .....+.+|+++++.++||||+++++++.+.+..++++||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            4567899999999999984 468999999876421    22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          85 DAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999998864322  22458899999999999999999999   99999999999999999999999999998876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...  .....+++.|+|||.+.+.  .++.++|+||||+++|||++|+.|+.
T Consensus       160 ~~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~  207 (267)
T cd08228         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             hHH--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            221  1234588999999998764  67889999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-36  Score=267.30  Aligned_cols=201  Identities=27%  Similarity=0.435  Sum_probs=170.4

Q ss_pred             HHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       131 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ....+.+.++||+|+||.||++...++..+|+|.+.......+.+.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            344556778999999999999987778889999987655556789999999999999999999999887 6789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          83 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             CCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999996532    2457889999999999999999998   89999999999999999999999999999765433


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ... ......++..|+|||++...  .++.++|+||||+++||+++ |+.|+.
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~  205 (260)
T cd05073         156 EYT-AREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYP  205 (260)
T ss_pred             Ccc-cccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCC
Confidence            211 11233456789999998764  68889999999999999998 888875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=290.03  Aligned_cols=194  Identities=22%  Similarity=0.334  Sum_probs=159.3

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhccc------ceeeEeeEEEcC-CeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF------HIVRLLGFCSEG-TRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~-~~~~l  205 (344)
                      .+.+.++||+|+||+||+|.. .+++.||||+++......+++..|+.++..++|.      +++++++++... ...++
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i  209 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI  209 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence            345567899999999999975 4578899999976544455667788888877654      588899988764 57889


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-----------
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-----------  274 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-----------  274 (344)
                      |||++ +++|.+++...      ..+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++           
T Consensus       210 v~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        210 VMPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence            99988 78899888532      468999999999999999999996  15999999999999998765           


Q ss_pred             -----ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          275 -----QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       275 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           .+||+|||.+......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             CCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                 4999999988643221     2345789999999999774  789999999999999999999999964

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-36  Score=272.06  Aligned_cols=208  Identities=26%  Similarity=0.457  Sum_probs=170.0

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEe--------CCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEE
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCS  198 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  198 (344)
                      +....+.+.+.||+|+||.||+++..        ++..||+|.+....  ...+++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            33444556788999999999999631        24579999987432  3346789999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 041350          199 EGTRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI  268 (344)
Q Consensus       199 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Ni  268 (344)
                      .....+++|||+++|+|.+++......          .....+++.++..++.|+++||+|||+   ++++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence            999999999999999999999764321          112458899999999999999999999   9999999999999


Q ss_pred             EEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       269 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++++++.+||+|||+++...............+++.|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999876543322222334567889999998664  68899999999999999998 677764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.2e-36  Score=269.69  Aligned_cols=202  Identities=27%  Similarity=0.456  Sum_probs=166.6

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.++||+|+||+||++...      ++..+|+|.+.... ...+.+.+|+++++.++|+||+++++++.++...+++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            35678999999999999632      35679999887533 334679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          209 FMPNGSLEKFIFSKTNS---------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      |+++++|.+++......         .....+++..++.++.|++.|++|||+   .+++||||||+|||+++++.++|+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence            99999999999654311         112358899999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |||++................+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            99999765433221111223357889999988764  68899999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-36  Score=272.16  Aligned_cols=194  Identities=27%  Similarity=0.397  Sum_probs=166.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||.||++... ++..+|+|.++...  ....++.+|++++++++||||+++++.+.+++..+++|||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            35678999999999999743 57889999886432  2235688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...      ..+++..+..++.|+++||+|||+  ..+++|+||+|+|||+++++.++|+|||++....... 
T Consensus        84 ~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          84 GSLDQVLKKA------GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999543      358899999999999999999996  2589999999999999999999999999987653321 


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                         .....+++.|+|||.+.+.  .++.++|+||||+++|||++|+.|++.
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             ---cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence               1335688999999998764  688899999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-36  Score=268.33  Aligned_cols=203  Identities=28%  Similarity=0.427  Sum_probs=165.7

Q ss_pred             hhcccccccCcEEEEEEEEeC------CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||.||+|...+      +..||+|.+.....  ....|.+|+.++++++|+||+++++++.+....+++|
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            345789999999999998643      56799998864332  2357899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEeecCC
Q 041350          208 EFMPNGSLEKFIFSKTNSS-SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGL  283 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfgl  283 (344)
                      ||+++++|.+++....... ....+++..+..++.||+.||+|||+   .+++|+||||+||++++++   .+||+|||+
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999997654211 12368999999999999999999999   8999999999999998654   599999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++................+..|+|||++.+.  .++.++|||||||++|||++ |+.||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~  224 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPG  224 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9876432221111222345789999998764  78999999999999999996 8888753

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-36  Score=271.11  Aligned_cols=204  Identities=27%  Similarity=0.460  Sum_probs=167.8

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||.||++...      ....+|+|.+.....  ...++.+|++++.++ +|+||+++++++..+...+
T Consensus        13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   92 (293)
T cd05053          13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY   92 (293)
T ss_pred             HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence            3445678999999999999753      236799999875322  235688999999999 7999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC
Q 041350          205 LVYEFMPNGSLEKFIFSKTN----------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF  274 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~  274 (344)
                      ++|||+++|+|.+++.....          ......+++..++.++.|++.||+|||+   .+++||||||+|||+++++
T Consensus        93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~  169 (293)
T cd05053          93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDH  169 (293)
T ss_pred             EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCC
Confidence            99999999999999965321          0123568999999999999999999998   9999999999999999999


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999876543222222334456789999988664  68899999999999999997 888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.1e-37  Score=283.50  Aligned_cols=193  Identities=25%  Similarity=0.352  Sum_probs=168.8

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHHHHHHHHHhhhc-cc-----ceeeEeeEEEcCCeEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HF-----HIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv  206 (344)
                      ++.+.+.||+|+||.|.||. ..+++.||||++++.+.-.++-..|+.+|..|+ |.     |+|+++++|...++++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            45567889999999999997 456899999999988777788889999999997 43     899999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC--CceEEeecCCc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLA  284 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~--~~~kl~Dfgla  284 (344)
                      +|.+ ..+|.++|..+.-    ..++...++.++.||+.||.+||+   .+|||.||||+||||.+-  ..+||+|||.|
T Consensus       267 fELL-~~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ehhh-hhhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999 6699999976543    569999999999999999999999   999999999999999643  47999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ........     ....+..|.|||++.+.  +|+.+.||||||||+.||++|.+-|
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCcccc
Confidence            87655422     34467889999999986  8999999999999999999996544

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=272.34  Aligned_cols=205  Identities=26%  Similarity=0.411  Sum_probs=164.9

Q ss_pred             HHHhhcccccccCcEEEEEEEEeC---------------CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEee
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFN---------------GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLG  195 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~  195 (344)
                      -.+.+.++||+|+||.||++....               ...||+|.++...  ...+.+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            345566889999999999986432               2348999987532  23357899999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCCHHHHHhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNS------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       196 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      ++......++||||+++++|.+++......      .....+++..++.++.|++.||+|||+   .+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            999999999999999999999999653211      011247899999999999999999999   99999999999999


Q ss_pred             EcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc--CCCCCC
Q 041350          270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG--CRKNKD  342 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~--g~~p~~  342 (344)
                      +++++.+||+|||++................+++.|+|||++...  .++.++||||||+++|||++  +..|++
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            999999999999999765433222212233457789999988654  68999999999999999987  555654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-36  Score=268.26  Aligned_cols=205  Identities=25%  Similarity=0.363  Sum_probs=169.2

Q ss_pred             HHhhcccccccCcEEEEEEEEeC-----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  205 (344)
                      .+.+.+.||+|+||.||+|...+     +..||+|.+....  ...+.+.+|+.++++++|+||+++++++.. +...++
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   86 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV   86 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence            44566889999999999998665     6889999987532  234678899999999999999999998766 467899


Q ss_pred             EEeccCCCCHHHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          206 VYEFMPNGSLEKFIFSKTNS--SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||+++++|.+++......  .....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+
T Consensus        87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            99999999999999654321  112468999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++.+.............++..|+|||++.+.  .++.++||||||+++||+++ |+.|++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence            9866443222111233467789999998764  68899999999999999998 9999863

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.2e-36  Score=273.84  Aligned_cols=199  Identities=19%  Similarity=0.194  Sum_probs=163.3

Q ss_pred             hccccccc--CcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          137 FKHRLGQG--GYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G--~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.++||+|  +||+||+++. .+|+.||+|.++...   ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34679999  7899999974 568999999997532   22245678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+.+......
T Consensus        82 ~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          82 AYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             CCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999954321    358999999999999999999999   99999999999999999999999999865433211


Q ss_pred             ccce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....     ......++..|+|||++.+....++.++|||||||++|||++|+.||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            1000     011234677899999987643468899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.5e-36  Score=272.07  Aligned_cols=205  Identities=28%  Similarity=0.474  Sum_probs=167.0

Q ss_pred             HHHhhcccccccCcEEEEEEEEe--------CCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCC
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGT  201 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  201 (344)
                      ..+.+.+.||+|+||.||+++..        ....+|+|.++....  ...++.+|+.+++++ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            34456788999999999999642        245799999875332  235788999999999 6999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      ..+++|||+++|+|.+++......          .....+++..+..++.|++.||+|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            999999999999999999764311          112458999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       272 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +++.+||+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            9999999999999866432221111223345689999998764  78899999999999999998 787764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.2e-36  Score=265.82  Aligned_cols=197  Identities=25%  Similarity=0.452  Sum_probs=166.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+++++.++|||++++++++..+...++|+||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            34577999999999999854 47788999986532 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|..++....     .++++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||++........ 
T Consensus        88 ~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          88 AVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            9999885432     468999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             eeeecccCCccccccccccc---ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       ......+++.|+|||++..   ....++.++|||||||++|||++|+.|++
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  209 (282)
T cd06643         159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH  209 (282)
T ss_pred             -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence             1233458899999998842   12357789999999999999999999985

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-36  Score=268.97  Aligned_cols=194  Identities=31%  Similarity=0.465  Sum_probs=160.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhh---cccceeeEeeEEEc-----CCeE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCSE-----GTRR  203 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~  203 (344)
                      .+.+.||+|+||+||+|... +++.||+|.++...   .....+.+|+.+++.+   +||||+++++++..     ....
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            45678999999999999754 68899999987432   2234566777777666   69999999998754     3457


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      +++|||++ ++|.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence            99999997 589988854322    358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++.......   .....+|+.|+|||++.+.  .++.++||||+||++|||++|+.||.
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~  208 (288)
T cd07863         155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFC  208 (288)
T ss_pred             cccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcC
Confidence            987653321   1334578999999998764  68899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=264.53  Aligned_cols=197  Identities=28%  Similarity=0.379  Sum_probs=166.8

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ...+.||+|++|.||++.. .+++.+|+|.+.....      ..+.+.+|++++++++||||+++++++.++...++++|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            3457899999999999975 4689999999864321      23568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++...
T Consensus        85 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          85 YMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             ECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999998543      358899999999999999999999   999999999999999999999999999997654


Q ss_pred             CCcccee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....... .....++..|+|||++.+.  .++.++||||+|+++|||++|+.|+..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            3211110 1234578899999999875  688999999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.2e-36  Score=270.05  Aligned_cols=195  Identities=25%  Similarity=0.385  Sum_probs=167.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||.||+|.. .++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            34457799999999999974 468899999987533 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++..       ..+++.++..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus       102 ~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            999999843       247899999999999999999999   9999999999999999999999999999876543321


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  .....+++.|+|||.+.+.  .++.++|||||||++|||++|+.||..
T Consensus       172 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             c--cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            1  1234588999999998764  678899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.3e-36  Score=267.57  Aligned_cols=196  Identities=28%  Similarity=0.433  Sum_probs=165.6

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||+|++|+||+|+.. ++..||+|.++...   ...+.+.+|+.++++++||||+++++++.++...++||||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            4578999999999999854 68899999986432   233678899999999999999999999999999999999997 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++.....   ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          83 MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            689888854332   2468999999999999999999999   9999999999999999999999999999876543211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||++.+. ..++.++||||||+++|||++|+.|+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~  203 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFH  203 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence              11234578899999988654 356889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.6e-36  Score=271.04  Aligned_cols=197  Identities=25%  Similarity=0.415  Sum_probs=165.8

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.++||+|+||.||+|+.. ++..||+|.++...  .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            345578999999999999754 57899999987432  234567899999999999999999999999999999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       ++|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.++|+|||++.......
T Consensus        88 -~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          88 -KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             -cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence             69998885432     358899999999999999999999   999999999999999999999999999997644322


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+++.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             C--cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence            1  11234578899999988654 3578899999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.7e-36  Score=263.19  Aligned_cols=197  Identities=28%  Similarity=0.520  Sum_probs=169.2

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||.||++...++..+|+|.+........++.+|++++++++|||++++++++......++++||+++++|
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            45678999999999999877788999999876555567899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..++++.+..++.|++.|++|||+   .+++|+||+|+||+++.++.++|+|||+++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          87 SDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             HHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            99985432     357899999999999999999999   89999999999999999999999999998765432211 1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .....++.+|+|||.+.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            1223356789999998764  68889999999999999998 8988863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-36  Score=266.95  Aligned_cols=199  Identities=30%  Similarity=0.512  Sum_probs=165.4

Q ss_pred             HhhcccccccCcEEEEEEEEeC-C---ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN-G---IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +++.+.||+|+||.||+|.... +   ..||+|.++...  ...++|.+|+.++++++||||+++++++.++...++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            4567889999999999998543 3   369999987532  234689999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        86 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          86 FMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             cCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999985432     358999999999999999999999   999999999999999999999999999988654


Q ss_pred             CCccceeeec---ccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          289 KDISIVSLTA---ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..........   ...+..|+|||.+...  .++.++||||||+++|||++ |..|+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence            4322111111   1124579999998764  78889999999999999986 9988753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-36  Score=263.28  Aligned_cols=200  Identities=31%  Similarity=0.524  Sum_probs=170.3

Q ss_pred             ccccccCcEEEEEEEEeC----CceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||.||+|....    +..+|+|.++.....  .+.+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998654    788999999864433  57889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNS---SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++|.+++......   .....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999654210   012568999999999999999999999   9999999999999999999999999999987765


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...........+++.|+|||.+...  .++.++||||+|+++|||++ |+.|++.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~  210 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPG  210 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence            4322223445678899999998764  78899999999999999998 5888753

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-36  Score=266.71  Aligned_cols=198  Identities=29%  Similarity=0.513  Sum_probs=165.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCc----eEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGI----PVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.+.||+|+||+||+|... +|.    .+|+|.+.....  ...++.+|+.++++++||||+++++++.. ...++++
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   87 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT   87 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence            345678999999999999753 333    589998875432  33678899999999999999999999987 7889999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||+++..
T Consensus        88 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          88 QLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             ecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999996543     348999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .............++..|+|||.+...  .++.++|+||||+++||+++ |+.|++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~  214 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEG  214 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence            544332222223346789999988653  78889999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-36  Score=274.60  Aligned_cols=210  Identities=28%  Similarity=0.454  Sum_probs=171.1

Q ss_pred             HHHHHHHHhhcccccccCcEEEEEEEEe--------CCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeE
Q 041350          128 KELKKITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGF  196 (344)
Q Consensus       128 ~~l~~~~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~  196 (344)
                      .++...++.+.+.||+|+||.||++...        .+..||+|.++...  ...+++.+|+++++++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3555556777889999999999999632        12368999887532  2346789999999999 79999999999


Q ss_pred             EEcCCeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041350          197 CSEGTRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH  266 (344)
Q Consensus       197 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~  266 (344)
                      +.++...++++||+++|+|.+++......          .....+++..+..++.|++.||+|||+   ++++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence            99999999999999999999999754211          122458899999999999999999999   99999999999


Q ss_pred             ceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       267 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |||+++++.+||+|||+++...............++..|+|||++.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            999999999999999999865443222222233456789999998764  78889999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.8e-36  Score=268.83  Aligned_cols=192  Identities=29%  Similarity=0.399  Sum_probs=168.3

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||++... +++.+|+|.+....    ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus         4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (290)
T cd05580           4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV   83 (290)
T ss_pred             EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence            45678999999999999854 58899999987532    23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||+++.....
T Consensus        84 ~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          84 PGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999998543      458999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           .....+++.|+|||.+.+.  ..+.++||||||+++|||++|+.|++.
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             -----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence                 1234588999999998764  678899999999999999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.2e-36  Score=263.99  Aligned_cols=197  Identities=23%  Similarity=0.337  Sum_probs=169.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||.||+++. .++..+|+|.++..  ....+.+.+|+.++++++|+||+++++.+.+++..+++|||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            3567899999999999974 46889999998643  23446788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....    ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          83 GDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            99999885433    2458899999999999999999999   9999999999999999999999999999976644322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  .....+++.|+|||++.+.  .++.++|+||||+++|+|++|+.||+.
T Consensus       156 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         156 Y--ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             c--cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCC
Confidence            1  1234588999999998764  688899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8e-36  Score=263.69  Aligned_cols=199  Identities=25%  Similarity=0.433  Sum_probs=170.2

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||.||+|... +|+.||+|.++..    ....+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            345678999999999999865 7899999988632    12346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++.....  ....+++..+..++.+++.||+|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          84 ADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             CCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999865322  23468999999999999999999999   9999999999999999999999999999886544


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  .....+++.|+|||.+.+.  .++.++||||||+++|||++|+.|+.
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~  207 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcc
Confidence            3221  1234588899999998764  68889999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.4e-36  Score=264.19  Aligned_cols=197  Identities=25%  Similarity=0.374  Sum_probs=167.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||.||+|+. .+++.||+|.++... .....+.+|+.+++.++||||+++++.+.+....+++|||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            44567899999999999975 458899999987543 2335678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...      ..+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          91 GSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            9999998543      358999999999999999999999   8999999999999999999999999999876543321


Q ss_pred             ceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......|++.|+|||++.. ..+.++.++|||||||++|||++|+.|+.
T Consensus       162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~  210 (267)
T cd06645         162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF  210 (267)
T ss_pred             --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence              1234568999999998742 12357889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.6e-36  Score=267.48  Aligned_cols=188  Identities=23%  Similarity=0.372  Sum_probs=156.4

Q ss_pred             cccccCcEEEEEEEEeC-------------------------CceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeE
Q 041350          140 RLGQGGYGSVFRGKLFN-------------------------GIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRL  193 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~  193 (344)
                      .||+|+||.||+|++..                         ...||+|++..... ..++|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13589999875332 34678899999999999999999


Q ss_pred             eeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       194 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ++++.++...++||||+++|+|..++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++++
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence            999999999999999999999999985432     358899999999999999999998   999999999999999764


Q ss_pred             C-------ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          274 F-------QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       274 ~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      +       .++++|||++......      ....+++.|+|||.+.+. ..++.++||||||+++|||+ +|+.|+.
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~  223 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLK  223 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3       3799999988654322      223467889999988654 46789999999999999995 7888875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.9e-36  Score=264.75  Aligned_cols=198  Identities=24%  Similarity=0.395  Sum_probs=157.6

Q ss_pred             cccccCcEEEEEEEEeCCc---eEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLFNGI---PVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +||+|+||+||+|...++.   .+++|.++...  ...+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5899999999999765543   45566655432  234689999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++......  ...+++..+..++.|+++||+|||+   .+++||||||+|||++.++.++|+|||++..........
T Consensus        82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999754321  2356778888999999999999999   999999999999999999999999999986432221111


Q ss_pred             eeecccCCcccccccccccc-----cCCCCcccchHhHHHHHHHHHcC-CCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRN-----FGEVSYKSDVYSYGMMLLEMVGC-RKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Dv~s~Gvvl~ell~g-~~p~~  342 (344)
                      ......+++.|+|||++...     ...++.++||||||+++|||+++ ..|++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            12344578899999987532     12457799999999999999964 55664

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-36  Score=269.47  Aligned_cols=203  Identities=27%  Similarity=0.446  Sum_probs=167.2

Q ss_pred             HhhcccccccCcEEEEEEEEeC-----------------CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEee
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN-----------------GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLG  195 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~  195 (344)
                      +.+.+.||+|+||.||+++..+                 +..||+|.+....  ...+.+.+|++++++++||||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            4556889999999999987432                 2468999987543  33467899999999999999999999


Q ss_pred             EEEcCCeEEEEEeccCCCCHHHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNS-----SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       196 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      ++..+...++++||+++++|.+++......     .....+++..++.++.|++.||+|||+   .+++|+||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence            999999999999999999999999654321     112368999999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc--CCCCCC
Q 041350          271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG--CRKNKD  342 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~--g~~p~~  342 (344)
                      ++++.++|+|||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++  +..|++
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            99999999999999865433222222344567899999998764  68899999999999999997  556654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.3e-36  Score=269.94  Aligned_cols=204  Identities=25%  Similarity=0.418  Sum_probs=165.9

Q ss_pred             HHhhcccccccCcEEEEEEEEe-----------------CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-----------------NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLL  194 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~  194 (344)
                      .+.+.+.||+|+||+||++...                 ++..+|+|.++...  ...+++.+|+.++++++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3456788999999999997422                 23468999997532  2346789999999999999999999


Q ss_pred             eEEEcCCeEEEEEeccCCCCHHHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNS-----SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       195 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      +++..+...+++|||+++++|.+++......     .....+++..+..++.|++.||+|||+   .+++|+||||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence            9999999999999999999999999764321     112358889999999999999999999   89999999999999


Q ss_pred             EcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc--CCCCCC
Q 041350          270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG--CRKNKD  342 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~--g~~p~~  342 (344)
                      +++++.++|+|||+++...............+++.|+|||...+.  .++.++||||||+++|||++  |..|+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            999999999999999865443221111223346789999987653  78899999999999999998  666663

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.1e-36  Score=266.70  Aligned_cols=195  Identities=32%  Similarity=0.469  Sum_probs=162.5

Q ss_pred             hhcccccccCcEEEEEEEE-----eCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  206 (344)
                      .+.+.||+|+||+||++..     .++..||+|.++....  ....+.+|++++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4557899999999988642     3577899999975432  346788999999999999999999988653  467899


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++..       ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||+++.
T Consensus        87 ~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence            999999999999843       248999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCcccee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......... .....++..|+|||.+.+.  .++.++||||||+++|||++|..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~  211 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQ  211 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCC
Confidence            654322111 1123356779999998764  68899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=264.18  Aligned_cols=195  Identities=26%  Similarity=0.336  Sum_probs=171.6

Q ss_pred             hhcccccccCcEEEEEEE-EeCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .|.+.||+|.||.|-+++ ..+++.+|+|++++.    +++...-+.|-.+|+..+||.+..+-..|+..+.+++||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            456889999999999997 456899999999853    233345578999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      .||.|.-+|..      ...+++...+.+...|..||.|||+   .+||.||||.+|.|+|.||++||+|||+++.--..
T Consensus       251 nGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  251 NGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             cCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            99999998844      3568999999999999999999999   99999999999999999999999999999864333


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+|||.|+|||++..+  .|....|.|.+|||+|||++||.||..
T Consensus       322 g--~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  322 G--DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             c--ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccc
Confidence            2  235678999999999999886  889999999999999999999999963

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.7e-36  Score=265.38  Aligned_cols=198  Identities=24%  Similarity=0.464  Sum_probs=169.5

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||++.. .++..+|||.+....    ...+++.+|+.+++.++|+||+++++++.+++..+++|||+
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            4557799999999999984 578999999886422    23357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          85 DAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999864321  23468999999999999999999999   99999999999999999999999999998866543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...  .....+++.|+|||.+.+.  .++.++||||||+++|||++|..|+.
T Consensus       160 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         160 TTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             Ccc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcc
Confidence            221  1234588999999998764  67889999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=261.66  Aligned_cols=193  Identities=35%  Similarity=0.562  Sum_probs=161.3

Q ss_pred             ccccccCcEEEEEEEEeC----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ++||+|+||.||+|+...    +..+|+|.+.....  ..+++.+|+.++++++|+||+++++++. ....+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            468999999999997422    26899999975543  4467899999999999999999999876 4567999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+|||+++++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            9999999543      258999999999999999999998   8999999999999999999999999999987654332


Q ss_pred             ce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          293 IV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .. ......++..|+|||.+...  .++.++||||||+++|||++ |+.|++.
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~  201 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGE  201 (257)
T ss_pred             ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCccc
Confidence            21 11222345789999988664  78899999999999999998 9998864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-35  Score=265.50  Aligned_cols=198  Identities=26%  Similarity=0.442  Sum_probs=166.9

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||.||+|+.. ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            345677999999999999864 48899999987543 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|..++.+..     ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus        94 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          94 GAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99998875432     358999999999999999999998   9999999999999999999999999999875433211


Q ss_pred             ceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||++...   ...++.++||||||+++|||++|+.|+.
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  216 (292)
T cd06644         166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH  216 (292)
T ss_pred             --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence              11234578899999988531   1356789999999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.4e-36  Score=266.53  Aligned_cols=198  Identities=28%  Similarity=0.446  Sum_probs=164.4

Q ss_pred             cccccCcEEEEEEEEeC-------CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          140 RLGQGGYGSVFRGKLFN-------GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .||+|+||.||+|+..+       +..+|+|.+....  .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999997532       2579999886433  34568899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-----ceEEeecCCc
Q 041350          211 PNGSLEKFIFSKTNSS-SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-----QPKISDFGLA  284 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-----~~kl~Dfgla  284 (344)
                      ++++|.+++....... ....+++..++.++.|++.||+|||+   .+++|+||+|+||+++++.     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997543221 22458899999999999999999998   8999999999999999877     8999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +...............++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~  215 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYP  215 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCc
Confidence            765433222222233457889999998764  78999999999999999998 888874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-36  Score=267.18  Aligned_cols=196  Identities=30%  Similarity=0.395  Sum_probs=167.9

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+++.+.||+|+||+||++... ++..+|+|++....  ...+.+.+|+++++.++||||+++++++......++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            3445678999999999999754 58899999886432  23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.+++.||.|||+  ..+++||||+|+||++++++.++|+|||++......
T Consensus        86 ~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          86 DCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999988432      358999999999999999999996  258999999999999999999999999998754322


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    .....++..|+|||++.+.  .++.++|+|||||++|||++|+.|++.
T Consensus       158 ~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         158 I----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAF  204 (284)
T ss_pred             c----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            1    1234689999999998664  788899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-36  Score=275.98  Aligned_cols=191  Identities=25%  Similarity=0.375  Sum_probs=161.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +...+.||+|+||+||+|.. .++..||||.+....   ...+.+.+|+.++++++||||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            33457799999999999974 467899999987532   2335678999999999999999999987543      3568


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +++|++ +++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        97 ~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          97 LVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence            999998 8899888732       358999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +......     ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||.
T Consensus       166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         166 RQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             eecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            8654431     345689999999998653 367889999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=258.74  Aligned_cols=205  Identities=29%  Similarity=0.437  Sum_probs=172.7

Q ss_pred             CHHHHHHHHHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccch-HHHHHHHHHHhhhc-ccceeeEeeEEEcCCe
Q 041350          126 TYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-QEFINEVATIGRIH-HFHIVRLLGFCSEGTR  202 (344)
Q Consensus       126 ~~~~l~~~~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  202 (344)
                      ++.|+-+.|.   +.||+|+|+.|--++ +.+|..+|||++.+..... ...++|++++...+ |+||+++++||.+++.
T Consensus        74 ~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            4666666553   469999999999886 7889999999998876655 57899999999995 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEe
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKIS  279 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~  279 (344)
                      .|||||-|.||+|..+|+..      ..+++.++.++..+|+.||.|||.   ++|.|||+||+|||-.+..   -+||+
T Consensus       151 FYLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             EEEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence            99999999999999999654      458999999999999999999999   9999999999999997554   37999


Q ss_pred             ecCCcccccC--C---ccceeeecccCCcccccccccc---cccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          280 DFGLAKLCSK--D---ISIVSLTAARGTAGYIAPELFS---RNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       280 Dfgla~~~~~--~---~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ||.++.-...  +   .+.......+|+..|||||+..   +....|+.++|.||+||+||-||+|-+||-
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv  292 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV  292 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence            9998753321  1   1122344667999999999763   333467889999999999999999999985

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.4e-36  Score=266.39  Aligned_cols=198  Identities=27%  Similarity=0.456  Sum_probs=164.6

Q ss_pred             HHhhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  204 (344)
                      ++...+.||+|+||.||+++.     .++..||+|.++...  ...+.+.+|+.++++++|||++++.+++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            445567899999999999973     357889999987432  2336789999999999999999999998775  5679


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++
T Consensus        85 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence            9999999999999985432     358999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          285 KLCSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       285 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +......... ......++..|+|||.+.+.  .++.++||||||+++|||++++.|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCC
Confidence            8764432211 11234467789999998764  6888999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-36  Score=277.89  Aligned_cols=192  Identities=26%  Similarity=0.324  Sum_probs=160.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +.+.+.||+|+||.||++.. ..++.||+|.+....   ...+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            34457899999999999974 458899999997532   2335778999999999999999999988543      3579


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++ +|.+.+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        99 lv~e~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          99 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             EEhhhhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            99999965 6766662        247889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.......   .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       167 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         167 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             ccCCCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            86543321   2345689999999998764  688999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-35  Score=261.26  Aligned_cols=195  Identities=28%  Similarity=0.452  Sum_probs=170.2

Q ss_pred             HhhcccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||.||+|...+ +..+|+|.+..... .+++.+|++++++++|+||+++++.+.+....++++||++++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            3455779999999999998654 78999999976433 678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        84 ~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          84 SVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999985432     468999999999999999999999   8999999999999999999999999999987654321 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       ......++..|+|||++.+.  .++.++||||||+++|||++|+.|++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~  200 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYS  200 (256)
T ss_pred             -ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence             11234578899999998765  78899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-36  Score=262.26  Aligned_cols=193  Identities=31%  Similarity=0.532  Sum_probs=168.1

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+.+.||+|+||.||+|.. .|+.||+|.++......+++.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS   86 (256)
T ss_pred             ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence            34568899999999999984 58899999998655556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++.....    ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.++......   
T Consensus        87 L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          87 LVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             HHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999965432    358999999999999999999999   999999999999999999999999999998764321   


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                        .....+..|+|||.+...  .++.++||||||+++|||++ |+.|+.
T Consensus       157 --~~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~  201 (256)
T cd05039         157 --DSGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             --ccCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence              123356789999988654  68889999999999999997 888875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.1e-36  Score=263.33  Aligned_cols=196  Identities=30%  Similarity=0.433  Sum_probs=166.7

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeecccc-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ..+.||+|+||+||+|...+++.+|+|.++....       ..+.+.+|++++++++|+||+++++++.+....++++||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            4567999999999999887899999999874321       124578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          84 VPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999542      357899999999999999999998   8999999999999999999999999999876432


Q ss_pred             Cc----cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DI----SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..    .........++..|+|||.+.+.  .++.++||||||+++|||++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            11    00111234588999999998764  678899999999999999999999853

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.1e-36  Score=262.84  Aligned_cols=189  Identities=23%  Similarity=0.400  Sum_probs=159.3

Q ss_pred             ccccccCcEEEEEEEEeCCc-----------eEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFNGI-----------PVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.||+|+||.||+|...+..           .+++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999865432           57888876544446789999999999999999999999988 7789999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-------ceEEee
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-------QPKISD  280 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-------~~kl~D  280 (344)
                      ||+++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++       .++|+|
T Consensus        80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            9999999999996533     258899999999999999999998   9999999999999999888       799999


Q ss_pred             cCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcC-CCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC-RKNKD  342 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g-~~p~~  342 (344)
                      ||++......      ....++..|+|||++......++.++||||||+++|||++| ..|+.
T Consensus       152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~  208 (259)
T cd05037         152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS  208 (259)
T ss_pred             CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence            9999865431      23346778999999876434678899999999999999984 66553

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.5e-36  Score=268.14  Aligned_cols=200  Identities=29%  Similarity=0.515  Sum_probs=163.1

Q ss_pred             hhcccccccCcEEEEEEEEeC-C--ceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-G--IPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||.||+|...+ +  ..+++|.++...  ...+.+.+|+.++.++ +||||+++++++.+....++++||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            356789999999999998644 3  347888887422  2346789999999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          210 MPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      +++++|.+++......          .....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEEC
Confidence            9999999999653211          112358899999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||++.......   .......+..|+|||++...  .++.++||||||+++|||++ |+.||..
T Consensus       162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             CcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999986432211   11122335679999988764  68899999999999999997 9999853

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.5e-36  Score=278.37  Aligned_cols=191  Identities=25%  Similarity=0.326  Sum_probs=160.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +.+.+.||+|+||.||++.. ..++.||||++...   ....+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            44567899999999999974 45889999999753   22346788999999999999999999987543      3579


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++ +|.+++.        ..+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||++
T Consensus       106 lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         106 IVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             EEEeCCCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            99999964 7777763        247889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.......   .....+|+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~  226 (364)
T cd07875         174 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFP  226 (364)
T ss_pred             cccCCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCC
Confidence            86543321   2345689999999999764  78899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=263.56  Aligned_cols=196  Identities=31%  Similarity=0.532  Sum_probs=161.0

Q ss_pred             ccccccCcEEEEEEEEeC-Cc--eEEEEEeecc--ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFN-GI--PVAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||.||+|+..+ +.  .+|+|.++..  ....+.+.+|+++++++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999998644 43  4788888743  23346788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          213 GSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       213 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      |+|.+++......          .....+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            9999999654311          112358899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++......   ........+..|+|||++...  .++.++||||||+++|||++ |+.||.
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~  213 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYC  213 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            98633211   111122346789999998654  68889999999999999997 999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.7e-36  Score=269.59  Aligned_cols=199  Identities=31%  Similarity=0.540  Sum_probs=163.1

Q ss_pred             hhcccccccCcEEEEEEEEe-CCc--eEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGI--PVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||.||+|... ++.  .+|+|.++...  ...+.+.+|++++.++ +|+||+++++++.+++..+++|||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            45688999999999999854 444  46777776432  2335788999999999 899999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          210 MPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      +++++|.+++......          .....+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeC
Confidence            9999999999754321          112368999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      |||+++.....   .......++..|+|||++.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       167 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         167 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             ccccCcccchh---hhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcc
Confidence            99998643211   111222346789999988664  67889999999999999998 999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=281.48  Aligned_cols=188  Identities=27%  Similarity=0.427  Sum_probs=165.2

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||.|+||.||-|. ..+...||||++.-+...    -+++++|+..|++++|||++.+-|+|..+...||||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            468999999999997 456788999999754332    368999999999999999999999999999999999999 66


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      |-.+++.-..     .++.+..+..|+.+.+.||+|||+   .+.||||||+.|||+++.|.+||+|||.|....+.   
T Consensus       111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            7777775433     578999999999999999999999   99999999999999999999999999999876654   


Q ss_pred             eeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                         ..++|||.|||||++.- ..|.|+-++||||+|++..||.-.++|.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence               56789999999998753 3368899999999999999999888885

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.7e-36  Score=262.17  Aligned_cols=194  Identities=31%  Similarity=0.441  Sum_probs=164.5

Q ss_pred             ccccccCcEEEEEEEEeC--C--ceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFN--G--IPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|++|.||+|...+  +  ..||+|.+.....  ..+.+.+|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997543  2  3699999976433  44688999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999965431    468999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             c-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          293 I-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      . .......++..|+|||.+...  .++.++||||||+++|||++ |+.|++
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            1 111234577899999998764  68889999999999999998 999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-35  Score=267.34  Aligned_cols=194  Identities=27%  Similarity=0.412  Sum_probs=168.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||.|+||+||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++|||++++++++..+...++|+||++++
T Consensus        22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  101 (296)
T cd06655          22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG  101 (296)
T ss_pred             EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence            3457799999999999974 568999999987533 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++..       ..+++.++..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........
T Consensus       102 ~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655         102 SLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             cHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99998842       348999999999999999999999   99999999999999999999999999998865443221


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .....+++.|+|||.+.+.  .++.++|||||||++|||++|+.||+.
T Consensus       172 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             --CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence              1234588899999998764  678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.6e-36  Score=263.55  Aligned_cols=195  Identities=27%  Similarity=0.360  Sum_probs=162.7

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc------cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEE
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVY  207 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  207 (344)
                      +.+.||+|+||.||+|.. .++..||+|.+....      ...+.+.+|+.++++++||||+++++++.+.  ...+++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            457899999999999985 458899999885321      1235678899999999999999999988763  4678999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++...      ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          86 EHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            999999999998533      347889999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..... ........++..|+|||.+.+.  .++.++||||||+++|||++|+.|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~  210 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWA  210 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCC
Confidence            42211 1112234588899999998764  67899999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-35  Score=266.67  Aligned_cols=196  Identities=26%  Similarity=0.382  Sum_probs=168.8

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||.||++.. .++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||++
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA   99 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence            344567899999999999985 568999999997533 334667899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++..       ..+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.++|+|||++.......
T Consensus       100 ~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656         100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             CCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999843       347899999999999999999999   999999999999999999999999999987654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||..
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         170 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             cC--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21  1234578899999998764  678899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=264.24  Aligned_cols=199  Identities=23%  Similarity=0.412  Sum_probs=168.6

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++.+.++...++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            445677999999999999854 58899999987543 3346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        87 ~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          87 GALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999985432     358999999999999999999999   9999999999999999999999999999876533211


Q ss_pred             ceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......+++.|+|||.+...   ...++.++||||||+++|||++|+.|+..
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence              11334588999999987521   13567899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-35  Score=258.94  Aligned_cols=194  Identities=30%  Similarity=0.489  Sum_probs=164.5

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ++||+|+||.||++...+++.||+|.+.....  ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999877799999999875433  3467899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +++....     ..+++..+..++.+++.||+|||+   ++++||||+|+||+++.++.++|+|||++............
T Consensus        81 ~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          81 TFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9985432     357899999999999999999999   99999999999999999999999999999865432211111


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....++..|+|||.+.+.  .++.++|+||||+++|||++ |..|+.
T Consensus       153 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~  197 (251)
T cd05041         153 GLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYP  197 (251)
T ss_pred             ccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCc
Confidence            122346679999998664  68899999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-35  Score=261.67  Aligned_cols=193  Identities=30%  Similarity=0.512  Sum_probs=156.8

Q ss_pred             ccccccCcEEEEEEEEeC----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEE-cCCeEEEEEeccC
Q 041350          139 HRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCS-EGTRRALVYEFMP  211 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  211 (344)
                      +.||+|+||.||+|+..+    +..||+|.+....  ...+.+.+|+.+++.++||||+++++++. .++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998532    3579999986432  23467889999999999999999999875 4556789999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999996433     246778889999999999999999   999999999999999999999999999997554321


Q ss_pred             cc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          292 SI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       292 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ..  .......++..|+|||.+...  .++.++||||||+++|||++|+.|+
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~  202 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPP  202 (262)
T ss_pred             ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCC
Confidence            11  111233467789999988764  7889999999999999999965543

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=284.26  Aligned_cols=193  Identities=30%  Similarity=0.434  Sum_probs=168.8

Q ss_pred             cccccCcEEEEEEEEe-CCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          140 RLGQGGYGSVFRGKLF-NGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      .||+|.||+||.|+.. +...+|||-+... ....+-...|+.+.+.++|.|||+.+|.+.+++..-+.||-+|||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            4999999999999854 4567999998753 3455778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceEEeecCCcccccCCccce
Q 041350          218 FIFSKTNSSSHRPL--SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       218 ~l~~~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      +|...-     +++  .+.++-.+.+||++||.|||+   +.|||||||-.|+|++ -.|.+||+|||-++.+..-.+. 
T Consensus       662 LLrskW-----GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~-  732 (1226)
T KOG4279|consen  662 LLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC-  732 (1226)
T ss_pred             HHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc-
Confidence            997654     345  788889999999999999999   9999999999999996 6899999999999877543322 


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       ...+.||+.|||||++......|...+|||||||++.||.|||+||.
T Consensus       733 -TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~  779 (1226)
T KOG4279|consen  733 -TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV  779 (1226)
T ss_pred             -ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence             23567999999999998766688999999999999999999999984

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=288.11  Aligned_cols=204  Identities=22%  Similarity=0.290  Sum_probs=164.9

Q ss_pred             hhcccccccCcEEEEEEEEeCC-ceEEEEEeecc-ccchHHHHHHHHHHhhhc-ccceeeEeeE-EEc---C---CeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNG-IPVAVKMLEHL-KGNGQEFINEVATIGRIH-HFHIVRLLGF-CSE---G---TRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~---~---~~~~l  205 (344)
                      .+.+.|.+|||+.||.|....+ ..+|+|++-.. +...+...+|+++|++|+ |+|||.+++. ...   +   -+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            3457799999999999987666 99999987543 344478899999999997 9999999993 211   1   35689


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      .||||++|.|-+++..+..    ..|++.++++|+.|+++|+++||. +..+|||||||-+||||+.+++.||||||.|.
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             ehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            9999999999999976553    349999999999999999999997 45779999999999999999999999999986


Q ss_pred             cccCCc-cce------eeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          286 LCSKDI-SIV------SLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       286 ~~~~~~-~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      ...... ...      ......-|+-|.|||++.-. .-.+++|+|||||||+||-|+....||+.+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            432221 100      01122358999999987421 126899999999999999999999999864

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-36  Score=276.32  Aligned_cols=188  Identities=26%  Similarity=0.389  Sum_probs=158.9

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||.||+|+.. ++..||+|.....     ....|+.++++++|+||+++++++.+....++|+||+ .+
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~  141 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS  141 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence            455678999999999999854 4678999975432     3457999999999999999999999999999999999 56


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       142 ~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  212 (357)
T PHA03209        142 DLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-  212 (357)
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence            8988885432     468999999999999999999999   9999999999999999999999999999975432211 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                        .....||+.|+|||++.+.  .++.++|||||||++|||+++..|+
T Consensus       213 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 --FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1245689999999999764  7889999999999999999865554

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.6e-36  Score=267.17  Aligned_cols=202  Identities=30%  Similarity=0.467  Sum_probs=165.7

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||.||++...      ++..||+|.+....  ...+++.+|+.++++++||||+++++++.++...++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (288)
T cd05050           8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF   87 (288)
T ss_pred             eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence            44578999999999999753      46789999987532  22467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          208 EFMPNGSLEKFIFSKTNS----------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      ||+++|+|.+++......                .....+++..++.++.|++.||+|||+   .+++||||+|+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEec
Confidence            999999999999643210                112357899999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       272 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      +++.++|+|||++.................++.|+|||.+.+.  .++.++||||||+++|||++ |..|+.
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999998765433221111223356789999988764  78899999999999999997 777774

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-35  Score=262.99  Aligned_cols=194  Identities=29%  Similarity=0.392  Sum_probs=163.8

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ..||+|+||.||+|+.. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            46999999999999854 57789999887543 34467899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCCccc
Q 041350          217 KFIFSKTNSSSHRPL--SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +++....     ..+  ++..+..++.|++.||+|||+   .+|+||||||+||+++. ++.++|+|||++.........
T Consensus        94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            9996532     234  788889999999999999999   99999999999999976 679999999998765432211


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        .....+++.|+|||++.+....++.++||||||+++|||++|+.|+.
T Consensus       166 --~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         166 --TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             --cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence              12345789999999986543357889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.2e-36  Score=265.15  Aligned_cols=194  Identities=25%  Similarity=0.428  Sum_probs=166.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +...+.||+|+||.||+|.. .++..||+|.++...  ...+.+.+|++++++++||||+++++++..+...++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            33446799999999999975 457889999987432  334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++..       ..+++..+..++.|+++|++|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        86 ~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          86 GGSALDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999998842       358899999999999999999998   999999999999999999999999999998655432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .  ......++..|+|||++.+.  .++.++||||||+++|||++|+.|++
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCc
Confidence            1  11234578899999998764  68889999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-35  Score=264.10  Aligned_cols=196  Identities=32%  Similarity=0.526  Sum_probs=161.7

Q ss_pred             hhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  207 (344)
                      .+.+.||+|+||+||++..     .++..||+|.+.... ...+.+.+|++++++++||||+++++++..  ....++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            4557899999999999964     357899999987543 234678999999999999999999998754  34689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++..
T Consensus        87 e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          87 EYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999995432     358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceee-ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          288 SKDISIVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       288 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ......... ....++..|+|||++.+.  .++.++||||||+++|||++|..|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~  211 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKS  211 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcC
Confidence            543221111 122244569999998764  6888999999999999999987664

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-35  Score=260.43  Aligned_cols=192  Identities=31%  Similarity=0.515  Sum_probs=162.9

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEE-cCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS-EGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||.||++. ..|..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. ++...++++||++++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~-~~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             CeeeeeecccCCCeEEEEE-EcCCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            4456789999999999997 45888999998653 34567999999999999999999999764 556789999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++......  
T Consensus        86 ~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          86 SLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             cHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999865332    358899999999999999999999   999999999999999999999999999987644321  


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                         ....++..|+|||++...  .++.++||||||+++|||++ |+.|+.
T Consensus       157 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~  201 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             ---CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence               223356789999998664  68889999999999999997 888874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-35  Score=263.24  Aligned_cols=197  Identities=29%  Similarity=0.509  Sum_probs=164.5

Q ss_pred             hhcccccccCcEEEEEEEEeC-C---ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-G---IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ...+.||+|+||.||+|+... +   ..+|+|.++...  ...+++.+|++++++++|+|++++.+++.+.+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            345789999999999998643 3   369999987532  2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++....     ..+++..+..++.|++.|++|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          88 MENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999985432     358999999999999999999999   8999999999999999999999999999986643


Q ss_pred             Ccccee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          290 DISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       290 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ...... ......++.|+|||++...  .++.++||||||+++|||++ |+.|+.
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            322111 1122245679999998764  67899999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-35  Score=259.40  Aligned_cols=197  Identities=24%  Similarity=0.367  Sum_probs=169.7

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||.++. .++..+++|.+...   ....+++.+|++++++++|+||+++++++.+....+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            4567899999999998873 55889999998643   2344678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          83 GGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             CCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999996542    2468999999999999999999999   899999999999999999999999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.|++.
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             c--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence            2  12345689999999998764  578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=270.42  Aligned_cols=196  Identities=26%  Similarity=0.418  Sum_probs=172.7

Q ss_pred             hhcccccccCcEEEEEEE-EeCCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|.|..|-+|+ ..+|..||||++.+.+-+   ...+++|+.-|+-++|||||+++.+.....++|||.|.=.
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            445679999999999996 689999999999876533   3578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE-cCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-DHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill-~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +|+|.+||....     ..+.++.+.++..||+.|+.|+|+   ..+|||||||+|+.+ ..-|-+||.|||++..+.+.
T Consensus       101 ~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen  101 GGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             CchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999996544     458999999999999999999999   999999999999877 45688999999999888766


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .+..+|++.|-|||++.+. ....+..||||+||+||-|++|+.||..
T Consensus       173 ~k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqe  221 (864)
T KOG4717|consen  173 KK---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQE  221 (864)
T ss_pred             ch---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence            43   4677899999999999886 2345689999999999999999999963

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-35  Score=262.30  Aligned_cols=198  Identities=29%  Similarity=0.499  Sum_probs=165.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-C---CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-N---GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||.||+|... +   +..+|+|.++...  ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE   85 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            345678999999999999753 2   3379999986532  234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++....     ..+++.++..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||+++...
T Consensus        86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          86 YMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             cCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999996432     358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCcccee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          289 KDISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       289 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....... .....++..|+|||.+.+.  .++.++|+||||+++||+++ |..|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~  211 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYW  211 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence            4322111 1222345689999998764  68899999999999999886 998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=265.24  Aligned_cols=195  Identities=28%  Similarity=0.439  Sum_probs=164.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|++|+||+|+.. +++.||+|.+....  .....+.+|++++++++|+||+++++++.++...++||||++ 
T Consensus         8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07844           8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-   86 (291)
T ss_pred             eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence            34578999999999999854 68899999987432  223567889999999999999999999999999999999997 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|+++||.|||+   .+++||||+|+||++++++.++|+|||+++.......
T Consensus        87 ~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          87 TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            59999885432     358899999999999999999999   9999999999999999999999999999875432211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......++..|+|||++.+. ..++.++||||+|+++|||++|+.|+.
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~  205 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFP  205 (291)
T ss_pred             --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              11223468899999988653 357889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-35  Score=264.88  Aligned_cols=200  Identities=27%  Similarity=0.425  Sum_probs=167.6

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +++.+.||+|+||+||++... ++..+|+|.++...  ...+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345678999999999999854 68999999887532  223678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|..++.....   ...+++..+..++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          83 AGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999864321   2368999999999999999999996  2589999999999999999999999999987653321


Q ss_pred             cceeeecccCCccccccccccccc----CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNF----GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    ....+++.|+|||.+.+..    ..++.++|+|||||++|||++|+.||++
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            1    2345788999999885431    2357899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-35  Score=262.47  Aligned_cols=196  Identities=27%  Similarity=0.430  Sum_probs=165.5

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccccc----------hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN----------GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      +.+.||+|+||.||+|.. .++..+|+|.+......          .+.+.+|+.++++++||||+++++++.+....++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            456799999999999975 45789999988642211          1457889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      +|||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          84 FLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999543      358899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCccce----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIV----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .........    ......+++.|+|||.+.+.  .++.++||||+|+++|||++|+.||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            765321110    11223578899999998764  678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-35  Score=263.27  Aligned_cols=195  Identities=25%  Similarity=0.372  Sum_probs=165.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||+|+.. +++.||+|++....   ...+.+.+|+.++++++|+|++++++++......++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            34577999999999999865 58899999986432   223567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|..++...      ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          84 HTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99888876322      358999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||.
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~  202 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWP  202 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            11  1234578899999998653 357889999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-35  Score=260.63  Aligned_cols=194  Identities=29%  Similarity=0.436  Sum_probs=167.7

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ..+.||+|+||+||+|... ++..|++|.+....      ...+.+.+|+.++++++|+||+++++++.++...++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4567999999999999865 78999999986532      2336788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999998532      358899999999999999999999   9999999999999999999999999999886544


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   ......+++.|+|||.+... ..++.++|+||||+++|||++|+.|++.
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            32   12345588999999998654 1378899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.9e-35  Score=264.25  Aligned_cols=201  Identities=24%  Similarity=0.351  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEE-----cCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCS-----EGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv~e  208 (344)
                      .+.+.||+|+||.||++.. .+++.+|+|.++.......++.+|+.+++++ +||||+++++++.     .+...++|||
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e  100 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE  100 (286)
T ss_pred             eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence            3457899999999999975 4578999999876544556788999999999 6999999999874     3457899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++.....  ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++...
T Consensus       101 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638         101 LCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             ecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            9999999998864321  22468899999999999999999999   999999999999999999999999999988654


Q ss_pred             CCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......|++.|+|||++...   ...++.++||||+||++|||++|+.|+..
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         176 STRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             cCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence            3221  11334689999999987532   13578899999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-35  Score=262.28  Aligned_cols=197  Identities=28%  Similarity=0.412  Sum_probs=165.8

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeecccc-----------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG-----------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.||+|+||.||+|.. .+|+.+|+|.++....           ..+.+.+|+.++++++|+|++++++++......++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            46799999999999974 4688999998863211           12457789999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++
T Consensus        86 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             EEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            99999999999998543      358899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...............++..|+|||.+......++.++|+||||+++|||++|..|++.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            6543222222234458899999999875422478899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-35  Score=258.24  Aligned_cols=197  Identities=25%  Similarity=0.382  Sum_probs=166.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  210 (344)
                      .+.+.||+|++|.||+++.. +++.+|+|.+....   ...+.+.+|++++++++|+|++++++.+.. +...+++|||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            45688999999999999854 47889999987532   233578899999999999999999998764 44679999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++....    ...+++.++..++.|++.|++|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          83 EGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             CCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999996532    2458999999999999999999999   99999999999999999999999999999866433


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  .....+++.|+|||++.+.  .++.++||||+|++++||++|+.|++.
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~  204 (257)
T cd08223         156 CDM--ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNA  204 (257)
T ss_pred             CCc--cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            221  2334578999999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.1e-36  Score=267.12  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=164.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+.. +|..+|+|.++...   .....+.+|++++++++|+||+++++++.+....++++||++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            34578999999999999854 68899999987432   223567889999999999999999999999999999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       ++|.+++....     ..+++..++.++.||++||.|||+   .+++||||||+||+++.++.++|+|||+++......
T Consensus        83 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          83 -QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             -CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence             58888875432     358999999999999999999999   999999999999999999999999999998654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .  ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       154 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             C--CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            1  12334578899999988653 356889999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=261.81  Aligned_cols=194  Identities=23%  Similarity=0.364  Sum_probs=169.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||.|+||.||+|+.. ++..||+|.+....  .....+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            45577999999999999854 58899999987532  3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...       .+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        84 ~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          84 GSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999998432       68999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......+++.|+|||.+.+.  .++.++||||||+++|||++|+.|++.
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence              12345688899999998765  588999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.6e-35  Score=262.63  Aligned_cols=189  Identities=26%  Similarity=0.368  Sum_probs=156.5

Q ss_pred             cccccCcEEEEEEEE-eCCceEEEEEeecccc---c-hHHHHHHHHHHhh---hcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---N-GQEFINEVATIGR---IHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~-~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .||+|+||.||++.. .+++.+|+|.+.....   . ...+.+|..+++.   .+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999985 4588999999865321   1 2234455444433   379999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            99999998532      358999999999999999999999   999999999999999999999999999987554321


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .    ....|++.|+|||.+.+. ..++.++||||+|+++|||++|+.||+
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~  197 (279)
T cd05633         152 P----HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFR  197 (279)
T ss_pred             c----cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence            1    234589999999988642 357889999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-35  Score=267.46  Aligned_cols=195  Identities=31%  Similarity=0.550  Sum_probs=160.8

Q ss_pred             hcccccccCcEEEEEEEEe-CCc----eEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGI----PVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ..+.||+|+||.||+|+.. ++.    .||+|.+......  ..++.+|+.+++.++||||++++|++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3467999999999999743 444    4788888754322  34788999999999999999999998754 46799999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....
T Consensus        90 ~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          90 MPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             cCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999986432     358899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ...........++..|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~  213 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYD  213 (303)
T ss_pred             cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3322222234457789999998764  78899999999999999997 888875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-35  Score=262.16  Aligned_cols=198  Identities=24%  Similarity=0.430  Sum_probs=164.2

Q ss_pred             HHhhcccccccCcEEEEEEEEeC----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.+.||+|+||.||+|...+    ...||+|......  ...+.+.+|+.++++++||||+++++++.+. ..++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~   85 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVM   85 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEE
Confidence            34567889999999999998543    2468999887543  3346789999999999999999999988764 568999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          86 ELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999995432     358999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...... ......+++.|+|||.+...  .++.++||||||+++|||++ |..||+.
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            544221 11233456789999988654  68899999999999999985 9999854

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-35  Score=260.70  Aligned_cols=195  Identities=26%  Similarity=0.358  Sum_probs=163.0

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc------cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEE
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVY  207 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  207 (344)
                      ..+.||+|+||.||+|.. .++..||+|.+....      ...+.+.+|+.++++++||||+++++++.+  ....++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            357799999999999975 458899999986432      123467889999999999999999998865  35778999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++...      ..+++...+.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          86 EYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            999999999999543      347899999999999999999998   99999999999999999999999999998765


Q ss_pred             cCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..... ........++..|+|||.+.+.  .++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~  210 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWA  210 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCcc
Confidence            32211 1111234578899999998764  68899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-35  Score=263.53  Aligned_cols=195  Identities=27%  Similarity=0.424  Sum_probs=162.5

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||.||+|.. .++..||+|.+....  .....+.+|+.+++.++|+||+++.+++.++...++|+||++ 
T Consensus         8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-   86 (291)
T cd07870           8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence            3457899999999999974 468899999987532  223467899999999999999999999999999999999995 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+|||++.+++++|+|||+++.......
T Consensus        87 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          87 TDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            78877764322     347888899999999999999999   8999999999999999999999999999875433211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||+
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~  205 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFP  205 (291)
T ss_pred             --CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              11234478999999998653 357789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-35  Score=266.10  Aligned_cols=190  Identities=30%  Similarity=0.456  Sum_probs=164.8

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ..||+|+||.||++.. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++++||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            3689999999999975 468899999986532 33467889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      .++..       ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++........  ..
T Consensus       107 ~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         107 DIVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             HHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            98732       348899999999999999999999   9999999999999999999999999999876543321  11


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....+++.|+|||++.+.  .++.++||||||+++|||++|+.|+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         175 KSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             cceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            335588999999998764  67889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=251.20  Aligned_cols=207  Identities=26%  Similarity=0.319  Sum_probs=171.2

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCC-----eEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-----RRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  206 (344)
                      ++.+.+.||+|||+-||.++ +.++..+|+|++.-.. ++.+..++|++..++++|||+++++++...+.     ..|++
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            45677889999999999997 6778999999987543 56678899999999999999999999875433     48999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ++|...|||.+.+.....  .+..+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+++.+++.|||.+..
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             eehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999977653  345799999999999999999999982 23599999999999999999999999999875


Q ss_pred             ccCCccc-------eeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISI-------VSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..-....       .......-|.-|.|||.+.- .....+.++|||||||+||+|+.|..||++
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            5322111       11122346889999999853 224678899999999999999999999985

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.3e-35  Score=263.30  Aligned_cols=197  Identities=24%  Similarity=0.322  Sum_probs=166.6

Q ss_pred             hhcccccccCcEEEEEEEE----eCCceEEEEEeeccc-----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK-----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.||+|+||.||+++.    .+|..||+|+++...     ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3457899999999999975    368899999997422     2336678899999999 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||+|+|||+++++.++|+|||+++
T Consensus        83 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          83 ILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999543      358899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... .......|+..|+|||.+......++.++||||||+++|||++|+.|++
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT  209 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence            6543321 1122345889999999987543456789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-35  Score=261.38  Aligned_cols=191  Identities=29%  Similarity=0.417  Sum_probs=164.3

Q ss_pred             ccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||+||++.. .+|+.+|+|.+....    ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999974 468899999986422    2335678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++.....    ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++........   
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---  150 (277)
T cd05577          81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---  150 (277)
T ss_pred             HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence            999965432    368999999999999999999999   9999999999999999999999999999876543221   


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....++..|+|||.+.+.  .++.++||||+|+++++|++|+.|+..
T Consensus       151 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            1234578899999998764  588899999999999999999999854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.1e-35  Score=260.65  Aligned_cols=190  Identities=26%  Similarity=0.363  Sum_probs=157.1

Q ss_pred             cccccCcEEEEEEEE-eCCceEEEEEeecccc---c-hHHHHHHHHH---HhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---N-GQEFINEVAT---IGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~-~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .||+|+||.||++.. .+++.||+|.+.....   . ...+.+|..+   ++..+||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            379999999999975 4588999999865321   1 1234445443   444579999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||++.......
T Consensus        81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            99999988432      468999999999999999999999   999999999999999999999999999987654321


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    ....|+..|+|||.+.+. ..++.++||||+|+++|||++|+.|++.
T Consensus       152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~  198 (278)
T cd05606         152 P----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQ  198 (278)
T ss_pred             C----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            1    234689999999998643 2578899999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.1e-36  Score=262.80  Aligned_cols=187  Identities=21%  Similarity=0.373  Sum_probs=156.7

Q ss_pred             ccccccCcEEEEEEEEeC--------CceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFN--------GIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.||+|+||.||+|....        ...+|+|.+.... ...+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999997422        3358888886433 3346789999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc--------eEEeec
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--------PKISDF  281 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~--------~kl~Df  281 (344)
                      +++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999996433     358899999999999999999999   99999999999999987765        599999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN  340 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p  340 (344)
                      |++......      ....+++.|+|||.+.+. ..++.++||||||+++|||++|..+
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~  204 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDK  204 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCC
Confidence            998754332      234578899999998753 3578899999999999999999544

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.8e-35  Score=259.21  Aligned_cols=193  Identities=23%  Similarity=0.414  Sum_probs=166.7

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      ..+.||+|+||.||+|... ++..||+|.+....  ...+.+.+|+.++++++|+||+++++.+.++...++||||++++
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            4467999999999999854 58899999987532  33467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        88 ~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          88 SALDLLRA-------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            99999842       347889999999999999999999   9999999999999999999999999999976644321 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......++..|+|||++.+.  .++.++|+||||+++|||++|..|+..
T Consensus       157 -~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             -ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence             11234578899999998764  688999999999999999999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.6e-35  Score=261.27  Aligned_cols=200  Identities=26%  Similarity=0.430  Sum_probs=166.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc------CCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE------GTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+|.. .+++.+|+|.+........++..|+.+++++ +|+||+++++++..      ....+++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            34457899999999999985 4578999999876555567788999999999 69999999999853      4578999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++|+|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        98 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          98 MEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            999999999999865332    357889999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......  ......+++.|+|||.+...   ...++.++||||||+++|||++|+.|++.
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            543211  11335588999999987531   23578899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.4e-35  Score=261.10  Aligned_cols=196  Identities=29%  Similarity=0.435  Sum_probs=167.8

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||+|+. .+|..||+|.+....   ...+.+.+|+.++++++||||+++++++.++...++|+||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            4567899999999999985 468899999987533   23467899999999999999999999999999999999999 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++....     ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            999999986433     468999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      . .......++..|+|||.+.+. ..++.++||||+|++++||++|+.|+.
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             C-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence            1 112345688999999988653 356889999999999999999977764

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=259.69  Aligned_cols=194  Identities=27%  Similarity=0.435  Sum_probs=167.0

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecc--ccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL--KGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.||+|+||.||+|.. .++..+|+|.++..  ....+++.+|+.++++++   |||++++++++.++...+++|||+
T Consensus         5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06917           5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA   84 (277)
T ss_pred             hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence            456799999999999985 56889999998643  334467889999999997   999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++..       ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          85 EGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             CCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999843       258999999999999999999999   99999999999999999999999999999876544


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  .....|+..|+|||.+.+. ..++.++||||||+++|||++|+.|++.
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCC
Confidence            321  2334688999999988643 3568899999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=257.29  Aligned_cols=199  Identities=25%  Similarity=0.391  Sum_probs=169.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++.++...+++|||+++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            345678999999999999854 57889999997543 3457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          85 GSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            99999985432     358999999999999999999999   9999999999999999999999999999886544321


Q ss_pred             ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......++..|+|||.+... ...++.++||||||+++|||++|+.|+..
T Consensus       157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD  206 (262)
T ss_pred             --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence              12334678899999988642 12577899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-35  Score=261.08  Aligned_cols=194  Identities=28%  Similarity=0.412  Sum_probs=169.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||++... ++..+|+|.+....    ...+.+.+|++.+++++||||+++++.+.++...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45678999999999999864 58899999997532    33468899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|+++||.|||+   ++++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          83 LGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999543      368999999999999999999998   99999999999999999999999999998876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....++..|+|||.+...  .++.++|+||+|+++|+|++|+.|++.
T Consensus       154 ~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~  201 (258)
T cd05578         154 TL---TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRG  201 (258)
T ss_pred             cc---ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCC
Confidence            21   2345588899999998765  578899999999999999999999864

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.7e-35  Score=264.30  Aligned_cols=191  Identities=29%  Similarity=0.457  Sum_probs=164.6

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ..||+|+||.||++.. .++..||||.+.... ...+.+.+|+..++.++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5689999999999975 458899999987533 33457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +++..       ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++.........  .
T Consensus       108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~  175 (292)
T cd06658         108 DIVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--R  175 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--C
Confidence            98832       347899999999999999999999   89999999999999999999999999998765433221  1


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....+++.|+|||.+.+.  .++.++||||||+++|||++|+.|+..
T Consensus       176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            234588999999998664  678899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.2e-35  Score=259.53  Aligned_cols=201  Identities=25%  Similarity=0.411  Sum_probs=162.5

Q ss_pred             hcccccccCcEEEEEEEEe----CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCC------eE
Q 041350          137 FKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RR  203 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~  203 (344)
                      +.+.||+|+||+||+|...    +++.||+|.+....   ...+++.+|+.++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4567999999999999743    36789999987532   23457889999999999999999999885432      24


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++++||+++|+|.+++...........+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence            7889999999999988643322223458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++...............+++.|++||.+...  .++.++||||||+++|||++ |+.|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~  217 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYA  217 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence            9876443222222233456789999988664  67889999999999999998 777764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.2e-35  Score=264.02  Aligned_cols=196  Identities=21%  Similarity=0.290  Sum_probs=164.6

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||.||++... +++.||+|.+....    ...+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            34578999999999999754 57899999987532    23357789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||+++.....
T Consensus        84 ~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          84 EGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999543      358999999999999999999999   99999999999999999999999999998742111


Q ss_pred             cc-------------ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 IS-------------IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..             ........++..|+|||.+...  .++.++|+||||+++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            00             0011123578899999998764  68899999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-35  Score=264.84  Aligned_cols=195  Identities=27%  Similarity=0.398  Sum_probs=165.6

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ++.+.||+|+||.||+|... +++.||+|.+.....   ..+.+.+|+++++.++||||+++++++.++...++|+||++
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            45578999999999999864 588999998864322   34578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|..+....      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        84 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          84 HTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99998876332      348999999999999999999999   899999999999999999999999999988654432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  .....++..|+|||++.+. ..++.++||||||+++|||++|+.|+.
T Consensus       155 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         155 EV--YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             cc--cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCC
Confidence            11  1234578899999998653 356789999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.1e-35  Score=257.63  Aligned_cols=189  Identities=26%  Similarity=0.372  Sum_probs=164.9

Q ss_pred             ccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||.|+||.||+++.. ++..+|+|.+....    ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999864 38899999987532    2346789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||+++......   .
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~  148 (262)
T cd05572          81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K  148 (262)
T ss_pred             HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence            9999543      348899999999999999999999   999999999999999999999999999998765432   1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....+++.|+|||.+.+.  .++.++|+||+|+++|||++|..|+..
T Consensus       149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  194 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGE  194 (262)
T ss_pred             cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence            1234578899999998654  678899999999999999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.1e-35  Score=263.65  Aligned_cols=195  Identities=29%  Similarity=0.407  Sum_probs=164.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc------hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN------GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.||+|+||.||+|... +++.||+|.++.....      ...+.+|++++++++|+||+++++++.+....++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34567999999999999854 6889999999754322      3457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+ +++|.+++....     ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||+++...
T Consensus        83 ~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          83 FM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             cc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            99 999999995432     258999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  ......+++.|+|||.+.+. ..++.++||||||+++|||++|..|++
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            4321  11234567889999988543 357889999999999999999977664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-34  Score=262.14  Aligned_cols=194  Identities=27%  Similarity=0.388  Sum_probs=163.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+.. +++.||+|.+....    ...+++.+|+++++.++||||+++.+++.+....++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445578999999999999854 68899999986432    2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++ |+|.+++....     ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        97 ~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          97 CL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             hC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            96 67777774322     358999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .      ....+++.|+|||++.+ ..+.++.++||||||+++|||++|+.|+..
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            3      23457889999998742 124678899999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8e-35  Score=260.93  Aligned_cols=199  Identities=25%  Similarity=0.364  Sum_probs=165.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcC-----CeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG-----TRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~lv~e~  209 (344)
                      +.+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.+++++ +|||++++++++...     ...++||||
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey  105 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL  105 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence            456799999999999985 4688999999976555556788999999999 799999999998653     358999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++.....  ....+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus       106 ~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         106 CNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             CCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            999999999864321  22468999999999999999999999   9999999999999999999999999999886543


Q ss_pred             CccceeeecccCCccccccccccccc---CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNF---GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  .....++..|+|||.+....   ..++.++|||||||++|||++|+.|+.
T Consensus       181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            2211  12345789999999875421   136789999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-35  Score=261.07  Aligned_cols=198  Identities=30%  Similarity=0.516  Sum_probs=166.9

Q ss_pred             hhcccccccCcEEEEEEEEe-----CCceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  206 (344)
                      .+.+.||+|+||.||+++..     ++..+|+|.++.....  .+.|.+|++.++.++|+||+++++++..  ....+++
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            45578999999999999743     3678999999865443  5789999999999999999999999877  5578999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        87 ~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          87 MEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999996533     258999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........ ......++..|+|||.+...  .++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCccc
Confidence            65332211 11123356679999988764  788899999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=264.40  Aligned_cols=198  Identities=29%  Similarity=0.363  Sum_probs=167.5

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ++.+.||+|+||+||++... ++..+|+|.+.....    ..+.+.+|+++++.++|+||+++++.+.++...+++|||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            34577999999999999865 489999999975432    3356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      .+++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          84 PGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             CCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999986432    2468999999999999999999999   99999999999999999999999999998754322


Q ss_pred             ccce---------------------------eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIV---------------------------SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....                           ......|+..|+|||++.+.  .++.++||||||+++|+|++|..|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            1100                           01123578899999998764  67889999999999999999999985

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-34  Score=258.06  Aligned_cols=195  Identities=23%  Similarity=0.401  Sum_probs=167.4

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.+.||+|+||.||+|.. .++..+|+|.+....  ...+.+.+|+..+++++||||+++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            344567899999999999974 468899999986432  23367889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++..       ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          85 GGGSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            99999999842       358899999999999999999999   99999999999999999999999999998765443


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  ......++..|+|||.+...  .++.++|+||||+++|||++|..|++
T Consensus       155 ~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         155 QI--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             hh--hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            21  11234578899999998654  67889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.8e-35  Score=256.21  Aligned_cols=191  Identities=32%  Similarity=0.558  Sum_probs=162.8

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+.+.||+|+||.||++. .+++.||+|.++.. ...+.+.+|+.++++++|||++++++++..+. .+++|||+++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~   84 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGN   84 (254)
T ss_pred             ceeeeeeccCCCCceEecc-cCCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCC
Confidence            4566889999999999997 57888999998653 24468899999999999999999999987654 789999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++.....    ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||+++......   
T Consensus        85 L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          85 LVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             HHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999965432    358899999999999999999999   999999999999999999999999999987643321   


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                        .....+..|+|||.+.+.  .++.++|+||||+++|||++ |+.|+.
T Consensus       155 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~  199 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYP  199 (254)
T ss_pred             --CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence              123346789999988653  78889999999999999997 888875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=285.02  Aligned_cols=201  Identities=20%  Similarity=0.302  Sum_probs=156.4

Q ss_pred             HHHhhcccccccCcEEEEEEEEeC--CceEEEE------------------EeeccccchHHHHHHHHHHhhhcccceee
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFN--GIPVAVK------------------MLEHLKGNGQEFINEVATIGRIHHFHIVR  192 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv~  192 (344)
                      ..+.+.++||+|+||+||++....  +...+.|                  .+.........+.+|+.+|++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            345566889999999999986432  2222222                  11222223356789999999999999999


Q ss_pred             EeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       193 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      +++++.+.+..++++|++ .++|.+++....... ........+..++.|++.||+|||+   ++|+||||||+|||++.
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC  302 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence            999999999999999999 568888875433211 1223466778899999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ++.+||+|||+++.+....... .....||+.|+|||++.+.  .++.++|||||||++|||++|+.++
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999998765432211 1245689999999999764  7889999999999999999987543

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.5e-35  Score=257.06  Aligned_cols=199  Identities=26%  Similarity=0.445  Sum_probs=169.5

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ...+.||+|+||.||+|... +++.+|+|.++....   ..+.+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            34578999999999999854 688999999976544   45688999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          83 GGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            99999998542      347889999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccee--eecccCCccccccccccccc-CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVS--LTAARGTAGYIAPELFSRNF-GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  .....+++.|+|||++.... ...+.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            2111  11345788999999987642 2378899999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=257.42  Aligned_cols=196  Identities=26%  Similarity=0.369  Sum_probs=163.6

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc------ccchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  206 (344)
                      .+.+.||+|+||.||+|.. .++..||+|.+...      ......+.+|++++++++|+||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            4567899999999999985 45889999987532      12235788999999999999999999998664  468899


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||+++++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          85 VEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            9999999999998532      347899999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...... ........++..|+|||.+.+.  .++.++|+||||+++|||++|+.|+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCC
Confidence            532111 1111234588999999998764  67889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.3e-35  Score=255.49  Aligned_cols=197  Identities=23%  Similarity=0.375  Sum_probs=168.3

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+++. .+|+.+|+|.+...   ....+++.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            4567899999999999974 46889999998743   2334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          83 GGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999864332    357899999999999999999999   999999999999999999999999999997654432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+++.|+|||++.+.  ..+.++|+||||++++||++|+.|+..
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~  203 (256)
T cd08218         156 EL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEA  203 (256)
T ss_pred             hh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccC
Confidence            11  1234578899999998764  678899999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=272.38  Aligned_cols=194  Identities=27%  Similarity=0.445  Sum_probs=172.1

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||+|.|++|..|+. .++..||+|.++++.-+   .+.+.+|+++|..++|||||+++.+......+|+||||..+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            457799999999999974 56899999999865333   35688999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |.+.+|+....      ...+..+..+..|+.+|++|||+   ..|+|||||++|+||+.+.++||+|||++..+.....
T Consensus       140 ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  140 GELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             chhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999996543      46668899999999999999999   9999999999999999999999999999998875432


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                         ....+|++-|.|||++.+. ....+++|+||+|+++|-|+.|..|||.
T Consensus       211 ---lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  211 ---LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             ---ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCC
Confidence               3467899999999999876 3567899999999999999999999984

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6e-35  Score=260.69  Aligned_cols=195  Identities=29%  Similarity=0.446  Sum_probs=164.4

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ..+.||+|+||.||+|+.. ++..||||.++...   ...+.+.+|++++++++||||+++++++.++...++||||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            4567999999999999754 68899999886432   223578899999999999999999999999999999999995 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....    ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            68999886533    2468999999999999999999999   9999999999999999999999999999876543221


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||.
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~  202 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFP  202 (284)
T ss_pred             --ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence              11233468899999988654 346889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.5e-35  Score=261.18  Aligned_cols=196  Identities=27%  Similarity=0.392  Sum_probs=168.1

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||.||++.. .++..||+|.+... ....+.+.+|+.++++++|||++++++.+......++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            344567899999999999974 46789999998643 2334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++..       ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus       100 ~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647         100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999843       247889999999999999999999   999999999999999999999999999987654332


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....+++.|+|||.+...  .++.++||||||+++||+++|+.||+.
T Consensus       170 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         170 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             cc--cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21  1234588899999998764  678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-34  Score=259.06  Aligned_cols=198  Identities=27%  Similarity=0.418  Sum_probs=162.3

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHH-HhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVAT-IGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||+++.. +|+.||+|.++....  ...++..|+.. ++.++||||+++++++..+...+++|||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            34578999999999999854 589999999875432  23456667665 566689999999999999999999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                       |+|.+++.....  ....+++..++.++.|++.||+|||+   . +++||||||+||++++++.+||+|||++......
T Consensus        84 -~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          84 -TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             -ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence             789888865432  12568999999999999999999998   5 8999999999999999999999999999865432


Q ss_pred             ccceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..   .+...++..|+|||.+.+..  ..++.++|+||||+++|||++|+.|++
T Consensus       158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            11   12345788999999886421  246789999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-34  Score=254.52  Aligned_cols=196  Identities=32%  Similarity=0.561  Sum_probs=166.8

Q ss_pred             hcccccccCcEEEEEEEEeC-----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.||.|+||.||+++..+     +..||+|.+.....  ..+.+.+|+..++.++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998544     37899999975443  457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++....
T Consensus        83 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999965331    128999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ...... ....+++.|+|||.+..  ..++.++||||+|++++||++ |+.|++
T Consensus       156 ~~~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~  206 (258)
T smart00219      156 DDYYKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYP  206 (258)
T ss_pred             cccccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            422211 12347789999998855  378899999999999999998 777765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-34  Score=255.11  Aligned_cols=201  Identities=25%  Similarity=0.350  Sum_probs=170.5

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||.|+||+||+|.. .++..+|+|++....  ...+.+.+|++.++.++|+|++++++.+......++++|++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            4567899999999999984 467899999986432  2457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++.....   ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          84 GSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999965322   1358999999999999999999998   9999999999999999999999999999876654322


Q ss_pred             ce--eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IV--SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ......++..|+|||++... ...+.++|+||||+++|||++|+.|++.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSK  209 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccc
Confidence            11  11234588999999998654 3678899999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.7e-36  Score=255.34  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=168.1

Q ss_pred             hhcccccccCcEEEEEEEEeC-----CceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  206 (344)
                      +....||+|.||.||+|+-.+     ...+|+|+++..+   +-.....+|+.+++.++|||++.+..++.. +...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            345679999999999995322     2379999998653   234678899999999999999999999877 7788999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC----CceEEeecC
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKISDFG  282 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfg  282 (344)
                      +||.+. +|...++-.+.... ..++...+..|+.||+.|+.|||+   +=|+||||||.|||+..+    |.+||+|||
T Consensus       107 fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            999976 89998876554333 579999999999999999999999   889999999999999876    999999999


Q ss_pred             CcccccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          283 LAKLCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       283 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +|+.+...... .+....+-|+.|.|||.+.+. ..||.+.||||+||++.||++..+-|
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccc
Confidence            99988655322 233445679999999999886 58999999999999999999987765

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=262.88  Aligned_cols=201  Identities=26%  Similarity=0.398  Sum_probs=165.2

Q ss_pred             hhcccccccCcEEEEEEEEe---CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  206 (344)
                      .+.+.||+|+||.||+|+..   ++..||+|.+....    ...+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            45577999999999999854   47899999997632    3346788999999999999999999999888  789999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC----CCceEEeecC
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH----NFQPKISDFG  282 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Dfg  282 (344)
                      |||+++ +|.+++..... .....+++..+..++.|++.||+|||+   .+++||||||+||+++.    ++.+||+|||
T Consensus        83 ~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EeCCCc-CHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            999964 77777643322 112468999999999999999999999   99999999999999999    9999999999


Q ss_pred             CcccccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          283 LAKLCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +++....... ........+++.|+|||.+.+. ..++.++||||||++++||++|+.|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~  217 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFK  217 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            9986543322 1112334578899999987653 357889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.4e-35  Score=257.41  Aligned_cols=195  Identities=26%  Similarity=0.428  Sum_probs=165.1

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecccc-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ..+.||+|+||.||++.. .++..+|+|.+.....       ..+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            346799999999999974 5688999999874321       23578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~  287 (344)
                      |+++++|.+++...      .++++..+..++.|++.||+|||+   .+++|+||+|+||+++.++ .++|+|||++...
T Consensus        84 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          84 WMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             ccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999998542      358899999999999999999999   9999999999999998775 5999999998876


Q ss_pred             cCCccce--eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIV--SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......  ......++..|+|||.+.+.  .++.++||||+|++++||++|+.|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~  209 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWN  209 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCC
Confidence            5431111  11234578899999998764  67889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-34  Score=258.82  Aligned_cols=196  Identities=27%  Similarity=0.355  Sum_probs=164.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  208 (344)
                      +.+.+.||+|+||.||+|+.. +++.+|+|.++....   ....+.+|+.++++++||||+++++++...  ...++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344578999999999999864 588999999974322   224577899999999999999999998777  88999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |++ ++|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++...
T Consensus        87 ~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          87 YVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             hcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            996 59999885432     358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  ......+++.|+|||.+.+. ...+.++|+||+|+++|||++|+.|+.
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~  208 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFP  208 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCC
Confidence            4321  11234578899999988654 346889999999999999999999885

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-34  Score=256.42  Aligned_cols=198  Identities=27%  Similarity=0.421  Sum_probs=165.4

Q ss_pred             hcccccccCcEEEEEEEEeC--CceEEEEEeeccc-----------cchHHHHHHHHHHhh-hcccceeeEeeEEEcCCe
Q 041350          137 FKHRLGQGGYGSVFRGKLFN--GIPVAVKMLEHLK-----------GNGQEFINEVATIGR-IHHFHIVRLLGFCSEGTR  202 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~  202 (344)
                      +.+.||+|+||.||+|....  +..+|+|.+....           ....++.+|+.++.+ ++||||+++++++.+++.
T Consensus         4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   83 (269)
T cd08528           4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR   83 (269)
T ss_pred             hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence            45679999999999998654  6789999875321           122457788888875 799999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .+++|||+++++|.+++.....  ....+++..++.++.|++.||.|||+  ..+++|+||+|+||++++++.++|+|||
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence            9999999999999998854321  22468999999999999999999995  2679999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ++.......   ......++..|+|||.+.+.  .++.++||||||+++|||++|+.|+..
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccc
Confidence            998765432   22345688999999998764  688999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=256.53  Aligned_cols=202  Identities=25%  Similarity=0.408  Sum_probs=168.8

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCC------eEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGT------RRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv  206 (344)
                      +.+.+.||+|+||+||+|... +++.+++|.+.......+++.+|+.+++++ +|+||+++++++.+..      ..+++
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            345678999999999999864 578899999987666667899999999999 6999999999986543      58999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        88 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          88 MELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            999999999999865331  12568999999999999999999999   9999999999999999999999999999876


Q ss_pred             ccCCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......  .....+++.|+|||++...   ...++.++||||||++++||++|+.|+..
T Consensus       163 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         163 LDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             cccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            5433221  2345588999999987532   13467899999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-34  Score=257.93  Aligned_cols=200  Identities=28%  Similarity=0.413  Sum_probs=165.0

Q ss_pred             hcccccccCcEEEEEEEEe------CCceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          137 FKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ..+.||+|+||+||+|+..      +...+|+|.+......  .+++.+|++++++++|+||+++++++.+....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3467999999999999753      2467999988754433  4689999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          209 FMPNGSLEKFIFSKTNSS---SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      |+++|+|.+++.......   ....+++..+..++.|++.||+|||+   .+++||||||+||++++++.++++|||+++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999996543211   12368999999999999999999998   899999999999999999999999999987


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....... .......+++.|+|||.+.+.  ..+.++||||||+++|||++ |..|+.
T Consensus       166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         166 DVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             ccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            5432211 112233467889999988654  67889999999999999998 677763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-34  Score=258.16  Aligned_cols=196  Identities=31%  Similarity=0.417  Sum_probs=165.5

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  211 (344)
                      +.++||.|++|.||++... +++.+|+|.+.....  ...++.+|++++++++||||+++++++.+.  ...++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            4578999999999999864 578999999875432  346789999999999999999999988653  46899999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          85 GGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             CCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            9999998764322  23468899999999999999999999   999999999999999999999999999987554321


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    ....++..|+|||.+.+.  .++.++||||+|+++|||++|+.|++.
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  205 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPP  205 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            1    233478899999998764  788899999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-34  Score=252.69  Aligned_cols=196  Identities=25%  Similarity=0.391  Sum_probs=167.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||++.. .++..+|+|.+....   ...+.+.+|++++++++|||++++++.+..+...++||||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            4567899999999999975 467899999986532   234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~~~~  290 (344)
                      +++|.+++....    ...+++..+..++.+++.||+|||+   ++++|+||+|+||+++++ +.++|+|||++......
T Consensus        83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          83 GGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999996543    2458999999999999999999999   999999999999999855 46899999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....++..|+|||.+.+.  .++.++||||||+++|+|++|+.|++.
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         156 SK---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEA  203 (256)
T ss_pred             cc---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCccc
Confidence            21   1234578899999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=276.86  Aligned_cols=194  Identities=24%  Similarity=0.419  Sum_probs=166.9

Q ss_pred             ccccccCcEEEEEEEEeC-CceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ..||.|+||.||+|+..+ +...|-|++... ....++++-|+++|...+||+||++++.|...+.+|++.|||+||-.+
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD  117 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD  117 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence            458999999999997544 455677888753 445589999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      ..+....     .+|++.++.-+++|++.||.|||+   ++|||||||+.|||++-+|.++|+|||.+......  ....
T Consensus       118 aimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkR  187 (1187)
T KOG0579|consen  118 AIMLELG-----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKR  187 (1187)
T ss_pred             HHHHHhc-----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH--Hhhh
Confidence            9886554     579999999999999999999999   99999999999999999999999999997644322  2233


Q ss_pred             ecccCCccccccccccc---ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          297 TAARGTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~---~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..+.|||.|||||+...   ...+|+.++||||||++|.||.-+.+|..
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh  236 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH  236 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence            56789999999998743   12478999999999999999999998864

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.7e-34  Score=256.01  Aligned_cols=195  Identities=30%  Similarity=0.437  Sum_probs=169.0

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.+.||+|+||.||+|... ++..+|+|.+.......+.+.+|++.++.++|+|++++++.+......++++||+++++|
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  102 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL  102 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence            3467999999999999865 588999999986544567889999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........  .
T Consensus       103 ~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  172 (286)
T cd06614         103 TDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--K  172 (286)
T ss_pred             HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--h
Confidence            99996543     368999999999999999999999   9999999999999999999999999999875543321  1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....+++.|+|||++.+.  .++.++||||||+++|||++|+.|+..
T Consensus       173 ~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            1234578899999998764  678999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.3e-34  Score=256.89  Aligned_cols=197  Identities=27%  Similarity=0.472  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.++||+|++|+||+|+.. +|..||+|.++...  ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34578999999999999864 58899999987532  2346778999999999999999999999999999999999974


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                       +|.+++.....   ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        83 -~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          83 -DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             -cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence             89888854332   2468999999999999999999999   8999999999999999999999999999976543221


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~  202 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFP  202 (284)
T ss_pred             --ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              11234578899999988654 356889999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-34  Score=253.68  Aligned_cols=202  Identities=25%  Similarity=0.379  Sum_probs=167.6

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  209 (344)
                      ++.+.||.|+||.||++.. .++..+|+|.+....   ...+.+.+|++++++++|+||+++++++..  +...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            3457799999999999974 467899999987432   233568899999999999999999998754  4567999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      +++++|.+++.....  ....+++..++.++.|++.||+|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          83 CEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             ccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999965431  2356899999999999999999999211  289999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......  .....+++.|+|||.+...  .++.++|+||||+++|+|++|+.|++.
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  212 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTA  212 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccC
Confidence            544321  1234689999999998764  688899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-34  Score=256.26  Aligned_cols=191  Identities=29%  Similarity=0.436  Sum_probs=165.6

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            6799999999999974 468899999987533 23456889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +++..       ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.++|+|||++.........  .
T Consensus       105 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~  172 (285)
T cd06648         105 DIVTH-------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--R  172 (285)
T ss_pred             HHHHh-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--c
Confidence            99854       248899999999999999999999   99999999999999999999999999988765443221  1


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....|++.|+|||.+.+.  .++.++||||||+++|||++|+.|+..
T Consensus       173 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         173 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             ccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence            234588999999998764  678899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=258.26  Aligned_cols=197  Identities=26%  Similarity=0.361  Sum_probs=166.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +++.+.||+|+||.||+|... +++.||+|.++..   ....+.+.+|++++++++|+||+++++++.+++..+++|||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            345678999999999999855 5789999998753   233467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +++.+..+...      ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          83 ERTLLELLEAS------PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            98777666532      2348999999999999999999999   99999999999999999999999999999876544


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ... ......++..|+|||++.+. ..++.++||||||+++|||++|+.|+.
T Consensus       154 ~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~  203 (288)
T cd07833         154 PAS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFP  203 (288)
T ss_pred             ccc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            321 11234578899999998764 367889999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=259.01  Aligned_cols=212  Identities=26%  Similarity=0.386  Sum_probs=172.5

Q ss_pred             cCHHHHHHHHHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccch--------HHHHHHHHHHhhhcccceeeEee
Q 041350          125 YTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG--------QEFINEVATIGRIHHFHIVRLLG  195 (344)
Q Consensus       125 ~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~  195 (344)
                      |.-......++-+...||+|||++||||. +...+.||||+-...+...        +...+|..+.+.|+||.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            33333444555667889999999999996 5668899999875433322        34568999999999999999999


Q ss_pred             EEE-cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC--
Q 041350          196 FCS-EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--  272 (344)
Q Consensus       196 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~--  272 (344)
                      ++. +.+..+-|+||++|.+|+-||.+.      ..+++++++.|+.||+.||.||.+ ...+|||-||||.||||-+  
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCc
Confidence            985 455678999999999999999554      458999999999999999999997 3579999999999999954  


Q ss_pred             -CCceEEeecCCcccccCCccc-----eeeecccCCcccccccccc--cccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          273 -NFQPKISDFGLAKLCSKDISI-----VSLTAARGTAGYIAPELFS--RNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       273 -~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       -|.+||.|||+++.+..+...     .-.....||.+|++||.+.  ...+.++.|.||||+||++|..+.||+||..
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence             578999999999988655322     1234567999999999774  2245789999999999999999999999953

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-34  Score=255.85  Aligned_cols=194  Identities=30%  Similarity=0.453  Sum_probs=168.1

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.||+|+||.||++... +++.+|+|.+....  ...+++.+|++++++++||||+++++.+..+...++++||++++
T Consensus         5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605           5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence            4567999999999999865 58899999987543  33467899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....     ..+++..+..++.|++.||+|||+  ..+++|+||+|+||++++++.++|+|||.+........ 
T Consensus        85 ~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          85 SLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999996532     468899999999999999999997  37999999999999999999999999999876543221 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                         ....++..|+|||.+.+.  .++.++||||||+++|+|++|+.|+.+
T Consensus       157 ---~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             ---hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence               125588899999998765  788999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-34  Score=255.15  Aligned_cols=192  Identities=27%  Similarity=0.374  Sum_probs=164.6

Q ss_pred             ccccCcEEEEEEEEeC-CceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||.||+++..+ |+.+|+|.+....    ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998654 8999999987532    2346788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc---
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS---  292 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~---  292 (344)
                      .+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++........   
T Consensus        81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            9999543      258999999999999999999999   9999999999999999999999999999876543211   


Q ss_pred             ---ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 ---IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                         ........++..|+|||.....  ..+.++||||||+++|||++|..|++.
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence               0112334578899999998764  578899999999999999999999863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=256.59  Aligned_cols=196  Identities=28%  Similarity=0.374  Sum_probs=165.8

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  210 (344)
                      +.++||+|+||.||+|+.. ++..+|+|.+...   ....+.+.+|++++++++|+|++++++++.+.  ...++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4578999999999999855 4789999999864   23346788999999999999999999999888  8899999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      + ++|.+++....     ..+++..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          83 D-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             c-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            7 48988885432     368999999999999999999999   89999999999999999999999999999876544


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .. .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|++.
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             Cc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21 112334568889999987653 3578899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=256.00  Aligned_cols=195  Identities=30%  Similarity=0.469  Sum_probs=164.8

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||.|++|+||+|.. .+|..||+|++....   ...+.+.+|++.+++++|||++++++++.++...+++|||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            457799999999999975 468999999987432   223578899999999999999999999999999999999994 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++.....    ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        82 ~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          82 LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            699999854432    358999999999999999999999   8999999999999999999999999999976543211


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......+++.|+|||++.+. ..++.++||||||+++|||++|+.||.
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~  201 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFP  201 (283)
T ss_pred             --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              11233468899999987653 356889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.3e-34  Score=257.31  Aligned_cols=199  Identities=28%  Similarity=0.413  Sum_probs=163.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCe-----EEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTR-----RAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~l  205 (344)
                      ...+.||+|+||+||+|... +++.||+|.++...   .....+.+|+.+++.++ |+||+++++++.....     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            34578999999999999854 68899999986432   23367889999999995 6999999999877655     899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLA  284 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla  284 (344)
                      +|||+++ +|.+++...... ....+++..++.++.||+.||+|||+   .+++||||+|+||+++. ++.++|+|||++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            9999975 899988654321 23568999999999999999999999   99999999999999998 899999999998


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.......  ......+++.|+|||++.+. ..++.++||||||+++|||++|..|+.
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~  213 (295)
T cd07837         159 RAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFP  213 (295)
T ss_pred             eecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence            86543211  11233468899999988653 357889999999999999999998874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.7e-34  Score=257.45  Aligned_cols=192  Identities=29%  Similarity=0.413  Sum_probs=162.6

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ...+.||+|+||.||+++. .++..+|+|.+....    .....+.+|++++++++|+|++++++++.++...++||||+
T Consensus        28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  107 (317)
T cd06635          28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC  107 (317)
T ss_pred             hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence            3456799999999999985 468899999987432    22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      + |+|.+++....     .++++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         108 L-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             C-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            6 58887775432     458999999999999999999999   99999999999999999999999999998754432


Q ss_pred             ccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                            ....+++.|+|||++.. ..+.++.++||||||+++|||++|+.|+.
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence                  23458889999998742 12467889999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.8e-34  Score=255.13  Aligned_cols=193  Identities=26%  Similarity=0.394  Sum_probs=160.8

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccceeeEeeEEEcC--CeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEG--TRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~  209 (344)
                      .+.++||+|+||.||+|+. .++..+|+|.++...  .......+|+..+.++. |+|++++++++.++  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            3457899999999999984 468899999987532  22345568999999995 99999999999887  889999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++ ++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||+|+||++++ +.+||+|||+++....
T Consensus        82 ~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          82 MD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             CC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            96 58888875432     368999999999999999999999   99999999999999999 9999999999986644


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....   ....+++.|+|||.+... +.++.++||||+||++|||++|..||.
T Consensus       152 ~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~  200 (282)
T cd07831         152 KPPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFP  200 (282)
T ss_pred             CCCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence            3221   234578899999976543 356889999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=252.22  Aligned_cols=188  Identities=27%  Similarity=0.319  Sum_probs=158.3

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHH-hhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATI-GRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|+||.||+|.. .+++.||+|.++....    ....+..|..++ ...+|+|++++++.+.+++..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4589999999999975 4588999999865321    123344555444 445899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.....  
T Consensus        82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence            9999998543      358899999999999999999999   89999999999999999999999999998764331  


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          ....+++.|+|||.+.+.  .++.++||||||+++|||++|..|+..
T Consensus       151 ----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  195 (260)
T cd05611         151 ----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHA  195 (260)
T ss_pred             ----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence                234578899999998765  578899999999999999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.7e-34  Score=247.84  Aligned_cols=194  Identities=28%  Similarity=0.498  Sum_probs=170.3

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ..+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.+++++|+|++++++++..+...++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            3567999999999999865 688999999976443 55789999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+........  
T Consensus        84 L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          84 LKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999985432     468999999999999999999999   9999999999999999999999999999987655432  


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       .....++..|+|||.+...  ..+.++||||||+++++|++|+.|++.
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  199 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSE  199 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence             1344578899999998765  578899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.8e-34  Score=255.72  Aligned_cols=196  Identities=28%  Similarity=0.440  Sum_probs=161.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|++|+||+|+.. +++.||+|.+....   ...+.+.+|++++++++|+||+++++++.++...++||||++
T Consensus         5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (294)
T PLN00009          5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence            44578999999999999854 68899999986432   223578899999999999999999999999999999999995


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~  290 (344)
                       ++|.+++.....    ..+++..+..++.||+.||+|||+   .+++|+||+|+||++++ ++.+||+|||++......
T Consensus        85 -~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         85 -LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             -ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence             588888744321    346788899999999999999999   89999999999999985 567999999999765432


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  ......+++.|+|||.+.+. ..++.++||||+|+++|||++|+.|+.
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~  205 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFP  205 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            11  11234568899999988653 357889999999999999999999984

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.1e-34  Score=256.97  Aligned_cols=199  Identities=29%  Similarity=0.377  Sum_probs=163.7

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--------
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--------  201 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  201 (344)
                      .+.+.+.||+|+||+||+|+.. +|+.||+|.++...   .....+.+|++++++++||||+++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            3455678999999999999864 58899999997432   23356788999999999999999999987654        


Q ss_pred             --eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          202 --RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       202 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                        ..++++||+++ +|..++...     ...+++..+..++.|++.||+|||+   .+|+|+||+|+||++++++.+||+
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence              78999999976 777777433     2368999999999999999999999   899999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||++........ .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|++.
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999987654321 111223467889999988643 3568899999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=281.60  Aligned_cols=212  Identities=29%  Similarity=0.462  Sum_probs=175.0

Q ss_pred             HHHHHHHHHhhcccccccCcEEEEEEEEeC--------CceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEee
Q 041350          127 YKELKKITSKFKHRLGQGGYGSVFRGKLFN--------GIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLG  195 (344)
Q Consensus       127 ~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~  195 (344)
                      ..|+......+.+.||+|.||.|++|....        ...||||+++...  .+.+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            345555544566799999999999997431        4579999998543  3457899999999999 6999999999


Q ss_pred             EEEcCCeEEEEEeccCCCCHHHHHhccC---CCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 041350          196 FCSEGTRRALVYEFMPNGSLEKFIFSKT---NSSSH-------RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP  265 (344)
Q Consensus       196 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~  265 (344)
                      +|...+..++|+||+..|+|.+||...+   .....       ..++..+++.++.|||.||+||++   .+++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            9999999999999999999999998766   10111       249999999999999999999999   9999999999


Q ss_pred             CceEEcCCCceEEeecCCcccccCCccceee-ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          266 HNILLDHNFQPKISDFGLAKLCSKDISIVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       266 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +|||+.++..+||+|||+|+.......+... ....-+..|||||.+...  .++.++|||||||+||||+|...+++|
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999999976555443321 111246679999999874  899999999999999999987777665

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.4e-34  Score=251.44  Aligned_cols=196  Identities=28%  Similarity=0.421  Sum_probs=170.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ++.+.||+|++|.||+++.. +++.||+|++....  ...+.+.+|+..+++++|+|++++++++......++++||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            34578999999999999865 48999999987543  2457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++...      ..+++..+..++.|+++|++|||+  ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          84 GSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999543      468999999999999999999996  27999999999999999999999999999987654332


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ....++..|+|||.+...  .++.++|+||||+++|||++|+.|+..
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~  202 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLP  202 (264)
T ss_pred             cc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            21  234578899999998764  788899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.2e-34  Score=249.80  Aligned_cols=196  Identities=28%  Similarity=0.377  Sum_probs=170.2

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  210 (344)
                      ..+.||+|++|.||+|... ++..|++|.+....   ...+.+.+|+..+++++|+||+++++.+.+.  ...++++||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            3467999999999999865 68899999987644   3457889999999999999999999999988  8899999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+......
T Consensus        84 ~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          84 SGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999543      268999999999999999999999   99999999999999999999999999999876554


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..........++..|+|||.+...  ..+.++||||||+++++|++|+.|++.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  205 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSE  205 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            321112345588999999998765  588899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6e-34  Score=260.71  Aligned_cols=196  Identities=28%  Similarity=0.381  Sum_probs=162.1

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhh-cccceeeEeeEEEcC--CeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEG--TRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~  207 (344)
                      +.+.+.||+|+||.||+|... ++..+|+|++...   ......+.+|+.+++++ +||||+++++++...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            445678999999999999854 5789999988532   22345678899999999 999999999998653  4689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++ ++|..++...       .+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||+++..
T Consensus        89 e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          89 EYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             cccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9996 5999888432       57889999999999999999999   99999999999999999999999999999866


Q ss_pred             cCCccc---eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISI---VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......   .......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~  214 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFP  214 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCC
Confidence            433211   112234578999999988653 367889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.2e-34  Score=251.06  Aligned_cols=181  Identities=22%  Similarity=0.300  Sum_probs=152.5

Q ss_pred             ccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCCHHHH
Q 041350          141 LGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF  218 (344)
Q Consensus       141 lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  218 (344)
                      ||+|+||.||++.. .++..+|+|.+........    |+.....+ +|||++++++.+...+..++||||+++++|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            59999999999974 4678899999875322211    22222222 699999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccCCccceeee
Q 041350          219 IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSLT  297 (344)
Q Consensus       219 l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~~~~~~~~  297 (344)
                      +...      ..+++..+..++.|+++||+|||+   .+++||||+|+||+++.++ .++|+|||+++.....      .
T Consensus       100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~  164 (267)
T PHA03390        100 LKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------S  164 (267)
T ss_pred             HHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------c
Confidence            9543      368999999999999999999999   8999999999999999988 9999999998765432      2


Q ss_pred             cccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       298 ~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...+++.|+|||++.+.  .++.++||||+|+++|||++|+.|+.
T Consensus       165 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~  207 (267)
T PHA03390        165 CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFK  207 (267)
T ss_pred             cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            33578999999999764  67889999999999999999999985

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-34  Score=262.01  Aligned_cols=199  Identities=27%  Similarity=0.361  Sum_probs=169.0

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEec
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.++||+||-+.||++...+.+.+|+|++....   ...+-|.+|+..|.+|+ |.+|+++++|-..++.+||||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            344557899999999999987777888988876433   33467999999999995 89999999999999999999998


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      = ..||...|.+...    ....| .++.+..||+.|+.+.|+   .+|||.||||.|+|+- .|.+||+|||.|.....
T Consensus       442 G-d~DL~kiL~k~~~----~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKS----IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             c-cccHHHHHHhccC----CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            6 6699999976543    22334 788999999999999999   9999999999999996 46899999999999888


Q ss_pred             CccceeeecccCCcccccccccccccC---------CCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFG---------EVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.........+||+.|||||.+..+..         ..+.++||||+||+||+|+.|+.||.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~  573 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG  573 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence            877666677889999999998854311         26789999999999999999999984

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.3e-34  Score=254.97  Aligned_cols=190  Identities=29%  Similarity=0.447  Sum_probs=163.9

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      .+||+|+||.||++.. .++..||+|.+.... .....+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5689999999999975 468899999986433 23456889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      +++..       ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++.........  .
T Consensus       106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~  173 (292)
T cd06657         106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  173 (292)
T ss_pred             HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence            98732       247899999999999999999999   89999999999999999999999999998765433211  1


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....+++.|+|||.+.+.  .++.++|+||+|+++|||++|..|+.
T Consensus       174 ~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~  217 (292)
T cd06657         174 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYF  217 (292)
T ss_pred             cccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            234578999999988654  67889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.7e-34  Score=258.22  Aligned_cols=195  Identities=27%  Similarity=0.362  Sum_probs=162.1

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  209 (344)
                      ++.+.||+|+||.||+|... +|..||+|.++....   ....+.+|+.++++++|+||+++++++.+.  +..++||||
T Consensus        10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (309)
T cd07845          10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY   89 (309)
T ss_pred             eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence            34577999999999999854 589999999874322   224567899999999999999999998755  568999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++ ++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|||++.....
T Consensus        90 ~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          90 CE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             CC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            96 58988885432     468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  .....+++.|+|||.+.+. ..++.++||||+|+++|||++|+.||.
T Consensus       161 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~  210 (309)
T cd07845         161 PAKP--MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLP  210 (309)
T ss_pred             ccCC--CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence            3211  1233457889999998653 357889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-35  Score=270.99  Aligned_cols=196  Identities=29%  Similarity=0.459  Sum_probs=165.7

Q ss_pred             hhcccccccCcEEEEEEEEe--CC--ceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF--NG--IPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.++||+|.||.|++|.+.  +|  ..||||.++....  ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999743  34  4689999986543  35899999999999999999999999988 678899999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++.|+|.+.|+...    ...|-...+..++.|||.||+||..   +++|||||..+|+||-....+||+||||.+-+..
T Consensus       192 aplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             cccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999997622    2467788899999999999999999   9999999999999999999999999999998765


Q ss_pred             Cccceeee-cccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCC
Q 041350          290 DISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNK  341 (344)
Q Consensus       290 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~  341 (344)
                      +.....+. ...-+..|.|||.+...  .++.++|||+|||++|||+| |..|+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCC
Confidence            54433322 33457789999999764  89999999999999999995 44554

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.9e-34  Score=259.80  Aligned_cols=198  Identities=22%  Similarity=0.293  Sum_probs=161.4

Q ss_pred             cccccc--CcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQG--GYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G--~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.||+|  +||+||+++. .+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999985 4789999999874332   235678899999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++++||+.+........
T Consensus        84 ~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            999999865432    358899999999999999999998   9999999999999999999999999986543221110


Q ss_pred             ce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..     ......++..|+|||++.+....++.++||||||+++|||++|+.|+..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            00     0011234567999999876544578899999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=263.69  Aligned_cols=193  Identities=29%  Similarity=0.451  Sum_probs=168.2

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.||+|.||+||-|+. .+|+.||||++.+.   ..+...+.+|+.+|++++||.||.+..-|...+..++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            36799999999999974 56999999999753   344577899999999999999999999999999999999999 67


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEeecCCcccccCC
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCSKD  290 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Dfgla~~~~~~  290 (344)
                      +..+.+.....    ..|++..-..+..||+.||.|||.   ++|+|.||||+|||+.+.   -.+||+|||+|+...+.
T Consensus       648 DMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  648 DMLEMILSSEK----GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            77777755432    569999999999999999999998   999999999999999654   36899999999988765


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .-   ....+|||.|+|||++...  .|...-|+||.||++|--|+|.-||+.
T Consensus       721 sF---RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  721 SF---RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hh---hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCC
Confidence            33   2457799999999999875  788899999999999999999999964

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6e-34  Score=257.29  Aligned_cols=198  Identities=26%  Similarity=0.364  Sum_probs=161.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--------e
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--------R  202 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~  202 (344)
                      +.+.++||+|+||.||+|.. .+++.||+|.+....   .....+.+|++++++++||||+++++++....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            44567899999999999985 468899999986432   22345678999999999999999999986543        4


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++||||++ ++|.+++....     ..+++.+++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence            599999995 58888874322     358999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccCCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          283 LAKLCSKDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++.........  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~  225 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99866432211  111234578899999988654 346789999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4e-34  Score=251.38  Aligned_cols=197  Identities=24%  Similarity=0.414  Sum_probs=167.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||.||++... +|..+|+|.+...   ....+.+.+|+++++.++|+||+++++.+.++...++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            35678999999999999854 5788999998653   2344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~  290 (344)
                      +++|.+++.....    ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++ .++|+|||.+......
T Consensus        83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          83 GGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999964332    357999999999999999999999   9999999999999999885 4699999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  .....|++.|+|||++.+.  .++.++||||||+++|||++|+.|++.
T Consensus       156 ~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         156 MEL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             ccc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            221  1234588999999988764  688899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-34  Score=262.55  Aligned_cols=196  Identities=29%  Similarity=0.447  Sum_probs=161.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  206 (344)
                      +.+.+.||+|+||.||+|+. .+|..||+|.++..  ......+.+|+.++++++|+||+++++++...     ...+++
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            34567899999999999974 56899999998642  22346788999999999999999999987554     357999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||++ ++|.+++..       ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++.
T Consensus        87 ~e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          87 QELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             ehhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            99996 588887732       358999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ........ ......+++.|+|||.+.+. ..++.++||||+|+++|||++|+.||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~  211 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFP  211 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            54322111 11234578999999987543 367889999999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.2e-34  Score=257.13  Aligned_cols=197  Identities=19%  Similarity=0.179  Sum_probs=162.5

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .+.+|.|+++.||+++ .+++.||+|+++..   ....+.+.+|+++++.++|+||+++++++.+....+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            3445666777777765 47899999998753   2334678999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc--
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS--  292 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~--  292 (344)
                      |.+++.....    ..+++..+..++.|+++||+|||+   .+|+||||||+||+++.++.++|+|||.+........  
T Consensus        86 l~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          86 CEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             HHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            9999965432    358899999999999999999999   9999999999999999999999999998875432211  


Q ss_pred             ---ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 ---IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         ........++..|+|||++......++.++||||||+++|||++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~  211 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK  211 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence               01112334678899999987643457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.3e-34  Score=257.44  Aligned_cols=197  Identities=23%  Similarity=0.264  Sum_probs=148.7

Q ss_pred             HHhhcccccccCcEEEEEEEEeC----CceEEEEEeeccccch------------HHHHHHHHHHhhhcccceeeEeeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG------------QEFINEVATIGRIHHFHIVRLLGFC  197 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~  197 (344)
                      .+.+.++||+|+||+||+|...+    +..+|+|+........            .....+...+..++|+|++++++.+
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            45567889999999999998544    3456666543222111            1123344556677899999999976


Q ss_pred             EcCC----eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          198 SEGT----RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       198 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ....    ..++++|++. .++.+.+...      ...++..+..++.|++.||+|||+   .+++||||||+|||++++
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            5543    3467888773 4666666322      235788899999999999999999   999999999999999999


Q ss_pred             CceEEeecCCcccccCCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          274 FQPKISDFGLAKLCSKDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       274 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.++|+|||+|+.+......     .......||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~  234 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWK  234 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999876432111     111234699999999998764  78999999999999999999999985

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.5e-34  Score=255.12  Aligned_cols=197  Identities=23%  Similarity=0.317  Sum_probs=165.7

Q ss_pred             hhcccccccCcEEEEEEEE----eCCceEEEEEeeccc-----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK-----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.||+|+||.||+++.    .++..||||.++...     ...+.+.+|+.++.++ +||||+++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            3457899999999999874    356889999987432     2235688999999999 59999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++|+|.+++...      ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||+++
T Consensus        83 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          83 ILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999998532      358899999999999999999999   999999999999999999999999999988


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......... .....+++.|+|||.+.+.....+.++||||||+++|||++|..|+.
T Consensus       154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  209 (288)
T cd05583         154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT  209 (288)
T ss_pred             ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence            755432211 12345789999999986643346889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-35  Score=243.62  Aligned_cols=194  Identities=25%  Similarity=0.411  Sum_probs=162.8

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      ...||.|+.|+|++.+. .+|..+|||.+....  ++.++++..+.++.+-+ .|.||+.+|+|..+...++-||.| ..
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence            36799999999999985 458899999998643  33456777777776665 799999999999999999999999 54


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      .++.++..-.     .++++..+-.+...+.+||.||.+  +++|+|||+||+|||+|+.|++||+|||++-.+-.....
T Consensus       176 C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  176 CAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            6666664333     568999999999999999999998  689999999999999999999999999999877554332


Q ss_pred             eeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         +...|.+.|||||.+.-. ...|+.++||||||+.|+||.||+.|+.
T Consensus       249 ---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~  295 (391)
T KOG0983|consen  249 ---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK  295 (391)
T ss_pred             ---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence               345689999999998643 4578899999999999999999999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=227.54  Aligned_cols=191  Identities=26%  Similarity=0.423  Sum_probs=164.9

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ++||+|.||+||+|+. .+++.||+|.++....   -....++|+-+++.++|.|||++++....+..+.+|+||| ..+
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqd   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHH
Confidence            5799999999999984 4578899999875332   2367899999999999999999999999999999999999 568


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |..|.....     ..++.+..+.++.|+++||.|.|+   +++.|||+||.|.||+.+|++|++|||+|+.+.-.... 
T Consensus        87 lkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-  157 (292)
T KOG0662|consen   87 LKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-  157 (292)
T ss_pred             HHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence            999886543     468999999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                       .....-|..|.+|.++-+. .-|+...|+||-||++.|+.....|.
T Consensus       158 -ysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  158 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             -eeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCC
Confidence             2345579999999999875 47888999999999999999655554

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.3e-34  Score=259.21  Aligned_cols=194  Identities=27%  Similarity=0.363  Sum_probs=161.3

Q ss_pred             cccccccCcEEEEEEEEe-CCceEEEEEeeccccch---------------HHHHHHHHHHhhhcccceeeEeeEEEcCC
Q 041350          138 KHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG---------------QEFINEVATIGRIHHFHIVRLLGFCSEGT  201 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  201 (344)
                      .+.||+|+||+||+|... +++.||+|.++......               ..+.+|+++++.++|+||+++++++..+.
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            456999999999999854 68899999986432211               24779999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..+++|||++ |+|.+++...      ..+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence            9999999996 6999998432      358999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCc------------cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          282 GLAKLCSKDI------------SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       282 gla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      |+++......            .........+++.|+|||.+.+. ..++.++||||+|+++|||++|..|+.
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9997654110            01111233468889999998653 356889999999999999999998874

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=293.78  Aligned_cols=195  Identities=27%  Similarity=0.373  Sum_probs=165.5

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ..||.|.||.||.|. ..+|...|+|-++-...   ......+|+.++..++|||+|+.+|+-.+.+..+|.||||++|+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            469999999999997 56789999998864332   23567899999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc-
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  293 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  293 (344)
                      |.+.+...      +..++....-+..|++.|++|||+   ++||||||||.||+|+.+|.+|++|||.|.....+... 
T Consensus      1321 La~ll~~g------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             HHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            99999433      346777778889999999999999   99999999999999999999999999999987655311 


Q ss_pred             -eeeecccCCccccccccccccc-CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 -VSLTAARGTAGYIAPELFSRNF-GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       .......||+.|||||++.+.. ....-+.||||+|||+.||+||++|+.
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence             1223557999999999997643 234458999999999999999999973

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=246.13  Aligned_cols=195  Identities=26%  Similarity=0.416  Sum_probs=169.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|++|.||+++.. +++.+|+|.+....   ...+.+.+|++++++++|+|++++++++.++...+++|||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            34578999999999999754 57899999997654   244678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          83 NGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999998543      458999999999999999999998   999999999999999999999999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....++..|+|||.+.+.  ..+.++||||+|+++|+|++|+.|+..
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            21  1234578999999998764  578899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-34  Score=265.01  Aligned_cols=194  Identities=23%  Similarity=0.327  Sum_probs=164.1

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||-|+||+|-++. .++...+|.|.+++..    .+......|-.||..-+.+-||+|+..|.+.+.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            459999999999996 4556789999997532    33345778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc------
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC------  287 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~------  287 (344)
                      ++-.+|-..      ..+.++.++.++..+..|+++.|.   .|+|||||||+|||||.||++||.||||+.-+      
T Consensus       715 DmMSLLIrm------gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  715 DMMSLLIRM------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             cHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999998543      458899999999999999999999   99999999999999999999999999997532      


Q ss_pred             ---cCCccc-------------------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHH
Q 041350          288 ---SKDISI-------------------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLE  333 (344)
Q Consensus       288 ---~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~e  333 (344)
                         .+....                               ......+||+.|+|||++.+.  .++..+|+||.||+|||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHH
Confidence               111000                               001234599999999999886  78999999999999999


Q ss_pred             HHcCCCCCCC
Q 041350          334 MVGCRKNKDP  343 (344)
Q Consensus       334 ll~g~~p~~~  343 (344)
                      |+.|+.||-.
T Consensus       864 m~~g~~pf~~  873 (1034)
T KOG0608|consen  864 MLVGQPPFLA  873 (1034)
T ss_pred             HhhCCCCccC
Confidence            9999999953

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=232.84  Aligned_cols=198  Identities=29%  Similarity=0.407  Sum_probs=164.2

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ..||+|++|.|-+-+ ..+|...|+|.++..-  ....+.++|+.+..+. ..|.+|.++|....+...++-||.| ..|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhh
Confidence            569999999987765 4689999999998543  2335677888776655 6899999999999999999999999 668


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |+.+-...-  .....+++..+-+|+..+.+||.|||+  ...++|||+||+||||+.+|++|++|||.+-.+.+...  
T Consensus       131 ldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--  204 (282)
T KOG0984|consen  131 LDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--  204 (282)
T ss_pred             HHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence            888765433  234678999999999999999999999  58899999999999999999999999999987765432  


Q ss_pred             eeecccCCcccccccccccc--cCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRN--FGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                       .+...|..-|||||.+...  ...|+.++||||+|+.+.||.++|.|++.+
T Consensus       205 -kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 -KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             -HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence             1334577889999988532  236889999999999999999999999864

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-33  Score=254.74  Aligned_cols=193  Identities=26%  Similarity=0.397  Sum_probs=162.0

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +...+.||+|+||+||+|+.. ++..+|+|.+....    ...+++.+|+++++.++|+|++++++++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            333467999999999999854 57889999986421    2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +. |+|.+++....     ..+++..+..++.|++.|+.|||+   .+++||||+|+||+++.++.++|+|||++.....
T Consensus        97 ~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          97 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             cC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            96 68888775332     358899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .      ....+++.|+|||.+.+ ..+..+.++||||||+++|||++|+.|+.
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence            2      23457889999998753 11357889999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-33  Score=252.78  Aligned_cols=198  Identities=27%  Similarity=0.363  Sum_probs=160.0

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.||+|+||+||++.. .+++.+|+|.+....  .....+.+|+.++.++. |+||+++++++......+++|||++ +
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-I   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-C
Confidence            46799999999999975 458899999987432  23457889999999996 9999999999999999999999985 4


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.++...... .....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||+++........
T Consensus        88 ~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          88 SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            66554321110 112468999999999999999999997  258999999999999999999999999999765433211


Q ss_pred             eeeecccCCccccccccccccc-CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNF-GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         ....+++.|+|||++.+.. ..++.++||||||+++|||++|+.||.
T Consensus       165 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  211 (288)
T cd06616         165 ---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP  211 (288)
T ss_pred             ---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence               2335788999999986531 257889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.4e-34  Score=260.19  Aligned_cols=197  Identities=27%  Similarity=0.418  Sum_probs=162.7

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEE----cCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCS----EGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~  207 (344)
                      .+.+.||+|+||.||+|.. .+|..||+|++....   ...+.+.+|+.++++++||||+++++++.    .....++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~   87 (334)
T cd07855           8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM   87 (334)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence            3457799999999999974 468999999987532   23467788999999999999999999875    335689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+. ++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        88 e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          88 DLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9995 6899888432      358999999999999999999999   99999999999999999999999999999765


Q ss_pred             cCCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......  .......++..|+|||.+.+. ..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCC
Confidence            432211  111234688999999998653 3578899999999999999999999853

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.5e-33  Score=251.76  Aligned_cols=191  Identities=29%  Similarity=0.412  Sum_probs=161.4

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .++||+|+||+||+|+. .++..||+|.+.....    ..+.+.+|++++++++|||++++++++.+....++||||++ 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            35699999999999985 4688999999874322    23568899999999999999999999999999999999995 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....     .++++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......  
T Consensus       105 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         105 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            67888775432     458999999999999999999999   99999999999999999999999999998643322  


Q ss_pred             ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          ....++..|+|||++... .+.++.++||||||+++|||++|+.|+..
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                234688899999998531 23678899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=252.24  Aligned_cols=194  Identities=27%  Similarity=0.427  Sum_probs=164.6

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||+|+||+||+|+.. +++.||+|.+.....  ......+|+..+++++ |+|++++++++.+++..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            4578999999999999865 478899999875432  2234567999999999 999999999999999999999999 8


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....    ...+++..+..++.|++.||.|||+   ++++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          82 GNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             CCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            89999886543    2468999999999999999999999   9999999999999999999999999999986644322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         .....++..|+|||++.+. ..++.++|+||||+++|||++|+.|+.
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~  200 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFP  200 (283)
T ss_pred             ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccC
Confidence               1234578899999988654 357889999999999999999998874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.4e-34  Score=249.09  Aligned_cols=197  Identities=31%  Similarity=0.500  Sum_probs=169.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.++||+|+||.||+++. .++..+|+|.+....   ....++.+|++++++++|+||+++++++.+....++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            3457899999999999974 467899999987532   334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....  ....+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          83 FGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             CCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999865331  22568999999999999999999999   999999999999999999999999999998765541


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          .....+++.|+|||.+.+.  .++.++|+||+|+++|||++|+.|++.
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~  203 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEA  203 (256)
T ss_pred             ----cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                1234578899999998764  678899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-33  Score=260.13  Aligned_cols=191  Identities=26%  Similarity=0.344  Sum_probs=160.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +...+.||+|+||.||+|.. .+++.||+|.+...   ......+.+|+.++++++|+||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            34457899999999999984 46899999998642   22335678899999999999999999988543      3579


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||++ ++|.+.+..        .+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        98 lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          98 LVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             EEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            9999995 588888732        27889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.......   .....+++.|+|||.+.+.  .++.++||||||+++|+|++|+.||.
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~  218 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCC
Confidence            87644321   1234578899999998764  78899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.5e-34  Score=253.10  Aligned_cols=197  Identities=28%  Similarity=0.437  Sum_probs=168.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||.||+++.. ++..||+|++....    ...+.+.+|.+++++++ |+||+++++++.+++..+++|||
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd05581           4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY   83 (280)
T ss_pred             eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence            35578999999999999854 68999999987522    22357889999999998 99999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          84 APNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999543      369999999999999999999999   9999999999999999999999999999886644


Q ss_pred             Cccc------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISI------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....                  .......++..|+|||.....  ..+.++|+||||++++|+++|+.|+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            3211                  112234578899999988764  678899999999999999999999853

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-33  Score=251.85  Aligned_cols=197  Identities=24%  Similarity=0.407  Sum_probs=162.6

Q ss_pred             hhcccccccCcEEEEEEEEeC-CceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+..+ +..||||.++...  ....++..|+.++.+.. |+||+++++++.+....+++|||++
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            456889999999999998654 8899999997543  23356777888777775 9999999999999999999999984


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       ++|.+++....     ..+++..+..++.|++.||+|||+  ..+++||||+|+||++++++.++|+|||++.......
T Consensus        98 -~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          98 -TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             -cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence             57777764422     368999999999999999999996  2589999999999999999999999999987654332


Q ss_pred             cceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   ....+++.|+|||.+.+..  +.++.++||||||+++|||++|+.|+..
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            21   2334788999999986542  3478899999999999999999999853

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.3e-33  Score=243.92  Aligned_cols=199  Identities=27%  Similarity=0.475  Sum_probs=171.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||.|+||.||++... ++..+|+|.+....   ...+.+.+|++.++.++|+|++++.+.+..+...++++||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34577999999999999854 58899999997543   344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++.....  ....+++..+..++.+++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        83 ~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          83 GGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             CCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999976431  22568999999999999999999999   899999999999999999999999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......+++.|+|||.+.+.  .++.++||||+|+++++|++|+.|++.
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~  205 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEG  205 (258)
T ss_pred             c--eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCC
Confidence            1  12334688899999988664  678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=255.22  Aligned_cols=202  Identities=25%  Similarity=0.304  Sum_probs=169.4

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeE
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  203 (344)
                      ++....+|...||+|+||.|-+|.. -+.+.+|||++++.    .++.+--+.|-++|+-. +-|.+++++..++.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            3444567888999999999999963 34567999999853    23334446677777766 467899999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      |+||||+.||+|--++++-.      .+.+..+..+|..||-||-+||+   .+|+.||||..|||||.+|++||+|||+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             eeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccc
Confidence            99999999999999996543      47788899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA  344 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~~  344 (344)
                      ++..--+  .......+|||.|+|||++.-  .+|...+|+|||||+|||||.|++|||.+
T Consensus       497 cKEni~~--~~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  497 CKENIFD--GVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             ccccccC--CcceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            9864332  223457889999999999865  48999999999999999999999999853

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-33  Score=248.37  Aligned_cols=193  Identities=31%  Similarity=0.479  Sum_probs=161.2

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhh---cccceeeEeeEEEcCCe-----EE
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRI---HHFHIVRLLGFCSEGTR-----RA  204 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~  204 (344)
                      +.+.||+|+||.||+|+.. ++..+|+|.++....   ....+.+|+.+++++   +|+|++++++++.+...     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            4578999999999999865 489999999974322   224566788777666   59999999999988776     89


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ++|||++ ++|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        83 l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          83 LVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             EEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence            9999996 589998865332    358999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .........   ....+++.|+|||.+.+.  .++.++|+||||+++|||++|+.|++
T Consensus       155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~  207 (287)
T cd07838         155 RIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFR  207 (287)
T ss_pred             eeccCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCccc
Confidence            876544221   233478899999998764  68889999999999999999988875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=249.46  Aligned_cols=198  Identities=26%  Similarity=0.349  Sum_probs=162.7

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ..||.|+||+|+|-. ...|+..|||+++...  .+.++++.|.+...+- +.||||+++|.+..++..|+-||.| ..|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            568999999999976 3569999999998543  3446788888766555 6899999999999999999999999 567


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |+.+-...- ......+++..+-.|+.-+..||.||.+  +..|||||+||+|||++..|.+||+|||.+..+.....  
T Consensus       149 lDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  149 LDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             HHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence            766532210 1122468898888999999999999998  58899999999999999999999999999887654422  


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       .+...|..-|||||.+......++.+|||||+|++|+|+.||+-|++.
T Consensus       224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence             245568889999999987655689999999999999999999999875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.4e-33  Score=256.67  Aligned_cols=194  Identities=28%  Similarity=0.425  Sum_probs=161.3

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  206 (344)
                      ...+.||+|+||+||+++. .++..||||.+...   ......+.+|+.+++.++|+||+++++++...     ...+++
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv   87 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV   87 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence            3456799999999999974 46889999998642   22345678899999999999999999987654     347999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||+. ++|.+++...      ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        88 ~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          88 YELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EeCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            99995 7898888432      458999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......  ......++..|+|||.+... ..++.++||||||+++|||++|+.||.
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~  210 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFP  210 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence            644321  11234578899999987643 257889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-33  Score=255.76  Aligned_cols=190  Identities=26%  Similarity=0.384  Sum_probs=160.3

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCC------eEEEE
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RRALV  206 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv  206 (344)
                      +.+.||+|+||.||++.. .++..||||.+.....   ..+.+.+|+.++++++||||+++++++..+.      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            456799999999999974 4688999999864221   2356889999999999999999999886543      45899


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+ +++|.+++..       ..+++..++.++.|++.||+|||+   .+|+||||+|+||++++++.++|+|||++..
T Consensus        99 ~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          99 MPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            9999 7899988742       358999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     ....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|+.||..
T Consensus       168 ~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         168 TDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             cccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            54321     234578899999998653 3578899999999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-33  Score=242.92  Aligned_cols=190  Identities=32%  Similarity=0.412  Sum_probs=164.8

Q ss_pred             ccccCcEEEEEEEEe-CCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ||+|+||.||+++.. +++.+|+|.+.....    ....+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999854 488999999875322    345788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++...      ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||++........  .
T Consensus        81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (250)
T cd05123          81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R  149 (250)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence            9999543      358999999999999999999999   9999999999999999999999999999887644311  1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....++..|+|||.+.+.  ..+.++|+||||+++|||++|+.|++.
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            2345578899999998764  578899999999999999999999853

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-33  Score=252.64  Aligned_cols=198  Identities=26%  Similarity=0.390  Sum_probs=160.1

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC--------Ce
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--------TR  202 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~  202 (344)
                      +.+.+.||+|+||.||+|+.. ++..+|+|.+....   .....+.+|++++++++|+||+++++++.+.        ..
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            345678999999999999854 58899999986432   1234678999999999999999999987543        34


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++|+||+++ +|...+....     ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.++|+|||
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             EEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCc
Confidence            6999999964 7777764322     368999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccce---------eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          283 LAKLCSKDISIV---------SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +++.........         ..+...+++.|+|||.+.+. ..++.++||||||+++|||++|+.|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~  228 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQ  228 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCC
Confidence            998654332111         11233568889999987653 357889999999999999999999885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=248.50  Aligned_cols=194  Identities=28%  Similarity=0.415  Sum_probs=165.4

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ..+.||+|++|.||++... ++..+|+|.++....   ....+.+|++++++++|+||+++++++.++...++++||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            3467999999999999854 688999999875432   246788999999999999999999999999999999999965


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                       +|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||.+........
T Consensus        83 -~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          83 -DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             -CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence             8888885432     468999999999999999999999   9999999999999999999999999999987655431


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||.
T Consensus       154 --~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~  200 (283)
T cd05118         154 --PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFP  200 (283)
T ss_pred             --cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence              11234578899999998653 367889999999999999999998874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-33  Score=254.32  Aligned_cols=188  Identities=27%  Similarity=0.412  Sum_probs=157.3

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEEEE
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRALVY  207 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  207 (344)
                      .+.||+|+||.||+|+. .+|..||+|.+...   ......+.+|+.++++++|+||+++++++...      ...++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            46799999999999985 46899999998642   22235688999999999999999999998654      3568999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+. .+|..++.        ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||+++..
T Consensus       100 e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879         100 PYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             cccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            9996 47776651        258899999999999999999999   89999999999999999999999999998765


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....     ....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||..
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         168 DAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            3321     234578899999998653 3578899999999999999999999863

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-33  Score=254.56  Aligned_cols=188  Identities=26%  Similarity=0.413  Sum_probs=157.7

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEEEE
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRALVY  207 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~  207 (344)
                      .+.||+|+||.||+|.. .++..||+|+++...   ...+.+.+|+.++++++|+||+++++++...      ...++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            46799999999999974 568899999987432   2245678999999999999999999987543      3467888


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      +++ +++|.+++..       ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.++|+|||+++..
T Consensus       102 ~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         102 HLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             hhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            887 7899888732       348999999999999999999999   99999999999999999999999999998865


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...     .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       171 ~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         171 DDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             ccc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            332     1234578899999987653 357889999999999999999999984

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7e-33  Score=253.13  Aligned_cols=196  Identities=27%  Similarity=0.372  Sum_probs=159.5

Q ss_pred             hhcccccccCcEEEEEEEEe-C--CceEEEEEeeccc---cchHHHHHHHHHHhhh-cccceeeEeeEEEcC----CeEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-N--GIPVAVKMLEHLK---GNGQEFINEVATIGRI-HHFHIVRLLGFCSEG----TRRA  204 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~  204 (344)
                      .+.+.||+|+||.||+++.. +  +..||+|.+....   ...+.+.+|+.+++++ +||||+++++.+...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999853 3  6789999987422   2246788999999999 599999999875332    4578


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +++||++ ++|.+++..      ...+++..+..++.|++.||+|||+   .+++||||||+|||+++++.++|+|||++
T Consensus        83 ~~~e~~~-~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          83 LYEELME-ADLHQIIRS------GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEeccc-CCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            8999985 689998843      2458999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +........  .......|++.|+|||.+.+. ..++.++|+||+|+++|+|++|..|++
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~  211 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFK  211 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence            865432211  112234689999999987653 367889999999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.5e-33  Score=247.05  Aligned_cols=199  Identities=26%  Similarity=0.387  Sum_probs=162.7

Q ss_pred             HhhcccccccCcEEEEEEEEeC-CceEEEEEeecc------ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.++||+|+||.||+++... +..+++|.++..      .....++..|+.++++++||||+++++++.+....++++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3456789999999999997543 455666666532      122345678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++.....  ....+++..++.++.|++.||+|||+   .+++|+||+|+||++++ +.++|+|||+++..
T Consensus        82 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          82 EYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999999865321  22568999999999999999999999   99999999999999975 56999999998866


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......  .....+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.|+++
T Consensus       156 ~~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         156 MGSCDL--ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCCccc--ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            443221  1234578899999988654  678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-33  Score=247.74  Aligned_cols=194  Identities=30%  Similarity=0.472  Sum_probs=165.6

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.||+|+||.||+|+.. +++.+|+|.+...   ....+.+.+|+.++++++|+|++++++++.+....++|+||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            3467999999999999865 4899999999754   2334678899999999999999999999999999999999997 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||+++.......
T Consensus        82 ~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          82 MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            59999996542     358999999999999999999999   8999999999999999999999999999986644321


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        ......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~  200 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFP  200 (282)
T ss_pred             --ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCC
Confidence              11233467889999988654 367889999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=241.13  Aligned_cols=189  Identities=25%  Similarity=0.302  Sum_probs=161.0

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc----CCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~  212 (344)
                      ++||-|-.|.|-.+.. .+|+.+|+|++.+.    +...+|+++.-.. .|||||++++++..    ...+.+|||.|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            5689999999998863 56889999999754    3456777776555 59999999998743    3467899999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc---CCCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfgla~~~~~  289 (344)
                      |.|.+.+.....    .++++.++..|+.||+.|+.|||+   .+|.||||||+|+|..   .|..+||+|||+|+....
T Consensus       144 GeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  144 GELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             hHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999976654    579999999999999999999999   9999999999999996   456799999999997665


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....+-||.|.|||++...  .|+..+|+||+||++|-||+|-+||++
T Consensus       217 ~~---~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  217 PG---DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             Cc---cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccc
Confidence            32   24567789999999999765  788899999999999999999999975

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=253.53  Aligned_cols=196  Identities=29%  Similarity=0.432  Sum_probs=165.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCC-----eEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-----RRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  206 (344)
                      .+.+.||+|+||.||+|+.. ++..+|+|.+...   ....+.+.+|+.+++.++|+||+++++++....     ..+++
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            45678999999999999864 4889999998753   234467899999999999999999999987765     78999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||++ ++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+|||+++++.++|+|||++..
T Consensus        83 ~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          83 TELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99997 5898888432      368999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... .......+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~  208 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFP  208 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence            6544210 112334578899999998764 267889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.4e-33  Score=254.40  Aligned_cols=197  Identities=26%  Similarity=0.364  Sum_probs=159.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcC------------
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------------  200 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------------  200 (344)
                      +.+.+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|++++++++||||+++++++...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            34567899999999999975 458899999987543 3346788999999999999999999876543            


Q ss_pred             --CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceE
Q 041350          201 --TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPK  277 (344)
Q Consensus       201 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~k  277 (344)
                        ...++||||++ ++|.+++..       ..+++..++.++.|++.||+|||+   .+++||||||+||+++ +++.++
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence              35789999996 589888732       358899999999999999999999   9999999999999997 556789


Q ss_pred             EeecCCcccccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          278 ISDFGLAKLCSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+|||+++......... ......++..|+|||.+.+. ..++.++|||||||++|||++|+.||+.
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999997654321111 11223578899999987543 3578899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.2e-32  Score=249.34  Aligned_cols=189  Identities=26%  Similarity=0.407  Sum_probs=159.4

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  211 (344)
                      +.+.||+|+||.||++.. .++..||+|.+...   ....+.+.+|++++++++||||+++.+++.. ....++++||+ 
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-   92 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-   92 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence            457899999999999974 47899999988542   2234678899999999999999999998865 56789999998 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++..       ..+++..+..++.|+++||+|||+   .+++||||+|+||++++++.++|+|||++.......
T Consensus        93 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~  162 (328)
T cd07856          93 GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM  162 (328)
T ss_pred             ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence            6689888742       347888899999999999999999   999999999999999999999999999987543321


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                           ....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||.
T Consensus       163 -----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~  207 (328)
T cd07856         163 -----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFP  207 (328)
T ss_pred             -----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                 234578899999987542 367889999999999999999999884

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-32  Score=239.56  Aligned_cols=179  Identities=22%  Similarity=0.189  Sum_probs=151.5

Q ss_pred             cCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhcc
Q 041350          144 GGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK  222 (344)
Q Consensus       144 G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  222 (344)
                      |.||+||++.. .+++.+|+|.+....    .+.+|...+....||||+++++++.+....+++|||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            89999999974 468899999997542    2344555556667999999999999999999999999999999998543


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCC
Q 041350          223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT  302 (344)
Q Consensus       223 ~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt  302 (344)
                            ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++++|||.+.......     ....++
T Consensus        80 ------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~  145 (237)
T cd05576          80 ------LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE  145 (237)
T ss_pred             ------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence                  348999999999999999999999   999999999999999999999999999876554321     223457


Q ss_pred             cccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       303 ~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..|+|||.+...  .++.++||||+|+++|||++|+.|++
T Consensus       146 ~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         146 NMYCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             ccccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhh
Confidence            789999988654  67889999999999999999997764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-33  Score=261.95  Aligned_cols=199  Identities=26%  Similarity=0.428  Sum_probs=175.0

Q ss_pred             HhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc-----CCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE-----GTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv~  207 (344)
                      ..|.+.||.|.+|.||+++ ..+++.+|+|++....+..++...|.++++.+ +|||++.++|++..     ++++||||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            3466889999999999997 56789999999998888888999999999998 69999999999853     57899999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      |||.+||..|++.+..    ...+.|..+..|++.++.|+.+||.   +.++|||||-.|||++.++.+||.|||++..+
T Consensus       101 EfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             eccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            9999999999997655    3679999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...  ..+.....|||.|||||++...   ...|+.++|+||+|++..||.-|.+|+-
T Consensus       174 dsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  174 DST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             ecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            543  2344667899999999998643   2357779999999999999999999873

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-32  Score=267.50  Aligned_cols=141  Identities=26%  Similarity=0.362  Sum_probs=125.6

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.++||+|+||+||+|... +++.||+|+++....    ..+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus         7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~   86 (669)
T cd05610           7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL   86 (669)
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence            35678999999999999855 588999999975321    2357888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ++++|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999542      357889999999999999999999   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9.3e-33  Score=269.77  Aligned_cols=190  Identities=31%  Similarity=0.447  Sum_probs=153.3

Q ss_pred             ccccccCcEEEEEEE-EeCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcC---------------
Q 041350          139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG---------------  200 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------------  200 (344)
                      +.||+||||.|||++ .-||+.+|||++...  ......+.+|+..+++|+|||||+++..|.+.               
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            469999999999997 468999999999765  33346788999999999999999987543110               


Q ss_pred             --------------------------------------------------------------------------------
Q 041350          201 --------------------------------------------------------------------------------  200 (344)
Q Consensus       201 --------------------------------------------------------------------------------  200 (344)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ------------------------CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 041350          201 ------------------------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ  256 (344)
Q Consensus       201 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~  256 (344)
                                              ..+||-||||+.-+|.+++..+...     -.....+++.++|++||+|+|+   .
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaYIH~---~  716 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAYIHD---Q  716 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHHHHh---C
Confidence                                    1257888999888888887544321     1467789999999999999999   9


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecCCccccc----------------CCccceeeecccCCcccccccccccccC-CCC
Q 041350          257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCS----------------KDISIVSLTAARGTAGYIAPELFSRNFG-EVS  319 (344)
Q Consensus       257 ~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~  319 (344)
                      ++|||||||.||+++++..+||+|||+|....                ........+...||--|+|||++.+... .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                0111123466789999999999977522 699


Q ss_pred             cccchHhHHHHHHHHHc
Q 041350          320 YKSDVYSYGMMLLEMVG  336 (344)
Q Consensus       320 ~~~Dv~s~Gvvl~ell~  336 (344)
                      .|+|+||+|||++||+.
T Consensus       797 ~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             chhhhHHHHHHHHHHhc
Confidence            99999999999999983

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-32  Score=251.52  Aligned_cols=189  Identities=25%  Similarity=0.404  Sum_probs=160.3

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCe------EEEE
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR------RALV  206 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv  206 (344)
                      +.+.||+|+||.||+|+.. ++..||+|.+...   ....+.+.+|+.++++++|+|++++++++.....      .++|
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence            4577999999999999864 5789999998643   2233567889999999999999999998765544      8999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +||+ +++|.+++..       ..+++..+..++.|+++||+|||+   .+++||||+|+||++++++.++|+|||++..
T Consensus        99 ~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          99 THLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9999 6799998843       358999999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....     .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||.
T Consensus       168 ~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         168 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             cccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            5433     1234578899999988653 257889999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-33  Score=253.65  Aligned_cols=191  Identities=24%  Similarity=0.305  Sum_probs=168.5

Q ss_pred             ccccccCcEEEEEEEEeCCc-eEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGI-PVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~-~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      ..||-|+||.|=+++..+.. .+|+|++++.    ..+.+....|-.+|...+.|.||+++-.|.++...|++||-|-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            45999999999998755443 4899988752    234466889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      .|...|..      ++.++..+...++.-+.+|++|||+   ++||.|||||+|++++.+|-+||.|||+|+....... 
T Consensus       506 ElWTiLrd------Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K-  575 (732)
T KOG0614|consen  506 ELWTILRD------RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK-  575 (732)
T ss_pred             hhhhhhhh------cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence            99999943      3568999999999999999999999   9999999999999999999999999999998766533 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ...++|||.|.|||++...  ..+..+|.||+|+++||||+|.+||..
T Consensus       576 --TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~  621 (732)
T KOG0614|consen  576 --TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSG  621 (732)
T ss_pred             --eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence              4568899999999999875  678899999999999999999999964

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=252.85  Aligned_cols=203  Identities=24%  Similarity=0.290  Sum_probs=150.2

Q ss_pred             HhhcccccccCcEEEEEEEE-----------------eCCceEEEEEeecccc-chHH--------------HHHHHHHH
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-----------------FNGIPVAVKMLEHLKG-NGQE--------------FINEVATI  182 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-----------------~~~~~vavK~~~~~~~-~~~~--------------~~~E~~~l  182 (344)
                      +.+.++||+|+||+||+|..                 .+++.||||.+..... ..++              +..|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            34567899999999999963                 2356799999864322 1223              34477778


Q ss_pred             hhhcccce-----eeEeeEEEc--------CCeEEEEEeccCCCCHHHHHhccCCC------------------CCCCCC
Q 041350          183 GRIHHFHI-----VRLLGFCSE--------GTRRALVYEFMPNGSLEKFIFSKTNS------------------SSHRPL  231 (344)
Q Consensus       183 ~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l  231 (344)
                      .+++|.++     ++++++|..        .+..++||||+++++|.++++.....                  .....+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            88876654     677787743        35689999999999999999753210                  011245


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCccccccccc
Q 041350          232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF  311 (344)
Q Consensus       232 ~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~  311 (344)
                      ++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence            788899999999999999999   89999999999999999999999999999765433221 11223458899999987


Q ss_pred             ccccC--------------------CCCcccchHhHHHHHHHHHcCCC-CC
Q 041350          312 SRNFG--------------------EVSYKSDVYSYGMMLLEMVGCRK-NK  341 (344)
Q Consensus       312 ~~~~~--------------------~~~~~~Dv~s~Gvvl~ell~g~~-p~  341 (344)
                      .....                    ....+.||||+||+++||+++.. |+
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~  433 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV  433 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            53210                    11235799999999999999875 44

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=249.44  Aligned_cols=190  Identities=27%  Similarity=0.341  Sum_probs=162.6

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccccchH---------HHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEE
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQ---------EFINEVATIGRIH---HFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  205 (344)
                      +.+|+|+||.|+.+... +...|+||.+.+.+--.+         ..-.|+.+|..++   |+||++++++|.+++.+||
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            56999999999999754 456899999876432222         2346999999997   9999999999999999999


Q ss_pred             EEecc-CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          206 VYEFM-PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       206 v~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||-. ++-+|.+++...      ..+++.++..|.+|++.|+++||+   .+|||||||-+|+.++.+|-+||+|||.|
T Consensus       647 ~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             EecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccch
Confidence            99975 466999999543      459999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......    ....+||..|.|||++.+. ......-|||++|++||.++....|++
T Consensus       718 a~~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            8765542    2467899999999999886 344667899999999999999998886

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=233.53  Aligned_cols=198  Identities=21%  Similarity=0.308  Sum_probs=162.0

Q ss_pred             cccccccCcEEEEEEEE------eCCceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcC-CeEEEEEe
Q 041350          138 KHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEG-TRRALVYE  208 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e  208 (344)
                      ...+-+|.||.||+|.+      .+.+.|.+|.++....+  ...++.|.-.+..+.|||+..+.+++.+. ...+.++.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            34689999999999943      34567888988754433  45789999999999999999999998665 46688999


Q ss_pred             ccCCCCHHHHHhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          209 FMPNGSLEKFIFSKTN--SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ++.-|+|..||...+.  .+..+.++..+...++.|++.|++|||+   +++||.||..+|++||+...+||+|=.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence            9999999999984332  2234678889999999999999999999   9999999999999999999999999999986


Q ss_pred             ccCC-ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCC
Q 041350          287 CSKD-ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNK  341 (344)
Q Consensus       287 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~  341 (344)
                      +-+. ...... ..-.+..||+||.+..+  .++..+|||||||+||||+| |+.|+
T Consensus       446 LFP~DYhcLGD-nEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~Py  499 (563)
T KOG1024|consen  446 LFPGDYHCLGD-NENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPY  499 (563)
T ss_pred             cCcccccccCC-CCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCc
Confidence            5443 322222 22357899999999876  89999999999999999995 55554

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-32  Score=235.21  Aligned_cols=193  Identities=23%  Similarity=0.346  Sum_probs=163.1

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.||+|+|.+|-.+.+ .+.+.+|+|++++.-    ++.+=...|-.+..+- +||.+|.+..+|+....+++|.||+
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv  333 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV  333 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence            346799999999999975 457789999987522    1112233454444444 6999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|--++++.      +.++++.++.+...|..||.|||+   .+|+.||||..|+|+|..|++||.|||+++..-.+
T Consensus       334 ~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  334 NGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             cCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            999998888543      469999999999999999999999   99999999999999999999999999999865443


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  .....+|||.|+|||++.+.  .|....|+|++||+++||+.||.|||
T Consensus       405 gd--~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             Cc--ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcc
Confidence            22  23578899999999999986  88889999999999999999999997

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=249.90  Aligned_cols=188  Identities=27%  Similarity=0.364  Sum_probs=159.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+...+|.|+|+.|-++.. .+++..++|++.....   +-.+|+.++... +||||+++.+.+.++.+.|+|||.+.+
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            44566799999999998864 5678899999986522   334567666666 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE-cCCCceEEeecCCcccccCCc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL-DHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill-~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +-|.+.+....       .....+..|+.+|+.|+.|||+   ++++||||||+|||+ ++.++++|+|||.++..+.. 
T Consensus       401 ~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  401 GELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             cHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            98888875433       2336788899999999999999   999999999999999 69999999999999987665 


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                          ....+-|..|.|||++...  .+++++|+||||++|||||+|+.|+.
T Consensus       470 ----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~  514 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFA  514 (612)
T ss_pred             ----hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccc
Confidence                1234578899999999864  89999999999999999999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=240.49  Aligned_cols=202  Identities=22%  Similarity=0.335  Sum_probs=171.4

Q ss_pred             cCHHHHHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhc-c-c----ceeeEeeEE
Q 041350          125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIH-H-F----HIVRLLGFC  197 (344)
Q Consensus       125 ~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~  197 (344)
                      +...|....++.+...+|+|.||.|-++... .+..||||+++....-.+.-+-|++.|+++. + |    -+|++.+++
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            4444555556666788999999999999643 3789999999988777788889999999994 2 3    378888999


Q ss_pred             EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-----
Q 041350          198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----  272 (344)
Q Consensus       198 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-----  272 (344)
                      .-.++.++|+|.+ |-|+.++|..+.    ..+++...++.++.|++++++|||+   .+++|.||||+|||+.+     
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~----y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENN----YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCC----ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence            9999999999999 779999996544    3678999999999999999999999   99999999999999932     


Q ss_pred             ---------------CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcC
Q 041350          273 ---------------NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       273 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                                     +..++|+|||.|..-..+.     +..+.|..|.|||++.+-  .++.++||||+||+|.|+.+|
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeecc
Confidence                           3458999999998766554     345679999999999987  899999999999999999999


Q ss_pred             CCCC
Q 041350          338 RKNK  341 (344)
Q Consensus       338 ~~p~  341 (344)
                      ...|
T Consensus       306 ~~LF  309 (415)
T KOG0671|consen  306 ETLF  309 (415)
T ss_pred             ceec
Confidence            8766

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-30  Score=223.51  Aligned_cols=197  Identities=31%  Similarity=0.490  Sum_probs=168.1

Q ss_pred             hcccccccCcEEEEEEEEeC-CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.||+|++|+||++...+ +..+|+|.+.....  ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45779999999999998765 88999999986433  4578899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....     .+++..+..++.+++.++.+||+   .+++|+|++|+||+++.++.++|+|||.+.........
T Consensus        83 ~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       83 DLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999964321     17899999999999999999999   89999999999999999999999999999876544200


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......++..|++||.+. ....++.++|||+||++++||++|+.||+.
T Consensus       155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             112345778899999884 224677899999999999999999999953

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.2e-33  Score=229.56  Aligned_cols=194  Identities=27%  Similarity=0.438  Sum_probs=160.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeec---cccchHHHHHHHHHHhhhcccceeeEeeEEEc--------CCeEEEE
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GTRRALV  206 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~~lv  206 (344)
                      .+||+|.||+||+|.. .+|+.||+|+.-.   ..+-....++|+.+|..++|+|++.++..|..        ....++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            4689999999999974 4577889886532   22334677899999999999999999998743        2358999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +++|+. +|.-+|.+..     ..++..++..++.++..||.|+|+   ..|+|||+||.|+||+.++.+||+|||+|+.
T Consensus       103 f~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             HHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            999965 8888884332     468999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++.....  .+.+..+-|+.|.+||.+.+. ..++++.|||.-||++.||.++.+-+.
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCcccc
Confidence            7543222  223445569999999999875 588999999999999999999887653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-33  Score=233.23  Aligned_cols=191  Identities=28%  Similarity=0.429  Sum_probs=160.0

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~  209 (344)
                      +-||.|+||.||..+. .+|+.||.|++.+.-   ...+.+++|+++|.-.+|.|++..++.-.-.     .++|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            5699999999999874 569999999987532   2347899999999999999999998876443     356788999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      | ..+|...+-      +.++++.+.+.-+..||++||+|||+   .+|.||||||.|.|++.+..+||+|||+|+.-+.
T Consensus       139 m-QSDLHKIIV------SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  139 M-QSDLHKIIV------SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             H-Hhhhhheec------cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            8 558888773      34678999999999999999999999   9999999999999999999999999999997765


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +.... ++..+-|-.|.|||++.+. ..|+...||||.||++.||+..|-.|
T Consensus       209 d~~~h-MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILF  258 (449)
T KOG0664|consen  209 RDRLN-MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILF  258 (449)
T ss_pred             hhhhh-hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhh
Confidence            54322 3444567899999999876 57999999999999999999776544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1e-30  Score=252.56  Aligned_cols=200  Identities=22%  Similarity=0.276  Sum_probs=138.7

Q ss_pred             hhcccccccCcEEEEEEEEeC-----CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeE------EEcCCeEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF------CSEGTRRA  204 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~~~~  204 (344)
                      .+.+.||+|+||+||+|+..+     +..||+|++.... ..+.+.+|  .+....+.++..++..      ...+...+
T Consensus       135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            456789999999999998643     6899999886432 22222222  1122222222222211      24566889


Q ss_pred             EEEeccCCCCHHHHHhccCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSS--------------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      +|+||+++++|.+++.......              .........+..++.|++.||+|||+   .+|+||||||+|||+
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl  288 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIF  288 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEE
Confidence            9999999999999986432100              00112234566899999999999999   999999999999999


Q ss_pred             cC-CCceEEeecCCcccccCCccceeeecccCCcccccccccccccC--------------------CCCcccchHhHHH
Q 041350          271 DH-NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG--------------------EVSYKSDVYSYGM  329 (344)
Q Consensus       271 ~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~~~~~Dv~s~Gv  329 (344)
                      ++ ++.+||+|||+|+......... .....+++.|+|||.+.....                    .++.++|||||||
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            85 6899999999998654432221 234568999999997642211                    2345679999999


Q ss_pred             HHHHHHcCCCCCC
Q 041350          330 MLLEMVGCRKNKD  342 (344)
Q Consensus       330 vl~ell~g~~p~~  342 (344)
                      ++|||+++..|.+
T Consensus       368 iL~el~~~~~~~~  380 (566)
T PLN03225        368 IFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHhCcCCCc
Confidence            9999998876654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=5.9e-30  Score=222.03  Aligned_cols=185  Identities=30%  Similarity=0.461  Sum_probs=161.5

Q ss_pred             CcEEEEEEEEe-CCceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhc
Q 041350          145 GYGSVFRGKLF-NGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS  221 (344)
Q Consensus       145 ~fG~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  221 (344)
                      +||.||+|+.. ++..+|+|++......  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999865 4899999999754332  57899999999999999999999999999999999999999999999854


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccC
Q 041350          222 KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG  301 (344)
Q Consensus       222 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  301 (344)
                      ..      .+++..+..++.+++.++.|||+   .+++|+||+|+||++++++.++|+|||.+.......   ......+
T Consensus        81 ~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       81 RG------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             cc------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            32      28899999999999999999999   899999999999999999999999999998765532   1234557


Q ss_pred             CcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       302 t~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +..|+|||.+...  .++.++||||+|+++++|++|..|++.
T Consensus       149 ~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      149 TPEYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CcCCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            8899999998753  678899999999999999999999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.8e-31  Score=214.29  Aligned_cols=189  Identities=22%  Similarity=0.458  Sum_probs=162.6

Q ss_pred             HhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcC--CeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEG--TRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~  210 (344)
                      +++.+++|+|.|++||.|. ..+.+.++||+++..  ..+.+.+|+.+|..|. ||||+++++...+.  ....||+||+
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            3455789999999999996 567889999999863  3467889999999997 99999999998664  4668999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCcccccC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSK  289 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~~~  289 (344)
                      .+.+...+-         ..++...++.++.++++||.|+|+   .||+|||+||.|++||.. -.++|+|+|+|.++.+
T Consensus       118 ~n~Dfk~ly---------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  118 NNTDFKQLY---------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             ccccHHHHh---------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999988776         468888999999999999999999   999999999999999854 5689999999998876


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ....   +..+.+..|--||.+..- ..++..-|+|||||++.+|+..+.||
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepF  233 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPF  233 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcc
Confidence            6443   344567788999998753 67888999999999999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=246.09  Aligned_cols=194  Identities=28%  Similarity=0.357  Sum_probs=157.2

Q ss_pred             ccccccCcEE-EEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGS-VFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.+|.|+-|+ ||+|. ++|+.||||++-.  +...-..+|+..|+.- +||||+++++.-.+.+..|+..|.| ..+|.
T Consensus       515 eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGV-YEGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHcccCCCCcEEEEEe-eCCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            5689999886 79997 7899999998853  2223456899999888 5999999999999999999999999 67999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---C--CceEEeecCCcccccCCc
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---N--FQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~--~~~kl~Dfgla~~~~~~~  291 (344)
                      +++.....  ..........+.+..|+++||++||+   .+||||||||.||||+.   +  ..++|+|||+++....+.
T Consensus       591 dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  591 DLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHhcccc--chhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99976411  11111214567788999999999999   99999999999999975   3  578999999999887654


Q ss_pred             cc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcC-CCCCCC
Q 041350          292 SI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC-RKNKDP  343 (344)
Q Consensus       292 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g-~~p~~~  343 (344)
                      .. .......||-+|+|||++...  .-+..+||||+|||+|..++| ..||.+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd  717 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGD  717 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCc
Confidence            33 234567799999999999875  556789999999999999866 888865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.7e-27  Score=199.61  Aligned_cols=183  Identities=37%  Similarity=0.636  Sum_probs=157.6

Q ss_pred             ccccCcEEEEEEEEeC-CceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      ||+|++|.||++...+ ++.+++|++......  .+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998654 889999999865442  5789999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCCccceee
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      ++....     ..+++..+..++.++++++++||+   .+++|+||+|.||++++ ++.++|+|||.+........  ..
T Consensus        81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            985432     358899999999999999999999   89999999999999999 89999999999987654421  11


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHH
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~el  334 (344)
                      ....+...|++||.+... ...+.++|+|++|+++++|
T Consensus       151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence            234578899999988653 3677899999999999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-28  Score=216.52  Aligned_cols=150  Identities=26%  Similarity=0.389  Sum_probs=123.5

Q ss_pred             hhhcccCCcccCHHHHHH-HHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-----c
Q 041350          115 EDYRTVNPTRYTYKELKK-ITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-----H  187 (344)
Q Consensus       115 ~~~~~~~~~~~~~~~l~~-~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h  187 (344)
                      .+|+..........|... .+|-..++||=|.|+|||++.. .+.+.||+|+.+...--.+..+.|+++|++++     |
T Consensus        59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~  138 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPND  138 (590)
T ss_pred             hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence            345555555556666666 7777889999999999999974 44678999999876656678899999999994     3


Q ss_pred             c---ceeeEeeEEE----cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 041350          188 F---HIVRLLGFCS----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILH  260 (344)
Q Consensus       188 ~---niv~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH  260 (344)
                      +   .||+|+++|.    .+.+.+||+|++ |-+|..+|.....    +.++...+++|++|++.||.|||+  ..+|||
T Consensus       139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIH  211 (590)
T KOG1290|consen  139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHR--ECGIIH  211 (590)
T ss_pred             CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHH--hcCccc
Confidence            3   6999999985    456899999999 7789888865443    568899999999999999999999  479999


Q ss_pred             cCCCCCceEEc
Q 041350          261 FDIKPHNILLD  271 (344)
Q Consensus       261 ~Dik~~Nill~  271 (344)
                      .||||+|||+.
T Consensus       212 TDlKPENvLl~  222 (590)
T KOG1290|consen  212 TDLKPENVLLC  222 (590)
T ss_pred             cCCCcceeeee
Confidence            99999999993

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=4.3e-28  Score=214.17  Aligned_cols=191  Identities=24%  Similarity=0.395  Sum_probs=160.4

Q ss_pred             cccccccCcEEEEEEEEeC----CceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .++||+|.|++||++++..    .+.||+|.+... .......+|++.|..+. +.||+++.+++..+++..+|+||+++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            4789999999999997543    678999998764 34457899999999995 89999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCCc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~~  291 (344)
                      -+..++.         ..++...+..+.+.++.||+++|.   +|||||||||.|+|.+. .+.-.|.|||+|.......
T Consensus       120 ~~f~~l~---------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  120 DRFRDLY---------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             cCHHHHH---------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            9999998         357788999999999999999999   99999999999999974 4667999999987221000


Q ss_pred             -------------c--------------------c---------eeeecccCCcccccccccccccCCCCcccchHhHHH
Q 041350          292 -------------S--------------------I---------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM  329 (344)
Q Consensus       292 -------------~--------------------~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gv  329 (344)
                                   .                    .         ...-...||++|.|||++.+. +..+.++||||.||
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GV  266 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccc
Confidence                         0                    0         001123499999999999875 67788999999999


Q ss_pred             HHHHHHcCCCCCC
Q 041350          330 MLLEMVGCRKNKD  342 (344)
Q Consensus       330 vl~ell~g~~p~~  342 (344)
                      +++.+++++.||-
T Consensus       267 I~Lslls~~~PFf  279 (418)
T KOG1167|consen  267 ILLSLLSRRYPFF  279 (418)
T ss_pred             eeehhhccccccc
Confidence            9999999999984

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.3e-28  Score=221.95  Aligned_cols=205  Identities=24%  Similarity=0.314  Sum_probs=171.9

Q ss_pred             ccCHHHHHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhc------ccceeeEeeE
Q 041350          124 RYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIH------HFHIVRLLGF  196 (344)
Q Consensus       124 ~~~~~~l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~  196 (344)
                      ++.+.|+...+|.+....|+|-|++|.+|... .|..||||++.+...-.+.=+.|+++|++|+      .-+.++++-.
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~  502 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH  502 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence            45667887778887788999999999999743 4789999999876655566789999999995      2378999999


Q ss_pred             EEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-c
Q 041350          197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-Q  275 (344)
Q Consensus       197 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~  275 (344)
                      |...+++|||+|-+ ..+|.+.|..-..   ...|....+..++.|+..||..|..   .+|+|.||||.|||+++.. .
T Consensus       503 F~hknHLClVFE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  503 FKHKNHLCLVFEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             hhhcceeEEEehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence            99999999999998 6799999965442   2457888999999999999999998   9999999999999999764 5


Q ss_pred             eEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          276 PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       276 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +||||||.|.....+.-    +...-+.-|.|||++.+.  +|+...|+||.||.||||.||+--|
T Consensus       576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             eeeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceec
Confidence            79999999987665422    223345679999999986  8999999999999999999998655

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=8.8e-28  Score=205.25  Aligned_cols=184  Identities=28%  Similarity=0.380  Sum_probs=152.2

Q ss_pred             cccccCcEEEEEEE-EeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEEEEec
Q 041350          140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRALVYEF  209 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~  209 (344)
                      -+|.|+- .|-.+. .-.+++||+|++...   ....+...+|...+..++|+||++++.++.-.      ...|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            4677877 444443 235789999988643   23346678899999999999999999998543      467899999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      | ..+|...+.        ..++-..+..|..|++.|++|||+   .+|+||||||+||++..+..+||.|||+|+.-..
T Consensus       103 m-~~nl~~vi~--------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen  103 M-DANLCQVIL--------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             h-hhHHHHHHH--------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCc
Confidence            9 668888885        247778899999999999999999   9999999999999999999999999999986544


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +   ..++....|..|.|||++.+.  .+...+||||.||++.||++|.--|
T Consensus       171 ~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  171 D---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             c---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEe
Confidence            4   344666788999999999887  5899999999999999999987544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-28  Score=226.15  Aligned_cols=193  Identities=26%  Similarity=0.396  Sum_probs=164.6

Q ss_pred             cccccccCcEEEEEEE-EeCCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      ..++|+|.||.|||++ ...++..|+|+++.... ...-...|+-+++..+||||+.++|.+......|+.|||+.+|+|
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl   99 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL   99 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence            4679999999999997 45689999999986543 335567899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+.-+.      ..++++.++..+++..++|++|||+   .+-+|||||-.|||+++.+.+|++|||.+-.+...  ..+
T Consensus       100 Qdiy~~------TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K  168 (829)
T KOG0576|consen  100 QDIYHV------TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK  168 (829)
T ss_pred             cceeee------cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence            886532      2579999999999999999999999   99999999999999999999999999998765433  233


Q ss_pred             eecccCCcccccccccc-cccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          296 LTAARGTAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~-~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ...+.||+.|||||+-. +..+.|..++|||+.|+...|+--.+.|.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            45778999999999752 22367899999999999999987666654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=210.00  Aligned_cols=160  Identities=19%  Similarity=0.154  Sum_probs=123.0

Q ss_pred             HhhcccccccCcEEEEEEEEe--CCceEEEEEeecc------ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF--NGIPVAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+|...  +++.||||++...      ....+.|.+|+++|++++|+|++..+..   .+..++|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            445678999999999999754  5777899987532      1124568999999999999999853322   2457999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceEEcCCCceEEeecCCcc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI-KPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di-k~~Nill~~~~~~kl~Dfgla~  285 (344)
                      |||+++++|....   .       ..   ...++.++++||+|||+   .+|+|||| ||+|||++.++.++|+|||+|+
T Consensus        97 mE~~~G~~L~~~~---~-------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         97 RGWTEGVPLHLAR---P-------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEccCCCCHHHhC---c-------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            9999999996321   0       11   14578899999999999   99999999 9999999999999999999999


Q ss_pred             cccCCcccee------eecccCCccccccccccc
Q 041350          286 LCSKDISIVS------LTAARGTAGYIAPELFSR  313 (344)
Q Consensus       286 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  313 (344)
                      .+........      .....+++.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            7755432111      134567889999998853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-27  Score=199.03  Aligned_cols=193  Identities=20%  Similarity=0.357  Sum_probs=154.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeE-EEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGF-CSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~  211 (344)
                      +++.+.||+|.||.+-++... +...+++|.+........+|.+|...=-.| .|.||+.-++. |+..+.+.+++||+|
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            445678999999999999754 467899999988777788999998765555 58999887765 677778899999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc--CCCceEEeecCCcccccC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~--~~~~~kl~Dfgla~~~~~  289 (344)
                      .|+|.+-+..       ..+.+.....++.|+++|+.|+|+   .++||||||.+||||-  +...+||+|||+.+....
T Consensus       106 ~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  106 RGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            9999988743       347788889999999999999999   9999999999999993  445799999999875443


Q ss_pred             CccceeeecccCCccccccccccccc---CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNF---GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...     ...-+..|-|||......   -...+.+|+|.||++++..|+|..|+.
T Consensus       176 tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  176 TVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             eeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            221     122456789999764321   134667999999999999999999974

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-24  Score=194.75  Aligned_cols=199  Identities=24%  Similarity=0.291  Sum_probs=160.3

Q ss_pred             HHhhcccccccCcEEEEEEEEeCC--ceEEEEEeeccccc-hHHHHHHHHHHhhhcc----cceeeEeeEE-EcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNG--IPVAVKMLEHLKGN-GQEFINEVATIGRIHH----FHIVRLLGFC-SEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~--~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  205 (344)
                      .+.+.++||+|+||.||++...+.  ..+|+|........ ...+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            345668899999999999985543  47888887754322 2377889999888873    5888999988 57778899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-----CceEEee
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-----FQPKISD  280 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~D  280 (344)
                      ||+.+ |.+|.++.....    ...++..+..+|+.|++.+|++||+   .+++||||||.|+++...     ..+.|.|
T Consensus        99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99998 889999875443    2569999999999999999999999   999999999999999865     4689999


Q ss_pred             cCCcc--cccCCcc-----cee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          281 FGLAK--LCSKDIS-----IVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       281 fgla~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ||+++  .+.....     ... ....+||..|+++....+.  ..+.+.|+||++.++.|++.|..|+.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~  238 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWE  238 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCc
Confidence            99999  3322211     111 1345699999999998875  78999999999999999999998863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.4e-25  Score=226.77  Aligned_cols=148  Identities=18%  Similarity=0.204  Sum_probs=113.3

Q ss_pred             hhcc-cceeeEeeEE-------EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041350          184 RIHH-FHIVRLLGFC-------SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN  255 (344)
Q Consensus       184 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  255 (344)
                      .++| .||+++++++       .++...++++||+ +++|.++|...     ...+++.+++.++.||++||+|||+   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHS---   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHh---
Confidence            4456 6888888887       2334567888988 66999999532     2458999999999999999999999   


Q ss_pred             CCeeecCCCCCceEEcC-------------------CCceEEeecCCcccccCCcc--------------ceeeecccCC
Q 041350          256 QRILHFDIKPHNILLDH-------------------NFQPKISDFGLAKLCSKDIS--------------IVSLTAARGT  302 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt  302 (344)
                      ++|+||||||+||||+.                   ++.+|++|||+++.......              ........||
T Consensus        99 ~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181         99 QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence            99999999999999954                   44566677777654211000              0001124578


Q ss_pred             cccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       303 ~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +.|||||++.+.  .++.++|||||||+||||++|..|+.
T Consensus       179 ~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        179 SWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             cceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchh
Confidence            999999998764  78999999999999999999988864

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=2e-24  Score=180.68  Aligned_cols=137  Identities=19%  Similarity=0.187  Sum_probs=107.6

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecccc---c-------hHH-----------------HHHHHHHHhhhccccee
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---N-------GQE-----------------FINEVATIGRIHHFHIV  191 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~h~niv  191 (344)
                      ..||+|+||.||+|...+|+.||||+++....   .       ...                 ..+|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999877899999999975321   1       112                 23499999999888764


Q ss_pred             eEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCceEE
Q 041350          192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL-HQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       192 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~Dik~~Nill  270 (344)
                      ....+...  ..++||||++++++......      ...+++..+..++.|++.+|+|| |+   .+|+||||||+|||+
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli  151 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY  151 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence            43333222  23899999998877655321      13588999999999999999999 67   899999999999999


Q ss_pred             cCCCceEEeecCCcccc
Q 041350          271 DHNFQPKISDFGLAKLC  287 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~  287 (344)
                      + ++.++|+|||+|...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5.2e-24  Score=183.18  Aligned_cols=196  Identities=27%  Similarity=0.386  Sum_probs=166.8

Q ss_pred             HhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||..+.|+ +.++++||||.-.. +....+...|....+.|. .++|...+.|..++.+-.||+|.+ |
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            3457899999999999997 78999999997654 445567788888888885 689999999999999999999999 8


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-----CceEEeecCCcccc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-----FQPKISDFGLAKLC  287 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~Dfgla~~~  287 (344)
                      -||.|+..-..     +.++.++...+|.|++.-++|+|+   +.+|.|||||+|+||...     ..+.++|||+|+.+
T Consensus       108 PSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  108 PSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             cCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            89999875443     469999999999999999999999   999999999999999643     35899999999987


Q ss_pred             cCC-----ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKD-----ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...     .++.......||.+||+-....+.  +.+.+.|+=|+|-+++..|-|..|+.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQ  237 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQ  237 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccc
Confidence            543     333444566799999999988876  78999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-24  Score=178.83  Aligned_cols=197  Identities=23%  Similarity=0.329  Sum_probs=163.5

Q ss_pred             HHhhcccccccCcEEEEEEE-EeCCceEEEEEeeccccchHHHHHHHHHHhhhcc-cceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.++||+|+||.+|.|. +.+|..||||+-+... ......-|..+...|++ ..|..+..|..+...-.+|||.+ 
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            34556889999999999997 6779999999876533 23466788899988876 57888888999999999999999 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Dfgla~~~~  288 (344)
                      |-||.++..-..     ..++.++.+-++-|++.-++|+|.   .+++||||||+|+|+.-+   ..+.++|||+|+.+.
T Consensus        94 GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   94 GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            889999885444     458899999999999999999999   999999999999999643   458999999999764


Q ss_pred             C-----CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 K-----DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .     +.+........||.+|.+-....+.  ..+.+.|+=|+|.+|..+.-|..|+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQ  222 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQ  222 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCccc
Confidence            3     2333444566799999998877664  67889999999999999999999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.9e-23  Score=184.94  Aligned_cols=199  Identities=33%  Similarity=0.472  Sum_probs=165.8

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeecccc----chHHHHHHHHHHhhhccc-ceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHF-HIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ..+.||.|+||.||++...  ..+++|.+.....    ....+.+|+.+++.+.|+ +++++.+.+......+++++++.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            4567999999999999865  7899999875432    356899999999999988 79999999987777899999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~  290 (344)
                      ++++.+++......   ..++......+..|++.++.|+|+   .+++|||+||+||+++... .++++|||.++.....
T Consensus        82 ~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          82 GGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999777443211   368899999999999999999999   8999999999999999988 7999999999865543


Q ss_pred             ccce----eeecccCCccccccccccccc-CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIV----SLTAARGTAGYIAPELFSRNF-GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....    ......|+..|+|||.+.... ...+...|+||+|++++++++|+.|+..
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~  213 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG  213 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            3211    235567999999999987631 3678899999999999999999998753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=4e-23  Score=173.34  Aligned_cols=141  Identities=19%  Similarity=0.162  Sum_probs=111.1

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccc---------------------------hHHHHHHHHHHhhhcccce
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---------------------------GQEFINEVATIGRIHHFHI  190 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni  190 (344)
                      .+.||+|+||.||+|+..+|+.||||+++.....                           ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3569999999999998778999999998753210                           1123578999999999987


Q ss_pred             eeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       191 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      .....+....  .++||||++++++.......      ..++......++.|++.++.+||+  ..+|+||||||+|||+
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEE
Confidence            5555444332  48999999988654432111      347788899999999999999997  3799999999999999


Q ss_pred             cCCCceEEeecCCcccccC
Q 041350          271 DHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~~  289 (344)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.6e-24  Score=178.95  Aligned_cols=166  Identities=14%  Similarity=0.108  Sum_probs=126.3

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHH----------HHHHHHHHhhhcccceeeEeeEEEcC---
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE----------FINEVATIGRIHHFHIVRLLGFCSEG---  200 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~~~~~~~~~---  200 (344)
                      .++..+.+|.|+||.||.... ++..+|+|.+.......+.          +.+|+..+.++.|++|..+.+++...   
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~  110 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK  110 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence            444567899999999999754 6778999999753322222          57899999999999999999886533   


Q ss_pred             -----CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc
Q 041350          201 -----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ  275 (344)
Q Consensus       201 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~  275 (344)
                           +..+++|||++|.+|.++.          .++.    ....+++.++..+|+   .+++|||++|+||++++++ 
T Consensus       111 ~~~~~~~~~lvmEyi~G~tL~~~~----------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        111 TLRYAHTYIMLIEYIEGVELNDMP----------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccCCeEEEEEEECCccHHHhh----------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence                 3578999999999998874          1233    245589999999999   9999999999999999988 


Q ss_pred             eEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHH
Q 041350          276 PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       276 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~el  334 (344)
                      ++|+|||.......+....              .+....  .+..++|+||||+.+.-+
T Consensus       173 i~liDfg~~~~~~e~~a~d--------------~~vler--~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD--------------RIDLER--HYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEEECCCcccccchhhHH--------------HHHHHh--HhcccccccceeEeehHH
Confidence            9999999887553321110              022222  355689999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=7.6e-23  Score=169.93  Aligned_cols=182  Identities=15%  Similarity=0.070  Sum_probs=138.3

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccchH-----HHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccC
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ-----EFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ...|++|+||+||.+. ..+..++.+.++......+     .+.+|+++|++++ |+++++++++    ...+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~-~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVR-GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEee-cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            3569999999999876 3778888888876554333     5789999999995 5789999886    34699999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceEEcCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI-KPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di-k~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      |.+|...+.            . ....+..|++++|+++|+   .+|+|||| ||+|||+++++.++|+|||+|......
T Consensus        82 G~~L~~~~~------------~-~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         82 GAAMYQRPP------------R-GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             CccHHhhhh------------h-hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999865431            0 113467899999999999   99999999 799999999999999999999865443


Q ss_pred             ccc----e-------eeecccCCcccccccccccccCCCC-cccchHhHHHHHHHHHcCCCCC
Q 041350          291 ISI----V-------SLTAARGTAGYIAPELFSRNFGEVS-YKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       291 ~~~----~-------~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ...    .       ...-...++.|++|+...-. ...+ ...+.++-|.-+|.++|++-+.
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCc
Confidence            210    0       01122368889999854322 1223 4678899999999999999876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=1e-22  Score=168.78  Aligned_cols=106  Identities=26%  Similarity=0.370  Sum_probs=91.9

Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |||.+++....     ..+++.+++.++.|+++||+|||+   .+      ||+|||+++++.+++  ||+++.....  
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--   62 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE--   62 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc--
Confidence            78999996432     469999999999999999999998   55      999999999999999  9998865442  


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           ...||+.|||||++.+.  .++.++|||||||++|||++|+.|+..
T Consensus        63 -----~~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       63 -----QSRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             -----cCCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                 22588999999999764  788999999999999999999999853

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-23  Score=175.82  Aligned_cols=195  Identities=20%  Similarity=0.401  Sum_probs=155.6

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ++.-+|.+...|+.|+|+ ..|..+++|+++..   ....++|..|.-.|+-+.||||+.++|.|....++.++..|||.
T Consensus       193 nl~tkl~e~hsgelwrgr-wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGR-WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccc-ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            455678999999999998 46667777887642   34457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|...|+....    ...+..++.+++.++|+|++|||+- ++-|.-.-|.++.+++|++.+++|+- +-+++.-    
T Consensus       272 gslynvlhe~t~----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf----  341 (448)
T KOG0195|consen  272 GSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF----  341 (448)
T ss_pred             hHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee----
Confidence            999999987654    4578889999999999999999983 23355557899999999999998762 2222211    


Q ss_pred             ceeeecccCCcccccccccccccCCC-CcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEV-SYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        +.......|.||+||.+.+..... -..+|+|||++++|||.|..-||.+
T Consensus       342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad  391 (448)
T KOG0195|consen  342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD  391 (448)
T ss_pred             --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence              112344688999999997652222 2478999999999999999999854

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.4e-20  Score=158.98  Aligned_cols=133  Identities=20%  Similarity=0.277  Sum_probs=102.8

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecc-ccchHHHHHHHHHHhhh-----cccceeeEeeEEEcCC---e-EEEEEe
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHL-KGNGQEFINEVATIGRI-----HHFHIVRLLGFCSEGT---R-RALVYE  208 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e  208 (344)
                      +.||+|+||.||. ...++. .+||++... ....+++.+|+.+++.+     +||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5699999999996 223333 468888653 23446789999999999     5799999999998863   3 347899


Q ss_pred             c--cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCceEEcC----CCceEEeec
Q 041350          209 F--MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV-EYLHQGCNQRILHFDIKPHNILLDH----NFQPKISDF  281 (344)
Q Consensus       209 ~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Df  281 (344)
                      |  +++|+|.+++.+.       .+++.  ..++.+++.++ +|||+   ++|+||||||+|||++.    +..++|+||
T Consensus        86 ~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         86 FDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             CCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            9  5689999999432       24544  35677888777 99999   99999999999999974    347999995


Q ss_pred             CCcc
Q 041350          282 GLAK  285 (344)
Q Consensus       282 gla~  285 (344)
                      +.+.
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            4443

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=2.2e-20  Score=161.60  Aligned_cols=140  Identities=16%  Similarity=0.124  Sum_probs=109.2

Q ss_pred             hhcccccccCcEEEEEEE--EeCCceEEEEEeeccccc-------------------------hHHHHHHHHHHhhhccc
Q 041350          136 KFKHRLGQGGYGSVFRGK--LFNGIPVAVKMLEHLKGN-------------------------GQEFINEVATIGRIHHF  188 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  188 (344)
                      .+.+.||+|+||.||+|.  ..+|+.||+|+++.....                         ...+..|+..+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            355789999999999998  568999999998743210                         02356899999999764


Q ss_pred             c--eeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCC
Q 041350          189 H--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR-ILHFDIKP  265 (344)
Q Consensus       189 n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-ivH~Dik~  265 (344)
                      +  +.+.+++    ...++||||+++.+|.......      ..+.......++.|++.++++||+   .+ ++||||||
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp  177 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE  177 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence            3  4444443    2358999999998887654221      235566778999999999999999   88 99999999


Q ss_pred             CceEEcCCCceEEeecCCcccccC
Q 041350          266 HNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       266 ~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +||+++ ++.++|+|||.+.....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCC
Confidence            999999 88999999999876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=4.5e-22  Score=184.68  Aligned_cols=184  Identities=26%  Similarity=0.296  Sum_probs=154.8

Q ss_pred             ccccCcEEEEEEE----EeCCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          141 LGQGGYGSVFRGK----LFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       141 lG~G~fG~Vy~~~----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +|+|.||.|+.+.    ...|..+|.|.++...   ........|..++..++ ||.++++...+...++.+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6999999999764    2446778888886422   12225567888888887 99999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|...+..      ...+++.....+...++-|++++|+   .+++|||+|++||+++.+|++++.|||+++..-... 
T Consensus        82 g~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-  151 (612)
T KOG0603|consen   82 GDLFTRLSK------EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-  151 (612)
T ss_pred             chhhhcccc------CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence            999988743      3457778888888899999999999   999999999999999999999999999998765442 


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           ..+||..|||||++.+    ....+|.||||++++||++|-.||..
T Consensus       152 -----~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 -----IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             -----hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch
Confidence                 2278999999999863    46689999999999999999999853

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=5.3e-20  Score=157.10  Aligned_cols=134  Identities=19%  Similarity=0.274  Sum_probs=113.4

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecccc---------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.||+|++|.||+|.. +|..|++|.......         ....+.+|+.++..++|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999985 778899998653211         113577899999999999988888777777888999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ++|++|.+++...         .+ .+..++.+++.+|.+||+   .+++|+|++|+|||++ ++.++|+|||.+...
T Consensus        81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999998421         12 788999999999999999   9999999999999999 789999999998764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=9.8e-21  Score=187.06  Aligned_cols=192  Identities=24%  Similarity=0.244  Sum_probs=150.6

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.+.||+|+||+||+|+..+|+.||+|+-+..  ...+|.--.+++.+|+   -+.|..+.......+.-++|+||.
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~--~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP--NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCC--CceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            34456789999999999999888999999987642  2233433344444554   223444444445566678999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-------CCCceEEeecCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-------HNFQPKISDFGL  283 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-------~~~~~kl~Dfgl  283 (344)
                      +.|||.+++..      ...++|.....++.|++..++.||.   .+|||+||||+|+||.       +..-++|+|||.
T Consensus       777 ~~Gtlld~~N~------~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  777 PYGTLLDLINT------NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             ccccHHHhhcc------CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            99999999952      3468999999999999999999999   9999999999999994       234589999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR  338 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~  338 (344)
                      +..+..-.........++|-.+--+|+..+.  .++++.|.|.++.+++-||.|+
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence            8755432223445677789999999999886  8999999999999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.6e-21  Score=188.49  Aligned_cols=193  Identities=25%  Similarity=0.294  Sum_probs=151.9

Q ss_pred             cccccccCcEEEEEEEEe-CCceEEEEEeec---cccch----HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          138 KHRLGQGGYGSVFRGKLF-NGIPVAVKMLEH---LKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~---~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+|.|++|.|+..+.. .....+.|....   .....    ..+..|+.+-..++|+|++..+....+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            456899999977777532 233344443321   11111    2256688888889999998888877777666666999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++ +|..++...      ..++..++..+..|+..|++|||.   .++.|||+|++|++++.++.+||+|||.+..+..
T Consensus       403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999 999999543      358888999999999999999999   9999999999999999999999999999987765


Q ss_pred             Cccc--eeeecccCCcccccccccccccCCCC-cccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISI--VSLTAARGTAGYIAPELFSRNFGEVS-YKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +...  .......|+..|+|||.+.+.  .|. ...||||.|+++..|++|+.|+-
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk  526 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWK  526 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccc
Confidence            5433  344677899999999999875  454 46899999999999999998873

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=1.2e-19  Score=153.50  Aligned_cols=131  Identities=20%  Similarity=0.299  Sum_probs=107.4

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccc--c-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLK--G-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .||+|+||+||+|. .++..|++|......  .       ....+.+|++++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            37999999999998 578899999865321  1       1245678999999999887665555666666779999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ++++|.+++....            . .++.+++.+|.+||+   .+++|+|++|+||+++ ++.++++|||++....
T Consensus        80 ~g~~l~~~~~~~~------------~-~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN------------D-ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH------------H-HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999999873211            0 789999999999999   9999999999999999 8899999999987643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.1e-19  Score=153.53  Aligned_cols=136  Identities=18%  Similarity=0.210  Sum_probs=107.4

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeecccc-----------------------chHHHHHHHHHHhhhcccc--
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-----------------------NGQEFINEVATIGRIHHFH--  189 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~n--  189 (344)
                      +.+.+.||+|+||.||++...+|+.||||++.....                       ....+..|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            445678999999999999877899999998764221                       0123567899999998874  


Q ss_pred             eeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       190 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      ++..++    ....+++|||+++++|.....            ......++.+++.++.++|+   .+++||||+|+||+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil  157 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL  157 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence            444443    234589999999999876541            02356788999999999999   99999999999999


Q ss_pred             EcCCCceEEeecCCcccccC
Q 041350          270 LDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++.++|+|||++.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=2.7e-19  Score=173.21  Aligned_cols=132  Identities=17%  Similarity=0.254  Sum_probs=108.6

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEe-ecc-c-------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKML-EHL-K-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~-~~~-~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.||+|+||+||+|.... ..+++|+. ... .       ...+.+.+|++++..++|++++....++.+....++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            4679999999999997544 34444433 211 1       112467899999999999999988888877778899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++.              ....++.+++++|.|||+   .+++||||||+|||+ +++.++|+|||+++...
T Consensus       417 ~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        417 YIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             ecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            999999999883              356789999999999999   999999999999999 67899999999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.6e-19  Score=155.53  Aligned_cols=195  Identities=23%  Similarity=0.329  Sum_probs=127.1

Q ss_pred             cccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhc----------ccceeeEeeEE-----
Q 041350          138 KHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIH----------HFHIVRLLGFC-----  197 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~----------h~niv~~~~~~-----  197 (344)
                      .+.||.|+++.||.++.. +++++|+|++....    ...+++.+|......+.          |-.++..++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            457999999999999854 48999999986432    22356666665554432          22333333322     


Q ss_pred             ----EcC---C-----eEEEEEeccCCCCHHHHHhc---cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecC
Q 041350          198 ----SEG---T-----RRALVYEFMPNGSLEKFIFS---KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFD  262 (344)
Q Consensus       198 ----~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~D  262 (344)
                          ...   +     +.+++|+-+ .+||.+++..   ...  ....+....++.+..|+.+.+++||+   .+++|+|
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~--~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd  170 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ--THSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD  170 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT--TSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc--ccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence                111   1     236678877 6788887643   221  12234455667788999999999999   9999999


Q ss_pred             CCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccc------cCCCCcccchHhHHHHHHHHHc
Q 041350          263 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN------FGEVSYKSDVYSYGMMLLEMVG  336 (344)
Q Consensus       263 ik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~Dv~s~Gvvl~ell~  336 (344)
                      |+|+|++++.+|.+.|+||+.........     .....+..|.+||.....      .-.++.+.|.|++|+++|.|.+
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999998776544321     113356789999976432      1257889999999999999999


Q ss_pred             CCCCCCC
Q 041350          337 CRKNKDP  343 (344)
Q Consensus       337 g~~p~~~  343 (344)
                      ++.|++-
T Consensus       246 ~~lPf~~  252 (288)
T PF14531_consen  246 GRLPFGL  252 (288)
T ss_dssp             SS-STCC
T ss_pred             ccCCCCC
Confidence            9999973

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=4.6e-19  Score=164.44  Aligned_cols=154  Identities=23%  Similarity=0.421  Sum_probs=127.3

Q ss_pred             HhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-ee
Q 041350          182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI-LH  260 (344)
Q Consensus       182 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~i-vH  260 (344)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+....     ..+++.....+.++++.||+|||.   .+| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN---SPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc---Ccceee
Confidence            467899999999999999999999999999999999996533     568999999999999999999998   444 99


Q ss_pred             cCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccc--cCC---CCcccchHhHHHHHHHHH
Q 041350          261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN--FGE---VSYKSDVYSYGMMLLEMV  335 (344)
Q Consensus       261 ~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~---~~~~~Dv~s~Gvvl~ell  335 (344)
                      +.+++.|+++|..+.+||+|||+.................-..-|.|||.+...  ...   .+.+.||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            999999999999999999999998876431111111222345679999998753  111   577899999999999999


Q ss_pred             cCCCCCCC
Q 041350          336 GCRKNKDP  343 (344)
Q Consensus       336 ~g~~p~~~  343 (344)
                      +...||+.
T Consensus       153 ~r~~~~~~  160 (484)
T KOG1023|consen  153 FRSGPFDL  160 (484)
T ss_pred             hccCcccc
Confidence            99999874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.77  E-value=3.8e-18  Score=137.15  Aligned_cols=134  Identities=22%  Similarity=0.183  Sum_probs=113.5

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc--cceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.||+|.++.||+++.. +..+++|....... ...+.+|+..+..++|  .++++++++....+..++++||++++++.
T Consensus         4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEec-CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            56899999999999854 47899999865433 5678999999999987  58999999888888899999999887765


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      .+             +......++.++++++++||.....+++|+|++|+||++++++.+++.|||.+...
T Consensus        82 ~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          82 EV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            33             45667788999999999999844457999999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.7e-18  Score=143.69  Aligned_cols=137  Identities=20%  Similarity=0.233  Sum_probs=99.0

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccch---HHH----------------------HHHHHHHhhhcccc--e
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEF----------------------INEVATIGRIHHFH--I  190 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i  190 (344)
                      .+.||+|+||+||+|...+++.||||+++......   ..+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            35799999999999997789999999987532111   111                      35666666665543  4


Q ss_pred             eeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       191 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      .+.++.    ...+++|||++++++........      ... .....++.+++.++.++|.  ..+++|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence            444443    24589999999965432211100      011 5678899999999999997  3789999999999999


Q ss_pred             cCCCceEEeecCCccccc
Q 041350          271 DHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~  288 (344)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-18  Score=170.41  Aligned_cols=196  Identities=21%  Similarity=0.241  Sum_probs=145.9

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeecccc--chHHHHHHHHH--HhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG--NGQEFINEVAT--IGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||++.|=+|.+|+...|. |+||++-+...  ..+.|.++++-  ....+|||.+.+.-+-..+...|||-+|. 
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv-  103 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV-  103 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-
Confidence            34577999999999999987786 99999865432  22445443333  45558999998887766666678888888 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc--cC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--SK  289 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~--~~  289 (344)
                      .-+|.|.|.      .+..+..-+.+-|+.|++.||..+|.   .+|+|||||.+||||+.-.-+.|+||..-+..  +.
T Consensus       104 khnLyDRlS------TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  104 KHNLYDRLS------TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             hhhhhhhhc------cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            448888883      33457777888899999999999999   99999999999999999999999999876532  22


Q ss_pred             Cccc---eeeecccCCcccccccccccc---------cCCCCcccchHhHHHHHHHHH-cCCCCCC
Q 041350          290 DISI---VSLTAARGTAGYIAPELFSRN---------FGEVSYKSDVYSYGMMLLEMV-GCRKNKD  342 (344)
Q Consensus       290 ~~~~---~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Dv~s~Gvvl~ell-~g~~p~~  342 (344)
                      +.+.   .-....+.-..|+|||.+...         .+..+++-||||.||++.||+ -|++||+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            2111   011122234589999987431         112677889999999999998 5688876

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=6e-17  Score=140.40  Aligned_cols=135  Identities=19%  Similarity=0.239  Sum_probs=105.2

Q ss_pred             cccc-ccCcEEEEEEEEeCCceEEEEEeeccc--------------cchHHHHHHHHHHhhhcccce--eeEeeEEEcCC
Q 041350          139 HRLG-QGGYGSVFRGKLFNGIPVAVKMLEHLK--------------GNGQEFINEVATIGRIHHFHI--VRLLGFCSEGT  201 (344)
Q Consensus       139 ~~lG-~G~fG~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~  201 (344)
                      ..|| .||.|+||+... ++..++||.+....              .....+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 899999999975 47789999875311              122467889999999998875  67777643322


Q ss_pred             ----eEEEEEeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          202 ----RRALVYEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       202 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                          ..++|||++++ .+|.+++..       .+++...    ..+++.++.+||+   .+|+||||||+|||++.++.+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~~----~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-------APLSEEQ----WQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-------CCCCHHH----HHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence                23599999997 699988743       2344433    5689999999999   999999999999999999999


Q ss_pred             EEeecCCccccc
Q 041350          277 KISDFGLAKLCS  288 (344)
Q Consensus       277 kl~Dfgla~~~~  288 (344)
                      +|+|||.+....
T Consensus       182 ~LIDfg~~~~~~  193 (239)
T PRK01723        182 WLIDFDRGELRT  193 (239)
T ss_pred             EEEECCCcccCC
Confidence            999999987643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=9.1e-17  Score=141.91  Aligned_cols=147  Identities=24%  Similarity=0.306  Sum_probs=110.6

Q ss_pred             cccceeeEeeEEEcC---------------------------CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHH
Q 041350          186 HHFHIVRLLGFCSEG---------------------------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK  238 (344)
Q Consensus       186 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~  238 (344)
                      +|||||++.++|.+.                           ..+|+||.-+ ..+|..|+..+       ..+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-------~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-------HRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-------CCchHHHHH
Confidence            699999999987432                           4578999887 45999999553       356667788


Q ss_pred             HHHHHHHHHHHHHhCCCCCeeecCCCCCceEE--cCCC--ceEEeecCCcccccCCc---ccee-eecccCCcccccccc
Q 041350          239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNF--QPKISDFGLAKLCSKDI---SIVS-LTAARGTAGYIAPEL  310 (344)
Q Consensus       239 i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill--~~~~--~~kl~Dfgla~~~~~~~---~~~~-~~~~~gt~~y~aPE~  310 (344)
                      +..|+++|+.|||+   ++|.|||+|++|||+  |+|+  .+.|+|||.+--...+.   .+.+ ....-|.-.-||||+
T Consensus       346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            88999999999999   999999999999999  4444  46899999865332211   0111 112336677899999


Q ss_pred             cccccCCC----CcccchHhHHHHHHHHHcCCCCCCC
Q 041350          311 FSRNFGEV----SYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       311 ~~~~~~~~----~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....++.    -.|+|.|+.|.+.||+++.+.||+.
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            86543322    2389999999999999999999974

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=1.4e-15  Score=142.83  Aligned_cols=139  Identities=22%  Similarity=0.257  Sum_probs=99.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccc---------------------------h--------------HHHHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---------------------------G--------------QEFIN  177 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~~  177 (344)
                      +.||.|++|.||+|++.+|+.||||+.+.....                           .              -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            359999999999999999999999997532100                           0              02455


Q ss_pred             HHHHHhhhc-----ccceeeEeeEE-EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 041350          178 EVATIGRIH-----HFHIVRLLGFC-SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR-GVEYL  250 (344)
Q Consensus       178 E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~-~l~yL  250 (344)
                      |...+.+++     ++++ .+-..+ ...+..++||||++|++|.++......     ..   .+..++.+++. .+..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHHHHHHH
Confidence            666666663     2333 222222 334567999999999999987643211     12   23456666666 46788


Q ss_pred             HhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       251 H~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      |.   .+++|+|++|.||+++++++++++|||++.....
T Consensus       274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            88   8999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=2.8e-17  Score=150.20  Aligned_cols=124  Identities=30%  Similarity=0.428  Sum_probs=106.7

Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      .+++.|+++...+|.++|.....   ....++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence            47899999999999999965443   2456788899999999999999      47899999999999999999999999


Q ss_pred             CCcccccCCc----cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc
Q 041350          282 GLAKLCSKDI----SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG  336 (344)
Q Consensus       282 gla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~  336 (344)
                      |+........    .....+...||..||+||++.++  .|+.++||||+|++|+|++.
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHH
Confidence            9987665544    23345677899999999999986  89999999999999999986

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=1.1e-16  Score=156.35  Aligned_cols=159  Identities=25%  Similarity=0.341  Sum_probs=111.6

Q ss_pred             cccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          138 KHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      .+.|-.|+||.||..+... .+.+|+|+ ++..-    +++-  ++.....|.+|                     ||-.
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~npfvv---------------------gDc~  139 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNPFVV---------------------GDCA  139 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCccee---------------------chhh
Confidence            3678999999999997543 56677743 22110    0100  22222223222                     5555


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC------
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD------  290 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~------  290 (344)
                      ..+.+.      .+++.        +++.+++|||+   .+|+|||+||+|.+|+.-|++|+.|||+++.....      
T Consensus       140 tllk~~------g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  140 TLLKNI------GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             hhcccC------CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            555321      23332        23789999999   99999999999999999999999999998743211      


Q ss_pred             -------ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 -------ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 -------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                             .........+|||.|.|||++...  .|...+|+|++|+++||.+-|..||+.
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccC
Confidence                   111223355799999999999875  788899999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=2.9e-17  Score=159.00  Aligned_cols=199  Identities=26%  Similarity=0.285  Sum_probs=159.6

Q ss_pred             hhcccccccCcEEEEEEEEe--CCceEEEEEeeccccc---hHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF--NGIPVAVKMLEHLKGN---GQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+|+.|-.....  ....+|+|.+......   ......|..+-..+. |.|++++++...+....++.++|
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            34456899999999887642  3455677776644322   233445777777776 99999999999999999999999


Q ss_pred             cCCCCHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCceEEcCCC-ceEEeecCCccc
Q 041350          210 MPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-QGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKL  286 (344)
Q Consensus       210 ~~~gsL~~~l~-~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~  286 (344)
                      ..++++.+-+. ...     ...+......+..|+..++.|+| .   .++.|||+||+|.+++..+ ..+++|||+|..
T Consensus       103 s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  103 SDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999988873 221     14566677889999999999999 7   9999999999999999999 999999999998


Q ss_pred             ccC-CccceeeecccC-CcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSK-DISIVSLTAARG-TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.. ...........| ++.|+|||...+. ....+..|+||.|+++.-+++|..|.+-
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~  232 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDF  232 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccc
Confidence            876 444444556678 9999999998774 3456789999999999999999999763

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=2.6e-14  Score=136.09  Aligned_cols=141  Identities=17%  Similarity=0.206  Sum_probs=91.5

Q ss_pred             ccccccCcEEEEEEEEeC-CceEEEEEeeccccc-----------------------------------hH------HHH
Q 041350          139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGN-----------------------------------GQ------EFI  176 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~------~~~  176 (344)
                      +.||+|++|.||+|++.+ |+.||||+.+.....                                   .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            359999999999999887 999999998632100                                   01      234


Q ss_pred             HHHHHHhhhc----ccceeeEeeEEEc-CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 041350          177 NEVATIGRIH----HFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH  251 (344)
Q Consensus       177 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH  251 (344)
                      +|+..+.+++    +.+.+.+-.++.+ .+..+|||||++|+++.++-.-.........+....+..+..|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            5555555553    3333333333332 55678999999999998753111110000122222233333333       3


Q ss_pred             hCCCCCeeecCCCCCceEEcCCC----ceEEeecCCcccccC
Q 041350          252 QGCNQRILHFDIKPHNILLDHNF----QPKISDFGLAKLCSK  289 (344)
Q Consensus       252 ~~~~~~ivH~Dik~~Nill~~~~----~~kl~Dfgla~~~~~  289 (344)
                      .   .+++|+|+||.||+++.++    .+++.|||++...++
T Consensus       278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3   7999999999999999888    999999999887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.53  E-value=6.2e-14  Score=115.26  Aligned_cols=131  Identities=19%  Similarity=0.113  Sum_probs=96.9

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      +.|+.|.++.||+++. .+..+++|...........+.+|+.++..+.+.++ .+++++..  ...++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence            4578999999999984 57789999986543333457889999999976554 44554432  34579999999988754


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ..           .   ....+..+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+...
T Consensus        81 ~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          81 ED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            20           0   11235678999999999821  12369999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=2.5e-12  Score=107.01  Aligned_cols=135  Identities=15%  Similarity=0.165  Sum_probs=98.5

Q ss_pred             ccccccCcEEEEEEEEeC-------CceEEEEEeeccc----------------------cc-hHHHH----HHHHHHhh
Q 041350          139 HRLGQGGYGSVFRGKLFN-------GIPVAVKMLEHLK----------------------GN-GQEFI----NEVATIGR  184 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~-~~~~~----~E~~~l~~  184 (344)
                      ..||.|--+.||.|.-.+       +..+|||+.+...                      .+ .+.+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997443       4799999874211                      00 11222    79999999


Q ss_pred             hcc--cceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeec
Q 041350          185 IHH--FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL-HQGCNQRILHF  261 (344)
Q Consensus       185 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~ivH~  261 (344)
                      +..  -++.+++++    ...++||||+.+..+..-...      ...++.+....+..+++.+|..| |+   .+++|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            964  467777764    456899999976544221111      12345566778889999999999 77   899999


Q ss_pred             CCCCCceEEcCCCceEEeecCCcccc
Q 041350          262 DIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       262 Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++.|||++ ++.+.|+|||.+...
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeC
Confidence            9999999997 467999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.40  E-value=4.1e-12  Score=108.95  Aligned_cols=141  Identities=17%  Similarity=0.197  Sum_probs=110.4

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeecccc--chHHHHHHHHHHhhhcc--cceeeEeeEEEcCC---eEEEEEeccC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHH--FHIVRLLGFCSEGT---RRALVYEFMP  211 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~  211 (344)
                      +.|+.|..+.||++...+|..+++|.......  ....+.+|.++++.+++  .++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999876678999999865433  35678999999999976  45677787766542   5689999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG--------------------------------------  253 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------------------------------------  253 (344)
                      +.++.+.+..       ..++......++.+++++|.+||+.                                      
T Consensus        84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9988775521       2467778888888888888888851                                      


Q ss_pred             ---------------CCCCeeecCCCCCceEEcC--CCceEEeecCCccc
Q 041350          254 ---------------CNQRILHFDIKPHNILLDH--NFQPKISDFGLAKL  286 (344)
Q Consensus       254 ---------------~~~~ivH~Dik~~Nill~~--~~~~kl~Dfgla~~  286 (344)
                                     ....++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           1245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=3.5e-12  Score=120.37  Aligned_cols=165  Identities=18%  Similarity=0.218  Sum_probs=125.5

Q ss_pred             EeCCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCC
Q 041350          154 LFNGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS  232 (344)
Q Consensus       154 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~  232 (344)
                      ..++.+|.|...+.... ..+...+-++.|+.++||||++++..+...+..|+|+|-+.  .|..++.+         ++
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence            56788999999886544 23456788999999999999999999999999999999874  46666632         34


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccc
Q 041350          233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS  312 (344)
Q Consensus       233 ~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  312 (344)
                      .....-.+.||+.||.|||+  +.+++|++|.-..|++++.|+.||++|.++...+.-..  ......---.|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            55666778999999999997  48899999999999999999999999998754332211  001111122356676543


Q ss_pred             cccCCCCcccchHhHHHHHHHHHcC
Q 041350          313 RNFGEVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       313 ~~~~~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                      .+  .  -..|.|-||+++||++.|
T Consensus       179 ~s--~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PS--E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--c--cchhhhhHHHHHHHHhCc
Confidence            32  1  246999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.9e-13  Score=125.32  Aligned_cols=203  Identities=23%  Similarity=0.232  Sum_probs=158.3

Q ss_pred             HHHHHHHHHhhcccccc--cCcEEEEEEEE---eCCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEE
Q 041350          127 YKELKKITSKFKHRLGQ--GGYGSVFRGKL---FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFC  197 (344)
Q Consensus       127 ~~~l~~~~~~~~~~lG~--G~fG~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~  197 (344)
                      ..+..+.+..+.+.+|.  |.+|.||.+..   .++..+|+|.-+...   .....=.+|.....+++ |+|.++....+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            44556666677788999  99999999975   457789998743211   22233456777777885 99999999999


Q ss_pred             EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR----GVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       198 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      .+.+..++-+|++ +.+|..+.+...     ..++...++....+..+    |+.++|.   .+++|-|+||.||++..+
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~  258 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSD  258 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccc
Confidence            9999999999999 578888886543     34667777788888888    9999999   999999999999999999


Q ss_pred             -CceEEeecCCcccccCCccce---eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          274 -FQPKISDFGLAKLCSKDISIV---SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       274 -~~~kl~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                       ...++.|||+........-..   ......|...|++||...+   .++...|+|++|.+..|...+-.++
T Consensus       259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccc
Confidence             889999999988765543111   1122357788999999875   5788999999999999988776654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1.5e-12  Score=112.90  Aligned_cols=155  Identities=23%  Similarity=0.380  Sum_probs=115.1

Q ss_pred             HHHHhhhcccceeeEeeEEEcC-----CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 041350          179 VATIGRIHHFHIVRLLGFCSEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG  253 (344)
Q Consensus       179 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  253 (344)
                      ...|-.+.|.|||+++.|+.+.     ....+++|||..|+|..+|..-..  ....+......+++.||..||.|||+ 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs-  194 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS-  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence            4456667899999999998654     356899999999999999976543  23568888899999999999999997 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecCCcccccC--CccceeeecccCCcccccccccccccCCCCcccchHhHHHHH
Q 041350          254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML  331 (344)
Q Consensus       254 ~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl  331 (344)
                      |.++|+|+++..+.|++..++-+|+.--.-......  ...........+-++|.|||.=..  ...+-.+|||+||+..
T Consensus       195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcA  272 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCA  272 (458)
T ss_pred             cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHH
Confidence            779999999999999999999888753211110000  000001123346789999996432  3556689999999999


Q ss_pred             HHHHcCC
Q 041350          332 LEMVGCR  338 (344)
Q Consensus       332 ~ell~g~  338 (344)
                      +||.-+.
T Consensus       273 lemailE  279 (458)
T KOG1266|consen  273 LEMAILE  279 (458)
T ss_pred             HHHHHhe
Confidence            9987554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=3.5e-11  Score=97.06  Aligned_cols=131  Identities=19%  Similarity=0.247  Sum_probs=98.5

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEe-eccccc--------hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKML-EHLKGN--------GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~-~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+++|+-+.+|.+.. -|.++.+|.- ++....        ...-.+|..++.+++--.|....=+..+.....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            478999999999954 4555666643 221111        134678999999998766665566666777788999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      +|..|.+++...             ...++..+-.-+.-||.   .+|+|+||.++||++..+. +.++||||+....
T Consensus        82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999998432             24456666666778999   9999999999999998765 9999999998543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=8.2e-11  Score=94.59  Aligned_cols=141  Identities=23%  Similarity=0.284  Sum_probs=105.4

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEee-ccc--------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLE-HLK--------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~-~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ..+-||+-+.|+++. ..|+...||.-. +..        -..+...+|+..|.+++--.|.-..-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~-~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGS-FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeec-cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            467899999999997 678777777432 111        1235678899999999866665555566676677899999


Q ss_pred             cCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEeecCCcc
Q 041350          210 MPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAK  285 (344)
Q Consensus       210 ~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfgla~  285 (344)
                      +++ -++.+++.....    .....+....++.+|-+.+.-||.   .+|+|+||..+||+|.+++   .+.++|||++.
T Consensus        92 ~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             ccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence            976 488888865432    122333347888899999999999   9999999999999997654   35899999986


Q ss_pred             cc
Q 041350          286 LC  287 (344)
Q Consensus       286 ~~  287 (344)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            53

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=2.2e-10  Score=95.02  Aligned_cols=125  Identities=25%  Similarity=0.270  Sum_probs=82.8

Q ss_pred             EEEEEEEeCCceEEEEEeeccc--------------c---------c----hHHHHHHHHHHhhhccc--ceeeEeeEEE
Q 041350          148 SVFRGKLFNGIPVAVKMLEHLK--------------G---------N----GQEFINEVATIGRIHHF--HIVRLLGFCS  198 (344)
Q Consensus       148 ~Vy~~~~~~~~~vavK~~~~~~--------------~---------~----~~~~~~E~~~l~~l~h~--niv~~~~~~~  198 (344)
                      .||.|...+|..+|||+.+...              .         .    .....+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899988899999999874210              0         0    02346799999999765  567776552 


Q ss_pred             cCCeEEEEEeccC--CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCceEEcCCCc
Q 041350          199 EGTRRALVYEFMP--NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY-LHQGCNQRILHFDIKPHNILLDHNFQ  275 (344)
Q Consensus       199 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~ivH~Dik~~Nill~~~~~  275 (344)
                         ...+||||++  +..+..+....        ++.+....+..+++..+.. +|.   .+++|+|+.+.|||++++ .
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence               3479999998  65555443211        1233456677778776555 567   999999999999999988 9


Q ss_pred             eEEeecCCccccc
Q 041350          276 PKISDFGLAKLCS  288 (344)
Q Consensus       276 ~kl~Dfgla~~~~  288 (344)
                      +.++|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.16  E-value=1.1e-09  Score=96.10  Aligned_cols=138  Identities=17%  Similarity=0.114  Sum_probs=99.8

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeecccc------------chHHHHHHHHHHhhhcccce--eeEeeEEEc-----CC
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKG------------NGQEFINEVATIGRIHHFHI--VRLLGFCSE-----GT  201 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~~  201 (344)
                      +-.-....|++.. .+|+.+.||.......            ....+.+|...+.++...+|  +..+++...     ..
T Consensus        30 v~~~~~rrvvr~~-~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFE-LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEE-ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            3333334466764 5778899997643221            11247899999999865443  444556533     23


Q ss_pred             eEEEEEeccCCC-CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-------C
Q 041350          202 RRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-------N  273 (344)
Q Consensus       202 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-------~  273 (344)
                      .-++|||++++- +|.+++.....    .+.+......++.+++..+.-||.   .+|+|+|++++|||++.       +
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence            568999999886 89999843221    235567778999999999999999   99999999999999975       4


Q ss_pred             CceEEeecCCccc
Q 041350          274 FQPKISDFGLAKL  286 (344)
Q Consensus       274 ~~~kl~Dfgla~~  286 (344)
                      ..+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.08  E-value=2.5e-09  Score=98.56  Aligned_cols=172  Identities=16%  Similarity=0.216  Sum_probs=131.1

Q ss_pred             CcEEEEEEE-EeCCceEEEEEeeccccc-hHHHHHHHHHHhhhcccceeeEeeEEE----cCCeEEEEEeccCC-CCHHH
Q 041350          145 GYGSVFRGK-LFNGIPVAVKMLEHLKGN-GQEFINEVATIGRIHHFHIVRLLGFCS----EGTRRALVYEFMPN-GSLEK  217 (344)
Q Consensus       145 ~fG~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~  217 (344)
                      .-.+.||+. ..||..+.+|+++-.+.. ......-+++++++.|+|+|++..++.    .+.-+++||+|+|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345789986 567999999999432221 223456688999999999999999876    34568999999987 78888


Q ss_pred             HHhccCCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          218 FIFSKTNSS---------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       218 ~l~~~~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      +-+......         ....+++..++.++.|+..||.++|+   .|+..+-|.+++||++.+.+++|+.-|..-...
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            766543221         23457889999999999999999999   899999999999999999899999888766554


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN  340 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p  340 (344)
                      .+.              .  |-+.     --.+-|.=.||.+++.|.+|...
T Consensus       445 ~d~--------------~--~~le-----~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP--------------T--EPLE-----SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC--------------C--cchh-----HHhhhhHHHHHHHHHHHhhcccc
Confidence            432              0  1121     12367888999999999999654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.07  E-value=5.1e-10  Score=106.24  Aligned_cols=140  Identities=22%  Similarity=0.265  Sum_probs=93.3

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccc-----------------------c----c----hH----------HHHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-----------------------G----N----GQ----------EFIN  177 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-----------------------~----~----~~----------~~~~  177 (344)
                      +-|+.++-|.||+|++.+|+.||||+.+..-                       .    .    .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            3488999999999999999999999863210                       0    0    01          1345


Q ss_pred             HHHHHhhhc-----ccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 041350          178 EVATIGRIH-----HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG-VEYLH  251 (344)
Q Consensus       178 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~-l~yLH  251 (344)
                      |...+.+++     .+++.-..=++.-.+...|+|||++|-.+.+......     ..++.   ..++..++++ +..+-
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~---k~ia~~~~~~f~~q~~  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDR---KELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCH---HHHHHHHHHHHHHHHH
Confidence            666665552     3443322223344567899999999999888853222     12332   2333333332 12222


Q ss_pred             hCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       252 ~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      .   .+++|.|.+|.||+++.++++-+.|||+....++
T Consensus       283 ~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 R---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             h---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2   7899999999999999999999999999876654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=3.8e-11  Score=112.23  Aligned_cols=188  Identities=19%  Similarity=0.215  Sum_probs=139.9

Q ss_pred             hcccccccCcEEEEEEEE--eCCceEEEEEeeccc-cchH--HHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEecc
Q 041350          137 FKHRLGQGGYGSVFRGKL--FNGIPVAVKMLEHLK-GNGQ--EFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~--~~~~~vavK~~~~~~-~~~~--~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +...||.|.|+.|++...  .++..+++|.+.+.- ...+  .-+.|+.+...+ .|.++++....|....+.++--||+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            346799999999998763  356788888776422 1112  224566666666 4888888888888888888999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCcccccC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSK  289 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~~~  289 (344)
                      .++++...+.      ....+++..++++..|++.++.++|+   ..++|+|++|+||++..+ +.-++.|||.+..+.-
T Consensus       349 ~~~s~~l~~~------~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  349 EGGSSSLRSV------TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cCcchhhhhH------HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccce
Confidence            9999887762      12457888899999999999999998   999999999999999886 7889999999864221


Q ss_pred             CccceeeecccCCcccc-cccccccccCCCCcccchHhHHHHHHHHHcCCC
Q 041350          290 DISIVSLTAARGTAGYI-APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK  339 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~  339 (344)
                      .     .......-+++ .+|++... ..+-.+.|++|||.-+.|.+++..
T Consensus       420 ~-----~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  420 S-----SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             e-----cccccccccccccchhhccc-cccccccccccccccccccccCcc
Confidence            1     11122333444 35555444 366779999999999988887654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.04  E-value=2.2e-09  Score=91.91  Aligned_cols=135  Identities=21%  Similarity=0.217  Sum_probs=96.3

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeecc-------cc----------------chHHHHHHHHHHhhhccc--c
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL-------KG----------------NGQEFINEVATIGRIHHF--H  189 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~-------~~----------------~~~~~~~E~~~l~~l~h~--n  189 (344)
                      +.+.++||-|--+.||.|...+|.++|||.-+..       +.                ......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3456789999999999999888999999974310       00                012346799999999755  6


Q ss_pred             eeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       190 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      +.+.+++    +..++||||+++-.|...-           ++.+....++..|++-+.-+-.   .++||+|+++=||+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIl  234 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNIL  234 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence            7776654    5568999999886664321           1223333344444444433334   79999999999999


Q ss_pred             EcCCCceEEeecCCcccc
Q 041350          270 LDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~  287 (344)
                      +++||.+.++||.-+...
T Consensus       235 V~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         235 VTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EecCCCEEEEeCcccccC
Confidence            999999999999876543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.98  E-value=1.2e-10  Score=114.73  Aligned_cols=193  Identities=19%  Similarity=0.210  Sum_probs=133.6

Q ss_pred             cccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      -+-+|.++.++.++-. .|...+.|......    ...+....+-.++-..++|-+++..--+......+|+++|+.+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            4677888888876522 23333444332211    111222233333333345666655555556678899999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc------
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS------  288 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~------  288 (344)
                      |...|++..      ..+.+-.+.....+..+++|||.   ..+.|+|++|.|.|...+++.+++|||......      
T Consensus       891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             chhhhhcCC------CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            999997654      35555566677788899999998   669999999999999999999999998432110      


Q ss_pred             ---------------CC----c----cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 ---------------KD----I----SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ---------------~~----~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                                     ..    .    .........+|+.|.+||.+.+.  .....+|+|+.|++++|.++|..||+.
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                           00    0    00112345689999999999876  667789999999999999999999975

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=2.2e-08  Score=90.38  Aligned_cols=195  Identities=14%  Similarity=0.189  Sum_probs=127.7

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeE------EEcCC-eEEEEEec
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGF------CSEGT-RRALVYEF  209 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~~~-~~~lv~e~  209 (344)
                      .+.||+|+-+.+|---  .-...+-|+.....-..+.  +-++.|... .||-+..-+.+      ..+.+ ..-++|..
T Consensus        16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecc--hhhchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            4669999999999642  2122334666543222111  122233333 35533221111      11222 36678888


Q ss_pred             cCCC-CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          210 MPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       210 ~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      +++. ....+........+....+|+.+++.++.+|.+.+-||+   .|.+-+|+.++|+|+.+++.+.|.|=..-....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeecc
Confidence            7764 344444444444445678999999999999999999999   999999999999999999999999855433332


Q ss_pred             CCccceeeecccCCcccccccccc-ccc--CCCCcccchHhHHHHHHHHHcC-CCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFS-RNF--GEVSYKSDVYSYGMMLLEMVGC-RKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~~~~~Dv~s~Gvvl~ell~g-~~p~~  342 (344)
                      ++.   -....+|...|.+||... +.+  ..-+..+|-|.+||+++++|.| ++||.
T Consensus       169 ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         169 NGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             CCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            221   224567899999999754 111  1346689999999999999854 99885

>PRK09902 hypothetical protein; Provisional

Probab=98.87  E-value=6.3e-08  Score=80.99  Aligned_cols=137  Identities=20%  Similarity=0.169  Sum_probs=102.6

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeec-c------ccchHHHHHHHHHHhhhccc--ceeeEeeEEE-c----CCeEEEE
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEH-L------KGNGQEFINEVATIGRIHHF--HIVRLLGFCS-E----GTRRALV  206 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~-~------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~-~----~~~~~lv  206 (344)
                      -|+||-+.|++-. .+|..+-+|.-.. .      .-....|.+|...|.++...  .+.+.+ ++. .    .-.-.||
T Consensus        26 ~~rgG~SgV~r~~-~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVE-RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEE-eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4779999999976 4555788887651 1      22446899999999999643  345555 332 1    1245799


Q ss_pred             EeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc--eEEeecCC
Q 041350          207 YEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGL  283 (344)
Q Consensus       207 ~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~--~kl~Dfgl  283 (344)
                      +|-+++ -||.+++.+...    .+.+......+..+++..++-||+   .++.|+|+.+.|||++.++.  +.++||.-
T Consensus       104 Te~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            997754 699988844321    346777788999999999999999   99999999999999986666  99999987


Q ss_pred             ccc
Q 041350          284 AKL  286 (344)
Q Consensus       284 a~~  286 (344)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=4.9e-08  Score=82.85  Aligned_cols=107  Identities=20%  Similarity=0.256  Sum_probs=84.7

Q ss_pred             HHHHHHHHHHhhhccc--ceeeEeeEEEcC----CeEEEEEeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHH
Q 041350          173 QEFINEVATIGRIHHF--HIVRLLGFCSEG----TRRALVYEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR  245 (344)
Q Consensus       173 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~  245 (344)
                      ....+|...+..+...  ..++.+++....    ...++|+|++++ .+|.+++....      ..+......++.+++.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALAR  129 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHHH
Confidence            4678888888888643  455666665442    245899999988 48999985422      2556678899999999


Q ss_pred             HHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEeecCCccccc
Q 041350          246 GVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCS  288 (344)
Q Consensus       246 ~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfgla~~~~  288 (344)
                      .++-||+   .+|+|+|+++.|||++.+.   .+.++||+.++...
T Consensus       130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999   9999999999999999887   89999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.82  E-value=1.5e-07  Score=80.86  Aligned_cols=141  Identities=15%  Similarity=0.191  Sum_probs=87.8

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc--eeeEeeEEEcCCeEEEEEeccCCCC-H
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGS-L  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L  215 (344)
                      ..||+|..+.||+.   .+..+++|..... .......+|.++++.+..-.  +.+.+++...++...++||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   2556778887642 34456789999999997543  4777888888888899999998864 2


Q ss_pred             HHHH---------------------hccCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHh-CCCCCeeecC
Q 041350          216 EKFI---------------------FSKTNSSSHRPLSWEKLKKIAF----------GVAR-GVEYLHQ-GCNQRILHFD  262 (344)
Q Consensus       216 ~~~l---------------------~~~~~~~~~~~l~~~~~~~i~~----------~ia~-~l~yLH~-~~~~~ivH~D  262 (344)
                      ...+                     +....  ....+... ...+..          .+.+ ..++|.. .....++|+|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            2111                     11100  00111100 000000          0111 1222221 1224578999


Q ss_pred             CCCCceEEcCCCceEEeecCCcccc
Q 041350          263 IKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       263 ik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      +.|.||++++++ +.++||+.+..-
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCcC
Confidence            999999999888 999999987643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.77  E-value=2.6e-08  Score=94.50  Aligned_cols=139  Identities=24%  Similarity=0.308  Sum_probs=91.1

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccc--------------------------------------hHHHHHHHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN--------------------------------------GQEFINEVA  180 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------------~~~~~~E~~  180 (344)
                      +-||.-+.|.||+|++.+|+.||||+-+..-..                                      .=+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            459999999999999999999999985321100                                      002555655


Q ss_pred             HHhhh----cccc------eeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 041350          181 TIGRI----HHFH------IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL  250 (344)
Q Consensus       181 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yL  250 (344)
                      ...+.    .|-+      |.+++  +.-.+...|+||||+|..+.+.-.-..     ..++...   ++..+.++  |+
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~---i~~~l~~~--~~  314 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHD---ILNKLVEA--YL  314 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHH---HHHHHHHH--HH
Confidence            54444    3445      22222  233457899999999988777643222     2344443   33333332  33


Q ss_pred             HhCCCCCeeecCCCCCceEEcC----CCceEEeecCCcccccC
Q 041350          251 HQGCNQRILHFDIKPHNILLDH----NFQPKISDFGLAKLCSK  289 (344)
Q Consensus       251 H~~~~~~ivH~Dik~~Nill~~----~~~~kl~Dfgla~~~~~  289 (344)
                      +.-...|++|.|-+|.||+++.    ++.+.+.|||+......
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3333378999999999999984    67899999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=8.4e-07  Score=75.46  Aligned_cols=136  Identities=21%  Similarity=0.250  Sum_probs=93.0

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccch--------------------HH-----HHHHHHHHhhhc--ccceee
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--------------------QE-----FINEVATIGRIH--HFHIVR  192 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~-----~~~E~~~l~~l~--h~niv~  192 (344)
                      .|.+|.-+.||+|.-.++..+|||+++......                    ++     ..+|...|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            477888899999987789999999986422111                    11     136777888874  345555


Q ss_pred             EeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       193 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      .+++.    +-.|||||+....+.     ... -+..++.......+..++++.+.-|-.  ..++||+||+.=|||+. 
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~p-----AP~-LkDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLP-----APR-LKDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCC-----CCC-cccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-
Confidence            55543    347999999654111     000 111223343566777777777776654  37999999999999999 


Q ss_pred             CCceEEeecCCccccc
Q 041350          273 NFQPKISDFGLAKLCS  288 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~  288 (344)
                      ++.+.++|||-|....
T Consensus       202 ~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEECccccccC
Confidence            8899999999887554

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.56  E-value=9.3e-07  Score=74.34  Aligned_cols=124  Identities=15%  Similarity=0.136  Sum_probs=78.2

Q ss_pred             cCcEEEEEEEEeCCceEEEEEeeccccchHH----------HHHHHHHHhhhccccee---eEeeEE-----EcCCeEEE
Q 041350          144 GGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE----------FINEVATIGRIHHFHIV---RLLGFC-----SEGTRRAL  205 (344)
Q Consensus       144 G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv---~~~~~~-----~~~~~~~l  205 (344)
                      ....-|.+-. .+|..+.+|..+......+.          ..+++..+.+++...+.   .++.+.     .-....++
T Consensus        42 ~~r~~ValIe-i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~l  120 (229)
T PF06176_consen   42 TKRNYVALIE-IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVL  120 (229)
T ss_pred             CCccEEEEEE-ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEE
Confidence            3333344433 46677888877643222222          23445555555433222   222221     22345578


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      +|||++|..|.++.          .+++    .++..+++++.-||+   .|++|+|.+|.|+++++++ ++++||+..+
T Consensus       121 l~EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  121 LMEYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEEEecCeecccch----------hcCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            99999999887664          1332    244567788999999   9999999999999999655 9999998765


Q ss_pred             c
Q 041350          286 L  286 (344)
Q Consensus       286 ~  286 (344)
                      .
T Consensus       183 ~  183 (229)
T PF06176_consen  183 M  183 (229)
T ss_pred             c
Confidence            3

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.52  E-value=2e-06  Score=75.01  Aligned_cols=143  Identities=14%  Similarity=0.121  Sum_probs=87.6

Q ss_pred             ccccCc-EEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCCCHHHH
Q 041350          141 LGQGGY-GSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF  218 (344)
Q Consensus       141 lG~G~f-G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  218 (344)
                      |-.|.. ..||+... ++..+.+|......  ..+..+|+++++.+. +--+.+++++...++..++|||+++|.+|...
T Consensus         6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcC-CCCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            334444 78999874 34678888876432  345678999988884 44566788887776678999999999887654


Q ss_pred             H-------------------hccCCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 041350          219 I-------------------FSKTNSSSHRPLSWE--KLKKIAF--------------------GVARGVEYLHQ----G  253 (344)
Q Consensus       219 l-------------------~~~~~~~~~~~l~~~--~~~~i~~--------------------~ia~~l~yLH~----~  253 (344)
                      .                   +....  ...++...  .......                    .+...++.|-.    .
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPV--ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCc--ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            2                   11110  00011100  0000000                    01111222211    1


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       254 ~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ....++|+|+.|.|||++++....|+||+.+....
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gd  195 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVAD  195 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccccc
Confidence            23568999999999999998878999999886543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=1.4e-06  Score=75.05  Aligned_cols=145  Identities=19%  Similarity=0.222  Sum_probs=86.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc--ceeeEeeEEEc---CCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGFCSE---GTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~g  213 (344)
                      +.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+...  .+.+++.+...   ....+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            458899999999998666 68999997654 4456778899999888644  35677765433   33568999999998


Q ss_pred             CHHH----------------HH---hccCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 041350          214 SLEK----------------FI---FSKTNSSSHRPLSWEK---------LKKI------------AFGVAR-GVEYLHQ  252 (344)
Q Consensus       214 sL~~----------------~l---~~~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~  252 (344)
                      ++..                .+   +....  .........         ....            ...+.. .++.+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   81 PLDDELSPEQRPELLRQLGRALAQLHQVPP--PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             EHHHTSTHHHHHHHHHHHHHHHHHHHHSHT--TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccchhhhhhcccccc--cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            8877                11   11110  011111110         0000            111222 2333332


Q ss_pred             ----CCCCCeeecCCCCCceEEc-CCCceEEeecCCcccc
Q 041350          253 ----GCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLC  287 (344)
Q Consensus       253 ----~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfgla~~~  287 (344)
                          .....++|+|+.|.|||++ +++.+.|+||+.+...
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence                2346799999999999999 6666789999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.51  E-value=2e-08  Score=94.87  Aligned_cols=180  Identities=17%  Similarity=0.129  Sum_probs=126.8

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEeccCCC-CHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYEFMPNG-SLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~  216 (344)
                      +..++|++++++|.+-...+....+.+...    ....-++++|.+++||| .+..++-+..+...++.++++..+ +-.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            457899999999886322333334444322    45566899999999999 777777777778889999999877 221


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL  296 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  296 (344)
                      .-..     .....+...+...+.+.-++++++||+   ..-+|+|    ||+..+ +..+..||+.+..+....   ..
T Consensus       324 ~~~~-----~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  324 LEMT-----VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             ccCC-----hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            1110     111234444555667777889999998   5568888    777665 678999999988776553   23


Q ss_pred             ecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCC
Q 041350          297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN  340 (344)
Q Consensus       297 ~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p  340 (344)
                      +...+|+.|+|||+...+  .+..+.|+|+.|+-..+|--|-.|
T Consensus       388 ~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             ccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCC
Confidence            556799999999988765  788899999999866666655554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=3.7e-08  Score=93.92  Aligned_cols=96  Identities=22%  Similarity=0.363  Sum_probs=73.6

Q ss_pred             HHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce-------eeecccCCccccccccccc
Q 041350          241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-------SLTAARGTAGYIAPELFSR  313 (344)
Q Consensus       241 ~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  313 (344)
                      .+++.|+.|+|+  ..++||++|.|++|.++.++..||+.|+.+........+.       -.........|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            355699999998  5899999999999999999999999999876443321110       0011124568999999977


Q ss_pred             ccCCCCcccchHhHHHHHHHHHcCCCC
Q 041350          314 NFGEVSYKSDVYSYGMMLLEMVGCRKN  340 (344)
Q Consensus       314 ~~~~~~~~~Dv~s~Gvvl~ell~g~~p  340 (344)
                      .  ..+.++|+||+|+++|-+..|+++
T Consensus       184 ~--~~~~~sd~fSlG~li~~i~~~gk~  208 (700)
T KOG2137|consen  184 T--TNTPASDVFSLGVLIYTIYNGGKS  208 (700)
T ss_pred             c--cccccccceeeeeEEEEEecCCcc
Confidence            4  567899999999999999866554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.44  E-value=1.1e-06  Score=73.23  Aligned_cols=105  Identities=25%  Similarity=0.272  Sum_probs=82.5

Q ss_pred             HHHHHHHhhhcc-cceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 041350          176 INEVATIGRIHH-FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC  254 (344)
Q Consensus       176 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  254 (344)
                      .+|..+++.+++ +++++++|+|-    ..+++||.+.+++...-..   -.....-+|..+.+||.++++.+.+|+++.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~---l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP---LSQFLQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc---cccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            358888888876 69999999994    3679999987766421000   001124689999999999999999999866


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ...+.-.|++++|+-+++++++|+.|...+...
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            566888899999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=98.36  E-value=1.1e-05  Score=72.36  Aligned_cols=75  Identities=11%  Similarity=0.071  Sum_probs=56.5

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc---cceeeEeeEEEcC---CeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH---FHIVRLLGFCSEG---TRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~~~  212 (344)
                      +.||.|..+.||+....++ .+.+|..+. ......+.+|.+.|+.+..   ..+.++++++..+   +..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4589999999999875555 466677433 2244688999999999853   3688888887543   568999999998


Q ss_pred             CCH
Q 041350          213 GSL  215 (344)
Q Consensus       213 gsL  215 (344)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.33  E-value=7.6e-06  Score=66.02  Aligned_cols=129  Identities=19%  Similarity=0.243  Sum_probs=88.0

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      .+.|++|.+|.||+|. +.|..+|+|+-+. ......+..|+++|..+.-.++..=+.++.+   ..+.|||+.|-.|.+
T Consensus        27 ~~~L~KG~~s~Vyl~~-~~~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~  101 (201)
T COG2112          27 EKELAKGTTSVVYLGE-WRGGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK  101 (201)
T ss_pred             hhhhhcccccEEEEee-ccCceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence            3569999999999997 5667899997654 3456789999999999987766443333322   234599999888877


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC--CceEEcCCCceEEeecCCccccc
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP--HNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~--~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      .-..         .+.+++.    .++++---|..   .+|-|..|.-  +||++. +..+.|+||..|....
T Consensus       102 ~~~~---------~~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k~  157 (201)
T COG2112         102 LEIG---------GDRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFKK  157 (201)
T ss_pred             hhhc---------ccHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEec-CCcEEEEEccchhhcc
Confidence            6521         1233333    34444333444   7888888864  455554 4489999999988543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=1.2e-05  Score=69.75  Aligned_cols=73  Identities=19%  Similarity=0.278  Sum_probs=46.4

Q ss_pred             ccccccCcE-EEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc---ceeeEeeEEEcC---CeEEEEEeccC
Q 041350          139 HRLGQGGYG-SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF---HIVRLLGFCSEG---TRRALVYEFMP  211 (344)
Q Consensus       139 ~~lG~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~  211 (344)
                      +.|+.|+.. .||+.    +..+.+|..+. ......+.+|.+.+..+...   .+.+.++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            346767766 48975    23466776554 23345788999999888532   345555544332   23478999999


Q ss_pred             CCCHH
Q 041350          212 NGSLE  216 (344)
Q Consensus       212 ~gsL~  216 (344)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            97764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.8e-05  Score=80.88  Aligned_cols=150  Identities=15%  Similarity=0.239  Sum_probs=91.3

Q ss_pred             ccccccCcEEEEEEEEeCC---ceEEEEEeeccc--cchHHHHHHHHHHhhhc-ccce--eeEeeEEEcC---CeEEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFNG---IPVAVKMLEHLK--GNGQEFINEVATIGRIH-HFHI--VRLLGFCSEG---TRRALVY  207 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv~  207 (344)
                      +.++.|.+..+|+....++   ..+++|+.....  .....+.+|.++++.+. |.++  .+++++|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4578999999999875543   356777654322  23357889999999995 6654  7888888764   4578999


Q ss_pred             eccCCCCHHH-----------------------HHhccCCCC-----CCCCCCH--HHHHHHH---------------HH
Q 041350          208 EFMPNGSLEK-----------------------FIFSKTNSS-----SHRPLSW--EKLKKIA---------------FG  242 (344)
Q Consensus       208 e~~~~gsL~~-----------------------~l~~~~~~~-----~~~~l~~--~~~~~i~---------------~~  242 (344)
                      ||+++..+.+                       .|+......     ...+..+  .++..+.               ..
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            9998764321                       111111100     0011111  1111111               12


Q ss_pred             HHHHHHHHHhCCC--------CCeeecCCCCCceEEcCC-Cc-eEEeecCCccccc
Q 041350          243 VARGVEYLHQGCN--------QRILHFDIKPHNILLDHN-FQ-PKISDFGLAKLCS  288 (344)
Q Consensus       243 ia~~l~yLH~~~~--------~~ivH~Dik~~Nill~~~-~~-~kl~Dfgla~~~~  288 (344)
                      +.+.+++|....+        ..++|+|+++.||+++.+ .. .-|.||+++..-.
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            3334566744211        359999999999999853 33 5799999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.16  E-value=9.2e-05  Score=62.03  Aligned_cols=129  Identities=21%  Similarity=0.321  Sum_probs=91.0

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccc-----------------cchHHHHHHHHHHhhhc------ccceeeEee
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-----------------GNGQEFINEVATIGRIH------HFHIVRLLG  195 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~~~~  195 (344)
                      ..||+|+.=.||.-  .+.....||+.....                 ...++..+|+.....+.      +..|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            45899999999974  556667888876433                 22356667776666665      788999999


Q ss_pred             EEEcCCeEEEEEeccCC------CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          196 FCSEGTRRALVYEFMPN------GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       196 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      +..++....+|+|.+.+      -||.+++...       .++. ...+.+.   +-.+||-+   ..|+.+|++|.||+
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-------~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG-------GLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIV  150 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcC-------CccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEE
Confidence            99999999999998643      3688888332       3444 3333333   33467776   89999999999999


Q ss_pred             EcCC---C-ceEEee-cCC
Q 041350          270 LDHN---F-QPKISD-FGL  283 (344)
Q Consensus       270 l~~~---~-~~kl~D-fgl  283 (344)
                      +..+   . .+.|+| ||-
T Consensus       151 ~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEecCCCceEEEEEeCCCC
Confidence            9632   2 577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=0.00011  Score=63.49  Aligned_cols=145  Identities=17%  Similarity=0.228  Sum_probs=83.1

Q ss_pred             ccccccCcEEEEEEEEeC--CceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKLFN--GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.|..|-...+|+....+  +..+.+|+........-+..+|+.+++.+...+ .+++++... +   .++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCcC
Confidence            346778888999987554  568889977643222223457888888885433 344444332 2   489999998776


Q ss_pred             HHH-----------------HhccCCCCC------CCCCCHHHHHHHHH----------------------HHHHHHHHH
Q 041350          216 EKF-----------------IFSKTNSSS------HRPLSWEKLKKIAF----------------------GVARGVEYL  250 (344)
Q Consensus       216 ~~~-----------------l~~~~~~~~------~~~l~~~~~~~i~~----------------------~ia~~l~yL  250 (344)
                      ...                 ++.......      ...-.++.+..+..                      .+...+..|
T Consensus        80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  159 (235)
T cd05157          80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL  159 (235)
T ss_pred             CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence            321                 111111110      01111222212111                      111111122


Q ss_pred             ----Hh-CCCCCeeecCCCCCceEEcC-CCceEEeecCCcccc
Q 041350          251 ----HQ-GCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLC  287 (344)
Q Consensus       251 ----H~-~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~  287 (344)
                          .. ..+..++|+|+.+.|||+++ +..+.++||..|...
T Consensus       160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~  202 (235)
T cd05157         160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN  202 (235)
T ss_pred             HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence                11 12356999999999999998 578999999987643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.08  E-value=0.0001  Score=68.44  Aligned_cols=74  Identities=16%  Similarity=0.107  Sum_probs=53.3

Q ss_pred             ccccccCcEEEEEEEEeCC-ceEEEEEeecc--------ccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFNG-IPVAVKMLEHL--------KGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.||.|.+..||+....+| +.+.||.-...        ....+.+..|.+.|..+.   -.++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998777 48999985311        123456777888888763   2457777776  44557899


Q ss_pred             EeccCCCC
Q 041350          207 YEFMPNGS  214 (344)
Q Consensus       207 ~e~~~~gs  214 (344)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=4.5e-05  Score=67.00  Aligned_cols=140  Identities=14%  Similarity=0.109  Sum_probs=81.3

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeeccccch-HHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCCHHHH
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-QEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGSLEKF  218 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~  218 (344)
                      +..|-.+.+|+.. .++..+++|......... -+..+|..+++.+....+ .++++...    -++|+||++|..+..-
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            4567888999987 567788888765432221 245788889988864433 34444432    3689999998765421


Q ss_pred             -----------------HhccCCCCCCCCCCHHH-HHHHHHH---------HHHHHHHHHh-----CCCCCeeecCCCCC
Q 041350          219 -----------------IFSKTNSSSHRPLSWEK-LKKIAFG---------VARGVEYLHQ-----GCNQRILHFDIKPH  266 (344)
Q Consensus       219 -----------------l~~~~~~~~~~~l~~~~-~~~i~~~---------ia~~l~yLH~-----~~~~~ivH~Dik~~  266 (344)
                                       ++....  ...+++... ...+..+         +...+..+-.     .....++|+|+.|.
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPR--FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence                             111111  111222211 1111111         1111222221     11246899999999


Q ss_pred             ceEEcCCCceEEeecCCccccc
Q 041350          267 NILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       267 Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ||++++++ +.|+||..|....
T Consensus       157 Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             cEEEeCCC-CEEEeccccCcCC
Confidence            99999877 7899999886543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.03  E-value=9.7e-05  Score=61.53  Aligned_cols=123  Identities=28%  Similarity=0.445  Sum_probs=87.3

Q ss_pred             HHhhcccccccCc-EEEEEEEEeCCceEEEEEeec------------cc----------cchHHHHHHHHHHhhhc---c
Q 041350          134 TSKFKHRLGQGGY-GSVFRGKLFNGIPVAVKMLEH------------LK----------GNGQEFINEVATIGRIH---H  187 (344)
Q Consensus       134 ~~~~~~~lG~G~f-G~Vy~~~~~~~~~vavK~~~~------------~~----------~~~~~~~~E~~~l~~l~---h  187 (344)
                      ..+|.+.||.|.- |.|||++ .+|+.+|+|+++.            ..          .....|..|.....+|+   +
T Consensus        38 ~I~flefLg~g~~~~~V~kv~-I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   38 DIEFLEFLGHGSHDGYVFKVE-IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             cEeeeeecCCCCceeEEEEEE-ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            3356688999999 9999998 5777999999421            00          01135788988888885   3


Q ss_pred             cce--eeEeeEEEcC------------------CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 041350          188 FHI--VRLLGFCSEG------------------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV  247 (344)
Q Consensus       188 ~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l  247 (344)
                      .++  |+.+||..-.                  ..+.||.||.+...               .++...    +.+|.+-|
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~----~~~~~~dl  177 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRD----IPQMLRDL  177 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhH----HHHHHHHH
Confidence            455  9999987221                  13467888876543               122223    34666667


Q ss_pred             HHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       248 ~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ..+|.   .+|+-+|+++.|..     .-+|+|||.+
T Consensus       178 ~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            88998   99999999999988     4589999864

>PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal

Probab=97.96  E-value=1.6e-05  Score=58.16  Aligned_cols=61  Identities=31%  Similarity=0.552  Sum_probs=47.4

Q ss_pred             CCCCCceeeeeeeeccccCc----------ccccceeEEEEec-cccccccccccceecCCCCCCceeeecc
Q 041350            3 MLPSSCTISQTVEISAEMTP----------NDAILRATLGWEA-LGGCHHCEKSGHYCGYNVTSSSTICVKQ   63 (344)
Q Consensus         3 ~~~~~c~~~~~~~~~~~~~~----------~~~~~~~~l~w~~-~~~C~~C~~~g~~C~~~~~~~~~~c~~~   63 (344)
                      .++..|.....|||+.+...          .-+..++.|+|.. ..+|..|+.+||+|+++.......|..+
T Consensus        20 ~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~Cgy~~~~~~f~C~C~   91 (94)
T PF14380_consen   20 DLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRCGYDSNSEQFTCFCS   91 (94)
T ss_pred             ccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEeCCCCCCceEEEECC
Confidence            46789999877777755332          2268899999993 3899999999999999988777777644

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.77  E-value=0.00041  Score=62.20  Aligned_cols=145  Identities=15%  Similarity=0.165  Sum_probs=87.5

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc--eeeEeeE------EEcCCeEEEEEecc
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGF------CSEGTRRALVYEFM  210 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~  210 (344)
                      +.|..|....+|+... ++..+++|+...  ........|++++..+.+.+  +.+++..      ...++..+++++|+
T Consensus        20 ~~i~~G~~n~~y~v~~-~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTT-DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEe-CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            3467787789999864 445788888764  34456777888888885433  4454432      22345668999999


Q ss_pred             CCCCHHH--------------HHhccCCC--C---CCCCCCHHHHH----------HHHHHHHHHHHHHHh----CCCCC
Q 041350          211 PNGSLEK--------------FIFSKTNS--S---SHRPLSWEKLK----------KIAFGVARGVEYLHQ----GCNQR  257 (344)
Q Consensus       211 ~~gsL~~--------------~l~~~~~~--~---~~~~l~~~~~~----------~i~~~ia~~l~yLH~----~~~~~  257 (344)
                      +|.++..              .++.....  .   ......|....          .....+..++.++.+    ..+.+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9876532              11111100  0   00111222111          011123334455443    23467


Q ss_pred             eeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          258 ILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       258 ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ++|+|+.|.|++++++....|.||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999987789999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.73  E-value=0.00064  Score=61.19  Aligned_cols=145  Identities=20%  Similarity=0.261  Sum_probs=86.6

Q ss_pred             cccccCcEEEEEEEEeC-------CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFN-------GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+..|--..+|+....+       ++.+++|+.........+..+|.+++..+....+ .++++++..    .+|+||++
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~   80 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP   80 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence            35556677899987554       4788999976644444566788888888864333 455555532    35899998


Q ss_pred             CCCHHHH-----------------HhccCCCC-C----CCCCCHHHHHH--------------------------HHHHH
Q 041350          212 NGSLEKF-----------------IFSKTNSS-S----HRPLSWEKLKK--------------------------IAFGV  243 (344)
Q Consensus       212 ~gsL~~~-----------------l~~~~~~~-~----~~~l~~~~~~~--------------------------i~~~i  243 (344)
                      |.++...                 ++...... .    ..+.-+..+..                          +...+
T Consensus        81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (302)
T cd05156          81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE  160 (302)
T ss_pred             CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence            8776431                 11111110 0    00111111111                          11122


Q ss_pred             HHHHHHHHh------CCCCCeeecCCCCCceEEcCC----CceEEeecCCccccc
Q 041350          244 ARGVEYLHQ------GCNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLCS  288 (344)
Q Consensus       244 a~~l~yLH~------~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfgla~~~~  288 (344)
                      ...+++|-.      .....++|+|+.+.|||++++    +.+.++||..|....
T Consensus       161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~  215 (302)
T cd05156         161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY  215 (302)
T ss_pred             HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence            223334432      245679999999999999985    889999999987543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.68  E-value=0.0013  Score=59.67  Aligned_cols=144  Identities=14%  Similarity=0.194  Sum_probs=79.2

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc--ceeeEee------EEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLG------FCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e~~~  211 (344)
                      .|+.|...++|+....+| .+++|+..  ....+....|+..+..|...  .+.+.+.      +....+..++++||++
T Consensus        29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         29 GIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             hhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            466777789999875555 68888876  22334445566666666422  2334332      1223456789999998


Q ss_pred             CCCHH-----------HH---HhccCCCC-----CCCCCCH-HHHHH-H-----------H-HHHHHHHHHHHh----CC
Q 041350          212 NGSLE-----------KF---IFSKTNSS-----SHRPLSW-EKLKK-I-----------A-FGVARGVEYLHQ----GC  254 (344)
Q Consensus       212 ~gsL~-----------~~---l~~~~~~~-----~~~~l~~-~~~~~-i-----------~-~~ia~~l~yLH~----~~  254 (344)
                      |..+.           ..   ++.....-     ....+.| ..... +           . ..+...++.+.+    ..
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            87532           11   11111100     0011111 11111 1           1 111112233321    13


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            46899999999999999776568999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.64  E-value=0.0017  Score=58.60  Aligned_cols=145  Identities=17%  Similarity=0.222  Sum_probs=83.4

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc--ceeeEeeEE------EcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLGFC------SEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~e~~~  211 (344)
                      .++.|....+|+....+| .+.+|+.... ...++...|.+++..|...  ++.+++...      ..++..++++||++
T Consensus        29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~  106 (307)
T TIGR00938        29 GIAEGVENSNYLLTTDVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ  106 (307)
T ss_pred             ccCCccccceEEEEeCCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence            467777789999874444 5777876542 2234556677777777432  244444421      22456789999998


Q ss_pred             CCCHHH--------------HHhccCCCC--C-C---CCCCHHHHH------------HHHHHHHHHHHHHHh----CCC
Q 041350          212 NGSLEK--------------FIFSKTNSS--S-H---RPLSWEKLK------------KIAFGVARGVEYLHQ----GCN  255 (344)
Q Consensus       212 ~gsL~~--------------~l~~~~~~~--~-~---~~l~~~~~~------------~i~~~ia~~l~yLH~----~~~  255 (344)
                      |.++..              .++.....-  . .   ..-.|....            .....+.+.++++..    ..+
T Consensus       107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~  186 (307)
T TIGR00938       107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP  186 (307)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            854321              112111100  0 0   001111110            011223344555543    234


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          256 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      .+++|+|+++.|+++++++...|+||+.+..
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            7899999999999999988778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.58  E-value=0.00021  Score=72.71  Aligned_cols=155  Identities=19%  Similarity=0.198  Sum_probs=110.8

Q ss_pred             HHHHHHHHhhhcccceeeEeeEEEcCCeE----EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 041350          175 FINEVATIGRIHHFHIVRLLGFCSEGTRR----ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL  250 (344)
Q Consensus       175 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yL  250 (344)
                      -.-|.+.+.++.|+|++.++.|..+....    .+..+++..-++...+...      ..++....+.+..+..+|++|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v------~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV------GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc------cccCHHHHHHHHHHHhhhHHHH
Confidence            34577888899999999999987655433    3456788888888887433      4678899999999999999999


Q ss_pred             HhCCCCCeeecCCCCC---ceEEcCCCceEEe--ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchH
Q 041350          251 HQGCNQRILHFDIKPH---NILLDHNFQPKIS--DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY  325 (344)
Q Consensus       251 H~~~~~~ivH~Dik~~---Nill~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~  325 (344)
                      |+   ....|.-+..+   +-..+.++....+  ||+..+.+......   ....-+..|.|||....+....+...|+|
T Consensus       303 h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence            98   55444444443   3444555666666  88887766543221   22334567889998876644555568999


Q ss_pred             hHHHHHHHHHcCCCCC
Q 041350          326 SYGMMLLEMVGCRKNK  341 (344)
Q Consensus       326 s~Gvvl~ell~g~~p~  341 (344)
                      .+|..+..+..|..+.
T Consensus       377 ~lgll~~~~~~~~~i~  392 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDIS  392 (1351)
T ss_pred             HHHHHHhhhhhcCccc
Confidence            9999999998876654

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.46  E-value=0.00093  Score=59.45  Aligned_cols=72  Identities=15%  Similarity=0.261  Sum_probs=48.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.++.|....+|+.+ .++..+.||+-..  .....|..|.+-|+.|.   --.+++.+++....+..+|++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            458889999999987 7788999998873  34457888888888884   346888999888777789999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.42  E-value=0.0041  Score=57.05  Aligned_cols=144  Identities=22%  Similarity=0.222  Sum_probs=83.6

Q ss_pred             ccccCcEEEEEEEEeC-----CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCC
Q 041350          141 LGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +-.|-.-.+|+....+     ++.+.+|+........-+..+|..+++.+...++ .++++.+..+    .|++|+++.+
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~  119 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART  119 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence            4447778899986432     3578888876543322234678888888865444 3555655332    5899998877


Q ss_pred             HHHH-----------------HhccCCCCCCCCCCHHHHHHHHHH-----------------HHHHHHHHH----h-CCC
Q 041350          215 LEKF-----------------IFSKTNSSSHRPLSWEKLKKIAFG-----------------VARGVEYLH----Q-GCN  255 (344)
Q Consensus       215 L~~~-----------------l~~~~~~~~~~~l~~~~~~~i~~~-----------------ia~~l~yLH----~-~~~  255 (344)
                      |...                 +|+...........+..+..+..+                 +...+..|.    . ...
T Consensus       120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~  199 (344)
T PLN02236        120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE  199 (344)
T ss_pred             CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence            6421                 122111111112223333333211                 111122222    1 223


Q ss_pred             CCeeecCCCCCceEEcC-CCceEEeecCCccccc
Q 041350          256 QRILHFDIKPHNILLDH-NFQPKISDFGLAKLCS  288 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~  288 (344)
                      ..++|+|+++.|||+++ ++.+.++||..|....
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence            57899999999999986 4789999999887543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.35  E-value=0.0018  Score=58.60  Aligned_cols=138  Identities=19%  Similarity=0.175  Sum_probs=94.4

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccc----------------------cchHH-----HHHHHHHHhhhccccee
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK----------------------GNGQE-----FINEVATIGRIHHFHIV  191 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~-----~~~E~~~l~~l~h~niv  191 (344)
                      ..|..|--+.||.++-.+|..+|||+++.+-                      .+.+.     ...|+..|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4588899999999998999999999875321                      01111     23688888888765543


Q ss_pred             eEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       192 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      -.--...  ....|||+|+..-....-.      -....++...+..+-.+++.-|.-|-+  ..++||.||.-=|+|+.
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~aPk------LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWAAPK------LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCcCcc------cccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE
Confidence            2211111  2347999999532221111      112357777788888888888888866  37899999999999996


Q ss_pred             CCCceEEeecCCcccc
Q 041350          272 HNFQPKISDFGLAKLC  287 (344)
Q Consensus       272 ~~~~~kl~Dfgla~~~  287 (344)
                       +|.+.++|.+-+...
T Consensus       300 -dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEH  314 (520)
T ss_pred             -CCEEEEEEccccccC
Confidence             568999998876543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.33  E-value=0.0025  Score=57.24  Aligned_cols=134  Identities=20%  Similarity=0.314  Sum_probs=79.9

Q ss_pred             ccCcE-EEEEEEEeCCceEEEEEeec---cccchHHHHHHHHHHhhhcc--cceeeEeeEEEcCC--eEEEEEeccCCCC
Q 041350          143 QGGYG-SVFRGKLFNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGT--RRALVYEFMPNGS  214 (344)
Q Consensus       143 ~G~fG-~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~~gs  214 (344)
                      +||++ .+|... .+++.+.+. ...   .........+|...++.+.-  .-+...++.|.++.  ..+.||+|.+|..
T Consensus        34 ~~G~sn~t~~~~-~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~  111 (321)
T COG3173          34 SGGWSNDTFRLG-DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV  111 (321)
T ss_pred             cCCcccceEEEe-cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence            34444 334433 337777777 331   22334566778888888753  23455666776665  6699999998854


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHH-HHHHHHH----------------------------------------------
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIA-FGVARGV----------------------------------------------  247 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~-~~ia~~l----------------------------------------------  247 (344)
                      +.+.+....       .+    .+++ ..+++.|                                              
T Consensus       112 ~~~~~~~~~-------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         112 VWSALPPES-------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ccCcCCccc-------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            333221100       00    1111 1333333                                              


Q ss_pred             ----HHHHh-----CCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          248 ----EYLHQ-----GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       248 ----~yLH~-----~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                          .+|++     .....++|+|+.+.|++++++.-+-|.||+++..-.+
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                34433     1224689999999999999988899999999876543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.25  E-value=0.00052  Score=60.95  Aligned_cols=142  Identities=17%  Similarity=0.230  Sum_probs=94.4

Q ss_pred             cCHHHHHHHHH-----hhcccccccCcEEEEEEEEeCCceEEEEEeec-------cccc----------h------HHHH
Q 041350          125 YTYKELKKITS-----KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEH-------LKGN----------G------QEFI  176 (344)
Q Consensus       125 ~~~~~l~~~~~-----~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~-------~~~~----------~------~~~~  176 (344)
                      +.|--|+..+.     .+.+.||-|.-+.+|.+...+|.+.++|.-+.       .+..          .      -...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            45555554433     45678999999999999988899999986321       0000          0      1235


Q ss_pred             HHHHHHhhhccc--ceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 041350          177 NEVATIGRIHHF--HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC  254 (344)
Q Consensus       177 ~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  254 (344)
                      +|...|+.+...  -+.+.++    .+..++|||++.+-.|...-+         ..+..++..   .+..-+.-|-.  
T Consensus       159 kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~---------v~d~~~ly~---~lm~~Iv~la~--  220 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH---------VEDPPTLYD---DLMGLIVRLAN--  220 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee---------cCChHHHHH---HHHHHHHHHHH--
Confidence            688888888532  3444444    356789999998877765421         122233222   22233344555  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                       +|+||+|..-=||++++++.++++||.-..
T Consensus       221 -~GlIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  221 -HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             -cCceecccchheeEEecCCCEEEeechHhh
Confidence             899999999999999999999999997543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.22  E-value=0.0041  Score=55.21  Aligned_cols=34  Identities=26%  Similarity=0.451  Sum_probs=27.6

Q ss_pred             CCeeecCCCCCceEEcCCCc-eEEeecCCcccccC
Q 041350          256 QRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSK  289 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~~~~-~kl~Dfgla~~~~~  289 (344)
                      ..++|+|++|.|||+++++. .-|.||+.+....+
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP  219 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP  219 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence            45899999999999997555 46999999876543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.22  E-value=0.0081  Score=54.49  Aligned_cols=143  Identities=23%  Similarity=0.308  Sum_probs=86.7

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc------eeeEeeE----EEcCCeEEEEEecc
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGF----CSEGTRRALVYEFM  210 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~----~~~~~~~~lv~e~~  210 (344)
                      |.+ .-..+|+....+|+. ++|+.+.. ....+...|++.|..+.-.+      +..+-|-    ...+...+-+++|+
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 455789988777766 88888776 66677888888888884322      2222221    11223778899999


Q ss_pred             CCCCHHH---------------HHhccC------CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHh----
Q 041350          211 PNGSLEK---------------FIFSKT------NSSSHRPLSWEK-------------LKKIAFGVARGVEYLHQ----  252 (344)
Q Consensus       211 ~~gsL~~---------------~l~~~~------~~~~~~~l~~~~-------------~~~i~~~ia~~l~yLH~----  252 (344)
                      +|..+..               .|+...      .........|..             ......++...+..+.+    
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988872               111111      111111233431             11123344445555544    


Q ss_pred             CCCCC---eeecCCCCCceEEcCCCc-eEEeecCCccc
Q 041350          253 GCNQR---ILHFDIKPHNILLDHNFQ-PKISDFGLAKL  286 (344)
Q Consensus       253 ~~~~~---ivH~Dik~~Nill~~~~~-~kl~Dfgla~~  286 (344)
                      ..+..   +||+|+.|.||+++++.. ..+.||+-+..
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            11223   999999999999998875 89999997753

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.16  E-value=0.012  Score=54.83  Aligned_cols=78  Identities=12%  Similarity=0.051  Sum_probs=51.3

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeec-----cc---cchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEH-----LK---GNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.||.|.-..||+... .+..+.||.-..     ..   -....-..|.+.|+.+.   ..++.+++.++.+  ..+++|
T Consensus        38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            5689999999999874 455788997641     11   12233444566666553   3478888888774  357889


Q ss_pred             eccCC--CCHHHHH
Q 041350          208 EFMPN--GSLEKFI  219 (344)
Q Consensus       208 e~~~~--gsL~~~l  219 (344)
                      ||+++  ..+.+.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3455533

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.06  E-value=0.02  Score=51.57  Aligned_cols=31  Identities=29%  Similarity=0.378  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ..+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            368999999999999987 5789999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=97.06  E-value=0.026  Score=51.38  Aligned_cols=141  Identities=18%  Similarity=0.149  Sum_probs=78.7

Q ss_pred             cCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc--ceeeEe---e--EEEcCCeEEEEEeccCCCCHH
Q 041350          144 GGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLL---G--FCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       144 G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~---~--~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.-..||+....++..+++|+.+.......+...|.+.+..|...  .++...   |  ....++..+.++++++|....
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~~  115 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAPE  115 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCCC
Confidence            345679998877788899998865444566777888888777422  122211   2  122345678899999876431


Q ss_pred             -----------H---HHhccCC--C-CCCCCCCHHH-----HH-----------------HHHHHHHHHHHH-HHh-CCC
Q 041350          217 -----------K---FIFSKTN--S-SSHRPLSWEK-----LK-----------------KIAFGVARGVEY-LHQ-GCN  255 (344)
Q Consensus       217 -----------~---~l~~~~~--~-~~~~~l~~~~-----~~-----------------~i~~~ia~~l~y-LH~-~~~  255 (344)
                                 .   -++....  . ..+..++...     +.                 .++.++...++- +.. ...
T Consensus       116 ~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  195 (325)
T PRK11768        116 LDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPSDLRPAYLAAADQLLAAVEACWARGDVR  195 (325)
T ss_pred             CCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence                       1   1222111  0 1111222111     00                 111111111111 111 134


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          256 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      .+++|+|+.+.|||++ + .+.|.||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            6789999999999995 4 578999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.04  E-value=0.002  Score=54.79  Aligned_cols=127  Identities=20%  Similarity=0.252  Sum_probs=64.2

Q ss_pred             CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCCHHHH-----------------
Q 041350          157 GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGSLEKF-----------------  218 (344)
Q Consensus       157 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~-----------------  218 (344)
                      .+.|.|++........-+..+|..+++.+...++ .++++++.. +   .|++|+++.+|..-                 
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4578888887765666677889999999876554 455555433 2   57799977654320                 


Q ss_pred             HhccCC-CCCCCCCCHHHHHHH----------------------HHHHHHHHHHHHh-----CCCCCeeecCCCCCceEE
Q 041350          219 IFSKTN-SSSHRPLSWEKLKKI----------------------AFGVARGVEYLHQ-----GCNQRILHFDIKPHNILL  270 (344)
Q Consensus       219 l~~~~~-~~~~~~l~~~~~~~i----------------------~~~ia~~l~yLH~-----~~~~~ivH~Dik~~Nill  270 (344)
                      +|.... ......--|..+..+                      ..++..-+..+.+     ..+..+.|.|+.|.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence            111110 000111112222222                      0111111222211     112467999999999999


Q ss_pred             -cCCCceEEeecCCcccc
Q 041350          271 -DHNFQPKISDFGLAKLC  287 (344)
Q Consensus       271 -~~~~~~kl~Dfgla~~~  287 (344)
                       +.++.++++||..|...
T Consensus       158 ~~~~~~~~lIDfEya~~n  175 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGYN  175 (211)
T ss_dssp             TSSSSCEEE--GTT-EEE
T ss_pred             ccCCCeEEEecHHHHhhc
Confidence             88999999999988643

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.03  E-value=0.014  Score=53.41  Aligned_cols=78  Identities=18%  Similarity=0.077  Sum_probs=49.2

Q ss_pred             cccccCcEEEEEEEEeCC-ceEEEEEeec--------cccchHHHHHHHHHHhhhc--cc-ceeeEeeEEEcCCeEEEEE
Q 041350          140 RLGQGGYGSVFRGKLFNG-IPVAVKMLEH--------LKGNGQEFINEVATIGRIH--HF-HIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~-~~vavK~~~~--------~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  207 (344)
                      .||.|.-.-||++...+| +.|.||.-..        .+-..++..-|.+.|+...  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999987654 5799997531        1222345556777776653  23 34444433  445567999


Q ss_pred             eccCCC-CHHHHH
Q 041350          208 EFMPNG-SLEKFI  219 (344)
Q Consensus       208 e~~~~g-sL~~~l  219 (344)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999653 444444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.02  E-value=0.00013  Score=76.13  Aligned_cols=161  Identities=12%  Similarity=0.038  Sum_probs=112.2

Q ss_pred             HHHHHHHHhhhcccceeeEeeEEE--cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 041350          175 FINEVATIGRIHHFHIVRLLGFCS--EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ  252 (344)
Q Consensus       175 ~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~  252 (344)
                      .+.|...++...|+++.....-..  ++...+..++|+..|.+.+.|.....  ....++..-......+...+..-.|+
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e--e~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE--ESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc--cCCcchhchHHHHHHHHHhccchhhh
Confidence            344555666678998866554332  34466899999999999999866543  22444444444444443555555554


Q ss_pred             C--CCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHH
Q 041350          253 G--CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM  330 (344)
Q Consensus       253 ~--~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvv  330 (344)
                      .  ...-.+|+++++-|.+|..+.++++.++|+.+...+...  ......+++.|++|++....  .++.++|+|..|+-
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLS 1429 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHH
Confidence            2  224479999999999999999999999999994433322  12345678899999987654  67778999999999


Q ss_pred             HHHHHcCCCCC
Q 041350          331 LLEMVGCRKNK  341 (344)
Q Consensus       331 l~ell~g~~p~  341 (344)
                      +|+.--|.+++
T Consensus      1430 ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1430 LYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHhcccHHH
Confidence            99987776654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.82  E-value=0.0098  Score=53.73  Aligned_cols=33  Identities=15%  Similarity=0.194  Sum_probs=29.2

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ..+++|+|+.+.|+|+++++.+.++||..+..-
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            457999999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.77  E-value=0.035  Score=50.66  Aligned_cols=145  Identities=15%  Similarity=0.205  Sum_probs=81.8

Q ss_pred             cccccCcEEEEEEEEeC----CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      .|-.|-...+|+....+    +..+.+|+........-+..+|..+++.+..-++ .++++++. ++   +|.+|+++.+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~   96 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART   96 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence            34447777889886443    2378889876543333344678889988876555 45566553 22   5899998766


Q ss_pred             HHH-----------------HHhccCCCCCCCCCCHHHHHHHHHHH----------------------HHHHHHHHh---
Q 041350          215 LEK-----------------FIFSKTNSSSHRPLSWEKLKKIAFGV----------------------ARGVEYLHQ---  252 (344)
Q Consensus       215 L~~-----------------~l~~~~~~~~~~~l~~~~~~~i~~~i----------------------a~~l~yLH~---  252 (344)
                      |..                 .+|.........+--|..+..+..++                      ..-+..+..   
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            532                 11111111111111233222222111                      111222211   


Q ss_pred             --CCCCCeeecCCCCCceEEcC-CCceEEeecCCccccc
Q 041350          253 --GCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCS  288 (344)
Q Consensus       253 --~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~  288 (344)
                        ..+.-.+|.|+.+.|||+++ ++.++++||..|....
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence              12234799999999999975 5789999999886543

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.70  E-value=0.014  Score=54.10  Aligned_cols=79  Identities=19%  Similarity=0.168  Sum_probs=50.7

Q ss_pred             ccccccCcEEEEEEEEeC-CceEEEEEeec---c----ccchHHHHHHHHHHhhhc--cc-ceeeEeeEEEcCCeEEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEH---L----KGNGQEFINEVATIGRIH--HF-HIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~---~----~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  207 (344)
                      +.||-|.-.-||++...+ +..|.||.-..   .    +-..++..-|.+.|+...  -| .+++++.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            568999999999998643 56799986431   1    223356667777777663  24 45555543  445567899


Q ss_pred             eccCCC-CHHHHH
Q 041350          208 EFMPNG-SLEKFI  219 (344)
Q Consensus       208 e~~~~g-sL~~~l  219 (344)
                      |+++.. .|.+.|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            998643 344433

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.70  E-value=0.0078  Score=55.29  Aligned_cols=62  Identities=23%  Similarity=0.217  Sum_probs=44.7

Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      ....++-+|+++-++..++....       .++.....++.-.+.|+--+--  -.+.+|.|+.|.||++.
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~~~-------~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKWKS-------QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ccceeeeeccccccHHhhhhccc-------ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            45567888999999999985433       3445666777666666543332  16899999999999995

>PRK06148 hypothetical protein; Provisional

Probab=96.67  E-value=0.035  Score=58.31  Aligned_cols=145  Identities=19%  Similarity=0.212  Sum_probs=79.8

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc--cc--eeeEee--------EEEc-CC--eEE
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH--FH--IVRLLG--------FCSE-GT--RRA  204 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~n--iv~~~~--------~~~~-~~--~~~  204 (344)
                      .|+ |..-.+|+.+..+|..+++|+.+... .......|.+.|..|..  +.  +.+.+-        .... ++  ..+
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v  109 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL  109 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence            454 45677899887778889999987542 33344455556655521  22  223221        1111 22  457


Q ss_pred             EEEeccCCCCHHHH-----------------Hhc----cCCCCCCCCCCHHH-----------------HHHHHHHHHHH
Q 041350          205 LVYEFMPNGSLEKF-----------------IFS----KTNSSSHRPLSWEK-----------------LKKIAFGVARG  246 (344)
Q Consensus       205 lv~e~~~~gsL~~~-----------------l~~----~~~~~~~~~l~~~~-----------------~~~i~~~ia~~  246 (344)
                      -+++|++|..|.+.                 ++.    .........+.|..                 .+.++.++.+.
T Consensus       110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~  189 (1013)
T PRK06148        110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR  189 (1013)
T ss_pred             EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence            78999999877651                 111    01111112222321                 11222233322


Q ss_pred             HHH----HHhCCCCCeeecCCCCCceEEcCCC--ceE-EeecCCccc
Q 041350          247 VEY----LHQGCNQRILHFDIKPHNILLDHNF--QPK-ISDFGLAKL  286 (344)
Q Consensus       247 l~y----LH~~~~~~ivH~Dik~~Nill~~~~--~~k-l~Dfgla~~  286 (344)
                      ..-    .-.....++||+|+.+.|||++.+.  ++. |+|||-+..
T Consensus       190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            211    1123457899999999999999875  454 999998754

>PTZ00384 choline kinase; Provisional

Probab=96.40  E-value=0.063  Score=49.96  Aligned_cols=73  Identities=11%  Similarity=0.174  Sum_probs=44.4

Q ss_pred             cccccCcEEEEEEEEeCC--ce-----EEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFNG--IP-----VAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .|..|--..+|++...++  ..     |.++.........-+-.+|.++++.+...++ .++++.+..    ++++||++
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIe  132 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVE  132 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEec
Confidence            354588889999875443  22     4444332222222234678999999976555 445555532    59999999


Q ss_pred             CCCHH
Q 041350          212 NGSLE  216 (344)
Q Consensus       212 ~gsL~  216 (344)
                      |.+|.
T Consensus       133 Gr~l~  137 (383)
T PTZ00384        133 GNTMG  137 (383)
T ss_pred             cccCC
Confidence            87765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.04  E-value=0.031  Score=50.79  Aligned_cols=73  Identities=16%  Similarity=0.175  Sum_probs=57.7

Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      ...|++|++. |++|...          ....+++...+..+.+.-++-+..  +.+.-|||+.-.||||+ +|++.|+|
T Consensus       299 ~y~yl~~kdh-gt~is~i----------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         299 LYLYLHFKDH-GTPISII----------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             eEEEEEEecC-Cceeeee----------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence            3557777775 5554321          245688899999998888888876  57889999999999999 99999999


Q ss_pred             cCCcccc
Q 041350          281 FGLAKLC  287 (344)
Q Consensus       281 fgla~~~  287 (344)
                      |-+++..
T Consensus       365 fklsRl~  371 (488)
T COG5072         365 FKLSRLS  371 (488)
T ss_pred             eeeeecc
Confidence            9999954

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.94  E-value=0.067  Score=45.31  Aligned_cols=115  Identities=23%  Similarity=0.264  Sum_probs=73.8

Q ss_pred             cCcEEEEEEEEeCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhc
Q 041350          144 GGYGSVFRGKLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS  221 (344)
Q Consensus       144 G~fG~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  221 (344)
                      ++-++.-+++-.-| +..+|++....-  ...-|.++..++++++  .|+++..-  .+..+.++.|+|..-..      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            44555555542223 456677765443  3456788889988875  46666632  44466789998843111      


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          222 KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       222 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                                  ... .++.-=+++|.-.|++ +.+.+|+|-.|+||+-|..|.+||.|-+.
T Consensus       142 ------------~~~-N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ------------NFS-NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ------------chh-HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence                        111 1111124567777853 47899999999999999999999999764

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.93  E-value=0.067  Score=45.55  Aligned_cols=74  Identities=18%  Similarity=0.303  Sum_probs=51.4

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      .+--|.--..|... ....++.||+-..  .....|..|+.-|..+.   .-++.+.+.+..+.++.++|+||++-|.+.
T Consensus        23 ~v~gG~inea~~v~-dg~~~~FvK~n~~--~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          23 EVSGGDINEAWRLR-DGTDPFFVKCNQR--EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccCCccccceeEee-cCCcceEEEecch--hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            34444444445443 3456788887543  33457788877776664   456788888888999999999999987666

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	344
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-33
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-31
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-19
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-19
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-18
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-17
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-17
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-17
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-15
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-15
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-15
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-08
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		8e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-06
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-06
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-06
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-06
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-06
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-06
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-06
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-06
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-06
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-05
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 96/226 (42%), Positives = 137/226 (60%), Gaps = 11/226 (4%)
Query: 124 RYTYKELKKITSKFKHR--LGQGGYGSVFRGKLFNGIPVAVKML--EHLKGNGQEFINEV 179
           R++ +EL+  +  F ++  LG+GG+G V++G+L +G  VAVK L  E  +G   +F  EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
             I    H +++RL GFC   T R LVY +M NGS+   +  +    S  PL W K ++I
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRI 144
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS-KDISIVSLTA 298
           A G ARG+ YLH  C+ +I+H D+K  NILLD  F+  + DFGLAKL   KD  +    A
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX--XA 202
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
            RGT G+IAPE  S   G+ S K+DV+ YG+MLLE++  ++  D A
Sbjct: 203 VRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 246

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 96/226 (42%), Positives = 136/226 (60%), Gaps = 11/226 (4%)
Query: 124 RYTYKELKKITSKF--KHRLGQGGYGSVFRGKLFNGIPVAVKML--EHLKGNGQEFINEV 179
           R++ +EL+  +  F  K+ LG+GG+G V++G+L +G  VAVK L  E  +G   +F  EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
             I    H +++RL GFC   T R LVY +M NGS+   +  +    S  PL W K ++I
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRI 136
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS-KDISIVSLTA 298
           A G ARG+ YLH  C+ +I+H D+K  NILLD  F+  + DFGLAKL   KD  +    A
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX--XA 194
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
            RG  G+IAPE  S   G+ S K+DV+ YG+MLLE++  ++  D A
Sbjct: 195 VRGXIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 95/235 (40%), Positives = 131/235 (55%), Gaps = 32/235 (13%)
Query: 120 VNPTRY---TYKELKKITSKFKHR--------LGQGGYGSVFRGKLFNGIPVAVKML--- 165
           V+ TR+   ++ ELK +T+ F  R        +G+GG+G V++G + N   VAVK L   
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 166 -----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
                E LK   Q+F  E+  + +  H ++V LLGF S+G    LVY +MPNGSL   + 
Sbjct: 66  VDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
               +    PLSW    KIA G A G+ +LH+  N  I H DIK  NILLD  F  KISD
Sbjct: 123 CLDGTP---PLSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKSANILLDEAFTAKISD 176
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           FGLA+   K    V  +   GT  Y+APE      GE++ KSD+YS+G++LLE++
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 95/235 (40%), Positives = 130/235 (55%), Gaps = 32/235 (13%)
Query: 120 VNPTRY---TYKELKKITSKFKHR--------LGQGGYGSVFRGKLFNGIPVAVKML--- 165
           V+ TR+   ++ ELK +T+ F  R        +G+GG+G V++G + N   VAVK L   
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 166 -----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
                E LK   Q+F  E+  + +  H ++V LLGF S+G    LVY +MPNGSL   + 
Sbjct: 66  VDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
               +    PLSW    KIA G A G+ +LH+  N  I H DIK  NILLD  F  KISD
Sbjct: 123 CLDGTP---PLSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKSANILLDEAFTAKISD 176
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           FGLA+   K    V      GT  Y+APE      GE++ KSD+YS+G++LLE++
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 95/235 (40%), Positives = 130/235 (55%), Gaps = 32/235 (13%)
Query: 120 VNPTRY---TYKELKKITSKFKHR--------LGQGGYGSVFRGKLFNGIPVAVKML--- 165
           V+ TR+   ++ ELK +T+ F  R        +G+GG+G V++G + N   VAVK L   
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 59
Query: 166 -----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
                E LK   Q+F  E+  + +  H ++V LLGF S+G    LVY +MPNGSL   + 
Sbjct: 60  VDITTEELK---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 116
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
               +    PLSW    KIA G A G+ +LH+  N  I H DIK  NILLD  F  KISD
Sbjct: 117 CLDGTP---PLSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKSANILLDEAFTAKISD 170
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           FGLA+   K    V      GT  Y+APE      GE++ KSD+YS+G++LLE++
Sbjct: 171 FGLARASEKFAQXVMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEII 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 91/227 (40%), Positives = 123/227 (54%), Gaps = 29/227 (12%)
Query: 125 YTYKELKKITSKFKHR--------LGQGGYGSVFRGKLFNGIPVAVKML--------EHL 168
           +++ ELK +T+ F  R         G+GG+G V++G + N   VAVK L        E L
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 169 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
           K   Q+F  E+    +  H ++V LLGF S+G    LVY + PNGSL   +     +   
Sbjct: 65  K---QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP-- 119
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
            PLSW    KIA G A G+ +LH+  N  I H DIK  NILLD  F  KISDFGLA+   
Sbjct: 120 -PLSWHXRCKIAQGAANGINFLHE--NHHI-HRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           K    V  +   GT  Y APE      GE++ KSD+YS+G++LLE++
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEII 219

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 79/218 (36%), Positives = 123/218 (56%), Gaps = 10/218 (4%)
Query: 124 RYTYKELKKITSKFKHR--LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVAT 181
           R    +L++ T+ F H+  +G G +G V++G L +G  VA+K        G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +    H H+V L+GFC E     L+Y++M NG+L++ ++     +    +SWE+  +I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEIC 145
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
            G ARG+ YLH    + I+H D+K  NILLD NF PKI+DFG++K  ++          +
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           GT GYI PE F +  G ++ KSDVYS+G++L E++  R
Sbjct: 203 GTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/218 (36%), Positives = 123/218 (56%), Gaps = 10/218 (4%)
Query: 124 RYTYKELKKITSKFKHR--LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVAT 181
           R    +L++ T+ F H+  +G G +G V++G L +G  VA+K        G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +    H H+V L+GFC E     L+Y++M NG+L++ ++     +    +SWE+  +I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEIC 145
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
            G ARG+ YLH    + I+H D+K  NILLD NF PKI+DFG++K  ++          +
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           GT GYI PE F +  G ++ KSDVYS+G++L E++  R
Sbjct: 203 GTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 121/214 (56%), Gaps = 15/214 (7%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRL 193
            K ++G G +G+V R + ++G  VAVK+L     + +   EF+ EVA + R+ H +IV  
Sbjct: 41  IKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G  ++    ++V E++  GSL + +     S +   L   +   +A+ VA+G+ YLH  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHK---SGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            N  I+H ++K  N+L+D  +  K+ DFGL++L  K  + +S  +A GT  ++APE+   
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRK---NKDPA 344
                + KSDVYS+G++L E+   ++   N +PA
Sbjct: 214 E--PSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 118/214 (55%), Gaps = 15/214 (7%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRIHHFHIVRL 193
            K ++G G +G+V R + ++G  VAVK+L     + +   EF+ EVA + R+ H +IV  
Sbjct: 41  IKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G  ++    ++V E++  GSL + +     S +   L   +   +A+ VA+G+ YLH  
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHK---SGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            N  I+H D+K  N+L+D  +  K+ DFGL++L  K    +    A GT  ++APE+   
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRK---NKDPA 344
                + KSDVYS+G++L E+   ++   N +PA
Sbjct: 214 E--PSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 115/222 (51%), Gaps = 20/222 (9%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQ--E 174
           P +   + LK+   K    LG G +G+V++G          IPVA+K+L    G     E
Sbjct: 27  PNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 86
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSW 233
           F++E   +  + H H+VRLLG C   T + LV + MP+G L +++   K N  S   L+W
Sbjct: 87  FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW 145
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
                    +A+G+ YL +   +R++H D+   N+L+      KI+DFGLA+L   D   
Sbjct: 146 ------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +    +    ++A E    ++ + +++SDV+SYG+ + E++
Sbjct: 197 YNADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 115/222 (51%), Gaps = 20/222 (9%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQ--E 174
           P +   + LK+   K    LG G +G+V++G          IPVA+K+L    G     E
Sbjct: 4   PNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 63
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSW 233
           F++E   +  + H H+VRLLG C   T + LV + MP+G L +++   K N  S   L+W
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNW 122
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
                    +A+G+ YL +   +R++H D+   N+L+      KI+DFGLA+L   D   
Sbjct: 123 ------CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +    +    ++A E    ++ + +++SDV+SYG+ + E++
Sbjct: 174 YNADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELM 213

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV+EFM +G L  ++ ++         + E L  +   V  G+ YL + C  
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC-- 123
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 179
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 180 RYSSKSDVWSFGVLMWEV 197

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV+EFM +G L  ++ ++         + E L  +   V  G+ YL + C  
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 177
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 178 RYSSKSDVWSFGVLMWEV 195

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV+EFM +G L  ++ ++         + E L  +   V  G+ YL + C  
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC-- 126
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 182
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 183 RYSSKSDVWSFGVLMWEV 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K ++    +  +FI E   + ++ H  +V+L G 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV+EFM +G L  ++ ++         + E L  +   V  G+ YL + C  
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC-- 143
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 199
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 200 RYSSKSDVWSFGVLMWEV 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 119 TVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEF 175
            ++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVV 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 173
Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A+    + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 174 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQI 120
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 121 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 176
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQI 120
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 121 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 176
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 177 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQI 120
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 121 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 176
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 177 KWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 64
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQI 120
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 121 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 176
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 177 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A +  I H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  ++  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAM 122
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+    + A
Sbjct: 123 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTA 178
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE  S  + + S KSDV+++G++L E+ 
Sbjct: 179 PE--SLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A +  I H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  ++  +
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAM 122
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+    + A
Sbjct: 123 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTA 178
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE  S  + + S KSDV+++G++L E+ 
Sbjct: 179 PE--SLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K   RLG G +G V+ G   N   VAVK L+    + Q F+ E   +  + H 
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 68
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    +      ++ E+M  GSL  F+ S        P    KL   +  +A G+ 
Sbjct: 69  KLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMA 124
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +   +  +H D++  N+L+  +   KI+DFGLA++  +D    +   A+    + AP
Sbjct: 125 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAP 180
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KSDV+S+G++L E+V
Sbjct: 181 EAI--NFGCFTIKSDVWSFGILLYEIV 205

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV EFM +G L  ++ ++         + E L  +   V  G+ YL + C  
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 180
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 181 RYSSKSDVWSFGVLMWEV 198

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 116/220 (52%), Gaps = 13/220 (5%)
Query: 119 TVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEF 175
           +++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF
Sbjct: 2   SMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL----RECNRQEVNAVV 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 173
Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A+    + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 174 HAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 116/220 (52%), Gaps = 13/220 (5%)
Query: 119 TVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEF 175
           +++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF
Sbjct: 2   SMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVV 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 173
Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A+    + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 174 HAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 121
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 122 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPI 177
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 178 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 12/216 (5%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINE 178
           V+P  Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E
Sbjct: 1   VSPN-YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
            A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLY 115
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   
Sbjct: 116 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAG 171
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           A+    + APE  S  + + S KSDV+++G++L E+
Sbjct: 172 AKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 122
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 123 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPI 178
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 179 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 26/232 (11%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG---IPVAVKMLEHL--KGNGQEF 175
           NP    Y  L     KF+  +G+G +G V + ++      +  A+K ++    K + ++F
Sbjct: 3   NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 62
Query: 176 INEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-----------FSKT 223
             E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F+           F+  
Sbjct: 63  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 122
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           NS++   LS ++L   A  VARG++YL Q   ++ +H D+   NIL+  N+  KI+DFGL
Sbjct: 123 NSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 178
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++   +++  V  T  R    ++A E  S N+   +  SDV+SYG++L E+V
Sbjct: 179 SR--GQEV-YVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 114/216 (52%), Gaps = 12/216 (5%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINE 178
           V+P  Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E
Sbjct: 1   VSPN-YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
            A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLY 115
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   
Sbjct: 116 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAG 171
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           A+    + APE  S  + + S KSDV+++G++L E+
Sbjct: 172 AKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 65
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 121
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 122 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPI 177
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 178 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 119 TVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEF 175
            ++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVV 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTA 173
Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A+    + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 174 HAGAKFPIKWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 119 TVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEF 175
            ++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 61
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVV 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L  +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +
Sbjct: 118 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 173
Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A+    + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 174 HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 211

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 26/232 (11%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG---IPVAVKMLEHL--KGNGQEF 175
           NP    Y  L     KF+  +G+G +G V + ++      +  A+K ++    K + ++F
Sbjct: 13  NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 72
Query: 176 INEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-----------FSKT 223
             E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F+           F+  
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           NS++   LS ++L   A  VARG++YL Q   ++ +H D+   NIL+  N+  KI+DFGL
Sbjct: 133 NSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++   +++  V  T  R    ++A E  S N+   +  SDV+SYG++L E+V
Sbjct: 189 SR--GQEV-YVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 68
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 124
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 125 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 180
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 181 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 210

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 18  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 77
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 133
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 134 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 189
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 190 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 76
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+  KT S     L+  KL  +A  +A G+ 
Sbjct: 77  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIK--LTINKLLDMAAQIAEGMA 131
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 132 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 187
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 188 EAI--NYGTFTIKSDVWSFGILLTEIV 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 122
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 123 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 178
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 179 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIG 183
           Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A + 
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 66
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  +A  +
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLYMATQI 122
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           +  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+   
Sbjct: 123 SSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 178
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            + APE  S  + + S KSDV+++G++L E+ 
Sbjct: 179 KWTAPE--SLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+  KT S     L+  KL  +A  +A G+ 
Sbjct: 75  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIK--LTINKLLDMAAQIAEGMA 129
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 185
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 186 EAI--NYGTFTIKSDVWSFGILLTEIV 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 70  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 125 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 180
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 181 EAI--NYGTFTIKSDVWSFGILLTEIV 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 180 EAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A +  I H
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 87
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            ++V+LLG C+      +V E+MP G+L  ++       +   ++   L  +A  ++  +
Sbjct: 88  PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL----RECNREEVTAVVLLYMATQISSAM 143
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+    + A
Sbjct: 144 EYLEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTA 199
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
           PE  + N    S KSDV+++G++L E+
Sbjct: 200 PESLAYN--TFSIKSDVWAFGVLLWEI 224

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 70
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 71  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 126 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 181
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 182 EAI--NYGTFTIKSDVWSFGILLTEIV 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 180 EAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 74  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 129 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 185 EAI--NYGTFTIKSDVWSFGILLTEIV 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 75  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 130 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 185
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 186 EAI--NYGTFTIKSDVWSFGILLTEIV 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+  KT S     L+  KL  +A  +A G+ 
Sbjct: 78  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIK--LTINKLLDMAAQIAEGMA 132
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 133 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAP 188
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 189 EAI--NYGTFTIKSDVWSFGILLTEIV 213

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 180 EAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 64  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 119 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 174
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 175 EAI--NYGTFTIKSDVWSFGILLTEIV 199

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+  KT S     L+  KL  +A  +A G+ 
Sbjct: 79  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIK--LTINKLLDMAAQIAEGMA 133
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 134 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 189
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 190 EAI--NYGTFTIKSDVWSFGILLTEIV 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           E+++     KH+LG G +G V+ G      + VAVK L+      +EF+ E A +  I H
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  ++  +
Sbjct: 67  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAM 122
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  +   A+    + A
Sbjct: 123 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTA 178
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE  + N  + S KSDV+++G++L E+ 
Sbjct: 179 PESLAYN--KFSIKSDVWAFGVLLWEIA 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 11/211 (5%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAV-KMLEHLKGNGQEFINEVATIGRI 185
           Y E++        R+G G +G+V++GK    + V + K+++      Q F NEVA + + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
            H +I+  +G+ ++    A+V ++    SL K +  +            +L  IA   A+
Sbjct: 90  RHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETK-----FQMFQLIDIARQTAQ 143
Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           G++YLH    + I+H D+K +NI L      KI DFGLA + S+      +    G+  +
Sbjct: 144 GMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 306 IAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
           +APE+   ++    S++SDVYSYG++L E++
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G  G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+  KT S     L+  KL  +A  +A G+ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL--KTPSGIK--LTINKLLDMAAQIAEGMA 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H D++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 124 FIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 180 EAI--NYGTFTIKSDVWSFGILLTEIV 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 10/207 (4%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K   +LG G +G V+ G   N   VAVK L+    + Q F+ E   +  + H 
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD 67
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ EFM  GSL  F+ S        P    KL   +  +A G+ 
Sbjct: 68  KLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP----KLIDFSAQIAEGMA 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +   +  +H D++  N+L+  +   KI+DFGLA++  +D    +   A+    + AP
Sbjct: 124 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KS+V+S+G++L E+V
Sbjct: 180 EAI--NFGCFTIKSNVWSFGILLYEIV 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C E     LV+EFM +G L  ++ ++         + E L  +   V  G+ YL +    
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYLEEA--- 122
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            ++H D+   N L+  N   K+SDFG+ +    D    S T  +    + +PE+FS  F 
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS--FS 179
Query: 317 EVSYKSDVYSYGMMLLEM 334
             S KSDV+S+G+++ E+
Sbjct: 180 RYSSKSDVWSFGVLMWEV 197

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 114/217 (52%), Gaps = 12/217 (5%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINE 178
           V+P  Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E
Sbjct: 208 VSPN-YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 266
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
            A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLY 322
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           +A  ++  +EYL +   +  +H ++   N L+  N   K++DFGL++L + D +  +   
Sbjct: 323 MATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAG 378
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           A+    + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 379 AKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 413

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 141 LGQGGYGSVFRGKLFNG-----IPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRL 193
           +G G +G V++G L        +PVA+K L+  + +    +F+ E   +G+  H +I+RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G  S+     ++ E+M NG+L+KF+  K         S  +L  +  G+A G++YL   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAAGMKYL--- 163
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA-ARGTAGYIAPELFS 312
            N   +H D+   NIL++ N   K+SDFGL+++   D      T+  +    + APE  S
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
             + + +  SDV+S+G+++ E++
Sbjct: 224 --YRKFTSASDVWSFGIVMWEVM 244

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 121/232 (52%), Gaps = 26/232 (11%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG---IPVAVKMLEHL--KGNGQEF 175
           NP    Y  L     KF+  +G+G +G V + ++      +  A+K ++    K + ++F
Sbjct: 10  NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF 69
Query: 176 INEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-----------FSKT 223
             E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F+           F+  
Sbjct: 70  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 129
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           NS++   LS ++L   A  VARG++YL Q   ++ +H ++   NIL+  N+  KI+DFGL
Sbjct: 130 NSTAS-TLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGL 185
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++   +++  V  T  R    ++A E  S N+   +  SDV+SYG++L E+V
Sbjct: 186 SR--GQEV-YVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 118/233 (50%), Gaps = 24/233 (10%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHR----LGQGGYGSVFRGKLFN-----GIPVAVKML 165
           E    ++P+    K L +I  + + R    LG G +G+V +G          IPV +K++
Sbjct: 9   ESIEPLDPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI 68
Query: 166 EHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           E   G    Q   + +  IG + H HIVRLLG C  G+   LV +++P GSL   +    
Sbjct: 69  EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHV---- 123
Query: 224 NSSSHR-PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
               HR  L  + L      +A+G+ YL +     ++H ++   N+LL    Q +++DFG
Sbjct: 124 --RQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFG 178
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +A L   D   +  + A+    ++A  L S +FG+ +++SDV+SYG+ + E++
Sbjct: 179 VADLLPPDDKQLLYSEAKTPIKWMA--LESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + T K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H 
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 64
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +VRL    ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ 
Sbjct: 65  RLVRLYAVVTQEP-IYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ +   +  +H +++  NIL+      KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 120 FIEE---RNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAP 175
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    N+G  + KSDV+S+G++L E+V
Sbjct: 176 EAI--NYGTFTIKSDVWSFGILLTEIV 200

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 114/209 (54%), Gaps = 16/209 (7%)
Query: 134 TSKFKH--RLGQGGYGSVFRG-KLFNGIPVAVK--MLEHLKGNGQEFINEVATIGRIHHF 188
           +S+FK   +LG G Y +V++G     G+ VA+K   L+  +G     I E++ +  + H 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +IVRL        +  LV+EFM N  L+K++ S+T  ++ R L    +K   + + +G+ 
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           + H+    +ILH D+KP N+L++   Q K+ DFGLA+     I + + ++   T  Y AP
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG--IPVNTFSSEVVTLWYRAP 177
Query: 309 ELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           ++     G  +Y +  D++S G +L EM+
Sbjct: 178 DVL---MGSRTYSTSIDIWSCGCILAEMI 203

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 114/217 (52%), Gaps = 12/217 (5%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINE 178
           V+P  Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E
Sbjct: 247 VSPN-YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 305
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
            A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + ++   L  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVNAVVLLY 361
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           +A  ++  +EYL +   +  +H ++   N L+  N   K++DFGL++L + D +  +   
Sbjct: 362 MATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAG 417
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           A+    + APE  + N  + S KSDV+++G++L E+ 
Sbjct: 418 AKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 452

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 18  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   + +     S      +KL  IA   ARG++YLH    
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA--- 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 187 SNPYSFQSDVYAFGIVLYELM 207

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 63
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 64  KLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 118
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 119 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAP 174
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 175 E--AALYGRFTIKSDVWSFGILLTELT 199

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K + +LG G +G V+         VAVK ++    + + F+ E   +  + H 
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    ++     ++ EFM  GSL  F+  K++  S +PL   KL   +  +A G+ 
Sbjct: 244 KLVKLHAVVTKEPI-YIITEFMAKGSLLDFL--KSDEGSKQPLP--KLIDFSAQIAEGMA 298
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ Q   +  +H D++  NIL+  +   KI+DFGLA++  +D    +   A+    + AP
Sbjct: 299 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAP 354
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KSDV+S+G++L+E+V
Sbjct: 355 EAI--NFGSFTIKSDVWSFGILLMEIV 379

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 110/207 (53%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K + +LG G +G V+         VAVK ++    + + F+ E   +  + H 
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 70
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    ++     ++ EFM  GSL  F+  K++  S +PL   KL   +  +A G+ 
Sbjct: 71  KLVKLHAVVTKEPIY-IITEFMAKGSLLDFL--KSDEGSKQPLP--KLIDFSAQIAEGMA 125
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ Q   +  +H D++  NIL+  +   KI+DFGLA++  +D    +   A+    + AP
Sbjct: 126 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAP 181
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KSDV+S+G++L+E+V
Sbjct: 182 EAI--NFGSFTIKSDVWSFGILLMEIV 206

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 122/235 (51%), Gaps = 22/235 (9%)
Query: 113 FLEDYRTVNP---TRYTYKELKKITSKFKHRLGQGGYGSVFRGKL-FNG---IPVAVKML 165
           F++ +   +P    R   KE+     K +  +G G +G V  G L   G   I VA+K L
Sbjct: 10  FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 69
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F++E + +G+  H +++ L G  ++ T   ++ EFM NGSL+ F+  + 
Sbjct: 70  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL--RQ 127
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           N      +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 128 NDGQFTVI---QLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGL 181
Query: 284 AKLCSKDISIVSLTAARG---TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++    D S  + T+A G      + APE     + + +  SDV+SYG+++ E++
Sbjct: 182 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVM 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 66
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 67  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 121
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 122 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 177
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 178 E--AALYGRFTIKSDVWSFGILLTELT 202

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + S   + A+V ++    SL   + +     S      +KL  IA   ARG++YLH    
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+   ++
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELM 219

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 240 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 294
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 350
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 351 E--AALYGRFTIKSDVWSFGILLTELT 375

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 240 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 294
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 350
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 351 E--AALYGRFTIKSDVWSFGILLTELT 375

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   + +     S      +KL  IA   ARG++YLH    
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+   ++
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELM 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 240 KLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 294
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 350
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 351 E--AALYGRFTIKSDVWSFGILLTELT 375

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +G G  G V  G+L       +PVA+K L+  + +   ++F++E + +G+  H +I+RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  + G    +V E+M NGSL+ F+ +          +  +L  +  GV  G+ YL    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGMRYL---S 168
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAGYIAPELFSR 313
           +   +H D+   N+L+D N   K+SDFGL+++   D  +  + T  +    + APE  + 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIA- 227
Query: 314 NFGEVSYKSDVYSYGMMLLEMVG 336
            F   S  SDV+S+G+++ E++ 
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 141 LGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRL 193
           LG G +G+V +G          IPV +K++E   G    Q   + +  IG + H HIVRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHR-PLSWEKLKKIAFGVARGVEYLHQ 252
           LG C  G+   LV +++P GSL   +        HR  L  + L      +A+G+ YL +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
                ++H ++   N+LL    Q +++DFG+A L   D   +  + A+    ++A  L S
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA--LES 188
Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
            +FG+ +++SDV+SYG+ + E++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +G G  G V  G+L       +PVA+K L+  + +   ++F++E + +G+  H +I+RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  + G    +V E+M NGSL+ F+ +          +  +L  +  GV  G+ YL    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGMRYL---S 168
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTAGYIAPELFSR 313
           +   +H D+   N+L+D N   K+SDFGL+++   D     + T  +    + APE  + 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA- 227
Query: 314 NFGEVSYKSDVYSYGMMLLEMVG 336
            F   S  SDV+S+G+++ E++ 
Sbjct: 228 -FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 118/233 (50%), Gaps = 27/233 (11%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 18  PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEH 76
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNS-SSHR 229
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N    ++
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 230 P-------LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
           P       L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI DFG
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 193
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           LA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  +A  +A G+ 
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMA 377
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 378 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 433
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 434 E--AALYGRFTIKSDVWSFGILLTELT 458

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + +I H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  ++  +A G+ 
Sbjct: 71  KLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLP----QLVDMSAQIASGMA 125
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAP 181
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 182 E--AALYGRFTIKSDVWSFGILLTELT 206

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           ELK+        LG G +G V  GK      VAVKM++    +  EF  E  T+ ++ H 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+  G CS+     +V E++ NG L  ++      S  + L   +L ++ + V  G+ 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-----RSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           +L    + + +H D+   N L+D +   K+SDFG+ +    D   VS    +    + AP
Sbjct: 119 FLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWSAP 174
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           E+F  ++ + S KSDV+++G+++ E+
Sbjct: 175 EVF--HYFKYSSKSDVWAFGILMWEV 198

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 70
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +T      P    +L  ++  +A G+ 
Sbjct: 71  KLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLP----QLVDMSAQIASGMA 125
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 126 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 181
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 182 E--AALYGRFTIKSDVWSFGILLTELT 206

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 113/225 (50%), Gaps = 20/225 (8%)
Query: 121 NPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGN 171
           +P R  +   KEL     K +  +G G +G V  G+L       + VA+K L+  + +  
Sbjct: 28  DPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ 87
Query: 172 GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL 231
            ++F+ E + +G+  H ++V L G  + G    +V EFM NG+L+ F+            
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-----F 142
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
           +  +L  +  G+A G+ YL    +   +H D+   NIL++ N   K+SDFGL+++   D 
Sbjct: 143 TVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDP 199
Query: 292 SIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             V + T  +    + APE     + + +  SDV+SYG+++ E++
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAI--QYRKFTSASDVWSYGIVMWEVM 242

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 62
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 63  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 117
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 118 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 173
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 174 E--AALYGRFTIKSDVWSFGILLTELT 198

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 64
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 65  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 119
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 120 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 175
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 176 E--AALYGRFTIKSDVWSFGILLTELT 200

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 115/219 (52%), Gaps = 23/219 (10%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLE--HLKGNGQEFINEV 179
           KE+     K +  +G G +G V RG+L    P      VA+K L+  + +   +EF++E 
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQRREFLSEA 66
Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
           + +G+  H +I+RL G  +      ++ EFM NG+L+ F+  + N      +   +L  +
Sbjct: 67  SIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVI---QLVGM 121
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
             G+A G+ YL +      +H D+   NIL++ N   K+SDFGL++   ++ S  + T++
Sbjct: 122 LRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS 178
Query: 300 RG---TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            G      + APE  +  F + +  SD +SYG+++ E++
Sbjct: 179 LGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEVM 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + +   RLG G +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD 64
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+         R L    L  +A  VA G+ 
Sbjct: 65  KLVQLYAVVSE-EPIYIVTEYMNKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+ +    KI+DFGLA+L  +D    +   A+    + AP
Sbjct: 120 YIER---MNYIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAP 175
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+V
Sbjct: 176 E--AALYGRFTIKSDVWSFGILLTELV 200

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           A++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KE++      +  +G G +G V  G+L       +PVA+K L+  + +   ++F+ E + 
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+ L G  ++     +V E+M NGSL+ F+  K N      +   +L  +  
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVI---QLVGMLR 131
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G++ G++YL    +   +H D+   NIL++ N   K+SDFGL+++   D      T   +
Sbjct: 132 GISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + APE  +  F + +  SDV+SYG+++ E+V
Sbjct: 189 IPIRWTAPEAIA--FRKFTSASDVWSYGIVMWEVV 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 116/224 (51%), Gaps = 23/224 (10%)
Query: 123 TRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLE--HLKGNGQE 174
            R   KE+     K +  +G G +G V RG+L    P      VA+K L+  + +   +E
Sbjct: 6   VREFAKEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQRRE 63
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
           F++E + +G+  H +I+RL G  +      ++ EFM NG+L+ F+  + N      +   
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVI--- 118
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           +L  +  G+A G+ YL +      +H D+   NIL++ N   K+SDFGL++   ++ S  
Sbjct: 119 QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 175
Query: 295 SLTAARG---TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           + T++ G      + APE  +  F + +  SD +SYG+++ E++
Sbjct: 176 TETSSLGGKIPIRWTAPEAIA--FRKFTSASDAWSYGIVMWEVM 217

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KE+     K +  +G G +G V  G L       I VA+K L+  + +   ++F++E + 
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +++ L G  ++ T   ++ EFM NGSL+ F+  + N      +   +L  +  
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVI---QLVGMLR 116
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
           G+A G++YL    +   +H  +   NIL++ N   K+SDFGL++    D S  + T+A G
Sbjct: 117 GIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 302 ---TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                 + APE     + + +  SDV+SYG+++ E++
Sbjct: 174 GKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVM 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + K + +LG G +G V+         VAVK ++    + + F+ E   +  + H 
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 237
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    ++     ++ EFM  GSL  F+  K++  S +PL   KL   +  +A G+ 
Sbjct: 238 KLVKLHAVVTKEPI-YIITEFMAKGSLLDFL--KSDEGSKQPLP--KLIDFSAQIAEGMA 292
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           ++ Q   +  +H D++  NIL+  +   KI+DFGLA++            A+    + AP
Sbjct: 293 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAP 338
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E    NFG  + KSDV+S+G++L+E+V
Sbjct: 339 EAI--NFGSFTIKSDVWSFGILLMEIV 363

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D+   NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  G L  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 16  PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEH 74
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 231 LSWEKLKK----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           ++ E L K           +F VA+G+E+L    +++ +H D+   NILL      KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGLA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHE 240
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+  +       P    +L  +A  +A G+ 
Sbjct: 241 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 295
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGL +L  +D    +   A+    + AP
Sbjct: 296 YVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAP 351
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 352 E--AALYGRFTIKSDVWSFGILLTELT 376

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 73
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  G L  F+  +       P    +L  +A  +A G+ 
Sbjct: 74  KLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMA 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L  +D    +   A+    + AP
Sbjct: 129 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAP 184
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E  +  +G  + KSDV+S+G++L E+ 
Sbjct: 185 E--AALYGRFTIKSDVWSFGILLTELT 209

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 23/244 (9%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 19  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 78
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K  
Sbjct: 79  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 138
Query: 225 SS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           +       RPL    L   +  VA+G+ +L    ++  +H D+   N+LL +    KI D
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 195
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           FGLA+    D + +    AR    ++APE +F   +   + +SDV+SYG++L E+     
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGL 252
Query: 340 NKDP 343
           N  P
Sbjct: 253 NPYP 256

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 120/260 (46%), Gaps = 40/260 (15%)
Query: 116 DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLE 166
           +Y  V+   Y Y    E  +   +F   LG G +G V     +        I VAVKML+
Sbjct: 25  EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84
Query: 167 HLKGNGQE---FINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK 222
             K +  E    ++E+  + ++  H +IV LLG C+      L++E+   G L  ++ SK
Sbjct: 85  E-KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 223 TNSSSHRPLSWEKLKKI-----------------AFGVARGVEYLH-QGCNQRILHFDIK 264
               S   + +E  K++                 A+ VA+G+E+L  + C    +H D+ 
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLA 199
Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSD 323
             N+L+ H    KI DFGLA+    D + V    AR    ++APE LF    G  + KSD
Sbjct: 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE---GIYTIKSD 256
Query: 324 VYSYGMMLLEMVGCRKNKDP 343
           V+SYG++L E+     N  P
Sbjct: 257 VWSYGILLWEIFSLGVNPYP 276

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 7   PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEH 65
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 231 LSWEKLKK----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           ++ E L K           +F VA+G+E+L    +++ +H D+   NILL      KI D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGLA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 119/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            ++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 117 YRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGN 171
           Y   +PT +  + LK I+     +LG+G +GSV   +        G  VAVK L+H   +
Sbjct: 12  YACQDPTIFEERHLKYIS-----QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD 66
Query: 172 GQ-EFINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSH 228
            Q +F  E+  +  +H   IV+  G      R++L  V E++P+G L  F+        H
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRH 120
Query: 229 RP-LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL- 286
           R  L   +L   +  + +G+EYL    ++R +H D+   NIL++     KI+DFGLAKL 
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 287 -CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              KD  +V     +    + APE  S N    S +SDV+S+G++L E+   C K+  P+
Sbjct: 178 PLDKDYYVVR-EPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + S   + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELM 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 113/244 (46%), Gaps = 23/244 (9%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 27  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K  
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 146
Query: 225 SS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           +       RPL    L   +  VA+G+ +L    ++  +H D+   N+LL +    KI D
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 203
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           FGLA+    D + +    AR    ++APE +F   +   + +SDV+SYG++L E+     
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIFSLGL 260
Query: 340 NKDP 343
           N  P
Sbjct: 261 NPYP 264

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 7   PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEH 65
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 231 LSWEKLKK----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           ++ E L K           +F VA+G+E+L    +++ +H D+   NILL      KI D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGLA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 183 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 16  PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEH 74
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 231 LSWEKLKK----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
           ++ E L K           +F VA+G+E+L    +++ +H D+   NILL      KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGLA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 192 FGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEV 179
           E  +   K    LG+G +G V     F GI        VAVKML+    + +    ++E+
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSEL 81
Query: 180 ATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      ++ E L 
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 238 K----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           K           +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 288 SKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRI-HHFHI 190
           LG+G +G V     F GI        VAVKML+    + +    ++E+  +  I HH ++
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 191 VRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP------LSWEKLKKIAFGV 243
           V LLG C++ G    ++ EF   G+L  ++ SK N            L+ E L   +F V
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           A+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD   V    AR   
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 304 GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 211 KWMAPETIFDRVY---TIQSDVWSFGVLLWEI 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 65
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 125 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 5   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 63
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLN 122
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 123 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 214

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           +++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEV 179
           E  +   K    LG+G +G V     F GI        VAVKML+    + +    ++E+
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSEL 118
Query: 180 ATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      ++ E L 
Sbjct: 119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 238 K----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           K           +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+  
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 235
Query: 288 SKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 236 YKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 280

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           +++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 20  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 79
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + 
Sbjct: 80  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 137
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 138 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 191
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 192 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 242

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 116/225 (51%), Gaps = 20/225 (8%)
Query: 121 NPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGN 171
           +PT+  +   KEL          +G G +G V  G+L       I VA+K L+  + +  
Sbjct: 30  DPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 172 GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL 231
            ++F+ E + +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + + +    +
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVI 147
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
              +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL+++   D 
Sbjct: 148 ---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 292 SIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 28/215 (13%)
Query: 141 LGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRI-HHFHI 190
           LG+G +G V     F GI        VAVKML+    + +    ++E+  +  I HH ++
Sbjct: 36  LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 94
Query: 191 VRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNS--SSHRP-------LSWEKLKKIA 240
           V LLG C++ G    ++ EF   G+L  ++ SK N       P       L+ E L   +
Sbjct: 95  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
           F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD   V    AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 301 GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
               ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 212 LPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 243

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 8   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 66
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 126 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 177 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEV 179
           E  +   K    LG+G +G V     F GI        VAVKML+    + +    ++E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 180 ATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      ++ E L 
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 238 K----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           K           +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 288 SKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 190 YKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 124 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 5   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 63
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 122
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 123 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELM 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 185 KNPYSFQSDVYAFGIVLYELM 205

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEV 179
           E  +   K    LG+G +G V     F GI        VAVKML+    + +    ++E+
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSEL 72
Query: 180 ATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      ++ E L 
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 238 K----------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           K           +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 288 SKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 190 YKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 234

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 27/225 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG-QEFINEVA 180
           + +K+     K  LG+G +G VF  + +N  P      VAVK L+    N  ++F  E  
Sbjct: 8   QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE 67
Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRPLSW 233
            +  + H HIV+  G C EG    +V+E+M +G L KF+ +           +    L+ 
Sbjct: 68  LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQ 127
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            ++  IA  +A G+ YL    +Q  +H D+   N L+  N   KI DFG+    S+D+  
Sbjct: 128 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGM----SRDVYS 180
Query: 294 VSLTAARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                  G       ++ PE  S  + + + +SDV+S G++L E+
Sbjct: 181 TDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSLGVVLWEI 223

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 127
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 188 KNPYSFQSDVYAFGIVLYELM 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 127
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 188 KNPYSFQSDVYAFGIVLYELM 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 116/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 6   DPTQFEERHLK-----FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ EF+P GSL +++        H    
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI--- 117
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 118 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 293 IVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 173 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KEL          +G G +G V  G+L       I VA+K L+  + +   ++F+ E + 
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + + +    +   +L  +  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVI---QLVGMLR 125
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G+A G++YL    +   +H D+   NIL++ N   K+SDFGL+++   D      T   +
Sbjct: 126 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 183 IPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 149
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 210 KNPYSFQSDVYAFGIVLYELM 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 119/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           F++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 65
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 125 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 65
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 125 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 111/215 (51%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KEL          +G G +G V  G+L       I VA+K L+  + +   ++F+ E + 
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + + +    +   +L  +  
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVI---QLVGMLR 142
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G+A G++YL    +   +H D+   NIL++ N   K+SDFGL+++   D      T   +
Sbjct: 143 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 200 IPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 10  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 68
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 69  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 127
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 128 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 179 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 219

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 150
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE+   ++
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 211 KNPYSFQSDVYAFGIVLYELM 231

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 124 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 7   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 65
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 124
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 125 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 11  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 69
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 129 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 220

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 116/235 (49%), Gaps = 29/235 (12%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE 174
           P   +  E  +   K    LG+G +G V     F GI        VAVKML+    + + 
Sbjct: 18  PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEH 76
Query: 175 --FINEVATIGRI-HHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNS---SS 227
              ++E+  +  I HH ++V LLG C++ G    ++ EF   G+L  ++ SK N      
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 228 HRP-------LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
             P       L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 193
Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGLA+   KD   V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 194 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 245

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQEFINEVATI 182
           +K+     K  LG+G +G VF  +  N +P      VAVK L E  +   Q+F  E   +
Sbjct: 15  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 74
Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS---------SHRPLSW 233
             + H HIVR  G C+EG    +V+E+M +G L +F+ S    +         +  PL  
Sbjct: 75  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 134
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            +L  +A  VA G+ YL        +H D+   N L+      KI DFG+    S+DI  
Sbjct: 135 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYS 187
Query: 294 VSLTAARGTA----GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
                  G       ++ PE +  R F   + +SDV+S+G++L E+
Sbjct: 188 TDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEI 230

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 14  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 72
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 73  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 131
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 132 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 183 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 29  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 87
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 88  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 146
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 147 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 198 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 238

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQEFINEVATI 182
           +K+     K  LG+G +G VF  +  N +P      VAVK L E  +   Q+F  E   +
Sbjct: 9   IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 68
Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS---------SHRPLSW 233
             + H HIVR  G C+EG    +V+E+M +G L +F+ S    +         +  PL  
Sbjct: 69  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 128
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            +L  +A  VA G+ YL        +H D+   N L+      KI DFG+    S+DI  
Sbjct: 129 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYS 181
Query: 294 VSLTAARGTA----GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
                  G       ++ PE +  R F   + +SDV+S+G++L E+
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEI 224

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 25/212 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRI-HHFHI 190
           LG+G +G V     F GI        VAVKML+    + +    ++E+  +  I HH ++
Sbjct: 35  LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 191 VRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP------LSWEKLKKIAFGV 243
           V LLG C++ G    ++ EF   G+L  ++ SK N            L+ E L   +F V
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           A+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD   V    AR   
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 304 GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
            ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 211 KWMAPETIFDRVY---TIQSDVWSFGVLLWEI 239

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 119/236 (50%), Gaps = 29/236 (12%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ-E 174
           +PT +  + LK I+     +LG+G +GSV   +        G  VAVK L+H   + Q +
Sbjct: 3   DPTIFEERHLKYIS-----QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 57
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRP-L 231
           F  E+  +  +H   IV+  G      R++L  V E++P+G L  F+        HR  L
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARL 111
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSK 289
              +L   +  + +G+EYL    ++R +H D+   NIL++     KI+DFGLAKL    K
Sbjct: 112 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168
Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
           D  +V     +    + APE  S N    S +SDV+S+G++L E+   C K+  P+
Sbjct: 169 DYYVVR-EPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPS 221

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 136 KFKHRLGQGGYGSVFRGK--LFNGIPVAVKML--------EHLKGNGQEFINEVATIGRI 185
           K   +LG GG  +V+  +  + N I VA+K +        E LK     F  EV    ++
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLK----RFEREVHNSSQL 68
Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
            H +IV ++    E     LV E++   +L ++I       SH PLS +        +  
Sbjct: 69  SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI------ESHGPLSVDTAINFTNQILD 122
Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           G+++ H   + RI+H DIKP NIL+D N   KI DFG+AK  S + S+       GT  Y
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQY 178
Query: 306 IAPELFSRNFGEVSYK-SDVYSYGMMLLEMV 335
            +PE   +  GE + + +D+YS G++L EM+
Sbjct: 179 FSPE---QAKGEATDECTDIYSIGIVLYEML 206

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 116/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 6   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++ +      H    
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI--- 117
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 118 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 173 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 119/236 (50%), Gaps = 29/236 (12%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ-E 174
           +PT +  + LK I+     +LG+G +GSV   +        G  VAVK L+H   + Q +
Sbjct: 4   DPTIFEERHLKYIS-----QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 58
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRP-L 231
           F  E+  +  +H   IV+  G      R++L  V E++P+G L  F+        HR  L
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARL 112
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSK 289
              +L   +  + +G+EYL    ++R +H D+   NIL++     KI+DFGLAKL    K
Sbjct: 113 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169
Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
           D  +V     +    + APE  S N    S +SDV+S+G++L E+   C K+  P+
Sbjct: 170 DYYVVR-EPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPS 222

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 93  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 144
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK 201
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 202 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 30/222 (13%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH 186
           YKE++      +  +G+G +G V + K +    VA+K +E  +   + FI E+  + R++
Sbjct: 8   YKEIE-----VEEVVGRGAFGVVCKAK-WRAKDVAIKQIES-ESERKAFIVELRQLSRVN 60
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN----SSSHRPLSWEKLKKIAFG 242
           H +IV+L G C       LV E+   GSL   +         +++H  +SW         
Sbjct: 61  HPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHA-MSW------CLQ 111
Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARG 301
            ++GV YLH    + ++H D+KP N+LL       KI DFG A  C  DI    +T  +G
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--C--DIQ-THMTNNKG 166
Query: 302 TAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           +A ++APE+F   N+ E   K DV+S+G++L E++  RK  D
Sbjct: 167 SAAWMAPEVFEGSNYSE---KCDVFSWGIILWEVITRRKPFD 205

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 94  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 145
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 203 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 39/236 (16%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQ-EFINEVA 180
           E  +   ++   +G+G +G VF+ +    +P      VAVKML E    + Q +F  E A
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS------------------K 222
            +    + +IV+LLG C+ G    L++E+M  G L +F+ S                  +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            +S    PLS  +   IA  VA G+ YL +   ++ +H D+   N L+  N   KI+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 283 LAKLCSKDISIVSLTAARGTAG----YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           L    S++I       A G       ++ PE  S  +   + +SDV++YG++L E+
Sbjct: 220 L----SRNIYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEI 269

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQEFINEVATI 182
           +K+     K  LG+G +G VF  +  N +P      VAVK L E  +   Q+F  E   +
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS---------SHRPLSW 233
             + H HIVR  G C+EG    +V+E+M +G L +F+ S    +         +  PL  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            +L  +A  VA G+ YL        +H D+   N L+      KI DFG+    S+DI  
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYS 210
Query: 294 VSLTAARGTA----GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
                  G       ++ PE +  R F   + +SDV+S+G++L E+
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWEI 253

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 3   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 115 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 293 IVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 170 FFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 221

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 93  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 144
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 145 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 201
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 202 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 86  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 138 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 194
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 195 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 30/222 (13%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH 186
           YKE++      +  +G+G +G V + K +    VA+K +E  +   + FI E+  + R++
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAK-WRAKDVAIKQIES-ESERKAFIVELRQLSRVN 59
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN----SSSHRPLSWEKLKKIAFG 242
           H +IV+L G C       LV E+   GSL   +         +++H  +SW         
Sbjct: 60  HPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHA-MSW------CLQ 110
Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARG 301
            ++GV YLH    + ++H D+KP N+LL       KI DFG A  C  DI    +T  +G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--C--DIQ-THMTNNKG 165
Query: 302 TAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           +A ++APE+F   N+ E   K DV+S+G++L E++  RK  D
Sbjct: 166 SAAWMAPEVFEGSNYSE---KCDVFSWGIILWEVITRRKPFD 204

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 91  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 142
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 143 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 199
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 200 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 94  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 145
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 146 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 202
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 203 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 34  DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 88
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 89  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 145
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 146 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 201 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 251

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 2   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 56
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 57  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 113
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 114 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 168
Query: 293 IVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 169 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 220

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 113 LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 164
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 165 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 221
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 222 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 92  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 143
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 144 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 200
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 201 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 1   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 55
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 56  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 112
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 113 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 167
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 168 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 219

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
           LGQG +G V + +   +    A+K + H +      ++EV  +  ++H ++VR      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 200 GTRRALV---------------YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
             RR  V                E+  NG+L   I S+ N +  R   W   ++I     
Sbjct: 74  --RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQIL---- 126
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV---------- 294
             + Y+H   +Q I+H D+KP NI +D +   KI DFGLAK   + + I+          
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 295 --SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +LT+A GTA Y+A E+     G  + K D+YS G++  EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 112 LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 163
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 164 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 220
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 221 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 9   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 63
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 64  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 120
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 121 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 175
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 176 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 226

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 3   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 115 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 293 IVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 170 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 112/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +      + T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 6   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 117
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 118 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 173 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 89  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 140
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKD-ISIVSLTAARGTAG 304
           ++YL    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 141 MKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 198 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 119/233 (51%), Gaps = 20/233 (8%)
Query: 113 FLEDYRTVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML 165
           +++ +   +PT+  +   KEL          +G G +G V  G+L       I VA+K L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 166 E--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           +  + +   ++F+ E + +G+  H +I+RL G  ++     +V E M NGSL+ F+  + 
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK 139
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           + +    +   +L  +  G+A G++YL    +   +H D+   NIL++ N   K+SDFGL
Sbjct: 140 HDAQFTVI---QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 284 AKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +++   D      T   +    + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 244

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQEFINEVAT 181
           LK+   K    LG G +G+V++G          IPVA+K L      K N +E ++E   
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 64
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSWEKLKKIA 240
           +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+W       
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 117
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +         +
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 301 GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
               ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 VPIKWMALESILHRIY---THQSDVWSYGVTVWELM 207

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 95  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 146
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 204 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 3   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 114
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 115 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 293 IVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 170 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 221

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 8   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 62
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 63  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 120 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 174
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 175 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 225

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 140 RLGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVKM++  K   +E + NEV  +    HF++V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    ++ EF+  G+L       T+  S   L+ E++  +   V + + YLH    Q 
Sbjct: 112 LVGEELWVLMEFLQGGAL-------TDIVSQVRLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           ++H DIK  +ILL  + + K+SDFG     SKD+         GT  ++APE+ SR+   
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKXLVGTPYWMAPEVISRSL-- 217
Query: 318 VSYKSDVYSYGMMLLEMV 335
            + + D++S G+M++EMV
Sbjct: 218 YATEVDIWSLGIMVIEMV 235

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/236 (32%), Positives = 118/236 (50%), Gaps = 31/236 (13%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ-EF 175
           PT +  + LK I+     +LG+G +GSV   +        G  VAVK L+H   + Q +F
Sbjct: 1   PTIFEERHLKYIS-----QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF 55
Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRA---LVYEFMPNGSLEKFIFSKTNSSSHRP-L 231
             E+  +  +H   IV+  G  S G  R    LV E++P+G L  F+        HR  L
Sbjct: 56  QREIQILKALHSDFIVKYRGV-SYGPGRPELRLVMEYLPSGCLRDFL------QRHRARL 108
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL--CSK 289
              +L   +  + +G+EYL    ++R +H D+   NIL++     KI+DFGLAKL    K
Sbjct: 109 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165
Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
           D  +V     +    + APE  S N    S +SDV+S+G++L E+   C K+  P+
Sbjct: 166 DXXVVR-EPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+   ++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELM 203

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 7   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 61
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 62  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 118
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 119 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 173
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 174 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 225

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 142
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+   ++
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 203 KNPYSFQSDVYAFGIVLYELM 223

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 25/233 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 10  DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 64
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 65  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H D+   NIL+++  + KI DFGL K+  +D  
Sbjct: 122 --KLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 176
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 177 XXKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 227

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG--------QEFINEVATIGRIH 186
           +++ ++G+GG+G V +G+L  +   VA+K L      G        QEF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H +IV+L G      R  +V EF+P G L   +  K +     P+ W    ++   +A G
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALG 134
Query: 247 VEYLHQGCNQRILHFDIKPHNILL---DHNFQ--PKISDFGLAKLCSKDISIVSLTAARG 301
           +EY+ Q  N  I+H D++  NI L   D N     K++DFGL++      S+ S++   G
Sbjct: 135 IEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
              ++APE         + K+D YS+ M+L
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMIL 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLG 195
            R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           + ++  + A+V ++    SL   +               KL  IA   A+G++YLH    
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHA--- 150
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+   ++
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               S++SDVY++G++L E++
Sbjct: 211 KNPYSFQSDVYAFGIVLYELM 231

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KEL          +G G +G V  G+L       I VA+K L+  + +   ++F+ E + 
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+RL G  ++     +V E M NGSL+ F+  + + +    +   +L  +  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVI---QLVGMLR 125
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G+A G++YL    +   +H D+   NIL++ N   K+SDFGL+++   D      T   +
Sbjct: 126 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + +PE  +  + + +  SDV+SYG++L E++
Sbjct: 183 IPIRWTSPEAIA--YRKFTSASDVWSYGIVLWEVM 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 141 LGQGGYGSVFRGKLF---NGIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG G +GSV +G        I VA+K+L+    K + +E + E   + ++ + +IVRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C +     LV E    G L KF+  K       P+S   + ++   V+ G++YL +   
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEI---PVS--NVAELLHQVSMGMKYLEE--- 128
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +  +H D+   N+LL +    KISDFGL+K L + D    + +A +    + APE    N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 186
Query: 315 FGEVSYKSDVYSYGMMLLE 333
           F + S +SDV+SYG+ + E
Sbjct: 187 FRKFSSRSDVWSYGVTMWE 205

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +   G  VAVK ++  K   +E + NEV  +   HH ++V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V R + YLH   NQ 
Sbjct: 112 LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQG 161
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL  + + K+SDFG     SK++         GT  ++APE+ SR  +G
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKXLVGTPYWMAPEVISRLPYG 219
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EM+
Sbjct: 220 T---EVDIWSLGIMVIEMI 235

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 94  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 145
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 203 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 92  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 143
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 201 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 95  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 146
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 204 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    L  G +G+V++G          IPVA+K L      K N +
Sbjct: 11  PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 69
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 129 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 220

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 206 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 202 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 130 LKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQEFINEVAT 181
           LK+   K    LG G +G+V++G          IPVA+K L      K N +E ++E   
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 67
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLSWEKLKKIA 240
           +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+W       
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 120
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +         +
Sbjct: 121 VQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 301 GTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
               ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 178 VPIKWMALESILHRIY---THQSDVWSYGVTVWELM 210

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 99  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 150
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 208 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+  L      K N +
Sbjct: 38  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN-K 96
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 97  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 155
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 156 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 207 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 247

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 153 LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 204
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 262 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 116/211 (54%), Gaps = 25/211 (11%)
Query: 137 FKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHI 190
           F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +    H ++
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 191 VRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARG 246
           + LLG C  SEG+   +V  +M +G L  FI ++T++ + + L       I FG  VA+G
Sbjct: 94  LSLLGICLRSEGSP-LVVLPYMKHGDLRNFIRNETHNPTVKDL-------IGFGLQVAKG 145
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDI-SIVSLTAARGTAG 304
           +++L    +++ +H D+   N +LD  F  K++DFGLA+ +  K+  S+ + T A+    
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++A E  S    + + KSDV+S+G++L E++
Sbjct: 203 WMALE--SLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 124 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 215

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 124 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 8   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 66
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLN 125
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 126 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 176
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 177 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 217

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 205 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 266 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    L  G +G+V++G          IPVA+K L      K N +
Sbjct: 11  PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 69
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 129 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    L  G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFGLAKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   +I+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 207 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 62
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 122 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 172
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 213

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 212 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++           N      ++++ L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 209 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 6   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 65  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 124 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHL---KGNGQ 173
           P +   + LK+   K    LG G +G+V++G          IPVA+K L      K N +
Sbjct: 11  PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-K 69
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS-KTNSSSHRPLS 232
           E ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++   K N  S   L+
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLN 128
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    ++R++H D+   N+L+      KI+DFG AKL   +  
Sbjct: 129 W------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R +   +++SDV+SYG+ + E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIY---THQSDVWSYGVTVWELM 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN-------SSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++         + SH P   LS + L   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 198 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 116/250 (46%), Gaps = 29/250 (11%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 27  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-- 222
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K  
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRP 146
Query: 223 -----TNSSSHRP---LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 274
                + + SH P   LS   L   +  VA+G+ +L    ++  +H D+   N+LL +  
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGH 203
Query: 275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLE 333
             KI DFGLA+    D + +    AR    ++APE +F   +   + +SDV+SYG++L E
Sbjct: 204 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWE 260
Query: 334 MVGCRKNKDP 343
           +     N  P
Sbjct: 261 IFSLGLNPYP 270

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN-------SSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++         + SH P   LS + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIXETDXXRKGGKGLLPVR 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIXETDXXRKGGKGLLPVR 194
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 195 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIXETDXXRKGGKGLLPVR 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 124
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT---AGYIAPELFSR 313
           + LH D+   N L++     K+SDFGL++    D      T++RG+     +  PE+   
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSRGSKFPVRWSPPEVLM- 179
Query: 314 NFGEVSYKSDVYSYGMMLLEM 334
            + + S KSD++++G+++ E+
Sbjct: 180 -YSKFSSKSDIWAFGVLMWEI 199

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K      VAVKML  +  + +  + I+E+  +  I  H +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK-------TNSSSHRP---LSWEKLKKI 239
           I+ LLG C++     ++ E+   G+L +++ ++       + + SH P   LS + L   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A+ VARG+EYL    +++ +H D+   N+L+  +   KI+DFGLA+           T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G++L E+
Sbjct: 254 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 20/218 (9%)
Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQEFINEVATIGRIHHFH 189
           KF  +LG+G +GSV   +        G  VAVK L+H  + + ++F  E+  +  + H +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           IV+  G C    RR   L+ E++P GSL  ++        H      KL +    + +G+
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-----KLLQYTSQICKGM 145
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AARGTAGYI 306
           EYL     +R +H D+   NIL+++  + KI DFGL K+  +D     +         + 
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
           APE  + +  + S  SDV+S+G++L E+     K+K P
Sbjct: 203 APESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 20/219 (9%)
Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQEFINEVATIGRIHHFH 189
           KF  +LG+G +GSV   +        G  VAVK L+H  + + ++F  E+  +  + H +
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 90
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           IV+  G C    RR   L+ E++P GSL  ++        H      KL +    + +G+
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI-----KLLQYTSQICKGM 145
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AARGTAGYI 306
           EYL     +R +H D+   NIL+++  + KI DFGL K+  +D     +         + 
Sbjct: 146 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
           APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 203 APESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 125/258 (48%), Gaps = 35/258 (13%)
Query: 105 ETQLKVEKFLE--DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN--- 156
           E Q KV + +   +Y  ++PT+  Y    E  +    F   LG G +G V     +    
Sbjct: 8   EVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK 67
Query: 157 ---GIPVAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF 209
               + VAVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    ++ E+
Sbjct: 68  SDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 126
Query: 210 MPNGSL--------EKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              G L        + FI SKT+ +        L  E L   ++ VA+G+ +L    ++ 
Sbjct: 127 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKN 183
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFG 316
            +H D+   NILL H    KI DFGLA+    D + V    AR    ++APE +F+  + 
Sbjct: 184 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY- 242
Query: 317 EVSYKSDVYSYGMMLLEM 334
             +++SDV+SYG+ L E+
Sbjct: 243 --TFESDVWSYGIFLWEL 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 125/258 (48%), Gaps = 35/258 (13%)
Query: 105 ETQLKVEKFLE--DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN--- 156
           E Q KV + +   +Y  ++PT+  Y    E  +    F   LG G +G V     +    
Sbjct: 13  EVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK 72
Query: 157 ---GIPVAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF 209
               + VAVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    ++ E+
Sbjct: 73  SDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 131
Query: 210 MPNGSL--------EKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              G L        + FI SKT+ +        L  E L   ++ VA+G+ +L    ++ 
Sbjct: 132 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKN 188
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFG 316
            +H D+   NILL H    KI DFGLA+    D + V    AR    ++APE +F+  + 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY- 247
Query: 317 EVSYKSDVYSYGMMLLEM 334
             +++SDV+SYG+ L E+
Sbjct: 248 --TFESDVWSYGIFLWEL 263

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG--------QEFINEVATIGRIH 186
           +++ ++G+GG+G V +G+L  +   VA+K L      G        QEF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H +IV+L G      R  +V EF+P G L   +  K +     P+ W    ++   +A G
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALG 134
Query: 247 VEYLHQGCNQRILHFDIKPHNILL---DHNFQ--PKISDFGLAKLCSKDISIVSLTAARG 301
           +EY+ Q  N  I+H D++  NI L   D N     K++DFG ++      S+ S++   G
Sbjct: 135 IEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-----SVHSVSGLLG 188
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
              ++APE         + K+D YS+ M+L
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMIL 218

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG--------QEFINEVATIGRIH 186
           +++ ++G+GG+G V +G+L  +   VA+K L      G        QEF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H +IV+L G      R  +V EF+P G L   +  K +     P+ W    ++   +A G
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALG 134
Query: 247 VEYLHQGCNQRILHFDIKPHNILL---DHNFQ--PKISDFGLAKLCSKDISIVSLTAARG 301
           +EY+ Q  N  I+H D++  NI L   D N     K++DF L++      S+ S++   G
Sbjct: 135 IEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ-----SVHSVSGLLG 188
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
              ++APE         + K+D YS+ M+L
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMIL 218

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/258 (29%), Positives = 125/258 (48%), Gaps = 35/258 (13%)
Query: 105 ETQLKVEKFLE--DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN--- 156
           E Q KV + +   +Y  ++PT+  Y    E  +    F   LG G +G V     +    
Sbjct: 13  EVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIK 72
Query: 157 ---GIPVAVKMLE---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF 209
               + VAVKML+   HL    +  ++E+  +  + +H +IV LLG C+ G    ++ E+
Sbjct: 73  SDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 131
Query: 210 MPNGSL--------EKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              G L        + FI SKT+ +        L  E L   ++ VA+G+ +L    ++ 
Sbjct: 132 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKN 188
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFG 316
            +H D+   NILL H    KI DFGLA+    D + V    AR    ++APE +F+  + 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVY- 247
Query: 317 EVSYKSDVYSYGMMLLEM 334
             +++SDV+SYG+ L E+
Sbjct: 248 --TFESDVWSYGIFLWEL 263

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 115/234 (49%), Gaps = 25/234 (10%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEH-LKGNGQE 174
           +PT++  + LK     F  +LG+G +GSV   +        G  VAVK L+H  + + ++
Sbjct: 4   DPTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 58
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           F  E+  +  + H +IV+  G C    RR   L+ E++P GSL  ++        H    
Sbjct: 59  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--- 115
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             KL +    + +G+EYL     +R +H ++   NIL+++  + KI DFGL K+  +D  
Sbjct: 116 --KLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170
Query: 293 IVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDPA 344
              +         + APE  + +  + S  SDV+S+G++L E+     K+K P 
Sbjct: 171 YYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPP 222

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-------NGQEFINEVA 180
           + +K+     K  LG+G +G VF  + +N  P   KML  +K          ++F  E  
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 69
Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS----------SHRP 230
            +  + H HIV+  G C +G    +V+E+M +G L KF+ +    +          +   
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L   ++  IA  +A G+ YL    +Q  +H D+   N L+  N   KI DFG+    S+D
Sbjct: 130 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM----SRD 182
Query: 291 ISIVSLTAARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           +         G       ++ PE  S  + + + +SDV+S+G++L E+
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPE--SIMYRKFTTESDVWSFGVILWEI 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 36/257 (14%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 12  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 71
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT- 223
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K  
Sbjct: 72  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 131
Query: 224 ----------------NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
                           +    RPL    L   +  VA+G+ +L    ++  +H D+   N
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 188
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +LL +    KI DFGLA+    D + +    AR    ++APE +F   +   + +SDV+S
Sbjct: 189 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWS 245
Query: 327 YGMMLLEMVGCRKNKDP 343
           YG++L E+     N  P
Sbjct: 246 YGILLWEIFSLGLNPYP 262

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++  +   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 113/248 (45%), Gaps = 27/248 (10%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 27  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K+ 
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 225 SSSHRP--------LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 276
                P        LS   L   +  VA+G+ +L    ++  +H D+   N+LL +    
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVA 203
Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           KI DFGLA+    D + +    AR    ++APE +F   +   + +SDV+SYG++L E+ 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIF 260
Query: 336 GCRKNKDP 343
               N  P
Sbjct: 261 SLGLNPYP 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 118/236 (50%), Gaps = 20/236 (8%)
Query: 110 VEKFLEDYRTVNP---TRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAV 162
           V  F++ +   +P    R   KE+     K +  +G G +G V  G+L       I VA+
Sbjct: 3   VRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAI 62
Query: 163 KMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
           K L+  +     ++F++E + +G+  H +I+ L G  ++     ++ E+M NGSL+ F+ 
Sbjct: 63  KTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL- 121
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
            + N      +   +L  +  G+  G++YL    +   +H D+   NIL++ N   K+SD
Sbjct: 122 -RKNDGRFTVI---QLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSD 174
Query: 281 FGLAKLCSKDISIVSLT-AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           FG++++   D      T   +    + APE  +  + + +  SDV+SYG+++ E++
Sbjct: 175 FGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVM 228

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 26/235 (11%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ- 173
           V+PT +  + LK+I       LG+G +G V   +        G  VAVK L+   G    
Sbjct: 13  VDPTHFEKRFLKRIRD-----LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 67
Query: 174 -EFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
            +   E+  +  ++H +IV+  G C+E  G    L+ EF+P+GSL++++    N      
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----- 122
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           ++ ++  K A  + +G++YL  G  Q + H D+   N+L++   Q KI DFGL K    D
Sbjct: 123 INLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
Query: 291 ISIVSLTAARGTAG-YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
               ++   R +   + APE   ++   ++  SDV+S+G+ L E++  C  +  P
Sbjct: 180 KEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFGVTLHELLTYCDSDSSP 232

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 123
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YS 180
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 181 KFSSKSDIWAFGVLMWEI 198

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 117/235 (49%), Gaps = 26/235 (11%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ- 173
           V+PT +  + LK+I       LG+G +G V   +        G  VAVK L+   G    
Sbjct: 1   VDPTHFEKRFLKRIRD-----LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI 55
Query: 174 -EFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
            +   E+  +  ++H +IV+  G C+E  G    L+ EF+P+GSL++++    N      
Sbjct: 56  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----- 110
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           ++ ++  K A  + +G++YL  G  Q + H D+   N+L++   Q KI DFGL K    D
Sbjct: 111 INLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETD 167
Query: 291 ISIVSLTAARGTAG-YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
               ++   R +   + APE   ++   ++  SDV+S+G+ L E++  C  +  P
Sbjct: 168 KEXXTVKDDRDSPVFWYAPECLMQSKFYIA--SDVWSFGVTLHELLTYCDSDSSP 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YS 176
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 177 KFSSKSDIWAFGVLMWEI 194

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
           LGQG +G V + +   +    A+K + H +      ++EV  +  ++H ++VR      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 200 GTRRALV---------------YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
             RR  V                E+  N +L   I S+ N +  R   W   ++I     
Sbjct: 74  --RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQIL---- 126
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV---------- 294
             + Y+H   +Q I+H D+KP NI +D +   KI DFGLAK   + + I+          
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 295 --SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +LT+A GTA Y+A E+     G  + K D+YS G++  EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 141 LGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LG+G +G V +   F+         VAVKML+      +  + ++E   + +++H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFI------------------FSKTNSSSHRPLSWE 234
           L G CS+     L+ E+   GSL  F+                   S  +    R L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   A+ +++G++YL      +++H D+   NIL+    + KISDFGL++   ++ S V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 295 SLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
             +  R    ++A E LF   +   + +SDV+S+G++L E+V    N  P 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI   +     G       
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIYETAYYRKGGKGLLPVR 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 141 LGQGGYGSVFRGKLF---NGIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG G +GSV +G        I VA+K+L+    K + +E + E   + ++ + +IVRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C +     LV E    G L KF+  K       P+S   + ++   V+ G++YL +   
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEI---PVS--NVAELLHQVSMGMKYLEE--- 454
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +  +H ++   N+LL +    KISDFGL+K L + D    + +A +    + APE    N
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F + S +SDV+SYG+ + E +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEAL 533

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 119/245 (48%), Gaps = 33/245 (13%)
Query: 116 DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLE 166
           +Y  ++PT+  Y    E  +    F   LG G +G V     +        + VAVKML+
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 167 ---HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSL------- 215
              HL    +  ++E+  +  + +H +IV LLG C+ G    ++ E+   G L       
Sbjct: 63  PSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 216 -EKFIFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 270
            + FI SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+   NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 178
Query: 271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGM 329
            H    KI DFGLA+    D + V    AR    ++APE +F+  +   +++SDV+SYG+
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGI 235
Query: 330 MLLEM 334
            L E+
Sbjct: 236 FLWEL 240

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 124
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YS 181
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 182 KFSSKSDIWAFGVLMWEI 199

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 141 LGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LG+G +G V +   F+         VAVKML+      +  + ++E   + +++H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFI------------------FSKTNSSSHRPLSWE 234
           L G CS+     L+ E+   GSL  F+                   S  +    R L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   A+ +++G++YL      +++H D+   NIL+    + KISDFGL++   ++ S V
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 295 SLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
             +  R    ++A E LF   +   + +SDV+S+G++L E+V    N  P 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 130
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 131 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YS 187
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 188 KFSSKSDIWAFGVLMWEI 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 139
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+    + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM--YS 196
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 197 KFSSKSDIWAFGVLMWEI 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKGLLPVR 196
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++APE  S   G  +  SD++S+G++L E+ 
Sbjct: 197 WMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
           C++     ++ E+M NG L  ++        HR    ++L ++   V   +EYL    ++
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL----REMRHR-FQTQQLLEMCKDVCEAMEYLE---SK 139
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           + LH D+   N L++     K+SDFGL++    D    S+  ++    +  PE+    + 
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLM--YS 196
Query: 317 EVSYKSDVYSYGMMLLEM 334
           + S KSD++++G+++ E+
Sbjct: 197 KFSSKSDIWAFGVLMWEI 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 110/216 (50%), Gaps = 28/216 (12%)
Query: 141 LGQGGYGSVF--------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFH 189
           LG+G +G V         + K    + VAVKML  +  + +  + ++E+  +  I  H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWEKLKKI 239
           I+ LLG C++     ++  +   G+L +++ ++           N      ++++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +ARG+EYL    +Q+ +H D+   N+L+  N   KI+DFGLA+  +        T  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           R    ++APE LF R +   +++SDV+S+G+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 24/224 (10%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG-----IPVAVKMLEH---LKGNGQ 173
           P +   + LK+   +    LG G +G+V++G          IPVA+K+L      K N +
Sbjct: 6   PNQALLRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-K 64
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLS 232
           E ++E   +  +   ++ RLLG C   T + LV + MP G L   +  ++    S   L+
Sbjct: 65  EILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLN 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           W         +A+G+ YL    + R++H D+   N+L+      KI+DFGLA+L   D +
Sbjct: 124 W------CMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 293 IVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                  +    ++A E +  R F   +++SDV+SYG+ + E++
Sbjct: 175 EYHADGGKVPIKWMALESILRRRF---THQSDVWSYGVTVWELM 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H D+   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKGLLPVR 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 196 KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 196 -FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E+M  GSL  ++ S+  S     L  + L K +  V   +EYL +G 
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGN 308
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           N   +H D+   N+L+  +   K+SDFGL K  S      +    +    + APE     
Sbjct: 309 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREK 361
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
             + S KSDV+S+G++L E+
Sbjct: 362 --KFSTKSDVWSFGILLWEI 379

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 109/233 (46%), Gaps = 35/233 (15%)
Query: 119 TVNPTRYTYKELKKI-TSKFKHR-LGQGGYGSVFRGKLFNG-IPVAVKMLE--------- 166
            +NP  Y  K+  KI  S FK R LG G YG V   K  NG    A+K+++         
Sbjct: 20  AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 167 -----HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS 221
                +++   +E  NE++ +  + H +I++L     +     LV EF   G L + I +
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 222 KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKI 278
           +         +      I   +  G+ YLH+     I+H DIKP NILL++       KI
Sbjct: 140 RHKFDECDAAN------IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190
Query: 279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
            DFGL+   SKD     L    GTA YIAPE+  + + E   K DV+S G+++
Sbjct: 191 VDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 33/231 (14%)
Query: 141 LGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LG+G +G V +   F+         VAVKML+      +  + ++E   + +++H H+++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFI------------------FSKTNSSSHRPLSWE 234
           L G CS+     L+ E+   GSL  F+                   S  +    R L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   A+ +++G++YL       ++H D+   NIL+    + KISDFGL++   ++ S V
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 295 SLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
             +  R    ++A E LF   +   + +SDV+S+G++L E+V    N  P 
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KE+     K +  +G G +G V  G+L       I VA+K L+  +     ++F++E + 
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+ L G  ++     ++ E+M NGSL+ F+  + N      +   +L  +  
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVI---QLVGMLR 123
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G+  G++YL    +   +H D+   NIL++ N   K+SDFG++++   D      T   +
Sbjct: 124 GIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + APE  +  + + +  SDV+SYG+++ E++
Sbjct: 181 IPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE--HLKGNGQEFINEVAT 181
           KE+     K +  +G G +G V  G+L       I VA+K L+  +     ++F++E + 
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+ L G  ++     ++ E+M NGSL+ F+  + N      +   +L  +  
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVI---QLVGMLR 117
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT-AAR 300
           G+  G++YL    +   +H D+   NIL++ N   K+SDFG++++   D      T   +
Sbjct: 118 GIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               + APE  +  + + +  SDV+SYG+++ E++
Sbjct: 175 IPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVM 207

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 24  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 196 -FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E+M  GSL  ++ S+  S     L  + L K +  V   +EYL +G 
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGN 136
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           N   +H D+   N+L+  +   K+SDFGL K  S      +    +    + APE     
Sbjct: 137 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREK 189
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
             + S KSDV+S+G++L E+
Sbjct: 190 --KFSTKSDVWSFGILLWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 9   KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 196 -FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E+M  GSL  ++ S+  S     L  + L K +  V   +EYL +G 
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGN 121
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           N   +H D+   N+L+  +   K+SDFGL K  S      +    +    + APE     
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREK 174
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
             + S KSDV+S+G++L E+
Sbjct: 175 --KFSTKSDVWSFGILLWEI 192

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 120 VNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLE---H 167
           ++PT+  Y    E  +    F   LG G +G V     +        + VAVKML+   H
Sbjct: 23  IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 82
Query: 168 LKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSL--------EKF 218
           L    +  ++E+  +  + +H +IV LLG C+ G    ++ E+   G L        + F
Sbjct: 83  LTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 141
Query: 219 IFSKTNSS----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF 274
           I SKT+ +        L  E L   ++ VA+G+ +L    ++  +H D+   NILL H  
Sbjct: 142 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGR 198
Query: 275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLE 333
             KI DFGLA+    D + V    AR    ++APE +F+  +   +++SDV+SYG+ L E
Sbjct: 199 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWE 255
Query: 334 M 334
           +
Sbjct: 256 L 256

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 27/248 (10%)
Query: 117 YRTVNPTRYTYKE---LKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEH 167
           Y  ++PT+  Y E     +   +F   LG G +G V     F        + VAVKML+ 
Sbjct: 27  YTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 168 LK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
                  +  ++E+  +  +  H +IV LLG C+ G    ++ E+   G L  F+  K+ 
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 225 SSSHRPL--------SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP 276
                P         S   L   +  VA+G+ +L    ++  +H D+   N+LL +    
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVA 203
Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           KI DFGLA+    D + +    AR    ++APE +F   +   + +SDV+SYG++L E+ 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIF 260
Query: 336 GCRKNKDP 343
               N  P
Sbjct: 261 SLGLNPYP 268

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G YG V++ K   G  VA+K +      +G     I E++ +  +HH +IV L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV+EFM           K    +   L   ++K   + + RGV + HQ    
Sbjct: 88  IHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---H 138
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           RILH D+KP N+L++ +   K++DFGLA+     I + S T    T  Y AP++     G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWYRAPDVL---MG 193
Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++S G +  EM+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMI 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G  + G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 15  KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 196 -FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     +V E+M  GSL  ++ S+  S     L  + L K +  V   +EYL +G 
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYL-EGN 127
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           N   +H D+   N+L+  +   K+SDFGL K  S      +    +    + APE     
Sbjct: 128 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE- 179
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
               S KSDV+S+G++L E+
Sbjct: 180 -AAFSTKSDVWSFGILLWEI 198

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 10  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 127 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIXETDXX 179
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 180 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 116/245 (47%), Gaps = 39/245 (15%)
Query: 117 YRTVNPTRYTYKEL----------KKITSKFKHRLGQGGYGSVFRGKLFNGIP------- 159
           Y +VNP  ++  ++          +KIT      LGQG +G V+ G +  G+        
Sbjct: 23  YASVNPEYFSAADVYVPDEWEVAREKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETR 79
Query: 160 VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
           VA+K +       +  EF+NE + +   +  H+VRLLG  S+G    ++ E M  G L+ 
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 139
Query: 218 FIFS----KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN 273
           ++ S      N+    P S  K+ ++A  +A G+ YL+     + +H D+   N ++  +
Sbjct: 140 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 196
Query: 274 FQPKISDFGLAKLCSKDISIVSLTAARG----TAGYIAPELFSRNFGEVSYKSDVYSYGM 329
           F  KI DFG+    ++DI         G       +++PE  S   G  +  SDV+S+G+
Sbjct: 197 FTVKIGDFGM----TRDIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGV 250
Query: 330 MLLEM 334
           +L E+
Sbjct: 251 VLWEI 255

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G YG V++ K   G  VA+K +      +G     I E++ +  +HH +IV L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV+EFM           K    +   L   ++K   + + RGV + HQ    
Sbjct: 88  IHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---H 138
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           RILH D+KP N+L++ +   K++DFGLA+     I + S T    T  Y AP++     G
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWYRAPDVL---MG 193
Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++S G +  EM+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMI 214

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 19  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 136 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIXETDXX 188
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 189 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H ++   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKGLLPVR 197
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 139 HRLGQGGYGSVFRGKL-FNGIPVAVK-----MLEHLKGNGQEFINEVATIGRIHHFHIVR 192
            ++G+G +G VF G+L  +   VAVK     +   LK    +F+ E   + +  H +IVR
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVR 176
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L+G C++     +V E +  G    F+  +T  +  R    + L ++    A G+EYL  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRV---KTLLQMVGDAAAGMEYLES 231
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
            C    +H D+   N L+      KISDFG+++  +  +   S    +    + APE   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL- 287
Query: 313 RNFGEVSYKSDVYSYGMMLLE 333
            N+G  S +SDV+S+G++L E
Sbjct: 288 -NYGRYSSESDVWSFGILLWE 307

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 141 LGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNGQ--EFINEVATIGRIHHFHIVR 192
           LGQG +G V+ G   + I       VAVK +       +  EF+NE + +      H+VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLKKIAFGVARGVE 248
           LLG  S+G    +V E M +G L+ ++ S      N+    P + +++ ++A  +A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG----TAG 304
           YL+    ++ +H ++   N ++ H+F  KI DFG+    ++DI         G       
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGM----TRDIYETDYYRKGGKGLLPVR 198
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++APE  S   G  +  SD++S+G++L E+
Sbjct: 199 WMAPE--SLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEH-----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           +G GG+G V+R   + G  VAVK   H     +    +    E      + H +I+ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C +     LV EF   G L + +       S + +  + L   A  +ARG+ YLH    
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL-------SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 256 QRILHFDIKPHNILLDHNFQP--------KISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
             I+H D+K  NIL+    +         KI+DFGLA+   +   +    +A G   ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMA 182
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE+   +    S  SDV+SYG++L E++
Sbjct: 183 PEVIRASM--FSKGSDVWSYGVLLWELL 208

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 39/243 (16%)
Query: 119 TVNPTRYTYKEL----------KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VA 161
           +VNP  ++  ++          +KIT      LGQG +G V+ G +  G+        VA
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVA 59
Query: 162 VKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI 219
           +K +       +  EF+NE + +   +  H+VRLLG  S+G    ++ E M  G L+ ++
Sbjct: 60  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 220 FSKTNSSSHRPL----SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            S   + ++ P+    S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F 
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT 176
Query: 276 PKISDFGLAKLCSKDISIVSLTAARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
            KI DFG+    ++DI         G       +++PE  S   G  +  SDV+S+G++L
Sbjct: 177 VKIGDFGM----TRDIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVL 230
Query: 332 LEM 334
            E+
Sbjct: 231 WEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 15  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL----SWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S   + ++ P+    S  K+ 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 132 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 184
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 185 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 87  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 136
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYG 194
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 195 P---EVDIWSLGIMVIEMV 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 96  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 145
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYG 203
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 204 P---EVDIWSLGIMVIEMV 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 91  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 140
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYG 198
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 199 P---EVDIWSLGIMVIEMV 214

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 18  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 135 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 187
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 188 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVK-----MLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           ++G+G +G VF G+L  +   VAVK     +   LK    +F+ E   + +  H +IVRL
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRL 177
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G C++     +V E +  G    F+  +T  +  R    + L ++    A G+EYL   
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRV---KTLLQMVGDAAAGMEYLESK 232
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
           C    +H D+   N L+      KISDFG+++  +  +   S    +    + APE    
Sbjct: 233 C---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-- 287
Query: 314 NFGEVSYKSDVYSYGMMLLE 333
           N+G  S +SDV+S+G++L E
Sbjct: 288 NYGRYSSESDVWSFGILLWE 307

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 98  LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 147
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKXLVGTPYWMAPELISRLPYG 205
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 206 P---EVDIWSLGIMVIEMV 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 26/232 (11%)
Query: 114 LEDYRTVNPTRYTYKEL------KKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKM 164
           LE  +  NP R   K+L      K+    F    +LG+G YGSV++      G  VA+K 
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 165 LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
           +  ++ + QE I E++ + +    H+V+  G   + T   +V E+   GS+   I  +  
Sbjct: 62  VP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 225 SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
           +     L+ +++  I     +G+EYLH     R +H DIK  NILL+     K++DFG+A
Sbjct: 121 T-----LTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYK--SDVYSYGMMLLEM 334
              +  ++        GT  ++APE+      E+ Y   +D++S G+  +EM
Sbjct: 173 GQLTDXMA--KRNXVIGTPFWMAPEVIQ----EIGYNCVADIWSLGITAIEM 218

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 115/243 (47%), Gaps = 39/243 (16%)
Query: 119 TVNPTRYTYKEL----------KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VA 161
           +VNP  ++  ++          +KIT      LGQG +G V+ G +  G+        VA
Sbjct: 3   SVNPEYFSAADVYVPDEWEVAREKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVA 59
Query: 162 VKMLEHLKGNGQ--EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI 219
           +K +       +  EF+NE + +   +  H+VRLLG  S+G    ++ E M  G L+ ++
Sbjct: 60  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 220 FS----KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            S      N+    P S  K+ ++A  +A G+ YL+     + +H D+   N ++  +F 
Sbjct: 120 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT 176
Query: 276 PKISDFGLAKLCSKDISIVSLTAARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
            KI DFG+    ++DI         G       +++PE  S   G  +  SDV+S+G++L
Sbjct: 177 VKIGDFGM----TRDIYETDYYRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVL 230
Query: 332 LEM 334
            E+
Sbjct: 231 WEI 233

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 18  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 135 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 187
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 188 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGI-------PVAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 12  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 129 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 181
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 182 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 19  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 136 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 188
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 189 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 16  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N ++  +F  KI DFG+    ++DI      
Sbjct: 133 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM----TRDIYETDYY 185
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 186 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG---QEFINE 178
           KE+     +F   LG+  +G V++G LF   P      VA+K L+  K  G   +EF +E
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHE 62
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
                R+ H ++V LLG  ++    ++++ +  +G L +F+  ++  S       ++  K
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 239 IAF----------GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
            A            +A G+EYL    +  ++H D+   N+L+      KISD GL +   
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                  L  +     ++APE     +G+ S  SD++SYG++L E+
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP------VAVKMLEHLKGNG---QEFINE 178
           KE+     +F   LG+  +G V++G LF   P      VA+K L+  K  G   +EF +E
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHE 79
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
                R+ H ++V LLG  ++    ++++ +  +G L +F+  ++  S       ++  K
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 239 IAF----------GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
            A            +A G+EYL    +  ++H D+   N+L+      KISD GL +   
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                  L  +     ++APE     +G+ S  SD++SYG++L E+
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 218 LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 267
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYG 325
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 326 P---EVDIWSLGIMVIEMV 341

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 141 LGQGGYGSVFRGKLFN--GIPVAVKMLEHLKGN-GQEF--INEVATIGRIHHF---HIVR 192
           +G+G YG VF+ +     G  VA+K +    G  G     I EVA +  +  F   ++VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 193 LLGFCS-----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           L   C+       T+  LV+E      +++ + +  +      +  E +K + F + RG+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           ++LH   + R++H D+KP NIL+  + Q K++DFGLA++ S  +++ S+     T  Y A
Sbjct: 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRA 187
Query: 308 PELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           PE+  ++    SY +  D++S G +  EM
Sbjct: 188 PEVLLQS----SYATPVDLWSVGCIFAEM 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 141 LGQGGYGSVFRGKLFN--GIPVAVKMLEHLKGN-GQEF--INEVATIGRIHHF---HIVR 192
           +G+G YG VF+ +     G  VA+K +    G  G     I EVA +  +  F   ++VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 193 LLGFCS-----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           L   C+       T+  LV+E      +++ + +  +      +  E +K + F + RG+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           ++LH   + R++H D+KP NIL+  + Q K++DFGLA++ S  +++ S+     T  Y A
Sbjct: 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRA 187
Query: 308 PELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           PE+  ++    SY +  D++S G +  EM
Sbjct: 188 PEVLLQS----SYATPVDLWSVGCIFAEM 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 140 RLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFC 197
           ++G+G  G V    +  +G  VAVK ++  K   +E + NEV  +    H ++V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
             G    +V EF+  G+L       T+  +H  ++ E++  +   V + +  LH    Q 
Sbjct: 141 LVGDELWVVMEFLEGGAL-------TDIVTHTRMNEEQIAAVCLAVLQALSVLHA---QG 190
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFG 316
           ++H DIK  +ILL H+ + K+SDFG     SK++         GT  ++APEL SR  +G
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYG 248
Query: 317 EVSYKSDVYSYGMMLLEMV 335
               + D++S G+M++EMV
Sbjct: 249 P---EVDIWSLGIMVIEMV 264

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 142 GQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT 201
            +G +G V++ +L N   VAVK+         +   EV ++  + H +I++ +G    GT
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 202 RRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ----- 252
                  L+  F   GSL  F+  K N      +SW +L  IA  +ARG+ YLH+     
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL--KANV-----VSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 253 --GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
             G    I H DIK  N+LL +N    I+DFGLA       S        GT  Y+APE+
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV 204
Query: 311 F--SRNFGEVSY-KSDVYSYGMMLLEMV 335
              + NF   ++ + D+Y+ G++L E+ 
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + + T    T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 141 LGQGGYGSVFRGKLFN--GIPVAVKMLEHLKGN-GQEF--INEVATIGRIHHF---HIVR 192
           +G+G YG VF+ +     G  VA+K +    G  G     I EVA +  +  F   ++VR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 193 LLGFCS-----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           L   C+       T+  LV+E      +++ + +  +      +  E +K + F + RG+
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           ++LH   + R++H D+KP NIL+  + Q K++DFGLA++ S  +++ S+     T  Y A
Sbjct: 134 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRA 187
Query: 308 PELFSRNFGEVSYKS--DVYSYGMMLLEM 334
           PE+  ++    SY +  D++S G +  EM
Sbjct: 188 PEVLLQS----SYATPVDLWSVGCIFAEM 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 128
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + + T    T  Y APE+     
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL---L 183
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
           LGQG +G V + +   +    A+K + H +      ++EV  +  ++H ++VR      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 200 GTRRALV---------------YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
             RR  V                E+  N +L   I S+ N +  R   W   ++I     
Sbjct: 74  --RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQIL---- 126
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV---------- 294
             + Y+H   +Q I+H ++KP NI +D +   KI DFGLAK   + + I+          
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 295 --SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +LT+A GTA Y+A E+     G  + K D YS G++  E +
Sbjct: 184 SDNLTSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQ--EFINEVAT 181
           +KIT      LGQG +G V+ G +  G+        VA+K +       +  EF+NE + 
Sbjct: 12  EKIT--MSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS----KTNSSSHRPLSWEKLK 237
           +   +  H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++A  +A G+ YL+     + +H D+   N  +  +F  KI DFG+    ++DI      
Sbjct: 129 QMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGM----TRDIYETDYY 181
Query: 298 AARG----TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              G       +++PE  S   G  +  SDV+S+G++L E+
Sbjct: 182 RKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 34/213 (15%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG 200
           +G GG+G VF+ K  + I     +++ +K N ++   EV  + ++ H +IV   G C +G
Sbjct: 19  IGSGGFGQVFKAK--HRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDG 75
Query: 201 -----------TRRA------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
                      + R+      +  EF   G+LE++I  +      + L+ E  ++I    
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT--- 132
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
            +GV+Y+H   ++++++ D+KP NI L    Q KI DFGL      D        ++GT 
Sbjct: 133 -KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRSKGTL 185
Query: 304 GYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
            Y++PE + S+++G+   + D+Y+ G++L E++
Sbjct: 186 RYMSPEQISSQDYGK---EVDLYALGLILAELL 215

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 119/262 (45%), Gaps = 39/262 (14%)
Query: 99  ESEKEKETQLKVEKFLEDYRTVNPT------RYTYKELKKITSK---FKHRLGQGGYGSV 149
           +S + K ++L+    + DY   NP         +  +LK++  K       LG G +G V
Sbjct: 7   QSPEYKLSKLRTSTIMTDY---NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 63
Query: 150 FRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEG 200
           + G++ +G+P       VAVK L  +     E  F+ E   I + +H +IVR +G   + 
Sbjct: 64  YEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 122
Query: 201 TRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
             R ++ E M  G L+ F+  ++   S    L+   L  +A  +A G +YL +      +
Sbjct: 123 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFI 179
Query: 260 HFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA----GYIAPELFS 312
           H DI   N LL         KI DFG+A    +DI   S     G A     ++ PE F 
Sbjct: 180 HRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYRKGGCAMLPVKWMPPEAFM 235
Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
              G  + K+D +S+G++L E+
Sbjct: 236 E--GIFTSKTDTWSFGVLLWEI 255

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLSFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 117/244 (47%), Gaps = 47/244 (19%)
Query: 123 TRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATI 182
           T+YT  +   +  K    +G GG+G VF+ K  + I     ++  +K N ++   EV  +
Sbjct: 2   TKYTVDKRFGMDFKEIELIGSGGFGQVFKAK--HRIDGKTYVIRRVKYNNEKAEREVKAL 59
Query: 183 GRIHHFHIVRLLGFCSEG------------------------TRRA------LVYEFMPN 212
            ++ H +IV   G C +G                        + R+      +  EF   
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 272
           G+LE++I  +      + L+ E  ++I     +GV+Y+H   +++++H D+KP NI L  
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQIT----KGVDYIH---SKKLIHRDLKPSNIFLVD 171
Query: 273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMML 331
             Q KI DFGL      D      T ++GT  Y++PE + S+++G+   + D+Y+ G++L
Sbjct: 172 TKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGK---EVDLYALGLIL 225
Query: 332 LEMV 335
            E++
Sbjct: 226 AELL 229

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 177
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 125
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + + T    T  Y APE+     
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL---L 180
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 41/263 (15%)
Query: 99  ESEKEKETQLKVEKFLEDYRTVNPTRYTY-------KELKKITSK---FKHRLGQGGYGS 148
           +S + K ++L+    + DY   NP  Y++        +LK++  K       LG G +G 
Sbjct: 17  QSPEYKLSKLRTSTIMTDY---NPN-YSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGE 72
Query: 149 VFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSE 199
           V+ G++ +G+P       VAVK L  +     E  F+ E   I + +H +IVR +G   +
Sbjct: 73  VYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 131
Query: 200 GTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
              R ++ E M  G L+ F+  ++   S    L+   L  +A  +A G +YL +      
Sbjct: 132 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HF 188
Query: 259 LHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA----GYIAPELF 311
           +H DI   N LL         KI DFG+A    +DI   S     G A     ++ PE F
Sbjct: 189 IHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYRKGGCAMLPVKWMPPEAF 244
Query: 312 SRNFGEVSYKSDVYSYGMMLLEM 334
               G  + K+D +S+G++L E+
Sbjct: 245 ME--GIFTSKTDTWSFGVLLWEI 265

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 77  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 128
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 183
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I +++H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 99  ALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 158
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 159 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 211
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 253

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLE----HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +  V+R + +  G+ VA+KM++    +  G  Q   NEV    ++ H  I+ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  +     LV E   NG + +++ ++      +P S  + +     +  G+ YLH   +
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLH---S 130
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSLTAARGTAGYIAPELFSRN 314
             ILH D+   N+LL  N   KI+DFGLA +L        +L    GT  YI+PE+ +R+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRS 187
Query: 315 FGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
              +  +SDV+S G M   ++  R   D
Sbjct: 188 AHGL--ESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I +++H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 85  ALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 144
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 145 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 197
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 239

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRL 193
           K    +G+G YG+V++G L +  PVAVK+      N Q FINE  +  +  + H +I R 
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVFSF--ANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 194 L----GFCSEGTRR-ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +       ++G     LV E+ PNGSL K++   T+        W    ++A  V RG+ 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------DWVSSCRLAHSVTRGLA 125
Query: 249 YLHQGCNQ------RILHFDIKPHNILLDHNFQPKISDFGLA------KLCSKDISIVSL 296
           YLH    +       I H D+   N+L+ ++    ISDFGL+      +L        + 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 297 TAARGTAGYIAPELFS-----RNFGEVSYKSDVYSYGMMLLEM 334
            +  GT  Y+APE+       R+      + D+Y+ G++  E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVA---VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA   +++    +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVA---VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA   +++    +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 118/258 (45%), Gaps = 41/258 (15%)
Query: 104 KETQLKVEKFLEDYRTVNPTRYTY-------KELKKITSK---FKHRLGQGGYGSVFRGK 153
           K ++L+    + DY   NP  Y++        +LK++  K       LG G +G V+ G+
Sbjct: 2   KLSKLRTSTIMTDY---NPN-YSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQ 57
Query: 154 LFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEGTRRA 204
           + +G+P       VAVK L  +     E  F+ E   I + +H +IVR +G   +   R 
Sbjct: 58  V-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 116
Query: 205 LVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI 263
           ++ E M  G L+ F+  ++   S    L+   L  +A  +A G +YL +      +H DI
Sbjct: 117 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDI 173
Query: 264 KPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA----GYIAPELFSRNFG 316
              N LL         KI DFG+A    +DI   S     G A     ++ PE F    G
Sbjct: 174 AARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYRKGGCAMLPVKWMPPEAFME--G 227
Query: 317 EVSYKSDVYSYGMMLLEM 334
             + K+D +S+G++L E+
Sbjct: 228 IFTSKTDTWSFGVLLWEI 245

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 140 RLGQGGYGSVFRGK--LFNGIPVAVK--MLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           +LG+G Y +V++GK  L + + VA+K   LEH +G     I EV+ +  + H +IV L  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV+E++ +  L++++    N      ++   +K   F + RG+ Y H+   
Sbjct: 68  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNI-----INMHNVKLFLFQLLRGLAYCHR--- 118
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           Q++LH D+KP N+L++   + K++DFGLA+  +K I   +      T  Y  P++     
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDIL---L 173
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++  G +  EM   R
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 144 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 196
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 75
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 76  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 135
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 136 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 188
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 144 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 196
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 238

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNGQ----EFINEVATIGRIHHFHIVR 192
           LG+G +GSV  G L       + VAVK ++ L  + Q    EF++E A +    H +++R
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMK-LDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 193 LLGFC----SEGTRRALV-YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           LLG C    S+G  + +V   FM  G L  ++      +  + +  + L K    +A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL    N+  LH D+   N +L  +    ++DFGL+K             A+    +IA
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEM 334
            E  +      + KSDV+++G+ + E+
Sbjct: 218 IESLADRV--YTSKSDVWAFGVTMWEI 242

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVYSEQDELDFLME 98
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 99  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 158
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 159 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 211
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 98
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 99  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 158
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 159 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 211
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 253

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 85  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 144
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 145 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRA 197
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 39/262 (14%)
Query: 99  ESEKEKETQLKVEKFLEDYRTVNPT------RYTYKELKKITSK---FKHRLGQGGYGSV 149
           +S + K ++L+    + DY   NP         +  +LK++  K       LG G +G V
Sbjct: 8   QSPEYKLSKLRTSTIMTDY---NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 64
Query: 150 FRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEG 200
           + G++ +G+P       VAVK L  +     E  F+ E   I + +H +IVR +G   + 
Sbjct: 65  YEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 123
Query: 201 TRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
             R ++ E M  G L+ F+  ++   S    L+   L  +A  +A G +YL +      +
Sbjct: 124 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFI 180
Query: 260 HFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA----GYIAPELFS 312
           H DI   N LL         KI DFG+A    +DI         G A     ++ PE F 
Sbjct: 181 HRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYRKGGCAMLPVKWMPPEAFM 236
Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
              G  + K+D +S+G++L E+
Sbjct: 237 E--GIFTSKTDTWSFGVLLWEI 256

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIP-------VAVKMLEHLKGNGQE--FINE 178
           KE+ +        LG G +G V+ G++ +G+P       VAVK L  +     E  F+ E
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 84
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLK 237
              I + +H +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L 
Sbjct: 85  ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 144
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIV 294
            +A  +A G +YL +      +H DI   N LL         KI DFG+A    +DI   
Sbjct: 145 HVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----QDIYRA 197
Query: 295 SLTAARGTA----GYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           S     G A     ++ PE F    G  + K+D +S+G++L E+
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEI 239

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 25/217 (11%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQ--EFINEVATIGR 184
           +++ +     +G+G +G V+ G+      N I  A+K L  +    Q   F+ E   +  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 185 IHHFHIVRLLGFC--SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
           ++H +++ L+G     EG    L+  +M +G L +FI S   + + + L       I+FG
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDL-------ISFG 130
Query: 243 --VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTA 298
             VARG+EYL     Q+ +H D+   N +LD +F  K++DFGLA+  L  +  S+     
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           AR    + A E  S      + KSDV+S+G++L E++
Sbjct: 188 ARLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 39/262 (14%)
Query: 99  ESEKEKETQLKVEKFLEDYRTVNPT------RYTYKELKKITSK---FKHRLGQGGYGSV 149
           +S + K ++L+    + DY   NP         +  +LK++  K       LG G +G V
Sbjct: 31  QSPEYKLSKLRTSTIMTDY---NPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEV 87
Query: 150 FRGKLFNGIP-------VAVKMLEHLKGNGQE--FINEVATIGRIHHFHIVRLLGFCSEG 200
           + G++ +G+P       VAVK L  +     E  F+ E   I + +H +IVR +G   + 
Sbjct: 88  YEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 201 TRRALVYEFMPNGSLEKFIF-SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
             R ++ E M  G L+ F+  ++   S    L+   L  +A  +A G +YL +      +
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFI 203
Query: 260 HFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA----GYIAPELFS 312
           H DI   N LL         KI DFG+A    +DI         G A     ++ PE F 
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYYRKGGCAMLPVKWMPPEAFM 259
Query: 313 RNFGEVSYKSDVYSYGMMLLEM 334
              G  + K+D +S+G++L E+
Sbjct: 260 E--GIFTSKTDTWSFGVLLWEI 279

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 123
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 178
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 123
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 178
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 74  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 125
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 180
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 177
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVF--RGKLFNGIPVAVKML--EHLKGNGQE 174
            V   R+   E  +    F+  LG G +  V     K    + VA+K +  E L+G    
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL-VAIKCIAKEALEGKEGS 62
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHR 229
             NE+A + +I H +IV L      G    L+ + +  G L     EK  +++ ++S   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--- 119
Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNFQPKISDFGLAKL 286
                   ++ F V   V+YLH   +  I+H D+KP N+L   LD + +  ISDFGL+K+
Sbjct: 120 --------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +D   V L+ A GT GY+APE+ ++     S   D +S G++
Sbjct: 169 --EDPGSV-LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 177
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVA---VKMLEHLKGNGQ-EFINEVATIGRIHHFHI 190
           + + ++G+G +  V+R   L +G+PVA   V++ + +    + + I E+  + +++H ++
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           ++      E     +V E    G L + I  K      R +    + K    +   +E++
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE 309
           H   ++R++H DIKP N+ +      K+ D GL +   SK  +  SL    GT  Y++PE
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPE 206
Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMVG 336
               N    ++KSD++S G +L EM  
Sbjct: 207 RIHEN--GYNFKSDIWSLGCLLYEMAA 231

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 71  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 177
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 72  VIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 123
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 178
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVF--RGKLFNGIPVAVKML--EHLKGNGQE 174
            V   R+   E  +    F+  LG G +  V     K    + VA+K +  E L+G    
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL-VAIKCIAKEALEGKEGS 62
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHR 229
             NE+A + +I H +IV L      G    L+ + +  G L     EK  +++ ++S   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--- 119
Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNFQPKISDFGLAKL 286
                   ++ F V   V+YLH   +  I+H D+KP N+L   LD + +  ISDFGL+K+
Sbjct: 120 --------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +D   V L+ A GT GY+APE+ ++     S   D +S G++
Sbjct: 169 --EDPGSV-LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 71  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 177
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVF--RGKLFNGIPVAVKML--EHLKGNGQE 174
            V   R+   E  +    F+  LG G +  V     K    + VA+K +  E L+G    
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL-VAIKCIAKEALEGKEGS 62
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHR 229
             NE+A + +I H +IV L      G    L+ + +  G L     EK  +++ ++S   
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS--- 119
Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNFQPKISDFGLAKL 286
                   ++ F V   V+YLH   +  I+H D+KP N+L   LD + +  ISDFGL+K+
Sbjct: 120 --------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 168
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +D   V L+ A GT GY+APE+ ++     S   D +S G++
Sbjct: 169 --EDPGSV-LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           LG+G YG V+ G+ L N + +A+K + E      Q    E+A    + H +IV+ LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK----IAF---GVARGVEYLH 251
           E     +  E +P GSL   + SK          W  LK     I F    +  G++YLH
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSK----------WGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 252 QGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE 309
              + +I+H DIK  N+L++ ++   KISDFG +K L   +    + T   GT  Y+APE
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 193
Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +  +        +D++S G  ++EM 
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMA 219

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 36/226 (15%)
Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG------KLFNGIPVAVKMLEHLKGNG 172
            V   R+   E  +    F+  LG G +  V         KL     +A K LE  +G+ 
Sbjct: 4   AVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSM 63
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSS 227
           +   NE+A + +I H +IV L      G    L+ + +  G L     EK  +++ ++S 
Sbjct: 64  E---NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS- 119
Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL---LDHNFQPKISDFGLA 284
                     ++ F V   V+YLH   +  I+H D+KP N+L   LD + +  ISDFGL+
Sbjct: 120 ----------RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 166
Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
           K+  +D   V L+ A GT GY+APE+ ++     S   D +S G++
Sbjct: 167 KM--EDPGSV-LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVA----VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
            ++G+G YG+VF+ K      +     V++ +  +G     + E+  +  + H +IVRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                  +  LV+EF  +  L+K+ F   N      L  E +K   F + +G+ + H   
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD----LDPEIVKSFLFQLLKGLGFCH--- 118
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++ +LH D+KP N+L++ N + K++DFGLA+  +  I +   +A   T  Y  P++    
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVL--- 173
Query: 315 FGEVSYKS--DVYSYGMMLLEMVGCRK 339
           FG   Y +  D++S G +  E+    +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +       +  GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +      S  SD+++ G ++ ++V 
Sbjct: 204 ELLTEK--SASKSSDLWALGCIIYQLVA 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 141 LGQGGYGSVFR--GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           LG+G +G   +   +    + V  +++   +   + F+ EV  +  + H ++++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +  R   + E++  G+L   I  K+  S +    W +    A  +A G+ YLH   +  I
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQY---PWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS----IVSLTAAR--------GTAGYI 306
           +H D+  HN L+  N    ++DFGLA+L   + +    + SL            G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 307 APELFS-RNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
           APE+ + R++ E   K DV+S+G++L E++G R N DP
Sbjct: 190 APEMINGRSYDE---KVDVFSFGIVLCEIIG-RVNADP 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +       A  GTA Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSP 201
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           LG+G YG V+ G+ L N + +A+K + E      Q    E+A    + H +IV+ LG  S
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK----IAF---GVARGVEYLH 251
           E     +  E +P GSL   + SK          W  LK     I F    +  G++YLH
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSK----------WGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 252 QGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPE 309
              + +I+H DIK  N+L++ ++   KISDFG +K L   +    + T   GT  Y+APE
Sbjct: 126 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 179
Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +  +        +D++S G  ++EM 
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMA 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+ F+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+ F+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 70  VIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 176
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+ F+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF+ +  L+ F+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 72  VIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 123
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + +      T  Y APE+     
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVTLWYRAPEIL---L 178
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 110
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 168 PEQSKRSXMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 110
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 168 PEQSKRSTMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
            LG G +G V++ K    G   A K++E   +   +++I E+  +    H +IV+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
               +  ++ EF P G+++  +         R L+  +++ +   +   + +LH   ++R
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIML-----ELDRGLTEPQIQVVCRQMLEALNFLH---SKR 129
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLA----KLCSKDISIVSLTAARGTAGYIAPELF-- 311
           I+H D+K  N+L+      +++DFG++    K   K  S +      GT  ++APE+   
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMC 183
Query: 312 -SRNFGEVSYKSDVYSYGMMLLEM 334
            +       YK+D++S G+ L+EM
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 4   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 111
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 112 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 168
Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 169 PEQSKRSXMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 211

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           LG G +G V++ K    G   A K++E   +   +++I E+  +    H +IV+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
              +  ++ EF P G+++  +         R L+  +++ +   +   + +LH   ++RI
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIML-----ELDRGLTEPQIQVVCRQMLEALNFLH---SKRI 138
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLA----KLCSKDISIVSLTAARGTAGYIAPELF--- 311
           +H D+K  N+L+      +++DFG++    K   K  S +      GT  ++APE+    
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCE 192
Query: 312 SRNFGEVSYKSDVYSYGMMLLEM 334
           +       YK+D++S G+ L+EM
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEM 215

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +      S  SD+++ G ++ ++V 
Sbjct: 204 ELLTEKSAXKS--SDLWALGCIIYQLVA 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 147
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +       +  GTA Y++P
Sbjct: 148 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 204
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 205 ELLTEK--SACKSSDLWALGCIIYQLVA 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+E + +  L+KF+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 73  VIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 124
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+     + + +      T  Y APE+     
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEIL---L 179
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 34/237 (14%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKGNG 172
           +PT +  + LKKI       LG+G +G V    L+         G  VAVK L+   G  
Sbjct: 24  DPTVFHKRYLKKIRD-----LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALKADAGPQ 75
Query: 173 QE--FINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSH 228
               +  E+  +  ++H HI++  G C +    +L  V E++P GSL  ++         
Sbjct: 76  HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PR 128
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   +L   A  +  G+ YLH    Q  +H D+   N+LLD++   KI DFGLAK   
Sbjct: 129 HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 289 KDISIVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
           +      +         + APE       +  Y SDV+S+G+ L E++  C  ++ P
Sbjct: 186 EGHEXYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSP 240

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLG 195
           LG G +G V  GK    G  VAVK+L   K    + +     E+  +    H HI++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             S  +   +V E++  G L  +I           L  ++ +++   +  GV+Y H+   
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR------LDEKESRRLFQQILSGVDYCHR--- 134
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+KP N+LLD +   KI+DFGL+ + S       L  + G+  Y APE+ S   
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCGSPNYAAPEVISGRL 191
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                + D++S G++L  ++
Sbjct: 192 -YAGPEVDIWSSGVILYALL 210

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 31/217 (14%)
Query: 134 TSKFKH--RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-----FINEVATIGRI 185
           TS+++    +G G YG+V++ +   +G  VA+K +     NG+E      + EVA + R+
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRL 60
Query: 186 HHF---HIVRLLGFCSEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             F   ++VRL+  C+        +  LV+E + +  L  ++    + +    L  E +K
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIK 115
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
            +     RG+++LH  C   I+H D+KP NIL+      K++DFGLA++ S  +++  + 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV 172
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               T  Y APE+  ++    +   D++S G +  EM
Sbjct: 173 V---TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP--------VAVKMLEHLKGNG 172
           +PT +  + LKKI       LG+G +G V    L+   P        VAVK L+  +G G
Sbjct: 2   DPTVFHKRYLKKIRD-----LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALK--EGCG 51
Query: 173 QE----FINEVATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSS 226
            +    +  E+  +  ++H HIV+  G C +   ++  LV E++P GSL  ++       
Sbjct: 52  PQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL------- 104
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
               +   +L   A  +  G+ YLH    Q  +H  +   N+LLD++   KI DFGLAK 
Sbjct: 105 PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKA 161
Query: 287 CSKDISIVSLTA-ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
             +      +         + APE       +  Y SDV+S+G+ L E++  C  N+ P
Sbjct: 162 VPEGHEYYRVREDGDSPVFWYAPECLKE--CKFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 143
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +       +  GTA Y++P
Sbjct: 144 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 200
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 201 ELLTEK--SACKSSDLWALGCIIYQLVA 226

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 38/239 (15%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP--------VAVKMLEHLKGNG 172
           +PT +  + LKKI       LG+G +G V    L+   P        VAVK L+  +G G
Sbjct: 1   DPTVFHKRYLKKIRD-----LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALK--EGCG 50
Query: 173 QE----FINEVATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSS 226
            +    +  E+  +  ++H HIV+  G C +   ++  LV E++P GSL  ++       
Sbjct: 51  PQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL------- 103
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
               +   +L   A  +  G+ YLH    Q  +H  +   N+LLD++   KI DFGLAK 
Sbjct: 104 PRHCVGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKA 160
Query: 287 CSKDISIVSLTA-ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
             +      +         + APE       +  Y SDV+S+G+ L E++  C  N+ P
Sbjct: 161 VPEGHEYYRVREDGDSPVFWYAPECLKE--CKFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 168 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL----EKFIFSKT 223
           +K    +F NE+  I  I + + +   G  +      ++YE+M N S+    E F     
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
           N +   P+  + +K I   V     Y+H   N  I H D+KP NIL+D N + K+SDFG 
Sbjct: 143 NYTCFIPI--QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 284 AK-LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           ++ +  K I       +RGT  ++ PE FS        K D++S G+ L  M
Sbjct: 199 SEYMVDKKIK-----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE---HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+E + +  L+ F+ +   +    PL    +K   F + +G+ + H   +
Sbjct: 69  VIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPL----IKSYLFQLLQGLAFCH---S 120
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R+LH D+KP N+L++     K++DFGLA+  +  + + + T    T  Y APE+     
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL---L 175
Query: 316 GEVSYKS--DVYSYGMMLLEMVGCR 338
           G   Y +  D++S G +  EMV  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVF--RGKLFNGIPVAVKML------EHLKGNGQEFINEVATIGRIHHFHIVR 192
           LG+G + +V+  R K  N I VA+K +      E   G  +  + E+  +  + H +I+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           LL      +  +LV++FM    LE  I  K NS    P     +K       +G+EYLHQ
Sbjct: 77  LLDAFGHKSNISLVFDFM-ETDLEVII--KDNSLVLTP---SHIKAYMLMTLQGLEYLHQ 130
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELF 311
                ILH D+KP+N+LLD N   K++DFGLAK   S + +       R    Y APEL 
Sbjct: 131 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELL 184
Query: 312 SRNFGEVSY--KSDVYSYGMMLLEMV 335
              FG   Y    D+++ G +L E++
Sbjct: 185 ---FGARMYGVGVDMWAVGCILAELL 207

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 23/228 (10%)
Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R++     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 3   EEILEKLRSI----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 58  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 110
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H DIK  NILL  +   K++DFG     +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 168 PEQSKRSEMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 191 VRLLGFCSEGTRRALV-YEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           V+L  FC +   +      +  NG L K+I      + +  R  + E        +   +
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSAL 150
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++
Sbjct: 151 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           PEL +         SD+++ G ++ ++V 
Sbjct: 208 PELLTEK--SACKSSDLWALGCIIYQLVA 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 121
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 122 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 179 ELLTEK--SACKSSDLWALGCIIYQLVA 204

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 43/220 (19%)
Query: 128 KELKKITSKFKHRLGQGGYGSVF------RGKLFNGIPVAVKML--EHLKGNGQEFINEV 179
           +++KKI  +FK  LG G +  V        GKLF     AVK +  + LKG      NE+
Sbjct: 18  EDIKKIF-EFKETLGTGAFSEVVLAEEKATGKLF-----AVKCIPKKALKGKESSIENEI 71
Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWE 234
           A + +I H +IV L           LV + +  G L     EK  +++ ++S+       
Sbjct: 72  AVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST------- 124
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSK-D 290
               +   V   V YLH+     I+H D+KP N+L    D   +  ISDFGL+K+  K D
Sbjct: 125 ----LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
           +    ++ A GT GY+APE+ ++     S   D +S G++
Sbjct: 178 V----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 122
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 180 ELLTEK--SACKSSDLWALGCIIYQLVA 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 123
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 124 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 181 ELLTEK--SACKSSDLWALGCIIYQLVA 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 137 FKHRLGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRL 193
           FK +LG G +G V    +  +G+   +K +   +     ++   E+  +  + H +I+++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                +     +V E    G L + I S    +  + LS   + ++   +   + Y H  
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSA--QARGKALSEGYVAELMKQMMNALAYFH-- 141
Query: 254 CNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
            +Q ++H D+KP NIL   +  P    KI DFGLA+L   D      T A GTA Y+APE
Sbjct: 142 -SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPE 196
Query: 310 LFSRNFGEVSYKSDVYSYG-MMLLEMVGC 337
           +F R+   V++K D++S G +M   + GC
Sbjct: 197 VFKRD---VTFKCDIWSAGVVMYFLLTGC 222

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 124
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 125 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 182 ELLTEK--SACKSSDLWALGCIIYQLVA 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 143
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 144 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 200
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 201 ELLTEK--SACKSSDLWALGCIIYQLVA 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 128
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 129 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 185
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 186 ELLTEK--SACKSSDLWALGCIIYQLVA 211

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 31/217 (14%)
Query: 134 TSKFKH--RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-----FINEVATIGRI 185
           TS+++    +G G YG+V++ +   +G  VA+K +     NG+E      + EVA + R+
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRL 60
Query: 186 HHF---HIVRLLGFCSEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             F   ++VRL+  C+        +  LV+E + +  L  ++    + +    L  E +K
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIK 115
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
            +     RG+++LH  C   I+H D+KP NIL+      K++DFGLA++ S  +++  + 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV 172
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               T  Y APE+  ++    +   D++S G +  EM
Sbjct: 173 V---TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVA----VKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
            ++G+G YG+VF+ K      +     V++ +  +G     + E+  +  + H +IVRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                  +  LV+EF  +  L+K+ F   N      L  E +K   F + +G+ + H   
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD----LDPEIVKSFLFQLLKGLGFCH--- 118
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++ +LH D+KP N+L++ N + K+++FGLA+  +  I +   +A   T  Y  P++    
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVVTLWYRPPDVL--- 173
Query: 315 FGEVSYKS--DVYSYGMMLLEMVG 336
           FG   Y +  D++S G +  E+  
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELAN 197

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 149
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 150 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 206
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 207 ELLTEK--SACKSSDLWALGCIIYQLVA 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 147
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 148 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 204
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 205 ELLTEK--SACKSSDLWALGCIIYQLVA 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 146
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 147 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 204 ELLTEK--SACKSSDLWALGCIIYQLVA 229

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVAT-----IGRIHHFHIVRLL 194
           +G+G YG V + +  + G  VA+K  + L+ +  + + ++A      + ++ H ++V LL
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIK--KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
             C +  R  LV+EF+ +  L+              L ++ ++K  F +  G+ + H   
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNG------LDYQVVQKYLFQIINGIGFCH--- 141
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +  I+H DIKP NIL+  +   K+ DFG A+  +    +     A  T  Y APEL    
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELL--- 196
Query: 315 FGEVSY--KSDVYSYGMMLLEM 334
            G+V Y    DV++ G ++ EM
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM 218

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE--SIN 185
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 34/237 (14%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP--------VAVKMLEHLKGNG 172
           +PT +  + LKKI       LG+G +G V    L+   P        VAVK L+   G  
Sbjct: 7   DPTVFHKRYLKKIRD-----LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALKADCGPQ 58
Query: 173 QE--FINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSH 228
               +  E+  +  ++H HI++  G C +   ++L  V E++P GSL  ++         
Sbjct: 59  HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------PR 111
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   +L   A  +  G+ YLH   +Q  +H ++   N+LLD++   KI DFGLAK   
Sbjct: 112 HSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 289 KDISIVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
           +      +         + APE       +  Y SDV+S+G+ L E++  C  ++ P
Sbjct: 169 EGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSP 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 125
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE--SIN 182
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTXXKASKGKLPIKWMAPE--SIN 185
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 131
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE--SIN 188
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 130
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE--SIN 187
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 110/217 (50%), Gaps = 31/217 (14%)
Query: 134 TSKFKH--RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-----FINEVATIGRI 185
           TS+++    +G G YG+V++ +   +G  VA+K +     NG+E      + EVA + R+
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGEEGLPISTVREVALLRRL 60
Query: 186 HHF---HIVRLLGFCSEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
             F   ++VRL+  C+        +  LV+E + +  L  ++    + +    L  E +K
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETIK 115
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
            +     RG+++LH  C   I+H D+KP NIL+      K++DFGLA++ S  +++  + 
Sbjct: 116 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV 172
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               T  Y APE+  ++    +   D++S G +  EM
Sbjct: 173 V---TLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE--SIN 185
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 156
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE--SIN 213
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAYLE--- 133
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+  N   K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE--SIN 190
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 136 KFKHRLGQGGYGS-VFRGKLFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHI 190
           KF   LG+G + + V   +L      A+K+LE    +K N   ++  E   + R+ H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           V+L     +  +      +  NG L K+I      + +  R  + E        +   +E
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALE 144
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +          GTA Y++P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           EL +         SD+++ G ++ ++V 
Sbjct: 202 ELLTEK--SACKSSDLWALGCIIYQLVA 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 29/203 (14%)
Query: 140 RLGQGGYGSVF--RGKLFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRL 193
           +LG G YG V   + KL  G   A+K+++        N    ++EVA + ++ H +I++L
Sbjct: 11  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 194 LGFCSEGTRRALVYEFMPNGSL-EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
             F  +     LV E    G L ++ I  +  S     +       I   V  G  YLH+
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK 122
Query: 253 GCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAAR-GTAGYIAP 308
                I+H D+KP N+LL+   +    KI DFGL    S    +      R GTA YIAP
Sbjct: 123 ---HNIVHRDLKPENLLLESKSRDALIKIVDFGL----SAHFEVGGKMKERLGTAYYIAP 175
Query: 309 ELFSRNFGEVSYKSDVYSYGMML 331
           E+  + + E   K DV+S G++L
Sbjct: 176 EVLRKKYDE---KCDVWSCGVIL 195

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG-FC 197
           +G G YG V++G+ +  G   A+K+++      +E   E+  + +  HH +I    G F 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 198 SEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +       +  LV EF   GS+   I +   ++    L  E +  I   + RG+ +LHQ
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSHLHQ 147
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
               +++H DIK  N+LL  N + K+ DFG++     D ++       GT  ++APE+ +
Sbjct: 148 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 313 ---RNFGEVSYKSDVYSYGMMLLEMV 335
                     +KSD++S G+  +EM 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 34/237 (14%)
Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIP--------VAVKMLEHLKGNG 172
           +PT +  + LKKI       LG+G +G V    L+   P        VAVK L+   G  
Sbjct: 7   DPTVFHKRYLKKIRD-----LGEGHFGKV---SLYCYDPTNDGTGEMVAVKALKADCGPQ 58
Query: 173 QE--FINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSH 228
               +  E+  +  ++H HI++  G C +   ++L  V E++P GSL  ++         
Sbjct: 59  HRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-------PR 111
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   +L   A  +  G+ YLH    Q  +H ++   N+LLD++   KI DFGLAK   
Sbjct: 112 HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP 168
Query: 289 KDISIVSL-TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP 343
           +      +         + APE       +  Y SDV+S+G+ L E++  C  ++ P
Sbjct: 169 EGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSP 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 85  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 137
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 195 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 25  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 84
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 85  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 137
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 195 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGF 196
           LG+G +G V + K        AVK++       ++    + EV  + ++ H +I++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             + +   +V E    G L   I  +   S H         +I   V  G+ Y+H+    
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA------ARIIKQVFSGITYMHK---H 140
Query: 257 RILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            I+H D+KP NILL   + +   KI DFGL+    ++     +    GTA YIAPE+   
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 314 NFGEVSYKSDVYSYGMML 331
            + E   K DV+S G++L
Sbjct: 198 TYDE---KCDVWSAGVIL 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGF 196
           LG+G +G V + K        AVK++       ++    + EV  + ++ H +I++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             + +   +V E    G L   I  +   S H         +I   V  G+ Y+H+    
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA------ARIIKQVFSGITYMHK---H 140
Query: 257 RILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            I+H D+KP NILL   + +   KI DFGL+    ++     +    GTA YIAPE+   
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 314 NFGEVSYKSDVYSYGMML 331
            + E   K DV+S G++L
Sbjct: 198 TYDE---KCDVWSAGVIL 212

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 27/202 (13%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLL 194
           +LG G YG V   K    G   A+K+++        N    ++EVA + ++ H +I++L 
Sbjct: 28  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 195 GFCSEGTRRALVYEFMPNGSL-EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            F  +     LV E    G L ++ I  +  S     +       I   V  G  YLH+ 
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVLSGTTYLHK- 139
Query: 254 CNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPE 309
               I+H D+KP N+LL+   +    KI DFGL    S    +      R GTA YIAPE
Sbjct: 140 --HNIVHRDLKPENLLLESKSRDALIKIVDFGL----SAHFEVGGKMKERLGTAYYIAPE 193
Query: 310 LFSRNFGEVSYKSDVYSYGMML 331
           +  + + E   K DV+S G++L
Sbjct: 194 VLRKKYDE---KCDVWSCGVIL 212

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 110/227 (48%), Gaps = 20/227 (8%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG 170
           ED  T+  TR    E+++   +    +G+G +G V +G   +     + VA+K  ++   
Sbjct: 374 EDTYTMPSTRDY--EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431
Query: 171 NG--QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
           +   ++F+ E  T+ +  H HIV+L+G  +E     ++ E    G L  F+  +  S   
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--- 487
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L    L   A+ ++  + YL    ++R +H DI   N+L+  N   K+ DFGL++   
Sbjct: 488 --LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM- 541
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +D +    +  +    ++APE  S NF   +  SDV+ +G+ + E++
Sbjct: 542 EDSTYYKASKGKLPIKWMAPE--SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 5   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 117
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 175 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 15  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 75  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 127
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 128 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 185 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 23  RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 82
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 83  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 135
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 136 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 193 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 220

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G VF       GKL+    +  K L+  KG  Q  + E   + ++H   IV L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRFIVSLA 251
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARGVEYLHQ 252
                 T   LV   M  G +   I+   N     P  +++ + I +   +  G+E+LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTAGY 305
              + I++ D+KP N+LLD +   +ISD GLA         V L A +       GT G+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGF 355
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +APEL      E  +  D ++ G+ L EM+  R
Sbjct: 356 MAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 3   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 62
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 63  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 115
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 116 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 173 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 200

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 9   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 68
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 69  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 121
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 179 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 9   RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 68
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 69  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 121
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 122 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 179 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 127
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG +  C    S    T   GT  Y+ PE+     
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSS--RRTTLSGTLDYLPPEMIEGRM 183
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 184 HDE--KVDLWSLGVLCYEFL 201

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G VF       GKL+    +  K L+  KG  Q  + E   + ++H   IV L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRFIVSLA 251
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARGVEYLHQ 252
                 T   LV   M  G +   I+   N     P  +++ + I +   +  G+E+LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTAGY 305
              + I++ D+KP N+LLD +   +ISD GLA         V L A +       GT G+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGF 355
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +APEL      E  +  D ++ G+ L EM+  R
Sbjct: 356 MAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G VF       GKL+    +  K L+  KG  Q  + E   + ++H   IV L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRFIVSLA 251
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARGVEYLHQ 252
                 T   LV   M  G +   I+   N     P  +++ + I +   +  G+E+LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTAGY 305
              + I++ D+KP N+LLD +   +ISD GLA         V L A +       GT G+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGF 355
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +APEL      E  +  D ++ G+ L EM+  R
Sbjct: 356 MAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G VF       GKL+    +  K L+  KG  Q  + E   + ++H   IV L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRFIVSLA 251
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG--VARGVEYLHQ 252
                 T   LV   M  G +   I+   N     P  +++ + I +   +  G+E+LHQ
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIY---NVDEDNP-GFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-------GTAGY 305
              + I++ D+KP N+LLD +   +ISD GLA         V L A +       GT G+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGF 355
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +APEL      E  +  D ++ G+ L EM+  R
Sbjct: 356 MAPELLLGE--EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSYCH---S 130
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL  N + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 187 HDE--KVDLWSLGVLCYEFL 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +     +    E+     ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH---GIG 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGF 196
           LG+G +G V + K        AVK++       ++    + EV  + ++ H +I++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
             + +   +V E    G L   I  +   S H         +I   V  G+ Y+H+    
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA------ARIIKQVFSGITYMHK---H 140
Query: 257 RILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            I+H D+KP NILL+   +    KI DFGL+    ++     +    GTA YIAPE+   
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG 197
Query: 314 NFGEVSYKSDVYSYGMML 331
            + E   K DV+S G++L
Sbjct: 198 TYDE---KCDVWSAGVIL 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G YG V++ +   G   A+K +   K   G     I E++ +  + H +IV+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                R  LV+E + +  L+K +           L     K     +  G+ Y H   ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           R+LH D+KP N+L++   + KI+DFGLA+     I +   T    T  Y AP++     G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVL---MG 174
Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++S G +  EMV
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK 169
           E+ LE  R +     +  + KK  ++F+ ++GQG  G+V+    +  G  VA++ +   +
Sbjct: 4   EEILEKLRII----VSVGDPKKKYTRFE-KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 58
Query: 170 GNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
              +E I NE+  +    + +IV  L     G    +V E++  GSL       T+  + 
Sbjct: 59  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-------TDVVTE 111
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             +   ++  +     + +E+LH   + +++H +IK  NILL  +   K++DFG     +
Sbjct: 112 TCMDEGQIAAVCRECLQALEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQIT 168
Query: 289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
            + S  S     GT  ++APE+ +R  +G    K D++S G+M +EM+
Sbjct: 169 PEQSKRSTMV--GTPYWMAPEVVTRKAYGP---KVDIWSLGIMAIEMI 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G YG V++ +   G   A+K +   K   G     I E++ +  + H +IV+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                R  LV+E + +  L+K +           L     K     +  G+ Y H   ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           R+LH D+KP N+L++   + KI+DFGLA+     I +   T    T  Y AP++     G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEVVTLWYRAPDVL---MG 174
Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++S G +  EMV
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G + K +   +     R  ++         +A  + Y H   +
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELANALSYCH---S 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 188 HDE--KVDLWSLGVLCYEFL 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 123
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 184 AE-PVDVWSCGIVLTAMLA 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGF 196
           ++G+G YG V++ +   G   A+K +   K   G     I E++ +  + H +IV+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                R  LV+E + +  L+K +           L     K     +  G+ Y H   ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLL-----DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           R+LH D+KP N+L++   + KI+DFGLA+     I +   T    T  Y AP++     G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVL---MG 174
Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++S G +  EMV
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/106 (38%), Positives = 62/106 (58%), Gaps = 7/106 (6%)
Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
           P++ E L   +F VARG+E+L    +++ +H D+   NILL  N   KI DFGLA+   K
Sbjct: 195 PITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 290 DISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           +   V     R    ++APE +F + +   S KSDV+SYG++L E+
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIY---STKSDVWSYGVLLWEI 294

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY------ITELANALSYCH---S 130
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL  N + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGW--------SVHAPSSRRDTLCGTLDYLPPEMI 182
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 183 EGRMHDE--KVDLWSLGVLCYEFL 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLG 195
           LG G +G V  G+    G  VAVK+L   K    + +     E+  +    H HI++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             S  T   +V E++  G L  +I        H  +   + +++   +   V+Y H+   
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR--- 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+KP N+LLD +   KI+DFGL+ + S       L  + G+  Y APE+ S   
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRL 186
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                + D++S G++L  ++
Sbjct: 187 -YAGPEVDIWSCGVILYALL 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH      
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH---GIG 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 28/224 (12%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGR 184
           ++++ K+TS+    LG+G Y  V     L NG   AVK++E   G+ +  +  EV T+ +
Sbjct: 10  FEDMYKLTSEL---LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 185 IH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
              + +I+ L+ F  + TR  LV+E +  GS+   I  K    + R  S     ++   V
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREAS-----RVVRDV 120
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQP-KISDFGLA---KL---CSKDISIV 294
           A  +++LH    + I H D+KP NIL +      P KI DF L    KL   C+  I+  
Sbjct: 121 AAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTP-ITTP 176
Query: 295 SLTAARGTAGYIAPELFSRNFGEVSY---KSDVYSYGMMLLEMV 335
            LT   G+A Y+APE+      + ++   + D++S G++L  M+
Sbjct: 177 ELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIML 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           +G+G YG V       N + VA+K +   EH +   Q  + E+  + R  H +I+ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
               T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H     
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA--- 147
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNF 315
            +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + 
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 316 GEVSYKSDVYSYGMMLLEMVGCR 338
           G  +   D++S G +L EM+  R
Sbjct: 208 G-YTKSIDIWSVGCILAEMLSNR 229

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH---GIG 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH---GIG 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH      
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH---GIG 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 148
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 209 -YTKSIDIWSVGCILAEMLSNR 229

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G + K +   +     R  ++         +A  + Y H   +
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY------ITELANALSYCH---S 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLXGTLDYLPPEMI 183
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 184 EGRMHDE--KVDLWSLGVLCYEFL 205

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 140 RLGQGGYGSVF--RGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLL 194
           +LG G YG V   R K+ + +  A+K++        +  + + EVA +  + H +I++L 
Sbjct: 44  KLGSGAYGEVLLCRDKVTH-VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 195 GFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
            F  +     LV E    G L      +  F++ +++            I   V  GV Y
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-----------IIKQVLSGVTY 151
Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           LH+     I+H D+KP N+LL+   +    KI DFGL+ +         +    GTA YI
Sbjct: 152 LHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYI 205
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLL 332
           APE+  + + E   K DV+S G++L 
Sbjct: 206 APEVLRKKYDE---KCDVWSIGVILF 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLG 195
           LG G +G V  G+    G  VAVK+L   K    + +     E+  +    H HI++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             S  T   +V E++  G L  +I        H  +   + +++   +   V+Y H+   
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR--- 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+KP N+LLD +   KI+DFGL+ + S       L  + G+  Y APE+ S   
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRDSCGSPNYAAPEVISGRL 186
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                + D++S G++L  ++
Sbjct: 187 -YAGPEVDIWSCGVILYALL 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 368 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 427
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 428 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 480
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 481 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 538 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 565

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
            LG G +G V++ +     +  A K+++   +   ++++ E+  +    H +IV+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
                  ++ EF   G+++  +         RPL+  +++ +       + YLH   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF---SRN 314
           I+H D+K  NIL   +   K++DFG++   ++  +I    +  GT  ++APE+    +  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
                YK+DV+S G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 23/179 (12%)
Query: 158 IPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
           I V +K +EH         +E   +  + H  I+R+ G   +  +  ++ +++  G L  
Sbjct: 43  IVVRLKQVEHTN-------DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-- 93
Query: 218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 277
             FS    S   P    K    A  V   +EYLH   ++ I++ D+KP NILLD N   K
Sbjct: 94  --FSLLRKSQRFPNPVAKF--YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIK 146
Query: 278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           I+DFG AK    D++        GT  YIAPE+ S      +   D +S+G+++ EM+ 
Sbjct: 147 ITDFGFAKYVP-DVTYXLC----GTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLA 198

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 144
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 205 -YTKSIDIWSVGCILAEMLSNR 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G YG V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 125
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 186 AE-PVDVWSCGIVLTAMLA 203

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------QEFINEVATIGR 184
           +K+ +     LG G +G+V +G       V    ++ LK          E + E   + +
Sbjct: 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 426
Query: 185 IHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           + + +IVR++G C E     LV E    G L K++        +R +  + + ++   V+
Sbjct: 427 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVS 479
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV-SLTAARGTA 303
            G++YL +      +H D+   N+LL      KISDFGL+K    D +   + T  +   
Sbjct: 480 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
            + APE    N+ + S KSDV+S+G+++ E
Sbjct: 537 KWYAPECI--NYYKFSSKSDVWSFGVLMWE 564

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 142
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 203 -YTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 142
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 203 -YTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 149
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 210 -YTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 150
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 211 -YTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 141
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 202 -YTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 148
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 209 -YTKSIDIWSVGCILAEMLSNR 229

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLL 194
           +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H HIV+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G  +E     ++ E    G L  F+  +  S     L    L   A+ ++  + YL    
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAYLE--- 128
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           ++R +H DI   N+L+      K+ DFGL++   +D +    +  +    ++APE  S N
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE--SIN 185
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           F   +  SDV+ +G+ + E++
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 144
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 205 -YTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 144
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 205 -YTKSIDIWSVGCILAEMLSNR 225

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 15/166 (9%)
Query: 169 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSS 226
           +G  ++   E+A + ++ H ++V+L+    +     L  V+E +  G +           
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------MEVP 129
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
           + +PLS ++ +     + +G+EYLH    Q+I+H DIKP N+L+  +   KI+DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS-DVYSYGMML 331
                +++S T   GT  ++APE  S      S K+ DV++ G+ L
Sbjct: 187 FKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 146
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 207 -YTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 144
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 205 -YTKSIDIWSVGCILAEMLSNR 225

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 186 HDE--KVDLWSLGVLCYEFL 203

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 141 LGQGGYGSVFRGKLFNG----IPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRL 193
           LG+G +GSV   +L       + VAVKML+       + +EF+ E A +    H H+ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 194 LGFCSEGTRRA------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           +G       +       ++  FM +G L  F+ +     +   L  + L +    +A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL    ++  +H D+   N +L  +    ++DFGL++            A++    ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            E  + N   V   SDV+++G+ + E++
Sbjct: 208 LESLADNLYTV--HSDVWAFGVTMWEIM 233

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 152
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 213 -YTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 144
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 205 -YTKSIDIWSVGCILAEMLSNR 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG 170
           ED  T+  TR    E+++   +    +G+G +G V +G   +     + VA+K  ++   
Sbjct: 374 EDTYTMPSTRDY--EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431
Query: 171 NG--QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH 228
           +   ++F+ E  T+ +  H HIV+L+G  +E     ++ E    G L  F+  +  S   
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFS--- 487
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L    L   A+ ++  + YL    ++R +H DI   N+L+      K+ DFGL++   
Sbjct: 488 --LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM- 541
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +D +    +  +    ++APE  S NF   +  SDV+ +G+ + E++
Sbjct: 542 EDSTYYKASKGKLPIKWMAPE--SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 143
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 199
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 200 HDE--KVDLWSLGVLCYEFL 217

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 187
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 188 HDE--KVDLWSLGVLCYEFL 205

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
            LG G +G V++ +     +  A K+++   +   ++++ E+  +    H +IV+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
                  ++ EF   G+++  +         RPL+  +++ +       + YLH   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF---SRN 314
           I+H D+K  NIL   +   K++DFG++   ++ I      +  GT  ++APE+    +  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ--RRDSFIGTPYWMAPEVVMCETSK 213
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
                YK+DV+S G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 164
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 225 -YTKSIDIWSVGCILAEMLSNR 245

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 152
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 208
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 209 HDE--KVDLWSLGVLCYEFL 226

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 127
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRDTLCGTLDYLPPEMI 179
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 180 EGRMHDE--KVDLWSLGVLCYEFL 201

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 127
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMI 179
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 180 EGRMHDE--KVDLWSLGVLCYEFL 201

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 186 HDE--KVDLWSLGVLCYEFL 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 183 HDE--KVDLWSLGVLCYEFL 200

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA++ +   +     Q  + E+  + R  H +I+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 148
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 209 -YTKSIDIWSVGCILAEMLSNR 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 128
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMI 180
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 181 EGRMHDE--KVDLWSLGVLCYEFL 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 139 HRLGQGGYGSVFR-GKLFNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLL 194
           + +G G YG   +  +  +G  +  K L++    +   Q  ++EV  +  + H +IVR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 195 GFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
               + T   L  V E+   G L   I   T    +  L  E + ++   +   ++  H+
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQLTLALKECHR 129
Query: 253 GCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
             +    +LH D+KP N+ LD     K+ DFGLA++ + D S     A  GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQ 187
Query: 311 FSRNFGEVSY--KSDVYSYGMMLLEM 334
            +R    +SY  KSD++S G +L E+
Sbjct: 188 MNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMI 183
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 184 EGRMHDE--KVDLWSLGVLCYEFL 205

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K     H  LS + +    + + RG++Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLY-KLLKCQH--LSNDHICYFLYQILRGLKYIHSA---N 148
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 209 -YTKSIDIWSVGCILAEMLSNR 229

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFL 200

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTDLCGTLDYLPPEMI 178
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFL 200

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 125
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 181
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 182 HDE--KVDLWSLGVLCYEFL 199

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRTELCGTLDYLPPEMI 178
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFL 200

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 142 GQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT 201
            +G +G V++ +L N   VAVK+         +   E+ +   + H ++++ +     G+
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 202 RRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ----- 252
                  L+  F   GSL  ++  K N      ++W +L  +A  ++RG+ YLH+     
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL--KGNI-----ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 253 ---GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
              G    I H D K  N+LL  +    ++DFGLA                GT  Y+APE
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE 195
Query: 310 LF--SRNFGEVSY-KSDVYSYGMMLLEMVG-CRKNKDP 343
           +   + NF   ++ + D+Y+ G++L E+V  C+    P
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGP 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 152
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRDDLCGTLDYLPPEMI 204
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 205 EGRMHDE--KVDLWSLGVLCYEFL 226

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 130
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 186
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 187 HDE--KVDLWSLGVLCYEFL 204

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 137 FKHRLGQGGYGSV-FRGKLFNGIPVAVK-MLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           F  +LG+GG+  V     L +G   A+K +L H + + +E   E       +H +I+RL+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 195 GFC--SEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
            +C    G +    L+  F   G+L   I    +  +   L+ +++  +  G+ RG+E +
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLEAI 150
Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFG-LAKLC------SKDISIVSLTAARGTA 303
           H    +   H D+KP NILL    QP + D G + + C       + +++    A R T 
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 304 GYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
            Y APELFS ++   +  ++DV+S G +L  M+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S         A  GT  Y+ PE+     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 186 HDE--KVDLWSLGVLCYEFL 203

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
            LG G +G V++ +     +  A K+++   +   ++++ E+  +    H +IV+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
                  ++ EF   G+++  +         RPL+  +++ +       + YLH   + +
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-----LERPLTESQIQVVCKQTLDALNYLH---DNK 155
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF---SRN 314
           I+H D+K  NIL   +   K++DFG++   ++ I         GT  ++APE+    +  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ--RRDXFIGTPYWMAPEVVMCETSK 213
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
                YK+DV+S G+ L+EM
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
           E +K     +   ++YL    NQRI+H D+KP NILLD +    I+DF +A +  ++  I
Sbjct: 115 ETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171
Query: 294 VSLTAARGTAGYIAPELFSRNFGE-VSYKSDVYSYGMMLLEMVGCRK 339
            ++    GT  Y+APE+FS   G   S+  D +S G+   E++  R+
Sbjct: 172 TTMA---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFC 197
           LG G +G V +  +   G+ +A K+++  +G  + +E  NE++ + ++ H ++++L    
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF--GVARGVEYLHQGCN 255
                  LV E++  G L    F +    S+   +  +L  I F   +  G+ ++HQ   
Sbjct: 156 ESKNDIVLVMEYVDGGEL----FDRIIDESY---NLTELDTILFMKQICEGIRHMHQ--- 205
Query: 256 QRILHFDIKPHNILLDHNF--QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
             ILH D+KP NIL  +    Q KI DFGLA+          L    GT  ++APE+ + 
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPEVVNY 262
Query: 314 NFGEVSYKSDVYSYGMM 330
           +F  VS+ +D++S G++
Sbjct: 263 DF--VSFPTDMWSVGVI 277

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S         A  GT  Y+ PE+     
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 183 HDE--KVDLWSLGVLCYEFL 200

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE- 199
           +G+G YG V+RG L++G  VAVK+             E+     + H +I   LGF +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIASD 71
Query: 200 ------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-- 251
                  T+  L+  +  +GSL  F+  +T    H  L      ++A   A G+ +LH  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT-LEPHLAL------RLAVSAACGLAHLHVE 124
Query: 252 ----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSLTAARGTAGY 305
               QG    I H D K  N+L+  N Q  I+D GLA + S+  D   +      GT  Y
Sbjct: 125 IFGTQG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRY 183
Query: 306 IAPELFSRNFGEVSYKS----DVYSYGMMLLEM 334
           +APE+         ++S    D++++G++L E+
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMI 181
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 182 EGRMHDE--KVDLWSLGVLCYEFL 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEMIEGRM 182
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 183 HDE--KVDLWSLGVLCYEFL 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 30/218 (13%)
Query: 134 TSKFKH--RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF------INEVATIGR 184
           TS+++    +G G YG+V++ +   +G  VA+K +    G G         + EVA + R
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 185 IHHF---HIVRLLGFCSEG-----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
           +  F   ++VRL+  C+        +  LV+E + +  L  ++    + +    L  E +
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL----DKAPPPGLPAETI 122
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
           K +     RG+++LH  C   I+H D+KP NIL+      K++DFGLA++ S  +   +L
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---AL 176
Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           T    T  Y APE+  ++    +   D++S G +  EM
Sbjct: 177 TPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 148
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      L     T  Y APE+   + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 209 -YTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 149
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      L     T  Y APE+   + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 210 -YTKSIDIWSVGCILAEMLSNR 230

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 40/209 (19%)
Query: 137 FKHRLGQGGYGSVF------RGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFH 189
           F   LG G +  VF       GKLF     A+K ++           NE+A + +I H +
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLF-----ALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 190 IVRLLGFCSEGTRRALVYEFMPNGS-----LEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           IV L       T   LV + +  G      LE+ ++++ ++S            +   V 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-----------VIQQVL 116
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
             V+YLH+     I+H D+KP N+L    + N +  I+DFGL+K+    I    ++ A G
Sbjct: 117 SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACG 169
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
           T GY+APE+ ++     S   D +S G++
Sbjct: 170 TPGYVAPEVLAQK--PYSKAVDCWSIGVI 196

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRXXLCGTLDYLPPEMI 178
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFL 200

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H HI+ L+      +   LV++ M  G L  ++  K        LS ++ + I   +   
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEA 212
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           V +LH      I+H D+KP NILLD N Q ++SDFG +        +  L    GT GY+
Sbjct: 213 VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYL 266
Query: 307 APELFSRNFGEV----SYKSDVYSYGMMLLEMVG 336
           APE+   +  E       + D+++ G++L  ++ 
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 123
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE+     
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 179
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 180 HDE--KVDLWSLGVLCYEFL 197

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPELF 311
           +R++H DIKP N+LL    + KI+DFG         S+ + ++ R    GT  Y+ PE+ 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGW--------SVHAPSSRRDDLCGTLDYLPPEMI 181
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                +   K D++S G++  E +
Sbjct: 182 EGRMHDE--KVDLWSLGVLCYEFL 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 22/201 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS-RN 314
           +R++H DIKP N+LL    + KI+DFG     S        T   GT  Y+ PE    R 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEXIEGRX 187
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
             E   K D++S G++  E +
Sbjct: 188 HDE---KVDLWSLGVLCYEFL 205

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 43/220 (19%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR---IHHFHIVR---L 193
           ++G+G YG V+ GK + G  VAVK+          F  E A+  R   I+   ++R   +
Sbjct: 44  QIGKGRYGEVWMGK-WRGEKVAVKVF---------FTTEEASWFRETEIYQTVLMRHENI 93
Query: 194 LGFCSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LGF +         T+  L+ ++  NGSL  ++ S T       L  + + K+A+    G
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSG 146
Query: 247 VEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TA 298
           + +LH      QG    I H D+K  NIL+  N    I+D GLA     D + V +    
Sbjct: 147 LCHLHTEIFSTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS----DVYSYGMMLLEM 334
             GT  Y+ PE+   +     ++S    D+YS+G++L E+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 117/247 (47%), Gaps = 26/247 (10%)
Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFR-GKL 154
           K  E E +++ + ++E FL   + V        ELK    +    LG G  G VF+    
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVG-------ELKDDDFEKISELGAGNGGVVFKVSHK 55
Query: 155 FNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTRRALVYEFMP 211
            +G+ +A K+  LE       + I E+  +   +  +IV   G F S+G   ++  E M 
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMD 114
Query: 212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
            GSL++ +  K        +  + L K++  V +G+ YL +    +I+H D+KP NIL++
Sbjct: 115 GGSLDQ-VLKKAGR-----IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
              + K+ DFG++      ++     +  GT  Y++PE         S +SD++S G+ L
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSL 220
Query: 332 LEMVGCR 338
           +EM   R
Sbjct: 221 VEMAVGR 227

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 139 HRLGQGGYGSVFR-GKLFNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLL 194
           + +G G YG   +  +  +G  +  K L++    +   Q  ++EV  +  + H +IVR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 195 GFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
               + T   L  V E+   G L   I   T    +  L  E + ++   +   ++  H+
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQLTLALKECHR 129
Query: 253 GCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
             +    +LH D+KP N+ LD     K+ DFGLA++ + D S        GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQ 187
Query: 311 FSRNFGEVSY--KSDVYSYGMMLLEM 334
            +R    +SY  KSD++S G +L E+
Sbjct: 188 MNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G V   K    G   AVK++       K + +  + EV  + ++ H +I++L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E    G L   I S+      +  S     +I   V  G+ Y+H+   
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN-- 145
Query: 256 QRILHFDIKPHNILLDHNFQP---KISDFGLAK--LCSKDISIVSLTAARGTAGYIAPEL 310
            +I+H D+KP N+LL+   +    +I DFGL+     SK      +    GTA YIAPE+
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEV 199
Query: 311 FSRNFGEVSYKSDVYSYGMML-LEMVGC 337
               + E   K DV+S G++L + + GC
Sbjct: 200 LHGTYDE---KCDVWSTGVILYILLSGC 224

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +++ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +++ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKM--LEHLK-GNGQEFIN 177
           P+  +    ++IT     +LG+G YG V++         VA+K   LEH + G     I 
Sbjct: 28  PSATSIDRYRRIT-----KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR 82
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  + H +I+ L        R  L++E+  N  L+K++    +      +S   +K
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD------VSMRVIK 135
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQP--KISDFGLAKLCSKDIS 292
              + +  GV + H   ++R LH D+KP N+LL   D +  P  KI DFGLA+     I 
Sbjct: 136 SFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IP 190
Query: 293 IVSLTAARGTAGYIAPELF--SRNFGEVSYKSDVYSYGMMLLEMV 335
           I   T    T  Y  PE+   SR++   S   D++S   +  EM+
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHY---STSVDIWSIACIWAEML 232

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLG 195
           LG+G +G V        G  VA+K++      K + Q  I  E++ +  + H HI++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    +V E+  N  L  +I  +        +S ++ ++    +   VEY H+   
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHR--- 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            +I+H D+KP N+LLD +   KI+DFGL+ + +       L  + G+  Y APE+ S   
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKL 188
Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
                + DV+S G++L  M+ CR+
Sbjct: 189 -YAGPEVDVWSCGVILYVML-CRR 210

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +++ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +I+ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +++ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 128
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI++FG     S        T   GT  Y+ PE+     
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 184
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 185 HDE--KVDLWSLGVLCYEFL 202

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKG-NGQEFINEVATIGR-IHHFHIVRLLGFC 197
           LG+G  G V           VAVK+++  +  +  E I +   I + ++H ++V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            EG  + L  E+   G L    F +       P      ++    +  GV YLH G    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEP--DAQRFFHQLMAGVVYLH-GIG-- 124
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APEL  R    
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 318 VSYKSDVYSYGMMLLEMVG 336
                DV+S G++L  M+ 
Sbjct: 185 AE-PVDVWSCGIVLTAMLA 202

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G V   K    G   AVK++       K + +  + EV  + ++ H +I++L  
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E    G L   I S+      +  S     +I   V  G+ Y+H+   
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN-- 151
Query: 256 QRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
            +I+H D+KP N+LL+   +    +I DFGL+       +   +    GTA YIAPE+  
Sbjct: 152 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLH 207
Query: 313 RNFGEVSYKSDVYSYGMML-LEMVGC 337
             + E   K DV+S G++L + + GC
Sbjct: 208 GTYDE---KCDVWSTGVILYILLSGC 230

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV+ + ++ H +++ L       T   L+ E +  G L  F+  K + S     S
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF---QPKISDFGLAKLCS 288
           + K       +  GV YLH    ++I HFD+KP NI LLD N      K+ DFGLA    
Sbjct: 120 FIK------QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
             +   ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 DGVEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLG 195
           LG+G +G V        G  VA+K++      K + Q  I  E++ +  + H HI++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    +V E+  N  L  +I  +        +S ++ ++    +   VEY H+   
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHR--- 130
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            +I+H D+KP N+LLD +   KI+DFGL+ + +       L  + G+  Y APE+ S   
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKL 187
Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
                + DV+S G++L  M+ CR+
Sbjct: 188 -YAGPEVDVWSCGVILYVML-CRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLG 195
           LG+G +G V        G  VA+K++      K + Q  I  E++ +  + H HI++L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    +V E+  N  L  +I  +        +S ++ ++    +   VEY H+   
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHR--- 125
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            +I+H D+KP N+LLD +   KI+DFGL+ + +       L  + G+  Y APE+ S   
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKL 182
Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
                + DV+S G++L  M+ CR+
Sbjct: 183 -YAGPEVDVWSCGVILYVML-CRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEH---LKGNGQEFIN-EVATIGRIHHFHIVRLLG 195
           LG+G +G V        G  VA+K++      K + Q  I  E++ +  + H HI++L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    +V E+  N  L  +I  +        +S ++ ++    +   VEY H+   
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHR--- 121
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            +I+H D+KP N+LLD +   KI+DFGL+ + +       L  + G+  Y APE+ S   
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKL 178
Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
                + DV+S G++L  M+ CR+
Sbjct: 179 -YAGPEVDVWSCGVILYVML-CRR 200

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VA+K+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   L+ E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA------HGRMKEKEARSKFRQIVSAVQYCHQ---K 133
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-VSLTAARGTAGYIAPELFSRNF 315
           RI+H D+K  N+LLD +   KI+DFG     S + ++   L A  G   Y APELF    
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGF----SNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   + DV+S G++L  +V
Sbjct: 190 YD-GPEVDVWSLGVILYTLV 208

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G V   K    G   AVK++       K + +  + EV  + ++ H +I++L  
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 117
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E    G L   I S+      +  S     +I   V  G+ Y+H+   
Sbjct: 118 FFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK--- 168
Query: 256 QRILHFDIKPHNILLDHNFQP---KISDFGLAK--LCSKDISIVSLTAARGTAGYIAPEL 310
            +I+H D+KP N+LL+   +    +I DFGL+     SK      +    GTA YIAPE+
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEV 223
Query: 311 FSRNFGEVSYKSDVYSYGMML-LEMVGC 337
               + E   K DV+S G++L + + GC
Sbjct: 224 LHGTYDE---KCDVWSTGVILYILLSGC 248

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 141 LGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQEFIN---EVATIGRIHHFHIVRL 193
           LGQG +G VF  +      +G   A+K+L+      ++ +    E   +  ++H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 194 -LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
              F +EG +  L+ +F+  G L       T  S     + E +K     +A G+++LH 
Sbjct: 96  HYAFQTEG-KLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALGLDHLH- 147
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELF 311
             +  I++ D+KP NILLD     K++DFGL+K     +    S     GT  Y+APE+ 
Sbjct: 148 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC---GTVEYMAPEVV 202
Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
           +R  G  S+ +D +SYG+++ EM+
Sbjct: 203 NRQ-GH-SHSADWWSYGVLMFEML 224

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G V   K    G   AVK++       K + +  + EV  + ++ H +I++L  
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 116
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E    G L   I S+      +  S     +I   V  G+ Y+H+   
Sbjct: 117 FFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN-- 168
Query: 256 QRILHFDIKPHNILLDHNFQP---KISDFGLAK--LCSKDISIVSLTAARGTAGYIAPEL 310
            +I+H D+KP N+LL+   +    +I DFGL+     SK      +    GTA YIAPE+
Sbjct: 169 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEV 222
Query: 311 FSRNFGEVSYKSDVYSYGMML-LEMVGC 337
               + E   K DV+S G++L + + GC
Sbjct: 223 LHGTYDE---KCDVWSTGVILYILLSGC 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V           VA+K +   +     Q  + E+  + R  H +++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T  A+   ++    +E  ++    S     LS + +    + + RG++Y+H      
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQ---LSNDHICYFLYQILRGLKYIHSA---N 164
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+L++     KI DFGLA++   +      LT    T  Y APE+   + G
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 225 -YTKSIDIWSVGCILAEMLSNR 245

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           +G G YG V   +    G  VA+K + +   +  N +  + E+  +    H +I+ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI--- 118
Query: 197 CSEGTRRALVYEFMPNGSLEKF--IFSKTNSSSHR------PLSWEKLKKIAFGVARGVE 248
                 + ++   +P G  +    +     S  H+      PL+ E ++   + + RG++
Sbjct: 119 ------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS-IVSLTAARGTAGYI 306
           Y+H     +++H D+KP N+L++ N + KI DFG+A+ LC+        +T    T  Y 
Sbjct: 173 YMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           APEL   +  E +   D++S G +  EM+  R+
Sbjct: 230 APELML-SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +      G+ F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           +G G YG V   +    G  VA+K + +   +  N +  + E+  +    H +I+ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI--- 119
Query: 197 CSEGTRRALVYEFMPNGSLEKF--IFSKTNSSSHR------PLSWEKLKKIAFGVARGVE 248
                 + ++   +P G  +    +     S  H+      PL+ E ++   + + RG++
Sbjct: 120 ------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDIS-IVSLTAARGTAGYI 306
           Y+H     +++H D+KP N+L++ N + KI DFG+A+ LC+        +T    T  Y 
Sbjct: 174 YMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           APEL   +  E +   D++S G +  EM+  R+
Sbjct: 231 APELM-LSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 129
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R++H DIKP N+LL    + KI++FG     S        T   GT  Y+ PE+     
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEMIEGRM 185
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 186 HDE--KVDLWSLGVLCYEFL 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  +    H +I+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 146
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 207 -YTKSIDIWSVGCILAEMLSNR 227

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +      G+ F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 139
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +      G+ F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P  ++ +     + +    P+ + KL    + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKL--YMYQLFRSLAYIH- 139
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  + R  H +I+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 198 S----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                E  +   +   +    L K + ++  S+ H       +    + + RG++Y+H  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDH-------ICYFLYQILRGLKYIHSA 163
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFS 312
               +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+  
Sbjct: 164 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 313 RNFGEVSYKSDVYSYGMMLLEMVGCR 338
            + G  +   D++S G +L EM+  R
Sbjct: 221 NSKG-YTKSIDIWSVGCILAEMLSNR 245

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 19/219 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 65  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 117
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++     +++        GT  
Sbjct: 118 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA----NEFVGTRS 171
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
           Y++PE         S +SD++S G+ L+EM   R  + P
Sbjct: 172 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++ +VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIP--VAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           R+G+G +G V++G + N     VA+K+++    +   ++   E+  + +    +I R  G
Sbjct: 26  RIGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL    +  I   + +G++YLH   +
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLH---S 134
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R +H DIK  N+LL      K++DFG+A   +   + +      GT  ++APE+  ++ 
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS- 191
Query: 316 GEVSYKSDVYSYGMMLLEMV-GCRKNKD 342
               +K+D++S G+  +E+  G   N D
Sbjct: 192 -AYDFKADIWSLGITAIELAKGEPPNSD 218

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFC 197
           +G+G YG V       N + VA+K +   +     Q  + E+  +    H +I+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
              T   +   ++    +E  ++ K   + H  LS + +    + + RG++Y+H      
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLY-KLLKTQH--LSNDHICYFLYQILRGLKYIHSA---N 146
Query: 258 ILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFG 316
           +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y APE+   + G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 317 EVSYKSDVYSYGMMLLEMVGCR 338
             +   D++S G +L EM+  R
Sbjct: 207 -YTKSIDIWSVGCILAEMLSNR 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+G +G V+ G   N     I VAVK  +      N ++F++E   +  + H HIV+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G   E     ++ E  P G L  ++  + N +S + L+   L   +  + + + YL    
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 126
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +   +H DI   NIL+      K+ DFGL++   +D      +  R    +++PE  S N
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPE--SIN 183
Query: 315 FGEVSYKSDVYSYGMMLLEMVG 336
           F   +  SDV+ + + + E++ 
Sbjct: 184 FRRFTTASDVWMFAVCMWEILS 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 103 EKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVA 161
           +++ + ++E FL   + V        ELK    +    LG G  G VF+     +G+ +A
Sbjct: 45  DEQQRKRLEAFLTQKQKVG-------ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 97
Query: 162 VKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKF 218
            K+  LE       + I E+  +   +  +IV   G F S+G   ++  E M  GSL++ 
Sbjct: 98  RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ- 155
Query: 219 IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 278
           +  K        +  + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+
Sbjct: 156 VLKKAGR-----IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 208
Query: 279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            DFG++      ++     +  GT  Y++PE         S +SD++S G+ L+EM   R
Sbjct: 209 CDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+       K    + V  K      G   +   EV     + H +I+RL G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +   +     R  ++         +A  + Y H   +
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELANALSYCH---S 126
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++++H DIKP N+LL    + KI+DFG     S         A  GT  Y+ PE+     
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEMIEGRM 182
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   K D++S G++  E +
Sbjct: 183 HDE--KVDLWSLGVLCYEFL 200

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+G +G V+ G   N     I VAVK  +      N ++F++E   +  + H HIV+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G   E     ++ E  P G L  ++  + N +S + L+   L   +  + + + YL    
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 142
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +   +H DI   NIL+      K+ DFGL++   +D      +  R    +++PE  S N
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPE--SIN 199
Query: 315 FGEVSYKSDVYSYGMMLLEMVG 336
           F   +  SDV+ + + + E++ 
Sbjct: 200 FRRFTTASDVWMFAVCMWEILS 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 141 LGQGGYGSVFRGKLFN----GIPVAVKMLEH--LKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+G +G V+ G   N     I VAVK  +      N ++F++E   +  + H HIV+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G   E     ++ E  P G L  ++  + N +S + L+   L   +  + + + YL    
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 130
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +   +H DI   NIL+      K+ DFGL++   +D      +  R    +++PE  S N
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPE--SIN 187
Query: 315 FGEVSYKSDVYSYGMMLLEMVG 336
           F   +  SDV+ + + + E++ 
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 160 VAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
           VA+K   LE  + +  E + E+  + + HH +IV             LV + +  GS+  
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 218 FIFSKTNSSSHRP--LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            I        H+   L    +  I   V  G+EYLH+      +H D+K  NILL  +  
Sbjct: 98  IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 154
Query: 276 PKISDFGLAKLCSKDISIVSLTAAR---GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLL 332
            +I+DFG++   +    I      +   GT  ++APE+  +  G   +K+D++S+G+  +
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAI 213
Query: 333 EM 334
           E+
Sbjct: 214 EL 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 11/182 (6%)
Query: 160 VAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
           VA+K   LE  + +  E + E+  + + HH +IV             LV + +  GS+  
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 218 FIFSKTNSSSHRP--LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            I        H+   L    +  I   V  G+EYLH+      +H D+K  NILL  +  
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGS 159
Query: 276 PKISDFGLAKLCSKDISIVSLTAAR---GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLL 332
            +I+DFG++   +    I      +   GT  ++APE+  +  G   +K+D++S+G+  +
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAI 218
Query: 333 EM 334
           E+
Sbjct: 219 EL 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 291 ISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
              V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 286

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 291 ISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
              V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 288

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VA+K+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   L+ E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVA------HGRMKEKEARSKFRQIVSAVQYCHQ---K 130
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-VSLTAARGTAGYIAPELFSRNF 315
           RI+H D+K  N+LLD +   KI+DFG     S + ++   L    G+  Y APELF    
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGF----SNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   + DV+S G++L  +V
Sbjct: 187 YD-GPEVDVWSLGVILYTLV 205

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 291 ISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
              V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 295

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           L+ E L   +F VA+G+E+L    +++ +H D+   NILL      KI DFGLA+   KD
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 291 ISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
              V    AR    ++APE +F R +   + +SDV+S+G++L E+
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI 293

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 45/217 (20%)
Query: 139 HRL-GQGGYGSVF------RGKLF-----NGIPVAVKMLEHLKGNGQEFINEVAT----- 181
           HR+ G+GG+G V+       GK++     +   + +K  E L  N +  ++ V+T     
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +   + FH    L F         + + M  G L   +      S H   S   ++  A
Sbjct: 254 IVCMSYAFHTPDKLSF---------ILDLMNGGDLHYHL------SQHGVFSEADMRFYA 298
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +  G+E++H   N+ +++ D+KP NILLD +   +ISD GLA  C  D S     A+ 
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASV 351
Query: 301 GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           GT GY+APE+  +    V+Y S  D +S G ML +++
Sbjct: 352 GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 45/217 (20%)
Query: 139 HRL-GQGGYGSVF------RGKLF-----NGIPVAVKMLEHLKGNGQEFINEVAT----- 181
           HR+ G+GG+G V+       GK++     +   + +K  E L  N +  ++ V+T     
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +   + FH    L F         + + M  G L   +      S H   S   ++  A
Sbjct: 254 IVCMSYAFHTPDKLSF---------ILDLMNGGDLHYHL------SQHGVFSEADMRFYA 298
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +  G+E++H   N+ +++ D+KP NILLD +   +ISD GLA  C  D S     A+ 
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASV 351
Query: 301 GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           GT GY+APE+  +    V+Y S  D +S G ML +++
Sbjct: 352 GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLL 385

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 167
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 168 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 222
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 223 ---FGATDYTSSIDVWSAGCVLAELL 245

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 45/217 (20%)
Query: 139 HRL-GQGGYGSVF------RGKLF-----NGIPVAVKMLEHLKGNGQEFINEVAT----- 181
           HR+ G+GG+G V+       GK++     +   + +K  E L  N +  ++ V+T     
Sbjct: 193 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 252
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +   + FH    L F         + + M  G L   +      S H   S   ++  A
Sbjct: 253 IVCMSYAFHTPDKLSF---------ILDLMNGGDLHYHL------SQHGVFSEADMRFYA 297
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +  G+E++H   N+ +++ D+KP NILLD +   +ISD GLA  C  D S     A+ 
Sbjct: 298 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASV 350
Query: 301 GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           GT GY+APE+  +    V+Y S  D +S G ML +++
Sbjct: 351 GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLL 384

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE----HLKGNGQEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+           +FI EV  +  + H
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 74
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 75  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 186 APESLKTRTF---SHASDTWMFGVTLWEM 211

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 45/217 (20%)
Query: 139 HRL-GQGGYGSVF------RGKLF-----NGIPVAVKMLEHLKGNGQEFINEVAT----- 181
           HR+ G+GG+G V+       GK++     +   + +K  E L  N +  ++ V+T     
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 182 -IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +   + FH    L F         + + M  G L   +      S H   S   ++  A
Sbjct: 254 IVCMSYAFHTPDKLSF---------ILDLMNGGDLHYHL------SQHGVFSEADMRFYA 298
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +  G+E++H   N+ +++ D+KP NILLD +   +ISD GLA  C  D S     A+ 
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA--C--DFSKKKPHASV 351
Query: 301 GTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           GT GY+APE+  +    V+Y S  D +S G ML +++
Sbjct: 352 GTHGYMAPEVLQKG---VAYDSSADWFSLGCMLFKLL 385

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 228
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 229 ---FGATDYTSSIDVWSAGCVLAELL 251

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 173
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 174 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 228
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 229 ---FGATDYTSSIDVWSAGCVLAELL 251

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 86/194 (44%), Gaps = 42/194 (21%)
Query: 141 LGQGGYGSVFRG-----------KLFNGI----PVAVKMLEHLKGNGQEFINEVATIGRI 185
           LGQG   +VFRG           K+FN I    PV V+M             E   + ++
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------------REFEVLKKL 64
Query: 186 HHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           +H +IV+L     E T R   L+ EF P GSL   +   +N+     L   +   +   V
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDV 121
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDISIVSLTAA 299
             G+ +L +     I+H +IKP NI+     D     K++DFG A+    D   VSL   
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-- 176
Query: 300 RGTAGYIAPELFSR 313
            GT  Y+ P+++ R
Sbjct: 177 -GTEEYLHPDMYER 189

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQE----FINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+    +  E    FI EV  +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 182 APESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 149 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 202
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 203 ---FGATDYTSSIDVWSAGCVLAELL 225

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 160 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 213
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 214 ---FGATDYTSSIDVWSAGCVLAELL 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 175
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 176 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 230
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 231 ---FGATDYTSSIDVWSAGCVLAELL 253

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 110 VEKFLEDYR-TVNPTRYTYKELKKITSKFKHRLGQGGYGSV--FRGKLFNGIPVAVKML- 165
           ++ FL  Y+ T+N  R     +K    +    +G+G +G V   R K    +  A+K+L 
Sbjct: 52  IDNFLSRYKDTINKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-YAMKLLS 108
Query: 166 --EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA-LVYEFMPNGSLEKFIFSK 222
             E +K +   F  E   I    +   V  L +  +  R   +V E+MP G L   +   
Sbjct: 109 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--- 165
Query: 223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
             S+   P  W +     F  A  V  L    +   +H D+KP N+LLD +   K++DFG
Sbjct: 166 --SNYDVPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMV 335
                +K+  +V    A GT  YI+PE+     G+  Y  + D +S G+ L EM+
Sbjct: 219 TCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE----HLKGNGQEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+           +FI EV  +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 81  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 192 APESLKTRTF---SHASDTWMFGVTLWEM 217

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 19/179 (10%)
Query: 161 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
           AVK+++  K +  E I  +   G+  H +I+ L     +G    +V E M  G L   I 
Sbjct: 51  AVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LDHNFQP--- 276
            +      +  S  +   + F + + VEYLH    Q ++H D+KP NIL +D +  P   
Sbjct: 109 RQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESI 159
Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +I DFG AK    +  +  L     TA ++APE+  R   + +   D++S G++L  M+
Sbjct: 160 RICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAA--CDIWSLGVLLYTML 214

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 177
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 178 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 232
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 233 ---FGATDYTSSIDVWSAGCVLAELL 255

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE----HLKGNGQEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+           +FI EV  +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 182 APESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 218
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 219 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 273
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 274 ---FGATDYTSSIDVWSAGCVLAELL 296

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 111/235 (47%), Gaps = 22/235 (9%)
Query: 108 LKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM-- 164
           L+  K LE + T    +    ELK    +    LG G  G VF+     +G+ +A K+  
Sbjct: 3   LQQRKRLEAFLT---QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH 59
Query: 165 LEHLKGNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKT 223
           LE       + I E+  +   +  +IV   G F S+G   ++  E M  GSL++ +  K 
Sbjct: 60  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKA 117
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
                  +  + L K++  V +G+ YL +    +I+H D+KP NIL++   + K+ DFG+
Sbjct: 118 GR-----IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 170
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +      ++     +  GT  Y++PE         S +SD++S G+ L+EM   R
Sbjct: 171 SGQLIDSMA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E++ +  + H HI++L    +  T   +V E+   G L  +I  K      + ++ ++ +
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK------KRMTEDEGR 111
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           +    +   +EY H+    +I+H D+KP N+LLD N   KI+DFGL+ + +       L 
Sbjct: 112 RFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLK 165
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            + G+  Y APE+ +        + DV+S G++L  M+  R
Sbjct: 166 TSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 154 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 207
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 208 ---FGATDYTSSIDVWSAGCVLAELL 230

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKXQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 62  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 114
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 168
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
           Y++PE         S +SD++S G+ L+EM   R    P
Sbjct: 169 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 153 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 206
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 207 ---FGATDYTSSIDVWSAGCVLAELL 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE----HLKGNGQEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+           +FI EV  +  + H
Sbjct: 15  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 74
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 75  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 186 APESLKTRTF---SHASDTWMFGVTLWEM 211

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQE----FINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+    +  E    FI EV  +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 182 APESLKTRTF---SHASDTWMFGVTLWEM 207

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 146 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 199
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 200 ---FGATDYTSSIDVWSAGCVLAELL 222

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G V + +   +G+ +A K+  LE       + I E+  +   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +         + +  E L K++  V 
Sbjct: 72  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL------KEAKRIPEEILGKVSIAVL 124
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           RG+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 125 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 178
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           Y+APE         S +SD++S G+ L+E+   R
Sbjct: 179 YMAPERLQGT--HYSVQSDIWSMGLSLVELAVGR 210

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 139 HRLGQGGYGSVFR-GKLFNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRLL 194
           + +G G YG   +  +  +G  +  K L++    +   Q  ++EV  +  + H +IVR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 195 GFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
               + T   L  V E+   G L   I   T    +  L  E + ++   +   ++  H+
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY--LDEEFVLRVMTQLTLALKECHR 129
Query: 253 GCN--QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
             +    +LH D+KP N+ LD     K+ DFGLA++ + D          GT  Y++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV--GTPYYMSPEQ 187
Query: 311 FSRNFGEVSY--KSDVYSYGMMLLEM 334
            +R    +SY  KSD++S G +L E+
Sbjct: 188 MNR----MSYNEKSDIWSLGCLLYEL 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 110 VEKFLEDYR-TVNPTRYTYKELKKITSKFKHRLGQGGYGSV--FRGKLFNGIPVAVKML- 165
           ++ FL  Y+ T+N  R     +K    +    +G+G +G V   R K    +  A+K+L 
Sbjct: 47  IDNFLSRYKDTINKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-YAMKLLS 103
Query: 166 --EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA-LVYEFMPNGSLEKFIFSK 222
             E +K +   F  E   I    +   V  L +  +  R   +V E+MP G L   +   
Sbjct: 104 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--- 160
Query: 223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
             S+   P  W +     F  A  V  L    +   +H D+KP N+LLD +   K++DFG
Sbjct: 161 --SNYDVPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMV 335
                +K+  +V    A GT  YI+PE+     G+  Y  + D +S G+ L EM+
Sbjct: 214 TCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLE----HLKGNGQEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+           +FI EV  +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +        H  L    L + A  VA G+
Sbjct: 81  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL    ++R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 307 APE-LFSRNFGEVSYKSDVYSYGMMLLEM 334
           APE L +R F   S+ SD + +G+ L EM
Sbjct: 192 APESLKTRTF---SHASDTWMFGVTLWEM 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 62  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 114
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 168
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           Y++PE         S +SD++S G+ L+EM   R
Sbjct: 169 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 153 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 206
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 207 ---FGATDYTSSIDVWSAGCVLAELL 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHRN 134
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D     +    GT  YIAPE+ S+
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSK 189
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
             G  S++ DV+S G ++  ++
Sbjct: 190 K-GH-SFEVDVWSIGCIMYTLL 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 11  PTFYR-QELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 64
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 65  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 118
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 119 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFG 175
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 176 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 62  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 114
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 168
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
           Y++PE         S +SD++S G+ L+EM   R    P
Sbjct: 169 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 110 VEKFLEDYR-TVNPTRYTYKELKKITSKFKHRLGQGGYGSV--FRGKLFNGIPVAVKML- 165
           ++ FL  Y+ T+N  R     +K    +    +G+G +G V   R K    +  A+K+L 
Sbjct: 52  IDNFLSRYKDTINKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV-YAMKLLS 108
Query: 166 --EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA-LVYEFMPNGSLEKFIFSK 222
             E +K +   F  E   I    +   V  L +  +  R   +V E+MP G L   +   
Sbjct: 109 KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--- 165
Query: 223 TNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
             S+   P  W +     F  A  V  L    +   +H D+KP N+LLD +   K++DFG
Sbjct: 166 --SNYDVPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 218
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMV 335
                +K+  +V    A GT  YI+PE+     G+  Y  + D +S G+ L EM+
Sbjct: 219 TCMKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 33/261 (12%)
Query: 86  LFALVIFLIYKSRESEKEKETQL-KVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQG 144
           L +LV+ L + +    K  +  L + EK ++  R +      Y  +K I        G+G
Sbjct: 35  LNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVI--------GRG 86
Query: 145 GYGSV--FRGKLFNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
            +G V   R K    +  A+K+L       + +   F  E   +   +   +V+L     
Sbjct: 87  AFGEVQLVRHKASQKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 145
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +     +V E+MP G L   +     S+   P  W K     F  A  V  L    +  +
Sbjct: 146 DDKYLYMVMEYMPGGDLVNLM-----SNYDVPEKWAK-----FYTAEVVLALDAIHSMGL 195
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSK--DISIVSLTAARGTAGYIAPELFSRNFG 316
           +H D+KP N+LLD +   K++DFG    C K  +  +V    A GT  YI+PE+     G
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 317 EVSY--KSDVYSYGMMLLEMV 335
           +  Y  + D +S G+ L EM+
Sbjct: 253 DGYYGRECDWWSVGVFLFEML 273

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 13  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 66
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 67  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+  + +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 178 LARHTADE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH- 143
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 144 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 198
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 199 ---FGATDYTSSIDVWSAGCVLAELL 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 142 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELI 195
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 196 ---FGATDYTSSIDVWSAGCVLAELL 218

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 141 LGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL-LGFC 197
           +G G +G V++ KL + G  VA+K +   K     F N E+  + ++ H +IVRL   F 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 198 SEGTRRALVY-----EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           S G ++  VY     +++P      +  ++  S + + L    +K   + + R + Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 253 GCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                I H DIKP N+LLD +    K+ DFG AK   +    VS   +R    Y APEL 
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELI 194
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y S  DV+S G +L E++
Sbjct: 195 ---FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 62  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 114
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 168
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           Y++PE         S +SD++S G+ L+EM   R
Sbjct: 169 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEH----LKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G V   K    G   AVK++       K + +  + EV  + ++ H +I +L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYE 93
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     LV E    G L   I S+      +  S     +I   V  G+ Y H+   
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYXHKN-- 145
Query: 256 QRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAAR------GTAGYI 306
            +I+H D+KP N+LL+   +    +I DFGL+             A++      GTA YI
Sbjct: 146 -KIVHRDLKPENLLLESKSKDANIRIIDFGLS---------THFEASKKXKDKIGTAYYI 195
Query: 307 APELFSRNFGEVSYKSDVYSYGMML-LEMVGC 337
           APE+    + E   K DV+S G++L + + GC
Sbjct: 196 APEVLHGTYDE---KCDVWSTGVILYILLSGC 224

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 32/229 (13%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPV----AVKMLEHLKG 170
           E +   +P+++   EL K+       LGQG +G VF  K  +G       A+K+L+    
Sbjct: 16  EGHEKADPSQF---ELLKV-------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL 65
Query: 171 NGQEFIN---EVATIGRIHHFHIVRL-LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS 226
             ++ +    E   +  ++H  IV+L   F +EG +  L+ +F+  G L       T  S
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL------FTRLS 118
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
                + E +K     +A  +++LH   +  I++ D+KP NILLD     K++DFGL+K 
Sbjct: 119 KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 174
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            S D    + +   GT  Y+APE+ +R     S  +D +S+G+++ EM+
Sbjct: 175 ESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEML 220

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKM--LEHLKGNGQEFINEVATIGRI 185
           ELK    +    LG G  G VF+     +G+ +A K+  LE       + I E+  +   
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61
Query: 186 HHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +  +IV   G F S+G   ++  E M  GSL++ +  K        +  + L K++  V 
Sbjct: 62  NSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR-----IPEQILGKVSIAVI 114
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           +G+ YL +    +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRS 168
Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           Y++PE         S +SD++S G+ L+EM   R
Sbjct: 169 YMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 136 KFKHRLGQGGYGSVFRG-KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
           + K RLG GG+G V R      G  VA+K    E    N + +  E+  + +++H ++V 
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 193 L------LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
                  L   +      L  E+   G L K++    N      L    ++ +   ++  
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSA 134
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAK------LCSKDISIVSLT 297
           + YLH+    RI+H D+KP NI+L    Q    KI D G AK      LC++ +      
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV------ 185
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              GT  Y+APEL  +    V+   D +S+G +  E +
Sbjct: 186 ---GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECI 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGXVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 13  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 66
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 67  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+  + +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 178 LARHTADE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 32/229 (13%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPV----AVKMLEHLKG 170
           E +   +P+++   EL K+       LGQG +G VF  K  +G       A+K+L+    
Sbjct: 16  EGHEKADPSQF---ELLKV-------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL 65
Query: 171 NGQEFIN---EVATIGRIHHFHIVRL-LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS 226
             ++ +    E   +  ++H  IV+L   F +EG +  L+ +F+  G L       T  S
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL------FTRLS 118
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
                + E +K     +A  +++LH   +  I++ D+KP NILLD     K++DFGL+K 
Sbjct: 119 KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 174
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            S D    + +   GT  Y+APE+ +R     S  +D +S+G+++ EM+
Sbjct: 175 ESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEML 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 136 KFKHRLGQGGYGSVFRG-KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
           + K RLG GG+G V R      G  VA+K    E    N + +  E+  + +++H ++V 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 193 L------LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
                  L   +      L  E+   G L K++    N      L    ++ +   ++  
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSA 133
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAK------LCSKDISIVSLT 297
           + YLH+    RI+H D+KP NI+L    Q    KI D G AK      LC++ +      
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV------ 184
Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              GT  Y+APEL  +    V+   D +S+G +  E +
Sbjct: 185 ---GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECI 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 114/229 (49%), Gaps = 32/229 (13%)
Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPV----AVKMLEHLKG 170
           E +   +P+++   EL K+       LGQG +G VF  K  +G       A+K+L+    
Sbjct: 17  EGHEKADPSQF---ELLKV-------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL 66
Query: 171 NGQEFIN---EVATIGRIHHFHIVRL-LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS 226
             ++ +    E   +  ++H  IV+L   F +EG +  L+ +F+  G L       T  S
Sbjct: 67  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL------FTRLS 119
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL 286
                + E +K     +A  +++LH   +  I++ D+KP NILLD     K++DFGL+K 
Sbjct: 120 KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 175
Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            S D    + +   GT  Y+APE+ +R     S  +D +S+G+++ EM+
Sbjct: 176 ESIDHEKKAYSFC-GTVEYMAPEVVNRRGHTQS--ADWWSFGVLMFEML 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 11  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 64
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 65  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 118
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 119 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFG 175
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 176 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           HR  +   G VF  K  N  P  +        +     NE++ + ++HH  ++ L     
Sbjct: 68  HRCVEKATGRVFVAKFIN-TPYPL--------DKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +     L+ EF+  G L    F +  +  ++ +S  ++         G++++H+     I
Sbjct: 119 DKYEMVLILEFLSGGEL----FDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSI 170
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +H DIKP NI+ +       KI DFGLA   + D  IV +T A  TA + APE+  R   
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTA--TAEFAAPEIVDRE-- 225
Query: 317 EVSYKSDVYSYGMM 330
            V + +D+++ G++
Sbjct: 226 PVGFYTDMWAIGVL 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHRN 158
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D     +    GT  YIAPE+ S+
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSK 213
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                S++ DV+S G ++  ++
Sbjct: 214 KGH--SFEVDVWSIGCIMYTLL 233

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV  +  I H +I+ L       T   L+ E +  G L  F+  K + +      
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 288
           +  LK+I      GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 120 F--LKQIL----DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
                 ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 171 AGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 207

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 13  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 66
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 67  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+  + +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 178 LARHTADE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 17  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 70
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 71  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 124
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 125 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFG 181
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 182 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAVK+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---K 132
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNF 315
            I+H D+K  N+LLD +   KI+DFG     S + +  + L A  G   Y APELF    
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGF----SNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   + DV+S G++L  +V
Sbjct: 189 YD-GPEVDVWSLGVILYTLV 207

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 36/234 (15%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQE 174
           PT Y  +EL K   +   R      +G G YGSV     + +G+ +AVK L       Q 
Sbjct: 35  PTFYR-QELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR---PFQS 90
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT--------N 224
            I+   T      +  +RLL          L+  F P  SLE+F  ++  T        N
Sbjct: 91  IIHAKRT------YRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNN 144
Query: 225 SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
               + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA
Sbjct: 145 IVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 201
Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 202 RHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV  +  I H +I+ L       T   L+ E +  G L  F+  K + +      
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 288
           +  LK+I      GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 113 F--LKQIL----DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
                 ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 164 AGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EV  +  I H +I+ L       T   L+ E +  G L  F+  K + +      
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QPKIS--DFGLAKLCS 288
           +  LK+I      GV YLH   ++RI HFD+KP NI LLD N   P+I   DFG+A    
Sbjct: 134 F--LKQIL----DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
                 ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 185 AGNEFKNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE----FINEVATIGRIHHFHIVRLLG 195
           LG+G YG V + + + +G  +AVK +     N QE     ++   ++  +     V   G
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    +  E M + SL+KF     +     P   + L KIA  + + +E+LH   +
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP--EDILGKIAVSIVKALEHLHSKLS 174
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+KP N+L++   Q K+ DFG++      +  V+ T   G   Y+APE  +   
Sbjct: 175 --VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPEL 229
Query: 316 GEVSY--KSDVYSYGMMLLEMVGCR 338
            +  Y  KSD++S G+ ++E+   R
Sbjct: 230 NQKGYSVKSDIWSLGITMIELAILR 254

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIV 191
           + +  +G+G +  V   + +  G  VAVK+++  + N    Q+   EV  +  ++H +IV
Sbjct: 18  RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           +L           LV E+   G +  ++ +      H  +  ++ +     +   V+Y H
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCH 131
Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPEL 310
           Q   + I+H D+K  N+LLD +   KI+DFG     S + ++ + L    G+  Y APEL
Sbjct: 132 Q---KYIVHRDLKAENLLLDGDMNIKIADFGF----SNEFTVGNKLDTFCGSPPYAAPEL 184
Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
           F     +   + DV+S G++L  +V
Sbjct: 185 FQGKKYD-GPEVDVWSLGVILYTLV 208

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHR- 159
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D     +    GT  YIAPE+ S+
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSK 215
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                S++ DV+S G ++  ++
Sbjct: 216 KGH--SFEVDVWSIGCIMYTLL 235

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 11  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 64
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 65  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 118
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 119 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 176 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 5   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 58
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 59  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 112
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 113 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 169
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 170 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 11  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 64
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 65  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 118
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 119 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 176 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 12  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 65
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 66  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 119
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFG 176
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 177 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 13  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 66
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 67  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 121 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 178 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 8   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 61
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 62  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 115
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 173 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 8   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 61
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 62  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 115
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFG 172
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 173 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK    L    
Sbjct: 18  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVK---KLSKPF 71
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 72  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 183 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 12  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 65
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 66  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 119
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 177 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 2   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 55
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 56  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 167 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 3   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 56
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 57  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 110
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 111 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 167
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 168 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 12  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 65
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 66  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 119
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 177 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 8   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 61
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 62  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 115
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 173 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 3   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 56
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 57  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 110
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 111 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 167
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 168 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 139 HRLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            ++G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   +
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ +H DIK  N+LL  + + K++DFG+A   + D  I   T   GT  ++APE+  ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFV-GTPFWMAPEVIKQS- 179
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                K+D++S G+  +E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 8   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 61
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 62  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 115
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 116 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 173 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 18  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 71
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 72  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 183 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 4   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 57
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 58  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 111
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 112 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 168
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 169 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 18  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 71
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 72  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 126 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 183 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           T   +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   
Sbjct: 5   TIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI--- 60
Query: 194 LGFCSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LGF +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASG 113
Query: 247 VEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTA 298
           + +LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++   
Sbjct: 114 LAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 299 ARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMV 335
             GT  Y+APE+   +      E   ++D+Y+ G++  E+ 
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 17  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 70
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 71  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 124
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 125 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 181
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 182 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFI 176
           + P  Y Y+E     +  + RLG+G +G V R K    G   AVK   LE  +      +
Sbjct: 60  LKPVDYEYREEVHWMT-HQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------V 112
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+     +    IV L G   EG    +  E +  GSL + I         R L +   
Sbjct: 113 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY--- 169
Query: 237 KKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD---I 291
                G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D    
Sbjct: 170 ----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 222
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
           S+++     GT  ++APE+          K D++S   M+L M+ GC
Sbjct: 223 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGC 267

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 139 HRLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            ++G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   +
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---S 142
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ +H DIK  N+LL  + + K++DFG+A   + D  I   T   GT  ++APE+  ++ 
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFV-GTPFWMAPEVIKQS- 199
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                K+D++S G+  +E+ 
Sbjct: 200 -AYDSKADIWSLGITAIELA 218

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           T   +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   
Sbjct: 10  TIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI--- 65
Query: 194 LGFCSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LGF +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASG 118
Query: 247 VEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTA 298
           + +LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++   
Sbjct: 119 LAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 299 ARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMV 335
             GT  Y+APE+   +      E   ++D+Y+ G++  E+ 
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
            +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   LGF
Sbjct: 46  LQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 101
Query: 197 CSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
            +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G+ +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAH 154
Query: 250 LH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTAARG 301
           LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++     G
Sbjct: 155 LHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 302 TAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+   +      E   ++D+Y+ G++  E+ 
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
            +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   LGF
Sbjct: 33  LQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI---LGF 88
Query: 197 CSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
            +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G+ +
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAH 141
Query: 250 LH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTAARG 301
           LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++     G
Sbjct: 142 LHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 200
Query: 302 TAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMV 335
           T  Y+APE+   +      E   ++D+Y+ G++  E+ 
Sbjct: 201 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 26  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 79
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 80  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 191 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 25  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 78
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 79  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 132
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 133 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 189
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 190 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 29  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 82
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 83  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 136
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 137 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 194 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           T   +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   
Sbjct: 7   TIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI--- 62
Query: 194 LGFCSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LGF +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASG 115
Query: 247 VEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTA 298
           + +LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++   
Sbjct: 116 LAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 299 ARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMV 335
             GT  Y+APE+   +      E   ++D+Y+ G++  E+ 
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
           T   +  +G+G +G V+RGK + G  VAVK+    +        E+     + H +I   
Sbjct: 4   TIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI--- 59
Query: 194 LGFCSEG-------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           LGF +         T+  LV ++  +GSL  ++   T       ++ E + K+A   A G
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASG 112
Query: 247 VEYLH------QGCNQRILHFDIKPHNILLDHNFQPKISDFGLA--KLCSKDISIVSLTA 298
           + +LH      QG    I H D+K  NIL+  N    I+D GLA     + D   ++   
Sbjct: 113 LAHLHMEIVGTQG-KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 299 ARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEM 334
             GT  Y+APE+   +      E   ++D+Y+ G++  E+
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHRN 136
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D          GT  YIAPE+ S+
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSK 191
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                S++ DV+S G ++  ++
Sbjct: 192 KGH--SFEVDVWSIGCIMYTLL 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHRN 136
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D          GT  YIAPE+ S+
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSK 191
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
             G  S++ DV+S G ++  ++
Sbjct: 192 K-GH-SFEVDVWSIGCIMYTLL 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 22/222 (9%)
Query: 125 YTYKELKKITSKFKHRLGQGGYGSVFRGKLF---NGIPVAVKMLEHL--KGNGQEFINEV 179
           +T ++LK +       +G+G YGSV   K+    +G  +AVK +     +   ++ + ++
Sbjct: 19  FTAEDLKDLG-----EIGRGAYGSV--NKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 180 ATIGRIHHF-HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
             + R     +IV+  G         +  E M + S +KF +    S     +  E L K
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKF-YKYVYSVLDDVIPEEILGK 129
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           I     + + +L +  N +I+H DIKP NILLD +   K+ DFG++    + +  ++ T 
Sbjct: 130 ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS---GQLVDSIAKTR 184
Query: 299 ARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMMLLEMVGCR 338
             G   Y+APE    +     Y  +SDV+S G+ L E+   R
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAVK+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---K 132
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            I+H D+K  N+LLD +   KI+DFG +   +    + +     G+  Y APELF     
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKY 189
Query: 317 EVSYKSDVYSYGMMLLEMV 335
           +   + DV+S G++L  +V
Sbjct: 190 D-GPEVDVWSLGVILYTLV 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAVK+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---K 132
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            I+H D+K  N+LLD +   KI+DFG +   +    + +     G+  Y APELF     
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKY 189
Query: 317 EVSYKSDVYSYGMMLLEMV 335
           +   + DV+S G++L  +V
Sbjct: 190 D-GPEVDVWSLGVILYTLV 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
           + SL+KF     +     P   + L KIA  + + +E+LH   +  ++H D+KP N+L++
Sbjct: 89  DTSLDKFYKQVIDKGQTIP--EDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN 144
Query: 272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGM 329
              Q K+ DFG++     D   V+     G   Y+APE  +    +  Y  KSD++S G+
Sbjct: 145 ALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGI 201
Query: 330 MLLEMVGCR 338
            ++E+   R
Sbjct: 202 TMIELAILR 210

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           LG+GG+   F        ++F G  V   +L  LK + +E ++   +I R + H H+V  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLL--LKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   L++I  G     +YLH+ 
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLEL--HKRRKALTEPEARYYLRQIVLGC----QYLHRN 140
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
              R++H D+K  N+ L+ + + KI DFGLA     D          GT  YIAPE+ S+
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC--GTPNYIAPEVLSK 195
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                S++ DV+S G ++  ++
Sbjct: 196 KGH--SFEVDVWSIGCIMYTLL 215

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 139 HRLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            ++G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   +
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---S 122
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ +H DIK  N+LL  + + K++DFG+A   +   + +      GT  ++APE+  ++ 
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS- 179
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                K+D++S G+  +E+ 
Sbjct: 180 -AYDSKADIWSLGITAIELA 198

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKSQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           L +    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LCRHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAVK+++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW--EKLKKIAF-GVARGVEYLHQG 253
                   LV E+   G +  ++ +           W  EK  +  F  +   V+Y HQ 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAH---------GWMKEKEARAKFRQIVSAVQYCHQ- 124
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
             + I+H D+K  N+LLD +   KI+DFG +   +    + +     G+  Y APELF  
Sbjct: 125 --KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQG 179
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
              +   + DV+S G++L  +V
Sbjct: 180 KKYD-GPEVDVWSLGVILYTLV 200

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 39/227 (17%)
Query: 128 KELKKITSKFKHRL------GQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQEFINE 178
           +EL K   +   RL      G G YGSV   +  +L     VAVK L       Q  I+ 
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSR---PFQSLIHA 71
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT--------NSSSH 228
             T      +  +RLL          L+  F P  S+E F  ++  T        N    
Sbjct: 72  RRT------YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS 125
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
           + LS E ++ + + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQAD 182
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++     +T    T  Y APE+   N+   +   D++S G ++ E++
Sbjct: 183 EE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 85/194 (43%), Gaps = 42/194 (21%)
Query: 141 LGQGGYGSVFRG-----------KLFNGI----PVAVKMLEHLKGNGQEFINEVATIGRI 185
           LGQG   +VFRG           K+FN I    PV V+M             E   + ++
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM------------REFEVLKKL 64
Query: 186 HHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           +H +IV+L     E T R   L+ EF P GSL   +   +N+     L   +   +   V
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG---LPESEFLIVLRDV 121
Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDISIVSLTAA 299
             G+ +L +     I+H +IKP NI+     D     K++DFG A+    D   V L   
Sbjct: 122 VGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY-- 176
Query: 300 RGTAGYIAPELFSR 313
            GT  Y+ P+++ R
Sbjct: 177 -GTEEYLHPDMYER 189

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE- 199
           +G+G YG V+RG  + G  VAVK+             E+     + H +I   LGF +  
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 100
Query: 200 ------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-- 251
                  T+  L+  +   GSL  ++   T       L      +I   +A G+ +LH  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIE 153
Query: 252 ----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TAARGTAGY 305
               QG    I H D+K  NIL+  N Q  I+D GLA + S+  + + +      GT  Y
Sbjct: 154 IFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 306 IAPELFSRNFGEVSYKS----DVYSYGMMLLEM 334
           +APE+         + S    D++++G++L E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 139 HRLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            ++G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   +
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---S 137
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ +H DIK  N+LL  + + K++DFG+A   +   + +      GT  ++APE+  ++ 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS- 194
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                K+D++S G+  +E+ 
Sbjct: 195 -AYDSKADIWSLGITAIELA 213

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 123 TRYT--YKELKKITSKFKHRLGQGGYGSVFR-GKLFNGIPVAVKMLEH-LKG--NGQEFI 176
           +RYT  + EL+KI        G G +GSVF+  K  +G   A+K  +  L G  + Q  +
Sbjct: 3   SRYTTEFHELEKI--------GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 54
Query: 177 NEV---ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
            EV   A +G+  H H+VR     +E     +  E+   GSL   I     S ++R +S+
Sbjct: 55  REVYAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSY 107
Query: 234 EK---LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGL 283
            K   LK +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+  
Sbjct: 108 FKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 164
Query: 284 AKLCSK--DIS----IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
            K+  K  D+     I S     G + ++A E+   N+  +  K+D+++  + ++   G 
Sbjct: 165 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVXAAGA 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE- 199
           +G+G YG V+RG  + G  VAVK+             E+     + H +I   LGF +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 200 ------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-- 251
                  T+  L+  +   GSL  ++   T       L      +I   +A G+ +LH  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIE 124
Query: 252 ----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TAARGTAGY 305
               QG    I H D+K  NIL+  N Q  I+D GLA + S+  + + +      GT  Y
Sbjct: 125 IFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 306 IAPELFSRNFGEVSYKS----DVYSYGMMLLEM 334
           +APE+         + S    D++++G++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFI 176
           + P  Y Y+E     +  + R+G+G +G V R K    G   AVK   LE  +      +
Sbjct: 46  LKPVDYEYREEVHWMT-HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------V 98
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+     +    IV L G   EG    +  E +  GSL + I         R L +   
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY--- 155
Query: 237 KKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD---I 291
                G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D    
Sbjct: 156 ----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
           S+++     GT  ++APE+          K D++S   M+L M+ GC
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGC 253

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE- 199
           +G+G YG V+RG  + G  VAVK+             E+     + H +I   LGF +  
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 200 ------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-- 251
                  T+  L+  +   GSL  ++   T       L      +I   +A G+ +LH  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHIE 124
Query: 252 ----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TAARGTAGY 305
               QG    I H D+K  NIL+  N Q  I+D GLA + S+  + + +      GT  Y
Sbjct: 125 IFGTQG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 306 IAPELFSRNFGEVSYKS----DVYSYGMMLLEM 334
           +APE+         + S    D++++G++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI D+G
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAVK+++  + N    Q+   EV     ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF-GVARGVEYLHQGCN 255
                   LV E+   G +  ++ +            EK  +  F  +   V+Y HQ   
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXK-------EKEARAKFRQIVSAVQYCHQ--- 131
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRN 314
           + I+H D+K  N+LLD +   KI+DFG     S + +  + L A  G   Y APELF   
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGF----SNEFTFGNKLDAFCGAPPYAAPELFQGK 187
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
             +   + DV+S G++L  +V
Sbjct: 188 KYD-GPEVDVWSLGVILYTLV 207

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 28/227 (12%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFI 176
           + P  Y Y+E     +  + R+G+G +G V R K    G   AVK   LE  +      +
Sbjct: 62  LKPVDYEYREEVHWMT-HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------V 114
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+     +    IV L G   EG    +  E +  GSL + I         R L +   
Sbjct: 115 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY--- 171
Query: 237 KKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD---I 291
                G A  G+EYLH    +RILH D+K  N+LL  +  +  + DFG A     D    
Sbjct: 172 ----LGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 224
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
           S+++     GT  ++APE+          K D++S   M+L M+ GC
Sbjct: 225 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGC 269

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 33/209 (15%)
Query: 141 LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G V        GK++    +  K ++  KG     +NE   + +++   +V L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                     LV   M  G L+  I+               + +  F  AR V Y  + C
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYH--------------MGQAGFPEARAVFYAAEIC 296
Query: 255 -------NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
                   +RI++ D+KP NILLD +   +ISD GLA    +  +I       GT GY+A
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMA 353
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           PE+        ++  D ++ G +L EM+ 
Sbjct: 354 PEVVKNE--RYTFSPDWWALGCLLYEMIA 380

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 138 KHRLGQGGYGSVFR--GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K  +G G Y    R   K  N +  AVK+++  K +  E I  +   G+  H +I+ L  
Sbjct: 32  KETIGVGSYSECKRCVHKATN-MEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKD 88
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              +G    LV E M  G L   I  +    S R  S+     +   + + VEYLH   +
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKIL-RQKFFSEREASF-----VLHTIGKTVEYLH---S 139
Query: 256 QRILHFDIKPHNIL-LDHNFQP---KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
           Q ++H D+KP NIL +D +  P   +I DFG AK    +  +  L     TA ++APE+ 
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVL 197
Query: 312 SRN-FGEVSYKSDVYSYGMMLLEMVG 336
            R  + E     D++S G++L  M+ 
Sbjct: 198 KRQGYDE---GCDIWSLGILLYTMLA 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 141 LGQGGYGSVFR---------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIV 191
           LG+GGYG VF+         GK+F    +   M+     +      E   +  + H  IV
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 192 RLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            L+     G +  L+ E++  G L      + IF +  +  +       L +I+  +   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAEISMALG-- 135
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
             +LHQ   + I++ D+KP NI+L+H    K++DFGL K    D ++       GT  Y+
Sbjct: 136 --HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC--GTIEYM 188
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE+  R+    +   D +S G ++ +M+
Sbjct: 189 APEILMRSGHNRAV--DWWSLGALMYDML 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 21/181 (11%)
Query: 161 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
           AVK+++  K +  E I  +   G+  H +I+ L     +G    LV E M  G L   I 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LDHNFQP--- 276
            +    S R  S+     +   + + VEYLH   +Q ++H D+KP NIL +D +  P   
Sbjct: 114 -RQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECL 164
Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV 335
           +I DFG AK    +  +  L     TA ++APE+  R  + E     D++S G++L  M+
Sbjct: 165 RICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLKRQGYDE---GCDIWSLGILLYTML 219
Query: 336 G 336
Sbjct: 220 A 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 169 KGNGQEFIN-EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSS 227
           +G  +E I  EV+ +  I H +++ L       T   L+ E +  G L  F+  K +   
Sbjct: 54  RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--- 110
Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGL 283
              L+ E+  +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGL
Sbjct: 111 ---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
           A          ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 165 AHKIDFGNEFKNIF---GTPAFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 33/209 (15%)
Query: 141 LGQGGYGSV------FRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           LG+GG+G V        GK++    +  K ++  KG     +NE   + +++   +V L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA 250
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                     LV   M  G L+  I+               + +  F  AR V Y  + C
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYH--------------MGQAGFPEARAVFYAAEIC 296
Query: 255 -------NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
                   +RI++ D+KP NILLD +   +ISD GLA    +  +I       GT GY+A
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMA 353
Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           PE+        ++  D ++ G +L EM+ 
Sbjct: 354 PEVVKNE--RYTFSPDWWALGCLLYEMIA 380

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 139 HRLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            R+G+G +G VF+G   +    + + +  LE  +   ++   E+  + +    ++ +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              +G++  ++ E++  GS    + +        P    ++  +   + +G++YLH   +
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLH---S 138
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ +H DIK  N+LL      K++DFG+A   + D  I   T   GT  ++APE+  ++ 
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFV-GTPFWMAPEVIQQS- 195
Query: 316 GEVSYKSDVYSYGMMLLEMV-GCRKNKD 342
                K+D++S G+  +E+  G   N D
Sbjct: 196 -AYDSKADIWSLGITAIELAKGEPPNSD 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 141 LGQGGYGSVFR---------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIV 191
           LG+GGYG VF+         GK+F    +   M+     +      E   +  + H  IV
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 192 RLLGFCSEGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
            L+     G +  L+ E++  G L      + IF +  +  +       L +I+  +   
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY-------LAEISMALG-- 135
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
             +LHQ   + I++ D+KP NI+L+H    K++DFGL K    D ++       GT  Y+
Sbjct: 136 --HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC--GTIEYM 188
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE+  R+    +   D +S G ++ +M+
Sbjct: 189 APEILMRSGHNRAV--DWWSLGALMYDML 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAV++++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---K 132
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
            I+H D+K  N+LLD +   KI+DFG +   +    + +     G+  Y APELF     
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKY 189
Query: 317 EVSYKSDVYSYGMMLLEMV 335
           +   + DV+S G++L  +V
Sbjct: 190 D-GPEVDVWSLGVILYTLV 207

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N    +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 39/227 (17%)
Query: 128 KELKKITSKFKHRL------GQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQEFINE 178
           +EL K   +   RL      G G YGSV   +  +L     VAVK L       Q  I+ 
Sbjct: 9   QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSR---PFQSLIHA 63
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT--------NSSSH 228
             T      +  +RLL          L+  F P  S+E F  ++  T        N    
Sbjct: 64  RRT------YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC 117
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
           + LS E ++ + + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD 174
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++     +T    T  Y APE+   N+   +   D++S G ++ E++
Sbjct: 175 EE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 215

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 136 KFKHRLGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRL 193
            F   +G G +G   + R KL   + VAVK +E      +    E+     + H +IVR 
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDENVQREIINHRSLRHPNIVRF 81
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                  T  A++ E+   G L + I +          S ++ +     +  GV Y H  
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGR------FSEDEARFFFQQLLSGVSYCH-- 133
Query: 254 CNQRILHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAP 308
            + +I H D+K  N LLD +  P  KI DFG +K   L S+  S V      GT  YIAP
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAP 186
Query: 309 ELFSRN--FGEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           E+  R    G++   +DV+S G+ L  M VG    +DP
Sbjct: 187 EVLLRQEYDGKI---ADVWSCGVTLYVMLVGAYPFEDP 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 29  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 82
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 83  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 136
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 137 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +     T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 194 LARHTDDE-----MXGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFM-PNGSLEKFIFSKTNSSSHRPLSWE 234
           EV  + ++      ++RLL +        L+ E M P   L  FI  +        L  E
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA------LQEE 114
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISI 293
             +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +  
Sbjct: 115 LARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-- 169
Query: 294 VSLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
              T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 170 --YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 208

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 39/227 (17%)
Query: 128 KELKKITSKFKHRL------GQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQEFINE 178
           +EL K   +   RL      G G YGSV   +  +L     VAVK L       Q  I+ 
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSR---PFQSLIHA 71
Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT--------NSSSH 228
             T      +  +RLL          L+  F P  S+E F  ++  T        N    
Sbjct: 72  RRT------YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC 125
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
           + LS E ++ + + + RG++Y+H      I+H D+KP N+ ++ + + +I DFGLA+   
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQAD 182
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           ++     +T    T  Y APE+   N+   +   D++S G ++ E++
Sbjct: 183 EE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 16  PTFYR-QELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 69
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 70  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 123
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 124 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 180
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 181 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VAV++++  + N    Q+   EV  +  ++H +IV+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV E+   G +  ++ +      H  +  ++ +     +   V+Y HQ   +
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVA------HGRMKEKEARAKFRQIVSAVQYCHQ---K 132
Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNF 315
            I+H D+K  N+LLD +   KI+DFG     S + +  + L    G+  Y APELF    
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGF----SNEFTFGNKLDEFCGSPPYAAPELFQGKK 188
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
            +   + DV+S G++L  +V
Sbjct: 189 YD-GPEVDVWSLGVILYTLV 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 12  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 65
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 66  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 119
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 120 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 177 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 2   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 55
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 56  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 167 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 123 TRYT--YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEH-LKG--NGQEFI 176
           +RYT  + EL+KI        G G +GSVF+  K  +G   A+K  +  L G  + Q  +
Sbjct: 5   SRYTTEFHELEKI--------GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 56
Query: 177 NEV---ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
            EV   A +G+  H H+VR     +E     +  E+   GSL   I     S ++R +S+
Sbjct: 57  REVYAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSY 109
Query: 234 EK---LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGL 283
            K   LK +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+  
Sbjct: 110 FKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 166
Query: 284 AKLCSK--DIS----IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
            K+  K  D+     I S     G + ++A E+   N+  +  K+D+++  + ++   G 
Sbjct: 167 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 225

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLG-F 196
           ++G+G YG V++ K  +G       L+ ++G G       E+A +  + H +++ L   F
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 197 CSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK--LKKIAFGVARGVEYLHQG 253
            S   R+  L++++  +       F + + ++ +P+   +  +K + + +  G+ YLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 254 CNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAGYIAP 308
               +LH D+KP NIL+        + KI+D G A+L +  +  +  L     T  Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 309 ELF--SRNFGEVSYKSDVYSYGMMLLEMV 335
           EL   +R++ +     D+++ G +  E++
Sbjct: 205 ELLLGARHYTKA---IDIWAIGCIFAELL 230

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 123 TRYT--YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEH-LKG--NGQEFI 176
           +RYT  + EL+KI        G G +GSVF+  K  +G   A+K  +  L G  + Q  +
Sbjct: 5   SRYTTEFHELEKI--------GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 56
Query: 177 NEV---ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
            EV   A +G+  H H+VR     +E     +  E+   GSL   I     S ++R +S+
Sbjct: 57  REVYAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSY 109
Query: 234 EK---LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGL 283
            K   LK +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+  
Sbjct: 110 FKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 166
Query: 284 AKLCSK--DIS----IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
            K+  K  D+     I S     G + ++A E+   N+  +  K+D+++  + ++   G 
Sbjct: 167 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLG 195
           LG GG   V   + L +   VAVK+L         F      E      ++H  IV +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 196 F----CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
                   G    +V E++   +L   + ++       P++ ++  ++     + + + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSH 133
Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPEL 310
           Q     I+H D+KP NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
              +   V  +SDVYS G +L E++
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVL 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 25  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 78
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 79  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 132
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 133 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 189
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 190 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 26  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 79
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 80  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 191 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V E++   +L   + ++       P++ ++  ++     + + + HQ     I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVK 143
Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYKSD 323
           P NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 324 VYSYGMMLLEMV 335
           VYS G +L E++
Sbjct: 202 VYSLGCVLYEVL 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V E++   +L   + ++       P++ ++  ++     + + + HQ     I+H D+K
Sbjct: 110 IVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVK 160
Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYKSD 323
           P NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++PE    +   V  +SD
Sbjct: 161 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 218
Query: 324 VYSYGMMLLEMV 335
           VYS G +L E++
Sbjct: 219 VYSLGCVLYEVL 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 12/132 (9%)
Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V E++   +L   + ++       P++ ++  ++     + + + HQ     I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVK 143
Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYKSD 323
           P NIL+      K+ DFG+A+  +   + V  TAA  GTA Y++PE    +   V  +SD
Sbjct: 144 PANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 324 VYSYGMMLLEMV 335
           VYS G +L E++
Sbjct: 202 VYSLGCVLYEVL 213

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 44/240 (18%)
Query: 123 TRYT--YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEH-LKG--NGQEFI 176
           +RYT  + EL+KI        G G +GSVF+  K  +G   A+K  +  L G  + Q  +
Sbjct: 7   SRYTTEFHELEKI--------GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 58
Query: 177 NEV---ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
            EV   A +G+  H H+VR     +E     +  E+   GSL   I     S ++R +S+
Sbjct: 59  REVYAHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSY 111
Query: 234 EK---LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS-------DFGL 283
            K   LK +   V RG+ Y+H   +  ++H DIKP NI +     P  +       D+  
Sbjct: 112 FKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168
Query: 284 AKLCSK--DIS----IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
            K+  K  D+     I S     G + ++A E+   N+  +  K+D+++  + ++   G 
Sbjct: 169 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 227

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 116
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 174 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           +V E++   +L   + ++       P++ ++  ++     + + + HQ     I+H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVK 143
Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYKSD 323
           P NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++PE    +   V  +SD
Sbjct: 144 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSD 201
Query: 324 VYSYGMMLLEMV 335
           VYS G +L E++
Sbjct: 202 VYSLGCVLYEVL 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 116
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 174 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 205

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHHFHIVRLLG 195
           LG GG   V   + L +   VAVK+L         F      E      ++H  IV +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 196 F----CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
                   G    +V E++   +L   + ++       P++ ++  ++     + + + H
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSH 133
Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPEL 310
           Q     I+H D+KP NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
              +   V  +SDVYS G +L E++
Sbjct: 191 ARGD--SVDARSDVYSLGCVLYEVL 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 19/195 (9%)
Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCS 198
           LG G +G V R  +   G   A K +     + +E +  E+ T+  + H  +V L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +     ++YEFM  G L    F K  +  H  +S ++  +    V +G+ ++H+      
Sbjct: 225 DDNEMVMIYEFMSGGEL----FEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 259 LHFDIKPHNILL--DHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +H D+KP NI+     + + K+ DFGL A L  K     S+    GTA + APE+     
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGK- 331
Query: 316 GEVSYKSDVYSYGMM 330
             V Y +D++S G++
Sbjct: 332 -PVGYYTDMWSVGVL 345

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 19/195 (9%)
Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCS 198
           LG G +G V R  +   G   A K +     + +E +  E+ T+  + H  +V L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
           +     ++YEFM  G L    F K  +  H  +S ++  +    V +G+ ++H+      
Sbjct: 119 DDNEMVMIYEFMSGGEL----FEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNY 170
Query: 259 LHFDIKPHNILL--DHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +H D+KP NI+     + + K+ DFGL A L  K     S+    GTA + APE+     
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGK- 225
Query: 316 GEVSYKSDVYSYGMM 330
             V Y +D++S G++
Sbjct: 226 -PVGYYTDMWSVGVL 239

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 161 AVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF 220
           AVK+++  K +  E I  +   G+  H +I+ L     +G    +V E    G L   I 
Sbjct: 51  AVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL 108
Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL-LDHNFQP--- 276
            +      +  S  +   + F + + VEYLH    Q ++H D+KP NIL +D +  P   
Sbjct: 109 RQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESI 159
Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           +I DFG AK    +  +  L     TA ++APE+  R   + +   D++S G++L
Sbjct: 160 RICDFGFAKQLRAENGL--LXTPCYTANFVAPEVLERQGYDAA--CDIWSLGVLL 210

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFC-S 198
           +G G +G VF+ KL     VA+K +   K     F N    I RI  H ++V L  F  S
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 199 EGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            G ++      LV E++P      +  S+  +   + +    +K   + + R + Y+H  
Sbjct: 104 NGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-- 158
Query: 254 CNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
            +  I H DIKP N+LLD    P    K+ DFG AK+       VS   +R    Y APE
Sbjct: 159 -SIGICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSXICSR---YYRAPE 211
Query: 310 LFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           L    FG  +Y +  D++S G ++ E++
Sbjct: 212 LI---FGATNYTTNIDIWSTGCVMAELM 236

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 140 RLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFC 197
           +LG+G Y  VF    + N   V VK+L+ +K N  +   E+  +  +    +I+ L    
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVKKN--KIKREIKILENLRGGPNIITLADIV 101
Query: 198 SEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            +   R  ALV+E + N   ++   + T+           ++   + + + ++Y H   +
Sbjct: 102 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKALDYCH---S 149
Query: 256 QRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
             I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G   PEL   +
Sbjct: 150 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLV-D 205
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
           +    Y  D++S G ML  M+
Sbjct: 206 YQMYDYSLDMWSLGCMLASMI 226

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFI 176
           + P  Y Y+E +   +  + RLG+G +G V R +    G   AVK   LE  +       
Sbjct: 81  LKPVDYEYRE-EVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE----- 134
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+     +    IV L G   EG    +  E +  GSL + +  +      R L +   
Sbjct: 135 -ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY--- 190
Query: 237 KKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD---I 291
                G A  G+EYLH   ++RILH D+K  N+LL  +     + DFG A     D    
Sbjct: 191 ----LGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGK 243
Query: 292 SIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
           S+++     GT  ++APE +  R+      K DV+S   M+L M+ GC
Sbjct: 244 SLLTGDYIPGTETHMAPEVVLGRS---CDAKVDVWSSCCMMLHMLNGC 288

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI D G
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G+V+  + + N   VA+K + +         Q+ I EV  + ++ H + ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV E+    + +     K      +PL   ++  +  G  +G+ YLH   +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---S 133
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRN 314
             ++H D+K  NILL      K+ DFG A + +     V      GT  ++APE + + +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 187
Query: 315 FGEVSYKSDVYSYGMMLLEM 334
            G+   K DV+S G+  +E+
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    D  +    A R    Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LAR--HTDDEMAGFVATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI  FG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI D G
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    D  +    A R    Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LAR--HTDDEMAGFVATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 141 LGQGGYGSV-FRGKLFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLG 195
           +G G +G+V F   + N   VA+K + +         Q+ I EV  + ++ H + ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV E+    + +     K      +PL   ++  +  G  +G+ YLH   +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH---S 172
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRN 314
             ++H D+K  NILL      K+ DFG A + +     V      GT  ++APE + + +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMD 226
Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
            G+   K DV+S G+  +E+ 
Sbjct: 227 EGQYDGKVDVWSLGITCIELA 247

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 2   PTFYR-QELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 55
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 56  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N      L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 110 NNIVKCAKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 167 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K     +G   +   E+     + H +I+R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  +  R  L+ EF P G L K +         R  ++ +       +A  + Y H+   
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME------ELADALHYCHE--- 133
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR--GTAGYIAPELFSR 313
           ++++H DIKP N+L+ +  + KI+DFG +      +   SL      GT  Y+ PE+   
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 314 NFGEVSYKSDVYSYGMMLLE-MVGCRKNKDPA 344
              +   K D++  G++  E +VG      P+
Sbjct: 188 KTHDE--KVDLWCAGVLCYEFLVGMPPFDSPS 217

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFH--I 190
           LG GG+GSV+ G ++ + +PVA+K +E  +        NG     EV  + ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +RLL +        L+ E  P    + F F     +    L+    +   + V   V + 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA----RSFFWQVLEAVRHC 126
Query: 251 HQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           H   N  +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  Y  PE
Sbjct: 127 H---NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 179
Query: 310 L--FSRNFGEVSYKSDVYSYGMMLLEMV 335
              + R  G     + V+S G++L +MV
Sbjct: 180 WIRYHRYHGR---SAAVWSLGILLYDMV 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 25/212 (11%)
Query: 141 LGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+     + K    + V  K     +G   +   E+     + H +I+R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  +  R  L+ EF P G L K +         R  ++ +       +A  + Y H+   
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME------ELADALHYCHE--- 132
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR--GTAGYIAPELFSR 313
           ++++H DIKP N+L+ +  + KI+DFG +      +   SL      GT  Y+ PE+   
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 314 NFGEVSYKSDVYSYGMMLLE-MVGCRKNKDPA 344
              +   K D++  G++  E +VG      P+
Sbjct: 187 KTHDE--KVDLWCAGVLCYEFLVGMPPFDSPS 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 17/166 (10%)
Query: 176 INEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
           + EV  + ++  H +I++L       T   LV++ M  G L  ++  K        LS +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEK 124
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           + +KI   +   +  LH+     I+H D+KP NILLD +   K++DFG +  C  D    
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPG-E 178
Query: 295 SLTAARGTAGYIAPELF--SRNFGEVSY--KSDVYSYGMMLLEMVG 336
            L +  GT  Y+APE+   S N     Y  + D++S G+++  ++ 
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 2   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 55
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 56  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 110 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    D  +    A R    Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 167 LAR--HTDDEMAGFVATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 118 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 170
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 171 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 131
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 132 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 184
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 185 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 38/215 (17%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSE 199
           LG G  G+V     F G PVAVK +  L       + E+  +     H +++R   +CSE
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YCSE 78
Query: 200 GTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEK-----LKKIAFGVARGVEYLHQG 253
            T R L     + N +L+  + SK  S  +  L  E      L++IA GVA    +LH  
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA----HLH-- 132
Query: 254 CNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKLCSKDISI-VSLTA 298
            + +I+H D+KP NIL+               N +  ISDFGL  KL S   S   +L  
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 299 ARGTAGYIAPELF--SRNFG---EVSYKSDVYSYG 328
             GT+G+ APEL   S N      ++   D++S G
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 131
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 132 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 184
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 185 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 132
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 133 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 185
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 186 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 224

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           EV+ +  I H +++ L       T   L+ E +  G L  F+  K +      L+ E+  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES------LTEEEAT 117
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNI-LLDHNF-QP--KISDFGLAKLCSKDISI 293
           +    +  GV YLH   + +I HFD+KP NI LLD N  +P  KI DFGLA         
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            ++    GT  ++APE+   N+  +  ++D++S G++
Sbjct: 175 KNIF---GTPEFVAPEIV--NYEPLGLEADMWSIGVI 206

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 132
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 133 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 185
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 186 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 224

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G+ VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGLRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI D G
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGG 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSE 199
           LG G  G+V     F G PVAVK +  L       + E+  +     H +++R   +CSE
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YCSE 96
Query: 200 GTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEK-----LKKIAFGVARGVEYLHQG 253
            T R L     + N +L+  + SK  S  +  L  E      L++IA GVA    +LH  
Sbjct: 97  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA----HLH-- 150
Query: 254 CNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKLCSKDISI-VSLTA 298
            + +I+H D+KP NIL+               N +  ISDFGL  KL S       +L  
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS-DVYSYG 328
             GT+G+ APEL   +      +S D++S G
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMG 240

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSE 199
           LG G  G+V     F G PVAVK +  L       + E+  +     H +++R   +CSE
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YCSE 96
Query: 200 GTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEK-----LKKIAFGVARGVEYLHQG 253
            T R L     + N +L+  + SK  S  +  L  E      L++IA GVA    +LH  
Sbjct: 97  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA----HLH-- 150
Query: 254 CNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKLCSKDISI-VSLTA 298
            + +I+H D+KP NIL+               N +  ISDFGL  KL S       +L  
Sbjct: 151 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS-DVYSYG 328
             GT+G+ APEL   +      +S D++S G
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMG 240

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 116
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 117 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 169
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 170 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 208

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 118 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 170
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 171 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 209

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 117
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 118 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 170
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 171 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 209

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 132
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 133 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 185
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 186 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 224

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 145
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 146 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 198
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 199 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 237

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 26  PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 79
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 80  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 133
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +     T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 191 LARHTDDE-----MXGXVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 145
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 146 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 198
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 199 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 144
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 145 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 197
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 198 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 236

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 144
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 145 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 197
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 198 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 236

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           + + SL+KF     +     P   + L KIA  + + +E+LH   +  ++H D+KP N+L
Sbjct: 114 LXDTSLDKFYKQVIDKGQTIPE--DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVL 169
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSY 327
           ++   Q K  DFG++     D   V+     G   Y APE  +    +  Y  KSD++S 
Sbjct: 170 INALGQVKXCDFGISGYLVDD---VAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSL 226
Query: 328 GMMLLEMVGCR 338
           G+  +E+   R
Sbjct: 227 GITXIELAILR 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 144
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 145 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 197
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 198 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 145
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 146 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 198
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 199 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 140 RLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVA-----TIGRIHHFHIVRL 193
           ++G+G YG VF+ +  + G  VA+K    L+      I ++A      + ++ H ++V L
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           L       R  LV+E+  +  L +    +     H       +K I +   + V + H+ 
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL------VKSITWQTLQAVNFCHK- 120
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
                +H D+KP NIL+  +   K+ DFG A+L +          A  T  Y +PEL   
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYRSPELL-- 174
Query: 314 NFGEVSY--KSDVYSYGMMLLEMVG 336
             G+  Y    DV++ G +  E++ 
Sbjct: 175 -VGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 144
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 145 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 197
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 198 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 236

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 145
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 146 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 198
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 199 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 159
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 160 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 212
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 213 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 251

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 159
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 160 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 212
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 213 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 251

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL 193
           LG+GG+   +        ++F G  V   ML  LK + +E ++ E+A    + + H+V  
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSML--LKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   +++      +GV+YLH  
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQ----TIQGVQYLH-- 143
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGYIAP 308
            N R++H D+K  N+ L+ +   KI DFGLA       + +     R     GT  YIAP
Sbjct: 144 -NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAP 195
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E+  +  G  S++ D++S G +L  ++
Sbjct: 196 EVLCKK-GH-SFEVDIWSLGCILYTLL 220

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFH--I 190
           LG GG+GSV+ G ++ + +PVA+K +E  +        NG     EV  + ++      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +RLL +        L+ E  P    + F F     +    L+    +   + V   V + 
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA----RSFFWQVLEAVRHC 129
Query: 251 HQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           H   N  +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  Y  PE
Sbjct: 130 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 182
Query: 310 L--FSRNFGEVSYKSDVYSYGMMLLEMV 335
              + R  G     + V+S G++L +MV
Sbjct: 183 WIRYHRYHGR---SAAVWSLGILLYDMV 207

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L  E 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA----LQEEL 150
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 151 ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 204
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 205 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 243

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL 193
           LG+GG+   +        ++F G  V   ML  LK + +E ++ E+A    + + H+V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSML--LKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   +++      +GV+YLH  
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQ----TIQGVQYLH-- 159
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            N R++H D+K  N+ L+ +   KI DFGLA     D          GT  YIAPE+  +
Sbjct: 160 -NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC--GTPNYIAPEVLCK 216
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
             G  S++ D++S G +L  ++
Sbjct: 217 K-GH-SFEVDIWSLGCILYTLL 236

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 176 INEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
           + EV  + ++  H +I++L       T   LV++ M  G L  ++  K        LS +
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEK 111
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           + +KI   +   +  LH+     I+H D+KP NILLD +   K++DFG +  C  D    
Sbjct: 112 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPG-E 165
Query: 295 SLTAARGTAGYIAPELF--SRNFGEVSY--KSDVYSYGMMLLEMVG 336
            L    GT  Y+APE+   S N     Y  + D++S G+++  ++ 
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL 193
           LG+GG+   +        ++F G  V   ML  LK + +E ++ E+A    + + H+V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSML--LKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   +++      +GV+YLH  
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQ----TIQGVQYLH-- 159
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            N R++H D+K  N+ L+ +   KI DFGLA     D          GT  YIAPE+  +
Sbjct: 160 -NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC--GTPNYIAPEVLCK 216
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
             G  S++ D++S G +L  ++
Sbjct: 217 K-GH-SFEVDIWSLGCILYTLL 236

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L+   
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA--- 139
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 140 -RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 192
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 193 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 19/176 (10%)
Query: 141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCS 198
           LG+G    V+R K      P A+K+L+  K   ++ +  E+  + R+ H +I++L     
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  +LV E +  G L   I  K   S     + + +K+I   VA    YLH+     I
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERD--AADAVKQILEAVA----YLHENG---I 169
Query: 259 LHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
           +H D+KP N+L      +   KI+DFGL+K+    + + ++    GT GY APE+ 
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEIL 222

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFIN-EVATIGRIHHFHIVRL 193
           LG+GG+   +        ++F G  V   ML  LK + +E ++ E+A    + + H+V  
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSML--LKPHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
            GF  +     +V E     SL +    K   +   P +   +++      +GV+YLH  
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQ----TIQGVQYLH-- 159
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGYIAP 308
            N R++H D+K  N+ L+ +   KI DFGLA       + +     R     GT  YIAP
Sbjct: 160 -NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAP 211
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E+  +  G  S++ D++S G +L  ++
Sbjct: 212 EVLCKK-GH-SFEVDIWSLGCILYTLL 236

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 17/166 (10%)
Query: 176 INEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
           + EV  + ++  H +I++L       T   LV++ M  G L  ++  K        LS +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEK 124
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           + +KI   +   +  LH+     I+H D+KP NILLD +   K++DFG +  C  D    
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPG-E 178
Query: 295 SLTAARGTAGYIAPELF--SRNFGEVSY--KSDVYSYGMMLLEMVG 336
            L    GT  Y+APE+   S N     Y  + D++S G+++  ++ 
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 120 VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLKGNGQEFI 176
           + P  Y Y+E +   +  + RLG+G +G V R +    G   AVK   LE  +       
Sbjct: 62  LKPVDYEYRE-EVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE----- 115
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+     +    IV L G   EG    +  E +  GSL + +  +      R L +   
Sbjct: 116 -ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYY--- 171
Query: 237 KKIAFGVA-RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKD---I 291
                G A  G+EYLH   ++RILH D+K  N+LL  +     + DFG A     D    
Sbjct: 172 ----LGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGK 224
Query: 292 SIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
            +++     GT  ++APE +  R+      K DV+S   M+L M+ GC
Sbjct: 225 DLLTGDYIPGTETHMAPEVVLGRS---CDAKVDVWSSCCMMLHMLNGC 269

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 128 KELKKITSKFK--HRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFIN 177
           KE + + S+++    LG GG+GSV+ G ++ + +PVA+K +E  +        NG     
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 178 EVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           EV  + ++      ++RLL +        L+ E  P    + F F     +    L  E 
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGA----LQEEL 163
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIV 294
            +   + V   V + H   N  +LH DIK  NIL+D N  + K+ DFG   L    +   
Sbjct: 164 ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 217
Query: 295 SLTAARGTAGYIAPEL--FSRNFGEVSYKSDVYSYGMMLLEMV 335
             T   GT  Y  PE   + R  G     + V+S G++L +MV
Sbjct: 218 -YTDFDGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMV 256

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 47/239 (19%)
Query: 136 KFKHRLGQGGYGSVFRG--KLFNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIV 191
           + +H +G G YG V     KL   +    K+L   +   + +  + E+A + R++H H+V
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 192 RLLGFC----SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           ++L        E      V   + +   +K   +         L+   +K + + +  GV
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY------LTELHIKTLLYNLLVGV 169
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS---------------KDIS 292
           +Y+H      ILH D+KP N L++ +   K+ DFGLA+                   D++
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 293 IVS----------LTAARGTAGYIAPE--LFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           +V+          LT    T  Y APE  L   N+ E     DV+S G +  E++   K
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA---IDVWSIGCIFAELLNMIK 282

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFH--I 190
           LG GG+GSV+ G ++ + +PVA+K +E  +        NG     EV  + ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +RLL +        L+ E  P    + F F     +    L+    +   + V   V + 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA----RSFFWQVLEAVRHC 126
Query: 251 HQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           H   N  +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  Y  PE
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 179
Query: 310 L--FSRNFGEVSYKSDVYSYGMMLLEMV 335
              + R  G     + V+S G++L +MV
Sbjct: 180 WIRYHRYHGR---SAAVWSLGILLYDMV 204

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFH--I 190
           LG GG+GSV+ G ++ + +PVA+K +E  +        NG     EV  + ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +RLL +        L+ E  P    + F F     +    L+    +   + V   V + 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELA----RSFFWQVLEAVRHC 126
Query: 251 HQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           H   N  +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  Y  PE
Sbjct: 127 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPE 179
Query: 310 L--FSRNFGEVSYKSDVYSYGMMLLEMV 335
              + R  G     + V+S G++L +MV
Sbjct: 180 WIRYHRYHGR---SAAVWSLGILLYDMV 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 141 LGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHF-HIVRLLG 195
           +G G  G V++ +    G  +AVK +    GN +E    + ++  + + H   +IV+  G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                T   +  E M   +       K       P+    L K+   + + + YL +   
Sbjct: 92  TFITNTDVFIAMELMGTCA------EKLKKRMQGPIPERILGKMTVAIVKALYYLKE--K 143
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF---S 312
             ++H D+KP NILLD   Q K+ DFG++     D    +   + G A Y+APE      
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPD 200
Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
               +   ++DV+S G+ L+E+ 
Sbjct: 201 PTKPDYDIRADVWSLGISLVELA 223

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 122 PTRYTYKELKKITSKF--KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN--GQEFI 176
           P R  Y     I+S F  K  LG+G YG V        G  VA+K +E           +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 177 NEVATIGRIHHFHIVRLLGF----CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
            E+  +    H +I+ +         E      + + +    L + I ++  S  H    
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---- 113
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
              ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++  +  +
Sbjct: 114 ---IQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 293 IVS--------LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             S        +T    T  Y APE+   +  + S   DV+S G +L E+
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIH-HFHIVRLLGFC 197
           LG+G +  V     L      AVK++E   G+ +  +  EV  + +   H +++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            E  R  LV+E M  GS+   I  +      R  +  +   +   VA  +++LH   N+ 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLH---NKG 131
Query: 258 ILHFDIKPHNILLDHNFQ---PKISDFGLA---KL---CSKDISIVSLTAARGTAGYIAP 308
           I H D+KP NIL +H  Q    KI DFGL    KL   CS  IS   L    G+A Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSP-ISTPELLTPCGSAEYMAP 190
Query: 309 EL---FSRNFGEVSYKSDVYSYGMML 331
           E+   FS        + D++S G++L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 141 LGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +G G +G   + R K  N + VAVK +E  +   +    E+     + H +IVR      
Sbjct: 27  IGAGNFGVARLMRDKQANEL-VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  A+V E+   G L    F +  ++     S ++ +     +  GV Y H     ++
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGR--FSEDEARFFFQQLISGVSYAHA---MQV 136
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAPE-LFS 312
            H D+K  N LLD +  P  KI+DFG +K   L S+  S V      GT  YIAPE L  
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV------GTPAYIAPEVLLK 190
Query: 313 RNF-GEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           + + G+V   +DV+S G+ L  M VG    +DP
Sbjct: 191 KEYDGKV---ADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRLLGFCSE 199
           LG G  G+V     F G PVAVK +  L       + E+  +     H +++R   +CSE
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRY--YCSE 78
Query: 200 GTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEK-----LKKIAFGVARGVEYLHQG 253
            T R L     + N +L+  + SK  S  +  L  E      L++IA GVA    +LH  
Sbjct: 79  TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA----HLH-- 132
Query: 254 CNQRILHFDIKPHNILLD-------------HNFQPKISDFGL-AKLCSKDISI-VSLTA 298
            + +I+H D+KP NIL+               N +  ISDFGL  KL S       +L  
Sbjct: 133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 191
Query: 299 ARGTAGYIAPELF--SRNFG---EVSYKSDVYSYG 328
             GT+G+ APEL   S N      ++   D++S G
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIV 191
           KI+   K  LG G  G++    +F+   VAVK    +      F +    + R    H  
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVK---RILPECFSFADREVQLLRESDEHPN 79
Query: 192 RLLGFCSEGTRR-ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
            +  FC+E  R+   +   +   +L++++  K  +     L  E +  +      G+ +L
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAH----LGLEPITLLQ-QTTSGLAHL 134
Query: 251 HQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLA-KLCSKDISIVSLTAARGTAG 304
           H   +  I+H D+KPHNIL+         +  ISDFGL  KL     S    +   GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 305 YIAPELFSRNFGE-VSYKSDVYSYG 328
           +IAPE+ S +  E  +Y  D++S G
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAG 216

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 97/242 (40%), Gaps = 52/242 (21%)
Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFIN---------EVATIGRIHH 187
            K  +GQG YG V R  + N    A++ ++ +  N    IN         EV  + ++HH
Sbjct: 30  LKGAIGQGSYG-VVRVAIENQTR-AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNG----SLEKFIFSKT-------------------- 223
            +I RL     +     LV E    G     L  FI   T                    
Sbjct: 88  PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 224 ---NSSSH---RPLSWEKLKKIAFGVAR----GVEYLHQGCNQRILHFDIKPHNILLDHN 273
              N S H     L + + +K+   + R     + YLH   NQ I H DIKP N L   N
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204
Query: 274 --FQPKISDFGLAKLCSK--DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM 329
             F+ K+ DFGL+K   K  +     +T   GT  ++APE+ +        K D +S G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 330 ML 331
           +L
Sbjct: 265 LL 266

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 122 PTRYTYKELKKITSKFKHR------LGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNG 172
           PT Y  +EL K   +   R      +G G YGSV   F  K   G  VAVK L       
Sbjct: 6   PTFYR-QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK--TGHRVAVKKLSR---PF 59
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--IFSKT------- 223
           Q  I+   T      +  +RLL          L+  F P  SLE+F  ++  T       
Sbjct: 60  QSIIHAKRT------YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 224 -NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG 282
            N    + L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DF 
Sbjct: 114 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFY 170
Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+    +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 171 LARHTDDE-----MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSV---FRGKLFNGIPVAVKMLEHLKGNGQE 174
           +T    R  Y++L+ +        G G YG+V     G+   G  VA+K L       + 
Sbjct: 18  KTAWEVRAVYRDLQPV--------GSGAYGAVCSAVDGR--TGAKVAIKKLY------RP 61
Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-------FSKTNSSS 227
           F +E+        +  +RLL          L+  F P+ +L+ F        F  T+   
Sbjct: 62  FQSELFAK---RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 118
Query: 228 ---HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
              H  L  ++++ + + + +G+ Y+H      I+H D+KP N+ ++ + + KI DFGLA
Sbjct: 119 LMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +    ++    +     T  Y APE+   N+   +   D++S G ++ EM+
Sbjct: 176 RQADSEMXGXVV-----TRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMI 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 122 PTRYTYKELKKITSKF--KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN--GQEFI 176
           P R  Y     I+S F  K  LG+G YG V        G  VA+K +E           +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 177 NEVATIGRIHHFHIVRLLGF----CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
            E+  +    H +I+ +         E      + + +    L + I ++  S  H    
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---- 113
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
              ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++  +  +
Sbjct: 114 ---IQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 293 IVS--------LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             S        +T    T  Y APE+   +  + S   DV+S G +L E+
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIG 183
           Y++LK I S       QG   + F   L  GI VAVK L     N    +    E+  + 
Sbjct: 24  YQQLKPIGSG-----AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLK 76
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSHRPLSWE 234
            ++H +I+ LL              F P  +LE+F         + +      H  L  E
Sbjct: 77  CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE 124
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           ++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+  S +  + 
Sbjct: 125 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMT 181
Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
                R    Y APE+     G + YK   D++S G ++ E+V
Sbjct: 182 PYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGELV 217

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 54/236 (22%)
Query: 137 FKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIV 191
            KH +G+G YG V+     N      I    +M E L  + +  + E+  + R+   +I+
Sbjct: 30  IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL-IDCKRILREITILNRLKSDYII 88
Query: 192 RLLGFCSEGTRRALVYEFMPNGSL---EKFIFSKTNSSSHRP-------LSWEKLKKIAF 241
           RL                +P+  L   E +I  +   S  +        L+ E +K I +
Sbjct: 89  RLYDL------------IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136
Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVS---- 295
            +  G  ++H+     I+H D+KP N LL+ +   K+ DFGLA+  +  KD +IV+    
Sbjct: 137 NLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 296 --------------LTAARGTAGYIAPELFSRNFGEVSYKS-DVYSYGMMLLEMVG 336
                         LT+   T  Y APEL      E   KS D++S G +  E++ 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELIL--LQENYTKSIDIWSTGCIFAELLN 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           +E   EVA +  + H +IV+      E     +V ++   G L    F + N+       
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQ 123
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
            +++      +   ++++H   +++ILH DIK  NI L  +   ++ DFG+A++ +  + 
Sbjct: 124 EDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           +    A  GT  Y++PE+        + KSD+++ G +L E+
Sbjct: 181 LA--RACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYEL 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 65/236 (27%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEF-----INEVATIGRIHHFHIVRLLG 195
           LG+GG+G VF  K  N +      ++ ++   +E      + EV  + ++ H  IVR   
Sbjct: 13  LGRGGFGVVFEAK--NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF- 69
Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW--------EKLKK--------- 238
                           N  LEK    K   SS +   +        E LK          
Sbjct: 70  ----------------NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 239 ---------IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
                    I   +A  VE+LH   ++ ++H D+KP NI    +   K+ DFGL     +
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 290 DISIVSL----------TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           D    ++          T   GT  Y++PE    N    S+K D++S G++L E++
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL 224

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 141 LGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +G G +G   + R K  N + VAVK +E  +   +    E+     + H +IVR      
Sbjct: 26  IGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  A+V E+   G L    F +  ++     S ++ +     +  GV Y H     ++
Sbjct: 85  TPTHLAIVMEYASGGEL----FERICNAGR--FSEDEARFFFQQLISGVSYCHA---MQV 135
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAPE-LFS 312
            H D+K  N LLD +  P  KI DFG +K   L S+  S V      GT  YIAPE L  
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLK 189
Query: 313 RNF-GEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           + + G+V   +DV+S G+ L  M VG    +DP
Sbjct: 190 KEYDGKV---ADVWSCGVTLYVMLVGAYPFEDP 219

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 137 FKHRLGQGGYGSVFRG--------KLFNGIPVAVKMLEHLKGNGQE-FINEVATIGRIHH 187
           F   LGQG +  +F+G           +   V +K+L+    N  E F    + + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            H+V   G C  G    LV EF+  GSL+ ++    N  +   + W+   ++A  +A  +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN---ILWK--LEVAKQLAAAM 126
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA--RGTAGY 305
            +L +     ++H ++   NILL      K  +    KL    ISI  L     +    +
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           + PE    N   ++  +D +S+G  L E+
Sbjct: 184 VPPECI-ENPKNLNLATDKWSFGTTLWEI 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGN---GQ 173
           + VN T +   EL K      H +G G YGSV       +G  VA+K L     +    +
Sbjct: 13  QDVNKTAW---ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF---MP--NGSLEKFIFSKTNSSSH 228
               E+  +  + H +++ LL   +  +     Y+F   MP     L+K +  K      
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK------ 122
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
              S EK++ + + + +G++Y+H      ++H D+KP N+ ++ + + KI DFGLA+   
Sbjct: 123 --FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            +     +T    T  Y APE+   ++   +   D++S G ++ EM+
Sbjct: 178 AE-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEML 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGN---GQ 173
           + VN T +   EL K      H +G G YGSV       +G  VA+K L     +    +
Sbjct: 31  QDVNKTAW---ELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 86
Query: 174 EFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF---MPNGSLEKFIFSKTNSSSHRP 230
               E+  +  + H +++ LL   +  +     Y+F   MP      F+ +         
Sbjct: 87  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP------FMQTDLQKIMGME 140
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
            S EK++ + + + +G++Y+H      ++H D+KP N+ ++ + + KI DFGLA+    +
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197
Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                +T    T  Y APE+   ++   +   D++S G ++ EM+
Sbjct: 198 -----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEML 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 141 LGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +G G +G   + R K  N + VAVK +E  +        E+     + H +IVR      
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  A+V E+   G L    F +  ++     S ++ +     +  GV Y H     ++
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGR--FSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAPE-LFS 312
            H D+K  N LLD +  P  KI DFG +K   L S+  S V      GT  YIAPE L  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLK 190
Query: 313 RNF-GEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           + + G+V   +DV+S G+ L  M VG    +DP
Sbjct: 191 KEYDGKV---ADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 137 FKHRLGQGGYGSVFRG--------KLFNGIPVAVKMLEHLKGNGQE-FINEVATIGRIHH 187
           F   LGQG +  +F+G           +   V +K+L+    N  E F    + + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            H+V   G C  G    LV EF+  GSL+ ++    N  +   + W+   ++A  +A  +
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCIN---ILWK--LEVAKQLAWAM 126
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA--RGTAGY 305
            +L +     ++H ++   NILL      K  +    KL    ISI  L     +    +
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           + PE    N   ++  +D +S+G  L E+
Sbjct: 184 VPPECI-ENPKNLNLATDKWSFGTTLWEI 211

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIG 183
           Y++LK I S       QG   + F   L  GI VAVK L     N    +    E+  + 
Sbjct: 26  YQQLKPIGSG-----AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLK 78
Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSHRPLSWE 234
            ++H +I+ LL              F P  +LE+F         + +      H  L  E
Sbjct: 79  CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE 126
Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           ++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+    +  + 
Sbjct: 127 RMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMT 183
Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV-GC 337
                R    Y APE+     G  +   D++S G ++ E+V GC
Sbjct: 184 PYVVTR---YYRAPEVI-LGMGYAA-NVDIWSVGCIMGELVKGC 222

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 59/244 (24%)
Query: 136 KFKHRLGQGGYGSVFRGKLFNGIP-VAVK----MLEHLKGNGQEFINEVATIGRIHHFHI 190
           + KH +G+G YG V+     N    VA+K    M E L  + +  + E+  + R+   +I
Sbjct: 31  EIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDL-IDCKRILREITILNRLKSDYI 89
Query: 191 VRLLGFCSEGTRRALVYEFMPNGSL---EKFIFSKTNSSSHRPL-------SWEKLKKIA 240
           +RL                +P   L   E +I  +   S  + L       + + +K I 
Sbjct: 90  IRLHDL------------IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTIL 137
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVS--- 295
           + +  G +++H+     I+H D+KP N LL+ +   KI DFGLA+  +  KDI IV+   
Sbjct: 138 YNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 296 ------------------LTAARGTAGYIAPE--LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                             LT+   T  Y APE  L   N+   +   D++S G +  E++
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY---TNSIDIWSTGCIFAELL 251
Query: 336 GCRK 339
              K
Sbjct: 252 NMMK 255

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 142 GQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF--- 196
           GQG +G+V  GK    G+ VA+K +++  +   +E +  +  +  +HH +IV+L  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 197 CSEGTRRAL----VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
             E  RR +    V E++P+ +L +   +        P     +K   F + R +  LH 
Sbjct: 91  LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL--IKVFLFQLIRSIGCLHL 147
Query: 253 GCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
             +  + H DIKPHN+L++  +   K+ DFG AK  S     V+   +R    Y APEL 
Sbjct: 148 P-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYRAPELI 203
Query: 312 SRNFGEVSYKS--DVYSYGMMLLEMV 335
              FG   Y +  D++S G +  EM+
Sbjct: 204 ---FGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIH-HFHIVRLLGFC 197
           LG+G +  V     L      AVK++E   G+ +  +  EV  + +   H +++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR 257
            E  R  LV+E M  GS+   I  +      R  +  +   +   VA  +++LH   N+ 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLH---NKG 131
Query: 258 ILHFDIKPHNILLDHNFQ---PKISDFGLA---KL---CSKDISIVSLTAARGTAGYIAP 308
           I H D+KP NIL +H  Q    KI DF L    KL   CS  IS   L    G+A Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP-ISTPELLTPCGSAEYMAP 190
Query: 309 EL---FSRNFGEVSYKSDVYSYGMML 331
           E+   FS        + D++S G++L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 122 PTRYTYKELKKITSKF--KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGN--GQEFI 176
           P R  Y     I+S F  K  LG+G YG V        G  VA+K +E           +
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 177 NEVATIGRIHHFHIVRLLGF----CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
            E+  +    H +I+ +         E      + + +    L + I ++  S  H    
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH---- 113
Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
              ++   +   R V+ LH G N  ++H D+KP N+L++ N   K+ DFGLA++  +  +
Sbjct: 114 ---IQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 293 IVSLTAAR--------GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             S    +         T  Y APE+   +  + S   DV+S G +L E+
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFIN-------EVATIGRI----HHF 188
           LG+GG+G+VF G +L + + VA+K++   +  G   ++       EVA + ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 189 HIVRLLGFCSEGTRRALVYE-FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG-VARG 246
            ++RLL +        LV E  +P   L  +I  K       PL  E   +  FG V   
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLG-EGPSRCFFGQVVAA 151
Query: 247 VEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           +++ H   ++ ++H DIK  NIL+D      K+ DFG   L   +      T   GT  Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVY 204
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PE  SR+    +  + V+S G++L +MV
Sbjct: 205 SPPEWISRHQYH-ALPATVWSLGILLYDMV 233

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 116 DYRTVNPTRYTYKELKKIT-SKFKHR-----------LGQGGYGSVFRGK-LFNGIPVAV 162
           D+R+ +P+  +  E  +++ +K KHR           LG+G +G V   K    G   A+
Sbjct: 122 DFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAM 181
Query: 163 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK 222
           K+L+      +E I  VA     H     R+L         AL Y F  +  L  F+   
Sbjct: 182 KILK------KEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL-CFVMEY 232
Query: 223 TNS-------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            N        S  R  S ++ +     +   ++YLH   N  +++ D+K  N++LD +  
Sbjct: 233 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 290
Query: 276 PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            KI+DFGL K   KD +  ++    GT  Y+APE+   N  +     D +  G+++ EM+
Sbjct: 291 IKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 346
Query: 336 GCR 338
             R
Sbjct: 347 CGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 116 DYRTVNPTRYTYKELKKIT-SKFKHR-----------LGQGGYGSVFRGK-LFNGIPVAV 162
           D+R+ +P+  +  E  +++ +K KHR           LG+G +G V   K    G   A+
Sbjct: 119 DFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAM 178
Query: 163 KMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK 222
           K+L+      +E I  VA     H     R+L         AL Y F  +  L  F+   
Sbjct: 179 KILK------KEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL-CFVMEY 229
Query: 223 TNS-------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
            N        S  R  S ++ +     +   ++YLH   N  +++ D+K  N++LD +  
Sbjct: 230 ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 287
Query: 276 PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            KI+DFGL K   KD +  ++    GT  Y+APE+   N  +     D +  G+++ EM+
Sbjct: 288 IKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 343
Query: 336 GCR 338
             R
Sbjct: 344 CGR 346

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 141 LGQGGYGSVF--RGKLFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLL 194
           LG+G +G+V+  R K  + I VA+K+L    ++  G E     E+     +HH +I+RL 
Sbjct: 31  LGKGKFGNVYLAREKKSHFI-VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLY 89
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  +  R  L+ E+ P G L K +         R  +      I   +A  + Y H   
Sbjct: 90  NYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTAT------IMEELADALMYCH--- 140
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR--GTAGYIAPELFS 312
            ++++H DIKP N+LL    + KI+DFG +      +   SL      GT  Y+ PE+  
Sbjct: 141 GKKVIHRDIKPENLLLGLKGELKIADFGWS------VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 313 -RNFGEVSYKSDVYSYGMMLLEMV 335
            R   E   K D++  G++  E++
Sbjct: 195 GRMHNE---KVDLWCIGVLCYELL 215

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 140 RLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIH-HFHIVRLL 194
           +LG+G YG V++      G  VAVK +     N    Q    E+  +  +  H +IV LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 195 GFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
                   R   LV+++M    L   I +      H+       + + + + + ++YLH 
Sbjct: 76  NVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHK-------QYVVYQLIKVIKYLHS 127
Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLA------KLCSKDISIV------------ 294
           G    +LH D+KP NILL+     K++DFGL+      +  + +I +             
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 295 -SLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             LT    T  Y APE+     G   Y    D++S G +L E++
Sbjct: 185 PILTDYVATRWYRAPEIL---LGSTKYTKGIDMWSLGCILGEIL 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 11/91 (12%)
Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCSKDISIVSLTAA 299
           +  GV YLHQ     I+H D+KP NILL   +     KI DFG+++   K      L   
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREI 193
Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMM 330
            GT  Y+APE+   N+  ++  +D+++ G++
Sbjct: 194 MGTPEYLAPEIL--NYDPITTATDMWNIGII 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEH---LKGNGQEFI---NEVATIGRIHHF 188
           +F   LG+G +G V   ++   G   AVK+L+    L+ +  E       + ++ R H F
Sbjct: 26  EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 85
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            + +L        R   V EF+  G L   +F    S   R     + +  A  +   + 
Sbjct: 86  -LTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKS---RRFDEARARFYAAEIISALM 138
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--LCSKDISIVSLTAARGTAGYI 306
           +LH   ++ I++ D+K  N+LLDH    K++DFG+ K  +C+     V+     GT  YI
Sbjct: 139 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTATFCGTPDYI 191
Query: 307 APELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           APE+      E+ Y    D ++ G++L EM+
Sbjct: 192 APEILQ----EMLYGPAVDWWAMGVLLYEML 218

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 117 YRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFR------GKLFNGIPVAVKM-LEHLK 169
           Y    P  +  +  ++++     RLG G YG VF+      G+L+     AVK  +   +
Sbjct: 46  YDPSRPESFFQQSFQRLS-----RLGHGSYGEVFKVRSKEDGRLY-----AVKRSMSPFR 95
Query: 170 G--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS 226
           G  +    + EV +  ++  H   VRL     EG    L  E     SL++       +S
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGAS 153
Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG-LAK 285
                 W  L+     +A    +LH   +Q ++H D+KP NI L    + K+ DFG L +
Sbjct: 154 LPEAQVWGYLRDTLLALA----HLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
           L +     V      G   Y+APEL   ++G     +DV+S G+ +LE V C
Sbjct: 207 LGTAGAGEVQ----EGDPRYMAPELLQGSYGTA---ADVFSLGLTILE-VAC 250

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 141 LGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +G G +G   + R K  N + VAVK +E  +   +    E+     + H +IVR      
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  A+V E+   G L    F +  ++     S ++ +     +  GV Y H     ++
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGR--FSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAPE-LFS 312
            H D+K  N LLD +  P  KI  FG +K   L S+  S V      GT  YIAPE L  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLK 190
Query: 313 RNF-GEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           + + G+V   +DV+S G+ L  M VG    +DP
Sbjct: 191 KEYDGKV---ADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     +G G +G V   
Sbjct: 8   KGXEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----IGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+MP G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYMPGGDM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     +G G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----IGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+MP G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYMPGGDM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS---RNF 315
           +H DIKP N+LLD N   +++DFG + L   D   V  + A GT  YI+PE+        
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
           G+   + D +S G+ + EM+
Sbjct: 272 GKYGPECDWWSLGVCMYEML 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS---RNF 315
           +H DIKP N+LLD N   +++DFG + L   D   V  + A GT  YI+PE+        
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
           G+   + D +S G+ + EM+
Sbjct: 256 GKYGPECDWWSLGVCMYEML 275

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 150
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 138
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 195 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 221

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 100 SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 153
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 154 LCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 139
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 140 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 195
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 196 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 222

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  S ++ +     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 101 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 158
Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
              KD + +      GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 159 EGIKDGATMKXFC--GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 158
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 159 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 214
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 215 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 241

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 150
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 138
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 139 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 194
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 195 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 129 ELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEFINEVATIGRIH 186
           EL ++  + +  L +GG+  V+  + + +G   A+K +L + +   +  I EV  + ++ 
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 187 -HFHIVRLLGFCSE----------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
            H +IV+   FCS           G    L+   +  G L +F+       S  PLS + 
Sbjct: 84  GHPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDT 137
Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS------- 288
           + KI +   R V+++H+     I+H D+K  N+LL +    K+ DFG A   S       
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 289 --KDISIVSLTAARGTAG-YIAPELFS--RNFGEVSYKSDVYSYGMML 331
             +  ++V     R T   Y  PE+     NF  +  K D+++ G +L
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNF-PIGEKQDIWALGCIL 243

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  S ++ +     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 100 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 157
Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
              KD + +      GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 158 EGIKDGATMKXFC--GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 150
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +IV+LL    +   +  +L++E++ N    K ++        R   +E LK         
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDF-KVLYPTLTDYDIRYYIYELLK--------A 137
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++Y H   +Q I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 138 LDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG- 193
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             PEL   +  +  Y  D++S G M   M+
Sbjct: 194 --PELLV-DLQDYDYSLDMWSLGCMFAGMI 220

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------------QEFINEVATIGRIHHF 188
           +  G YG+V  G    GIPVA+K + +   +G            +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +I+ L          A+ ++      L +   ++        +S + ++   + +  G+ 
Sbjct: 90  NILGLRDIFVHFEEPAM-HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
            LH+     ++H D+ P NILL  N    I DF LA+  + D +       R    Y AP
Sbjct: 149 VLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR---WYRAP 202
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           EL  + F   +   D++S G ++ EM
Sbjct: 203 ELVMQ-FKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG------------QEFINEVATIGRIHHF 188
           +  G YG+V  G    GIPVA+K + +   +G            +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +I+ L          A+ ++      L +   ++        +S + ++   + +  G+ 
Sbjct: 90  NILGLRDIFVHFEEPAM-HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
            LH+     ++H D+ P NILL  N    I DF LA+  + D +       R    Y AP
Sbjct: 149 VLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR---WYRAP 202
Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEM 334
           EL  + F   +   D++S G ++ EM
Sbjct: 203 ELVMQ-FKGFTKLVDMWSAGCVMAEM 227

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 102 SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 155
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 156 LCKEGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 141 LGQGGYGSVFRGKLFNGIPV-AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLL 194
           +G+G Y  V   +L     + A+K+++    N  E I+ V T   +     +H  +V L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                 +R   V E++  G L   +F   +    R L  E  +  +  ++  + YLH+  
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL---MF---HMQRQRKLPEEHARFYSAEISLALNYLHE-- 139
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF-SR 313
            + I++ D+K  N+LLD     K++D+G+ K   +     S     GT  YIAPE+    
Sbjct: 140 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGE 196
Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           ++G   +  D ++ G+++ EM+  R   D
Sbjct: 197 DYG---FSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  S ++ +     +   ++YLH   N  +++ D+K  N++LD +   KI+DFGL K
Sbjct: 102 SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 159
Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
              KD + +      GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 160 EGIKDGATMKXFC--GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 150
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S  R  + E+ +     +   +EYLH   ++ +++ DIK  N++LD +   KI+DFG   
Sbjct: 97  SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG--- 150
Query: 286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LC + IS   ++    GT  Y+APE+   N  +     D +  G+++ EM+  R
Sbjct: 151 LCKEGISDGATMKXFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFGLAK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 15/107 (14%)
Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD---ISIVS 295
           I   +A  VE+LH   ++ ++H D+KP NI    +   K+ DFGL     +D    ++++
Sbjct: 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 296 LTAAR-------GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              A        GT  Y++PE    N    S+K D++S G++L E++
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFELL 270

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 141 LGQGGYG--SVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS 198
           +G G +G   + R K  N + VAVK +E  +   +    E+     + H +IVR      
Sbjct: 27  IGSGNFGVARLMRDKQSNEL-VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRI 258
             T  A+V E+   G L    F +  ++     S ++ +     +  GV Y H     ++
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGR--FSEDEARFFFQQLISGVSYCHA---MQV 136
Query: 259 LHFDIKPHNILLDHNFQP--KISDFGLAK---LCSKDISIVSLTAARGTAGYIAPE-LFS 312
            H D+K  N LLD +  P  KI  FG +K   L S+    V      GT  YIAPE L  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV------GTPAYIAPEVLLK 190
Query: 313 RNF-GEVSYKSDVYSYGMMLLEM-VGCRKNKDP 343
           + + G+V   +DV+S G+ L  M VG    +DP
Sbjct: 191 KEYDGKV---ADVWSCGVTLYVMLVGAYPFEDP 220

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I++L+    +   +  ALV+E++ N   ++ ++        R   +E LK + +  ++G 
Sbjct: 100 IIKLIDTVKDPVSKTPALVFEYINNTDFKQ-LYQILTDFDIRFYMYELLKALDYCHSKG- 157
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
                     I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 158 ----------IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG-- 205
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
            PEL   ++    Y  D++S G ML  M+  R+
Sbjct: 206 -PELLV-DYQMYDYSLDMWSLGCMLASMIFRRE 236

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 189 HIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           +I++L+    +   +  ALV+E++ N   ++ ++        R   +E LK + +  ++G
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQ-LYQILTDFDIRFYMYELLKALDYCHSKG 152
Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGY 305
                      I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G 
Sbjct: 153 -----------IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKG- 200
Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
             PEL   ++    Y  D++S G ML  M+  R+
Sbjct: 201 --PELLV-DYQMYDYSLDMWSLGCMLASMIFRRE 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 141 LGQGGYGSVFRGKLFNGIPV-AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLL 194
           +G+G Y  V   +L     + A+K+++    N  E I+ V T   +     +H  +V L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                 +R   V E++  G L        +    R L  E  +  +  ++  + YLH+  
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL------MFHMQRQRKLPEEHARFYSAEISLALNYLHE-- 124
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF-SR 313
            + I++ D+K  N+LLD     K++D+G+ K   +     S     GT  YIAPE+    
Sbjct: 125 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGE 181
Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           ++G   +  D ++ G+++ EM+  R   D
Sbjct: 182 DYG---FSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF--INEVATIGR-IHHFHIVRL 193
           K  LG+G +  V R      G+  A K++   K + ++F  +   A I R + H +IVRL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFI----FSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
                E +   LV++ +  G L + I    F     +SH     + L+ IA+  + G   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQILESIAYCHSNG--- 125
Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAAR---GTA 303
                   I+H ++KP N+LL    +    K++DFGLA      I +    A     GT 
Sbjct: 126 --------IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEVNDSEAWHGFAGTP 171
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
           GY++PE+  ++    S   D+++ G++L
Sbjct: 172 GYLSPEVLKKD--PYSKPVDIWACGVIL 197

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLK-GNGQEFINEVATIGRIHHFHIVRLLG 195
           ++GQG +G VF+ +    G  VA+K  ++E+ K G     + E+  +  + H ++V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 196 FCSEGTRRA--------LVYEF-------MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            C               LV++F       + +  L KF  S+             +K++ 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRVM 131
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVSLTA 298
             +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  S  K+        
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
              T  Y  PEL     GE  Y    D++  G ++ EM
Sbjct: 189 RVVTLWYRPPELL---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF--INEVATIGR-IHHFHIVRL 193
           K  LG+G +  V R      G+  A K++   K + ++F  +   A I R + H +IVRL
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFI----FSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
                E +   LV++ +  G L + I    F     +SH     + L+ IA+  + G   
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQILESIAYCHSNG--- 124
Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAAR---GTA 303
                   I+H ++KP N+LL    +    K++DFGLA      I +    A     GT 
Sbjct: 125 --------IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEVNDSEAWHGFAGTP 170
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
           GY++PE+  ++    S   D+++ G++L
Sbjct: 171 GYLSPEVLKKD--PYSKPVDIWACGVIL 196

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 141 LGQGGYGSVFRGKLFNGIPV-AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLL 194
           +G+G Y  V   +L     + A+K+++    N  E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                 +R   V E++  G L        +    R L  E  +  +  ++  + YLH+  
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL------MFHMQRQRKLPEEHARFYSAEISLALNYLHE-- 128
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF-SR 313
            + I++ D+K  N+LLD     K++D+G+ K   +     S     GT  YIAPE+    
Sbjct: 129 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC--GTPNYIAPEILRGE 185
Query: 314 NFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
           ++G   +  D ++ G+++ EM+  R   D
Sbjct: 186 DYG---FSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 293
           K   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   +
Sbjct: 117 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
            +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 174 RTLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 293
           K   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   +
Sbjct: 117 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
            +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 174 RTLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 116
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 293
           K   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   +
Sbjct: 117 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
            +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 174 RTLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 210

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     
Sbjct: 70  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 122
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 293
           K   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   +
Sbjct: 123 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 179
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
            +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 180 RTLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     
Sbjct: 63  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATC 115
Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISI 293
           K   + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   +
Sbjct: 116 KLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 172
Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
            +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 173 RTLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 209

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 120 VNPTRYTYKELKKITSKFKHR-LGQGGYGSVFRGKL-----FNGIPVAVKMLEHLKGNGQ 173
           +N  R + +   KI     H+ LG+G +G VF  +      F  I    K +  +  + +
Sbjct: 3   LNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE 62
Query: 174 EFINE--VATIGRIHHF--HIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSS 227
             + E  V ++   H F  H+     FC+  T+  L  V E++  G L   I      S 
Sbjct: 63  CTMVEKRVLSLAWEHPFLTHM-----FCTFQTKENLFFVMEYLNGGDLMYHI-----QSC 112
Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           H+     +    A  +  G+++LH   ++ I++ D+K  NILLD +   KI+DFG+ K  
Sbjct: 113 HK-FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-- 166
Query: 288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              +         GT  YIAPE+      + ++  D +S+G++L EM+
Sbjct: 167 ENMLGDAKTNXFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEML 212

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+L+DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLK-GNGQEFINEVATIGRIHHFHIVRLLG 195
           ++GQG +G VF+ +    G  VA+K  ++E+ K G     + E+  +  + H ++V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 196 FCSEGTRRA--------LVYEF-------MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            C               LV++F       + +  L KF  S+             +K++ 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRVM 131
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVSLTA 298
             +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  S  K+        
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
              T  Y  PEL     GE  Y    D++  G ++ EM
Sbjct: 189 RVVTLWYRPPELL---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLK-GNGQEFINEVATIGRIHHFHIVRLLG 195
           ++GQG +G VF+ +    G  VA+K  ++E+ K G     + E+  +  + H ++V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 196 FCSEGTRRA--------LVYEF-------MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            C               LV++F       + +  L KF  S+             +K++ 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRVM 130
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVSLTA 298
             +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  S  K+        
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
              T  Y  PEL     GE  Y    D++  G ++ EM
Sbjct: 188 RVVTLWYRPPELL---LGERDYGPPIDLWGAGCIMAEM 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 141 LGQGGYGSVFRGKLFNGIPV-AVKMLEHLKGNGQEFINEVATIGRI-----HHFHIVRLL 194
           +G+G Y  V   +L     + A+++++    N  E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                 +R   V E++  G L   +F   +    R L  E  +  +  ++  + YLH+  
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL---MF---HMQRQRKLPEEHARFYSAEISLALNYLHE-- 171
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELF-S 312
            + I++ D+K  N+LLD     K++D+G   +C + +     T+   GT  YIAPE+   
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 313 RNFGEVSYKSDVYSYGMMLLEMVGCRKNKD 342
            ++G   +  D ++ G+++ EM+  R   D
Sbjct: 228 EDYG---FSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF--INEVATIGR-IHHFHIVRL 193
           K  LG+G +  V R      G+  A K++   K + ++F  +   A I R + H +IVRL
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFI----FSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
                E +   LV++ +  G L + I    F     +SH     + L+ IA+  + G   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQILESIAYCHSNG--- 125
Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAAR---GTA 303
                   I+H ++KP N+LL    +    K++DFGLA      I +    A     GT 
Sbjct: 126 --------IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEVNDSEAWHGFAGTP 171
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
           GY++PE+  ++    S   D+++ G++L
Sbjct: 172 GYLSPEVLKKD--PYSKPVDIWACGVIL 197

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 42/218 (19%)
Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVK--MLEHLK-GNGQEFINEVATIGRIHHFHIVRLLG 195
           ++GQG +G VF+ +    G  VA+K  ++E+ K G     + E+  +  + H ++V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 196 FCSEGTRRA--------LVYEF-------MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            C               LV++F       + +  L KF  S+             +K++ 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------------IKRVM 131
Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVSLTA 298
             +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  S  K+        
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 299 ARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEM 334
              T  Y  PEL     GE  Y    D++  G ++ EM
Sbjct: 189 RVVTLWYRPPELL---LGERDYGPPIDLWGAGCIMAEM 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     +G G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----IGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGXEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI 185
           YK+ + I  +   +LG G + +V+  K + N   VA+K++   K   +   +E+  + R+
Sbjct: 16  YKDARYILVR---KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 186 HHF-----------HIVRLLGFCS----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
           +             HI++LL   +     G    +V+E      L + + +      HR 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-----LGENLLALIKKYEHRG 127
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL------DHNFQPKISDFGLA 284
           +    +K+I+  +  G++Y+H+ C   I+H DIKP N+L+      ++  Q KI+D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 285 KLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
             C  D      T +  T  Y +PE L    +G     +D++S   ++ E++
Sbjct: 186 --CWYD---EHYTNSIQTREYRSPEVLLGAPWG---CGADIWSTACLIFELI 229

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 70/142 (49%), Gaps = 15/142 (10%)
Query: 196 FCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           FC+  T+  L  V E++  G L   I      S H+     +    A  +  G+++LH  
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHK-FDLSRATFYAAEIILGLQFLH-- 136
Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            ++ I++ D+K  NILLD +   KI+DFG+ K     +         GT  YIAPE+   
Sbjct: 137 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
              + ++  D +S+G++L EM+
Sbjct: 194 Q--KYNHSVDWWSFGVLLYEML 213

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 178 EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           E+  +  ++H +I+ LL  F  + T        LV E M + +L + I           L
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI--------QMEL 123
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
             E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+      
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 181 MMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 219

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEF--INEVATIGR-IHHFHIVRL 193
           K  LG+G +  V R      G+  A K++   K + ++F  +   A I R + H +IVRL
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFI----FSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
                E +   LV++ +  G L + I    F     +SH     + L+ IA+  + G   
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQILESIAYCHSNG--- 148
Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAAR---GTA 303
                   I+H ++KP N+LL    +    K++DFGLA      I +    A     GT 
Sbjct: 149 --------IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEVNDSEAWHGFAGTP 194
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
           GY++PE+  ++    S   D+++ G++L
Sbjct: 195 GYLSPEVLKKD--PYSKPVDIWACGVIL 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     K
Sbjct: 204 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATCK 256
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIV 294
              + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   + 
Sbjct: 257 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
           +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 314 TLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 349

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E+  + +++H  I+++  F  +     +V E M  G L    F K     ++ L     K
Sbjct: 190 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL----FDKV--VGNKRLKEATCK 242
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIV 294
              + +   V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +   + 
Sbjct: 243 LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLL 332
           +L    GT  Y+APE+   + G   Y    D +S G++L 
Sbjct: 300 TLC---GTPTYLAPEVLV-SVGTAGYNRAVDCWSLGVILF 335

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI 185
           YK+ + I  +   +LG G + +V+  K + N   VA+K++   K   +   +E+  + R+
Sbjct: 16  YKDARYILVR---KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 186 HHF-----------HIVRLLGFCS----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP 230
           +             HI++LL   +     G    +V+E      L + + +      HR 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-----LGENLLALIKKYEHRG 127
Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL------DHNFQPKISDFGLA 284
           +    +K+I+  +  G++Y+H+ C   I+H DIKP N+L+      ++  Q KI+D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 285 KLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
             C  D      T +  T  Y +PE L    +G     +D++S   ++ E++
Sbjct: 186 --CWYD---EHYTNSIQTREYRSPEVLLGAPWG---CGADIWSTACLIFELI 229

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 33/169 (19%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSH 228
           E+  +  ++H +I+ LL              F P  SLE+F         + +  +    
Sbjct: 73  ELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
               +      R    Y APE+     G + YK   D++S G+++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGVIMGEMI 219

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     +++DFGLAK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 143
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 198
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 199 -PELLV-DYQMYDYSLDMWSLGCMLASMI 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 33/169 (19%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSH 228
           E+  +  ++H +I+ LL              F P  SLE+F         + +  +    
Sbjct: 73  ELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
               +      R    Y APE+     G + YK   D++S G+++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGVIMGEMI 219

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 141 LGQGGYGSVFR--GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH------FHIVR 192
           LG+G +G V         G  VAVK+++++    +   +E+  +  ++       F  V+
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           +L +        +V+E +    L  + F K N     P   + ++K+A+ + + V +LH 
Sbjct: 82  MLEWFEHHGHICIVFELL---GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 253 GCNQRILHFDIKPHNILLDHN-----FQPKISDFGLAKLCSKDISIVSLTAAR------- 300
             + ++ H D+KP NIL   +     + PKI       L + DI +V   +A        
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKR-DERTLINPDIKVVDFGSATYDDEHHS 192
Query: 301 ---GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
               T  Y APE+     G  S   DV+S G +L+E
Sbjct: 193 TLVSTRHYRAPEVI-LALG-WSQPCDVWSIGCILIE 226

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR---NF 315
           +H DIKP NIL+D N   +++DFG      +D ++ S + A GT  YI+PE+        
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGK 255
Query: 316 GEVSYKSDVYSYGMMLLEMV 335
           G    + D +S G+ + EM+
Sbjct: 256 GRYGPECDWWSLGVCMYEML 275

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 143
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 144 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 198
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 199 -PELLV-DYQMYDYSLDMWSLGCMLASMI 225

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGXEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G  E F   +       P +    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGG--EMFSHLRRIGRFXEPHA----RFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 142
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 143 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 197
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 198 -PELLV-DYQMYDYSLDMWSLGCMLASMI 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G  E F   +       P +    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGG--EMFSHLRRIGRFXEPHA----RFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 99  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---------IRFYMYEILKAL 149
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 150 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 204
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 205 -PELLV-DYQMYDYSLDMWSLGCMLASMI 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G  E F   +       P +    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYVPGG--EMFSHLRRIGRFXEPHA----RFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 123 DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 173
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEMV 335
             SR  G    ++S KSDV+S G +L  M 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMT 261

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGF 196
           +G+G +  V R  KL  G   A K++  + L     + +   A I R+  H +IVRL   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            SE     LV++ +  G L + I ++   S                +   V + HQ    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSE------ADASHCIQQILEAVLHCHQ---M 122
Query: 257 RILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            ++H D+KP N+LL    +    K++DFGLA     D    +     GT GY++PE+  +
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRK 180
Query: 314 N-FGEVSYKSDVYSYGMML 331
             +G+     D+++ G++L
Sbjct: 181 EAYGK---PVDIWACGVIL 196

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G  E F   +       P +    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYAPGG--EMFSHLRRIGRFXEPHA----RFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 16/153 (10%)
Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H +IV+L     +     LV E +  G L    F +     H   S  +   I   +   
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKH--FSETEASYIMRKLVSA 118
Query: 247 VEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           V ++H   +  ++H D+KP N+L    + N + KI DFG A+L   D     L     T 
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTL 173
Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
            Y APEL ++N  + S   D++S G++L  M+ 
Sbjct: 174 HYAAPELLNQNGYDES--CDLWSLGVILYTMLS 204

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 79  DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 129
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 130 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEM 334
             SR  G    ++S KSDV+S G +L  M
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYM 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 76  DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 126
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 127 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEMV 335
             SR  G    ++S KSDV+S G +L  M 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMT 214

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 123 DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 173
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEMV 335
             SR  G    ++S KSDV+S G +L  M 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMT 261

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 190 IVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           I+ L     +   R  ALV+E + N   ++   + T+           ++   + + + +
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTDFKQLRQTLTDYD---------IRFYMYEILKAL 144
Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +Y H   +  I+H D+KPHN+++DH  +  ++ D+GLA+            A+R   G  
Sbjct: 145 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG-- 199
Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PEL   ++    Y  D++S G ML  M+
Sbjct: 200 -PELLV-DYQMYDYSLDMWSLGCMLASMI 226

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 95  DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 145
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 146 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEM 334
             SR  G    ++S KSDV+S G +L  M
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYM 232

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 141 LGQGGYGSVFR------GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           +G+G +  V R      G+ F    V V       G   E +   A+I   + H HIV L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 194 LGFCSEGTRRALVYEFMPNGSL---------EKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           L   S      +V+EFM    L           F++S+  +S +     E L+       
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR------- 144
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILL--DHNFQP-KISDFGLAKLCSKDISIVSLTAARG 301
               Y H   +  I+H D+KP N+LL    N  P K+ DFG+A    +  S +      G
Sbjct: 145 ----YCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE--SGLVAGGRVG 195
Query: 302 TAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMV-GC 337
           T  ++APE+  R  +G+     DV+  G++L  ++ GC
Sbjct: 196 TPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGC 230

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 205 LVYEFMPNGSLEKF---------IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           L+  F P  SLE+F         + +         L  E++  + + +  G+++LH    
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG- 148
Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             I+H D+KP NI++  +   KI DFGLA+       +V     R    Y APE+     
Sbjct: 149 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTR---YYRAPEVI---L 200
Query: 316 GEVSYKS--DVYSYGMMLLEMV 335
           G + YK   D++S G ++ EM+
Sbjct: 201 G-MGYKENVDIWSVGCIMGEMI 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 25/209 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 75  DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 125
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D + V   +  GT  Y+ PE     
Sbjct: 126 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEM 334
             SR  G    ++S KSDV+S G +L  M
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYM 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 178 EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           E+  +  ++H +I+ LL  F  + T        LV E M + +L + I           L
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI--------QMEL 123
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
             E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+      
Sbjct: 124 DHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 181 MMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 178 EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           E+  +  ++H +I+ LL  F  + T        LV E M + +L + I           L
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI--------QMEL 123
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
             E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+      
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 181 MMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 33/169 (19%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSH 228
           E+  +  ++H +I+ LL              F P  SLE+F         + +  +    
Sbjct: 73  ELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
               +      R    Y APE+     G + YK   D++S G ++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMI 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 178 EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           E+  +  ++H +I+ LL  F  + T        LV E M + +L + I           L
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVI--------QMEL 116
Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
             E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+      
Sbjct: 117 DHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 173
Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 174 MMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 24/200 (12%)
Query: 141 LGQGGYGSVFRG-KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGF 196
           LG+G +  V R  K+  G   A K++  + L     + +   A I R+  H +IVRL   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            SE     L+++ +  G L + I ++   S     +   +++I   V      LH  C+Q
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD--ASHCIQQILEAV------LH--CHQ 139
Query: 257 R-ILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
             ++H D+KP N+LL    +    K++DFGLA     +    +     GT GY++PE+  
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLR 197
Query: 313 RN-FGEVSYKSDVYSYGMML 331
           ++ +G+     D+++ G++L
Sbjct: 198 KDPYGK---PVDLWACGVIL 214

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 140 RLGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATI-----GRIHHFH 189
           +LG G + +V+     +GK F  + V VK  EH      + I  + ++        +   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKV-VKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 190 IVRLLGFCS----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           +V+LL         GT   +V+E + +  L+  I      S+++ L    +KKI   V +
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII-----KSNYQGLPLPCVKKIIQQVLQ 157
Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
           G++YLH  C  RI+H DIKP NILL  N Q
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQ 185

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 22/150 (14%)
Query: 140 RLGQGGYGSVF-----RGKLFNGIPVAVKMLEHLKGNGQEFINEVATI-----GRIHHFH 189
           +LG G + +V+     +GK F  + V VK  EH      + I  + ++        +   
Sbjct: 28  KLGWGHFSTVWLSWDIQGKKFVAMKV-VKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 86
Query: 190 IVRLLGFCS----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           +V+LL         GT   +V+E + +  L+  I      S+++ L    +KKI   V +
Sbjct: 87  VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII-----KSNYQGLPLPCVKKIIQQVLQ 141
Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
           G++YLH  C  RI+H DIKP NILL  N Q
Sbjct: 142 GLDYLHTKC--RIIHTDIKPENILLSVNEQ 169

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQ---EFINEVATIGRI--HHFHIVRLL 194
           ++G GG   VF+         A+K +   + + Q    + NE+A + ++  H   I+RL 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            +  E T +  +Y  M  G+++   + K   S      WE+ K     +   V  +HQ  
Sbjct: 95  DY--EITDQ-YIYMVMECGNIDLNSWLKKKKSID---PWER-KSYWKNMLEAVHTIHQ-- 145
Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF--- 311
              I+H D+KP N L+      K+ DFG+A     D   V   +  GT  Y+ PE     
Sbjct: 146 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 312 --SRNFG----EVSYKSDVYSYGMMLLEM 334
             SR  G    ++S KSDV+S G +L  M
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYM 232

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K    G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGF 196
           LG+G +  V R  K+  G   A K++  + L     + +   A I R+  H +IVRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            SE     LV++ +  G L + I ++   S             +  + + +E ++     
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSE---------ADASHCIQQILESVNHCHLN 122
Query: 257 RILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            I+H D+KP N+LL    +    K++DFGLA     D    +     GT GY++PE+  +
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRK 180
Query: 314 N-FGEVSYKSDVYSYGMML 331
           + +G+     D+++ G++L
Sbjct: 181 DPYGK---PVDMWACGVIL 196

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 111 EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH 167
           E FL+ +   NP + T    + ++I +     LG G +G V   K +  G   A+K+L+ 
Sbjct: 10  EDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKHMETGNHYAMKILDK 62
Query: 168 LK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
            K       +  +NE   +  ++   +V+L     + +   +V E++P G +    FS  
Sbjct: 63  QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHL 118
Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL 283
                   S    +  A  +    EYLH   +  +++ D+KP N+L+D     +++DFG 
Sbjct: 119 RRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 173
Query: 284 AKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           AK        +      GT  Y+APE + S+ + +     D ++ G+++ EM  
Sbjct: 174 AKRVKGRTWTLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAA 219

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K    G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 141 LGQGGYGSVFR-GKLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGF 196
           LG+G +  V R  K+  G   A K++  + L     + +   A I R+  H +IVRL   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
            SE     LV++ +  G L + I ++   S             +  + + +E ++     
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSE---------ADASHCIQQILESVNHCHLN 122
Query: 257 RILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
            I+H D+KP N+LL    +    K++DFGLA     D    +     GT GY++PE+  +
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPGYLSPEVLRK 180
Query: 314 N-FGEVSYKSDVYSYGMML 331
           + +G+     D+++ G++L
Sbjct: 181 DPYGK---PVDMWACGVIL 196

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGXEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   + +L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 60
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K    G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V 
Sbjct: 61  KHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVM 120
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E++P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 121 EYVPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 171
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +L+D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 223
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 224 LGVLIYEMAA 233

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 141 LGQGGYGSVFR--GKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH------FHIVR 192
           LG+G +G V         G  VAVK+++++    +   +E+  +  ++       F  V+
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           +L +        +V+E +    L  + F K N     P   + ++K+A+ + + V +LH 
Sbjct: 82  MLEWFEHHGHICIVFELL---GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLH- 135
Query: 253 GCNQRILHFDIKPHNILLDHN-----FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
             + ++ H D+KP NIL   +     + PKI       L + DI +V   +A     + +
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKR-DERTLINPDIKVVDFGSATYDDEHHS 192
Query: 308 PELFSRNF--GEV------SYKSDVYSYGMMLLE 333
             +  R++   EV      S   DV+S G +L+E
Sbjct: 193 TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIE 226

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   + +L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYAPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + +         + ++I +     LG G +G V   K 
Sbjct: 29  KGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKH 83
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
              G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 84  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 143
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N+L
Sbjct: 144 VPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLL 194
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++ G
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALG 246
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 247 VLIYEMAA 254

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 33/169 (19%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSH 228
           E+  +  ++H +I+ LL              F P  SLE+F         + +  +    
Sbjct: 73  ELVLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQ 120
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
               +      R    Y APE+     G + YK   D++S G ++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMI 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           E+A + R+ H +I+++L          LV E   +G L+ F F   +     PL+    +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFR 137
Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLT 297
           ++   V     YL     + I+H DIK  NI++  +F  K+ DFG A    +     +  
Sbjct: 138 QLVSAVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 298 AARGTAGYIAPELFSRNFGEVSYKS---DVYSYGMMLLEMV 335
              GT  Y APE+   N     Y+    +++S G+ L  +V
Sbjct: 191 ---GTIEYCAPEVLMGN----PYRGPELEMWSLGVTLYTLV 224

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 178 EVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------IFSKTNSSSH 228
           E+  +  ++H +I+ LL              F P  +LE+F         + +       
Sbjct: 73  ELVLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQ 120
Query: 229 RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS 288
             L  E++  + + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+   
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG 177
Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
               +      R    Y APE+     G + YK   D++S G ++ EMV
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVI---LG-MGYKENVDIWSVGCIMGEMV 219

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + +         + ++I +     LG G +G V   K 
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKH 63
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
              G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N+L
Sbjct: 124 VPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLL 174
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++ G
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALG 226
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 227 VLIYEMAA 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 209 FMPNGSLEKF---------IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
           F P  SLE+F         + +  +      L  E++  + + +  G+++LH      I+
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVS 319
           H D+KP NI++  +   KI DFGLA+       +      R    Y APE+     G + 
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVI---LG-MG 201
Query: 320 YKS--DVYSYGMMLLEMV 335
           YK   D++S G ++ EM+
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + +         + ++I +     LG G +G V   K 
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKH 63
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
              G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N+L
Sbjct: 124 VPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLL 174
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++ G
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALG 226
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 227 VLIYEMAA 234

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 70  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 125
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 126 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 179
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 180 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 207

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + +         + ++I +     LG G +G V   K 
Sbjct: 9   KGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKH 63
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
              G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N+L
Sbjct: 124 VPGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLL 174
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     +++DFG AK        +      GT  Y+APE + S+ + +     D ++ G
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALG 226
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 227 VLIYEMAA 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + T +       +  +I +     LG G +G V   K 
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT-----LGTGSFGRVMLVKH 62
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
             +G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +  G +    FS          S    +  A  +    EYLH   +  +++ D+KP N+L
Sbjct: 123 VAGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLL 173
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     +++DFG AK        ++     GT  Y+APE + S+ + +     D ++ G
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKA---VDWWALG 225
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 226 VLIYEMAA 233

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 109/250 (43%), Gaps = 33/250 (13%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYT--YKELKKITSKFKHRLGQGGYGSVFRG 152
           K  E E  KE   K  E FL+ +   NP + T    + ++I +     LG G +G V   
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWE--NPAQNTAHLDQFERIKT-----LGTGSFGRVMLV 61
Query: 153 K-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY 207
           K +  G   A+K+L+  K       +  +NE   +  ++   + +L     + +   +V 
Sbjct: 62  KHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVM 121
Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E+ P G  E F   +       P +    +  A  +    EYLH   +  +++ D+KP N
Sbjct: 122 EYAPGG--EMFSHLRRIGRFXEPHA----RFYAAQIVLTFEYLH---SLDLIYRDLKPEN 172
Query: 268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYS 326
           +++D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++
Sbjct: 173 LMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWA 224
Query: 327 YGMMLLEMVG 336
            G+++ EM  
Sbjct: 225 LGVLIYEMAA 234

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 71  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 126
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 127 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 180
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 181 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 208

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 78  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 133
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 134 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 187
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 188 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 215

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 122 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 177
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 178 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 231
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 232 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 259

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 171
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 172 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 225
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 226 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 253

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 105/248 (42%), Gaps = 29/248 (11%)
Query: 96  KSRESEKEKETQLKV-EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK- 153
           K  E E  KE   K  E FL+ + +         + ++I +     LG G +G V   K 
Sbjct: 9   KGSEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKT-----LGTGSFGRVMLVKH 63
Query: 154 LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
              G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E+
Sbjct: 64  KETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 123
Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
            P G +    FS          S    +  A  +    EYLH   +  +++ D+KP N++
Sbjct: 124 APGGEM----FSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLM 174
Query: 270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYG 328
           +D     K++DFG AK        +      GT  Y+APE + S+ + +     D ++ G
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALG 226
Query: 329 MMLLEMVG 336
           +++ EM  
Sbjct: 227 VLIYEMAA 234

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
           A  ++ G+ +LH+   + I++ D+K  N++LD     KI+DFG+ K    D   V+    
Sbjct: 126 AAEISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREF 180
Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
            GT  YIAPE+ +  +       D ++YG++L EM+ 
Sbjct: 181 CGTPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLA 215

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 40/74 (54%), Gaps = 3/74 (4%)
Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVS 319
           H D+KP NIL+  +    + DFG+A   + D  +  L    GT  Y APE FS +    +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYXAPERFSES--HAT 213
Query: 320 YKSDVYSYGMMLLE 333
           Y++D+Y+   +L E
Sbjct: 214 YRADIYALTCVLYE 227

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 127
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 128 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 181
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 182 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 209

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 77  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 132
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 133 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 186
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 187 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 214

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 64/138 (46%), Gaps = 21/138 (15%)
Query: 209 FMPNGSLEKF---------IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRIL 259
           F P  SLE+F         + +  +      L  E++  + + +  G+++LH      I+
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 260 HFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVS 319
           H D+KP NI++  +   KI DFGLA+       +      R    Y APE+     G + 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR---YYRAPEVI---LG-MG 201
Query: 320 YKS--DVYSYGMMLLEMV 335
           YK   D++S G ++ EM+
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 189 HIVRLLGFCSE--GTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HIVR++         R+ L  V E +  G L    FS+      +  +  +  +I   + 
Sbjct: 86  HIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIG 141
Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKDISIVSLTAARG 301
             ++YLH   +  I H D+KP N+L      N   K++DFG AK   +  S  SLT    
Sbjct: 142 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY 195
Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           T  Y+APE+      + S   D++S G+++
Sbjct: 196 TPYYVAPEVLGPEKYDKS--CDMWSLGVIM 223
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	344
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-102
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-89
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-89
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-56
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-37
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-12
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  303 bits (778), Expect = e-102
 Identities = 97/228 (42%), Positives = 138/228 (60%), Gaps = 9/228 (3%)

Query: 121 NPTRYTYKELKKITSKF--KHRLGQGGYGSVFRGKLFNGIPVAVKML--EHLKGNGQEFI 176
              R++ +EL+  +  F  K+ LG+GG+G V++G+L +G  VAVK L  E  +G   +F 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            EV  I    H +++RL GFC   T R LVY +M NGS+   +  +  S    PL W K 
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP--PLDWPKR 133

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
           ++IA G ARG+ YLH  C+ +I+H D+K  NILLD  F+  + DFGLAKL     + V+ 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT- 192

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           TA RGT G+IAPE  S   G+ S K+DV+ YG+MLLE++  ++  D A
Sbjct: 193 TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLA 238

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  269 bits (691), Expect = 1e-89
 Identities = 86/237 (36%), Positives = 127/237 (53%), Gaps = 25/237 (10%)

Query: 121 NPTRYTYKELKKITSKFKHR--------LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG 172
               +++ ELK +T+ F  R        +G+GG+G V++G + N   VAVK L  +    
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 173 -----QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSS 227
                Q+F  E+  + +  H ++V LLGF S+G    LVY +MPNGSL   +     +  
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP- 128

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
             PLSW    KIA G A G+ +LH+      +H DIK  NILLD  F  KISDFGLA+  
Sbjct: 129 --PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 288 -SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
                ++++ +   GT  Y+APE      GE++ KSD+YS+G++LLE++      D 
Sbjct: 184 EKFAQTVMT-SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDE 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  269 bits (691), Expect = 3e-89
 Identities = 85/225 (37%), Positives = 129/225 (57%), Gaps = 12/225 (5%)

Query: 124 RYTYKELKKITSKF--KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG-QEFINEVA 180
           R    +L++ T+ F  K  +G G +G V++G L +G  VA+K        G +EF  E+ 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
           T+    H H+V L+GFC E     L+Y++M NG+L++ ++          +SWE+  +I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS--DLPTMSMSWEQRLEIC 145

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC-SKDISIVSLTAA 299
            G ARG+ YLH      I+H D+K  NILLD NF PKI+DFG++K     D + +S T  
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVV 201

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           +GT GYI PE F +  G ++ KSDVYS+G++L E++  R     +
Sbjct: 202 KGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQS 244

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  210 bits (536), Expect = 5e-66
 Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 24/244 (9%)

Query: 115 EDYRTVNPTRYTYKELKKITSKFK--HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG 172
             +   +      + L   +   +      +G +G V++ +      VAVK+        
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS 62

Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEG----TRRALVYEFMPNGSLEKFIFSKTNSSSH 228
            +   EV ++  + H +I++ +G    G        L+  F   GSL  F+         
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-------KA 115

Query: 229 RPLSWEKLKKIAFGVARGVEYLHQ-------GCNQRILHFDIKPHNILLDHNFQPKISDF 281
             +SW +L  IA  +ARG+ YLH+       G    I H DIK  N+LL +N    I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 282 GLAKLCSKDISIVSLTAARGTAGYIAPELFS---RNFGEVSYKSDVYSYGMMLLEMVGCR 338
           GLA       S        GT  Y+APE+         +   + D+Y+ G++L E+    
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235

Query: 339 KNKD 342
              D
Sbjct: 236 TAAD 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (531), Expect = 2e-65
 Identities = 66/203 (32%), Positives = 114/203 (56%), Gaps = 12/203 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVR 192
             K ++G G +G+V R + ++G  VAVK+L     +     EF+ EVA + R+ H +IV 
Sbjct: 40  NIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +G  ++    ++V E++  GSL + +     S +   L   +   +A+ VA+G+ YLH 
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLL---HKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
             N  I+H ++K  N+L+D  +  K+ DFGL++L  K  + +S  +A GT  ++APE+  
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR 212

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
                 + KSDVYS+G++L E+ 
Sbjct: 213 DE--PSNEKSDVYSFGVILWELA 233

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (499), Expect = 5e-61
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG--------QEFINEVATIGRIH 186
           +++ ++G+GG+G V +G+L  +   VA+K L      G        QEF  EV  +  ++
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H +IV+L G         +V EF+P G L   +  K       P+ W    ++   +A G
Sbjct: 82  HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALG 134

Query: 247 VEYLHQGCNQRILHFDIKPHNILLD-----HNFQPKISDFGLAKLCSKDISIVSLTAARG 301
           +EY+    N  I+H D++  NI L           K++DFGL++         S++   G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLG 188

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              ++APE         + K+D YS+ M+L  ++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  195 bits (498), Expect = 1e-60
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 15/205 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           + +  +G+G +G V + K +    VA+K +E  +   + FI E+  + R++H +IV+L G
Sbjct: 11  EVEEVVGRGAFGVVCKAK-WRAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C       LV E+   GSL   +            +           ++GV YLH    
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEPLP---YYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 256 QRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
           + ++H D+KP N+LL       KI DFG A           +T  +G+A ++APE+F  +
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS 178

Query: 315 FGEVSYKSDVYSYGMMLLEMVGCRK 339
               S K DV+S+G++L E++  RK
Sbjct: 179 --NYSEKCDVFSWGIILWEVITRRK 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  187 bits (477), Expect = 7e-58
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKML-----EHLKGNGQEFINEVATIGRIHHFHI 190
             +  +G GG+G V+R   + G  VAVK       E +    +    E      + H +I
Sbjct: 10  TLEEIIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           + L G C +     LV EF   G L + +       S + +  + L   A  +ARG+ YL
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-------SGKRIPPDILVNWAVQIARGMNYL 121

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQP--------KISDFGLAKLCSKDISIVSLTAARGT 302
           H      I+H D+K  NIL+    +         KI+DFGLA+   +     +  +A G 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGA 177

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             ++APE+   +    S  SDV+SYG++L E++
Sbjct: 178 YAWMAPEVIRAS--MFSKGSDVWSYGVLLWELL 208

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (468), Expect = 2e-56
 Identities = 41/206 (19%), Positives = 85/206 (41%), Gaps = 19/206 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVR 192
            F  +L +   G +++G+ + G  + VK+L+    +    ++F  E   +    H +++ 
Sbjct: 13  NFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 193 LLGFCSE--GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +LG C         L+  +MP GSL   +   TN      +   +  K A  +ARG+ +L
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFL 127

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H      I    +   ++++D +   +IS   +                     ++APE 
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179

Query: 311 F-SRNFGEVSYKSDVYSYGMMLLEMV 335
              +        +D++S+ ++L E+V
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELV 205

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 5e-56
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVR 192
               R+G G +G+V++GK ++G  VAVKML          Q F NEV  + +  H +I+ 
Sbjct: 27  TVGQRIGSGSFGTVYKGK-WHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +G+ +   + A+V ++    SL   + +            +KL  IA   ARG++YLH 
Sbjct: 85  FMGYSTAP-QLAIVTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHA 138

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF- 311
              + I+H D+K +NI L  +   KI DFGLA   S+           G+  ++APE+  
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
            ++    S++SDVY++G++L E++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELM 219

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (458), Expect = 2e-54
 Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRL 193
           K    +G+G YG+V++G L +  PVAVK+      N Q FINE  +  +  + H +I R 
Sbjct: 16  KLLELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 194 LGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +      T        LV E+ PNGSL K++   T         W    ++A  V RG+ 
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLA 125

Query: 249 YLHQ------GCNQRILHFDIKPHNILLDHNFQPKISDFGLAK------LCSKDISIVSL 296
           YLH            I H D+   N+L+ ++    ISDFGL+       L        + 
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 297 TAARGTAGYIAPELFS-----RNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
            +  GT  Y+APE+       R+      + D+Y+ G++  E+     +  P
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  178 bits (454), Expect = 6e-54
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 25/222 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQ-EFINEVATIGRIHHFHIVRL 193
                LG+G +G   +      G  + +K L       Q  F+ EV  +  + H ++++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G   +  R   + E++  G+L   I S           W +    A  +A G+ YLH  
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAYLHS- 126

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKL------------CSKDISIVSLTAARG 301
               I+H D+  HN L+  N    ++DFGLA+L              K           G
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
              ++APE+   N      K DV+S+G++L E++G R N DP
Sbjct: 185 NPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIG-RVNADP 223

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  178 bits (453), Expect = 9e-54
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVR 192
           +    +G+G +G V+ G+ ++G  VA+++++  + N    + F  EV    +  H ++V 
Sbjct: 36  EIGELIGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +G C      A++       +L   +           L   K ++IA  + +G+ YLH 
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHA 148

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL---CSKDISIVSLTAARGTAGYIAPE 309
              + ILH D+K  N+  D+  +  I+DFGL  +            L    G   ++APE
Sbjct: 149 ---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 310 LFSRNFGEV-------SYKSDVYSYGMMLLEMV 335
           +  +   +        S  SDV++ G +  E+ 
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 8e-51
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 27/217 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRL 193
           +   ++G+G YG V+ GK + G  VAVK+          +  E  +     + H +I+  
Sbjct: 40  QMVKQIGKGRYGEVWMGK-WRGEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENILGF 96

Query: 194 LGFCSEGTRR----ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           +    +GT       L+ ++  NGSL  ++           L  + + K+A+    G+ +
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL-------KSTTLDAKSMLKLAYSSVSGLCH 149

Query: 250 LH-----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TAARGT 302
           LH           I H D+K  NIL+  N    I+D GLA     D + V +      GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 303 AGYIAPELF----SRNFGEVSYKSDVYSYGMMLLEMV 335
             Y+ PE+     +RN  +    +D+YS+G++L E+ 
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (429), Expect = 2e-50
 Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 32/229 (13%)

Query: 124 RYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINE--VAT 181
           R   +++          +G+G YG V+RG  + G  VAVK+      + + +  E  +  
Sbjct: 4   RTVARDIT-----LLECVGKGRYGEVWRGS-WQGENVAVKIF--SSRDEKSWFRETELYN 55

Query: 182 IGRIHHFHIVRLLGFCSEG----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
              + H +I+  +          T+  L+  +   GSL  ++           L      
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-------QLTTLDTVSCL 108

Query: 238 KIAFGVARGVEYLH-----QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
           +I   +A G+ +LH           I H D+K  NIL+  N Q  I+D GLA + S+  +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 293 IVSL--TAARGTAGYIAPELF--SRNFGEVSY--KSDVYSYGMMLLEMV 335
            + +      GT  Y+APE+   +          + D++++G++L E+ 
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  169 bits (430), Expect = 4e-50
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINE--VATIGRIHHFHIVRL 193
             +  +G+G +G V+RGK + G  VAVK+        + +  E  +     + H +I+  
Sbjct: 45  VLQESIGKGRFGEVWRGK-WRGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGF 101

Query: 194 LGFC----SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           +          T+  LV ++  +GSL  ++       +   ++ E + K+A   A G+ +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAH 154

Query: 250 LHQ-----GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL--TAARGT 302
           LH           I H D+K  NIL+  N    I+D GLA         + +      GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 303 AGYIAPELF--SRNFGEVSY--KSDVYSYGMMLLEMV 335
             Y+APE+   S N        ++D+Y+ G++  E+ 
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  144 bits (366), Expect = 3e-40
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
               ++G+G +G VF G+L  +   VAVK            +F+ E   + +  H +IVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L+G C++     +V E +  G    F+  +T       L  + L ++    A G+EYL  
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL--RTEG---ARLRVKTLLQMVGDAAAGMEYLES 231

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI-----A 307
              +  +H D+   N L+      KISDFG+++  +  +       A G    +     A
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTA 283

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE    N+G  S +SDV+S+G++L E  
Sbjct: 284 PEAL--NYGRYSSESDVWSFGILLWETF 309

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  141 bits (358), Expect = 7e-40
 Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 29/233 (12%)

Query: 119 TVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKML--EHL 168
                  T       +K   K    LG+G +G V   +        G  VAVK L  E  
Sbjct: 4   VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63

Query: 169 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSS 226
             +  +   E+  +  ++H +IV+  G C+E       L+ EF+P+GSL++++       
Sbjct: 64  GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL------P 117

Query: 227 SHRP-LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
            ++  ++ ++  K A  + +G++YL     ++ +H D+   N+L++   Q KI DFGL K
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

Query: 286 LCSKDISIVSLTAARGTAGYI---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               D      T        +   APE       +    SDV+S+G+ L E++
Sbjct: 175 AIETDKEYY--TVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTLHELL 223

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 4e-39
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
                LG G +G V  GK      VAVKM++    +  EF  E  T+ ++ H  +V+  G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARGVEYLHQGC 254
            CS+     +V E++ NG L  ++       SH   L   +L ++ + V  G+ +L    
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL------RSHGKGLEPSQLLEMCYDVCEGMAFLES-- 122

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELF 311
             + +H D+   N L+D +   K+SDFG+ +    D       ++ GT   +   APE  
Sbjct: 123 -HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPE-- 175

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
             ++ + S KSDV+++G+++ E+ 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVF 199

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (353), Expect = 6e-39
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 20/222 (9%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG-----IPVAVKML--EHLKGNGQE 174
           P +   + LK+   K    LG G +G+V++G          IPVA+K L         +E
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSW 233
            ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++        H+  +  
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV------REHKDNIGS 116

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
           + L      +A+G+ YL     +R++H D+   N+L+      KI+DFGLAKL   +   
Sbjct: 117 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                 +    ++A E  S      +++SDV+SYG+ + E++
Sbjct: 174 YHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELM 213

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (351), Expect = 7e-39
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKML-EHLKGNGQEFINEVATIGRIHHFH 189
           KF  +LG+G +GSV   +        G  VAVK L    + + ++F  E+  +  + H +
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 190 IVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARG 246
           IV+  G C    RR   L+ E++P GSL  ++        H+  +   KL +    + +G
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKG 126

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +EYL     +R +H D+   NIL+++  + KI DFGL K+  +D               I
Sbjct: 127 MEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF--KVKEPGESPI 181

Query: 307 ---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              APE  S    + S  SDV+S+G++L E+ 
Sbjct: 182 FWYAPE--SLTESKFSVASDVWSFGVVLYELF 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (349), Expect = 1e-38
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARGVEYLHQGC 254
            C++     ++ E+M NG L  ++         R     ++L ++   V   +EYL    
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLLEMCKDVCEAMEYLES-- 138

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELF 311
            ++ LH D+   N L++     K+SDFGL++    D      T++ G+   +    PE  
Sbjct: 139 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPE-- 191

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
              + + S KSD++++G+++ E+ 
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIY 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  137 bits (347), Expect = 1e-38
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C E     LV EFM +G L  ++  +T        + E L  +   V  G+ YL +   
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYL--RTQRGL---FAAETLLGMCLDVCEGMAYLEE--- 122

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELFS 312
             ++H D+   N L+  N   K+SDFG+ +    D      T++ GT   +   +PE   
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPE--V 176

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
            +F   S KSDV+S+G+++ E+ 
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVF 199

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (359), Expect = 2e-38
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           E+++     KH+LG G YG V+ G      + VAVK L+      +EF+ E A +  I H
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 275

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L  +A  ++  +
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAM 331

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYL +   +  +H ++   N L+  N   K++DFGL++L + D        A+    + A
Sbjct: 332 EYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTA 387

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE     + + S KSDV+++G++L E+ 
Sbjct: 388 PESL--AYNKFSIKSDVWAFGVLLWEIA 413

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  138 bits (350), Expect = 2e-38
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKMLEHLKGNGQ-EFINEVATIGRIHHFH 189
           K+  +LG+G +GSV   +        G  VAVK L+H   + Q +F  E+  +  +H   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 190 IVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARG 246
           IV+  G      R++  LV E++P+G L  F+        HR  L   +L   +  + +G
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLLYSSQICKG 139

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +EYL     +R +H D+   NIL++     KI+DFGLAKL   D               I
Sbjct: 140 MEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY--VVREPGQSPI 194

Query: 307 ---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              APE  S +    S +SDV+S+G++L E+ 
Sbjct: 195 FWYAPE--SLSDNIFSRQSDVWSFGVVLYELF 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  138 bits (349), Expect = 2e-38
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 30/214 (14%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN-----GIPVAVKML--EHLKGNGQEFINEVATIGRIHHF 188
           K    LG+G +G V            G  VAVK L  +    +   +  E+  +  ++H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 189 HIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           HI++  G C +    +  LV E++P GSL  ++        H  +   +L   A  +  G
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHS-IGLAQLLLFAQQICEG 146

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           + YLH    Q  +H D+   N+LLD++   KI DFGLAK   +      +       G  
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----EDGDS 199

Query: 307 -----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                APE       +  Y SDV+S+G+ L E++
Sbjct: 200 PVFWYAPE--CLKEYKFYYASDVWSFGVTLYELL 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (349), Expect = 2e-38
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLF-----NGIPVAVKML-EHLKGNGQEFINEVATIGRIHHFH 189
           KF  +LG+G +GSV   +        G  VAVK L    + + ++F  E+  +  + H +
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 190 IVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARG 246
           IV+  G C    RR   L+ E++P GSL  ++        H+  +   KL +    + +G
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL------QKHKERIDHIKLLQYTSQICKG 157

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           +EYL     +R +H D+   NIL+++  + KI DFGL K+  +D               I
Sbjct: 158 MEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY--KVKEPGESPI 212

Query: 307 ---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              APE  S    + S  SDV+S+G++L E+ 
Sbjct: 213 FWYAPE--SLTESKFSVASDVWSFGVVLYELF 242

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (354), Expect = 4e-38
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 17/218 (7%)

Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVA 180
            P      E+ + + K + +LG G +G V+         VAVK ++    + + F+ E  
Sbjct: 176 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEAN 235

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +  + H  +V+L    ++     ++ EFM  GSL  F+     S         KL   +
Sbjct: 236 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFS 290

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             +A G+ ++ Q   +  +H D++  NIL+  +   KI+DFGLA++   +      TA  
Sbjct: 291 AQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTARE 343

Query: 301 GTAGYI---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           G    I   APE  + NFG  + KSDV+S+G++L+E+V
Sbjct: 344 GAKFPIKWTAPE--AINFGSFTIKSDVWSFGILLMEIV 379

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  135 bits (343), Expect = 5e-38
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 17/203 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H  +VRL  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             ++     ++ E+M NGSL  F+     + S   L+  KL  +A  +A G+ ++ +   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELFS 312
           +  +H D++  NIL+      KI+DFGLA+L   +      TA  G    I   APE  +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTAPE--A 181

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
            N+G  + KSDV+S+G++L E+V
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIV 204

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (340), Expect = 2e-37
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVK---MLEHLKGNGQEFINEVATIGRIHHFHIV 191
           KF   +G+G + +V++G      + VA       +  K   Q F  E   +  + H +IV
Sbjct: 29  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88

Query: 192 RLLGFCSEGTRRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           R         +      LV E M +G+L+ ++         + +  + L+     + +G+
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYL------KRFKVMKIKVLRSWCRQILKGL 142

Query: 248 EYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           ++LH      I+H D+K  NI +       KI D GLA L           A  GT  ++
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFM 197

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE++   + E     DVY++GM +LEM 
Sbjct: 198 APEMYEEKYDE---SVDVYAFGMCMLEMA 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  135 bits (342), Expect = 2e-37
 Identities = 61/216 (28%), Positives = 111/216 (51%), Gaps = 20/216 (9%)

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF-----NGIPVAVKML--EHLKGNGQEFINEVA 180
           +  K+   +    LG G +G+V +G          IPV +K++  +  + + Q   + + 
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKI 239
            IG + H HIVRLLG C   + + LV +++P GSL   +        HR  L  + L   
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHV------RQHRGALGPQLLLNW 120

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
              +A+G+ YL +     ++H ++   N+LL    Q +++DFG+A L   D   +  + A
Sbjct: 121 GVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +    ++A E  S +FG+ +++SDV+SYG+ + E++
Sbjct: 178 KTPIKWMALE--SIHFGKYTHQSDVWSYGVTVWELM 211

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 3e-37
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 18/221 (8%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG-----IPVAVKML--EHLKGNGQE 174
           P +   + LK+   K    LG G +G+V++G          IPVA+K L         +E
Sbjct: 4   PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
            ++E   +  + + H+ RLLG C   T + L+ + MP G L  ++    ++     +  +
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-----IGSQ 117

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L      +A+G+ YL     +R++H D+   N+L+      KI+DFGLAKL   +    
Sbjct: 118 YLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                +    ++A E  S      +++SDV+SYG+ + E++
Sbjct: 175 HAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVWELM 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (339), Expect = 3e-37
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG-IPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
             KH+LG G YG V+ G      + VAVK L+      +EF+ E A +  I H ++V+LL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G C+      ++ EFM  G+L  ++       + + +S   L  +A  ++  +EYL +  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK-- 129

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELF 311
            +  +H D+   N L+  N   K++DFGL++L + D      TA  G    I   APE  
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPE-- 182

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
           S  + + S KSDV+++G++L E+ 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIA 206

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (347), Expect = 5e-37
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 239

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+       + + L   +L  +A  +A G+ 
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMA 294

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L   +        A+    + AP
Sbjct: 295 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAP 350

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E     +G  + KSDV+S+G++L E+ 
Sbjct: 351 EAA--LYGRFTIKSDVWSFGILLTELT 375

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  134 bits (340), Expect = 5e-37
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
                LGQG +G V+ G             VA+K +          EF+NE + +   + 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----TNSSSHRPLSWEKLKKIAFGV 243
            H+VRLLG  S+G    ++ E M  G L+ ++ S      N+    P S  K+ ++A  +
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSLTAARGT 302
           A G+ YL+     + +H D+   N ++  +F  KI DFG+   +   D         +G 
Sbjct: 148 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------YRKGG 198

Query: 303 AGYI-----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            G +     +PE  S   G  +  SDV+S+G++L E+ 
Sbjct: 199 KGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  134 bits (339), Expect = 7e-37
 Identities = 69/242 (28%), Positives = 106/242 (43%), Gaps = 36/242 (14%)

Query: 119 TVNPTRYTYKELKKITS---KFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHL 168
             NP  ++   +  I       K  LG+G +G VF  +  N +P      VAVK L E  
Sbjct: 24  IENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS 83

Query: 169 KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---------I 219
           +   Q+F  E   +  + H HIVR  G C+EG    +V+E+M +G L +F         +
Sbjct: 84  ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143

Query: 220 FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 279
            +     +  PL   +L  +A  VA G+ YL        +H D+   N L+      KI 
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200

Query: 280 DFGLAKLCSKDISIVSLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYSYGMMLLE 333
           DFG+    S+DI         G    +      PE +  R F   + +SDV+S+G++L E
Sbjct: 201 DFGM----SRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKF---TTESDVWSFGVVLWE 252

Query: 334 MV 335
           + 
Sbjct: 253 IF 254

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (348), Expect = 9e-37
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           E+ + + + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 322

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            +V+L    SE     +V E+M  GSL  F+       + + L   +L  +A  +A G+ 
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQIASGMA 377

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Y+ +      +H D++  NIL+  N   K++DFGLA+L   +        A+    + AP
Sbjct: 378 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAP 433

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E     +G  + KSDV+S+G++L E+ 
Sbjct: 434 EAA--LYGRFTIKSDVWSFGILLTELT 458

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (337), Expect = 1e-36
 Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 37/249 (14%)

Query: 110 VEKFLEDYRT-VNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG---IPVAVKML 165
           ++K    +    NP    Y  L     KF+  +G+G +G V + ++      +  A+K +
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 166 --EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF---- 218
                K + ++F  E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F    
Sbjct: 61  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120

Query: 219 ------IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH 272
                       +S+   LS ++L   A  VARG++YL Q   ++ +H D+   NIL+  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 177

Query: 273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYS 326
           N+  KI+DFGL++   +++        + T G +     A E L    +   +  SDV+S
Sbjct: 178 NYVAKIADFGLSR--GQEV------YVKKTMGRLPVRWMAIESLNYSVY---TTNSDVWS 226

Query: 327 YGMMLLEMV 335
           YG++L E+V
Sbjct: 227 YGVLLWEIV 235

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (337), Expect = 1e-36
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKML--EHLKGNGQEFINEVAT 181
           +E++      +  +G G  G V  G+L       +PVA+K L   + +   ++F++E + 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+RL G  + G    +V E+M NGSL+ F+      +     +  +L  +  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLR 158

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
           GV  G+ YL        +H D+   N+L+D N   K+SDFGL+++   D       A   
Sbjct: 159 GVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTT 211

Query: 302 TAGYI-----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T G I     APE  +  F   S  SDV+S+G+++ E++
Sbjct: 212 TGGKIPIRWTAPE--AIAFRTFSSASDVWSFGVVMWEVL 248

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (335), Expect = 2e-36
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 25/216 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG----IPVAVKML---EHLKGNGQEFINEVATIGRIHHF 188
                LG+G +GSV  G L       + VAVK +      +   +EF++E A +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 189 HIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           +++RLLG C E + +      ++  FM  G L  ++      +  + +  + L K    +
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           A G+EYL     +  LH D+   N +L  +    ++DFGL+    K I           A
Sbjct: 157 ALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLS----KKIYSGDYYRQGRIA 209

Query: 304 G----YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                +IA E  S      + KSDV+++G+ + E+ 
Sbjct: 210 KMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIA 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 3e-36
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG----IPVAVKML---EHLKGNGQEFINEVATIGRIHHF 188
                LG+G +GSV   +L       + VAVKML        + +EF+ E A +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 189 HIVRLLGFCSEGTRRA------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
           H+ +L+G       +       ++  FM +G L  F+ +     +   L  + L +    
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +A G+EYL     +  +H D+   N +L  +    ++DFGL+    + I           
Sbjct: 146 IACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS----RKIYSGDYYRQGCA 198

Query: 303 AGY----IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +      +A E  S      +  SDV+++G+ + E++
Sbjct: 199 SKLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEIM 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (333), Expect = 3e-36
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 132 KITSKFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVATIGRI 185
           ++ +     +G+G +G V+ G+  +     I  A+K L         + F+ E   +  +
Sbjct: 20  RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79

Query: 186 HHFHIVRLLGFCSEGTRRAL-VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +H +++ L+G           +  +M +G L +FI      S  R  + + L      VA
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-----RSPQRNPTVKDLISFGLQVA 134

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
           RG+EYL +   Q+ +H D+   N +LD +F  K++DFGLA    +DI      + +    
Sbjct: 135 RGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLA----RDILDREYYSVQQHRH 187

Query: 305 ------YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                 + A E  S      + KSDV+S+G++L E++
Sbjct: 188 ARLPVKWTALE--SLQTYRFTTKSDVWSFGVLLWELL 222

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  132 bits (334), Expect = 3e-36
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNG-----IPVAVKML--EHLKGNGQEFINEVA 180
            E+       +  +G G +G V++G L        +PVA+K L   + +    +F+ E  
Sbjct: 39  TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKI 239
            +G+  H +I+RL G  S+     ++ E+M NG+L+KF+             S  +L  +
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL------REKDGEFSVLQLVGM 152

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
             G+A G++YL        +H D+   NIL++ N   K+SDFGL+++   D         
Sbjct: 153 LRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT--YTT 207

Query: 300 RGTAGYI---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            G    I   APE  + ++ + +  SDV+S+G+++ E++
Sbjct: 208 SGGKIPIRWTAPE--AISYRKFTSASDVWSFGIVMWEVM 244

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (335), Expect = 5e-36
 Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVAT 181
           KEL          +G G +G V  G+L       I VA+K L   + +   ++F+ E + 
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           +G+  H +I+RL G  ++     +V E+M NGSL+ F+  + + +     +  +L  +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQ---FTVIQLVGMLR 154

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
           G+A G++YL        +H D+   NIL++ N   K+SDFGL ++   D         RG
Sbjct: 155 GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRG 209

Query: 302 TAGYI---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               I   +PE  +  + + +  SDV+SYG++L E++
Sbjct: 210 GKIPIRWTSPE--AIAYRKFTSASDVWSYGIVLWEVM 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  132 bits (335), Expect = 5e-36
 Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 71  SISLISTGTSIGGIVLFALVIFLIYKSRESEK---EKETQLKVEKFLEDYRTVNPTRYTY 127
            I +      + GI     +   +YK   SE    +    + ++    +   V   ++  
Sbjct: 24  GILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVV 83

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVAT 181
                +   F   +G+G +G V+ G L +     I  AVK L      G   +F+ E   
Sbjct: 84  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 143

Query: 182 IGRIHHFHIVRLLGFCSEGTR-RALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKI 239
           +    H +++ LLG C        +V  +M +G L  FI       +     + + L   
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKDLIGF 197

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
              VA+G+++L     ++ +H D+   N +LD  F  K++DFGL    ++D+      + 
Sbjct: 198 GLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEFDSV 250

Query: 300 RGTAG------YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               G      ++A E  S    + + KSDV+S+G++L E++
Sbjct: 251 HNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELM 290

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (331), Expect = 6e-36
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIP------VAVKML-EHLKGNGQEFINEVATIGRIHHF 188
             K  LG+G +G VF  + +N  P      VAVK L +      ++F  E   +  + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWEKLKK 238
           HIV+  G C +G    +V+E+M +G L KF          +       +   L   ++  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
           IA  +A G+ YL     Q  +H D+   N L+  N   KI DFG++    +D+       
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMS----RDVYSTDYYR 190

Query: 299 ARGTAGY----IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             G        + PE  S  + + + +SDV+S+G++L E+ 
Sbjct: 191 VGGHTMLPIRWMPPE--SIMYRKFTTESDVWSFGVILWEIF 229

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 6e-36
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 138 KHRLGQGGYGSVFRGKLFNG---IPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
              LG G +GSV +G        I VA+K+L     K + +E + E   + ++ + +IVR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           L+G C       LV E    G L KF+           +    + ++   V+ G++YL +
Sbjct: 75  LIGVCQAEALM-LVMEMAGGGPLHKFL--VGKREE---IPVSNVAELLHQVSMGMKYLEE 128

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APE 309
              +  +H D+   N+LL +    KISDFGL+K    D S    TA       +   APE
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY--TARSAGKWPLKWYAPE 183

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMV 335
               NF + S +SDV+SYG+ + E +
Sbjct: 184 --CINFRKFSSRSDVWSYGVTMWEAL 207

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (330), Expect = 8e-36
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 29/222 (13%)

Query: 128 KELKKITSKFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVAT 181
                +   F   +G+G +G V+ G L +     I  AVK L      G   +F+ E   
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79

Query: 182 IGRIHHFHIVRLLGFCSEGTRRAL-VYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKI 239
           +    H +++ LLG C       L V  +M +G L  FI       +     + + L   
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKDLIGF 133

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
              VA+G++YL     ++ +H D+   N +LD  F  K++DFGL    ++D+      + 
Sbjct: 134 GLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGL----ARDMYDKEYYSV 186

Query: 300 RGTAG------YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               G      ++A E  S    + + KSDV+S+G++L E++
Sbjct: 187 HNKTGAKLPVKWMALE--SLQTQKFTTKSDVWSFGVLLWELM 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (328), Expect = 1e-35
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 26/210 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVATIGRIHHFH 189
           +    +G+G +G V +G   +     + VA+K           ++F+ E  T+ +  H H
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRP-LSWEKLKKIAFGVARGVE 248
           IV+L+G  +E     ++ E    G L  F+         +  L    L   A+ ++  + 
Sbjct: 78  IVKLIGVITENP-VWIIMELCTLGELRSFL------QVRKYSLDLASLILYAYQLSTALA 130

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI-- 306
           YL     +R +H DI   N+L+  N   K+ DFGL++         +   A      I  
Sbjct: 131 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKW 183

Query: 307 -APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            APE  S NF   +  SDV+ +G+ + E++
Sbjct: 184 MAPE--SINFRRFTSASDVWMFGVCMWEIL 211

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 1e-35
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 35/226 (15%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           +    LGQG +G V + +   +    A+K + H +      ++EV  +  ++H ++VR  
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 195 GFCSEGTRRA-------------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
               E                  +  E+  NG+L   I    N +  R   W   ++I  
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWRLFRQIL- 126

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS------ 295
                + Y+H    Q I+H D+KP NI +D +   KI DFGLAK   + + I+       
Sbjct: 127 ---EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 296 ------LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                 LT+A GTA Y+A E+     G  + K D+YS G++  EM+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMI 225

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (327), Expect = 1e-35
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG----IPVAVKML--EHLKGNGQEFINEVATIGRIHHFH 189
                LG+G +G V+ G   N     I VAVK    +    N ++F++E   +  + H H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           IV+L+G   E     ++ E  P G L  ++    NS     L    L   +  + + + Y
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAY 128

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI--- 306
           L        +H DI   NIL+      K+ DFGL++    +        A  T   I   
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM 181

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +PE  S NF   +  SDV+ + + + E++
Sbjct: 182 SPE--SINFRRFTTASDVWMFAVCMWEIL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (327), Expect = 1e-35
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRL 193
           K    +G+G +G V  G    G  VAVK +   K +   Q F+ E + + ++ H ++V+L
Sbjct: 24  KLLQTIGKGEFGDVMLGDY-RGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 194 LGFCSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           LG   E      +V E+M  GSL  ++     S     L  + L K +  V   +EYL  
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APE 309
                 +H D+   N+L+  +   K+SDFGL     K+ S    +        +   APE
Sbjct: 136 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEAS----STQDTGKLPVKWTAPE 184

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +    + S KSDV+S+G++L E+ 
Sbjct: 185 --ALREKKFSTKSDVWSFGILLWEIY 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (325), Expect = 3e-35
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 24/218 (11%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKL----FNGIPVAVKML----EHLKGNGQEFINEVA 180
            + +   +   +LG G +G V RG+        + VAVK L            +FI EV 
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
            +  + H +++RL G       + +V E  P GSL   +  + +           L + A
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRL--RKHQGH---FLLGTLSRYA 127

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             VA G+ YL     +R +H D+   N+LL      KI DFGL +   ++          
Sbjct: 128 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQE 182

Query: 301 GTAGYI---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                    APE  S      S+ SD + +G+ L EM 
Sbjct: 183 HRKVPFAWCAPE--SLKTRTFSHASDTWMFGVTLWEMF 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (333), Expect = 4e-35
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIH 186
            L     K    +G+G +G V  G  + G  VAVK +   K +   Q F+ E + + ++ 
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 244

Query: 187 HFHIVRLLGFCSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           H ++V+LLG   E      +V E+M  GSL  ++     S     L  + L K +  V  
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCE 300

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
            +EYL        +H D+   N+L+  +   K+SDFGL     K+ S    +        
Sbjct: 301 AMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT----KEAS----STQDTGKLP 349

Query: 306 I---APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +   APE  +    + S KSDV+S+G++L E+ 
Sbjct: 350 VKWTAPE--ALREKKFSTKSDVWSFGILLWEIY 380

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (326), Expect = 6e-35
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
                LG G +G V+ G++         + VAVK L     + +  +F+ E   I + +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSH-RPLSWEKLKKIAFGVARG 246
            +IVR +G   +   R ++ E M  G L+ F+       S    L+   L  +A  +A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 247 VEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
            +YL +      +H DI   N LL         KI DFG+A    +DI   S    +G  
Sbjct: 153 CQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYY-RKGGC 204

Query: 304 GYI-----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +      PE  +   G  + K+D +S+G++L E+ 
Sbjct: 205 AMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIF 239

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (323), Expect = 7e-35
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 35/224 (15%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
           +F   LG+  +G V++G LF          VA+K L  +      +EF +E     R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWEKLK 237
            ++V LLG  ++    ++++ +  +G L +F            +  + +    L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISIVSL 296
            +   +A G+EYL       ++H D+   N+L+      KISD GL  ++ + D      
Sbjct: 132 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD------ 182

Query: 297 TAARGTAGYI-----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                    +     APE  +  +G+ S  SD++SYG++L E+ 
Sbjct: 183 YYKLLGNSLLPIRWMAPE--AIMYGKFSIDSDIWSYGVVLWEVF 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  128 bits (323), Expect = 7e-35
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 140 RLGQGGYGSVFRGKLFNG---IPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIVRL 193
            LG G +G+V +G          VAVK+L++         E + E   + ++ + +IVR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G C   +   LV E    G L K++        +R +  + + ++   V+ G++YL + 
Sbjct: 84  IGICEAESWM-LVMEMAELGPLNKYL------QQNRHVKDKNIIELVHQVSMGMKYLEE- 135

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APEL 310
                +H D+   N+LL      KISDFGL+K    D +     A       +   APE 
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY--KAQTHGKWPVKWYAPE- 190

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
              N+ + S KSDV+S+G+++ E  
Sbjct: 191 -CINYYKFSSKSDVWSFGVLMWEAF 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (325), Expect = 8e-35
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 24/218 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKML--EHLKGNGQEFINEVATIGRI-H 186
           +F   LG G +G V     F        + VAVKML         +  ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF--------IFSKTNSSSHRPLSWEKLKK 238
           H +IV LLG C+ G    ++ E+   G L  F              + ++   S   L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
            +  VA+G+ +L     +  +H D+   N+LL +    KI DFGLA+    D + +    
Sbjct: 169 FSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 299 ARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           AR    ++APE +F   +   + +SDV+SYG++L E+ 
Sbjct: 226 ARLPVKWMAPESIFDCVY---TVQSDVWSYGILLWEIF 260

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  128 bits (323), Expect = 2e-34
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
                LG G +G V+ G++         + VAVK L     + +  +F+ E   I + +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI-FSKTNSSSHRPLSWEKLKKIAFGVARG 246
            +IVR +G   +   R ++ E M  G L+ F+  ++   S    L+   L  +A  +A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 247 VEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
            +YL +      +H DI   N LL         KI DFG+A    +DI        +G  
Sbjct: 194 CQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRAGYY-RKGGC 245

Query: 304 GYI-----APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             +      PE  +   G  + K+D +S+G++L E+ 
Sbjct: 246 AMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEIF 280

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (318), Expect = 5e-34
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 26/221 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKML--EHLKGNGQEFINEVATIGRI-H 186
            F   LG G +G V     +        + VAVKML         +  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF------------IFSKTNSSSHRPLSWE 234
           H +IV LLG C+ G    ++ E+   G L  F                        L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   ++ VA+G+ +L     +  +H D+   NILL H    KI DFGLA+    D + V
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
               AR    ++APE  S      +++SDV+SYG+ L E+ 
Sbjct: 203 VKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELF 241

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  130 bits (329), Expect = 6e-34
 Identities = 56/235 (23%), Positives = 105/235 (44%), Gaps = 27/235 (11%)

Query: 115 EDYRTVNPTRYTY-------KELKKITSKFKHRLGQGGYGSVFRGKLFNG----IPVAVK 163
           +DY  +     TY        E+++   +    +G+G +G V +G   +     + VA+K
Sbjct: 365 DDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424

Query: 164 ML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS 221
                      ++F+ E  T+ +  H HIV+L+G  +E     ++ E    G L  F+  
Sbjct: 425 TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-- 481

Query: 222 KTNSSSHRP-LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
                  +  L    L   A+ ++  + YL     +R +H DI   N+L+  N   K+ D
Sbjct: 482 ----QVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGD 534

Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           FGL++   +D +    +  +    ++APE  S NF   +  SDV+ +G+ + E++
Sbjct: 535 FGLSRYM-EDSTYYKASKGKLPIKWMAPE--SINFRRFTSASDVWMFGVCMWEIL 586

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  125 bits (317), Expect = 7e-34
 Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 35/239 (14%)

Query: 111 EKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKM--LEHL 168
           E       +V    Y+  +           +G GG   VF+         A+K   LE  
Sbjct: 16  ENLYFQSMSVKGRIYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65

Query: 169 KGNGQE-FINEVATIGRI--HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNS 225
                + + NE+A + ++  H   I+RL  +        +V E   N  L  ++      
Sbjct: 66  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL------ 118

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
              + +   + K     +   V  +HQ     I+H D+KP N L+      K+ DFG+A 
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIAN 174

Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGE---------VSYKSDVYSYGMMLLEMV 335
               D + V   +  GT  Y+ PE                 +S KSDV+S G +L  M 
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 8e-34
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQ---EFINEVATIGRIHHFHIVRLL 194
           +LG GG  +V+  +     I VA+K +    +   +    F  EV    ++ H +IV ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
               E     LV E++   +L ++I       SH PLS +        +  G+++ H   
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI------ESHGPLSVDTAINFTNQILDGIKHAHD-- 129

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
             RI+H DIKP NIL+D N   KI DFG+AK  S + S+       GT  Y +PE     
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG- 186

Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
                  +D+YS G++L EM+
Sbjct: 187 -EATDECTDIYSIGIVLYEML 206

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  126 bits (319), Expect = 8e-34
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIP------VAVKML--EHLKGNGQEFINEVATIGRIHH 187
           ++   +G+G +G VF+ +    +P      VAVKML  E       +F  E A +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKF------------------IFSKTNSSSHR 229
            +IV+LLG C+ G    L++E+M  G L +F                    ++ +S    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCS 288
           PLS  +   IA  VA G+ YL +   ++ +H D+   N L+  N   KI+DFGL+  + S
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 289 KDISIVSLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
            D               I      PE +F   +   + +SDV++YG++L E+ 
Sbjct: 227 ADY------YKADGNDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEIF 270

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  126 bits (318), Expect = 9e-34
 Identities = 54/231 (23%), Positives = 89/231 (38%), Gaps = 35/231 (15%)

Query: 119 TVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKM--LEHLKGNGQE-F 175
           +V    Y+  +           +G GG   VF+         A+K   LE       + +
Sbjct: 5   SVKGRIYSILKQ----------IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 54

Query: 176 INEVATIGRI--HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
            NE+A + ++  H   I+RL  +        +V E   N  L  ++         + +  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDP 107

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            + K     +   V  +HQ     I+H D+KP N L+      K+ DFG+A     D + 
Sbjct: 108 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 163

Query: 294 VSLTAARGTAGYIAPELFSR---------NFGEVSYKSDVYSYGMMLLEMV 335
           V   +  GT  Y+ PE             +  ++S KSDV+S G +L  M 
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 1e-33
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 24/215 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVR 192
                LGQG   +VFRG+    G   A+K+             + E   + +++H +IV+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 193 LLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           L     E T R   L+ EF P GSL   +   +N+     L   +   +   V  G+ +L
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHL 128

Query: 251 HQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
            +     I+H +IKP NI+     D     K++DFG A+    D       +  GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYL 182

Query: 307 APELFSRNFGEVSY------KSDVYSYGMMLLEMV 335
            P+++ R      +        D++S G+      
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  125 bits (316), Expect = 1e-33
 Identities = 60/232 (25%), Positives = 107/232 (46%), Gaps = 43/232 (18%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
                LG+G +G V +   F+         VAVKML         ++ ++E   + +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKF------------------IFSKTNSSSHR 229
            H+++L G CS+     L+ E+   GSL  F                    S  +    R
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
            L+   L   A+ +++G++YL +    +++H D+   NIL+    + KISDFGL+    +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLS----R 198

Query: 290 DISIVSLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           D+     +  + + G I     A E LF   +   + +SDV+S+G++L E+V
Sbjct: 199 DV-YEEDSYVKRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIV 246

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 1e-33
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 22/247 (8%)

Query: 98  RESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKF-KHRLGQGGYGSVFRGKLFN 156
              +K +   +    F   +      +     LK+         LG G +GSV +G    
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRM 359

Query: 157 G---IPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP 211
               I VA+K+L     K + +E + E   + ++ + +IVRL+G C       LV E   
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAG 418

Query: 212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
            G L KF+  K        +    + ++   V+ G++YL +   +  +H ++   N+LL 
Sbjct: 419 GGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLV 470

Query: 272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI---APELFSRNFGEVSYKSDVYSYG 328
           +    KISDFGL+K    D S    TA       +   APE    NF + S +SDV+SYG
Sbjct: 471 NRHYAKISDFGLSKALGADDSYY--TARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYG 526

Query: 329 MMLLEMV 335
           + + E +
Sbjct: 527 VTMWEAL 533

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (312), Expect = 2e-33
 Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 41/234 (17%)

Query: 119 TVNPTRYT-YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI 176
           TV+      +KE++ I        G GG+G VF+ K   +G    +K +++   N ++  
Sbjct: 4   TVDKRFGMDFKEIELI--------GSGGFGQVFKAKHRIDGKTYVIKRVKY---NNEKAE 52

Query: 177 NEVATIGRIHHFHIVRLLGF-------------CSEGTRRALVY---EFMPNGSLEKFIF 220
            EV  + ++ H +IV   G               S  ++   ++   EF   G+LE++I 
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI- 111

Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD 280
                     L      ++   + +GV+Y+H    +++++ D+KP NI L    Q KI D
Sbjct: 112 ---EKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGD 165

Query: 281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           FGL      D      T ++GT  Y++PE  S    +   + D+Y+ G++L E+
Sbjct: 166 FGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAEL 214

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (314), Expect = 2e-33
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 27/232 (11%)

Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEF 175
             V      Y  ++K+        G+GG+  V   + L +G   A+K +L H + + +E 
Sbjct: 22  HMVIIDNKHYLFIQKL--------GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRA----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
             E       +H +I+RL+ +C           L+  F   G+L   I  +        L
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFL 131

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
           + +++  +  G+ RG+E +H    +   H D+KP NILL    QP + D G        +
Sbjct: 132 TEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188

Query: 292 SIVS-------LTAARGTAGYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
                        A R T  Y APELFS ++   +  ++DV+S G +L  M+
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (315), Expect = 3e-33
 Identities = 73/275 (26%), Positives = 121/275 (44%), Gaps = 41/275 (14%)

Query: 95  YKSRESEKEKETQLKVEKFLE----DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYG 147
           +K ++     E+QL++ +       +Y  V+   Y Y    E  +   +F   LG G +G
Sbjct: 1   HKYKKQ-FRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59

Query: 148 SVFRGKLFNG------IPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCS 198
            V     +        I VAVKML  +      +  ++E+  + ++  H +IV LLG C+
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 199 EGTRRALVYEFMPNGSLEKF-----------------IFSKTNSSSHRPLSWEKLKKIAF 241
                 L++E+   G L  +                             L++E L   A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
            VA+G+E+L     +  +H D+   N+L+ H    KI DFGLA+    D + V    AR 
Sbjct: 180 QVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236

Query: 302 TAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
              ++APE LF   +   + KSDV+SYG++L E+ 
Sbjct: 237 PVKWMAPESLFEGIY---TIKSDVWSYGILLWEIF 268

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  124 bits (313), Expect = 4e-33
 Identities = 58/228 (25%), Positives = 107/228 (46%), Gaps = 40/228 (17%)

Query: 136 KFKHRLGQGGYGSVFRGKLF--------NGIPVAVKML--EHLKGNGQEFINEVATIGRI 185
                LG+G +G V   +            + VAVKML  +  + +  + ++E+  +  I
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 186 -HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWE 234
             H +I+ LLG C++     ++ E+   G+L ++               N      ++++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA-KLCSKDISI 293
            L    + +ARG+EYL     Q+ +H D+   N+L+  N   KI+DFGLA  + + D   
Sbjct: 158 DLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 294 VSLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                 + T G +     APE LF R +   +++SDV+S+G+++ E+ 
Sbjct: 215 ------KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIF 253

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 1e-32
 Identities = 49/233 (21%), Positives = 93/233 (39%), Gaps = 41/233 (17%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIG 183
           ++ ++ +        G+GG+G VF  K   +    A+K   L + +   ++ + EV  + 
Sbjct: 7   FEPIQCL--------GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58

Query: 184 RIHHFHIVRLLGFCSEGTRRA------------LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           ++ H  IVR      E                 +  +     +L+ ++  +    +    
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR---CTIEER 115

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL----- 286
                  I   +A  VE+LH   ++ ++H D+KP NI    +   K+ DFGL        
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 287 -----CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
                 +   +    T   GT  Y++PE    N    S+K D++S G++L E+
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (313), Expect = 2e-32
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 19/211 (9%)

Query: 132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHI 190
           KI+   K  LG G  G++    +F+   VAVK +  L         EV  +     H ++
Sbjct: 23  KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHPNV 80

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +R      +   + +  E     +L++++  K  +         +   +      G+ +L
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL-----EPITLLQQTTSGLAHL 134

Query: 251 HQGCNQRILHFDIKPHNILL-----DHNFQPKISDFGLAKLCSKDI-SIVSLTAARGTAG 304
           H      I+H D+KPHNIL+         +  ISDFGL K  +    S    +   GT G
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 305 YIAPELFSRNFGE-VSYKSDVYSYGMMLLEM 334
           +IAPE+ S +  E  +Y  D++S G +   +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  123 bits (311), Expect = 2e-32
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVR 192
                LGQG   +VFRG+    G   A+K+             + E   + +++H +IV+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 193 LLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           L     E T R   L+ EF P GSL   +   +N+     L   +   +   V  G+ +L
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY---GLPESEFLIVLRDVVGGMNHL 128

Query: 251 HQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
            +     I+H +IKP NI+     D     K++DFG A+    D   VSL    GT  Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYL 182

Query: 307 APELFSRNFGEVSY------KSDVYSYGMMLLEMV 335
            P+++ R      +        D++S G+      
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (311), Expect = 2e-32
 Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 25/254 (9%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLF 155
           ++  ++ E++     +   +D    + +      +K        ++G GG   VF+    
Sbjct: 19  ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE 78

Query: 156 NGIPVAVKMLEHLKGNGQE---FINEVATIGRIHH--FHIVRLLGFCSEGTRRALVYEFM 210
                A+K +   + + Q    + NE+A + ++      I+RL  +        +V E  
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137

Query: 211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL 270
            N  L  ++         + +   + K     +   V  +HQ     I+H D+KP N L+
Sbjct: 138 GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLI 188

Query: 271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE---------VSYK 321
                 K+ DFG+A     D + V   +  G   Y+ PE                 +S K
Sbjct: 189 VDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247

Query: 322 SDVYSYGMMLLEMV 335
           SDV+S G +L  M 
Sbjct: 248 SDVWSLGCILYYMT 261

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  126 bits (318), Expect = 3e-32
 Identities = 44/209 (21%), Positives = 79/209 (37%), Gaps = 38/209 (18%)

Query: 140 RLGQGGYGSVFRGK--LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLL 194
            +  GG G ++       NG PV +K L    G+ +     + E   +  + H  IV++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 195 GFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
            F     R       +V E++   SL++           + L   +       +   + Y
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--------GQKLPVAEAIAYLLEILPALSY 197

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR---GTAGYI 306
           LH      +++ D+KP NI+L    Q K+ D G             + +     GT G+ 
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS---------RINSFGYLYGTPGFQ 244

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           APE+        +  +D+Y+ G  L  + 
Sbjct: 245 APEIVR---TGPTVATDIYTVGRTLAALT 270

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (308), Expect = 4e-32
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 38/227 (16%)

Query: 136 KFKHRLGQGGYGSVFRGKLF--------NGIPVAVKML--EHLKGNGQEFINEVATIGRI 185
                LG+G +G V   +            + VAVKML  +  + +  + ++E+  +  I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 186 -HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWE 234
             H +I+ LLG C++     ++ E+   G+L ++               N      ++++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L    + +ARG+EYL     Q+ +H D+   N+L+  N   KI+DFGLA+  +      
Sbjct: 204 DLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 295 SLTAARGTAGYI-----APE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                + T G +     APE LF R +   +++SDV+S+G+++ E+ 
Sbjct: 261 -----KTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIF 299

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 5e-32
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 36/226 (15%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN--------GIPVAVKML--EHLKGNGQEFINEVATIGRI 185
                LG+G +G V   +              VAVKML  +  + +  + I+E+  +  I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 186 -HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWE 234
             H +I+ LLG C++     ++ E+   G+L ++               + +    LS +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   A+ VARG+EYL     ++ +H D+   N+L+  +   KI+DFGLA    +DI  +
Sbjct: 192 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLA----RDIHHI 244

Query: 295 SLTAARGTAGY----IAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                          +APE LF R +   +++SDV+S+G++L E+ 
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIF 287

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (302), Expect = 7e-32
 Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 50/226 (22%)

Query: 136 KFKHRLGQGGYGSVFRGKL--------FNGIPVAVKML-EHLKGNGQEFINEVATIGRIH 186
            F   LGQG +  +F+G           +   V +K+L +  +   + F    + + ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           H H+V   G C  G    LV EF+  GSL+ ++  K N +    ++     ++A  +A  
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNC---INILWKLEVAKQLAAA 125

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP--------KISDFGLAKLCSKDISIVSLTA 298
           + +L +     ++H ++   NILL              K+SD G++              
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------- 174

Query: 299 ARGTAGY-------IAPE--LFSRNFGEVSYKSDVYSYGMMLLEMV 335
                         + PE     +N    +  +D +S+G  L E+ 
Sbjct: 175 -----DILQERIPWVPPECIENPKNL---NLATDKWSFGTTLWEIC 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 7e-32
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 17/201 (8%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNG---QEFINEVATIGRIHHFHIVRLL 194
            +G+GG G V+  +       VA+K++ E L  +         E  T GR+   H+V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            F     +  +    +    L   +          PL+  +   I   +   ++  H   
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML------RRQGPLAPPRAVAIVRQIGSALDAAHA-- 152

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
                H D+KP NIL+  +    + DFG+A   + D  +  L    GT  Y+APE FS  
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 315 FGEVSYKSDVYSYGMMLLEMV 335
               +Y++D+Y+   +L E +
Sbjct: 210 -SHATYRADIYALTCVLYECL 229

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (304), Expect = 9e-32
 Identities = 64/247 (25%), Positives = 98/247 (39%), Gaps = 22/247 (8%)

Query: 98  RESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFN 156
               +    + +  + +     + P  Y Y+E        + R+G+G +G V R K    
Sbjct: 24  SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM-THQPRVGRGSFGEVHRMKDKQT 82

Query: 157 GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE 216
           G   AVK +  L+    E   E+     +    IV L G   EG    +  E +  GSL 
Sbjct: 83  GFQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138

Query: 217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQ 275
           + I           L  ++          G+EYLH    +RILH D+K  N+LL  +  +
Sbjct: 139 QLI------KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSR 189

Query: 276 PKISDFGLAKLCSKDISIVSLTAA---RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLL 332
             + DFG A     D    SL       GT  ++APE+          K D++S   M+L
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMML 247

Query: 333 EMV-GCR 338
            M+ GC 
Sbjct: 248 HMLNGCH 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (302), Expect = 1e-31
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 27/221 (12%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKML--EHLKGNGQEFINEVATIGRI-H 186
           K    LG+G +G V     F          VAVKML         +  ++E+  +  I H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 187 HFHIVRLLGFCS-EGTRRALVYEFMPNGSLEKF----------IFSKTNSSSHRPLSWEK 235
           H ++V LLG C+  G    ++ EF   G+L  +                      L+ E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L   +F VA+G+E+L     ++ +H D+   NILL      KI DFGLA+   KD   V 
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 296 LTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
              AR    ++APE +F R +   + +SDV+S+G++L E+ 
Sbjct: 207 KGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIF 244

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (306), Expect = 2e-31
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 32/232 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI- 185
           +++  K     +  LG G  G+V     F G PVAVK +  L       + E+  +    
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESD 66

Query: 186 HHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK-LKKIAFG 242
            H +++R   +CSE T R   +  E   N +L+  + SK  S  +  L  E     +   
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDH-------------NFQPKISDFGLAKLCSK 289
           +A GV +LH     +I+H D+KP NIL+               N +  ISDFGL K    
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 290 DIS--IVSLTAARGTAGYIAPELFSRNFGEV-----SYKSDVYSYGMMLLEM 334
             S    +L    GT+G+ APEL   +         +   D++S G +   +
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  118 bits (298), Expect = 4e-31
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKML-EHLKGNGQ---EFINEVATIGRIHHFHIVRLL 194
            LG GG   V   + L +   VAVK+L   L  +      F  E      ++H  IV + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 195 --GFCSEGTRRALVY---EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
             G  +E     L Y   E++   +L   +       +  P++ ++  ++     + + +
Sbjct: 79  DTG-EAETPAGPLPYIVMEYVDGVTLRDIV------HTEGPMTPKRAIEVIADACQALNF 131

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAP 308
            HQ     I+H D+KP NI++      K+ DFG+A+  +   + V+ TAA  GTA Y++P
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           E        V  +SDVYS G +L E++
Sbjct: 189 EQARG--DSVDARSDVYSLGCVLYEVL 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 1e-30
 Identities = 58/242 (23%), Positives = 91/242 (37%), Gaps = 46/242 (19%)

Query: 123 TRYT--YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNG---QEFI 176
           +RYT  + EL+KI        G G +GSVF+  K  +G   A+K  +         Q  +
Sbjct: 7   SRYTTEFHELEKI--------GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL 58

Query: 177 NEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
            EV     +  H H+VR     +E     +  E+   GSL   I    N          +
Sbjct: 59  REVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAE 116

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP------------------- 276
           LK +   V RG+ Y+H      ++H DIKP NI +     P                   
Sbjct: 117 LKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173

Query: 277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG 336
           KI D G     S            G + ++A E+   N+     K+D+++  + ++   G
Sbjct: 174 KIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAG 226

Query: 337 CR 338
             
Sbjct: 227 AE 228

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (290), Expect = 1e-29
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 23/212 (10%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATI 182
           Y  L+KI        G+G +G     K   +G    +K +   + + +E      EVA +
Sbjct: 26  YVRLQKI--------GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL 77

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             + H +IV+      E     +V ++   G L K I    N+        +++      
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQ 133

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +   ++++H    ++ILH DIK  NI L  +   ++ DFG+A++ +  + +    A  GT
Sbjct: 134 ICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL--ARACIGT 188

Query: 303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
             Y++PE+        + KSD+++ G +L E+
Sbjct: 189 PYYLSPEICENK--PYNNKSDIWALGCVLYEL 218

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  114 bits (288), Expect = 2e-29
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 18/200 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLG 195
           LG+GG+   F           A K++    L    Q      E++    + H H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     +V E     SL +           + L+  + +     +  G +YLH+   
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH------KRRKALTEPEARYYLRQIVLGCQYLHR--- 159

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R++H D+K  N+ L+ + + KI DFGLA     D          GT  YIAPE+ S+  
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK- 216

Query: 316 GEVSYKSDVYSYGMMLLEMV 335
              S++ DV+S G ++  ++
Sbjct: 217 -GHSFEVDVWSIGCIMYTLL 235

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  113 bits (286), Expect = 2e-29
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 22/213 (10%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG----QEFINEVAT 181
           ++  KKI        G+G +  V+R   L +G+PVA+K ++           + I E+  
Sbjct: 34  FRIEKKI--------GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           + +++H ++++      E     +V E    G L + I  K      R +    + K   
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTVWKYFV 143

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
            +   +E++H    +R++H DIKP N+ +      K+ D GL +  S   +     +  G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVG 198

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           T  Y++PE    N    ++KSD++S G +L EM
Sbjct: 199 TPYYMSPERIHEN--GYNFKSDIWSLGCLLYEM 229

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (284), Expect = 2e-29
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 22/227 (9%)

Query: 115 EDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG- 172
           E     +   Y Y+  +         LG+G YG V+ G+ L N + +A+K +        
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVV---LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS 63

Query: 173 QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
           Q    E+A    + H +IV+ LG  SE     +  E +P GSL   + SK         +
Sbjct: 64  QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL---KDN 120

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAK----LC 287
            + +      +  G++YLH     +I+H DIK  N+L++ ++   KISDFG +K    + 
Sbjct: 121 EQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177

Query: 288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
               +        GT  Y+APE+  +        +D++S G  ++EM
Sbjct: 178 PCTETFT------GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (284), Expect = 3e-29
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 18/200 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLG 195
           LG+GG+   F           A K++    L    Q      E++    + H H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           F  +     +V E     SL +           + L+  + +     +  G +YLH+   
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH------KRRKALTEPEARYYLRQIVLGCQYLHR--- 133

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            R++H D+K  N+ L+ + + KI DFGLA     D          GT  YIAPE+ S+  
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKK- 190

Query: 316 GEVSYKSDVYSYGMMLLEMV 335
              S++ DV+S G ++  ++
Sbjct: 191 -GHSFEVDVWSIGCIMYTLL 209

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (283), Expect = 3e-29
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATI 182
           Y+ L  I        G G YG   + +   +G  +  K L++      E    ++EV  +
Sbjct: 8   YEVLYTI--------GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59

Query: 183 GRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIA 240
             + H +IVR      + T   L  V E+   G L   I     +   + L  E + ++ 
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVM 117

Query: 241 FGVARGVEYLHQ--GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTA 298
             +   ++  H+       +LH D+KP N+ LD     K+ DFGLA++ + D S      
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKT 175

Query: 299 ARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
             GT  Y++PE  +R     + KSD++S G +L E+ 
Sbjct: 176 FVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELC 210

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (282), Expect = 4e-29
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 38/209 (18%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+  +   +   +A+K+L    L+  G E     EV     + H +I+RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  + TR  L+ E+ P G++ + +              ++       +A  + Y H    
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALSYCHS--- 127

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK---------LCSKDISIVSLTAARGTAGYI 306
           +R++H DIKP N+LL    + KI+DFG +          LC             GT  Y+
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------------GTLDYL 174

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            PE+          K D++S G++  E +
Sbjct: 175 PPEMIEGR--MHDEKVDLWSLGVLCYEFL 201

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  113 bits (284), Expect = 4e-29
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQE---FINEVATI 182
           ++ L ++        G G YG VF+     +G   AVK         ++    + EV + 
Sbjct: 59  FQRLSRL--------GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110

Query: 183 GRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
            ++  H   VRL     EG    L  E     SL++        +    L   ++     
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-----EAWGASLPEAQVWGYLR 164

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
                + +LH   +Q ++H D+KP NI L    + K+ DFGL        +        G
Sbjct: 165 DTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---G 218

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
              Y+APEL   ++G     +DV+S G+ +LE+
Sbjct: 219 DPRYMAPELLQGSYG---TAADVFSLGLTILEV 248

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 6e-29
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLL 194
            LG+G YG V + + + +G  +AVK +     N QE    + ++    R +     V   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 195 G-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           G    EG    +  E M + SL+KF   K      + +  + L KIA  + + +E+LH  
Sbjct: 73  GALFREGDV-WICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPELFS 312
               ++H D+KP N+L++   Q K+ DFG+   L      +     A G   Y+APE  +
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDA-GCKPYMAPERIN 182

Query: 313 RNFGEVSY--KSDVYSYGMMLLEM 334
               +  Y  KSD++S G+ ++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIEL 206

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (282), Expect = 8e-29
 Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 37/250 (14%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTV----NPTRYTYKELKKITSKFKHRLGQGGYGSVFR 151
              E+   +   +  E+F    R V    +P         KI        G+G  G V  
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLL-LDSYVKI--------GEGSTGIVCL 63

Query: 152 GK-LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF 209
            +   +G  VAVKM++  K   +E + NEV  +    HF++V +      G    ++ EF
Sbjct: 64  AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123

Query: 210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL 269
           +  G+L       T+  S   L+ E++  +   V + + YLH    Q ++H DIK  +IL
Sbjct: 124 LQGGAL-------TDIVSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173

Query: 270 LDHNFQPKISDFG----LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
           L  + + K+SDFG    ++K   K  S+V      GT  ++APE+ SR+    + + D++
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRS--LYATEVDIW 225

Query: 326 SYGMMLLEMV 335
           S G+M++EMV
Sbjct: 226 SLGIMVIEMV 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  115 bits (289), Expect = 9e-29
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 25/223 (11%)

Query: 119 TVNPTRYTYKELKKITS--KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE----HLKGN 171
              P  +        +   K +  LG+G +G V   K    G   AVK++       K +
Sbjct: 10  HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69

Query: 172 GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL 231
            +  + EV  + ++ H +I++L  F  +     LV E    G L    F +  S      
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKR--F 123

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS 288
           S     +I   V  G+ Y+H+    +I+H D+KP N+LL     +   +I DFGL+    
Sbjct: 124 SEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
                  +    GTA YIAPE+    + E   K DV+S G++L
Sbjct: 181 AS---KKMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGVIL 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (282), Expect = 9e-29
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLL 194
            +G+G YGSV +     +G  +AVK +     + +E    + ++  + R     +IV+  
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G         +  E M + S +KF      S     +  E L KI     + + +L +  
Sbjct: 88  GALFREGDCWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLKE-- 143

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPELFSR 313
           N +I+H DIKP NILLD +   K+ DFG+  +L    +  ++ T   G   Y+APE    
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDP 199

Query: 314 NFGEVSY--KSDVYSYGMMLLEM 334
           +     Y  +SDV+S G+ L E+
Sbjct: 200 SASRQGYDVRSDVWSLGITLYEL 222

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  110 bits (278), Expect = 2e-28
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLG 195
           LG+G +  V+R + +  G+ VA+KM+  + +   G      NEV    ++ H  I+ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  +     LV E   NG + +++ ++      +P S  + +     +  G+ YLH    
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLHS--- 130

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ILH D+   N+LL  N   KI+DFGLA                GT  YI+PE+ +R+ 
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRS- 187

Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                +SDV+S G M   ++
Sbjct: 188 -AHGLESDVWSLGCMFYTLL 206

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (281), Expect = 2e-28
 Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 38/249 (15%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKL- 154
           K  E E +++ + ++E FL   + V        + +KI       LG G  G VF+    
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVG--ELKDDDFEKI-----SELGAGNGGVVFKVSHK 55

Query: 155 FNGIPVAVKMLEHLKGNGQEF---INEVATIGRIHHFHIVRLLG-FCSEGTRRALVY--- 207
            +G+ +A K++ HL+         I E+  +   +  +IV   G F S+G     +    
Sbjct: 56  PSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICM 110

Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           E M  GSL++ +           +  + L K++  V +G+ YL +    +I+H D+KP N
Sbjct: 111 EHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSN 162

Query: 268 ILLDHNFQPKISDFGLAKLCSKDI--SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVY 325
           IL++   + K+ DFG++      +  S V      GT  Y++PE         S +SD++
Sbjct: 163 ILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT--HYSVQSDIW 214

Query: 326 SYGMMLLEM 334
           S G+ L+EM
Sbjct: 215 SMGLSLVEM 223

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (286), Expect = 2e-28
 Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 35/233 (15%)

Query: 119 TVNPTRYTYKELKKITSK--FKHRLGQGGYGSVFRGK-LFNGIPVAVKML---------- 165
            +NP  Y  K+  KI        +LG G YG V   K        A+K++          
Sbjct: 20  AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79

Query: 166 ----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS 221
               ++++   +E  NE++ +  + H +I++L     +     LV EF   G L    F 
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE 135

Query: 222 KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKI 278
           +  +             I   +  G+ YLH+     I+H DIKP NILL   +     KI
Sbjct: 136 QIINRHK--FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190

Query: 279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
            DFGL+   SKD     L    GTA YIAPE+  + + E   K DV+S G+++
Sbjct: 191 VDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  114 bits (287), Expect = 3e-28
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 25/213 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
           + K RLG GG+G V R      G  VA+K    E    N + +  E+  + +++H ++V 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 193 LL------GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
                      +      L  E+   G L K++    N      L    ++ +   ++  
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISSA 133

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAARGTA 303
           + YLH+    RI+H D+KP NI+L    Q    KI D G AK   +       T   GT 
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTL 187

Query: 304 GYIAPELFS-RNFGEVSYKSDVYSYGMMLLEMV 335
            Y+APEL   + +       D +S+G +  E +
Sbjct: 188 QYLAPELLEQKKYTV---TVDYWSFGTLAFECI 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (284), Expect = 3e-28
 Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 24/239 (10%)

Query: 102 KEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSK--FKHRLGQGGYGSVFRGK-LFNGI 158
               +  +   + +      P  +   +   ++       +LG G YG V   +     +
Sbjct: 4   HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63

Query: 159 PVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL 215
             A+K++     +       + EVA +  + H +I++L  F  +     LV E    G L
Sbjct: 64  ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123

Query: 216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DH 272
               F +         +      I   V  GV YLH+     I+H D+KP N+LL   + 
Sbjct: 124 ----FDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEK 174

Query: 273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           +   KI DFGL+ +         +    GTA YIAPE+  + + E   K DV+S G++L
Sbjct: 175 DALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLRKKYDE---KCDVWSIGVIL 227

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (278), Expect = 6e-28
 Identities = 40/219 (18%), Positives = 70/219 (31%), Gaps = 28/219 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK------LFNGIPVAVKMLEHLKGNGQEF---INEVATIGRIH 186
              H LG+G +  V+           N     +K+ +    N  EF      +  +    
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERLKPSM 125

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
               ++            LV E    G+L   I    N+     +    +   A  +   
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK-VMPQGLVISFAMRMLYM 184

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP-----------KISDFGLAKLCSKDISIVS 295
           +E +H   +  I+H DIKP N +L + F              + D G +           
Sbjct: 185 IEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241

Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
            TA   T+G+   E+ S      +Y+ D +     +  M
Sbjct: 242 FTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 9e-28
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 17/202 (8%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE--HLKGNGQEFINEVATIGRIHHFHIVR 192
            FK +LG G +G V   +   +G+   +K +     +   ++   E+  +  + H +I++
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           +     +     +V E    G L + I S         LS   + ++   +   + Y H 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALAYFHS 142

Query: 253 GCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
              Q ++H D+KP NIL      +   KI DFGLA+L   D      T A GTA Y+APE
Sbjct: 143 ---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPE 196

Query: 310 LFSRNFGEVSYKSDVYSYGMML 331
           +F R+      K D++S G+++
Sbjct: 197 VFKRDVTF---KCDIWSAGVVM 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (275), Expect = 1e-27
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 27/215 (12%)

Query: 141 LGQGGYGSVFRGKLFNGIPVAVKMLE------------------HLKGNGQEFINEVATI 182
           L QG +  +   +  +    A+K  E                   +K    +F NE+  I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFI--FSKTNSSSHRPLSWEKLKKIA 240
             I + + +   G  +      ++YE+M N S+ KF   F   + +    +  + +K I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR 300
             V     Y+H   N  I H D+KP NIL+D N + K+SDFG ++          +  +R
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSR 211

Query: 301 GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           GT  ++ PE FS        K D++S G+ L  M 
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (275), Expect = 2e-27
 Identities = 25/231 (10%), Positives = 54/231 (23%), Gaps = 39/231 (16%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML----EHLKGNGQEFINEVATIGRIHHFHI 190
           K    L  G    VF  + +      A+K+     E+ +   +          R+     
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 191 VRLLGFC-----------------------SEGTRRALVYEFMP--NGSLEKFI-FSKTN 224
                                          +    A     MP  +  LE         
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 225 SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
                      L  +   + R    L     + ++H    P N+ +  + +  + D    
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
                     S         Y   E  + +    ++  + +  G+ +  + 
Sbjct: 242 WKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 2e-27
 Identities = 30/231 (12%), Positives = 70/231 (30%), Gaps = 39/231 (16%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRIHH------- 187
            LGQ    +         G    V +    +      I     EV  +  +         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 188 ---------FHIVRLLGFCS------EGTRRALVYEFM----PNGSLEKFIFS-KTNSSS 227
                    F +V+            +     ++  F        +L+ F     ++SS+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
           H+ L      ++   V R +  LH      ++H  ++P +I+LD      ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260

Query: 288 SKDISIVSLTAARGTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMV 335
               ++  +          A  +      +   +++  D ++ G+ +  + 
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (271), Expect = 4e-27
 Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 33/239 (13%)

Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEF 175
           +TV       +  + +         +GG+  V+  + + +G   A+K +L + +   +  
Sbjct: 21  QTVELGELRLRVRRVL--------AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 176 INEVATIGRI-HHFHIVRLLGFCSEGTRRA-------LVYEFMPNGSLEKFIFSKTNSSS 227
           I EV  + ++  H +IV+     S G   +       L+   +  G L +F+       S
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMES 129

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
             PLS + + KI +   R V+++H+     I+H D+K  N+LL +    K+ DFG A   
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188

Query: 288 SKDISIVSLTAAR----------GTAGYIAPELFSRNFGE-VSYKSDVYSYGMMLLEMV 335
           S           R           T  Y  PE+        +  K D+++ G +L  + 
Sbjct: 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 4e-27
 Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 19/242 (7%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKF--KHRLGQGGYGSVFRGK 153
           + +    +       + ++ D       +    +   +   +     LG G +G V R  
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT 177

Query: 154 -LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP 211
               G   A K +     + +E +  E+ T+  + H  +V L     +     ++YEFM 
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
            G L + +  + N      +S ++  +    V +G+ ++H+      +H D+KP NI+  
Sbjct: 238 GGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFT 289

Query: 272 HNFQP--KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM 329
                  K+ DFGL           S+    GTA + APE+       V Y +D++S G+
Sbjct: 290 TKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGV 344

Query: 330 ML 331
           + 
Sbjct: 345 LS 346

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (275), Expect = 6e-27
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 24/220 (10%)

Query: 121 NPTRYTYKELKKITSK--FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE--HLKGNGQE- 174
           +  R           +      LG+G +G V + K        AVK++     K      
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
            + EV  + ++ H +I++L     + +   +V E    G L    F +         S  
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKR--FSEH 121

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDI 291
              +I   V  G+ Y+H+     I+H D+KP NILL   + +   KI DFGL+    ++ 
Sbjct: 122 DAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
               +    GTA YIAPE+    + E   K DV+S G++L
Sbjct: 178 --TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  105 bits (264), Expect = 2e-26
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQE--FINEVATIGRIHHFHIVRLLG 195
           LG+G +G+V+  +   N   +A+K+L    L+  G E     E+     + H +I+R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
           +  +  R  L+ EF P G L K +        H     ++       +A  + Y H+   
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL------QKHGRFDEQRSATFMEELADALHYCHE--- 132

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++++H DIKP N+L+ +  + KI+DFG +                GT  Y+ PE+     
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGK- 187

Query: 316 GEVSYKSDVYSYGMMLLEMV 335
                K D++  G++  E +
Sbjct: 188 -THDEKVDLWCAGVLCYEFL 206

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 2e-26
 Identities = 62/242 (25%), Positives = 113/242 (46%), Gaps = 38/242 (15%)

Query: 100 SEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGI 158
           S++E   +L+    + D     P +  Y   +KI        GQG  G+V+    +  G 
Sbjct: 1   SDEEILEKLRSIVSVGD-----PKKK-YTRFEKI--------GQGASGTVYTAMDVATGQ 46

Query: 159 PVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
            VA++ +   +   +E I NE+  +    + +IV  L     G    +V E++  GSL  
Sbjct: 47  EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL-- 104

Query: 218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 277
                T+  +   +   ++  +     + +E+LH   + +++H DIK  NILL  +   K
Sbjct: 105 -----TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVK 156

Query: 278 ISDFGL-AKLC---SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLE 333
           ++DFG  A++    SK  ++V      GT  ++APE+ +R       K D++S G+M +E
Sbjct: 157 LTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIE 208

Query: 334 MV 335
           M+
Sbjct: 209 MI 210

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 5e-26
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 31/244 (12%)

Query: 97  SRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LF 155
               +     + +++K  ED  T  P    +  L+K+        G+G YGSV++     
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEV-FDVLEKL--------GEGSYGSVYKAIHKE 52

Query: 156 NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL 215
            G  VA+K +  ++ + QE I E++ + +    H+V+  G   + T   +V E+   GS+
Sbjct: 53  TGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111

Query: 216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
              I        ++ L+ +++  I     +G+EYLH     R +H DIK  NILL+    
Sbjct: 112 SDII-----RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGH 163

Query: 276 PKISDFG----LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
            K++DFG    L    +K  +++      GT  ++APE+        +  +D++S G+  
Sbjct: 164 AKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE--IGYNCVADIWSLGITA 215

Query: 332 LEMV 335
           +EM 
Sbjct: 216 IEMA 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (260), Expect = 7e-26
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 121 NPTRYTYKELKKITSK--FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE--- 174
           +  R           +      LG+G +G V + K        AVK++       ++   
Sbjct: 8   SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
            + EV  + ++ H +I++L     + +   +V E    G L   I  +   S       E
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-------E 120

Query: 235 KL-KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKD 290
               +I   V  G+ Y+H+     I+H D+KP NILL   + +   KI DFGL+    ++
Sbjct: 121 HDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
                +    GTA YIAPE+    + E   K DV+S G++L
Sbjct: 178 ---TKMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (261), Expect = 7e-26
 Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 14/201 (6%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           +LG G Y +V++G     G+ VA+K   L+  +G     I E++ +  + H +IVRL   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                +  LV+EFM N  L+K++ S+T  ++ R L    +K   + + +G+ + H+    
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---N 127

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           +ILH D+KP N+L++   Q K+ DFGLA+  +  I + + ++   T  Y AP++     G
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSSEVVTLWYRAPDVL---MG 182

Query: 317 EVSYKS--DVYSYGMMLLEMV 335
             +Y +  D++S G +L EM+
Sbjct: 183 SRTYSTSIDIWSCGCILAEMI 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  103 bits (259), Expect = 7e-26
 Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 20/201 (9%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRL 193
             ++ +G+G +G V         I  A K +        + F  E+  +  + H +I+RL
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                + T   LV E    G L + +  K               +I   V   V Y H+ 
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK- 124

Query: 254 CNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
               + H D+KP N L      +   K+ DFGLA           +    GT  Y++P++
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQV 179

Query: 311 FSRNFGEVSYKSDVYSYGMML 331
               +G    + D +S G+M+
Sbjct: 180 LEGLYGP---ECDEWSAGVMM 197

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 9e-26
 Identities = 55/254 (21%), Positives = 90/254 (35%), Gaps = 50/254 (19%)

Query: 125 YTYKELKKITSK--FKHRLGQGGYGSVFRGK-LFNGIPVAVKML------EHLKGNGQEF 175
           +    L ++  K   K  +GQG YG V            A+K++      +    + +  
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
             EV  + ++HH +I RL     +     LV E    G L   +    + S+ +      
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 236 LKKIAFGVAR----------------------------------GVEYLHQGCNQRILHF 261
             +I                                         + YLH    Q I H 
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHR 192

Query: 262 DIKPHNILL--DHNFQPKISDFGLAKLCS--KDISIVSLTAARGTAGYIAPELFSRNFGE 317
           DIKP N L   + +F+ K+ DFGL+K      +     +T   GT  ++APE+ +     
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252

Query: 318 VSYKSDVYSYGMML 331
              K D +S G++L
Sbjct: 253 YGPKCDAWSAGVLL 266

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (260), Expect = 2e-25
 Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 23/208 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI------NEVATIGRIHHF 188
           +    +G+G +  V R      G   AVK+++  K      +       E +    + H 
Sbjct: 27  ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           HIV LL   S      +V+EFM    L   I  +  + +    S          +   + 
Sbjct: 87  HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR--ADAGFVYSEAVASHYMRQILEALR 144

Query: 249 YLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           Y H      I+H D+KPH +LL   +++   K+  FG+A    +   +       GT  +
Sbjct: 145 YCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHF 199

Query: 306 IAPELFSRNFGEVSY--KSDVYSYGMML 331
           +APE+  R      Y    DV+  G++L
Sbjct: 200 MAPEVVKRE----PYGKPVDVWGCGVIL 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  102 bits (257), Expect = 2e-25
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML----------EHLKGNGQEFINEVATIGR 184
           + K  LG+G    V R          AVK++          E ++   +  + EV  + +
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 185 I-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           +  H +I++L       T   LV++ M  G L  ++  K        LS ++ +KI   +
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRAL 133

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
              +  LH      I+H D+KP NILLD +   K++DFG +           L    GT 
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTP 187

Query: 304 GYIAPELFSRNFGEVS--Y--KSDVYSYGMML 331
            Y+APE+   +  +    Y  + D++S G+++
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (257), Expect = 2e-25
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEF--INEVATIGRIHHFHIVRLL 194
           ++G+G YG+VF+ K       VA+K   L+     G     + E+  +  + H +IVRL 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLH 67

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                  +  LV+EF     L+K+       S +  L  E +K   F + +G+ + H   
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYF-----DSCNGDLDPEIVKSFLFQLLKGLGFCHS-- 119

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
            + +LH D+KP N+L++ N + K+++FGLA+     I +   +A   T  Y  P++    
Sbjct: 120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFG--IPVRCYSAEVVTLWYRPPDVL--- 173

Query: 315 FGEVSYKS--DVYSYGMMLLEMVGCRK 339
           FG   Y +  D++S G +  E+    +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  104 bits (260), Expect = 3e-25
 Identities = 51/242 (21%), Positives = 96/242 (39%), Gaps = 19/242 (7%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKF--KHRLGQGGYGSVFRGK 153
                + +       +KF ED       +    +   +   +     LG G +G V R  
Sbjct: 12  SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71

Query: 154 -LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP 211
               G     K +       +  + NE++ + ++HH  ++ L     +     L+ EF+ 
Sbjct: 72  EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
            G L   I ++        +S  ++         G++++H+     I+H DIKP NI+ +
Sbjct: 132 GGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCE 183

Query: 272 H--NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGM 329
                  KI DFGLA   + D     +     TA + APE+  R    V + +D+++ G+
Sbjct: 184 TKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREP--VGFYTDMWAIGV 238

Query: 330 ML 331
           + 
Sbjct: 239 LG 240

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  102 bits (256), Expect = 3e-25
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 25/205 (12%)

Query: 136 KFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIV 191
             K  LG+G +  V R      G+  A K++   K + ++      E     ++ H +IV
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           RL     E +   LV++ +  G L + I ++         S          +   + Y H
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCH 122

Query: 252 QGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
                 I+H ++KP N+LL         K++DFGLA   +      +     GT GY++P
Sbjct: 123 S---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSP 176

Query: 309 ELFSRNFGEVSY--KSDVYSYGMML 331
           E+  ++     Y    D+++ G++L
Sbjct: 177 EVLKKD----PYSKPVDIWACGVIL 197

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (261), Expect = 3e-25
 Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 37/225 (16%)

Query: 126 TYKELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVK-MLEHLKGNGQEFIN-EVATI 182
           +Y + K I        G G +G V++ KL  +G  VA+K +L+      + F N E+  +
Sbjct: 55  SYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIM 101

Query: 183 GRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            ++ H +IVRL   F S G ++      LV +++P  ++ +    +  S + + L    +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTLPVIYV 158

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVS 295
           K   + + R + Y+H   +  I H DIKP N+LLD +    K+ DFG AK   +    VS
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCR 338
              +R    Y APEL    FG   Y S  DV+S G +L E++  +
Sbjct: 216 YICSR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (255), Expect = 4e-25
 Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 16/205 (7%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
            +G G    V           VA+K   LE  + +  E + E+  + + HH +IV     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF---GVARGVEYLHQG 253
                   LV + +  GS+   I        H+    ++   IA     V  G+EYLH  
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE-STIATILREVLEGLEYLH-- 138

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR----GTAGYIAPE 309
                +H D+K  NILL  +   +I+DFG++         ++    R    GT  ++APE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSA-FLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEM 334
           +  +  G   +K+D++S+G+  +E+
Sbjct: 197 VMEQVRG-YDFKADIWSFGITAIEL 220

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  103 bits (259), Expect = 5e-25
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 36/234 (15%)

Query: 116 DYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVK-MLEHLKGNGQE 174
           D +T       Y   K I        G G +G VF+ KL     VA+K +L+      + 
Sbjct: 31  DGKTGEQREIAYTNCKVI--------GNGSFGVVFQAKLVESDEVAIKKVLQD-----KR 77

Query: 175 FIN-EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSS 227
           F N E+  +  + H ++V L   F S G ++      LV E++P  ++ +    +  +  
Sbjct: 78  FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS--RHYAKL 134

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKL 286
            + +    +K   + + R + Y+H      I H DIKP N+LLD  +   K+ DFG AK+
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191

Query: 287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCR 338
                  VS   +R    Y APEL    FG  +Y +  D++S G ++ E++  +
Sbjct: 192 LIAGEPNVSYICSR---YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (256), Expect = 7e-25
 Identities = 33/246 (13%), Positives = 74/246 (30%), Gaps = 50/246 (20%)

Query: 131 KKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI----NEVATIGRI 185
           +  T      LGQ    +         G    V +    +      I     EV  +  +
Sbjct: 71  RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130

Query: 186 -------------------------HHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKF 218
                                        ++R+     +    +   +Y  M +      
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190

Query: 219 IFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI 278
               ++SS+H+ L      ++   V R +  LH      ++H  ++P +I+LD      +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFL 247

Query: 279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGE---------VSYKSDVYSYGM 329
           + F                 +  + G+  PEL +R             +++  D ++ G+
Sbjct: 248 TGFEHLVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301

Query: 330 MLLEMV 335
           ++  + 
Sbjct: 302 VIYWIW 307

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (255), Expect = 8e-25
 Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 30/240 (12%)

Query: 101 EKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIP 159
              +   LK     E +   +P +  + +L++I        G G +G+V+  + + N   
Sbjct: 31  AGGRAGSLKDPDVAELFFKDDPEKL-FSDLREI--------GHGSFGAVYFARDVRNSEV 81

Query: 160 VAVKML----EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL 215
           VA+K +    +      Q+ I EV  + ++ H + ++  G         LV E+   GS 
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140

Query: 216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ 275
              +         +PL   ++  +  G  +G+ YLH   +  ++H D+K  NILL     
Sbjct: 141 SDLL-----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192

Query: 276 PKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL-FSRNFGEVSYKSDVYSYGMMLLEM 334
            K+ DFG A + +   S V      GT  ++APE+  + + G+   K DV+S G+  +E+
Sbjct: 193 VKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (255), Expect = 1e-24
 Identities = 56/250 (22%), Positives = 108/250 (43%), Gaps = 25/250 (10%)

Query: 94  IYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHR--------LGQGG 145
           ++ + +  +    + K    L       P  + ++ +                  LG G 
Sbjct: 42  VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101

Query: 146 YGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRR 203
           +G V + +    G+ +A K+++      +E + NE++ + ++ H ++++L          
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161

Query: 204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI 263
            LV E++  G L    F +    S+  L+          +  G+ ++HQ     ILH D+
Sbjct: 162 VLVMEYVDGGEL----FDRIIDESYN-LTELDTILFMKQICEGIRHMHQ---MYILHLDL 213

Query: 264 KPHNILLDH--NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYK 321
           KP NIL  +    Q KI DFGLA+          L    GT  ++APE+ + +F  VS+ 
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPEVVNYDF--VSFP 268

Query: 322 SDVYSYGMML 331
           +D++S G++ 
Sbjct: 269 TDMWSVGVIA 278

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (252), Expect = 1e-24
 Identities = 48/203 (23%), Positives = 97/203 (47%), Gaps = 25/203 (12%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            ++G+G +G VF+G        VA+K+  LE  +   ++   E+  + +    ++ +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
              + T+  ++ E++  GS    +          PL   ++  I   + +G++YLH   +
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLH---S 137

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFG----LAKLCSKDISIVSLTAARGTAGYIAPELF 311
           ++ +H DIK  N+LL  + + K++DFG    L     K  + V      GT  ++APE+ 
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 191

Query: 312 SRNFGEVSYKSDVYSYGMMLLEM 334
            +       K+D++S G+  +E+
Sbjct: 192 KQ--SAYDSKADIWSLGITAIEL 212

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  101 bits (253), Expect = 2e-24
 Identities = 61/251 (24%), Positives = 101/251 (40%), Gaps = 35/251 (13%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-L 154
           + + +E      +  E  L D+         Y          K  +G+G    V R    
Sbjct: 65  QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYD--------PKDVIGRGVSSVVRRCVHR 116

Query: 155 FNGIPVAVKML---------EHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRA 204
             G   AVK++         E L+   +    E   + ++  H HI+ L+      +   
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK 264
           LV++ M  G L  ++  K        LS ++ + I   +   V +LH      I+H D+K
Sbjct: 177 LVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSFLHA---NNIVHRDLK 227

Query: 265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEV----SY 320
           P NILLD N Q ++SDFG +           L    GT GY+APE+   +  E       
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGYGK 284

Query: 321 KSDVYSYGMML 331
           + D+++ G++L
Sbjct: 285 EVDLWACGVIL 295

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  100 bits (250), Expect = 2e-24
 Identities = 54/235 (22%), Positives = 108/235 (45%), Gaps = 32/235 (13%)

Query: 109 KVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH 167
           K  ++    R ++P    ++ + ++        G G +G V++ K    G   A K++E 
Sbjct: 4   KSREYEHVRRDLDPNEV-WEIVGEL--------GDGAFGKVYKAKNKETGALAAAKVIET 54

Query: 168 LKGNG-QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSS 226
                 +++I E+  +    H +IV+LLG      +  ++ EF P G+++  +       
Sbjct: 55  KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM-----LE 109

Query: 227 SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG---- 282
             R L+  +++ +   +   + +LH    +RI+H D+K  N+L+      +++DFG    
Sbjct: 110 LDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166

Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPEL-FSRNFGEVSY--KSDVYSYGMMLLEM 334
             K   K  S +      GT  ++APE+       +  Y  K+D++S G+ L+EM
Sbjct: 167 NLKTLQKRDSFI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (250), Expect = 2e-24
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF---INEVATIGR-IHHFHIVRLL 194
            +G G  G V++ +    G  +AVK +    GN +E    + ++  + +     +IV+  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
           G     T   +  E M     EK            P+    L K+   + + + YL +  
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLK-----KRMQGPIPERILGKMTVAIVKALYYLKE-- 142

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGL-AKLCSKDISIVSLTAARGTAGYIAPE-LFS 312
              ++H D+KP NILLD   Q K+ DFG+  +L    +   +   + G A Y+APE +  
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAGCAAYMAPERIDP 198

Query: 313 RNFGEVSY--KSDVYSYGMMLLEM 334
            +  +  Y  ++DV+S G+ L+E+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVEL 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =   99 bits (250), Expect = 3e-24
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKM--LEHLKGNGQEF--INEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ K   G  VA+K   L+     G     I E++ +  +HH +IV L+ 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLID 86

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                    LV+EFM    L+K +       +   L   ++K   + + RGV + HQ   
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVL-----DENKTGLQDSQIKIYLYQLLRGVAHCHQ--- 137

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            RILH D+KP N+L++ +   K++DFGLA+     I + S T    T  Y AP++     
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFG--IPVRSYTHEVVTLWYRAPDVL---M 192

Query: 316 GEVSYKS--DVYSYGMMLLEMV 335
           G   Y +  D++S G +  EM+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMI 214

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 3e-24
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 138 KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-FINEVATIGRI-HHFHIVRLL 194
           +  LG+G +  V     L      AVK++E   G+ +     EV  + +   H +++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
            F  E  R  LV+E M  GS+     S  +   H   +  +   +   VA  +++LH   
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRH--FNELEASVVVQDVASALDFLH--- 128

Query: 255 NQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCS-----KDISIVSLTAARGTAGYI 306
           N+ I H D+KP NIL +H  Q    KI DF L            IS   L    G+A Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 307 APE-LFSRNFGEVSY--KSDVYSYGMML 331
           APE + + +     Y  + D++S G++L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.1 bits (248), Expect = 3e-24
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 21/202 (10%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKM--LEHLKGNGQEF--INEVATIGRIHHFHIVRLLG 195
           ++G+G YG V++ +   G   A+K   LE     G     I E++ +  + H +IV+L  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYD 67

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 R  LV+E +    L+K +           L     K     +  G+ Y H    
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLL-----DVCEGGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +R+LH D+KP N+L++   + KI+DFGLA+     I +   T    T  Y AP++     
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFG--IPVRKYTHEIVTLWYRAPDVL---M 173

Query: 316 GEVSYKS--DVYSYGMMLLEMV 335
           G   Y +  D++S G +  EMV
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMV 195

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 26/204 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE-HLKGNGQEFINEVATIGRIHHFHIVRL 193
            F   LG G +  VF  K    G   A+K ++           NE+A + +I H +IV L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL-KKIAFGVARGVEYLHQ 252
                  T   LV + +  G L   I  +   +       EK    +   V   V+YLH+
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQVLSAVKYLHE 124

Query: 253 GCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
                I+H D+KP N+L    + N +  I+DFGL+K+    I    ++ A GT GY+APE
Sbjct: 125 ---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPE 177

Query: 310 LFSRNFGEVSY--KSDVYSYGMML 331
           + ++      Y    D +S G++ 
Sbjct: 178 VLAQK----PYSKAVDCWSIGVIT 197

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  100 bits (251), Expect = 3e-24
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEF----INEVATIGRIHHFHIVR 192
            LG+G + +V++ +       VA+K   L H            + E+  +  + H +I+ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           LL      +  +LV++FM    LE  I       +   L+   +K       +G+EYLHQ
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
                ILH D+KP+N+LLD N   K++DFGLAK  S      + T    T  Y APEL  
Sbjct: 131 ---HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELL- 184

Query: 313 RNFGEVSYKS--DVYSYGMMLLEMV 335
             FG   Y    D+++ G +L E++
Sbjct: 185 --FGARMYGVGVDMWAVGCILAELL 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 42/206 (20%), Positives = 82/206 (39%), Gaps = 18/206 (8%)

Query: 131 KKITSKF--KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           K++  K+     LG+G +G V R     +      K ++    +      E++ +    H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +I+ L           +++EF+    + + I +         L+  ++      V   +
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115

Query: 248 EYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++LH      I HFDI+P NI+     +   KI +FG A+         +         Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEY 169

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMML 331
            APE+   +   VS  +D++S G ++
Sbjct: 170 YAPEVHQHDV--VSTATDMWSLGTLV 193

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML-------EHLKGNGQEFINEVATIGRIHH 187
                LG G +  V + +    G+  A K +            + +E   EV+ + ++ H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++ L       T   L+ E +  G L  F+  K +      LS E+       +  GV
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGV 128

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA 303
            YLH    ++I HFD+KP NI+L     P    K+ DFGLA         V      GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTP 182

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
            ++APE+ +     +  ++D++S G++ 
Sbjct: 183 EFVAPEIVNYEP--LGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  100 bits (250), Expect = 4e-24
 Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML-------EHLKGNGQEFINEVATIGRIHH 187
                LG G +  V + +    G+  A K +              +E   EV+ + ++ H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +I+ L       T   L+ E +  G L  F+  K +      LS E+       +  GV
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES------LSEEEATSFIKQILDGV 128

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA 303
            YLH    ++I HFD+KP NI+L     P    K+ DFGLA         V      GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTP 182

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
            ++APE+ +     +  ++D++S G++ 
Sbjct: 183 EFVAPEIVNYEP--LGLEADMWSIGVIT 208

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (250), Expect = 5e-24
 Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 27/221 (12%)

Query: 122 PTRYTYKELKKITSK--FKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQE---F 175
            + +      K +     K  LG+G +  V R      G+  A K++   K + ++    
Sbjct: 16  GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
             E     ++ H +IVRL     E +   LV++ +  G L + I ++         S   
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEAD 129

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDIS 292
                  +   + Y H      I+H ++KP N+LL         K++DFGLA   +    
Sbjct: 130 ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 184

Query: 293 IVSLTAARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMML 331
             +     GT GY++PE+  ++     Y    D+++ G++L
Sbjct: 185 -EAWHGFAGTPGYLSPEVLKKD----PYSKPVDIWACGVIL 220

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =   99 bits (249), Expect = 6e-24
 Identities = 42/242 (17%), Positives = 81/242 (33%), Gaps = 22/242 (9%)

Query: 102 KEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPV 160
                      + +   +  P    Y+ L  I        G     +V   +    G  V
Sbjct: 2   AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGK------GFEDLMTVNLARYKPTGEYV 55

Query: 161 AVKM--LEHLKGNGQEFI-NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEK 217
            V+   LE        F+  E+      +H +IV             +V  FM  GS + 
Sbjct: 56  TVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115

Query: 218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK 277
            I     +     ++   +  I  GV + ++Y+H       +H  +K  +IL+  + +  
Sbjct: 116 LI----CTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVY 168

Query: 278 ISDFG----LAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLL 332
           +S       +     +   +            +++PE+  +N      KSD+YS G+   
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228

Query: 333 EM 334
           E+
Sbjct: 229 EL 230

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.0 bits (245), Expect = 8e-24
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 26/208 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE-------FINEVATIGRIHH 187
           +    LG G +  V + +    G   A K ++  + +             EV  +  I H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +I+ L       T   L+ E +  G L  F+  K +      L+ ++  +    +  GV
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGV 121

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA 303
            YLH    +RI HFD+KP NI+L     P    K+ DFG+A                GT 
Sbjct: 122 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTP 175

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
            ++APE+ +     +  ++D++S G++ 
Sbjct: 176 EFVAPEIVNYEP--LGLEADMWSIGVIT 201

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
           +LG+G Y +V++GK       VA+K   LEH +G     I EV+ +  + H +IV L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   LV+E++    L++++           ++   +K   F + RG+ Y H+   Q
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYL-----DDCGNIINMHNVKLFLFQLLRGLAYCHR---Q 119

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           ++LH D+KP N+L++   + K++DFGLA+  +K I   +      T  Y  P++     G
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDIL---LG 174

Query: 317 EVSYKS--DVYSYGMMLLEMV 335
              Y +  D++  G +  EM 
Sbjct: 175 STDYSTQIDMWGVGCIFYEMA 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 32/211 (15%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFIN-EVATIGRIHHFHIVRLL 194
           LG+G YG V            AVK+L+  K     NG+  +  E+  + R+ H ++++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 195 GFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR------- 245
                  ++   +V E+   G  E       +S   +              A        
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML-----DSVPEKRFP-VC-------QAHGYFCQLI 119

Query: 246 -GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
            G+EYLH    Q I+H DIKP N+LL      KIS  G+A+      +  +   ++G+  
Sbjct: 120 DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +  PE+ +       +K D++S G+ L  + 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNIT 207

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 97.6 bits (244), Expect = 2e-23
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEFIN--EVATI 182
           Y+++ KI        G+G YG VF+ +    G  VA+K  LE       + I   E+  +
Sbjct: 5   YEKIGKI--------GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRML 56

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
            ++ H ++V LL       R  LV+E+  + ++   +         R +    +K I + 
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-----DRYQRGVPEHLVKSITWQ 110

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
             + V + H+      +H D+KP NIL+  +   K+ DFG A+L +             T
Sbjct: 111 TLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVAT 165

Query: 303 AGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             Y +PEL     G+  Y    DV++ G +  E++
Sbjct: 166 RWYRSPELL---VGDTQYGPPVDVWAIGCVFAELL 197

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 29/211 (13%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---------FINEVATIGRI 185
                LG G  G V           VA++++   K                 E+  + ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           +H  I+++  F  +     +V E M  G L   +           L     K   + +  
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLL 250

Query: 246 GVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
            V+YLH+     I+H D+KP N+LL   + +   KI+DFG +K+  +      +    GT
Sbjct: 251 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGT 304

Query: 303 AGYIAPELFSRNFGEVSY--KSDVYSYGMML 331
             Y+APE+   + G   Y    D +S G++L
Sbjct: 305 PTYLAPEVLV-SVGTAGYNRAVDCWSLGVIL 334

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 97.3 bits (242), Expect = 3e-23
 Identities = 33/137 (24%), Positives = 58/137 (42%), Gaps = 18/137 (13%)

Query: 208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN 267
           +     +L+ ++       S           I   +A  VE+LH    + ++H D+KP N
Sbjct: 141 QLCRKENLKDWM---NRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSN 194

Query: 268 ILLDHNFQPKISDFGLAK----------LCSKDISIVSLTAARGTAGYIAPELFSRNFGE 317
           I    +   K+ DFGL            + +   +  + T   GT  Y++PE    N   
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--N 252

Query: 318 VSYKSDVYSYGMMLLEM 334
            S+K D++S G++L E+
Sbjct: 253 YSHKVDIFSLGLILFEL 269

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.7 bits (239), Expect = 5e-23
 Identities = 61/209 (29%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
           LG+G YG V           VAVK++  +      +    E+     ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GVEY 249
            EG  + L  E+   G L   I           +  E         A+        GV Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI------EPDIGMP-EP-------DAQRFFHQLMAGVVY 120

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           LH      I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 310 LFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           L  R      +     DV+S G++L  M+
Sbjct: 178 LLKRR----EFHAEPVDVWSCGIVLTAML 202

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 136 KFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATIGR-IHHFHIVRL 193
           + K  +G G Y    R       +  AVK+++  K +  E   E+  + R   H +I+ L
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITL 81

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
                +G    +V E M  G L   I  +         S  +   + F + + VEYLH  
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLH-- 133

Query: 254 CNQRILHFDIKPHNILL---DHNFQP-KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
             Q ++H D+KP NIL      N +  +I DFG AK    +  +  L     TA ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPE 190

Query: 310 LFSRNFGEVSY--KSDVYSYGMML 331
           +  R      Y    D++S G++L
Sbjct: 191 VLERQ----GYDAACDIWSLGVLL 210

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 8e-23
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG- 195
             +G G YG V++G+ +  G   A+K+++      +E   E+  + +  HH +I    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 196 -----FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
                      +  LV EF   GS+   I     ++    L  E +  I   + RG+ +L
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-----GTAGY 305
           H     +++H DIK  N+LL  N + K+ DFG++    +       T  R     GT  +
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-------TVGRRNTFIGTPYW 195

Query: 306 IAPE-LFSRNFGEVSY--KSDVYSYGMMLLEM 334
           +APE +      + +Y  KSD++S G+  +EM
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 28/208 (13%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEF--INEVATIGRIHHFHIVRLL 194
           +LG+G YG V++         VA+K   LEH +  G     I EV+ +  + H +I+ L 
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELK 99

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
                  R  L++E+  N  L+K++        +  +S   +K   + +  GV + H   
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYM------DKNPDVSMRVIKSFLYQLINGVNFCHS-- 150

Query: 255 NQRILHFDIKPHNILLDHNFQP-----KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
            +R LH D+KP N+LL  +        KI DFGLA+     I I   T    T  Y  PE
Sbjct: 151 -RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG--IPIRQFTHEIITLWYRPPE 207

Query: 310 LFSRNFGEVSYKS--DVYSYGMMLLEMV 335
           +     G   Y +  D++S   +  EM+
Sbjct: 208 IL---LGSRHYSTSVDIWSIACIWAEML 232

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 23/223 (10%)

Query: 120 VNPTRYTYKELKKITSKF---KHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG--- 172
           +      ++ ++   + +      LG+G +  V +      G   A K L+  +      
Sbjct: 13  LGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72

Query: 173 QEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL 231
            E ++E+A +        ++ L       +   L+ E+   G +      +        +
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM----V 128

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS 288
           S   + ++   +  GV YLHQ     I+H D+KP NILL         KI DFG+++   
Sbjct: 129 SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
                  L    GT  Y+APE+ + +   ++  +D+++ G++ 
Sbjct: 186 HA---CELREIMGTPEYLAPEILNYDP--ITTATDMWNIGIIA 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 24/205 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIV 191
           +    LG+G +  V R   +  G   A  ++   K + ++      E      + H +IV
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           RL    SE     L+++ +  G L + I ++         S          +   V + H
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCH 127

Query: 252 QGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           Q     ++H ++KP N+LL         K++DFGLA     +          GT GY++P
Sbjct: 128 Q---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSP 182

Query: 309 ELFSRNFGEVSY--KSDVYSYGMML 331
           E+  ++     Y    D+++ G++L
Sbjct: 183 EVLRKD----PYGKPVDLWACGVIL 203

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 61/209 (29%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLGFC 197
           LG+G YG V           VAVK++  +      +    E+     ++H ++V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GVEY 249
            EG  + L  E+   G L   I           +  E         A+        GV Y
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI------EPDIGMP-EP-------DAQRFFHQLMAGVVY 120

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           LH      I H DIKP N+LLD     KISDFGLA +   +     L    GT  Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 310 LFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           L  R      +     DV+S G++L  M+
Sbjct: 178 LLKRR----EFHAEPVDVWSCGIVLTAML 202

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 26/208 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML-------EHLKGNGQEFINEVATIGRIHH 187
                LG G +  V + +    G+  A K +            + ++   EV+ +  I H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++ L       T   L+ E +  G L  F+  K +      L+ E+  +    +  GV
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGV 127

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA 303
            YLH     +I HFD+KP NI+L     P    KI DFGLA                GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 181

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMML 331
            ++APE+ +     +  ++D++S G++ 
Sbjct: 182 EFVAPEIVNYEP--LGLEADMWSIGVIT 207

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVK-MLEHLKGNGQEFIN--EVATI 182
           Y+ L  +        G+G YG V + +    G  VA+K  LE       + I   E+  +
Sbjct: 27  YENLGLV--------GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78

Query: 183 GRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
            ++ H ++V LL  C +  R  LV+EF+ + ++   +           L ++ ++K  F 
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-----ELFPNGLDYQVVQKYLFQ 132

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +  G+ + H      I+H DIKP NIL+  +   K+ DFG A+  +             T
Sbjct: 133 IINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEVYDDEVAT 187

Query: 303 AGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             Y APEL     G+V Y    DV++ G ++ EM 
Sbjct: 188 RWYRAPELL---VGDVKYGKAVDVWAIGCLVTEMF 219

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN---EVATIGRIHHFHIVRLLGF 196
           +G+G +  V   + +  G  VA+K+++  + N         EV  +  ++H +IV+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 197 CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ 256
                   L+ E+   G +  ++       +H  +  ++ +     +   V+Y HQ   +
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQYCHQ---K 133

Query: 257 RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG 316
           RI+H D+K  N+LLD +   KI+DFG +   +       L A  G   Y APELF     
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGK-- 188

Query: 317 EVSY---KSDVYSYGMMLLEMV 335
              Y   + DV+S G++L  +V
Sbjct: 189 --KYDGPEVDVWSLGVILYTLV 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.9 bits (234), Expect = 5e-22
 Identities = 50/210 (23%), Positives = 82/210 (39%), Gaps = 27/210 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE---------FINEVATIGRI 185
                LG G  G V           VA+K++   K                 E+  + ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
           +H  I+++  F  +     +V E M  G L   +           L     K   + +  
Sbjct: 73  NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLL 125

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQP---KISDFGLAKLCSKDISIVSLTAARGT 302
            V+YLH+     I+H D+KP N+LL    +    KI+DFG +K+  +      +    GT
Sbjct: 126 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGT 179

Query: 303 AGYIAPE-LFSRNFGEVSYKSDVYSYGMML 331
             Y+APE L S      +   D +S G++L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGR-----------IHHF 188
           LG+GG+G+VF G  L + + VA+K++   +  G   +++  T                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 189 HIVRLLGFCSEGTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG-VARG 246
            ++RLL +        LV E  +P   L  +I      +   PL  E   +  FG V   
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI------TEKGPLG-EGPSRCFFGQVVAA 151

Query: 247 VEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           +++ H    + ++H DIK  NIL+D      K+ DFG   L   +      T   GT  Y
Sbjct: 152 IQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVY 204

Query: 306 IAPELFSRNFGEVSY---KSDVYSYGMMLLEMV 335
             PE  SR+     Y    + V+S G++L +MV
Sbjct: 205 SPPEWISRH----QYHALPATVWSLGILLYDMV 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 40/226 (17%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEF----INEV 179
           Y+ + +I        G G YG+V++ +   +G  VA+K   + +  G G       + EV
Sbjct: 11  YEPVAEI--------GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62

Query: 180 ATIGRIH---HFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPL 231
           A + R+    H ++VRL+  C+           LV+E +    L  ++    + +    L
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGL 117

Query: 232 SWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI 291
             E +K +     RG+++LH      I+H D+KP NIL+      K++DFGLA++ S   
Sbjct: 118 PAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ- 173

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
             ++LT    T  Y APE+        +Y +  D++S G +  EM 
Sbjct: 174 --MALTPVVVTLWYRAPEVL---LQS-TYATPVDMWSVGCIFAEMF 213

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 34/211 (16%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN-------EVATIGRIHHF--HI 190
           LG GG+GSV+ G  + + +PVA+K +E  + +    +        EV  + ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 191 VRLLGFCSEGTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG-VARGVE 248
           +RLL +        L+ E   P   L  FI      +    L  E+L +  F  V   V 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFI------TERGALQ-EELARSFFWQVLEAVR 163

Query: 249 YLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           + H      +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  Y  
Sbjct: 164 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 216

Query: 308 PELFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           PE    +     Y    + V+S G++L +MV
Sbjct: 217 PEWIRYH----RYHGRSAAVWSLGILLYDMV 243

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.1 bits (229), Expect = 2e-21
 Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 32/210 (15%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN---------EVATIGRIHHFHI 190
           LG G +G V+          V VK ++  K     +I          E+A + R+ H +I
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 191 VRLLGFCSEGTRRALVYEFMPNGS-LEKFIFSKTNSSSHRPLSWEKLKKIAFG-VARGVE 248
           +++L          LV E   +G  L  FI              E L    F  +   V 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLD-------EPLASYIFRQLVSAVG 144

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL     + I+H DIK  NI++  +F  K+ DFG A    +           GT  Y AP
Sbjct: 145 YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAP 198

Query: 309 ELFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           E+   N     Y   + +++S G+ L  +V
Sbjct: 199 EVLMGN----PYRGPELEMWSLGVTLYTLV 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 25/203 (12%), Positives = 53/203 (26%), Gaps = 51/203 (25%)

Query: 140 RLGQGGYGSVFRG---KLFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVR 192
             G       ++     L     VA+  ++          QE ++    + RI    + R
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           +L          +V E++  GSL++              S     +    +A   +  H+
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA--------DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
                +      P  +         +S  G   L                   +      
Sbjct: 148 ---AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPD---- 178

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
                 + + D+   G  L  ++
Sbjct: 179 -----ANPQDDIRGIGASLYALL 196

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.0 bits (229), Expect = 4e-21
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 31/224 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVK-MLEHLKGNGQEFINEVATIGR 184
           ++  +          GQG +G+V  GK    G+ VA+K +++  +   +E +  +  +  
Sbjct: 25  FQVERMA--------GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAV 75

Query: 185 IHHFHIVRLL-GFCSEGTRR------ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
           +HH +IV+L   F + G R        +V E++P+ +L +    +             +K
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC--RNYYRRQVAPPPILIK 132

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSL 296
              F + R +  LH      + H DIKPHN+L++  +   K+ DFG AK  S     V+ 
Sbjct: 133 VFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMVGCR 338
             +R    Y APEL    FG   Y +  D++S G +  EM+   
Sbjct: 192 ICSR---YYRAPELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 57/209 (27%), Positives = 80/209 (38%), Gaps = 38/209 (18%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
           +G G +G     +       VAVK +E      +    E+     + H +IVR       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GVEYLH 251
            T  A++ E+   G L + I       +    S E         AR        GV Y H
Sbjct: 88  PTHLAIIMEYASGGELYERI------CNAGRFS-ED-------EARFFFQQLLSGVSYCH 133

Query: 252 QGCNQRILHFDIKPHNILLDHNFQP--KISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
                +I H D+K  N LLD +  P  KI DFG +K            +  GT  YIAPE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPE 187

Query: 310 LFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           +  R      Y    +DV+S G+ L  M+
Sbjct: 188 VLLRQ----EYDGKIADVWSCGVTLYVML 212

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.9 bits (226), Expect = 6e-21
 Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 28/204 (13%)

Query: 138 KHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLG 195
           K  LG G  G V        G   A+K+L       QE    V    +     HIV +L 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCILD 89

Query: 196 FCSEGTRRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
                        ++ E M  G L    FS+      +  +  +  +I   +   +++LH
Sbjct: 90  VYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 252 QGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
                 I H D+KP N+L    + +   K++DFG AK  +++    +L     T  Y+AP
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAP 198

Query: 309 E-LFSRNFGEVSYKSDVYSYGMML 331
           E L    + +     D++S G+++
Sbjct: 199 EVLGPEKYDK---SCDMWSLGVIM 219

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 25/203 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
           + +  LG+G    V+R K      P A+K+L+    + +    E+  + R+ H +I++L 
Sbjct: 56  EVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 195 GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL-KKIAFGVARGVEYLHQG 253
                 T  +LV E +  G L   I  K   S       E+        +   V YLH+ 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYS-------ERDAADAVKQILEAVAYLHE- 166

Query: 254 CNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
               I+H D+KP N+L      +   KI+DFGL+K+       V +    GT GY APE+
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEI 221

Query: 311 FSRNFGEVSY--KSDVYSYGMML 331
                   +Y  + D++S G++ 
Sbjct: 222 LRGC----AYGPEVDMWSVGIIT 240

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 55/240 (22%), Positives = 101/240 (42%), Gaps = 35/240 (14%)

Query: 121 NPTRYTYK-----ELKKITSKFK---HRLGQGGYGSVFRGK---LFNGIPVAVKMLEHLK 169
           +   Y +K     E +++   F+    ++G+G YG V++ K     +    A+K +E   
Sbjct: 1   DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT- 59

Query: 170 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA--LVYEFMPNGSLEKFIFSKTNSSS 227
           G       E+A +  + H +++ L         R   L++++  +  L   I     S +
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118

Query: 228 HR---PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP----KISD 280
           ++    L    +K + + +  G+ YLH      +LH D+KP NIL+          KI+D
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175

Query: 281 FGLAKLCSKDISIVSLTAARG---TAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            G A+L +    +  L        T  Y APEL     G   Y    D+++ G +  E++
Sbjct: 176 MGFARLFN--SPLKPLADLDPVVVTFWYRAPELL---LGARHYTKAIDIWAIGCIFAELL 230

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 38/226 (16%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKGNGQEF--INEVAT 181
           Y++L KI        GQG +G VF+ +    G  VA+K   +E+ K  G     + E+  
Sbjct: 19  YEKLAKI--------GQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKI 69

Query: 182 IGRIHHFHIVRLLGFCSEGTRRA--------LVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
           +  + H ++V L+  C               LV++F  +  L   +     S+     + 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-----SNVLVKFTL 123

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
            ++K++   +  G+ Y+H+    +ILH D+K  N+L+  +   K++DFGLA+  S   + 
Sbjct: 124 SEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 294 VS--LTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
                T    T  Y  PEL     GE  Y    D++  G ++ EM 
Sbjct: 181 QPNRYTNRVVTLWYRPPELL---LGERDYGPPIDLWGAGCIMAEMW 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 54/216 (25%), Positives = 84/216 (38%), Gaps = 33/216 (15%)

Query: 124 RYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKMLEHLKGNGQEFINEVATI 182
            Y      K        LG+G +    +     +    AVK++   K        E+  +
Sbjct: 9   HYDLDLKDKP-------LGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITAL 59

Query: 183 GRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL-KKIA 240
                H +IV+L     +     LV E +  G L + I  K + S       E     I 
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS-------ETEASYIM 112

Query: 241 FGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKDISIVSLT 297
             +   V ++H      ++H D+KP N+L    + N + KI DFG A+L   D     L 
Sbjct: 113 RKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LK 167

Query: 298 AARGTAGYIAPELFSRNFGEVSY--KSDVYSYGMML 331
               T  Y APEL ++N     Y    D++S G++L
Sbjct: 168 TPCFTLHYAAPELLNQN----GYDESCDLWSLGVIL 199

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 56/235 (23%), Positives = 90/235 (38%), Gaps = 44/235 (18%)

Query: 107 QLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRG-KLFNGIPVAVKML 165
           Q+K    ++DY+                      LG G  G V +          A+KML
Sbjct: 53  QIKKNAIIDDYKV-----------------TSQVLGLGINGKVLQIFNKRTQEKFALKML 95

Query: 166 EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA----LVYEFMPNGSLEKFIF 220
           +    +  +   EV    R     HIVR++              +V E +  G L    F
Sbjct: 96  Q----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----F 147

Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPK 277
           S+      +  +  +  +I   +   ++YLH      I H D+KP N+L      N   K
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 204

Query: 278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMML 331
           ++DFG AK  +      SLT    T  Y+APE L    + +     D++S G+++
Sbjct: 205 LTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGVIM 253

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 67/256 (26%)

Query: 126 TYKELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFIN-EVATIG 183
            Y   K +        G G +G V       +G   A+K +         + N E+  + 
Sbjct: 8   KYSLGKTL--------GTGSFGIVCEVFDIESGKRFALKKVL----QDPRYKNRELDIMK 55

Query: 184 RIHHFHIVRLL-GFCSEGTRRA-------------------------------------L 205
            + H +I++L+  F + G                                         +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKP 265
           + E++P+ +L K +  K+   S R +    +    + + R V ++H   +  I H DIKP
Sbjct: 116 IMEYVPD-TLHKVL--KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKP 169

Query: 266 HNILLD-HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS-- 322
            N+L++  +   K+ DFG AK        V+   +R    Y APEL     G   Y    
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATEYTPSI 223

Query: 323 DVYSYGMMLLEMVGCR 338
           D++S G +  E++  +
Sbjct: 224 DLWSIGCVFGELILGK 239

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 6e-20
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFIN-------------------- 177
           +G+G YG V       +    A+K+L  + L                             
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 178 -----EVATIGRIHHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRP 230
                E+A + ++ H ++V+L+    +     L  V+E +  G + +         + +P
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------TLKP 133

Query: 231 LSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD 290
           LS ++ +     + +G+EYLH    Q+I+H DIKP N+L+  +   KI+DFG++      
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 291 ISIVSLTAARGTAGYIAPELFSRNFGEVS-YKSDVYSYGMMLLEMV 335
            +++S T   GT  ++APE  S      S    DV++ G+ L   V
Sbjct: 191 DALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 51/226 (22%), Positives = 99/226 (43%), Gaps = 42/226 (18%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI 185
           Y+ ++K+        G+G Y  VF    + N   V VK+L+ +K   ++   E+    +I
Sbjct: 38  YQLVRKL--------GRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREI----KI 83

Query: 186 -----HHFHIVRLLG-FCSEGTRR-ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKK 238
                   +I+ L        +R  ALV+E + N   ++           + L+   ++ 
Sbjct: 84  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRF 134

Query: 239 IAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVSLT 297
             + + + ++Y H      I+H D+KPHN+++DH + + ++ D+GLA+            
Sbjct: 135 YMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYN 188

Query: 298 AARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP 343
               +  +  PEL   ++    Y  D++S G ML  M+     K+P
Sbjct: 189 VRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIF---RKEP 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 40/225 (17%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK--LFNGIPVAVKM--LEHLKGNGQEF--INEVA 180
           Y+ + +I        G+G YG VF+ +     G  VA+K   ++  +  G     I EVA
Sbjct: 13  YECVAEI--------GEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVA 63

Query: 181 T---IGRIHHFHIVRLL-----GFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLS 232
               +    H ++VRL            T+  LV+E +    L  ++    +      + 
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVP 118

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
            E +K + F + RG+++LH     R++H D+KP NIL+  + Q K++DFGLA++ S    
Sbjct: 119 TETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173

Query: 293 IVSLTAARGTAGYIAPELFSRNFGEVSYKS--DVYSYGMMLLEMV 335
            ++LT+   T  Y APE+        SY +  D++S G +  EM 
Sbjct: 174 -MALTSVVVTLWYRAPEVL---LQS-SYATPVDLWSVGCIFAEMF 213

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 83.0 bits (206), Expect = 2e-18
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLG 195
           LG G +G V  G+    G  VAVK+L   K    + +     E+  +    H HI++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             S  T   +V E++  G L  +I        H  +   + +++   +   V+Y H+   
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDYCHR--- 129

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+KP N+LLD +   KI+DFGL+ + S       L  + G+  Y APE+ S   
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGR- 185

Query: 316 GEVSY---KSDVYSYGMMLLEMV 335
               Y   + D++S G++L  ++
Sbjct: 186 ---LYAGPEVDIWSCGVILYALL 205

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 40/211 (18%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLG 195
           LG G +G V  GK    G  VAVK+L   K    + +     E+  +    H HI++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GV 247
             S  +   +V E++  G L  +I        +  L  EK        +R        GV
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI------CKNGRLD-EK-------ESRRLFQQILSGV 129

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           +Y H+     ++H D+KP N+LLD +   KI+DFGL+ + S       L  + G+  Y A
Sbjct: 130 DYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAA 183

Query: 308 PELFSRNFGEVSY---KSDVYSYGMMLLEMV 335
           PE+ S       Y   + D++S G++L  ++
Sbjct: 184 PEVISGR----LYAGPEVDIWSSGVILYALL 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 42/213 (19%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKMLE--HLKGNGQEF--INE---VATIGRIHH 187
           +G+GG+G V+       GK++     A+K L+   +K    E   +NE   ++ +     
Sbjct: 197 IGRGGFGEVYGCRKADTGKMY-----AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 188 FHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
             IV +    +  T   L  + + M  G L        + S H   S   ++  A  +  
Sbjct: 252 PFIVCM--SYAFHTPDKLSFILDLMNGGDL------HYHLSQHGVFSEADMRFYAAEIIL 303

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAG 304
           G+E++H    + +++ D+KP NILLD +   +ISD GLA   SK         A  GT G
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHG 355

Query: 305 YIAPELFSRNFGEVSYKSDV--YSYGMMLLEMV 335
           Y+APE+  +      Y S    +S G ML +++
Sbjct: 356 YMAPEVLQKGVA---YDSSADWFSLGCMLFKLL 385

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 37/256 (14%)

Query: 98  RESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSK-FKHR--LGQGGYGSVFR--- 151
             +      Q   ++FL+    +   ++ + E + +    F     LG+GG+G VF    
Sbjct: 147 LRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQM 206

Query: 152 ---GKLFNGIPVAVKML--EHLKGNGQEF--INEVATIGRIHHFHIVRLLGFCSEGTRRA 204
              GKL+     A K L  + LK        + E   + ++H   IV L    +  T+  
Sbjct: 207 KATGKLY-----ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AYAFETKTD 259

Query: 205 L--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFD 262
           L  V   M  G +            +      +       +  G+E+LHQ   + I++ D
Sbjct: 260 LCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRD 314

Query: 263 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAPELFSRNFGEVSYK 321
           +KP N+LLD +   +ISD GLA    +  +  + T    GT G++APEL         Y 
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLGE----EYD 367

Query: 322 SDV--YSYGMMLLEMV 335
             V  ++ G+ L EM+
Sbjct: 368 FSVDYFALGVTLYEMI 383

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 25/203 (12%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRIHHFHIVRLLG 195
           LG+G +G V           VA+K +        +       E++ +  + H HI++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             +  T   +V E+   G L  +I         + ++ ++ ++    +   +EY H+   
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAIEYCHR--- 126

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
            +I+H D+KP N+LLD N   KI+DFGL+ + +       L  + G+  Y APE+ +   
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGK- 182

Query: 316 GEVSY---KSDVYSYGMMLLEMV 335
               Y   + DV+S G++L  M+
Sbjct: 183 ---LYAGPEVDVWSCGIVLYVML 202

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 45/255 (17%)

Query: 99  ESEKEKETQLKVEKFLEDYRTVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVF--RGKL 154
              K K     + ++ +    +   R   +  E+ K+       +G+G +G V   R K 
Sbjct: 40  ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKS 92

Query: 155 FNGIPVAVKML---EHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSEGTRRALVYEFM 210
              +  A+K+L   E +K +   F  E   I    +   +V+L     +     +V E+M
Sbjct: 93  TRKV-YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151

Query: 211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GVEYLHQGCNQRILHFD 262
           P G L               ++      +    AR         ++ +H       +H D
Sbjct: 152 PGGDL---------------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRD 193

Query: 263 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS 322
           +KP N+LLD +   K++DFG     +K+  +   TA  GT  YI+PE+     G+  Y  
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR 252

Query: 323 DV--YSYGMMLLEMV 335
           +   +S G+ L EM+
Sbjct: 253 ECDWWSVGVFLYEML 267

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 63/269 (23%)

Query: 98  RESEKEKETQLKVEKFLEDYRTVNPTRYT---YKELKKIT-SKFKHR--LGQGGYGSVFR 151
           +E  +     L V  F +   ++   R+    + E + +T + F+    LG+GG+G V  
Sbjct: 143 QELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA 202

Query: 152 ------GKLFNGIPVAVKML--EHLKGNGQEF--INEVATIGRIHHFHIVRLLGFCSEGT 201
                 GK++     A K L  + +K    E   +NE   + +++   +V L    +  T
Sbjct: 203 CQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYET 255

Query: 202 RRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR----------GVEY 249
           + AL  V   M  G L+  I                + +  F  AR          G+E 
Sbjct: 256 KDALCLVLTLMNGGDLKFHI--------------YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAGYIAP 308
           LH+   +RI++ D+KP NILLD +   +ISD GLA      +        R GT GY+AP
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAP 354

Query: 309 ELFSRNFGEVSYKSDV--YSYGMMLLEMV 335
           E+         Y      ++ G +L EM+
Sbjct: 355 EVVKNE----RYTFSPDWWALGCLLYEMI 379

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 48/255 (18%)

Query: 101 EKEKETQLKVEKFLEDYRTVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVF------RG 152
            +EK     +E        V   R   +  E+ K+       +G+G +G V         
Sbjct: 47  RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKV-------IGRGAFGEVAVVKLKNAD 99

Query: 153 KLFNGIPVAVKML---EHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSEGTRRAL--V 206
           K+F     A+K+L   E LK        E   +        I  L    +      L  V
Sbjct: 100 KVF-----AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLV 152

Query: 207 YEFMPNGSLEKFIFSKTNSSSHR-PLSWEKLKKIAFGVAR---GVEYLHQGCNQRILHFD 262
            ++   G L     +  +    R P    +     F +A     ++ +HQ      +H D
Sbjct: 153 MDYYVGGDL----LTLLSKFEDRLPEEMAR-----FYLAEMVIAIDSVHQ---LHYVHRD 200

Query: 263 IKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVSYK 321
           IKP NIL+D N   +++DFG      +D ++ S  A  GT  YI+PE L +   G+  Y 
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYG 259

Query: 322 SDV--YSYGMMLLEM 334
            +   +S G+ + EM
Sbjct: 260 PECDWWSLGVCMYEM 274

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 32/225 (14%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FIN---------E 178
           + S +     +  G YG+V  G    GIPVA+K + +   +G+      +         E
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 179 VATIGRIHHFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSW 233
           +  +   HH +I+ L          A     LV E M    L + I           +S 
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI-----HDQRIVISP 133

Query: 234 EKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI 293
           + ++   + +  G+  LH+     ++H D+ P NILL  N    I DF LA+  + D   
Sbjct: 134 QHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD--- 187

Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            + T       Y APEL    F   +   D++S G ++ EM   +
Sbjct: 188 ANKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT 302
           +   ++YL     QRI+H D+KP NILLD +    I+DF +A +  ++  I ++    GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GT 177

Query: 303 AGYIAPELFSRNFGEVSYKS-DVYSYGMMLLEM 334
             Y+APE+FS   G     + D +S G+   E+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 32/208 (15%)

Query: 141 LGQGGYGSVFRGKL-FNGIPVAVKML--EH-LKGNGQEFIN-EVATIGRIHHFHIVRLLG 195
           LG+G + +V   +        A+K+L   H +K N   ++  E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR--------GV 247
              +  +      +  NG L K+I               K+        R         +
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI--------------RKIGSFDETCTRFYTAEIVSAL 143

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           EYLH    + I+H D+KP NILL+ +   +I+DFG AK+ S +       +  GTA Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PEL +         SD+++ G ++ ++V
Sbjct: 201 PELLTEK--SACKSSDLWALGCIIYQLV 226

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 42/220 (19%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQ---------EFINEVATIGRIH--HF 188
           LG G + +V+  K + N   VA+K++   K   +         + +N+            
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 189 HIVRLLG-FCSEGTRRA---LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           HI++LL  F  +G       +V+E +   +L   I  K     HR +    +K+I+  + 
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI--KKYE--HRGIPLIYVKQISKQLL 141

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHNFQP------KISDFGLAKLCSKDIS--IVSL 296
            G++Y+H+ C   I+H DIKP N+L++    P      KI+D G A    +  +  I + 
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 297 TAARGTAGYIAPELFSRNFG-EVSYKSDVYSYGMMLLEMV 335
                   Y +PE+     G      +D++S   ++ E++
Sbjct: 200 E-------YRSPEVL---LGAPWGCGADIWSTACLIFELI 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 61/271 (22%), Positives = 98/271 (36%), Gaps = 77/271 (28%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKM----------------LEHLKGNGQ 173
           K    LG+G +G V     F          VAVKM                L+ L   G 
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 174 ------------------EFINEVATIGRIHHF---HIVRLLGFCSEGTRRALVYEFMPN 212
                               I E    G +  +        + + ++G R     +++  
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144

Query: 213 GSLEKFIFSKTNSSSH---------------------------RPLSWEKLKKIAFGVAR 245
             ++      + +SS                              L+ E L   +F VA+
Sbjct: 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAK 204

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           G+E+L     ++ +H D+   NILL      KI DFGLA+   KD   V    AR    +
Sbjct: 205 GMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 306 IAPE-LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +APE +F R +   + +SDV+S+G++L E+ 
Sbjct: 262 MAPETIFDRVY---TIQSDVWSFGVLLWEIF 289

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 42/253 (16%)

Query: 101 EKEKETQLKVEKFLEDYRTVNPTRYTYK--ELKKITSKFKHRLGQGGYGSVF--RGKLFN 156
            ++K     ++        +   R      E+ K+       +G+G +  V   + K   
Sbjct: 34  AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKV-------IGRGAFSEVAVVKMKQTG 86

Query: 157 GIPVAVKML---EHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSEGTRRAL--VYEFM 210
            +  A+K++   + LK        E   +        I +L    +      L  V E+ 
Sbjct: 87  QV-YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYY 143

Query: 211 PNGSLEKFIFSKTNSSSHR-PLSWEKLKKIAFGVAR---GVEYLHQGCNQRILHFDIKPH 266
             G L     +  +    R P    +     F +A     ++ +H+      +H DIKP 
Sbjct: 144 VGGDL----LTLLSKFGERIPAEMAR-----FYLAEIVMAIDSVHR---LGYVHRDIKPD 191

Query: 267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKS---- 322
           NILLD     +++DFG       D ++ SL A  GT  Y++PE+     G     S    
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 323 -DVYSYGMMLLEM 334
            D ++ G+   EM
Sbjct: 251 CDWWALGVFAYEM 263

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 23/201 (11%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFK--HRLGQGGYGSVFRGK 153
              +       Q   ++          +        +I  +++  H +G G YG V    
Sbjct: 14  SGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAY 73

Query: 154 -LFNGIPVAVK----MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA---- 204
                  VA+K    + E L  + +  + E+A + R++H H+V++L              
Sbjct: 74  DKLEKRVVAIKKILRVFEDL-IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 205 -LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI 263
            +V E   +   +K         +   L+   +K + + +  GV+Y+H      ILH D+
Sbjct: 133 YVVLEIADS-DFKKLF------RTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDL 182

Query: 264 KPHNILLDHNFQPKISDFGLA 284
           KP N L++ +   K+ DFGLA
Sbjct: 183 KPANCLVNQDCSVKVCDFGLA 203

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 133 ITSKFKH--RLGQGGYGSVFRGK-LFNGIPVAVKML----EHLKGNGQEFINEVATIGRI 185
           +  ++++   +G G  G V           VA+K L    ++   + +    E+  +  +
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT-HAKRAYRELVLMKCV 81

Query: 186 HHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
           +H +I+ LL  F  + +        +V E M   +L + I           L  E++  +
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--------QMELDHERMSYL 132

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + +  G+++LH      I+H D+KP NI++  +   KI DFGLA+          +T  
Sbjct: 133 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPY 186

Query: 300 RGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             T  Y APE +    +       D++S G ++ EM+   
Sbjct: 187 VVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMIKGG 223

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 40/158 (25%), Positives = 60/158 (37%), Gaps = 20/158 (12%)

Query: 137 FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLL 194
               LG G  G V +          A+KML+       +   EV    R     HIVR++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIV 77

Query: 195 GFCSEGTRRA----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
                         +V E +  G L    FS+      +  +  +  +I   +   ++YL
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 251 HQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAK 285
           H      I H D+KP N+L      N   K++DFG AK
Sbjct: 134 HS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 31/219 (14%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKML----EHLKGNGQEFINEVATIGRI 185
           + + ++    +G G YG+V        G  VA+K L    +      +    E+  +  +
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHM 81

Query: 186 HHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
            H +++ LL  F  + T        LV  FM    L K +        H  L  ++++ +
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM-------KHEKLGEDRIQFL 133

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + + +G+ Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +     +T  
Sbjct: 134 VYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGY 185

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             T  Y APE+   N+   +   D++S G ++ EM+  +
Sbjct: 186 VVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 31/222 (13%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATI 182
           Y  L  I        G+G YG V       N + VA+K +   EH     Q  + E+  +
Sbjct: 29  YTNLSYI--------GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-YCQRTLREIKIL 79

Query: 183 GRIHHFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLK 237
            R  H +I+ +       T        +V + M    L K + ++        LS + + 
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ-------HLSNDHIC 131

Query: 238 KIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS-L 296
              + + RG++Y+H      +LH D+KP N+LL+     KI DFGLA++   D      L
Sbjct: 132 YFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           T    T  Y APE+   N    +   D++S G +L EM+  R
Sbjct: 189 TEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 32/225 (14%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATIGRIH 186
           I+S F+    LG+G YG V        G  VA+K +   +         + E+  +    
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTLREIKILKHFK 67

Query: 187 HFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           H +I+ +       +        ++ E M    L + I       S + LS + ++   +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-------STQMLSDDHIQYFIY 119

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
              R V+ LH      ++H D+KP N+L++ N   K+ DFGLA++  +  +  S    + 
Sbjct: 120 QTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 302 TA--GYI------APELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           +    ++      APE+      + S   DV+S G +L E+   R
Sbjct: 177 SGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 63/262 (24%)

Query: 97  SRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVF--RGKL 154
            +ES KE   + K E FL+ + T +       +           LG G +G V   + K 
Sbjct: 11  EQESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFD-----RIKTLGTGSFGRVMLVKHKE 64

Query: 155 FNGIPVAVKML-----------EHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR 203
            +G   A+K+L           EH         NE   +  ++   +V+L     + +  
Sbjct: 65  -SGNHYAMKILDKQKVVKLKQIEHTL-------NEKRILQAVNFPFLVKLEFSFKDNSNL 116

Query: 204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI 263
            +V E++  G +    FS             +    A  +    EYLH   +  +++ D+
Sbjct: 117 YMVMEYVAGGEM----FSHLRRIGRFSEPHARF--YAAQIVLTFEYLH---SLDLIYRDL 167

Query: 264 KPHNILLDHNFQPKISDFGLAK--------LCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           KP N+L+D     +++DFG AK        LC             GT   +APE+     
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------------GTPEALAPEIILSK- 213

Query: 316 GEVSY-KS-DVYSYGMMLLEMV 335
               Y K+ D ++ G+++ EM 
Sbjct: 214 ---GYNKAVDWWALGVLIYEMA 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 32/219 (14%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKML----EHLKGNGQEFINEVATIGRI 185
           +   +     +G G YGSV       +G  VA+K L    +      +    E+  +  +
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI-FAKRAYRELLLLKHM 80

Query: 186 HHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
            H +++ LL  F    + R      LV  FM    L+K +            S EK++ +
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--------GLKFSEEKIQYL 131

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
            + + +G++Y+H      ++H D+KP N+ ++ + + KI DFGLA+    +     +T  
Sbjct: 132 VYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGY 183

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             T  Y APE+   ++   +   D++S G ++ EM+  +
Sbjct: 184 VVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 44/239 (18%)

Query: 121 NPTRYTYKELKK---ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE 174
            PT Y  +  K    +  +++    +G G YGSV        G+ VAVK L       + 
Sbjct: 12  RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRP 65

Query: 175 FIN---------EVATIGRIHHFHIVRLLG-FCSEGTRRA-----LVYEFMPNGSLEKFI 219
           F +         E+  +  + H +++ LL  F    +        LV   M    L   +
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV 124

Query: 220 FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS 279
             +        L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI 
Sbjct: 125 KCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 174

Query: 280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           DFGLA+  + +     +T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 175 DFGLARHTADE-----MTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 57/259 (22%), Positives = 102/259 (39%), Gaps = 46/259 (17%)

Query: 102 KEKETQLKVEKFLEDYRTVNPTRYTYKELKK---ITSKFK--HRLGQGGYGSVFRGK-LF 155
           K+ +     + +      V+   Y+ +       +  +++    +G G  G V       
Sbjct: 26  KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAV 85

Query: 156 NGIPVAVKMLEHLKGNGQEFIN---------EVATIGRIHHFHIVRLLG-FCSEGTRRA- 204
               VA+K L       + F N         E+  +  ++H +I+ LL  F  + T    
Sbjct: 86  LDRNVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139

Query: 205 ----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILH 260
               LV E M   +L + I           L  E++  + + +  G+++LH      I+H
Sbjct: 140 QDVYLVMELMDA-NLCQVI--------QMELDHERMSYLLYQMLCGIKHLHSAG---IIH 187

Query: 261 FDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LFSRNFGEVS 319
            D+KP NI++  +   KI DFGLA+          +T    T  Y APE +    +    
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGY---K 241

Query: 320 YKSDVYSYGMMLLEMVGCR 338
              D++S G ++ EMV  +
Sbjct: 242 ENVDIWSVGCIMGEMVRHK 260

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.9 bits (164), Expect = 9e-13
 Identities = 53/241 (21%), Positives = 99/241 (41%), Gaps = 40/241 (16%)

Query: 119 TVNPTRYTYKELKKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQ 173
           ++N   +       + S++     LG GG G VF          VA+K +     + + +
Sbjct: 1   SMNIHGFD------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-SVK 53

Query: 174 EFINEVATIGRIHHFHIVRLLG-FCSEGTRRA-------------LVYEFMPNGSLEKFI 219
             + E+  I R+ H +IV++       G++               +V E+M    L   +
Sbjct: 54  HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL 112

Query: 220 FSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKI 278
                     PL  E  +   + + RG++Y+H      +LH D+KP N+ ++  +   KI
Sbjct: 113 EQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162

Query: 279 SDFGLAKLCSKDISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
            DFGLA++     S    L+    T  Y +P L   +    +   D+++ G +  EM+  
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTG 221

Query: 338 R 338
           +
Sbjct: 222 K 222

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 44/213 (20%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI------HHFHIVRL 193
           +G+G +G V +         VA+KM+ + K   ++   E+  +  +      +  +++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 194 LGF-------CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
           L         C       + +E + + +L + I  K N    +  S   ++K A  + + 
Sbjct: 165 LENFTFRNHIC-------MTFELL-SMNLYELI--KKNK--FQGFSLPLVRKFAHSILQC 212

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQP--KISDFGLAKLCSKDIS--IVSLTAARGT 302
           ++ LH+    RI+H D+KP NILL    +   K+ DFG +    + +   I S       
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF----- 264

Query: 303 AGYIAPELFSRNFG-EVSYKSDVYSYGMMLLEM 334
             Y APE+     G       D++S G +L E+
Sbjct: 265 --YRAPEVI---LGARYGMPIDMWSLGCILAEL 292

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRL 193
           +   ++G G +G +  GK L+    VA+K LE +K    +   E     ++     I ++
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 194 LGFCSEGTRRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
             F   G   A+V E +  G SLE  +F   +    R  S + +  IA  +   +EY+H 
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLED-LFDLCD----RTFSLKTVLMIAIQLISRMEYVH- 122

Query: 253 GCNQRILHFDIKPHNILLDHNFQPK-----ISDFGLAK 285
             ++ +++ D+KP N L+            I DF LAK
Sbjct: 123 --SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 54/249 (21%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN---------EVA 180
           +   +   H +G+G YG V+          VA+K +  +      F +         E+ 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREIT 77

Query: 181 TIGRIHHFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
            + R+   +I+RL                +V E   +  L+K         +   L+ E 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF------KTPIFLTEEH 130

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           +K I + +  G  ++H+     I+H D+KP N LL+ +   K+ DFGLA+  + +     
Sbjct: 131 IKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 296 LTAARGTAG--------------------YIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +                            Y APEL        +   D++S G +  E++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-LQENYTKSIDIWSTGCIFAELL 246

Query: 336 GCRKNKDPA 344
              ++    
Sbjct: 247 NMLQSHIND 255

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 73/225 (32%)

Query: 141 LGQGGYGSVF--RGKLFNGIPVAVKML-----------EHLKGNGQEFINEVATIGRIHH 187
           LG G +G V   R +  NG   A+K+L           EH         +E   +  + H
Sbjct: 14  LGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTN-------DERLMLSIVTH 65

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR-- 245
             I+R+ G   +  +  ++ +++  G L    FS         L   K ++    VA+  
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FS------L--LR--KSQRFPNPVAKFY 111

Query: 246 ------GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK--------LCSKDI 291
                  +EYLH    + I++ D+KP NILLD N   KI+DFG AK        LC    
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---- 164

Query: 292 SIVSLTAARGTAGYIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
                    GT  YIAPE+ S       Y KS D +S+G+++ EM
Sbjct: 165 ---------GTPDYIAPEVVSTK----PYNKSIDWWSFGILIYEM 196

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 80/264 (30%)

Query: 139 HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH--------HFH 189
            +LG G + +V+    +     VA+K+++  +   +  ++E+  +  +            
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 190 IVRLLG-FC---SEGTRRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
           +V+LL  F      GT   +V+E +  G  L K+I      S+++ L    +KKI   V 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWI----IKSNYQGLPLPCVKKIIQQVL 156

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILL---------------------------------- 270
           +G++YLH  C   I+H DIKP NILL                                  
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 271 ---------------DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
                              + KI+D G A    K       T    T  Y + E+     
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL---I 266

Query: 316 G-EVSYKSDVYSYGMMLLEMVGCR 338
           G   +  +D++S   M  E+    
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 54/250 (21%), Positives = 94/250 (37%), Gaps = 72/250 (28%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVK--------------------MLEHLK 169
           +  K++   +LG+G YG V++      G  VAVK                    +L  L 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 170 GNGQEFINEVATIGRIHHFHIVRLLG-FCSEGTRRA-LVYEFMPNGSLEKFIFSKTNSSS 227
           G                H +IV LL    ++  R   LV+++M    L   I +      
Sbjct: 67  G----------------HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN----- 104

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
              L     + + + + + ++YLH G    +LH D+KP NILL+     K++DFGL++  
Sbjct: 105 --ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159

Query: 288 SKDISIVSLTAARGTAG-------------------YIAPELFSRNFGEVSYKSDVYSYG 328
                + +                            Y APE+      + +   D++S G
Sbjct: 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLG 218

Query: 329 MMLLEMVGCR 338
            +L E++  +
Sbjct: 219 CILGEILCGK 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 3e-11
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 17/157 (10%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRL 193
           K   R+G+G +G +F G  L N   VA+K  E  + +  +  +E  T   +     I  +
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
             F  EG    LV + +   SLE  +         R  S + +   A  +   V+ +H  
Sbjct: 72  YYFGQEGLHNVLVIDLLGP-SLED-LLDLCG----RKFSVKTVAMAAKQMLARVQSIH-- 123

Query: 254 CNQRILHFDIKPHNILLDHNFQPK-----ISDFGLAK 285
             + +++ DIKP N L+            + DFG+ K
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 4e-11
 Identities = 43/278 (15%), Positives = 75/278 (26%), Gaps = 77/278 (27%)

Query: 106 TQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVK-- 163
           +Q     F     +        +  +KI        G+G +G VF+    +  PVA+K  
Sbjct: 6   SQKGPVPF-----SHCLPTEKLQRCEKI--------GEGVFGEVFQTIA-DHTPVAIKII 51

Query: 164 ------------------------MLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE 199
                                   + + L     E  N       ++  H V+  G    
Sbjct: 52  AIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ--GSYPP 109

Query: 200 GTRRALVYEFMPNGSLEKFIFSKTNSSSH-----------------RPLSWEKLKKIAFG 242
              +A  +     GS         +                     +  S    K I   
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQ 169

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-----LCSKDISIVSLT 297
           +   +            H D+   N+LL      K+      K      C   +SI+  T
Sbjct: 170 LTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227

Query: 298 AARGTAG--------YIAPELFSRNFGEVSYKSDVYSY 327
            +R             +  +LF+   G+  Y+ D+Y  
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFT---GDGDYQFDIYRL 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 51/217 (23%), Positives = 86/217 (39%), Gaps = 50/217 (23%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEF----INEVATIGRI------HHFH 189
           +G+G +G V +         VA+K+++    N + F      EV  +  +        ++
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 190 IVRLLGF-------CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
           IV L          C       LV+E +   S   +   +  +   R +S    +K A  
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTN--FRGVSLNLTRKFAQQ 165

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--KISDFGLAKLCSKDIS--IVSLTA 298
           +   + +L       I+H D+KP NILL +  +   KI DFG +    + I   I S   
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF- 223

Query: 299 ARGTAGYIAPELFSRNFG-EVSYKSDVYSYGMMLLEM 334
                 Y +PE+     G       D++S G +L+EM
Sbjct: 224 ------YRSPEVL---LGMPYDLAIDMWSLGCILVEM 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 47/214 (21%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKML-----------EHLKGNGQEFINEVATIG 183
           LG+G +G V        G L+     AVK+L           E       E    + ++ 
Sbjct: 31  LGKGSFGKVMLARVKETGDLY-----AVKVLKKDVILQDDDVECTMT---E--KRILSLA 80

Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           R H F + +L        R   V EF+  G L   I         R     + +  A  +
Sbjct: 81  RNHPF-LTQLFCCFQTPDRLFFVMEFVNGGDLMFHI------QKSRRFDEARARFYAAEI 133

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GT 302
              + +LH    + I++ D+K  N+LLDH    K++DFG+ K     I     TA   GT
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCGT 187

Query: 303 AGYIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
             YIAPE+         Y  + D ++ G++L EM
Sbjct: 188 PDYIAPEILQEM----LYGPAVDWWAMGVLLYEM 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 17/156 (10%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRL 193
           +   ++G G +G ++ G  +  G  VA+K+ E +K    +   E      +     I  +
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 194 LGFCSEGTRRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
               +EG    +V E +  G SLE  +F+  +    R  S + +  +A  +   +EY+H 
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLED-LFNFCS----RKFSLKTVLLLADQMISRIEYIH- 122

Query: 253 GCNQRILHFDIKPHNILL---DHNFQPKISDFGLAK 285
             ++  +H D+KP N L+          I DFGLAK
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 49/215 (22%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKML-----------EHLKGNGQEFINEVATIG 183
           LG+G +G VF        + F     A+K L           E       E    V ++ 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFF-----AIKALKKDVVLMDDDVECTMV---E--KRVLSLA 74

Query: 184 RIHHFHIVRLLG-FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
             H F +  +   F ++      V E++  G L   I       S       +    A  
Sbjct: 75  WEHPF-LTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI------QSCHKFDLSRATFYAAE 126

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +  G+++LH    + I++ D+K  NILLD +   KI+DFG+ K    ++   + T    G
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCG 180

Query: 302 TAGYIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
           T  YIAPE+         Y  S D +S+G++L EM
Sbjct: 181 TPDYIAPEILLGQ----KYNHSVDWWSFGVLLYEM 211

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 28/92 (30%), Positives = 47/92 (51%), Gaps = 13/92 (14%)

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-GTAG 304
            + YLH+   + I++ D+K  N+LLD     K++D+G+ K     +     T+   GT  
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 175

Query: 305 YIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
           YIAPE+         Y  S D ++ G+++ EM
Sbjct: 176 YIAPEILRGE----DYGFSVDWWALGVLMFEM 203

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 13/95 (13%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           ++  + YLH+   + I++ D+K  N+LLD     K++D+G+ K     +     T+   G
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCG 215

Query: 302 TAGYIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
           T  YIAPE+         Y  S D ++ G+++ EM
Sbjct: 216 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEM 246

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 69/225 (30%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKML--EHLKGNGQEFINEVA-TIG--RI---- 185
           LG+G +G V        G+ +     A+K+L  E +        +EVA T+   R+    
Sbjct: 156 LGKGTFGKVILVKEKATGRYY-----AMKILKKEVIVAK-----DEVAHTLTENRVLQNS 205

Query: 186 -HHFHIVRLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
            H F +  L    S  T   L  V E+   G L    F       H  LS E++    F 
Sbjct: 206 RHPF-LTAL--KYSFQTHDRLCFVMEYANGGEL----FF------H--LSRERV----FS 246

Query: 243 VAR----------GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS 292
             R           ++YLH   N  +++ D+K  N++LD +   KI+DFGL K     I 
Sbjct: 247 EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE---GIK 301

Query: 293 IVSLTAAR-GTAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
             +      GT  Y+APE+   N     Y   V  +  G+++ EM
Sbjct: 302 DGATMKTFCGTPEYLAPEVLEDN----DYGRAVDWWGLGVVMYEM 342

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 17/162 (10%)

Query: 131 KKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH- 186
            ++ +KF+   ++G G +G ++ G  +     VA+K+ E++K    + + E      +  
Sbjct: 3   PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQG 61

Query: 187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARG 246
              I  +  F  EG    LV + +   SLE  +F+  +    R LS + +  +A  +   
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCS----RKLSLKTVLMLADQMINR 115

Query: 247 VEYLHQGCNQRILHFDIKPHNILLDHNFQPK---ISDFGLAK 285
           VE++H   ++  LH DIKP N L+    +     I DFGLAK
Sbjct: 116 VEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 58.3 bits (142), Expect = 7e-10
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 66/224 (29%)

Query: 141 LGQGGYGSVF---------RGKLFNGIPVAVKML--EHLKGNGQEFINEVATIG------ 183
           LGQG +G VF           +L+     A+K+L    LK       + V T        
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLY-----AMKVLKKATLKVR-----DRVRTKMERDILV 81

Query: 184 RIHHFHIVRLLGFCS--EGTRRALVYEFMPNGSL-----EKFIFSKTNSSSHRPLSWEKL 236
            ++H  IV+L    +     +  L+ +F+  G L     ++ +F+            E+ 
Sbjct: 82  EVNHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT------------EED 127

Query: 237 KKI-AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
            K     +A  +++LH      I++ D+KP NILLD     K++DFGL+K      SI  
Sbjct: 128 VKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-----SIDH 179

Query: 296 LTAAR---GTAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
              A    GT  Y+APE+ +R      +      +S+G+++ EM
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRR----GHTQSADWWSFGVLMFEM 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 13/95 (13%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A  + YLH      I++ D+KP NILLD      ++DFGL K    +I   S T+   G
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCG 201

Query: 302 TAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
           T  Y+APE+  +      Y   V  +  G +L EM
Sbjct: 202 TPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEM 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 58.0 bits (141), Expect = 9e-10
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 13/95 (13%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +   +EYLH    + +++ DIK  N++LD +   KI+DFGL K     IS  +      G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCG 167

Query: 302 TAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
           T  Y+APE+   N     Y   V  +  G+++ EM
Sbjct: 168 TPEYLAPEVLEDN----DYGRAVDWWGLGVVMYEM 198

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
            +E+LH+     I++ DIK  NILLD N    ++DFGL+K    D +  +     GT  Y
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEM 334
           +AP++            D +S G+++ E+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 13/95 (13%)

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A G+ +L     + I++ D+K  N++LD     KI+DFG+ K    +I     T    G
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG 183

Query: 302 TAGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
           T  YIAPE+ +       Y   V  +++G++L EM
Sbjct: 184 TPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEM 214

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 31/215 (14%), Positives = 66/215 (30%), Gaps = 43/215 (20%)

Query: 96  KSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-- 153
              E+   +     +E         + +   +K              +   G ++     
Sbjct: 13  LGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQ--------TRDNQGILYEAAPT 64

Query: 154 -------LFNGIPVAVKMLEHLKGNG------------QEFINEVATIGRIHHFHIVRLL 194
                         ++K L+   G                 +N+   +       I   +
Sbjct: 65  STLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCM 123

Query: 195 GF-CSEGTRRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
           GF   +   R LV   +  G SL+  +    + S    LS   + ++A  +   +E+LH 
Sbjct: 124 GFGVHQDKYRFLVLPSL--GRSLQSAL----DVSPKHVLSERSVLQVACRLLDALEFLH- 176

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAK 285
                 +H ++   NI +D   Q ++  + +G A 
Sbjct: 177 --ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 49/215 (22%)

Query: 141 LGQGGYGSVF------RGKLFNGIPVAVKML-----------EHLKGNGQEFINEVATIG 183
           LG+G +G V         +L+     AVK+L           E       E    V  + 
Sbjct: 349 LGKGSFGKVMLSERKGTDELY-----AVKILKKDVVIQDDDVECTMV---E--KRVLALP 398

Query: 184 RIHHFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFG 242
               F + +L   C +   R   V E++  G L   I                    A  
Sbjct: 399 GKPPF-LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAE 450

Query: 243 VARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR-G 301
           +A G+ +L     + I++ D+K  N++LD     KI+DFG+ K    +I     T    G
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCG 504

Query: 302 TAGYIAPELFSRNFGEVSY-KS-DVYSYGMMLLEM 334
           T  YIAPE+ +       Y KS D +++G++L EM
Sbjct: 505 TPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEM 535

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 17/94 (18%)

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAAR---GT 302
            + +LHQ   + I++ D+KP NI+L+H    K++DFGL K      SI   T      GT
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-----SIHDGTVTHTFCGT 184

Query: 303 AGYIAPELFSRNFGEVSYKSDV--YSYGMMLLEM 334
             Y+APE+  R+     +   V  +S G ++ +M
Sbjct: 185 IEYMAPEILMRS----GHNRAVDWWSLGALMYDM 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 41/231 (17%), Positives = 83/231 (35%), Gaps = 48/231 (20%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK----GNGQ--------------EFIN 177
           K    +GQGG+G ++   + +   V       +K     NG               E I 
Sbjct: 38  KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97

Query: 178 EVATIGRIHHFHIVRLLGFCSEGTR----RALVYEFMPNG-SLEKFIFSKTNSSSHRPLS 232
           +     ++ +  + +  G           R ++ +    G  L+K I+        +  S
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANA----KRFS 150

Query: 233 WEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAKL---- 286
            + + +++  +   +EY+H       +H DIK  N+LL++    ++   D+GLA      
Sbjct: 151 RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 287 -CSKDISIVSLTAARGTAGYIAPELFSRN--FG-EVSYKSDVYSYGMMLLE 333
              K  +        GT  +      S +   G   S + D+   G  +++
Sbjct: 208 GVHKAYAADPKRCHDGTIEFT-----SIDAHNGVAPSRRGDLEILGYCMIQ 253

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.3 bits (126), Expect = 9e-08
 Identities = 53/243 (21%), Positives = 90/243 (37%), Gaps = 82/243 (33%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRI-----HHFHI 190
           +G G +G V   + + N    AVK++     N +++      E   + +I     ++ +I
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNI 98

Query: 191 VRLLGF-------CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           V+  G        C       L++E +   SL + I    N+  +     E +K     +
Sbjct: 99  VKYHGKFMYYDHMC-------LIFEPL-GPSLYEII--TRNN--YNGFHIEDIKLYCIEI 146

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-------------------------KI 278
            + + YL +     + H D+KP NILLD  +                           K+
Sbjct: 147 LKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 279 SDFGLAKLCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEV------SYKSDVYSYGMML 331
            DFG A   S     I++      T  Y AP        EV         SD++S+G +L
Sbjct: 204 IDFGCATFKSDYHGSIIN------TRQYRAP--------EVILNLGWDVSSDMWSFGCVL 249

Query: 332 LEM 334
            E+
Sbjct: 250 AEL 252

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 39/229 (17%), Positives = 78/229 (34%), Gaps = 47/229 (20%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKM--LEHLKG-------------NGQEFINEV 179
               ++G GG+G ++           A  +  +E+ +                ++ I + 
Sbjct: 40  VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99

Query: 180 ATIGRIHHFHIVRLLGF----CSEGTRRALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWE 234
               ++ +  I    G         + R +V E +  G  L+K          +      
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS------GQNGTFKKS 151

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI--SDFGLAKLCS---- 288
            + ++   +   +EY+H       +H DIK  N+LL +    ++  +D+GL+        
Sbjct: 152 TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 289 -KDISIVSLTAARGTAGYIAPELFSRN--FG-EVSYKSDVYSYGMMLLE 333
            K           GT  +      S +   G  +S +SDV   G  +L 
Sbjct: 209 HKQYQENPRKGHNGTIEFT-----SLDAHKGVALSRRSDVEILGYCMLR 252

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 47/239 (19%), Positives = 86/239 (35%), Gaps = 78/239 (32%)

Query: 141 LGQGGYGSVFRG--KLFNGIPVAVKMLEHLKGNGQEFIN----EVATIGRIHH------F 188
           LG+G +G V            VA+K++     N  ++      E+  + +I        F
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKF 82

Query: 189 HIVRLLGF-------CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
             V +  +       C       + +E +       F F K N+   +P     ++ +A+
Sbjct: 83  LCVLMSDWFNFHGHMC-------IAFELL---GKNTFEFLKENN--FQPYPLPHVRHMAY 130

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP-------------------KISDFG 282
            +   + +LH+    ++ H D+KP NIL  ++                      +++DFG
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 283 LAKLCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEV------SYKSDVYSYGMMLLEM 334
            A    +  + IV+      T  Y  P        EV      +   DV+S G +L E 
Sbjct: 188 SATFDHEHHTTIVA------TRHYRPP--------EVILELGWAQPCDVWSIGCILFEY 232

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 59/246 (23%), Positives = 86/246 (34%), Gaps = 92/246 (37%)

Query: 141 LGQGGYGSVFRGK--LFNGIPVAVK-----------------MLEHLKGNGQEFINEVAT 181
           LG+G +G V         G  VAVK                 +LEHL             
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPN------- 74

Query: 182 IGRIHHFHIVRLLGF-------CSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
                 F  V++L +       C       +V+E +   S   FI  K N     P   +
Sbjct: 75  ----STFRCVQMLEWFEHHGHIC-------IVFELL-GLSTYDFI--KENG--FLPFRLD 118

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP------------------ 276
            ++K+A+ + + V +LH     ++ H D+KP NIL   +                     
Sbjct: 119 HIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 277 -KISDFGLAKLCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEV------SYKSDVYSYG 328
            K+ DFG A    +  S +VS      T  Y AP        EV      S   DV+S G
Sbjct: 176 IKVVDFGSATYDDEHHSTLVS------TRHYRAP--------EVILALGWSQPCDVWSIG 221

Query: 329 MMLLEM 334
            +L+E 
Sbjct: 222 CILIEY 227

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.7 bits (102), Expect = 7e-05
 Identities = 45/304 (14%), Positives = 84/304 (27%), Gaps = 85/304 (27%)

Query: 62  KQNRGLGPLSISLISTGTSIGGIVLFALVIFLIYKSRESEKEKETQLKVEKFLEDYRTVN 121
           ++     P  +S+I+     G      L  +  +K    +K       +E  L     + 
Sbjct: 320 REVLTTNPRRLSIIAESIRDG------LATWDNWKHVNCDKLTTI---IESSLNV---LE 367

Query: 122 PT--RYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEV 179
           P   R  +  L                 SVF         +   +L  +  +  +  ++V
Sbjct: 368 PAEYRKMFDRL-----------------SVFP----PSAHIPTILLSLIWFDVIK--SDV 404

Query: 180 ATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPL-------- 231
             +  ++  H   L+    E   +      +P+  LE  +  +   + HR +        
Sbjct: 405 MVV--VNKLHKYSLV----EKQPKESTI-SIPSIYLELKVKLENEYALHRSIVDHYNIPK 457

Query: 232 ---SWEKLKKIAFGVARGVEYL------HQGCNQRILHFDIKPHNILLDHNF-QPKISDF 281
              S + +            Y       H    +      +    + LD  F + KI   
Sbjct: 458 TFDSDDLIPPYLDQ------YFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHD 510

Query: 282 GLAKLCSKDISIVSLTAARGTAGYIA---PEL---------FSRNFGEVSYKS---DVYS 326
             A   S  I    L   +    YI    P+          F     E    S   D+  
Sbjct: 511 STAWNASGSILNT-LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569

Query: 327 YGMM 330
             +M
Sbjct: 570 IALM 573

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	344
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.97
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.27
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.22
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.01
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.63
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.59
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.38
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.19
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.99
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.86
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.76
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.71
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.49
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.31
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.98
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.49
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.42
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.96
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.39
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.74
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.65
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	89.5
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	84.2
2knc_B	79	Integrin beta-3; transmembrane signaling, protein	81.24
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	80.38

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-55  Score=394.13  Aligned_cols=210  Identities=25%  Similarity=0.435  Sum_probs=178.5

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcC
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG  200 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  200 (344)
                      |+...+.+|.++||+|+||+||+|++.      +++.||||+++...  ...++|.+|+.++++++|||||+++|+|.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            344444567899999999999999852      46789999997533  3457899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL  270 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill  270 (344)
                      +..+||||||++|||.++|......          .....++|..+++++.|||+||+|||+   ++|+||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEE
Confidence            9999999999999999999754321          112469999999999999999999999   999999999999999


Q ss_pred             cCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          271 DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       271 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++++++||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~  250 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCG  250 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999976554333334556799999999999764  89999999999999999998 8889864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-54  Score=386.37  Aligned_cols=203  Identities=28%  Similarity=0.470  Sum_probs=172.8

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.++||+|+||+||+|+..      ++..||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+||||
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E   95 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence            45788999999999999853      47789999997643 334789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          209 FMPNGSLEKFIFSKT-------NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~-------~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ||++|+|.++|....       .......++|.+++.++.|||+||+|||+   ++|+||||||+||||++++++||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCc
Confidence            999999999997532       11223579999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999876554333333345689999999999875  89999999999999999998 8999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-54  Score=383.58  Aligned_cols=197  Identities=32%  Similarity=0.532  Sum_probs=164.6

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.++||+|+||+||+|++.  ..||||+++...   ...++|.+|+.+|++++|||||+++|++.+ +..+||||||++
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            46788999999999999853  369999997533   234679999999999999999999999865 568999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.++|....     ..+++.++..|+.|||+||+|||+   ++|+||||||+||||++++++||+|||+|+.......
T Consensus       116 GsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          116 SSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999996543     469999999999999999999999   9999999999999999999999999999987655433


Q ss_pred             ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........||+.|||||++.+. .+.++.++|||||||++|||+||+.||+.
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~  239 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH  239 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence            3334566899999999998643 24689999999999999999999999963

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.9e-54  Score=387.12  Aligned_cols=203  Identities=29%  Similarity=0.467  Sum_probs=166.6

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.++||+|+||+||+|+..      +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+....+||||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35688999999999999853      47889999997543 334789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          209 FMPNGSLEKFIFSKTNS---------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      ||++|+|.++++.....         ....+++|.+++.++.|||+||+|||+   ++|+||||||+||||++++++||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence            99999999999764321         123579999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCC
Confidence            99999976554333333456799999999999875  79999999999999999998 8999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-53  Score=379.27  Aligned_cols=198  Identities=26%  Similarity=0.400  Sum_probs=177.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            55678999999999999984 56899999999742    34457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+....
T Consensus       114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999654      359999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..........+||+.|||||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~  236 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRA  236 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            4443344567899999999999875  789999999999999999999999964

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.1e-53  Score=382.29  Aligned_cols=198  Identities=23%  Similarity=0.362  Sum_probs=168.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.++||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            44568899999999999985 568999999997543   23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.++|.....    ..+++..++.++.||+.||+|||+   ++|+||||||+||||++++++||+|||+|+.....
T Consensus       106 ~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          106 EGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             TTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999965432    458999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ......||+.|||||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       179 ~~--~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~  227 (350)
T 4b9d_A          179 VE--LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEA  227 (350)
T ss_dssp             HH--HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cc--cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            21  12346799999999999875  789999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-52  Score=379.96  Aligned_cols=195  Identities=29%  Similarity=0.418  Sum_probs=173.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+++.+||||||+++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            34557899999999999985 468999999997533 3446789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++..       ..+++..+..++.||+.||+|||+   ++|+||||||+||||+.++++||+|||+|+.......
T Consensus       156 g~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          156 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999954       248999999999999999999999   9999999999999999999999999999997765432


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  .....||+.|||||++.+.  .|+.++||||+||++|||++|+.||..
T Consensus       226 ~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~  272 (346)
T 4fih_A          226 R--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFN  272 (346)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            2  3457899999999999765  789999999999999999999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.1e-52  Score=368.97  Aligned_cols=192  Identities=28%  Similarity=0.463  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc----CCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE----GTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  207 (344)
                      .|.++||+|+||+||+|.. .++..||+|++....   ...+.|.+|+++|++++|||||++++++.+    ...++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999985 458899999997533   234678999999999999999999999865    34679999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEc-CCCceEEeecCCc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLD-HNFQPKISDFGLA  284 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~-~~~~~kl~Dfgla  284 (344)
                      |||++|+|.+++...      ..+++..+..++.||+.||+|||+   ++  |+||||||+||||+ +++++||+|||+|
T Consensus       109 Ey~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            999999999999653      358999999999999999999998   66  99999999999997 4899999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +......    .....||+.|||||++.+   .++.++|||||||++|||++|+.||..
T Consensus       180 ~~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          180 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EeCCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            8654332    245679999999999864   589999999999999999999999953

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-51  Score=372.67  Aligned_cols=192  Identities=28%  Similarity=0.341  Sum_probs=165.7

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.++||+|+||+||+|+. .+|+.||||+++....    ..+|+.++++++|||||++++++.+++..+|||||+++|+|
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            456799999999999985 4689999999975432    24799999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccCCccc-
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSKDISI-  293 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~~~~-  293 (344)
                      .++|...      ..+++..+..++.||+.||+|||+   ++|+||||||+||||+.++ ++||+|||+|+....+... 
T Consensus       138 ~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          138 GQLIKQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999654      359999999999999999999999   9999999999999999987 6999999999977543221 


Q ss_pred             --eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 --VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .......||+.|||||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~  258 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQ  258 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             ceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence              112345799999999999875  789999999999999999999999964

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-51  Score=381.23  Aligned_cols=195  Identities=29%  Similarity=0.422  Sum_probs=173.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++.+|||||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            34557899999999999985 468999999997543 3446789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++..       ..+++..+..++.||+.||+|||+   ++|+||||||+||||+.++++||+|||+|+.......
T Consensus       233 G~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          233 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999854       248999999999999999999999   9999999999999999999999999999997765432


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .....+||+.|||||++.+.  .|+.++|||||||++|||++|+.||..
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~  349 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFN  349 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              23456799999999999775  789999999999999999999999964

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-51  Score=369.49  Aligned_cols=198  Identities=26%  Similarity=0.377  Sum_probs=161.2

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~  211 (344)
                      .+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|++.+++    .++||||||+
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~   84 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE   84 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence            3568899999999999985 7899999999764433333445666778899999999999997653    6899999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG-----CNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      +|+|.++|+.       ..++|+.+.+++.|+++||+|||+.     ..++|+||||||+||||++++++||+|||+|+.
T Consensus        85 ~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           85 HGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             TCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999964       3489999999999999999999972     124999999999999999999999999999987


Q ss_pred             ccCCccce--eeecccCCccccccccccccc----CCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          287 CSKDISIV--SLTAARGTAGYIAPELFSRNF----GEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       287 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ........  ......||+.|||||++.+..    ..++.++|||||||++|||+||+.|+
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            75443221  223457999999999986531    24677999999999999999998765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.6e-52  Score=369.95  Aligned_cols=196  Identities=27%  Similarity=0.342  Sum_probs=165.1

Q ss_pred             HhhcccccccCcEEEEEEEEe----CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +++.+.||+|+||+||+|+..    +++.||||+++...   .....+.+|+++|++++|||||++++++.+++..++||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            456789999999999999742    46789999997432   23357889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||+   ++|+||||||+|||+++++++||+|||+|+..
T Consensus       106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999654      359999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  ......||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~  228 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQG  228 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCC
Confidence            44322  22456799999999999775  789999999999999999999999964

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-51  Score=360.60  Aligned_cols=195  Identities=27%  Similarity=0.442  Sum_probs=158.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++...    ...+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            45678899999999999984 468999999997432    2346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      + +|+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+....
T Consensus        95 ~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           95 A-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             C-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             C-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9 78999999653      469999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|||||++.+. ..++.++||||+||++|||++|+.||+.
T Consensus       165 ~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          165 GNF---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             -------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCc---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence            322   2456799999999999875 2346799999999999999999999975

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-51  Score=376.24  Aligned_cols=210  Identities=32%  Similarity=0.478  Sum_probs=177.2

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEeC------CceEEEEEeecccc--chHHHHHHHHHHhhhcc-cceeeEeeEEEc
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKG--NGQEFINEVATIGRIHH-FHIVRLLGFCSE  199 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h-~niv~~~~~~~~  199 (344)
                      |+....+.+.+.||+|+||+||+|+...      ++.||||+++....  ..++|.+|+++|++++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3444455677899999999999997543      35799999975432  34679999999999965 899999999976


Q ss_pred             -CCeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 041350          200 -GTRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI  268 (344)
Q Consensus       200 -~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Ni  268 (344)
                       ++.+++|||||++|+|.++|......          .....+++..+..++.|||+||+|||+   ++||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence             45789999999999999999754321          123569999999999999999999999   9999999999999


Q ss_pred             EEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       269 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |+++++++||+|||+|+....+..........||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999987665544445567799999999999875  89999999999999999998 8999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-49  Score=354.46  Aligned_cols=197  Identities=25%  Similarity=0.393  Sum_probs=156.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCC----------
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGT----------  201 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------  201 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++....  ..+.+.+|+.+|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            34568899999999999984 4689999999975432  3367899999999999999999999986543          


Q ss_pred             --eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          202 --RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       202 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                        .+++||||+++|+|.+++.....   ....++..++.++.||++||+|||+   ++|+||||||+|||++.++++||+
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence              47999999999999999965432   1345677889999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccc----------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          280 DFGLAKLCSKDISI----------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       280 Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      |||+|+....+...          ...+...||+.|||||++.+.  .++.++|||||||++|||++   ||.
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCC
Confidence            99999977543221          112345799999999999875  78999999999999999996   664

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-47  Score=349.03  Aligned_cols=195  Identities=19%  Similarity=0.326  Sum_probs=166.2

Q ss_pred             HhhcccccccCcEEEEEEEEe----CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.++||+|+||+||+|+..    +++.||+|.+... .....+.+|+++|+.+ +||||+++++++.+.+..++||||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~  101 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY  101 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence            455688999999999999743    4678999998654 3456788999999998 699999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCccccc
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCS  288 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~~  288 (344)
                      +++|+|.+++         ..+++.+++.++.|++.||+|||+   ++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       102 ~~g~~L~~~~---------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          102 LEHESFLDIL---------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCHHHHH---------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCcccHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999998         348999999999999999999999   999999999999999877 799999999998654


Q ss_pred             CCcc--------------------------ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDIS--------------------------IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....                          ........||+.|||||++.+. ..++.++||||+||++|||++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3211                          0112345699999999998764 358899999999999999999999995


Q ss_pred             C
Q 041350          343 P  343 (344)
Q Consensus       343 ~  343 (344)
                      +
T Consensus       249 ~  249 (361)
T 4f9c_A          249 K  249 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=354.70  Aligned_cols=198  Identities=26%  Similarity=0.424  Sum_probs=167.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEc------CCeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE------GTRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~  204 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++....   ..+.+.+|+++|++++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            44568899999999999985 5699999999975432   23578899999999999999999998753      36789


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ||||||+ |+|.+++..      ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|
T Consensus       136 ivmE~~~-g~L~~~i~~------~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHS------SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEECCS-EEHHHHHTS------SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEeCCC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence            9999995 789999943      3469999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCc--cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDI--SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.+....  .........||+.|||||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            8764321  11223456899999999998764 3578999999999999999999999964

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-46  Score=364.51  Aligned_cols=193  Identities=26%  Similarity=0.359  Sum_probs=166.6

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHH---HHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFIN---EVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.||+|+||+||+|+. .+|+.||||+++..    ........+   ++.+++.++|||||++++++.+.+.+|+|||
T Consensus       193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmE  272 (689)
T 3v5w_A          193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD  272 (689)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEe
Confidence            346799999999999985 46899999999742    222233344   4667777899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |++||+|.++|...      ..+++..++.++.||+.||+|||+   ++|+||||||+||||+.+|++||+|||+|+...
T Consensus       273 y~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          273 LMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             CCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999654      359999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...    ....+||+.|||||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~  393 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQ  393 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred             CCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            542    2456899999999999643 2688999999999999999999999953

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-45  Score=357.45  Aligned_cols=196  Identities=24%  Similarity=0.396  Sum_probs=173.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||+|++.... ...+.+.+|+.+|+.++|||||++++++.+...++||||||++
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            45678899999999999985 468999999997543 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC--CceEEeecCCcccccCC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLAKLCSKD  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~--~~~kl~Dfgla~~~~~~  290 (344)
                      |+|.++|....     ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+.....
T Consensus       239 g~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          239 GELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999995332     469999999999999999999999   999999999999999854  89999999999987654


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       311 ~~---~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~  358 (573)
T 3uto_A          311 QS---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGG  358 (573)
T ss_dssp             SE---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             Cc---eeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32   2456799999999999875  789999999999999999999999964

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-43  Score=331.13  Aligned_cols=199  Identities=25%  Similarity=0.305  Sum_probs=171.4

Q ss_pred             hhcccccccCcEEEEEEEEeC-CceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+..+ ++.||+|+++..    ....+.+.+|..++..++||||+++++++.+....++||||+
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~  156 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY  156 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence            345789999999999998654 789999999752    222345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+|+.....
T Consensus       157 ~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          157 VGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             TTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999996532     469999999999999999999999   99999999999999999999999999999876544


Q ss_pred             ccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++...   .+.++.++|||||||++|||++|+.||..
T Consensus       229 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          229 GTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             SCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            322 22346799999999998621   24688999999999999999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-42  Score=312.83  Aligned_cols=208  Identities=29%  Similarity=0.417  Sum_probs=179.9

Q ss_pred             CcccCHHHHHHHHHh------------hcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcc
Q 041350          122 PTRYTYKELKKITSK------------FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHH  187 (344)
Q Consensus       122 ~~~~~~~~l~~~~~~------------~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h  187 (344)
                      +..+++++++.++..            ..+.||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            356788888877754            2357999999999999865 69999999997543 345778999999999999


Q ss_pred             cceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 041350          188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN  267 (344)
Q Consensus       188 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~N  267 (344)
                      |||+++++++...+..++||||+++++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~N  171 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDS  171 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGG
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHH
Confidence            9999999999999999999999999999999842       358999999999999999999999   999999999999


Q ss_pred             eEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       268 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ||++.++.+||+|||+++........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             EEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999876554322  2355799999999999764  788999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=321.38  Aligned_cols=200  Identities=21%  Similarity=0.228  Sum_probs=170.8

Q ss_pred             HhhcccccccCcEEEEEEE------EeCCceEEEEEeeccccchHHHHHHHHHHhhhc---ccceeeEeeEEEcCCeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGK------LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH---HFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  205 (344)
                      +.+.+.||+|+||+||+|.      ..+++.||||+++.  ...+++..|++++.+++   |+||+++++++...+..++
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS--CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC--CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            3455789999999999993      45688999999975  34567888888888886   9999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-----------CC
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----------NF  274 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-----------~~  274 (344)
                      ||||+++|+|.+++..... .....+++..++.++.|+++||+|||+   .+|+||||||+|||++.           ++
T Consensus       145 v~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             EEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccC
Confidence            9999999999999975322 123569999999999999999999999   99999999999999998           89


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .+||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||++|+.||.
T Consensus       221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccc
Confidence            9999999999865433333344567799999999999875  68999999999999999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-42  Score=315.87  Aligned_cols=195  Identities=26%  Similarity=0.356  Sum_probs=171.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +|+.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~   87 (337)
T 1o6l_A            8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence            45678999999999999854 5899999999752    345578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        88 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           88 NGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             TTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999653      358999999999999999999999   99999999999999999999999999999864332


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       159 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCC
Confidence            21  22456799999999999764  789999999999999999999999964

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-42  Score=314.90  Aligned_cols=195  Identities=26%  Similarity=0.427  Sum_probs=171.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+. .+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~   97 (328)
T 3fe3_A           18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence            4567899999999999985 5789999999975432   33678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus        98 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           98 GGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             TCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999654      358999999999999999999999   999999999999999999999999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....||+.|+|||++.+. ...+.++||||+|+++|||++|+.||+.
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            2   2456799999999999765 2335799999999999999999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-42  Score=309.34  Aligned_cols=194  Identities=25%  Similarity=0.395  Sum_probs=171.9

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus        23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~  102 (297)
T 3fxz_A           23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG  102 (297)
T ss_dssp             CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence            4557899999999999974 56899999999754 344577899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++...       .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........ 
T Consensus       103 ~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A          103 SLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             BHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            999999542       48999999999999999999999   9999999999999999999999999999987654432 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             22456799999999999765  789999999999999999999999854

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.5e-43  Score=325.15  Aligned_cols=197  Identities=24%  Similarity=0.333  Sum_probs=170.5

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+.. +++.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34578999999999999864 5889999999752    233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...       .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+|+.....
T Consensus       152 ~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          152 PGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             TTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            999999998542       48999999999999999999999   99999999999999999999999999999876544


Q ss_pred             ccceeeecccCCccccccccccccc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNF--GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .. .......||+.|+|||++.+..  +.++.++|||||||++|||++|+.||..
T Consensus       222 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          222 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             SE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Cc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence            22 2224567999999999987541  1278899999999999999999999964

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.4e-43  Score=316.72  Aligned_cols=197  Identities=30%  Similarity=0.466  Sum_probs=169.0

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+. .++.||||++.........+..|+.++++++||||+++++++.+..    ..++||||++
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           27 QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            4567899999999999984 5889999999876555567778999999999999999999997743    4799999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeeecCCCCCceEEcCCCceEEeec
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ----------RILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~----------~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      +|+|.+++..       ..+++..++.++.|+++||+|||+   .          +|+||||||+|||++.++.+||+||
T Consensus       106 ~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          106 KGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             TCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999954       248999999999999999999998   7          9999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCccccccccccccc---CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF---GEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++...............||+.|+|||++.+..   ..++.++||||||+++|||++|+.||+.
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            9998776544333334467999999999987521   2456688999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=317.91  Aligned_cols=196  Identities=26%  Similarity=0.351  Sum_probs=167.9

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+.. +|+.||+|+++..    ....+.+.+|..+++.+ +||||+++++++.+.+..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            445688999999999999854 5889999999753    23446788999999988 69999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       105 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          105 FVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999654      358999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       176 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~  226 (353)
T 3txo_A          176 CNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEA  226 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCC
Confidence            3221  22456799999999999765  688999999999999999999999964

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-42  Score=318.86  Aligned_cols=204  Identities=26%  Similarity=0.454  Sum_probs=172.8

Q ss_pred             HhhcccccccCcEEEEEEEEe--------CCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCCeE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  203 (344)
                      +.+.+.||+|+||+||+|+..        ++..||||+++....  ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        83 ~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  162 (370)
T 2psq_A           83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL  162 (370)
T ss_dssp             EEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSC
T ss_pred             CEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCE
Confidence            345678999999999999753        345799999975432  336789999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus       163 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred             EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCC
Confidence            9999999999999999765421          112458999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          274 FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       274 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999876544333333445678999999998764  78999999999999999998 8888853

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.6e-42  Score=312.49  Aligned_cols=200  Identities=39%  Similarity=0.679  Sum_probs=173.2

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.+.||+|+||+||+|+..+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            346799999999999998789999999987543 3457899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++.....  ....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..........
T Consensus       123 ~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          123 KRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             GGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             HHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999965432  22468999999999999999999999   9999999999999999999999999999986543322222


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....||+.|+|||++.+.  .++.++||||||+++|||++|+.|+..
T Consensus       198 ~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             ccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccc
Confidence            2345689999999998764  789999999999999999999999853

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=309.95  Aligned_cols=192  Identities=28%  Similarity=0.399  Sum_probs=170.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +|+.||+|+++..    ....+.+.+|..+++.++||||+++++++.+....++||||+
T Consensus         9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   88 (318)
T 1fot_A            9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   88 (318)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence            45678999999999999854 6899999999753    234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        89 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           89 EGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999653      358999999999999999999999   99999999999999999999999999999875442


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             -----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCC
Confidence                 2345799999999998764  788999999999999999999999964

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.5e-42  Score=314.11  Aligned_cols=195  Identities=26%  Similarity=0.425  Sum_probs=171.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+++.. +|+.||+|+++....       ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            345688999999999999854 589999999975322       246889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC----ceEEeecC
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDFG  282 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Dfg  282 (344)
                      |||+++|+|.+++..      ...+++..+..++.||+.||+|||+   .+|+||||||+|||+++++    .+||+|||
T Consensus        94 ~e~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           94 LELVSGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EECCCSCBHHHHHTT------CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEcCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999943      2469999999999999999999999   9999999999999998877    79999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++.......   .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~  220 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLG  220 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9987655422   2345699999999998764  788999999999999999999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-42  Score=314.60  Aligned_cols=216  Identities=43%  Similarity=0.756  Sum_probs=183.8

Q ss_pred             CcccCHHHHHHHHHhh--cccccccCcEEEEEEEEeCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEE
Q 041350          122 PTRYTYKELKKITSKF--KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFC  197 (344)
Q Consensus       122 ~~~~~~~~l~~~~~~~--~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~  197 (344)
                      ...+++.++.....++  .+.||+|+||+||+|+..+++.||||++....  .....+.+|++++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            4567888888776666  47799999999999987789999999997533  2234789999999999999999999999


Q ss_pred             EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceE
Q 041350          198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  277 (344)
Q Consensus       198 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~k  277 (344)
                      .+.+..++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+.+..+|+||||||+|||+++++.+|
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            999999999999999999999976542  235699999999999999999999992222999999999999999999999


Q ss_pred             EeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      |+|||+++........ ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+
T Consensus       175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             eccCccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCccc
Confidence            9999999876544322 22445699999999998764  68899999999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-42  Score=311.12  Aligned_cols=196  Identities=20%  Similarity=0.288  Sum_probs=172.9

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||+||+++.. +++.+|+|.+.......+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~   86 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence            345678999999999999854 5889999999866555677899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC--CCceEEeecCCcccccCCc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~--~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++......
T Consensus        87 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           87 DIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             BHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999995432     468999999999999999999999   99999999999999987  7899999999998775543


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          159 N---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence            2   2345689999999999764  678999999999999999999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=322.36  Aligned_cols=199  Identities=22%  Similarity=0.279  Sum_probs=171.6

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +|+.||+|+++...    ...+.+.+|..++..++||||+++++++.+.+..++||||+
T Consensus        64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~  143 (412)
T 2vd5_A           64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY  143 (412)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence            34578999999999999864 68999999997522    23345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus       144 ~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          144 VGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             CSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999996543     358999999999999999999999   99999999999999999999999999999876554


Q ss_pred             ccceeeecccCCcccccccccccc-----cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN-----FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... ......||+.|+|||++...     ...++.++|||||||++|||++|+.||..
T Consensus       216 ~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          216 GTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             SCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Ccc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            321 22345799999999998631     13678999999999999999999999964

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=317.70  Aligned_cols=195  Identities=23%  Similarity=0.357  Sum_probs=169.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+++.. +++.||+|+++...    ...+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            345688999999999999854 57899999997532    2234678999999887 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|..++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       134 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          134 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999654      358999999999999999999999   999999999999999999999999999998633


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             cCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            2211  23456799999999999875  78999999999999999999999995

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.6e-42  Score=313.08  Aligned_cols=196  Identities=24%  Similarity=0.333  Sum_probs=171.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+.. +|+.||+|+++..    ....+.+..|..++..+ +||||+++++++.+....++|||
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E   98 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   98 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            345678999999999999864 5889999999753    34556788999999987 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus        99 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           99 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999653      358999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            3221  12456799999999999775  789999999999999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-42  Score=312.38  Aligned_cols=198  Identities=30%  Similarity=0.400  Sum_probs=169.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||+||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus        10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~   89 (323)
T 3tki_A           10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   89 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence            45678999999999999854 68899999996432  2336788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        90 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           90 GELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999998432      458999999999999999999999   9999999999999999999999999999987654433


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........||+.|+|||++.+. ...+.++||||||+++|||++|+.||+.
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence            2233456799999999998764 2347789999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-41  Score=305.34  Aligned_cols=212  Identities=41%  Similarity=0.684  Sum_probs=183.9

Q ss_pred             CcccCHHHHHHHHHhhc--------ccccccCcEEEEEEEEeCCceEEEEEeeccc-----cchHHHHHHHHHHhhhccc
Q 041350          122 PTRYTYKELKKITSKFK--------HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-----GNGQEFINEVATIGRIHHF  188 (344)
Q Consensus       122 ~~~~~~~~l~~~~~~~~--------~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~  188 (344)
                      ...+++.++..++.+|.        +.||+|+||+||+|+. ++..||||++....     ...+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45789999999999886        4599999999999984 78899999986432     2346789999999999999


Q ss_pred             ceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 041350          189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI  268 (344)
Q Consensus       189 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Ni  268 (344)
                      ||+++++++.+.+..++||||+++++|.+++.....   ...+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni  164 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI  164 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence            999999999999999999999999999999964322   2468999999999999999999999   9999999999999


Q ss_pred             EEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       269 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ++++++.+||+|||+++...............||+.|+|||++.+   .++.++||||||+++|||++|+.|++.
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            999999999999999987654433333344568999999998865   478899999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=306.43  Aligned_cols=198  Identities=25%  Similarity=0.463  Sum_probs=170.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||+|+||+||+|+.. +++.||+|.+... ....+.+.+|++++++++||||+++++++.++...++||||+++|
T Consensus        13 ~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCC
Confidence            35678999999999999854 5889999988653 334578999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus        93 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           93 TLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             BHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             cHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999997543     458999999999999999999999   99999999999999999999999999999876443221


Q ss_pred             e------------eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 V------------SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .            ......||+.|+|||++.+.  .++.++||||||+++|||++|..|+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            1            11145699999999999774  789999999999999999999988753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-42  Score=306.42  Aligned_cols=197  Identities=30%  Similarity=0.418  Sum_probs=166.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|.. .++..||+|.+.....    ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            44568899999999999984 4688999999864322    235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      .++++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           93 IEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             CCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999654      358999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .... ......||+.|+|||++.+.  .++.++||||+|+++|||++|+.||+.
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             ------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            3221 12345689999999999775  678899999999999999999999964

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-42  Score=302.60  Aligned_cols=198  Identities=29%  Similarity=0.499  Sum_probs=174.8

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+.+.||+|+||+||+|...++..||+|++.......+++.+|++++++++||||+++++++.+....++||||+++++
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   91 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence            34567899999999999998888999999998777777889999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++....... .
T Consensus        92 L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           92 LSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             HHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             HHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            999996533     458999999999999999999999   9999999999999999999999999999986654321 1


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ......+|+.|+|||++.+.  .++.++||||+|+++|||++ |+.|++.
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence            22344578899999998764  78999999999999999999 8988864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.8e-42  Score=315.66  Aligned_cols=196  Identities=24%  Similarity=0.396  Sum_probs=172.0

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||++... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   96 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL   96 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            345688999999999999854 5789999999742    34457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           97 LLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             CTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999543      458999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...   .....||+.|+|||++... ...++.++|||||||++|||++|+.||.
T Consensus       168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            422   2456799999999998643 1357889999999999999999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-41  Score=306.82  Aligned_cols=202  Identities=29%  Similarity=0.474  Sum_probs=163.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||+|+++...  ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD   86 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence            34457899999999999975 458999999997532  334788999999999999999999999999999999999997


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                       |+|.+++...........+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence             6999999765433334568999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          163 N--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             C--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2  12345689999999998753 3578999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.7e-42  Score=300.67  Aligned_cols=198  Identities=28%  Similarity=0.487  Sum_probs=175.7

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+.+.||+|+||+||+|+..++..||+|+++......+++.+|++++++++||||+++++++.+....++||||+++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            44568899999999999998888899999998777677889999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||+++........ 
T Consensus        90 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  160 (268)
T 3sxs_A           90 LLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-  160 (268)
T ss_dssp             HHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-
T ss_pred             HHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-
Confidence            999996543     358999999999999999999999   99999999999999999999999999999876554322 


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence            22345577889999998764  68889999999999999998 9999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-41  Score=306.34  Aligned_cols=196  Identities=30%  Similarity=0.422  Sum_probs=167.7

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.++||+|+||+||+|+..+|+.||+|++.....   ..+.+.+|++++++++||||+++++++.+....++||||++ 
T Consensus        24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-  102 (311)
T 3niz_A           24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-  102 (311)
T ss_dssp             EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred             HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence            44578999999999999988899999999974322   23678899999999999999999999999999999999997 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       103 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          103 KDLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            58888885433     458999999999999999999999   9999999999999999999999999999987653322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......+|+.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~  222 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPG  222 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence              22345689999999998654 3678999999999999999999999853

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-41  Score=311.38  Aligned_cols=192  Identities=22%  Similarity=0.291  Sum_probs=171.3

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+++.. +|+.||+|+++..    ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  123 (350)
T 1rdq_E           44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence            45678999999999999854 6899999999743    234578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 ~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          124 AGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            999999999654      358999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       195 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          195 T-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             c-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCC
Confidence            1     345689999999999765  788999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-41  Score=311.04  Aligned_cols=196  Identities=24%  Similarity=0.290  Sum_probs=171.2

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+.. +++.||+|+++..    ....+.+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            345678999999999999865 4789999999753    34456788999999988 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       102 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          102 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999654      358999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCC
Confidence            3221  22456799999999999764  789999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=305.87  Aligned_cols=196  Identities=25%  Similarity=0.393  Sum_probs=172.0

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||++... +|..||+|+++....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4566788999999999999854 588999999975321       35789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC----ceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Df  281 (344)
                      ||||+++|+|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++    .+||+||
T Consensus        92 v~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           92 ILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEECCCSCBHHHHHTT------SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEcCCCCCHHHHHHh------cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999943      2468999999999999999999999   9999999999999999887    8999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            99987654322   2345699999999998764  788999999999999999999999853

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-41  Score=311.69  Aligned_cols=202  Identities=24%  Similarity=0.296  Sum_probs=173.0

Q ss_pred             HHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      ..+.+.+.||+|+||+||+|.. .+++.||||++....      ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3556778999999999999975 468999999986421      245789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc---eEEeecC
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFG  282 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~---~kl~Dfg  282 (344)
                      ||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|||
T Consensus       104 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999988865431  12458999999999999999999999   99999999999999986654   9999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++.......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            9987655422  12345699999999999764  689999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-41  Score=306.73  Aligned_cols=198  Identities=32%  Similarity=0.579  Sum_probs=162.1

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|+ .+|..||||++......   .+++.+|++++++++||||+++++++.+....++||||++
T Consensus        39 y~i~~~lG~G~~g~V~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  117 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS  117 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEE-ETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred             ceeeeEeecCCCeEEEEEE-ECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence            3456789999999999997 47889999999754322   3578999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +|+|.+++.....   ...+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.+||+|||+++....
T Consensus       118 ~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          118 RGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             TCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             CCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999964321   1248999999999999999999999   78  99999999999999999999999999986543


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       192 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          192 TFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             ------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             ccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            321  12345689999999999775  688999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=309.17  Aligned_cols=199  Identities=29%  Similarity=0.498  Sum_probs=167.6

Q ss_pred             HhhcccccccCcEEEEEEEEe----CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|...    .+..||||+++...  ...+.+.+|+.++++++||||+++++++.++...++|||
T Consensus        51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  130 (325)
T 3kul_A           51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE  130 (325)
T ss_dssp             EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred             eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence            345578999999999999864    34569999998532  334679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       131 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          131 YMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999996432     468999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          289 KDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..... .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~  257 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN  257 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence            43221 222334568899999999764  78899999999999999998 9999853

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.3e-41  Score=309.21  Aligned_cols=194  Identities=24%  Similarity=0.360  Sum_probs=169.3

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc----chHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG----NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||+||+++.. +++.||+|+++....    ..+.+.+|..++.++ +||||+++++++.+....++||||
T Consensus        12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~   91 (345)
T 3a8x_A           12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY   91 (345)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence            45678999999999999864 588999999975422    235678899999988 899999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++....
T Consensus        92 ~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           92 VNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999653      358999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...  ......||+.|+|||++.+.  .++.++|||||||++|||++|+.||+
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~  211 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcC
Confidence            211  22456799999999999775  78999999999999999999999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-41  Score=308.13  Aligned_cols=196  Identities=26%  Similarity=0.357  Sum_probs=162.0

Q ss_pred             HhhcccccccCcEEEEEEEE----eCCceEEEEEeeccc-----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      +.+.+.||+|+||+||+++.    .+++.||+|+++...     .....+.+|+.++++++||||+++++++.+.+..++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   98 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL   98 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence            44568899999999999986    468999999997532     233567899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           99 ILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999653      358899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            6443321  12345699999999998764  688999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-41  Score=309.81  Aligned_cols=197  Identities=25%  Similarity=0.358  Sum_probs=171.1

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ..+.+.+.||+|+||+||+|... +|+.||+|++.....   ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34566788999999999999854 588999999975432   33578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEeecCCcc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLAK  285 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Dfgla~  285 (344)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+   +.+||+|||+++
T Consensus       109 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          109 LVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999999432      468999999999999999999999   999999999999999865   459999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~  232 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWD  232 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            7654322   2345799999999999764  789999999999999999999999854

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-41  Score=302.08  Aligned_cols=196  Identities=28%  Similarity=0.413  Sum_probs=166.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||+||+|+..+|+.||+|++....   ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            4567899999999999998779999999996433   2347889999999999999999999999999999999999975


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                       +|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 -~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           85 -DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             -EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             -CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence             9999986432     458999999999999999999999   9999999999999999999999999999986643321


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......+|+.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12345689999999998654 3578999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-41  Score=301.07  Aligned_cols=199  Identities=26%  Similarity=0.448  Sum_probs=172.4

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.+.||+|+||+||+++..++..||+|+++......+++.+|++++++++||||+++++++.+....++||||++++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG  104 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence            34456889999999999999888889999999877667788999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       105 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          105 CLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             BHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            9999996532     358999999999999999999999   9999999999999999999999999999986644321 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .......+|+.|+|||++.+.  .++.++||||+|+++|||++ |+.||+.
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            112344578899999998764  78999999999999999998 9999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4e-42  Score=318.17  Aligned_cols=200  Identities=27%  Similarity=0.415  Sum_probs=169.8

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.+.||+|+||+||+|+.. +++.||||.++....  ..++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            3445688999999999999865 688999999975422  2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++|+|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++.....
T Consensus       195 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          195 QGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999996543     358999999999999999999999   99999999999999999999999999999865443


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..........+++.|+|||++...  .++.++||||||+++|||++ |+.|+..
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            221111223357889999998764  78899999999999999998 8888753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.1e-41  Score=307.05  Aligned_cols=195  Identities=27%  Similarity=0.444  Sum_probs=169.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|.. .+++.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            34567899999999999985 56889999999742    23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      + +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++.....
T Consensus        91 ~-~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           91 A-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             C-CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             C-CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9 78999998654      358999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|+|||++.+. ...+.++||||+|+++|||++|+.||+.
T Consensus       161 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~  210 (336)
T 3h4j_B          161 GNF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDD  210 (336)
T ss_dssp             SBT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred             Ccc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence            432   2345699999999999764 2237899999999999999999999964

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.8e-42  Score=323.34  Aligned_cols=203  Identities=27%  Similarity=0.433  Sum_probs=174.3

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +....+.+.+.||+|+||+||+|+..++..||||+++......+.|.+|+.+|++++||||+++++++. ....++||||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            333445567889999999999999888889999999876667789999999999999999999999986 5678999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       264 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             CTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999964321    257899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ... .......+|+.|+|||++...  .++.++||||||+++|||++ |+.||..
T Consensus       337 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          337 NEY-TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             HHH-HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             Cce-eccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence            321 112334568899999999764  78999999999999999999 9999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.6e-41  Score=323.65  Aligned_cols=195  Identities=28%  Similarity=0.409  Sum_probs=172.1

Q ss_pred             hcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          137 FKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.||+|+||+||+|+.. +|+.||+|++...    ......+.+|+.+|++++||||+++++++.+.+..++||||++
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~  267 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN  267 (576)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence            3467999999999999864 6899999999742    2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++.....    ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus       268 gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          268 GGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             SCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999965432    358999999999999999999999   999999999999999999999999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       341 ~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~  387 (576)
T 2acx_A          341 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQ  387 (576)
T ss_dssp             C---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred             c---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            2   2345799999999999764  688999999999999999999999964

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=316.41  Aligned_cols=197  Identities=23%  Similarity=0.325  Sum_probs=170.3

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      .+.+.+.||+|+||+||++.. .+|+.+|+|++....   ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            455678899999999999974 568999999997543   2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc---CCCceEEeecCCccc
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKL  286 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfgla~~  286 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++   +++.+||+|||+++.
T Consensus        92 ~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           92 VTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             CBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999653      358999999999999999999999   9999999999999998   568899999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......  .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          163 VEGEQQA--WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             CCTTCCB--CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecCCCce--eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            6544221  2346799999999999764  789999999999999999999999854

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=300.64  Aligned_cols=199  Identities=26%  Similarity=0.298  Sum_probs=166.6

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc---hHHHHHHHHHHhhh-cccceeeEeeEEEcCCeE
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN---GQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  203 (344)
                      ++....+.+.++||+|+||+||+|+.. +|+.||||++......   ...+..|+..+.++ +||||+++++++.+++..
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            444456666789999999999999865 6899999998653322   24556677666666 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||||+ +++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             EEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcccee
Confidence            9999999 779999986653     359999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++.......   .....||+.|+|||++.+   .++.++||||||+++|||++|+.|+.
T Consensus       204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          204 LVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             CEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             eeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            987654322   234569999999999865   58899999999999999999987764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.2e-41  Score=321.78  Aligned_cols=196  Identities=29%  Similarity=0.419  Sum_probs=172.0

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||+||+++.. +|+.||+|++...    ....+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            56999999999999864 5899999999743    234467899999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....  ....+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++........
T Consensus       271 ~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          271 DIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             BHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            99999965432  23469999999999999999999999   99999999999999999999999999999876544221


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       346 --~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~  391 (543)
T 3c4z_A          346 --TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRA  391 (543)
T ss_dssp             --BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCC
Confidence              2345799999999999774  789999999999999999999999964

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-41  Score=324.50  Aligned_cols=204  Identities=30%  Similarity=0.500  Sum_probs=177.1

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      ++....+.+.+.||+|+||+||+|+... +..||||.++......++|.+|+.+|++++||||+++++++.+....++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            3444445667889999999999998654 889999999877667789999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus       296 E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             ECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999975432    458999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ..... .......+|+.|+|||++...  .++.++||||||+++|||++ |+.|+.
T Consensus       369 ~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~  421 (495)
T 1opk_A          369 TGDTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYP  421 (495)
T ss_dssp             TTCCE-ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCce-eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence            54322 122344567899999998764  78999999999999999998 888875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-41  Score=312.56  Aligned_cols=199  Identities=28%  Similarity=0.488  Sum_probs=158.0

Q ss_pred             HhhcccccccCcEEEEEEEEe----CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+..    ++..||||.++...  ...++|.+|+.++++++||||+++++++.+....++|||
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE  126 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence            345678999999999999854    57789999997542  234679999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       127 ~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          127 YMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             CCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999996432     468999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          289 KDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..... .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             ---------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             cCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            43221 112233457889999998764  78999999999999999997 9999853

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=302.47  Aligned_cols=199  Identities=27%  Similarity=0.413  Sum_probs=170.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--eEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--RRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+.. +++.||||+++...  ...+.+.+|++++++++||||+++++++.+..  ..++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (319)
T 4euu_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (319)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence            45678999999999999864 48999999997533  34578899999999999999999999987765  779999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE----cCCCceEEeecCCccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKL  286 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfgla~~  286 (344)
                      ++++|.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           92 PCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             TTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             CCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999975432   1348999999999999999999999   999999999999999    7788899999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccc------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRN------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......   .....||+.|+|||++...      ...++.++||||||+++|||++|+.||++
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            655432   2345699999999988521      24788999999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-41  Score=311.48  Aligned_cols=196  Identities=24%  Similarity=0.342  Sum_probs=162.3

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHH-HhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVAT-IGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+++.. +++.||+|+++...    ...+.+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            456688999999999999854 47889999997532    223456777776 577899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999654      358899999999999999999999   999999999999999999999999999998643


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            3221  22456799999999999765  789999999999999999999999964

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=312.16  Aligned_cols=210  Identities=28%  Similarity=0.434  Sum_probs=176.6

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEe--------CCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEE
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFC  197 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~  197 (344)
                      ++....+.+.+.||+|+||+||+|+..        ++..||||+++....  ..+.+.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            344445566788999999999999753        235799999976432  236789999999999 899999999999


Q ss_pred             EcCCeEEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 041350          198 SEGTRRALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN  267 (344)
Q Consensus       198 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~N  267 (344)
                      .+.+..++||||+++|+|.+++......          .....+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence            9999999999999999999999765421          112469999999999999999999999   999999999999


Q ss_pred             eEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       268 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ||+++++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999876544333333455678999999998764  78999999999999999999 9888853

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-41  Score=303.30  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=165.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCC----------
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT----------  201 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------  201 (344)
                      +.+.+.||+|+||+||+|+.. +|+.||||+++...  ...+.+.+|+.++++++||||+++++++.+..          
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            445688999999999999865 78999999997433  34478999999999999999999999986543          


Q ss_pred             -----------------------------------------------eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHH
Q 041350          202 -----------------------------------------------RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE  234 (344)
Q Consensus       202 -----------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~  234 (344)
                                                                     ..++||||+++|+|.+++.....   ....++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~  164 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDREHG  164 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGGSCHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccchhhH
Confidence                                                           37999999999999999975432   2346778


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc----------eeeecccCCcc
Q 041350          235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI----------VSLTAARGTAG  304 (344)
Q Consensus       235 ~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~  304 (344)
                      .++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            899999999999999999   99999999999999999999999999999876554211          11234569999


Q ss_pred             cccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       305 y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      |+|||++.+.  .++.++||||||+++|||++|..|+
T Consensus       242 y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          242 YMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             GSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCCh
Confidence            9999999764  7899999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=313.66  Aligned_cols=205  Identities=27%  Similarity=0.419  Sum_probs=171.4

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|+..      ++..||||+++...  ....++.+|+.++++++||||+++++++.+....++
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  151 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI  151 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence            3456788999999999999842      46789999997532  333578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNS-SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Df  281 (344)
                      ||||+++|+|.+++...... .....+++..++.++.|+++||+|||+   .+|+||||||+|||++.++   .+||+||
T Consensus       152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            99999999999999765432 222468999999999999999999999   9999999999999999554   5999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999865433222223445689999999998764  78999999999999999998 8888864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-41  Score=300.64  Aligned_cols=197  Identities=26%  Similarity=0.388  Sum_probs=163.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---------------------------chHHHHHHHHHHhhhc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---------------------------NGQEFINEVATIGRIH  186 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~  186 (344)
                      +.+.+.||+|+||+||+|+. .+++.||||++.....                           ..+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            34567899999999999985 4588999999864321                           1246889999999999


Q ss_pred             ccceeeEeeEEEc--CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 041350          187 HFHIVRLLGFCSE--GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK  264 (344)
Q Consensus       187 h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik  264 (344)
                      ||||+++++++.+  ....++||||+++++|.+++.       ...+++..+..++.|+++||+|||+   .+|+|||||
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  164 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK  164 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence            9999999999986  568899999999999987652       2469999999999999999999999   999999999


Q ss_pred             CCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccC-CCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          265 PHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFG-EVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       265 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+|||++.++.+||+|||+++........  .....||+.|+|||++.+... ..+.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999876544221  234579999999999876421 136789999999999999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.4e-41  Score=298.51  Aligned_cols=195  Identities=26%  Similarity=0.402  Sum_probs=166.5

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+.. +++.||+|++.....   ..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (292)
T 3o0g_A            5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence            45678999999999999854 588999999975332   23678899999999999999999999999999999999997


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      + +|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           85 Q-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             E-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             C-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            5 6666664432     469999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .  ......||+.|+|||++.+. ..++.++||||+|+++|||++|+.|+.
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~  203 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             c--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence            2  22345689999999998764 347999999999999999999988863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-40  Score=308.80  Aligned_cols=202  Identities=18%  Similarity=0.177  Sum_probs=172.1

Q ss_pred             Hhhccccccc--CcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQG--GYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|  +||+||+|+.. +|+.||||+++....   ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            4456889999  99999999865 689999999975432   23567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.+....
T Consensus       107 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          107 FMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             CCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             ccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999976432    458999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .......||+.|+|||++.+....++.++|||||||++|||++|+.||..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            22110     11123468999999999977434789999999999999999999999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.6e-41  Score=305.11  Aligned_cols=205  Identities=24%  Similarity=0.415  Sum_probs=158.4

Q ss_pred             HHhhcccccccCcEEEEEEEEeCC----ceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeE---
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR---  203 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~----~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---  203 (344)
                      .+.+.+.||+|+||+||+|+....    ..||||+++..   ....+.+.+|++++++++||||+++++++.+....   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            445678899999999999985432    27999999753   23447899999999999999999999999877655   


Q ss_pred             ---EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          204 ---ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       204 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                         ++||||+++|+|.+++...........+++..++.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEee
Confidence               9999999999999999765433333469999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ||+++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            9999876554333333345578899999998775  78999999999999999999 8888864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.5e-41  Score=304.98  Aligned_cols=196  Identities=23%  Similarity=0.290  Sum_probs=169.8

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +||||+++++++.++...++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (330)
T 2izr_A           12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP   89 (330)
T ss_dssp             EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence            4567899999999999984 578999999987542 335688999999999 9999999999999999999999999 99


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc-----eEEeecCCccccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-----PKISDFGLAKLCS  288 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~Dfgla~~~~  288 (344)
                      +|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++...
T Consensus        90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           90 SLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9999996542     469999999999999999999999   99999999999999998887     9999999998765


Q ss_pred             CCccce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~  219 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQG  219 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccc
Confidence            432211     12356799999999999874  789999999999999999999999964

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=308.63  Aligned_cols=196  Identities=24%  Similarity=0.374  Sum_probs=170.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|... +|+.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            455688999999999999854 58899999997543 2345788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC--CCceEEeecCCcccccCC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~--~~~~kl~Dfgla~~~~~~  290 (344)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||+++.....
T Consensus       133 g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          133 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999985432     368999999999999999999999   99999999999999974  578999999999877554


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             cc---eeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            32   2344699999999999764  788999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=309.08  Aligned_cols=193  Identities=26%  Similarity=0.407  Sum_probs=164.2

Q ss_pred             cccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          138 KHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.||+|+||+||+|.. .+|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            35699999999999985 468999999998643 3456889999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE--cCCCceEEeecCCcccccCCccc
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL--DHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill--~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      .+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||+  +.++.+||+|||+++....... 
T Consensus       174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            99986432     358999999999999999999999   999999999999999  5678999999999987654432 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        .....||+.|+|||++...  .++.++||||||+++|||++|+.||..
T Consensus       245 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             --cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence              2345699999999998764  788999999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-40  Score=301.87  Aligned_cols=190  Identities=26%  Similarity=0.352  Sum_probs=150.3

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      +.||+|+||+||+|... +++.||||++..  .....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEG--GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEECh--hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            67999999999999864 588999999975  34567889999999997 999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ceEEeecCCcccccCCccc
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Dfgla~~~~~~~~~  293 (344)
                      +++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++   .+||+|||+++....... 
T Consensus        95 ~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           95 ERIKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             HHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            999653      358999999999999999999999   9999999999999998765   899999999986654322 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             --------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             -cccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence             12345689999999999765  789999999999999999999999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.3e-41  Score=308.31  Aligned_cols=195  Identities=28%  Similarity=0.331  Sum_probs=162.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  101 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG  101 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence            456688999999999999854 6889999999876666688999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc--eEEeecCCcccccCCc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGLAKLCSKDI  291 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~--~kl~Dfgla~~~~~~~  291 (344)
                      +|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+++......
T Consensus       102 ~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          102 ELYERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            999999653      358999999999999999999999   99999999999999987765  9999999998543322


Q ss_pred             cceeeecccCCcccccccccccccCCCCc-ccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSY-KSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....||+.|+|||++.+.  .++. ++||||+|+++|||++|+.||..
T Consensus       173 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          173 Q---PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             C---CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence            1   2345699999999998764  4444 48999999999999999999964

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-40  Score=315.31  Aligned_cols=192  Identities=31%  Similarity=0.508  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC-eEEEEEeccCCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-RRALVYEFMPNGS  214 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gs  214 (344)
                      .+.+.||+|+||+||+|+. +|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||+++|+
T Consensus       196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            4457899999999999985 58899999998643 5678999999999999999999999987665 7899999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++.....    ..+++..++.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++......   
T Consensus       274 L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---  343 (450)
T 1k9a_A          274 LVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  343 (450)
T ss_dssp             HHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             HHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence            9999976532    347999999999999999999999   999999999999999999999999999998644321   


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                        ....+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              233578999999999764  78999999999999999998 9998853

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5e-41  Score=304.92  Aligned_cols=198  Identities=28%  Similarity=0.477  Sum_probs=162.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCce----EEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIP----VAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.+.||+|+||+||+|+.. +++.    ||+|.+...  ....+.+.+|+.++++++||||+++++++.++. .++++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            345678999999999999843 4443    588887543  244578999999999999999999999998765 78999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++..
T Consensus        96 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             ECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999997643     458999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  222 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence            655443333455678899999999764  78999999999999999999 9999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-41  Score=306.96  Aligned_cols=203  Identities=29%  Similarity=0.452  Sum_probs=170.6

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+..      +++.||||+++....  ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  129 (343)
T 1luf_A           50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF  129 (343)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence            45678999999999999864      347899999975432  3467899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          208 EFMPNGSLEKFIFSKTNSS------------------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      ||+++|+|.+++.......                  ....+++..++.++.|+++||+|||+   .+|+||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEE
Confidence            9999999999997643210                  12569999999999999999999999   99999999999999


Q ss_pred             EcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++.++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999876543322233455689999999998764  78999999999999999998 9989853

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8e-41  Score=306.26  Aligned_cols=194  Identities=27%  Similarity=0.394  Sum_probs=154.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  133 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG  133 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence            345678999999999999865 47889999998643 3467889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccccCC
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~~~~  290 (344)
                      +|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       134 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          134 ELFDRIVEK------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             BHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999432      458999999999999999999999   99999999999999975   889999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          205 VL---MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cc---cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            21   2345689999999999764  789999999999999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.4e-42  Score=313.66  Aligned_cols=206  Identities=32%  Similarity=0.457  Sum_probs=171.6

Q ss_pred             HHHhhcccccccCcEEEEEEEE------eCCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCC-e
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGT-R  202 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~  202 (344)
                      ..+.+.+.||+|+||.||+|+.      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            3445678899999999999973      2357899999975432  235789999999999 7999999999998755 4


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCC--------------------------------------------------------
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSS--------------------------------------------------------  226 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  226 (344)
                      .++||||+++|+|.+++.......                                                        
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            899999999999999997653210                                                        


Q ss_pred             ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCC
Q 041350          227 ----SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGT  302 (344)
Q Consensus       227 ----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt  302 (344)
                          ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...............||
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                01238999999999999999999999   99999999999999999999999999999876554443444556789


Q ss_pred             cccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          303 AGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       303 ~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       259 ~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  298 (359)
T 3vhe_A          259 LKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPG  298 (359)
T ss_dssp             GGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence            999999998764  78999999999999999998 9999854

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.1e-40  Score=303.32  Aligned_cols=194  Identities=26%  Similarity=0.390  Sum_probs=168.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +...+.||+|+||+||+|+. .+++.||||++.....    ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            44567899999999999985 5789999999975332    235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++ |+|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          136 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             CS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            96 68888885433     468999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .      ....||+.|+|||++.. ..+.++.++||||||+++|||++|+.|+..
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3      34568999999999853 124688899999999999999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-41  Score=304.86  Aligned_cols=205  Identities=31%  Similarity=0.494  Sum_probs=171.5

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeecc--ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||+||+|+..      ++..||+|++...  ....+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  125 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  125 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence            4455688999999999999852      3568999999753  23447899999999999 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNS-----------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN  267 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~N  267 (344)
                      +||||+++|+|.+++......                 .....+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhh
Confidence            999999999999999764321                 011348999999999999999999999   999999999999


Q ss_pred             eEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          268 ILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       268 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ||++.++.+||+|||++................+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999876554443333455678999999998764  78999999999999999998 9999854

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.3e-40  Score=304.27  Aligned_cols=195  Identities=25%  Similarity=0.317  Sum_probs=171.8

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-----ccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-----HFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.++||+|+||+||+|+. .+++.||||+++......+.+..|+.+++.++     ||||+++++++...+..++||
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~  115 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF  115 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence            445568899999999999985 46889999999865556677888999999996     999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---------------
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---------------  272 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---------------  272 (344)
                      ||+ +++|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++               
T Consensus       116 e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          116 EPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             CCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             cCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccc
Confidence            999 9999999976442    358999999999999999999999   99999999999999975               


Q ss_pred             ----------CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          273 ----------NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       273 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                                ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCC
Confidence                      7899999999998654432     345689999999999875  78999999999999999999999996


Q ss_pred             C
Q 041350          343 P  343 (344)
Q Consensus       343 ~  343 (344)
                      .
T Consensus       261 ~  261 (360)
T 3llt_A          261 T  261 (360)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-41  Score=319.23  Aligned_cols=201  Identities=29%  Similarity=0.455  Sum_probs=167.7

Q ss_pred             HHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ...+.+.++||+|+||+||+|...++..||||+++......++|.+|+.+|++++||||+++++++.+ ...++||||++
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            33445678899999999999998777889999998766667899999999999999999999999876 66899999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus       262 ~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          262 KGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             TCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999964321    358999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      . .......+|+.|+|||++...  .++.++||||||+++|||++ |+.|+..
T Consensus       335 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          335 Y-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             ---------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             e-ecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence            2 112334578899999998764  78999999999999999999 8888853

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-41  Score=318.08  Aligned_cols=197  Identities=25%  Similarity=0.351  Sum_probs=161.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            34567899999999999984 46889999999742    23346778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+|+....
T Consensus       230 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          230 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999654      358999999999999999999995  26899999999999999999999999999986443


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       302 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          302 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            322  22456799999999999764  789999999999999999999999964

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-41  Score=308.24  Aligned_cols=198  Identities=24%  Similarity=0.297  Sum_probs=168.9

Q ss_pred             HhhcccccccCcEEEEEEEE----eCCceEEEEEeecc-----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHL-----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      +.+.+.||+|+||+||+++.    .+++.||||+++..     ....+.+.+|+++++++ +||||+++++++.+....+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            44568899999999999986    36899999998642     23346678899999999 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       136 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999654      358999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +........ ......||+.|+|||++.+....++.++||||||+++|||++|+.||.
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  263 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT  263 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            866443221 123456999999999997643457889999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.1e-41  Score=301.29  Aligned_cols=204  Identities=27%  Similarity=0.457  Sum_probs=173.1

Q ss_pred             HhhcccccccCcEEEEEEEE------eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+|+.      .++..||+|+++...  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  104 (314)
T 2ivs_A           25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI  104 (314)
T ss_dssp             EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence            44568899999999999975      235789999997543  2336789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 041350          207 YEFMPNGSLEKFIFSKTNSS------------------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI  268 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Ni  268 (344)
                      |||+++|+|.+++.......                  ....+++..++.++.|+++||+|||+   .+|+||||||+||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI  181 (314)
T 2ivs_A          105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI  181 (314)
T ss_dssp             EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence            99999999999997643210                  12358999999999999999999999   9999999999999


Q ss_pred             EEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       269 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |+++++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999877554443333455678999999998764  68899999999999999999 9998853

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=304.11  Aligned_cols=197  Identities=25%  Similarity=0.328  Sum_probs=162.9

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccc---hHHHHHHHHHHhhhcc--cceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHH--FHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++...+++.||||++......   .+.+.+|+.++.+++|  +||+++++++.++...++||| +
T Consensus        12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~   90 (343)
T 3dbq_A           12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C   90 (343)
T ss_dssp             EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred             EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence            456789999999999999888999999999754332   3678899999999976  999999999999999999999 5


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      .+++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        91 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           91 GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             CSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            688999999653      358999999999999999999999   9999999999999997 578999999999877654


Q ss_pred             ccceeeecccCCcccccccccccc---------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRN---------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..........||+.|+|||++.+.         ...++.++||||||+++|||++|+.||+.
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            333333456799999999998541         13678899999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.1e-41  Score=294.06  Aligned_cols=197  Identities=29%  Similarity=0.494  Sum_probs=173.7

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||+||++...++..||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            45678999999999999988888999999987766778899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....... ..
T Consensus        91 ~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~  161 (267)
T 3t9t_A           91 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  161 (267)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred             HHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-cc
Confidence            99996543     358999999999999999999999   9999999999999999999999999999986643321 11


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .....+++.|+|||++.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCC
Confidence            2344578899999998764  78899999999999999999 8888864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-40  Score=315.78  Aligned_cols=196  Identities=29%  Similarity=0.454  Sum_probs=171.6

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+.. +|+.||||++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            345678999999999999854 68999999997532    3346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++..      ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           98 VSGGELFDYICK------NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             CSSEEHHHHTTS------SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999943      2469999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|+|||++.+. ...+.++||||+|+++|||++|+.||+.
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          169 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             TCC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            322   2345799999999998764 2346899999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-40  Score=299.73  Aligned_cols=205  Identities=31%  Similarity=0.497  Sum_probs=174.4

Q ss_pred             HHhhcccccccCcEEEEEEEE------eCCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||+||+|+.      .+++.||+|+++....  ..+.+.+|+.+++++ +||||+++++++.+++..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            445678899999999999974      2467899999975432  346789999999999 9999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          205 LVYEFMPNGSLEKFIFSKTNS------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      +||||+++|+|.+++......            .....+++..++.++.|+++||+|||+   .+++||||||+|||++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcC
Confidence            999999999999999765421            112358999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999877655443333445678899999998764  78999999999999999998 9988853

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.8e-41  Score=303.54  Aligned_cols=198  Identities=25%  Similarity=0.358  Sum_probs=161.4

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l  205 (344)
                      +.+.+.||+|+||+||+++. .+++.||||+++.....    .+.+.+|+.++++++||||+++++++....    ..++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            44568899999999999985 56899999999754222    256889999999999999999999986654    3499


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        94 v~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            99999999999999654      358999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........ .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            76543221 122345689999999999764  789999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=296.64  Aligned_cols=198  Identities=29%  Similarity=0.447  Sum_probs=167.0

Q ss_pred             HHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc------cchHHHHHHHHHHhhhc---ccceeeEeeEEEcCC-
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK------GNGQEFINEVATIGRIH---HFHIVRLLGFCSEGT-  201 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~-  201 (344)
                      ..+.+.+.||+|+||+||+|+. .+++.||+|++....      .....+.+|+.++++++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            3455678899999999999984 568899999997432      22356778888887775   999999999997754 


Q ss_pred             ----eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceE
Q 041350          202 ----RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  277 (344)
Q Consensus       202 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~k  277 (344)
                          ..++||||++ ++|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence                5799999996 699999965432    349999999999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+|||+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             EeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999987654322   2445689999999999764  789999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-40  Score=307.21  Aligned_cols=198  Identities=25%  Similarity=0.315  Sum_probs=164.4

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeecccc---chHHHHHHHHHHhhhc--ccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIH--HFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||++...+++.||||++.....   ..+.+.+|+.++++++  ||||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            445678999999999999877799999999975432   2367899999999996  5999999999999999999999 


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +.+++|.+++...      ..+++..+..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++....
T Consensus       137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            5689999999653      358899999999999999999999   9999999999999995 58899999999987755


Q ss_pred             CccceeeecccCCcccccccccccc---------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRN---------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...........||+.|+|||++.+.         ...++.++|||||||++|||++|+.||..
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence            4332223456799999999998641         13588899999999999999999999964

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.5e-41  Score=299.57  Aligned_cols=199  Identities=30%  Similarity=0.509  Sum_probs=164.6

Q ss_pred             HHhhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|+.     .+++.||||++.... ...+.+.+|+.++++++||||+++++++...  ...++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            345678899999999999973     358899999997543 3346789999999999999999999998654  45899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++
T Consensus        91 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999996543     358999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ........ .......+++.|+|||++.+.  .++.++||||||+++|||++|..|+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccC
Confidence            76544221 112334578889999999765  78999999999999999999998875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.3e-41  Score=298.94  Aligned_cols=202  Identities=30%  Similarity=0.494  Sum_probs=176.3

Q ss_pred             HHHHhhcccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      ...+.+.+.||+|+||+||+|.... +..||+|.+.......+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            3344566889999999999998654 889999999877667788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++.....    ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        92 ~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           92 TYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             TTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             CCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999976432    468999999999999999999999   99999999999999999999999999999876544


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .. .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~  215 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG  215 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cc-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            32 222345578899999998764  78999999999999999999 8888753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-40  Score=305.81  Aligned_cols=198  Identities=19%  Similarity=0.291  Sum_probs=162.7

Q ss_pred             HHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccccc------------hHHHHHHHHHHhhhcccceeeEee
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLKGN------------GQEFINEVATIGRIHHFHIVRLLG  195 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~  195 (344)
                      .+.+.+.||+|+||+||+|...+      ++.||||++......            ...+..|+..+..++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            34556889999999999998654      478999998754311            123445666777888999999999


Q ss_pred             EEEcC----CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          196 FCSEG----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       196 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      ++...    ...++||||+ +++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence            98764    4589999999 999999996542     469999999999999999999999   9999999999999999


Q ss_pred             --CCCceEEeecCCcccccCCccce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          272 --HNFQPKISDFGLAKLCSKDISIV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       272 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                        .++.+||+|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence              88999999999998765432211     11234599999999999775  68999999999999999999999996

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.8e-40  Score=297.09  Aligned_cols=196  Identities=26%  Similarity=0.433  Sum_probs=172.1

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc-------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG-------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|+.. +|+.||+|.++....       ..+.+.+|+.++++++||||+++++++.+....++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4566789999999999999854 588999999975321       35779999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC----ceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Df  281 (344)
                      ||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++    .+||+||
T Consensus        93 v~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999542      458999999999999999999999   9999999999999999888    7999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            99987655422   2345689999999998764  788999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-40  Score=303.56  Aligned_cols=207  Identities=26%  Similarity=0.309  Sum_probs=168.2

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeecc------ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL------KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      .+.+.+.||+|+||+||+|.. .++..||+|++...      ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            455678899999999999985 45789999998643      23447899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 041350          207 YEFMPNGSLEKFIFSKTNSS----------------------------------SHRPLSWEKLKKIAFGVARGVEYLHQ  252 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~  252 (344)
                      |||+++|+|.+++.......                                  ....+++..++.++.|++.||+|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999985311100                                  01234678888999999999999999


Q ss_pred             CCCCCeeecCCCCCceEEcCCC--ceEEeecCCcccccCCcc--ceeeecccCCcccccccccccccCCCCcccchHhHH
Q 041350          253 GCNQRILHFDIKPHNILLDHNF--QPKISDFGLAKLCSKDIS--IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYG  328 (344)
Q Consensus       253 ~~~~~ivH~Dik~~Nill~~~~--~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~G  328 (344)
                         .+|+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++.+....++.++||||||
T Consensus       187 ---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             ---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             ---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence               8999999999999998776  899999999986543211  112345669999999999875435788999999999


Q ss_pred             HHHHHHHcCCCCCCC
Q 041350          329 MMLLEMVGCRKNKDP  343 (344)
Q Consensus       329 vvl~ell~g~~p~~~  343 (344)
                      +++|||++|+.||..
T Consensus       264 ~il~el~~g~~pf~~  278 (345)
T 3hko_A          264 VLLHLLLMGAVPFPG  278 (345)
T ss_dssp             HHHHHHHHSSCSSCC
T ss_pred             HHHHHHHHCCCCCCC
Confidence            999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-40  Score=296.97  Aligned_cols=190  Identities=27%  Similarity=0.440  Sum_probs=157.8

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhh--hcccceeeEeeEEEc----CCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSE----GTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+. +++.||||++...  ..+.+..|.+++..  ++||||+++++++.+    ....++|||
T Consensus        10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e   86 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH   86 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence            34567899999999999985 7999999999753  34566667777666  799999999998654    356899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH--------QGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      |+++|+|.+++..       ..+++..++.++.|++.||+|||        +   .+|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           87 YHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             CCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             hccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence            9999999999932       35899999999999999999999        7   8999999999999999999999999


Q ss_pred             cCCcccccCCccce--eeecccCCcccccccccccccC----CCCcccchHhHHHHHHHHHcC
Q 041350          281 FGLAKLCSKDISIV--SLTAARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       281 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                      ||+++.........  ......||+.|+|||++.+...    .++.++||||||+++|||++|
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            99998765443221  1223469999999999876411    344689999999999999999

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.8e-40  Score=326.41  Aligned_cols=196  Identities=24%  Similarity=0.289  Sum_probs=171.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+.. +++.||||+++..    ....+.+..|..++..+ +||||+++++++.+.+.+++|||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            345678999999999999854 5788999999742    34457788999999988 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....      .+++..++.++.||+.||+|||+   .+|+||||||+||||+.++++||+|||+|+...
T Consensus       423 ~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          423 YVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             CCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             CcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999996543      58999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCC
Confidence            3222  23456799999999999764  789999999999999999999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-40  Score=290.98  Aligned_cols=200  Identities=30%  Similarity=0.391  Sum_probs=171.9

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.+.||+|+||+||+|+.. +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            3455688999999999999864 68899999997533  33478899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++..      ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        88 ~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           88 SGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             TTEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCcHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999843      2458999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..........||+.|+|||++.+. ...+.++||||||+++|||++|+.||+.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~  210 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred             cchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            322223456689999999998764 2347789999999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-40  Score=291.56  Aligned_cols=196  Identities=31%  Similarity=0.507  Sum_probs=152.1

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+. .+|+.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        14 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (278)
T 3cok_A           14 KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC   93 (278)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence            3467899999999999985 578999999997432    23477899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++....     ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           94 HNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             TTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999996432     468999999999999999999999   99999999999999999999999999999876533


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.|++.
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CC--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22  11245689999999998764  678899999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-40  Score=300.10  Aligned_cols=206  Identities=26%  Similarity=0.444  Sum_probs=172.4

Q ss_pred             HHHhhcccccccCcEEEEEEEE--------eCCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCC
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKL--------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGT  201 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  201 (344)
                      ..+.+.+.||+|+||+||+|+.        .++..||+|+++...  ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            3455678899999999999975        346789999997543  2346789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSS----------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD  271 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~  271 (344)
                      ..++||||+++|+|.+++.......          ....+++..++.++.|++.||+|||+   .+|+||||||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence            9999999999999999997643210          12358999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       272 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .++.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            9999999999999876654333333455678999999998764  68899999999999999999 9988853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-40  Score=306.54  Aligned_cols=197  Identities=27%  Similarity=0.375  Sum_probs=156.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCC--eEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGT--RRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lv~  207 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||||++....   ...+.+.+|+.+++++. ||||+++++++...+  ..++||
T Consensus        11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~   90 (388)
T 3oz6_A           11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF   90 (388)
T ss_dssp             EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred             eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence            44567899999999999975 468999999986432   23467889999999997 999999999997544  689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++ ++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+|+..
T Consensus        91 e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           91 DYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             ECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             cccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9997 699999854       258999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCc-------------------cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDI-------------------SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....                   .....+...||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            3210                   01122345799999999998763 3689999999999999999999999964

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.3e-40  Score=306.68  Aligned_cols=189  Identities=26%  Similarity=0.335  Sum_probs=156.2

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc----CCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||++... +++.||||+++.    ...+.+|+.++.++ +||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999854 588999999964    34677888887554 89999999998865    5678999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~~~  289 (344)
                      |+|.+++.....    ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       144 g~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          144 GELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999965332    469999999999999999999999   99999999999999997   78999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       217 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~  265 (400)
T 1nxk_A          217 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_dssp             -------------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCc---cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence            322   2456689999999999764  789999999999999999999999964

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-39  Score=287.72  Aligned_cols=195  Identities=24%  Similarity=0.335  Sum_probs=171.4

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||+||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.++...++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            4556788999999999999854 4678999999754 4456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~~  288 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+   +.++.++|+|||++....
T Consensus        90 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           90 GGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             SCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999998654      358999999999999999999999   999999999999999   788999999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....   .....||+.|+|||++.+   .++.++||||||+++|||++|+.||..
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCC
Confidence            4432   234568999999999865   478899999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-40  Score=302.60  Aligned_cols=197  Identities=28%  Similarity=0.479  Sum_probs=163.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCce----EEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIP----VAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+.. ++..    ||+|.+....  ...+.+.+|+.++++++||||+++++++. +...++|||
T Consensus        16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            35678999999999999853 4554    7778775432  23357789999999999999999999986 456889999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           95 YLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             CCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             eCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999996532     358899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~  220 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAG  220 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence            55433333455688899999999764  78999999999999999999 9999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=301.96  Aligned_cols=197  Identities=26%  Similarity=0.298  Sum_probs=169.7

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  203 (344)
                      .+.+.+.||+|+||+||+|.. .+++.||||+++....         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            345567899999999999974 5688999999975431         234677899999999999999999999999999


Q ss_pred             EEEEeccCCC-CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          204 ALVYEFMPNG-SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       204 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      ++||||+.+| +|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999777 999999543      358999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++.......   .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9987655432   2345689999999998764 2337899999999999999999999853

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-40  Score=293.57  Aligned_cols=199  Identities=28%  Similarity=0.423  Sum_probs=167.6

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.+.||+|+||+||++.. .++..||+|++....  ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            456778999999999999985 458899999997543  34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCcccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLC  287 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~  287 (344)
                      ++|+|.+++.....  ....+++..++.++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       103 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          103 EGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             SCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999865321  12468999999999999999999999   999999999999999   45688999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....   .....||+.|+|||++.+   .++.++||||||+++|||++|+.||..
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            54322   234568999999999864   578899999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=295.59  Aligned_cols=196  Identities=24%  Similarity=0.379  Sum_probs=164.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|... +|+.||+|++......   .+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (311)
T 4agu_A            6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD   85 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence            45678999999999999864 4899999998654332   3567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           86 HTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999988533      358999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....||+.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            21  2345689999999998753 3678999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-40  Score=293.29  Aligned_cols=199  Identities=30%  Similarity=0.480  Sum_probs=171.3

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.+.||+|+||+||+|...++..||+|.++......+.+.+|++++++++||||+++++++.+ +..++||||++++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~   92 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG   92 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence            345668899999999999998778899999998766677889999999999999999999999864 4589999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++........ 
T Consensus        93 ~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           93 SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             BHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            99999954221    258999999999999999999999   9999999999999999999999999999987654422 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .......+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence            112334578899999998754  68899999999999999999 8888853

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.4e-40  Score=290.81  Aligned_cols=194  Identities=29%  Similarity=0.539  Sum_probs=165.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc--------hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN--------GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      +.+.+.||+|+||+||+|+. .+++.||+|++......        .+.+.+|+.++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            34567899999999999985 46889999998643211        167899999999999999999999987665  69


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEcCCCc-----eEE
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQ-----PKI  278 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~~~~~-----~kl  278 (344)
                      ||||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+  ++||||||+|||++.++.     +||
T Consensus        99 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             EEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            999999999999986533     468999999999999999999999   78  999999999999988776     999


Q ss_pred             eecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +|||+++.....     .....||+.|+|||++......++.++||||||+++|||++|+.||+.
T Consensus       171 ~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          171 ADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             CCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999999854432     244669999999999854434678899999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1e-40  Score=321.93  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=173.6

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +....+.+.++||+|+||+||+|+..++..||||+++......++|.+|+++|++++|+||+++++++.+ ...++||||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3333445678899999999999998777889999998766667899999999999999999999999876 668999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++.....    ..+++..++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus       343 ~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          343 MSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             hcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999964321    358999999999999999999999   9999999999999999999999999999987653


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ... .......+++.|+|||++...  .++.++||||||+++|||++ |+.||..
T Consensus       416 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          416 NEY-TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             HHH-HTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred             Cce-ecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            321 112334578899999998764  78999999999999999999 8888853

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.9e-41  Score=298.36  Aligned_cols=194  Identities=23%  Similarity=0.391  Sum_probs=165.9

Q ss_pred             HHhhcccccccCcEEEEEEEEeC-C-------ceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN-G-------IPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||+||+|.... +       ..||+|++.... ...+.+.+|+.++++++||||+++++++.+++..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            34566889999999999997443 3       469999997543 44578999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc--------e
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--------P  276 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~--------~  276 (344)
                      +||||+++|+|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.        +
T Consensus        89 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999996543     348999999999999999999999   99999999999999998887        9


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ||+|||++......      ....+|+.|+|||++.+. ..++.++||||||+++|||++|+.|+.
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~  219 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPL  219 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence            99999999765432      234478999999998763 368899999999999999999665553

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.1e-40  Score=309.35  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=162.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  205 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++.....   ..+.+.+|+.++++++||||+++++++...     ...++
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            34567899999999999985 4578999999975322   336789999999999999999999998766     57899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||++ ++|.+++...      ..+++..++.++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+|+
T Consensus       108 v~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          108 VLEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            999995 6999999542      459999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccc--------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISI--------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ........                    ...+...||+.|+|||++... ..++.++||||+||++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence            76543211                    123456799999999987443 468999999999999999998765553

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-40  Score=292.78  Aligned_cols=198  Identities=24%  Similarity=0.424  Sum_probs=156.4

Q ss_pred             HHhhcccccccCcEEEEEEEEeC----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.+.||+|+||+||+|....    +..||+|.++...  ...+.+.+|+.++++++||||+++++++. ++..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence            34566889999999999998533    4569999987533  23467899999999999999999999985 45689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        95 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999996543     358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...... ......+|+.|+|||++...  .++.++||||||+++|||++ |+.||+.
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~  220 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG  220 (281)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             Cccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence            543221 12344578899999998764  78899999999999999996 8889863

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.1e-40  Score=290.04  Aligned_cols=191  Identities=32%  Similarity=0.498  Sum_probs=156.5

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccc-----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|.. .+..||||+++...     ...+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (271)
T 3dtc_A           10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred             eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence            4567899999999999984 58899999986532     22467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eeecCCCCCceEEcC--------CCceEEe
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR---ILHFDIKPHNILLDH--------NFQPKIS  279 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~---ivH~Dik~~Nill~~--------~~~~kl~  279 (344)
                      ++++|.+++..       ..+++..++.++.|++.||+|||+   .+   ++||||||+|||++.        ++.+||+
T Consensus        89 ~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           89 RGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             TTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             CCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            99999999842       358999999999999999999999   66   999999999999986        7789999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||+++.......    ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             cCCcccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999986654322    245689999999998764  789999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-40  Score=296.42  Aligned_cols=201  Identities=27%  Similarity=0.451  Sum_probs=169.7

Q ss_pred             HHHHhhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcC--Ce
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TR  202 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  202 (344)
                      ...+.+.+.||+|+||+||+|+.     .+++.||+|+++...  ...+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            33455678899999999999973     468899999997432  3447899999999999999999999999876  66


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++||||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence            899999999999999996543     358999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          283 LAKLCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       283 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +++........ .......+|+.|+|||++.+.  .++.++||||+|+++|||++|+.|+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCc
Confidence            99877654322 122345688899999998764  67889999999999999999988753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=300.08  Aligned_cols=196  Identities=27%  Similarity=0.419  Sum_probs=161.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccch--HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||+||+|+.. +++.||+|++.......  ..+.+|+.++++++||||+++++++.+.+..++||||++ 
T Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-   83 (324)
T 3mtl_A            5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-   83 (324)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred             EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence            45678999999999999864 68899999997533222  245689999999999999999999999999999999996 


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           84 KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            69999986543     358999999999999999999999   9999999999999999999999999999986543322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              12345689999999998753 3678999999999999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4e-40  Score=312.42  Aligned_cols=192  Identities=27%  Similarity=0.415  Sum_probs=149.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEc-----CCeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE-----GTRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l  205 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++.....   ..+.+.+|+.+|++++||||+++++++..     ....++
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            45568899999999999974 4689999999975322   33678899999999999999999999843     357899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+ +++|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+|+
T Consensus       135 v~e~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EECCC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEecc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence            99998 57999998542      459999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccc-------------------------eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcC
Q 041350          286 LCSKDISI-------------------------VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       286 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                      ........                         ...+...||+.|+|||++... ..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence            76432110                         123445689999999986443 3689999999999999999994

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-39  Score=294.36  Aligned_cols=196  Identities=27%  Similarity=0.349  Sum_probs=162.3

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.||+|+||+||+|+. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            5799999999999984 468999999997543 3457899999999985 799999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc---eEEeecCCcccccCCcc
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCSKDIS  292 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~---~kl~Dfgla~~~~~~~~  292 (344)
                      .+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|||++........
T Consensus        99 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           99 LSHIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            9999654      358999999999999999999999   99999999999999998776   99999999986542211


Q ss_pred             -----ceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 -----IVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 -----~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                           ........||+.|+|||++.+.   ...++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  228 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG  228 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence                 1112234589999999998641   12578899999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-39  Score=287.39  Aligned_cols=196  Identities=26%  Similarity=0.416  Sum_probs=168.8

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+++.. +++.||+|.++...       ...+.+.+|+.++++++||||+++++++.+....++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4566788999999999999865 58999999987532       135789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC----ceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Df  281 (344)
                      ||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++    .+||+||
T Consensus        86 v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999653      358999999999999999999999   9999999999999998877    8999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |++........   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            99987654322   2345689999999998764  788999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.4e-39  Score=298.20  Aligned_cols=197  Identities=27%  Similarity=0.400  Sum_probs=170.3

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc---------hHHHHHHHHHHhhh-cccceeeEeeEEEcCCeE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN---------GQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  203 (344)
                      +.+.+.||+|+||.||+|+.. +|+.||||+++.....         .+.+.+|+.+++++ +||||+++++++...+..
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  175 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM  175 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred             cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence            344578999999999999875 6999999999753311         34678999999999 799999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+
T Consensus       176 ~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          176 FLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             EEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence            9999999999999999643      358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccc----cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRN----FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +........   .....||+.|+|||++.+.    ...++.++||||||+++|||++|+.||..
T Consensus       247 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          247 SCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            987654422   2346799999999998642    12578899999999999999999999854

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.2e-40  Score=299.89  Aligned_cols=194  Identities=28%  Similarity=0.409  Sum_probs=165.9

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||+||++... +++.||+|+++....   ...+|++++.++ +||||+++++++.++...++||||++
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   99 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK   99 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence            4556688999999999999854 588999999976433   345788888888 79999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC----CceEEeecCCcccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLC  287 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfgla~~~  287 (344)
                      +|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+.++    +.+||+|||+++..
T Consensus       100 gg~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A          100 GGELLDKILRQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             SCBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999543      358999999999999999999999   999999999999998543    35999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            54322  12345789999999998764  578899999999999999999999963

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.1e-40  Score=295.28  Aligned_cols=204  Identities=26%  Similarity=0.433  Sum_probs=159.2

Q ss_pred             HhhcccccccCcEEEEEEEEeC----CceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCC-----e
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGT-----R  202 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~  202 (344)
                      +.+.+.||+|+||+||+|+...    +..||+|.++....   ..+.+.+|+.++++++||||+++++++.+..     .
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  115 (313)
T 3brb_A           36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK  115 (313)
T ss_dssp             EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred             eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence            3456789999999999997543    45799999975432   2367899999999999999999999997755     3


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++||||+++|+|.+++...........+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecC
Confidence            49999999999999999654433344679999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +++...............+++.|+|||.+.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            99876544322223345578899999998764  78999999999999999999 8888753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-39  Score=291.44  Aligned_cols=197  Identities=23%  Similarity=0.326  Sum_probs=169.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++... ...+.+.+|+.+++++ +|+|++++++++.++...++||||+ +
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~   89 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   89 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence            34567899999999999984 67899999998653 2345688999999999 7999999999999999999999999 9


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc-----eEEeecCCcccc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-----PKISDFGLAKLC  287 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~Dfgla~~~  287 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++..
T Consensus        90 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           90 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99999996543     358999999999999999999999   99999999999999987776     999999999876


Q ss_pred             cCCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~  220 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQG  220 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcch
Confidence            544221     122455699999999998764  689999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-39  Score=287.73  Aligned_cols=194  Identities=25%  Similarity=0.375  Sum_probs=169.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|... +++.||+|++.....   ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   88 (284)
T 3kk8_A            9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   88 (284)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence            45678999999999999854 588999999975432   23678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc---eEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~---~kl~Dfgla~~~~  288 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++....
T Consensus        89 ~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           89 GGELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             SCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999998654      358999999999999999999999   99999999999999986655   9999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....   .....||+.|+|||++.+.  .++.++||||+|+++|||++|+.||..
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          160 DSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             SSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCC
Confidence            4422   2345689999999999764  789999999999999999999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-39  Score=288.97  Aligned_cols=193  Identities=26%  Similarity=0.433  Sum_probs=165.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|... ++..||+|++...    ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (279)
T 3fdn_A           12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA   91 (279)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence            35678999999999999754 4678999998642    233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++....      .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.++|+|||++......
T Consensus        92 ~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           92 PLGTVYRELQKLS------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             TTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999996543      48999999999999999999999   99999999999999999999999999998654433


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          163 R----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            2    2345689999999998764  678899999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6e-40  Score=292.60  Aligned_cols=201  Identities=31%  Similarity=0.493  Sum_probs=156.5

Q ss_pred             HHHHhhcccccccCcEEEEEEEEeCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ...+.+.+.||+|+||+||+|+.  ...||+|+++....   ..+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            33445678899999999999974  34699999975432   236789999999999999999999965 4556899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             CCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             ecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999995432     468999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCccceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ............||+.|+|||++... ...++.++||||||+++|||++|+.||+.
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            43322233455689999999998621 23678899999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.1e-40  Score=312.05  Aligned_cols=197  Identities=29%  Similarity=0.421  Sum_probs=172.8

Q ss_pred             HHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      ...+.+.+.||+|+||+||+|+.. +|+.||||++...    ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345667789999999999999854 6899999999643    33457899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCC
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGL  283 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgl  283 (344)
                      |||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|||+
T Consensus       105 ~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             ECCCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999998543      458999999999999999999999   999999999999999   5678999999999


Q ss_pred             cccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ++.......   .....||+.|+|||++.+   .++.++||||+|+++|||++|+.||..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            987654432   234569999999999865   588899999999999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.4e-39  Score=286.97  Aligned_cols=192  Identities=28%  Similarity=0.467  Sum_probs=165.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc----CCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE----GTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|.. .++..||+|.+....   ...+.+.+|+.++++++||||+++++++..    ....++||
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            3557799999999999975 457889999997543   234678999999999999999999998865    45689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEc-CCCceEEeecCCc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLD-HNFQPKISDFGLA  284 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~-~~~~~kl~Dfgla  284 (344)
                      ||+++++|.+++...      ..+++..++.++.|++.||+|||+   .+  ++||||||+|||++ +++.+||+|||++
T Consensus       109 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999653      358999999999999999999998   77  99999999999997 8899999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........    ....||+.|+|||++.+   .++.++||||+|+++|||++|+.||..
T Consensus       180 ~~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          180 TLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             GGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            76544322    34568999999998864   588999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.3e-40  Score=313.00  Aligned_cols=192  Identities=26%  Similarity=0.324  Sum_probs=158.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  204 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++....   ...+.+.+|+.+++.++||||+++++++...      ...+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            34567899999999999974 458899999997532   2346788999999999999999999999654      4679


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+++ +|.+.+.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+|
T Consensus       144 lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            99999965 5666662        248999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.......   .+...||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          212 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             -----CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            87654321   2456799999999999875  789999999999999999999999964

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-39  Score=309.15  Aligned_cols=196  Identities=28%  Similarity=0.426  Sum_probs=170.8

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ..+.+.+.||+|+||+||+|+.. +++.||||++...   ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            45667889999999999999854 6899999999642   3456789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc---CCCceEEeecCCcc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAK  285 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfgla~  285 (344)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++   .++.+||+|||+++
T Consensus       102 ~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          102 LYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999998654      358999999999999999999999   9999999999999995   56689999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......   .....||+.|+|||++.+   .++.++||||+||++|||++|+.||..
T Consensus       173 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~  224 (486)
T 3mwu_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYG  224 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            7654422   234569999999999865   588999999999999999999999854

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=296.25  Aligned_cols=198  Identities=28%  Similarity=0.469  Sum_probs=159.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCce----EEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIP----VAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.+.||+|+||+||+|.. .+++.    ||+|.+...  ....+.+.+|+.++++++||||+++++++.++. .++++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            34567899999999999984 34554    477776532  345578999999999999999999999998765 78999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             CCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999997643     358999999999999999999999   99999999999999999999999999999877


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            554333333455678899999999764  78999999999999999999 9999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.9e-39  Score=287.91  Aligned_cols=195  Identities=25%  Similarity=0.376  Sum_probs=170.1

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++... +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   97 (294)
T 2rku_A           18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC   97 (294)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence            34678999999999999865 47889999987532    23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           98 RRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             TTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            999999998553      358999999999999999999999   99999999999999999999999999999876533


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.|++.
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          169 GER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             TCC--BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccc--cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            221  2345689999999998764  678899999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-39  Score=309.48  Aligned_cols=196  Identities=29%  Similarity=0.435  Sum_probs=167.5

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      ..+.+.+.||+|+||+||+|+.. ++..||+|++...   ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34566789999999999999854 6889999999753   2345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAK  285 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~  285 (344)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       117 ~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          117 CYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999998654      358999999999999999999999   99999999999999976   4559999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......   .....||+.|+|||++.+   .++.++||||+||++|||++|+.||..
T Consensus       188 ~~~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          188 VFENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             ECBTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ECCCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            7665422   244569999999999864   688999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-39  Score=288.31  Aligned_cols=197  Identities=24%  Similarity=0.376  Sum_probs=167.7

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.+.||+|+||+||+|+.. +++.||+|+++..   .....++.+|+..+.++ +||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            3455688999999999999864 6899999999753   22346788999999999 99999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC----------------
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH----------------  272 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~----------------  272 (344)
                      |+++++|.+++.....  ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.                
T Consensus        92 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           92 YCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             CCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             ecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999965421  11458999999999999999999999   99999999999999984                


Q ss_pred             ---CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          273 ---NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       273 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                         ...+||+|||++......      ....||+.|+|||++.+. ..++.++||||||+++|||++|+.++.
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence               447999999999876543      234589999999998764 356679999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.5e-40  Score=294.59  Aligned_cols=194  Identities=31%  Similarity=0.508  Sum_probs=159.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||+||+|+. .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+  ..++||||+++|+|
T Consensus        11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L   86 (307)
T 2eva_A           11 EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred             eeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence            4567899999999999984 6889999999743 345789999999999999999999998874  47899999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc-eEEeecCCcccccCCccce
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ-PKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~-~kl~Dfgla~~~~~~~~~~  294 (344)
                      .+++.....   ...+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.......   
T Consensus        87 ~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~---  160 (307)
T 2eva_A           87 YNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---  160 (307)
T ss_dssp             HHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             HHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence            999965431   134789999999999999999999854468999999999999998886 7999999997654331   


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       161 --~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          161 --TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             ------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             --ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence              234589999999999764  789999999999999999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-39  Score=294.11  Aligned_cols=195  Identities=25%  Similarity=0.379  Sum_probs=170.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||++... +++.||+|++....    ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  123 (335)
T 2owb_A           44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC  123 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence            34678999999999999864 47889999987532    23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 ~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          124 RRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             TTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999998653      358999999999999999999999   99999999999999999999999999999876533


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence            22  12345689999999998764  678899999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-39  Score=287.58  Aligned_cols=193  Identities=21%  Similarity=0.397  Sum_probs=165.3

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC--CeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG--TRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+. ++..||||+++...   ...+.+.+|+.++++++||||+++++++.+.  ...++||||+
T Consensus        13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            4567899999999999985 58899999997543   2336789999999999999999999999887  7789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ++|+|.+++.....    ..+++..++.++.|++.||+|||+   .+  ++||||||+|||+++++.++|+|||++....
T Consensus        92 ~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           92 PYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             TTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             CCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999965432    368999999999999999999998   78  9999999999999999999999998876433


Q ss_pred             CCccceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .       ....||+.|+|||++.+. ...++.++||||||+++|||++|+.||+.
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            2       234589999999998753 12334489999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.3e-39  Score=296.71  Aligned_cols=199  Identities=24%  Similarity=0.363  Sum_probs=166.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc--------CCe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GTR  202 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~  202 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||+|++....   .....+.+|+.++++++||||+++++++.+        .+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (351)
T 3mi9_A           19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   98 (351)
T ss_dssp             EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred             eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence            44568899999999999986 568999999986432   234678899999999999999999999876        456


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++||||+++ +|.+.+....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        99 ~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           99 IYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             EEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            8999999974 7887775433     358999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCcc--ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDIS--IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++.......  ........||+.|+|||++.+. ..++.++||||||+++|||++|+.||+.
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9987653211  1222445689999999998654 3578999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=306.65  Aligned_cols=199  Identities=27%  Similarity=0.413  Sum_probs=168.8

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--eEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--RRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|... +|+.||||+++...  ...+.+.+|++++++++||||+++++++.+..  ..++||||+
T Consensus        12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~   91 (396)
T 4eut_A           12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC   91 (396)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred             EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence            45678999999999999864 48999999997532  34578889999999999999999999998755  779999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE----cCCCceEEeecCCccc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAKL  286 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfgla~~  286 (344)
                      ++|+|.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        92 ~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           92 PCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             TTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             CCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999965432   1348999999999999999999999   999999999999999    7778899999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccc------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRN------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......   .....||+.|+|||++.+.      ...++.++||||||+++|||++|+.||.+
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            654432   2345699999999988641      12567899999999999999999999853

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=289.28  Aligned_cols=194  Identities=31%  Similarity=0.499  Sum_probs=165.9

Q ss_pred             ccccccCcEEEEEEEEe---CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||+||+|+..   ++..||+|+++...  ...+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999743   57789999998643  3346789999999999999999999999 455689999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++...     ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        95 ~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           95 PLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CHHHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            999999533     2468999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             e-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 V-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      . ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            1 12334568999999998764  68899999999999999998 9999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=319.26  Aligned_cols=193  Identities=31%  Similarity=0.505  Sum_probs=161.7

Q ss_pred             cccccCcEEEEEEEEe---CCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLF---NGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +||+|+||+||+|...   ++..||||+++..  ....++|.+|+++|++++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999754   4567999999753  3345789999999999999999999999976 55899999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc-
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  293 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  293 (344)
                      |.+++...     ...+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++........ 
T Consensus       422 L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            99999543     2469999999999999999999999   99999999999999999999999999999876543221 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .......+|+.|+|||++...  .++.++|||||||++|||++ |+.||..
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~  542 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK  542 (613)
T ss_dssp             --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            112234467899999999764  78999999999999999998 9999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.4e-39  Score=310.54  Aligned_cols=194  Identities=31%  Similarity=0.444  Sum_probs=167.4

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--------------cchHHHHHHHHHHhhhcccceeeEeeEEEc
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--------------GNGQEFINEVATIGRIHHFHIVRLLGFCSE  199 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  199 (344)
                      +.+.++||+|+||+||+|+.. ++..||+|++....              ...+.+.+|+.++++++||||+++++++.+
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            445688999999999999854 57899999997532              234678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC---ce
Q 041350          200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF---QP  276 (344)
Q Consensus       200 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~---~~  276 (344)
                      ....++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++   .+
T Consensus       118 ~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          118 KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence            99999999999999999999654      358999999999999999999999   9999999999999998775   69


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ||+|||+++.......   .....||+.|+|||++.+   .++.++||||+|+++|||++|+.||..
T Consensus       189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999987765432   234569999999999864   588999999999999999999999964

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-39  Score=290.24  Aligned_cols=195  Identities=29%  Similarity=0.431  Sum_probs=168.7

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc-chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG-NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||+||+++.. +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            4556788999999999999854 689999999985432 34678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~~  288 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||++   ++++.+||+|||+++...
T Consensus        90 ~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           90 GGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             SCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             CccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999998654      358999999999999999999999   999999999999999   788999999999997654


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...    .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          161 NGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             CBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            331    1334589999999998764  788999999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.2e-40  Score=296.32  Aligned_cols=205  Identities=26%  Similarity=0.441  Sum_probs=171.8

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|+..      ++..||+|.+.....  ....+.+|+.++++++||||+++++++.++...++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            3455688999999999999753      367899999975432  33578999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTN----SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ||||+++|+|.+++.....    ......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcC
Confidence            9999999999999965321    1112457999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence            999876544332222344578999999998764  78999999999999999999 8888753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6e-40  Score=307.59  Aligned_cols=197  Identities=24%  Similarity=0.358  Sum_probs=158.1

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  203 (344)
                      .+.+.+.||+|+||+||+|.. .+++.||||++.....         ....+.+|+.++++++||||+++++++.. ...
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cce
Confidence            455678899999999999975 4578999999975321         11247899999999999999999999754 557


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEee
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISD  280 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~D  280 (344)
                      ++||||+++|+|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.+   ..+||+|
T Consensus       215 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             EEEEECCTTCBGGGGTSS------SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence            999999999999998843      2468999999999999999999999   999999999999999654   4599999


Q ss_pred             cCCcccccCCccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          281 FGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       281 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ||+++.......   .....||+.|+|||++.+ ....++.++||||||+++|||++|+.||..
T Consensus       286 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          286 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999987654321   234569999999999853 224678899999999999999999999863

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-39  Score=292.04  Aligned_cols=197  Identities=23%  Similarity=0.366  Sum_probs=161.0

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|... +++.||+|++......    .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            345678999999999999854 6889999999754222    36788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       116 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          116 INGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             CCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999654      358999999999999999999999   9999999999999999999999999999986654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ... .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            321 122345689999999998764  788899999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-39  Score=287.30  Aligned_cols=194  Identities=24%  Similarity=0.395  Sum_probs=170.1

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+.. ++..||+|++...    ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            345678999999999999854 5788999999643    23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999654      258999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..    .....|++.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cc----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCC
Confidence            22    1345689999999998764  688999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-39  Score=293.35  Aligned_cols=194  Identities=28%  Similarity=0.437  Sum_probs=157.8

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhh--cccceeeEeeEEEcC----Ce
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI--HHFHIVRLLGFCSEG----TR  202 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~  202 (344)
                      +.....+.+.+.||+|+||+||+|+. +++.||||++...  ....+..|.+++..+  +||||+++++++.+.    ..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc--ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            33444566778999999999999985 5899999999753  334455566655554  899999999999877    78


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CeeecCCCCCceEEcCCC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ--------RILHFDIKPHNILLDHNF  274 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~--------~ivH~Dik~~Nill~~~~  274 (344)
                      .++||||+++|+|.+++..       ..+++..++.++.|++.||+|||+   .        +|+||||||+|||++.++
T Consensus       110 ~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             eEEEEeccCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCC
Confidence            8999999999999999954       248999999999999999999998   6        999999999999999999


Q ss_pred             ceEEeecCCcccccCCccce--eeecccCCcccccccccccccCCCCc------ccchHhHHHHHHHHHcC
Q 041350          275 QPKISDFGLAKLCSKDISIV--SLTAARGTAGYIAPELFSRNFGEVSY------KSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~------~~Dv~s~Gvvl~ell~g  337 (344)
                      .+||+|||+++.........  ......||+.|+|||++.+.  ..+.      ++||||||+++|||++|
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhc
Confidence            99999999998665432211  11245699999999998764  3333      49999999999999999

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-40  Score=302.78  Aligned_cols=197  Identities=29%  Similarity=0.519  Sum_probs=154.6

Q ss_pred             hhcccccccCcEEEEEEEEeC--C--ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN--G--IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~--~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+..+  +  ..||+|.++...  ...++|.+|+.++++++||||+++++++.+ ++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            345789999999999998542  2  468999987533  334789999999999999999999998754 457899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       172 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          172 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999996433     458899999999999999999999   999999999999999999999999999998654


Q ss_pred             CCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          289 KDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       289 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      .....  .......+|+.|+|||++.+.  .++.++||||||+++|||++ |..|+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~  298 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYP  298 (373)
T ss_dssp             --------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             ccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence            33211  112344578899999998764  78999999999999999999 555553

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=299.71  Aligned_cols=194  Identities=30%  Similarity=0.483  Sum_probs=155.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHH--HHhhhcccceeeEeeEEEc-----CCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVA--TIGRIHHFHIVRLLGFCSE-----GTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~--~l~~l~h~niv~~~~~~~~-----~~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+ .+++.||||++....  .+.+..|.+  .+..++||||+++++.+..     ....++|||
T Consensus        16 ~~~~~lg~G~~g~Vy~~~-~~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e   92 (336)
T 3g2f_A           16 KLLELIGRGRYGAVYKGS-LDERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME   92 (336)
T ss_dssp             EEEEEEEECSSEEEEEEE-ETTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred             heeeecccCCCeEEEEEE-ECCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence            456789999999999997 478999999997543  344444444  4556899999999986532     336789999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CeeecCCCCCceEEcCCCceEEe
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ---------RILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~---------~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      |+++|+|.+++...       ..++..+..++.|+++||+|||+   .         +|+||||||+|||++.++.+||+
T Consensus        93 ~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           93 YYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             CCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             cCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence            99999999999543       35899999999999999999998   6         99999999999999999999999


Q ss_pred             ecCCcccccCCcc------ceeeecccCCccccccccccccc-----CCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          280 DFGLAKLCSKDIS------IVSLTAARGTAGYIAPELFSRNF-----GEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       280 Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      |||+++.......      ........||+.|+|||++.+..     ..++.++||||||+++|||++|+.|+.
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999987653321      11123456999999999987521     245678999999999999999987764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=299.68  Aligned_cols=192  Identities=25%  Similarity=0.381  Sum_probs=160.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCC------eEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  204 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            34557899999999999985 4689999999964322   2367889999999999999999999997653      469


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+ +++|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       107 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            999999 8899999854       248999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.....     .....+|+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            876543     2345689999999998763 3688999999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.1e-40  Score=305.48  Aligned_cols=201  Identities=27%  Similarity=0.365  Sum_probs=169.8

Q ss_pred             HHHHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc--------ccceeeEeeEEE
Q 041350          128 KELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH--------HFHIVRLLGFCS  198 (344)
Q Consensus       128 ~~l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~  198 (344)
                      .++....+.+.+.||+|+||+||+|+. .+++.||||+++......+.+.+|+.+++.++        |+||+++++++.
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            333334556678899999999999974 45889999999865555678899999999996        788999999987


Q ss_pred             ----cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCC
Q 041350          199 ----EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHN  273 (344)
Q Consensus       199 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~  273 (344)
                          ++...++||||+ +++|.+++.....    ..+++..++.++.||+.||+|||+   . +|+||||||+|||++.+
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~  183 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCC
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEecc
Confidence                566889999999 6677777654321    458999999999999999999999   7 99999999999999977


Q ss_pred             C-------------------------------------------------ceEEeecCCcccccCCccceeeecccCCcc
Q 041350          274 F-------------------------------------------------QPKISDFGLAKLCSKDISIVSLTAARGTAG  304 (344)
Q Consensus       274 ~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  304 (344)
                      +                                                 .+||+|||+++.....     .....||+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~  258 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ  258 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence            5                                                 7999999999876543     234568999


Q ss_pred             cccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       305 y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+|||++.+.  .++.++|||||||++|||++|+.||++
T Consensus       259 y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~  295 (397)
T 1wak_A          259 YRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEP  295 (397)
T ss_dssp             GCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence            9999999775  689999999999999999999999964

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.1e-40  Score=297.82  Aligned_cols=205  Identities=29%  Similarity=0.464  Sum_probs=171.5

Q ss_pred             HHhhcccccccCcEEEEEEEEeC------CceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN------GIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  204 (344)
                      .+.+.+.||+|+||+||+|....      ...||+|.+....  ...+.+.+|+.+++++ +||||+++++++.+++..+
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  126 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL  126 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence            34456789999999999998532      2479999997643  2346789999999999 8999999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCce
Q 041350          205 LVYEFMPNGSLEKFIFSKTNS--------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP  276 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~  276 (344)
                      +||||+++|+|.+++......        .....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeE
Confidence            999999999999999753210        012458999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          277 KISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       277 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|++.
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence            99999999876554333333445678899999998764  78999999999999999998 8888853

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-39  Score=295.03  Aligned_cols=196  Identities=26%  Similarity=0.403  Sum_probs=164.1

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|+.. +|+.||+|++......   .+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  107 (331)
T 4aaa_A           28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD  107 (331)
T ss_dssp             EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence            44578999999999999864 4889999998654333   3567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       108 ~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          108 HTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            99999887432      358999999999999999999999   999999999999999999999999999998665432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2  12345689999999998764 3678899999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.1e-39  Score=304.74  Aligned_cols=194  Identities=22%  Similarity=0.324  Sum_probs=168.7

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhh------cccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRI------HHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +.+.+.||+|+||+||+|... +++.||||+++......+.+.+|+.+++.+      +|+||+++++++......++||
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~  178 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF  178 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence            455688999999999999754 588999999987655567788899998888      4679999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc--eEEeecCCcc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ--PKISDFGLAK  285 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~--~kl~Dfgla~  285 (344)
                      ||++ ++|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+++
T Consensus       179 e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          179 ELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             CCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9995 699999976442    358999999999999999999999   89999999999999999887  9999999997


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            65433     2345689999999999775  789999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.6e-40  Score=300.26  Aligned_cols=194  Identities=27%  Similarity=0.415  Sum_probs=168.8

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||++... ++..||+|++....  ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  114 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD  114 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence            445678999999999999854 58899999997542  234678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +++|.+++....      .+++..+..++.|++.||+|||+   . +|+||||||+|||++.++.+||+|||++......
T Consensus       115 ~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          115 GGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             TCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999996543      58999999999999999999998   5 8999999999999999999999999999765332


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.+
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             c----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            1    2345689999999999764  789999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.6e-39  Score=292.01  Aligned_cols=191  Identities=24%  Similarity=0.413  Sum_probs=166.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEc--CCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSE--GTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  210 (344)
                      +.+.+.||+|+||+||+|.. .+++.||+|+++.  ...+.+.+|+.++++++ ||||+++++++.+  ....++||||+
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            34567899999999999974 5689999999974  34578999999999997 9999999999987  66789999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSK  289 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~  289 (344)
                      ++++|.+++.         .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+++....
T Consensus       116 ~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          116 NNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             CchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999982         48899999999999999999999   9999999999999999776 899999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||.+
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            432   2345689999999998753 3688999999999999999999999843

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-39  Score=290.35  Aligned_cols=196  Identities=29%  Similarity=0.518  Sum_probs=161.7

Q ss_pred             hhcccccccCcEEEEEEEEeC----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEE-cCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCS-EGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+..+    ...+|+|.+.....  ..+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e  107 (298)
T 3f66_A           28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  107 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred             hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence            456789999999999998533    23589999875432  3467899999999999999999999865 4567899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++...
T Consensus       108 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          108 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999996432     458999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCcc--ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          289 KDIS--IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       289 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ....  ........+|+.|+|||.+.+.  .++.++||||+|+++|||++|+.|+
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~  232 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPP  232 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCC
Confidence            4321  1122345678899999999764  7889999999999999999955544

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.9e-40  Score=294.76  Aligned_cols=205  Identities=32%  Similarity=0.466  Sum_probs=171.4

Q ss_pred             HHhhcccccccCcEEEEEEEE------eCCceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCC-eE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGT-RR  203 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~  203 (344)
                      .+.+.+.||+|+||+||+|+.      .+++.||||+++....  ..+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  107 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL  107 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence            345568899999999999974      3467899999975432  335789999999999 7999999999987654 58


Q ss_pred             EEEEeccCCCCHHHHHhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSS----------SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ++||||+++|+|.+++.......          ....+++..++.++.|+++||+|||+   .+|+||||||+|||++.+
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCC
Confidence            99999999999999997643210          12238999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          274 FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       274 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +.+||+|||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999876554443334455688999999998764  78999999999999999998 9998853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.7e-40  Score=297.02  Aligned_cols=196  Identities=27%  Similarity=0.386  Sum_probs=159.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||+++....   ..+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  115 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA  115 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence            34567899999999999974 4688999999975332   2356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-----CCCceEEeecCCcc
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-----HNFQPKISDFGLAK  285 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-----~~~~~kl~Dfgla~  285 (344)
                      + |+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++     +++.+||+|||+++
T Consensus       116 ~-~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          116 E-NDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             S-EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             C-CCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            7 5999999654      348999999999999999999999   9999999999999994     55569999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......  ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       186 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          186 AFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            7653322  12345689999999998764 3579999999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-39  Score=289.01  Aligned_cols=195  Identities=28%  Similarity=0.459  Sum_probs=164.3

Q ss_pred             hcccccccCcEEEEEEEEeC-C---ceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeE-EEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-G---IPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR-ALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~  209 (344)
                      ..+.||+|+||+||+|...+ +   ..||+|.+.....  ..+.+.+|+.++++++||||+++++++.+.+.. +++|||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            34789999999999998543 2   3699999975433  346789999999999999999999999876655 999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +.+|+|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus       105 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999996532     468999999999999999999999   9999999999999999999999999999986543


Q ss_pred             Ccc--ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          290 DIS--IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       290 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ...  ........+|+.|+|||.+.+.  .++.++||||||+++|||++|+.|+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCC
Confidence            321  1122345678999999999764  7889999999999999999976665

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-39  Score=288.09  Aligned_cols=197  Identities=27%  Similarity=0.444  Sum_probs=169.2

Q ss_pred             HHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc---------
Q 041350          130 LKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE---------  199 (344)
Q Consensus       130 l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  199 (344)
                      .....+.+.+.||+|+||.||+|+.. +++.||+|.++...   +.+.+|++++++++||||+++++++..         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            33445566788999999999999865 68999999997543   457789999999999999999998854         


Q ss_pred             -------CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          200 -------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       200 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                             ....++||||+++++|.+++.....    ..+++..++.++.|++.||+|||+   .+|+|+||||+|||+++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence                   4457999999999999999975432    468999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ++.+||+|||++........   .....||+.|+|||++.+.  .++.++||||||+++|||++|..|+
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             CCCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcc
Confidence            99999999999987655422   2345689999999998764  6889999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.4e-40  Score=298.71  Aligned_cols=197  Identities=19%  Similarity=0.238  Sum_probs=160.5

Q ss_pred             HHhhcccccccCcEEEEEEEEe----CCceEEEEEeecccc------------chHHHHHHHHHHhhhcccceeeEeeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKG------------NGQEFINEVATIGRIHHFHIVRLLGFC  197 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~  197 (344)
                      .+.+.+.||+|+||+||+|...    ++..+|+|++.....            ..+.+.+|+..++.++||||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            3456688999999999999864    577899999875432            123467888999999999999999999


Q ss_pred             Ec----CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          198 SE----GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       198 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      .+    ....++||||+ +++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            87    77899999999 99999998543      268999999999999999999999   999999999999999988


Q ss_pred             C--ceEEeecCCcccccCCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          274 F--QPKISDFGLAKLCSKDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       274 ~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      +  .+||+|||+++........     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            7  9999999999876433211     111345699999999998764  78999999999999999999999994

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.2e-39  Score=291.65  Aligned_cols=203  Identities=23%  Similarity=0.358  Sum_probs=169.3

Q ss_pred             HHHHHHHhhc-ccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCe
Q 041350          129 ELKKITSKFK-HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTR  202 (344)
Q Consensus       129 ~l~~~~~~~~-~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  202 (344)
                      +.....+.+. +.||+|+||+||+|... +++.||+|+++...   .....+.+|+.++.++. ||||+++++++.+...
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3333444444 78999999999999854 58999999997532   33578899999999995 6999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEe
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKIS  279 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~  279 (344)
                      .++||||+++|+|.+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             EEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999985432    2468999999999999999999999   99999999999999987   7899999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999987654322   2345699999999999764  788999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=291.93  Aligned_cols=199  Identities=27%  Similarity=0.440  Sum_probs=164.7

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc------CCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE------GTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+. .+++.||+|++.......+.+.+|+.+++++ +||||+++++++..      ....++||
T Consensus        27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~  106 (326)
T 2x7f_A           27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM  106 (326)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence            3467899999999999985 4689999999987666778999999999999 79999999999976      46889999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++.....    ..+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||++...
T Consensus       107 e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          107 EFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             ECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            99999999999975431    468999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  ......||+.|+|||++...   ...++.++||||||+++|||++|+.||..
T Consensus       180 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          180 DRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            44321  12345689999999998621   23678899999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.8e-39  Score=287.54  Aligned_cols=195  Identities=23%  Similarity=0.403  Sum_probs=171.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +...+.||+|+||+||+|.. .+++.||+|++...  ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            34467899999999999975 46889999999754  3445789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++..       ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus       104 ~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          104 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             TEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999842       358999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......||+.|+|||++.+.  .++.++||||||+++|||++|+.|++.
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             c--ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCC
Confidence            2  12345689999999998764  788899999999999999999999863

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-39  Score=318.73  Aligned_cols=193  Identities=29%  Similarity=0.461  Sum_probs=161.2

Q ss_pred             ccccccCcEEEEEEEEe---CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ++||+|+||+||+|...   +++.||||+++...   ...+++.+|++++++++||||+++++++.+ ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46999999999999643   45789999997543   234789999999999999999999999965 457899999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            9999999643      358999999999999999999999   9999999999999999999999999999987654432


Q ss_pred             c-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          293 I-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       293 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      . .......+|+.|+|||++...  .++.++||||||+++|||++ |+.||..
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1 122334578899999999764  78999999999999999998 9999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.8e-39  Score=291.37  Aligned_cols=195  Identities=29%  Similarity=0.451  Sum_probs=166.3

Q ss_pred             hhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALV  206 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  206 (344)
                      .+.+.||+|+||+||++..     .+++.||||+++...  ...+.+.+|++++++++||||+++++++.+  ....++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            4568899999999988753     367899999998643  234678999999999999999999999987  4678999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++|+|.+++...       .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       114 ~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             ECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999542       38999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... .......+|+.|+|||++.+.  .++.++||||||+++|||++|+.|+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCccc
Confidence            7654322 122345578899999999764  67889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=289.13  Aligned_cols=197  Identities=28%  Similarity=0.434  Sum_probs=168.6

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.+.||+|+||+||+|... +|+.||+|.+... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  108 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA  108 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence            3445678999999999999864 4899999999764 3457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........
T Consensus       109 ~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          109 GSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             EEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999996432     468999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence              12345689999999998764  688999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-39  Score=297.02  Aligned_cols=198  Identities=28%  Similarity=0.367  Sum_probs=165.5

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeecccc------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      .+.+.+.||+|+||+||+|+.. +|+.||||++.....      ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            3455688999999999999854 589999999874221      124688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++ +|.+++....     ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999975 8998885432     458889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ......  ......||+.|+|||++.+. ..++.++||||||+++|||++|..|+..
T Consensus       162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          162 FGSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             TTSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            654322  12345689999999998654 3578899999999999999999998754

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-39  Score=293.72  Aligned_cols=197  Identities=29%  Similarity=0.509  Sum_probs=161.0

Q ss_pred             hcccccccCcEEEEEEEEeC-----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.||+|+||+||+|....     +..||+|.++....  ....+.+|+.++++++||||+++++++.+....++||||
T Consensus        48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  127 (333)
T 1mqb_A           48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY  127 (333)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence            35789999999999997543     23599999975432  335789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          128 MENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             CTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             CCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999996542     468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             Cccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .... .......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~  253 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWE  253 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence            3221 112234568899999998764  78899999999999999998 9999853

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=288.98  Aligned_cols=200  Identities=24%  Similarity=0.309  Sum_probs=166.5

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc-----ccchHHHHHHHHHHhhhcccceeeEeeEEE--cCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL-----KGNGQEFINEVATIGRIHHFHIVRLLGFCS--EGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  207 (344)
                      .+.+.||+|+||.||++.. .+++.||+|+++..     ....+.+.+|+.++++++||||+++++++.  +....++||
T Consensus         8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (305)
T 2wtk_C            8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM   87 (305)
T ss_dssp             CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred             eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence            4567899999999999985 45789999999753     234478899999999999999999999984  455789999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++++ |.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        88 e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           88 EYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             ECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             hhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999876 7777765432    468999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .............||+.|+|||++.+.....+.++||||||+++|||++|+.||+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            54332233345669999999999876423457799999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-40  Score=307.11  Aligned_cols=197  Identities=17%  Similarity=0.203  Sum_probs=158.4

Q ss_pred             hcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHH---HHHhhhcccceeeEe-------eEEEcCC
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEV---ATIGRIHHFHIVRLL-------GFCSEGT  201 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~~~~  201 (344)
                      +.+.||+|+||+||+|+. .+|+.||||++...    ....+.+.+|+   .++++++||||++++       +++.+.+
T Consensus        77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~  156 (377)
T 3byv_A           77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  156 (377)
T ss_dssp             EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred             EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence            457899999999999984 56899999999742    23347788999   556666899999998       6655543


Q ss_pred             -----------------eEEEEEeccCCCCHHHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 041350          202 -----------------RRALVYEFMPNGSLEKFIFSKTNSS-SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI  263 (344)
Q Consensus       202 -----------------~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di  263 (344)
                                       ..++||||+ +|+|.+++....... ....+++..++.++.|++.||+|||+   .+|+||||
T Consensus       157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDi  232 (377)
T 3byv_A          157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL  232 (377)
T ss_dssp             SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred             CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence                             278999999 689999997542111 12345578899999999999999999   99999999


Q ss_pred             CCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccc---------cCCCCcccchHhHHHHHHHH
Q 041350          264 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN---------FGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       264 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Dv~s~Gvvl~el  334 (344)
                      ||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.         ...++.++||||||+++|||
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            99999999999999999999986433     2234567 999999998753         01578999999999999999


Q ss_pred             HcCCCCCCC
Q 041350          335 VGCRKNKDP  343 (344)
Q Consensus       335 l~g~~p~~~  343 (344)
                      ++|+.||..
T Consensus       307 ltg~~Pf~~  315 (377)
T 3byv_A          307 WCADLPITK  315 (377)
T ss_dssp             HHSSCCC--
T ss_pred             HHCCCCCcc
Confidence            999999853

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-39  Score=294.42  Aligned_cols=198  Identities=32%  Similarity=0.482  Sum_probs=169.2

Q ss_pred             HhhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEE--cCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCS--EGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+++.     .+++.||||++.... ...+.+.+|++++++++||||+++++++.  +....++|
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv  104 (327)
T 3lxl_A           25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV  104 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred             hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence            34567899999999999983     467899999997543 33467899999999999999999999986  45678999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          105 MEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            99999999999996543     358999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... .......+|+.|+|||++.+.  .++.++||||||+++|||++|+.|+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~  231 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSC  231 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            6544322 122344588899999998764  67889999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.3e-39  Score=290.81  Aligned_cols=195  Identities=25%  Similarity=0.379  Sum_probs=170.2

Q ss_pred             HHhhcccccccCcEEEEEEEE--eCCceEEEEEeeccccchHHHHHHHHHHhhhcccc------eeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL--FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|..  .+++.||||+++......+.+.+|+.+++.++|+|      ++++++++.+.+..++
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l   94 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI   94 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence            345678899999999999975  36889999999865555678899999999998775      9999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-------------
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-------------  272 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-------------  272 (344)
                      ||||+ +++|.+++.....    .++++..+..++.|++.||+|||+   .+|+||||||+|||++.             
T Consensus        95 v~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           95 VFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999 8999999965432    468999999999999999999999   99999999999999987             


Q ss_pred             ------CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          273 ------NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       273 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                            ++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                  6789999999998654431     345689999999999764  789999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7e-40  Score=302.49  Aligned_cols=194  Identities=11%  Similarity=0.042  Sum_probs=148.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhh--cccceeeEe-------eEEEcC-
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRI--HHFHIVRLL-------GFCSEG-  200 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~-  200 (344)
                      .+.+.||+|+||+||+|+. .+|+.||||++.....    ..+.+.+|+.+++.+  +||||++++       +++... 
T Consensus        65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~  144 (371)
T 3q60_A           65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS  144 (371)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred             eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence            4567899999999999985 4689999999986432    235667785555555  599988755       444332 


Q ss_pred             ----------------CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 041350          201 ----------------TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL------KKIAFGVARGVEYLHQGCNQRI  258 (344)
Q Consensus       201 ----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~~i  258 (344)
                                      ...++||||++ |+|.+++.....     .+++..+      ..++.|+++||+|||+   .+|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i  215 (371)
T 3q60_A          145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQS---KGL  215 (371)
T ss_dssp             SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence                            34799999998 899999976421     2344455      7888999999999999   999


Q ss_pred             eecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCC
Q 041350          259 LHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR  338 (344)
Q Consensus       259 vH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~  338 (344)
                      +||||||+|||++.++.+||+|||+|+.....     .....+|+.|+|||++.+....++.++||||||+++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999866432     1245577999999999763237899999999999999999999


Q ss_pred             CCCCC
Q 041350          339 KNKDP  343 (344)
Q Consensus       339 ~p~~~  343 (344)
                      .||..
T Consensus       291 ~Pf~~  295 (371)
T 3q60_A          291 LPFGL  295 (371)
T ss_dssp             CSTTB
T ss_pred             CCCCC
Confidence            99864

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-39  Score=294.55  Aligned_cols=207  Identities=26%  Similarity=0.421  Sum_probs=167.7

Q ss_pred             HHHHhhcccccccCcEEEEEEEE------eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeE
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKL------FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  203 (344)
                      ...+.+.+.||+|+||+||+|+.      .++..||||.+....  ....++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            33445678899999999999973      346789999996432  3346789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEe
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSS-SHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKIS  279 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~  279 (344)
                      ++||||+++++|.+++....... ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999997654321 22458999999999999999999999   99999999999999984   4569999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||+++...............+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99999865443332233445689999999998764  78999999999999999998 8888853

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=301.20  Aligned_cols=199  Identities=24%  Similarity=0.384  Sum_probs=152.5

Q ss_pred             cccccccCcEEEEEEEEe---CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEE--cCCeEEEEEeccCC
Q 041350          138 KHRLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCS--EGTRRALVYEFMPN  212 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~  212 (344)
                      .++||+|+||+||+|+..   +++.||+|++... ...+.+.+|+.+|++++||||+++++++.  .....++||||++ 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            357999999999999854   4789999999753 33467889999999999999999999995  4678999999996 


Q ss_pred             CCHHHHHhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE----cCCCceEEeecCCcc
Q 041350          213 GSLEKFIFSKTN---SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL----DHNFQPKISDFGLAK  285 (344)
Q Consensus       213 gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill----~~~~~~kl~Dfgla~  285 (344)
                      |+|.+++.....   ......+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            588888753211   1122359999999999999999999999   999999999999999    778999999999998


Q ss_pred             cccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ....... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||.
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCC
Confidence            7654321 1222446789999999998764 358999999999999999999999995

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=286.51  Aligned_cols=196  Identities=29%  Similarity=0.388  Sum_probs=166.5

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      ..||+|+||+||+|.. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999985 468899999997643 33578899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecCCcccccCCcccee
Q 041350          217 KFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       217 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      +++.....   ...+++..+..++.|++.||+|||+   .+++|+||||+||+++. ++.+||+|||+++.......  .
T Consensus       108 ~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~  179 (295)
T 2clq_A          108 ALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--C  179 (295)
T ss_dssp             HHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred             HHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--c
Confidence            99976432   2357799999999999999999999   99999999999999987 89999999999987654321  1


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....||+.|+|||++.+....++.++||||||+++|||++|+.||.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            23456899999999987642347889999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.7e-39  Score=283.61  Aligned_cols=195  Identities=28%  Similarity=0.433  Sum_probs=162.4

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+.+.||+|+||+||+|+.. +|+.||+|++...    ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   93 (276)
T 2h6d_A           14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence            45678999999999999865 6899999999743    234468899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        94 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           94 SGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             CCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            999999999654      348999999999999999999999   99999999999999999999999999999876543


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....+|+.|+|||++.+. ...+.++||||||+++|||++|+.|++.
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             ---------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            22   2345689999999998764 2336799999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-39  Score=285.17  Aligned_cols=196  Identities=24%  Similarity=0.401  Sum_probs=163.4

Q ss_pred             HhhcccccccCcEEEEEEEEeC----CceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+..+    +..||+|.+....  ...+.+.+|+.++++++||||+++++++.++ ..++|||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e   92 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME   92 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence            3456789999999999998543    2359999997542  3347789999999999999999999998654 5689999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        93 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           93 LYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             CCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             cCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999996543     358999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ..... ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||.
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~  216 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFF  216 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ccccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcc
Confidence            43221 12345578899999998764  78899999999999999998 999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.2e-39  Score=296.13  Aligned_cols=194  Identities=26%  Similarity=0.361  Sum_probs=158.2

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccccc------------hHHHHHHHHHHhhhcccceeeEeeEEEc-----
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN------------GQEFINEVATIGRIHHFHIVRLLGFCSE-----  199 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~-----  199 (344)
                      +.+.||+|+||+||+|...+|..||||++......            .+.+.+|+.++++++||||+++++++..     
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred             EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence            45789999999999998888999999998642211            2678999999999999999999999843     


Q ss_pred             CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       200 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      ....++||||++ |+|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence            346899999997 68888886432     468999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||+++.......   .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       177 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          177 DFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9999985544322   2345689999999998763 3688999999999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.3e-39  Score=298.50  Aligned_cols=196  Identities=24%  Similarity=0.310  Sum_probs=162.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc--------------
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE--------------  199 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------------  199 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||++.....   ...+|+++++.++||||+++++++..              
T Consensus         9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            44568899999999999975 5689999999875432   23479999999999999999999843              


Q ss_pred             ------------------------CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 041350          200 ------------------------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN  255 (344)
Q Consensus       200 ------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  255 (344)
                                              ....++||||++ |+|.+.+.....  ....+++..+..++.|+++||+|||+   
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---  159 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGFIHS---  159 (383)
T ss_dssp             ------------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence                                    334889999997 588887754221  12469999999999999999999999   


Q ss_pred             CCeeecCCCCCceEEc-CCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHH
Q 041350          256 QRILHFDIKPHNILLD-HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~el  334 (344)
                      .+|+||||||+|||++ +++.+||+|||+|+.......   .....+|+.|+|||++.+. ..++.++||||+|+++|||
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHH
Confidence            9999999999999998 689999999999987654432   2345689999999998764 3589999999999999999


Q ss_pred             HcCCCCCCC
Q 041350          335 VGCRKNKDP  343 (344)
Q Consensus       335 l~g~~p~~~  343 (344)
                      ++|+.||..
T Consensus       236 l~g~~pf~~  244 (383)
T 3eb0_A          236 ILGKPLFSG  244 (383)
T ss_dssp             HHSSCSSCC
T ss_pred             HhCCCCCCC
Confidence            999999964

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-39  Score=289.89  Aligned_cols=200  Identities=24%  Similarity=0.450  Sum_probs=159.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||+|+++...    ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  113 (310)
T 2wqm_A           34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence            45668899999999999985 568999999997422    2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++.....  ....+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus       114 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             CCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             CCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            999999999965321  12468999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  .....|++.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       189 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          189 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             CCcc--ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            3221  2345689999999998764  788999999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-38  Score=290.35  Aligned_cols=197  Identities=26%  Similarity=0.435  Sum_probs=165.7

Q ss_pred             HHHHHHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhh--hcccceeeEeeEEEcCC----
Q 041350          128 KELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGR--IHHFHIVRLLGFCSEGT----  201 (344)
Q Consensus       128 ~~l~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----  201 (344)
                      .+.....+.+.+.||+|+||+||+|+. +++.||||++...  ..+.+.+|.+++..  ++||||+++++++....    
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            344445666778999999999999985 6899999999643  45678889998887  78999999999998876    


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeecCCCCCceEEcCC
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH--------QGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ..++||||+++|+|.+++..       ..+++..++.++.|++.||+|||        +   .+|+||||||+|||++.+
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTT
T ss_pred             eeEEEEeecCCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCC
Confidence            78999999999999999954       24899999999999999999999        6   899999999999999999


Q ss_pred             CceEEeecCCcccccCCccce--eeecccCCcccccccccccccC----CCCcccchHhHHHHHHHHHcC
Q 041350          274 FQPKISDFGLAKLCSKDISIV--SLTAARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMVGC  337 (344)
Q Consensus       274 ~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Dv~s~Gvvl~ell~g  337 (344)
                      +++||+|||+++.........  ......||+.|+|||++.+...    .++.++||||||+++|||++|
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999998765543221  1234569999999999875311    223689999999999999999

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=297.71  Aligned_cols=195  Identities=20%  Similarity=0.209  Sum_probs=164.4

Q ss_pred             HhhcccccccCcEEEEEEEEe---------CCceEEEEEeeccccchHHHHHHHHHHhhhcccceee-------------
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF---------NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVR-------------  192 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------------  192 (344)
                      +.+.+.||+|+||+||+|+..         +++.||+|++...    +.+.+|++++++++||||++             
T Consensus        44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            445688999999999999865         3789999999754    46889999999999999988             


Q ss_pred             --EeeEEEc-CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          193 --LLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       193 --~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                        +++++.. +...++||||+ +++|.+++....    ...+++..++.++.|++.||+|||+   .+|+||||||+|||
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             cchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence              6777765 77889999999 999999997542    1469999999999999999999999   99999999999999


Q ss_pred             EcCCC--ceEEeecCCcccccCCccce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          270 LDHNF--QPKISDFGLAKLCSKDISIV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       270 l~~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ++.++  .+||+|||+++.........     ......||+.|+|||++.+.  .++.++||||||+++|||++|+.||.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99998  99999999998765432211     11334799999999999764  78999999999999999999999986


Q ss_pred             C
Q 041350          343 P  343 (344)
Q Consensus       343 ~  343 (344)
                      .
T Consensus       270 ~  270 (352)
T 2jii_A          270 N  270 (352)
T ss_dssp             G
T ss_pred             c
Confidence            3

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.6e-39  Score=286.08  Aligned_cols=195  Identities=29%  Similarity=0.469  Sum_probs=163.1

Q ss_pred             hcc-cccccCcEEEEEEEEe---CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          137 FKH-RLGQGGYGSVFRGKLF---NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       137 ~~~-~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+ .||+|+||+||+|...   +++.||||+++....   ..+++.+|+.+++.++||||+++++++ +.+..++||||
T Consensus        20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   98 (291)
T 1xbb_A           20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM   98 (291)
T ss_dssp             EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence            445 8999999999999643   367899999975422   246789999999999999999999999 56678999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++++|.+++...      ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        99 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           99 AELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             CTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            9999999999653      358999999999999999999999   9999999999999999999999999999987654


Q ss_pred             Cccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ..... ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            43321 12234567899999998764  67889999999999999999 9999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.7e-39  Score=294.75  Aligned_cols=197  Identities=27%  Similarity=0.406  Sum_probs=166.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  206 (344)
                      +.+.+.||+|+||+||+|.. .++..||||++.....  ..+.+.+|++++++++||||+++++++...     ...++|
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  108 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV  108 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence            44567899999999999975 4688999999975332  236789999999999999999999998654     368999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||++ |+|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          109 QDLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99996 599999854       248999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........ ......||+.|+|||++.+. ..++.++||||+|+++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  234 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPG  234 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence            65432211 12345799999999987654 3588999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.2e-39  Score=298.96  Aligned_cols=196  Identities=25%  Similarity=0.304  Sum_probs=160.2

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC------eEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+..++..||+|++......   ..+|+++++.++||||+++++++....      ..++|||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            4456789999999999999877777999988643322   236999999999999999999985433      3789999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfgla~~~  287 (344)
                      |++++.+........   ....+++..++.++.|+++||+|||+   .+|+||||||+|||++ .++.+||+|||+|+..
T Consensus       119 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          119 YVPETVYRASRHYAK---LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             CCSEEHHHHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ccCccHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            997754443332111   12468999999999999999999999   9999999999999999 7999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....   .....+|+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            54432   2345689999999998654 3589999999999999999999999964

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-39  Score=287.45  Aligned_cols=199  Identities=27%  Similarity=0.385  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEE--cCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCS--EGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~  209 (344)
                      .+.+.||+|+||+||++... +++.||+|.+....   ...+.+.+|+.++++++||||+++++++.  .....++||||
T Consensus         9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   88 (279)
T 2w5a_A            9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY   88 (279)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred             eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence            45678999999999999854 68999999997533   23467899999999999999999999875  35688999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eeecCCCCCceEEcCCCceEEeecCCc
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR-----ILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~-----ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +++++|.+++.....  ....+++..++.++.|++.||+|||+   .+     ++||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           89 CEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             CTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             CCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999975432  22458999999999999999999999   67     999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +........  .....||+.|+|||++.+.  .++.++||||||+++|||++|+.|++.
T Consensus       164 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          164 RILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             HHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            876543221  1234689999999998764  788999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.1e-39  Score=290.02  Aligned_cols=198  Identities=24%  Similarity=0.360  Sum_probs=164.5

Q ss_pred             HHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCe
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR  202 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  202 (344)
                      ..+.+.+.||+|+||+||+|... +++.||||++....         .....+.+|++++++++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            35566789999999999999854 57899999986432         12245889999999999999999999987665 


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc---eEEe
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKIS  279 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~---~kl~  279 (344)
                      .++||||+++++|.+++..      ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||+
T Consensus        89 ~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             EEEEEECCTTEETHHHHST------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             eEEEEecCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence            8999999999999999843      2468999999999999999999999   99999999999999987654   9999


Q ss_pred             ecCCcccccCCccceeeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |||+++.......   .....||+.|+|||++.. ....++.++||||||+++|||++|+.||+.
T Consensus       160 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (322)
T 2ycf_A          160 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  221 (322)
T ss_dssp             CCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9999987654321   123468999999998742 124678899999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-38  Score=294.70  Aligned_cols=192  Identities=25%  Similarity=0.315  Sum_probs=156.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCC------eEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  204 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||++.....   ..+.+.+|+.+++.++||||+++++++....      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            34567899999999999974 4588999999975322   2357889999999999999999999997654      789


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||++ ++|.+++.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       107 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          107 IVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEECCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             EEEEcCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            9999996 57888873        248899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          175 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             ------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccccc---cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            86644321   2345689999999999774  788999999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.1e-39  Score=293.54  Aligned_cols=198  Identities=26%  Similarity=0.322  Sum_probs=155.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC-------eEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT-------RRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+. .+|+.||||++.......+.+.+|++.++.++||||+++++++....       ..++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~  105 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM  105 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence            3457899999999999986 45899999999766556667888999999999999999999986533       278999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeecCCCCCceEEcC-CCceEEeecCCc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH--QGCNQRILHFDIKPHNILLDH-NFQPKISDFGLA  284 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfgla  284 (344)
                      ||+++ +|...+....  .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||++
T Consensus       106 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          106 EYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             ECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             ecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            99976 5555443211  12256899999999999999999999  7   99999999999999997 899999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.......   .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       180 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          180 KKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             BCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence            87654432   2345689999999998654 3589999999999999999999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.7e-39  Score=301.05  Aligned_cols=195  Identities=27%  Similarity=0.355  Sum_probs=159.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+.. +|+.||||++.....   ...+|++++++++||||+++++++...      ...++|||
T Consensus        57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  133 (420)
T 1j1b_A           57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD  133 (420)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred             EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence            44678999999999999864 589999999865322   234799999999999999999988532      23679999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-CceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-~~~kl~Dfgla~~~  287 (344)
                      |+++ +|.+.+....  .....+++..++.++.|+++||+|||+   .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus       134 ~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          134 YVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             CCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             cccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            9975 6766654321  112568999999999999999999999   999999999999999955 67899999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....   .....+|+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus       208 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          208 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             CTTCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            54322   2345689999999998653 3688999999999999999999999964

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=290.97  Aligned_cols=198  Identities=30%  Similarity=0.510  Sum_probs=168.0

Q ss_pred             HhhcccccccCcEEEEEEEE-----eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCC--eEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGT--RRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  206 (344)
                      +.+.+.||+|+||+||+++.     .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            34568899999999999973     368899999997543 33468999999999999999999999987654  67999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++....     ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       123 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999996543     358999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCcccee-eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          287 CSKDISIVS-LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       287 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......... .....+++.|+|||++.+.  .++.++||||||+++|||++|+.|+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            765433211 1234577889999998764  67889999999999999999988864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=289.07  Aligned_cols=203  Identities=28%  Similarity=0.371  Sum_probs=166.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEE----cCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCS----EGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+++. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.    .....++|||
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            34567899999999999985 578999999986532 34467899999999999999999999986    3457899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++.....  ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus       111 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          111 FFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             CCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             eCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            9999999999976432  23569999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCccc-------eeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISI-------VSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....       .......||+.|+|||++.+. ...++.++||||||+++|||++|+.||+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            22110       011234579999999998653 1236889999999999999999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-38  Score=283.10  Aligned_cols=196  Identities=27%  Similarity=0.352  Sum_probs=169.0

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc----------cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK----------GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  203 (344)
                      .+.+.||+|+||.||+|... +|+.||||+++...          ...+.+.+|+.+++++. ||||+++++++.+....
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   99 (298)
T 1phk_A           20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF   99 (298)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeE
Confidence            34578999999999999864 58899999997532          12356789999999996 99999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||||+++++|.+++...      ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus       100 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A          100 FLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             EEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999653      358999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccceeeecccCCccccccccccc----ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISIVSLTAARGTAGYIAPELFSR----NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +........   .....+++.|+|||++..    ....++.++||||||+++|||++|+.|+..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence            987654322   234568999999998852    123678899999999999999999999853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-38  Score=284.88  Aligned_cols=193  Identities=30%  Similarity=0.462  Sum_probs=159.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc-------------C
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE-------------G  200 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------------~  200 (344)
                      +.+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.++++++||||+++++++.+             .
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   87 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK   87 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence            44567899999999999985 468999999997655556789999999999999999999998865             4


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEee
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      ...++||||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           88 STLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence            56899999999999999996533     357889999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccccCCcc------------ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc
Q 041350          281 FGLAKLCSKDIS------------IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG  336 (344)
Q Consensus       281 fgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~  336 (344)
                      ||+++.......            ........||+.|+|||++.+. +.++.++||||||+++|||++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh
Confidence            999986643211            1112345689999999998754 468899999999999999998

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.4e-39  Score=292.42  Aligned_cols=201  Identities=26%  Similarity=0.340  Sum_probs=170.1

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccc------------------hHHHHHHHHHHhhhcccceeeEeeE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGN------------------GQEFINEVATIGRIHHFHIVRLLGF  196 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~h~niv~~~~~  196 (344)
                      +.+.+.||+|+||+||+|.. +++.||+|.+......                  .+.+.+|+.++++++||||++++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34567899999999999987 9999999999743211                  1789999999999999999999999


Q ss_pred             EEcCCeEEEEEeccCCCCHHHHHhccC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC
Q 041350          197 CSEGTRRALVYEFMPNGSLEKFIFSKT--NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF  274 (344)
Q Consensus       197 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~  274 (344)
                      +.+.+..++||||+++|+|.+++....  .......+++..++.++.|++.||+|||+  ..+++||||||+|||++.++
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~  189 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNG  189 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTS
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCC
Confidence            999999999999999999999832110  01113579999999999999999999996  37999999999999999999


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCc-ccchHhHHHHHHHHHcCCCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSY-KSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .+||+|||++......    ......||+.|+|||++.+. ..++. ++||||||+++|||++|+.||..
T Consensus       190 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          190 RVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999876543    23456799999999998764 24555 99999999999999999999964

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.2e-39  Score=290.31  Aligned_cols=205  Identities=23%  Similarity=0.330  Sum_probs=153.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|.. .+++.||||.+...  ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   96 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS   96 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred             hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence            34567899999999999974 46889999998643  2344678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          212 NGSLEKFIFSKT--NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       212 ~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|.+++....  .......+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT  173 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence            999999986421  11123568999999999999999999999   9999999999999999999999999999876543


Q ss_pred             Cccc---eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISI---VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....   .......||+.|+|||++.+. ..++.++||||||+++|||++|+.||+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             --------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            3211   112345689999999998653 2578899999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.3e-39  Score=296.60  Aligned_cols=191  Identities=26%  Similarity=0.402  Sum_probs=148.3

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcC------CeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEG------TRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  205 (344)
                      .+.+.||+|+||+||+|.. .+|+.||||++....   ...+.+.+|+.+++.++||||+++++++...      ...++
T Consensus        32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l  111 (367)
T 2fst_X           32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  111 (367)
T ss_dssp             EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence            4557899999999999974 568899999997532   2346788999999999999999999998654      56799


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ++|++ +++|.+++..       ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       112 v~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          112 VTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             Eeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            99999 7899988843       358999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            75432     2345689999999998763 3688999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-38  Score=287.10  Aligned_cols=196  Identities=31%  Similarity=0.499  Sum_probs=165.9

Q ss_pred             HhhcccccccCcEEEEEEEE--eCCceEEEEEeeccc---cchHHHHHHHHHHhhh---cccceeeEeeEEE-----cCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL--FNGIPVAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCS-----EGT  201 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~  201 (344)
                      +.+.+.||+|+||+||+|..  .+|+.||+|+++...   .....+.+|+.+++.+   +||||+++++++.     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   92 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   92 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence            34567899999999999986  458899999997432   2234677788877777   7999999999987     556


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..++||||++ |+|.+++.....    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        93 ~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           93 KLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             eEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence            7899999997 699999976432    358999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       165 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          165 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccCCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            99987654321   2345689999999998764  688999999999999999999999964

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.5e-38  Score=281.68  Aligned_cols=196  Identities=23%  Similarity=0.311  Sum_probs=165.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEE-EcCCeEEEEEeccCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC-SEGTRRALVYEFMPNG  213 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.||+|+||+||+|+. .+++.||||++.... ..+++.+|+.+++.++|++++..++++ .++...++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 3uzp_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence            4567899999999999985 678999999987543 335789999999999988766655554 6677889999999 99


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCcccccCC
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~~~~  290 (344)
                      +|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||+   ++++.+||+|||+++.....
T Consensus        90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           90 SLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9999996433     358999999999999999999999   999999999999999   58899999999999876544


Q ss_pred             ccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||+.
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            221     112345699999999999775  689999999999999999999999864

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.5e-39  Score=285.90  Aligned_cols=193  Identities=31%  Similarity=0.502  Sum_probs=159.2

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcC-CeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-TRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||+||+++. +|+.||||+++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||++++
T Consensus        23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~  100 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  100 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             ceEEeEEecCCCceEEEEEE-cCCEEEEEEecch-hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence            34567899999999999974 6889999999754 3557899999999999999999999997654 4689999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....    ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......  
T Consensus       101 ~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A          101 SLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             EHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            99999965321    237899999999999999999999   999999999999999999999999999998654331  


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                         ....+++.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       172 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ---cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence               234578899999998764  78899999999999999998 9998853

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.2e-38  Score=289.23  Aligned_cols=201  Identities=31%  Similarity=0.539  Sum_probs=165.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCce--EEEEEeecc--ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIP--VAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+. .++..  +|+|.++..  ....+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            34568899999999999985 45654  499998753  23446789999999999 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEE
Q 041350          209 FMPNGSLEKFIFSKTN----------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  278 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl  278 (344)
                      |+++|+|.+++.....          ......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEE
Confidence            9999999999965420          0112468999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +|||+++......   ......+++.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       184 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          184 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             CCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence            9999987433221   12334578899999998764  67899999999999999998 9999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6e-39  Score=287.59  Aligned_cols=199  Identities=25%  Similarity=0.445  Sum_probs=165.6

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|+.. ++..||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG  100 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence            345678999999999999865 4889999998753 34557899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++........
T Consensus       101 ~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A          101 GAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999986543     358999999999999999999999   9999999999999999999999999998764322111


Q ss_pred             ceeeecccCCccccccccccc---ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|+|||++..   ....++.++||||||+++|||++|+.|+..
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  224 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE  224 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence              1133568999999998841   123678899999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.4e-38  Score=282.61  Aligned_cols=198  Identities=23%  Similarity=0.305  Sum_probs=165.1

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEE-EcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFC-SEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++.++|++++..++.+ .++...++||||+ 
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            345678899999999999985 568899999876532 234688999999999988766666655 6777889999999 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~~  288 (344)
                      +++|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999999996433     358999999999999999999999   999999999999999   789999999999998765


Q ss_pred             CCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            44221     112345689999999999875  689999999999999999999999963

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.2e-38  Score=290.26  Aligned_cols=196  Identities=26%  Similarity=0.400  Sum_probs=163.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcC-----CeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEG-----TRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+.. +|+.||||++.....  ....+.+|+.++++++||||+++++++...     ...++||
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   93 (353)
T 2b9h_A           14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ   93 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred             EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence            45678999999999999854 588999999974332  235788999999999999999999987654     6789999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||++ ++|.+++..       ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        94 e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           94 ELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            9996 699999854       358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccce--------eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIV--------SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .......        ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            5332111        12234689999999987643 3688999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=288.51  Aligned_cols=203  Identities=25%  Similarity=0.346  Sum_probs=152.2

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhc-ccceeeEeeEEE--------cCCe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIH-HFHIVRLLGFCS--------EGTR  202 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~~  202 (344)
                      .+.+.+.||+|+||+||+|+. .+++.||+|++.... ...+.+.+|+.++.++. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            345668899999999999985 468999999986433 33467899999999996 999999999984        3446


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEcCCCceEEee
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLDHNFQPKISD  280 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~~~~~~kl~D  280 (344)
                      .+++|||++ |+|.+++.....   ...+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.+||+|
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHT---TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             EEEEEEecC-CCHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence            799999995 799999865322   2469999999999999999999998   77  99999999999999999999999


Q ss_pred             cCCcccccCCccce----------eeecccCCccccccccccc-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          281 FGLAKLCSKDISIV----------SLTAARGTAGYIAPELFSR-NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       281 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ||+++.........          ......||+.|+|||++.. ....++.++||||||+++|||++|+.||+.
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99998765432211          1113458999999999832 123678899999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-38  Score=284.17  Aligned_cols=200  Identities=26%  Similarity=0.364  Sum_probs=153.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc--h-HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN--G-QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~--~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  210 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||+|+++.....  . +.+.++...++.++||||+++++++.+++..++||||+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~   88 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM   88 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence            34567899999999999985 46899999999754222  2 33445555688889999999999999999999999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      + |+|.+++.....  ....+++..++.++.|++.||+|||+   . +++||||||+|||++.++.+||+|||+++....
T Consensus        89 ~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           89 D-TSLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             S-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             c-cchHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            7 588888754221  12469999999999999999999998   7 999999999999999999999999999987654


Q ss_pred             CccceeeecccCCccccccccccc--ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSR--NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|+|||++..  ....++.++||||+|+++|||++|+.|++.
T Consensus       163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            422   233468999999999731  113678899999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.4e-38  Score=292.32  Aligned_cols=197  Identities=23%  Similarity=0.262  Sum_probs=167.0

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhc-cc-----ceeeEeeEEEcCCeEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HF-----HIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~lv  206 (344)
                      .+.+.+.||+|+||+||+|... +++.||||+++......+++..|+.+++.++ |+     +|+++++++...+..++|
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  134 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV  134 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence            3445678999999999999854 5789999999865555567888999998885 44     499999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc--CCCceEEeecCCc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLA  284 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~--~~~~~kl~Dfgla  284 (344)
                      |||++ |+|.+++.....    ..+++..+..++.|++.||+|||. ...+|+||||||+|||++  .++.+||+|||++
T Consensus       135 ~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          135 FEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99995 599999976432    358999999999999999999994 127899999999999995  4788999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.....     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eecccc-----cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            876543     2345689999999999875  789999999999999999999999964

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.3e-38  Score=283.70  Aligned_cols=198  Identities=25%  Similarity=0.315  Sum_probs=161.6

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeecccc---chHHHHHHHHHHhhhc--ccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---NGQEFINEVATIGRIH--HFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||++...+++.||||++.....   ..+.+.+|+.++.+++  |+||+++++++.+....++||| 
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-  108 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  108 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence            345678999999999999987899999999975332   3367899999999997  4999999999999999999999 


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +.+++|.+++...      ..+++..++.++.|+++||+|||+   .+|+||||||+|||+++ +.+||+|||+++....
T Consensus       109 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          109 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            5689999999653      358999999999999999999999   99999999999999975 8999999999987655


Q ss_pred             CccceeeecccCCcccccccccccc---------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRN---------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...........||+.|+|||++.+.         ...++.++||||||+++|||++|+.||..
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            4332222345689999999998641         13678899999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=284.57  Aligned_cols=196  Identities=26%  Similarity=0.377  Sum_probs=157.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEE--------------c
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCS--------------E  199 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------------~  199 (344)
                      .+.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.              +
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   93 (320)
T 2i6l_A           14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE   93 (320)
T ss_dssp             EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred             eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence            44578999999999999865 48999999987543 33467899999999999999999999873              4


Q ss_pred             CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceEE
Q 041350          200 GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKI  278 (344)
Q Consensus       200 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~kl  278 (344)
                      ....++||||++ |+|.+++..       ..+++..++.++.|++.||+|||+   .+|+||||||+|||++ +++.+||
T Consensus        94 ~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           94 LNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence            467899999997 699999842       358999999999999999999999   9999999999999997 5779999


Q ss_pred             eecCCcccccCCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          279 SDFGLAKLCSKDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +|||+++........ .......+|+.|+|||++.+. ..++.++||||||+++|||++|+.||..
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence            999999876433211 112344579999999988653 3688999999999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6.8e-38  Score=286.72  Aligned_cols=195  Identities=21%  Similarity=0.345  Sum_probs=168.0

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CC-ceEEEEEeeccccchHHHHHHHHHHhhhcccc------eeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NG-IPVAVKMLEHLKGNGQEFINEVATIGRIHHFH------IVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|... ++ ..||+|+++......+.+.+|+.++++++|++      ++.+.+++...+..++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~l   99 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCI   99 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEE
Confidence            4456788999999999999853 34 68999999865555678889999999998877      9999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---------------
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---------------  270 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---------------  270 (344)
                      ||||+ +++|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||+               
T Consensus       100 v~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A          100 AFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence            99999 6777777755432    468999999999999999999999   999999999999999               


Q ss_pred             ----cCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          271 ----DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       271 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          +.++.+||+|||+++......     ....||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                678899999999998654332     345689999999999764  789999999999999999999999964

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-38  Score=291.89  Aligned_cols=191  Identities=26%  Similarity=0.390  Sum_probs=161.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc---hHHHHHHHHHHhhhcccceeeEeeEEEcCCeE------E
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN---GQEFINEVATIGRIHHFHIVRLLGFCSEGTRR------A  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------~  204 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++......      +
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  123 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  123 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence            34457899999999999975 46899999999753322   36788999999999999999999999877654      9


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||++ ++|.+++.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       124 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          124 LVMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             EEEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             EEEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            9999996 68988872        348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +.....     .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||+.
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence            865433     2345689999999998763 3688999999999999999999999964

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=8.2e-38  Score=278.44  Aligned_cols=197  Identities=27%  Similarity=0.420  Sum_probs=170.1

Q ss_pred             HHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      ...+.+.+.||+|+||+||+|+.. +++.||+|++...   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            345566789999999999999864 6889999999643   234578999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC---CceEEeecCCc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN---FQPKISDFGLA  284 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Dfgla  284 (344)
                      ||+++++|.+++...      ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.+   +.+||+|||++
T Consensus       101 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A          101 ELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             CCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            999999999998654      258999999999999999999999   999999999999999754   47999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........   .....+|+.|+|||++.+   .++.++||||||+++|||++|+.|+..
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            87654322   123458899999999865   578899999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-38  Score=292.63  Aligned_cols=195  Identities=25%  Similarity=0.392  Sum_probs=166.6

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-----------ccceeeEeeEEEcCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-----------HFHIVRLLGFCSEGT  201 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~~  201 (344)
                      .+.+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.++++++           |+||+++++++...+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~   99 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   99 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence            445678899999999999985 56899999999865555678889999999886           889999999987654


Q ss_pred             ----eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEc-----
Q 041350          202 ----RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLD-----  271 (344)
Q Consensus       202 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~-----  271 (344)
                          ..+++|||+ +++|.+++.....    ..+++..+..++.|++.||+|||+   . +|+||||||+|||++     
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A          100 PNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             TTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred             CCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence                789999999 9999999976432    358999999999999999999999   7 999999999999994     


Q ss_pred             -CCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          272 -HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       272 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                       .++.+||+|||+++.....     .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||++
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence             4458999999999876543     2345689999999999774  689999999999999999999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.7e-38  Score=296.73  Aligned_cols=200  Identities=26%  Similarity=0.337  Sum_probs=155.2

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      .+.||+|+||+||.+...+|+.||||++...  ..+.+.+|+.+++++ +||||+++++++.++...++||||++ |+|.
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            4679999999998776678999999998753  345678999999987 89999999999999999999999995 6999


Q ss_pred             HHHhccCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC-------------CceEEeecC
Q 041350          217 KFIFSKTNSSSH-RPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-------------FQPKISDFG  282 (344)
Q Consensus       217 ~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~-------------~~~kl~Dfg  282 (344)
                      +++......... ...++..++.++.||+.||+|||+   .+|+||||||+|||++.+             +.+||+|||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            999754321111 112344567899999999999999   999999999999999754             489999999


Q ss_pred             CcccccCCccce--eeecccCCcccccccccccc-----cCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          283 LAKLCSKDISIV--SLTAARGTAGYIAPELFSRN-----FGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      +++.........  ......||+.|+|||++.+.     ...++.++|||||||++|||++ |+.||+.
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence            998775542211  12345699999999998651     1368899999999999999998 8999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-38  Score=281.45  Aligned_cols=198  Identities=28%  Similarity=0.397  Sum_probs=158.2

Q ss_pred             HhhcccccccCcEEEEEEEEeC--Cc--eEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFN--GI--PVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~--~~--~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      +.+.+.||+|+||+||+|+...  +.  .||+|+++..    ....+.+.+|+.++++++||||+++++++.+.. .++|
T Consensus        20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v   98 (291)
T 1u46_A           20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV   98 (291)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred             eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence            4456789999999999997532  33  6899998743    233468899999999999999999999998765 8899


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||+++++|.+++....     ..+++..+..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++.
T Consensus        99 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           99 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            99999999999996543     358999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          287 CSKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ........ ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.|+..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            65443221 12334578899999998764  67889999999999999999 9999854

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-37  Score=295.69  Aligned_cols=197  Identities=25%  Similarity=0.322  Sum_probs=167.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcc-cceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||+||+|+. .+++.||||++.... ..+++.+|+++++.++| +++..+..++.+....++||||+ +
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g   86 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G   86 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence            34567899999999999985 568999999887543 33468899999999987 56667777778888999999999 9


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEE---cCCCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILL---DHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill---~~~~~~kl~Dfgla~~~~~  289 (344)
                      ++|.+++....     ..+++..++.++.||+.||+|||+   .+|+||||||+||||   +.++.+||+|||+++....
T Consensus        87 ~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           87 PSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99999996433     359999999999999999999999   999999999999999   6889999999999987655


Q ss_pred             Cccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....     .......||+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4321     112356799999999999875  789999999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.9e-38  Score=309.55  Aligned_cols=198  Identities=24%  Similarity=0.428  Sum_probs=163.8

Q ss_pred             HHhhcccccccCcEEEEEEEEeC----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.+.||+|+||+||+|....    +..||+|.++....  ..+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~  469 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM  469 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEE
Confidence            34556789999999999998542    45799999875332  23678999999999999999999999854 5689999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       470 E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             ECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999996533     358999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...... ......+|+.|+|||++.+.  .++.++||||||+++|||++ |+.||..
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            543221 22345578899999998764  78999999999999999997 8889864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.1e-38  Score=285.69  Aligned_cols=195  Identities=29%  Similarity=0.392  Sum_probs=167.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc-------chHHHHHHHHHHhhhc--ccceeeEeeEEEcCCeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG-------NGQEFINEVATIGRIH--HFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  204 (344)
                      +.+.+.||+|+||+||+|+. .+++.||||++.....       ..+.+.+|+.++++++  |+||+++++++.+.+..+
T Consensus        45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            44568899999999999974 5688999999975422       2246778999999996  599999999999999999


Q ss_pred             EEEeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCCceEEeecC
Q 041350          205 LVYEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNFQPKISDFG  282 (344)
Q Consensus       205 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~~~kl~Dfg  282 (344)
                      +|+|++.+ ++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++ +++.+||+|||
T Consensus       125 lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          125 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999976 8999999653      358999999999999999999999   9999999999999999 78999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++......    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||+.
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            998765432    2345689999999998754 2346789999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=287.32  Aligned_cols=190  Identities=26%  Similarity=0.385  Sum_probs=160.0

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCCe------EEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGTR------RAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~l  205 (344)
                      .+.+.||+|+||+||+|.. .+|+.||||++.....   ..+.+.+|+.++++++||||+++++++.....      .++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l  106 (353)
T 3coi_A           27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL  106 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred             EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence            4457899999999999985 4689999999975332   23678899999999999999999999987654      499


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||++ ++|.+++.        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       107 v~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          107 VMPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             EEECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             Eecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            999996 68888762        248999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .....+|+.|+|||++.+. ..++.++||||||+++|||++|+.||+.
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            65433     2345689999999998753 3678899999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.2e-38  Score=284.83  Aligned_cols=189  Identities=23%  Similarity=0.299  Sum_probs=140.0

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc----CCeEEEEEeccCCC
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE----GTRRALVYEFMPNG  213 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~g  213 (344)
                      +.||+|+||+||+|... +++.||||++.....   ...+....++.++||||+++++++..    ....++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999865 689999999975322   22222334566789999999999876    45589999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccccCC
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~~~~  290 (344)
                      +|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       112 ~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~  184 (336)
T 3fhr_A          112 ELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN  184 (336)
T ss_dssp             EHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             CHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence            99999975432    469999999999999999999999   99999999999999976   455999999999865533


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .    .....+|+.|+|||++.+.  .++.++||||||+++|||++|+.||..
T Consensus       185 ~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          185 A----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             -----------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             c----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            2    2345689999999998654  678899999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-37  Score=282.38  Aligned_cols=200  Identities=27%  Similarity=0.350  Sum_probs=146.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc--chHHHHHHHH-HHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG--NGQEFINEVA-TIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|... +|+.||||+++....  ...++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            34578999999999999864 689999999975432  2345666666 7778899999999999999999999999997


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      + +|.+++..... .....+++..+..++.|++.||+|||+   . +++||||||+|||++.++.+||+|||+++.....
T Consensus       105 ~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          105 T-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             E-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             C-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            5 88887753211 112468999999999999999999999   7 9999999999999999999999999999876543


Q ss_pred             ccceeeecccCCccccccccccc--ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSR--NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|+|||++..  ....++.++||||||+++|||++|+.||+.
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            22   233468999999999842  113678899999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-38  Score=290.18  Aligned_cols=190  Identities=19%  Similarity=0.201  Sum_probs=158.0

Q ss_pred             HHHHhhcccccccCcEEEEEEEEeCCceEEEEEeeccc---------cchHHHHHHHHHHhhhc---------ccceeeE
Q 041350          132 KITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---------GNGQEFINEVATIGRIH---------HFHIVRL  193 (344)
Q Consensus       132 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------h~niv~~  193 (344)
                      ...+.+.+.||+|+||+||+|+. +|+.||||+++...         ...+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34566788999999999999985 88999999997532         12378899999999996         7777766


Q ss_pred             eeEE-----------------Ec-------------CCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Q 041350          194 LGFC-----------------SE-------------GTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV  243 (344)
Q Consensus       194 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i  243 (344)
                      .+.+                 .+             ....++||||+++|++.+.+..       ..+++..++.++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQL  170 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHH
Confidence            6654                 22             6789999999999987776622       358999999999999


Q ss_pred             HHHHHHHH-hCCCCCeeecCCCCCceEEcCCC--------------------ceEEeecCCcccccCCccceeeecccCC
Q 041350          244 ARGVEYLH-QGCNQRILHFDIKPHNILLDHNF--------------------QPKISDFGLAKLCSKDISIVSLTAARGT  302 (344)
Q Consensus       244 a~~l~yLH-~~~~~~ivH~Dik~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt  302 (344)
                      +.||+||| +   .+|+||||||+|||++.++                    .+||+|||+|+.....       ...||
T Consensus       171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt  240 (336)
T 2vuw_A          171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC  240 (336)
T ss_dssp             HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred             HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence            99999999 8   8999999999999999887                    8999999999876543       23689


Q ss_pred             cccccccccccccCCCCcccchHhHHHH-HHHHHcCCCCCC
Q 041350          303 AGYIAPELFSRNFGEVSYKSDVYSYGMM-LLEMVGCRKNKD  342 (344)
Q Consensus       303 ~~y~aPE~~~~~~~~~~~~~Dv~s~Gvv-l~ell~g~~p~~  342 (344)
                      +.|+|||++.+.   .+.++||||++++ .+++++|..|+.
T Consensus       241 ~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          241 DVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             CCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             ecccChhhhcCC---CccceehhhhhCCCCcccccccCCCc
Confidence            999999999864   3789999998777 777888988873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=283.64  Aligned_cols=201  Identities=28%  Similarity=0.387  Sum_probs=162.1

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc-------chHHHHHHHHHHhhh----cccceeeEeeE
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG-------NGQEFINEVATIGRI----HHFHIVRLLGF  196 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~~~~~  196 (344)
                      +.....+.+.+.||+|+||+||+|+. .+++.||||++.....       ....+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            33344566778999999999999974 4688999999975432       223456799999999    89999999999


Q ss_pred             EEcCCeEEEEEec-cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc-CCC
Q 041350          197 CSEGTRRALVYEF-MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD-HNF  274 (344)
Q Consensus       197 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~-~~~  274 (344)
                      +.+.+..++|+|| +++++|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+||+++ +++
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence            9999999999999 7899999999653      358999999999999999999999   8999999999999999 899


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .+||+|||+++......    .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||+.
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            99999999998765432    2345689999999998754 2335589999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=284.11  Aligned_cols=198  Identities=24%  Similarity=0.369  Sum_probs=161.3

Q ss_pred             HhhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|+..  ..+|+|+++...   ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            345678999999999999753  359999987432   233567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|.+++....     ..+++..++.++.|++.||+|||+   .+++||||||+|||++ ++.+||+|||+++......
T Consensus       113 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          113 GRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             SEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999995432     468999999999999999999999   9999999999999998 6799999999987653211


Q ss_pred             ---cceeeecccCCcccccccccccc-------cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 ---SIVSLTAARGTAGYIAPELFSRN-------FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ---~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                         .........||+.|+|||++...       ...++.++||||||+++|||++|+.||+.
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence               11112344589999999998642       13578899999999999999999999864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=291.55  Aligned_cols=197  Identities=24%  Similarity=0.328  Sum_probs=154.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      ...+.||+|+||+||.....+++.||||++....  ...+.+|+.+++++ +||||+++++++.+....++||||++ |+
T Consensus        27 ~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~  103 (432)
T 3p23_A           27 CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT  103 (432)
T ss_dssp             EEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred             ecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence            3457899999999765556789999999996432  23456899999999 79999999999999999999999995 69


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-----CCceEEeecCCcccccC
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLAKLCSK  289 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~Dfgla~~~~~  289 (344)
                      |.+++.....     .+.+..+..++.||++||+|||+   .+|+||||||+|||++.     ...+||+|||+++....
T Consensus       104 L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          104 LQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             HHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             HHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            9999975432     34445567899999999999999   99999999999999953     33588999999987654


Q ss_pred             Ccc-ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          290 DIS-IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       290 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ... ........||+.|+|||++.+. ...++.++|||||||++|||++ |+.||..
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence            321 1223456799999999998642 2367789999999999999999 8888753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-37  Score=307.26  Aligned_cols=187  Identities=24%  Similarity=0.345  Sum_probs=159.7

Q ss_pred             HhhcccccccCcEEEEEEEEe--CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCe-----EEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF--NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTR-----RAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~l  205 (344)
                      +.+.+.||+|+||+||+|...  +|+.||||++....  ...+.+.+|+.++++++||||+++++++.+.+.     .++
T Consensus        82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l  161 (681)
T 2pzi_A           82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI  161 (681)
T ss_dssp             EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence            445678999999999999864  58999999986532  233578899999999999999999999987654     799


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++++|.+++.        ..+++..++.++.||++||+|||+   .+|+||||||+|||++++ .+||+|||+++
T Consensus       162 v~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          162 VMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence            999999999988763        258999999999999999999999   999999999999999986 89999999998


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....      ....||+.|+|||++.+.   .+.++||||||+++|||++|..|+.
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             hcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCc
Confidence            76543      345699999999998753   4889999999999999999988865

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.3e-37  Score=301.07  Aligned_cols=199  Identities=28%  Similarity=0.412  Sum_probs=169.4

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEc------CCeEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE------GTRRA  204 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~  204 (344)
                      .+.+.+.||+|+||+||+|.. .+|+.||||+++...  ...+.+.+|+.++++++||||+++++++..      ++..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            456678999999999999975 468999999987532  234678999999999999999999998755      67789


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCc---eEEeec
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQ---PKISDF  281 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~---~kl~Df  281 (344)
                      +||||+++|+|.+++.....   ...+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.   +||+||
T Consensus        95 LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            99999999999999975432   2358899999999999999999999   99999999999999997665   999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||||+++|||++|+.||.+
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            99987655432   2345789999999999764  789999999999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.6e-37  Score=275.12  Aligned_cols=196  Identities=24%  Similarity=0.364  Sum_probs=146.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccccch---HHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.||+|+||+||+|... +|+.||||++.......   +.+.++..+++.++||||+++++++.+.+..++||||+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-  106 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence            34578999999999999864 68999999997543222   23444556788889999999999999999999999999 


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeecCCCCCceEEcCCCceEEeecCCcccccCC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQ-RILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~-~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  290 (344)
                      ++.+..+.....     ..+++..+..++.|++.||+|||+   . +++||||||+|||++.++.+||+|||++......
T Consensus       107 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          107 GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            556655553322     458999999999999999999998   5 9999999999999999999999999999766543


Q ss_pred             ccceeeecccCCccccccccccc---ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSR---NFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....+|+.|+|||++..   ....++.++||||||+++|||++|+.||+.
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            22   234468999999999853   123678899999999999999999999864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-35  Score=263.75  Aligned_cols=168  Identities=13%  Similarity=0.060  Sum_probs=146.0

Q ss_pred             HHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.+.||+|+||+||+|... +++.||||++......    .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            4556788999999999999864 4899999999764332    2678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++..       . ....++..++.|++.||+|||+   .+|+||||||+|||+++++.+||++++      
T Consensus       112 ~~~g~~L~~~l~~-------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          112 WIRGGSLQEVADT-------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             CCCEEEHHHHHTT-------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             ecCCCCHHHHHhc-------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999832       1 3556788999999999999999   999999999999999999999998443      


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                                      |++         .++.++||||||+++|||++|+.||+.
T Consensus       175 ----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~  204 (286)
T 3uqc_A          175 ----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPE  204 (286)
T ss_dssp             ----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred             ----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                            333         357799999999999999999999964

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4e-36  Score=281.10  Aligned_cols=197  Identities=16%  Similarity=0.198  Sum_probs=149.4

Q ss_pred             hcccccccCcEEEEEEE-EeCCceEEEEEeeccc----cchHHHHHHHHHHhhhcc-cce---------e------e---
Q 041350          137 FKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK----GNGQEFINEVATIGRIHH-FHI---------V------R---  192 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~ni---------v------~---  192 (344)
                      ..+.||+|+||+||+|+ ..+|+.||||++....    ...+.+.+|+.+++.++| +|.         +      .   
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            34679999999999998 4568999999987322    224788999999999977 211         1      1   


Q ss_pred             ---EeeEEEc-----CCeEEEEEeccCCCCHHHHHhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 041350          193 ---LLGFCSE-----GTRRALVYEFMPNGSLEKFIFSKTN-SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDI  263 (344)
Q Consensus       193 ---~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Di  263 (344)
                         +..+...     ....+++|+++ +++|.+++..... ......+++..++.++.|+++||+|||+   .+|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence               1111111     12356777766 7899999852210 0122468899999999999999999999   99999999


Q ss_pred             CCCceEEcCCCceEEeecCCcccccCCccceeeecccCCccccccccccc--------ccCCCCcccchHhHHHHHHHHH
Q 041350          264 KPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR--------NFGEVSYKSDVYSYGMMLLEMV  335 (344)
Q Consensus       264 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~Dv~s~Gvvl~ell  335 (344)
                      ||+|||++.++.+||+|||+++.....     .....| +.|+|||++..        ....++.++|||||||++|||+
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999865433     234567 99999999831        1135788999999999999999


Q ss_pred             cCCCCCCC
Q 041350          336 GCRKNKDP  343 (344)
Q Consensus       336 ~g~~p~~~  343 (344)
                      +|+.||+.
T Consensus       312 tg~~Pf~~  319 (413)
T 3dzo_A          312 CADLPNTD  319 (413)
T ss_dssp             HSSCCCCT
T ss_pred             HCCCCCCC
Confidence            99999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-34  Score=259.00  Aligned_cols=168  Identities=24%  Similarity=0.310  Sum_probs=146.2

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHH-hhhcccceeeEeeEEEc----CCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATI-GRIHHFHIVRLLGFCSE----GTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||++.. .+++.||+|+++.    ...+.+|+.++ +..+||||+++++++..    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            6699999999999985 4688999999964    34677888888 55589999999999876    6778999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~~~  289 (344)
                      |+|.+++.....    ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||++.....
T Consensus       100 ~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  172 (299)
T 3m2w_A          100 GELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG  172 (299)
T ss_dssp             CBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred             CcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence            999999976432    469999999999999999999999   99999999999999998   78999999999864321


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                                                ..++.++||||||+++|||++|+.||..
T Consensus       173 --------------------------~~~~~~~DiwslG~il~el~tg~~pf~~  200 (299)
T 3m2w_A          173 --------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS  200 (299)
T ss_dssp             --------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                                      2467799999999999999999999853

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=8.7e-35  Score=281.62  Aligned_cols=182  Identities=21%  Similarity=0.198  Sum_probs=129.6

Q ss_pred             cccccCcEEEEEEE-EeCCceEEEEEeeccc-----------cchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEE
Q 041350          140 RLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK-----------GNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  206 (344)
                      ..+.|++|.+..+. ...|+.+|+|.+....           ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46777888777764 5668999999996431           1235799999999999 799999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          207 YEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |||++|++|.++|...      .+++..   +|+.||+.||+|+|+   ++||||||||+||||++++++||+|||+|+.
T Consensus       321 MEyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCee
Confidence            9999999999999543      346654   588999999999999   9999999999999999999999999999987


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR  338 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~  338 (344)
                      ...+..  ......||+.|||||++.+   .+..++|+||+|++++++.++.
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhcccc
Confidence            655432  2345679999999999976   4567899999999987765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.97  E-value=2.2e-31  Score=256.41  Aligned_cols=185  Identities=19%  Similarity=0.216  Sum_probs=147.2

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeecccc---------chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---------NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.||+|+||+||+|+ ..+..+++|.......         ..+.+.+|++++++++||||+++..++.+.+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            4579999999999994 6788899998753221         12457999999999999999977666667778899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++++|.+++..              +..++.|+++||+|||+   ++|+||||||+|||+++  ++||+|||+++...
T Consensus       420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999832              56899999999999999   99999999999999998  99999999999876


Q ss_pred             CCccce-----eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISIV-----SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......     ......||+.|||||++......|+..+|+||..+-..+-+-+|.++.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            532211     113457999999999997643467888999999999999888887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=7.2e-27  Score=207.08  Aligned_cols=154  Identities=17%  Similarity=0.137  Sum_probs=120.3

Q ss_pred             cccccccCcEEEEEEEEeCCceEEEEEeecccc-------------------chHHHHHHHHHHhhhcccceeeEeeEEE
Q 041350          138 KHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-------------------NGQEFINEVATIGRIHHFHIVRLLGFCS  198 (344)
Q Consensus       138 ~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~  198 (344)
                      .+.||+|+||.||+|...+|+.||+|+++....                   ....+.+|+.++++++  | +++.+++.
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            478999999999999886799999999964221                   2356889999999999  4 56666543


Q ss_pred             cCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEE
Q 041350          199 EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKI  278 (344)
Q Consensus       199 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl  278 (344)
                      . +..++||||+++++|.+ +.          .  .....++.|+++||+|||+   .+|+||||||+|||++ ++.+||
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~----------~--~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VR----------V--ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEE
T ss_pred             c-cceEEEEEecCCCcHHH-cc----------h--hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEE
Confidence            3 55699999999999988 41          1  1245799999999999999   9999999999999999 999999


Q ss_pred             eecCCcccccCCccceeeecccCCcccccccccccc-------c-CCCCcccchHhH
Q 041350          279 SDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN-------F-GEVSYKSDVYSY  327 (344)
Q Consensus       279 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~-~~~~~~~Dv~s~  327 (344)
                      +|||+|+.               +..++|||++.+.       + ..+...+|+|.+
T Consensus       234 ~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          234 IDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             CCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             EECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            99999863               3456889987531       0 134456677653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=8.6e-23  Score=178.61  Aligned_cols=134  Identities=20%  Similarity=0.228  Sum_probs=105.2

Q ss_pred             hcccccccCcEEEEEEEE-eCCce--EEEEEeeccccc-------------------------hHHHHHHHHHHhhhccc
Q 041350          137 FKHRLGQGGYGSVFRGKL-FNGIP--VAVKMLEHLKGN-------------------------GQEFINEVATIGRIHHF  188 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~  188 (344)
                      +.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+.++.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            456799999999999986 68989  999987542111                         13578999999999988


Q ss_pred             ce--eeEeeEEEcCCeEEEEEeccCC-C----CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeee
Q 041350          189 HI--VRLLGFCSEGTRRALVYEFMPN-G----SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH-QGCNQRILH  260 (344)
Q Consensus       189 ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~ivH  260 (344)
                      ++  +.++++    ...++||||+.+ |    +|.++...         .++..+..++.|++.||.||| +   .+|+|
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~givH  194 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE---AELVH  194 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence            64  444432    356899999942 4    77766522         234467889999999999999 8   99999


Q ss_pred             cCCCCCceEEcCCCceEEeecCCccccc
Q 041350          261 FDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       261 ~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |||||+|||+++  .++|+|||+|....
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=4.7e-20  Score=168.11  Aligned_cols=135  Identities=14%  Similarity=0.117  Sum_probs=97.1

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeecccc---------------chHHH--------HHHHHHHhhhcccceee
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG---------------NGQEF--------INEVATIGRIHHFHIVR  192 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~--------~~E~~~l~~l~h~niv~  192 (344)
                      .+.+.||+|+||.||+|...+|+.||||+++....               .....        .+|...|.++.+.++..
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v  177 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV  177 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            34578999999999999988899999998753110               11122        24566666665554322


Q ss_pred             EeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       193 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      ..-+...  ..+|||||+++++|..+..          .  .....++.|++.+|.|||+   .+||||||||.|||+++
T Consensus       178 p~p~~~~--~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          178 PEPIAQS--RHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CCEEEEE--TTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred             Ceeeecc--CceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence            1111111  2379999999988866531          1  1245678999999999999   99999999999999988


Q ss_pred             CC----------ceEEeecCCcccc
Q 041350          273 NF----------QPKISDFGLAKLC  287 (344)
Q Consensus       273 ~~----------~~kl~Dfgla~~~  287 (344)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.7e-13  Score=119.54  Aligned_cols=139  Identities=13%  Similarity=0.034  Sum_probs=109.1

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccc-cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +...++.|+.+.||+.. .++..+++|+..... .....+.+|+.+++.+. +.++.++++++.+.+..++||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~-~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEE-CCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            34567888889999987 347889999987522 33356889999999985 6788899999998889999999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG-----------------------------------------  253 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----------------------------------------  253 (344)
                      |.+.+.           +......++.+++++|+.||+-                                         
T Consensus        97 l~~~~~-----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           97 CSEEYE-----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             HHHHCC-----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             hhhccC-----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            987641           1122347888999999999981                                         


Q ss_pred             ---------------CCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          254 ---------------CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       254 ---------------~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                                     ....++|+|++|.|||++++..+.|+||+.+...
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                           0145899999999999987666679999988654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.40  E-value=1.5e-12  Score=113.05  Aligned_cols=132  Identities=18%  Similarity=0.080  Sum_probs=99.8

Q ss_pred             cc-ccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc--eeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          141 LG-QGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       141 lG-~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      ++ .|..+.||+....+|..+++|.....  ....+.+|+.+++.+.+.+  +.+++++..+++..++||||++|.+|. 
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            44 55669999998667888999997653  3356788999999996544  567888888888899999999998884 


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC-------------------------------------------  254 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-------------------------------------------  254 (344)
                       ..         ..+   ...++.++++.|+.||+..                                           
T Consensus       104 -~~---------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          104 -SS---------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             -TS---------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             -cC---------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence             21         111   2356777888888888621                                           


Q ss_pred             ------------CCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          255 ------------NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       255 ------------~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                                  ...++|+|++|.|||++++..+.|+||+.+....
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~  216 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD  216 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence                        1229999999999999887667799999987543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.27  E-value=1.8e-11  Score=111.72  Aligned_cols=140  Identities=15%  Similarity=0.184  Sum_probs=106.1

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEee--ccc--cchHHHHHHHHHHhhhc--ccceeeEeeEEEcC---CeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLE--HLK--GNGQEFINEVATIGRIH--HFHIVRLLGFCSEG---TRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~  209 (344)
                      +.|+.|.++.||+.... +..+++|+..  ...  .....+.+|..+++.+.  +..++++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            45899999999998754 4678888776  322  22357788999999997  45688999988776   457899999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC-----------------------------------  254 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----------------------------------  254 (344)
                      ++|.++.+..        ...++...+..++.++++.|+.||+..                                   
T Consensus       123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9998875421        134678888999999999999999720                                   


Q ss_pred             --------------------CCCeeecCCCCCceEEcCCCc--eEEeecCCcccc
Q 041350          255 --------------------NQRILHFDIKPHNILLDHNFQ--PKISDFGLAKLC  287 (344)
Q Consensus       255 --------------------~~~ivH~Dik~~Nill~~~~~--~kl~Dfgla~~~  287 (344)
                                          ...++|+|++|.|||+++++.  +.|+||+.+...
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                257999999999999997753  689999998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.22  E-value=1.3e-11  Score=109.96  Aligned_cols=187  Identities=19%  Similarity=0.202  Sum_probs=122.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccc--eeeEeeEEEcCC---eEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFH--IVRLLGFCSEGT---RRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~  212 (344)
                      +.++.|....||+..    ..+++|+.... .....+.+|.++++.+. +..  +.+.+.......   ..++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            347899999999863    56888886532 33467889999998883 332  455555543333   34889999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG---------------------------------------  253 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------------------------------------  253 (344)
                      .+|.+...        ..++..++..++.++++.++.||+.                                       
T Consensus       101 ~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A          101 VPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             eECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            88875432        2367778888888888888888851                                       


Q ss_pred             ----------------CCCCeeecCCCCCceEEcC--CCceEEeecCCcccccCCccceeeecccCCcccccccccc---
Q 041350          254 ----------------CNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS---  312 (344)
Q Consensus       254 ----------------~~~~ivH~Dik~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---  312 (344)
                                      ....++|+|++|.||++++  +..+.|+||+.+................   .-..|+...   
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~---~~~~~~~~~~~l  249 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD---EEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT---TSCCHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc---cccCHHHHHHHH
Confidence                            1135899999999999998  4567899999987654321110000000   001222111   


Q ss_pred             cccCCC---------CcccchHhHHHHHHHHHcCCCCC
Q 041350          313 RNFGEV---------SYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       313 ~~~~~~---------~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      ..++..         ....+.|+++.++|++.+|+.++
T Consensus       250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111111         12358999999999999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=6.4e-08  Score=86.09  Aligned_cols=138  Identities=16%  Similarity=0.153  Sum_probs=98.3

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc---ceeeEeeEEE-cCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF---HIVRLLGFCS-EGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gs  214 (344)
                      +.++.|....||+.    |..+++|+-.. ......+.+|..+|+.+.+.   .+.+.+.+.. ..+..+++|||++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            34788888899987    57788888532 22346788999999999752   4667777764 4556789999999988


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG-----------------------------------------  253 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----------------------------------------  253 (344)
                      |.+...        ..++......++.++++.|+.||+.                                         
T Consensus       100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A          100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            876321        1245555666666666666666641                                         


Q ss_pred             ----------------CCCCeeecCCCCCceEEcC---CCc-eEEeecCCcccccC
Q 041350          254 ----------------CNQRILHFDIKPHNILLDH---NFQ-PKISDFGLAKLCSK  289 (344)
Q Consensus       254 ----------------~~~~ivH~Dik~~Nill~~---~~~-~kl~Dfgla~~~~~  289 (344)
                                      ....++|+|++|.||++++   ++. ..|+||+.+....+
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                            2235699999999999987   455 48999998876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=8.4e-08  Score=83.53  Aligned_cols=136  Identities=14%  Similarity=0.110  Sum_probs=98.0

Q ss_pred             ccccCcE-EEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          141 LGQGGYG-SVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       141 lG~G~fG-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      +..|..| .||+.... ++..+.+|+-..  ....++.+|...|+.+. +-.+.++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET--HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC--CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445444 68987644 456788998654  23467888999998884 3457888999999999999999999998887


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG--------------------------------------------  253 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------------------------------------------  253 (344)
                      .....          ......+..+++..|+.||+.                                            
T Consensus       110 ~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          110 VLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            65321          122345566667777777730                                            


Q ss_pred             -----------CCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          254 -----------CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       254 -----------~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                                 ....++|+|+.+.|||+++++.+-|+||+.+....
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd  225 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD  225 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence                       01237999999999999988777899999987544

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.59  E-value=1.7e-07  Score=85.09  Aligned_cols=78  Identities=5%  Similarity=-0.016  Sum_probs=56.1

Q ss_pred             ccc-cccCcEEEEEEEEe-------CCceEEEEEeeccc---c-chHHHHHHHHHHhhhcc---cceeeEeeEEEcC---
Q 041350          139 HRL-GQGGYGSVFRGKLF-------NGIPVAVKMLEHLK---G-NGQEFINEVATIGRIHH---FHIVRLLGFCSEG---  200 (344)
Q Consensus       139 ~~l-G~G~fG~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---  200 (344)
                      +.| +.|....+|+....       ++..+++|+.....   . ....+.+|..+++.+..   ..+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78889999998754       26678888765432   1 22567889999988853   3577888887665   


Q ss_pred             CeEEEEEeccCCCCHH
Q 041350          201 TRRALVYEFMPNGSLE  216 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~  216 (344)
                      +..++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.41  E-value=5.5e-07  Score=83.01  Aligned_cols=73  Identities=14%  Similarity=0.018  Sum_probs=49.1

Q ss_pred             ccccccCcEEEEEEEEe-CCceEEEEEeeccc--------cchHHHHHHHHHHhhhcc--c-ceeeEeeEEEcCCeEEEE
Q 041350          139 HRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--------GNGQEFINEVATIGRIHH--F-HIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~lv  206 (344)
                      +.||.|..+.||+++.. +++.++||......        ...+.+..|.++++.+..  + .+.+++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999753 46789999864321        123456789999888753  3 44566654  33446899


Q ss_pred             EeccCCC
Q 041350          207 YEFMPNG  213 (344)
Q Consensus       207 ~e~~~~g  213 (344)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.38  E-value=2.7e-06  Score=76.41  Aligned_cols=144  Identities=15%  Similarity=0.156  Sum_probs=82.7

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccc--ceeeEee------EEEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF--HIVRLLG------FCSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~------~~~~~~~~~lv~e~~~  211 (344)
                      .|+.|..+.||+....+| .+++|+....   ..+...|..++..+...  .+.+++.      +....+..+++|+|++
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            466677889999875444 5889988752   23444566666666421  2344443      2234667899999999


Q ss_pred             CCCHH--------------HHHhccCCCC--C------CCCCCHHHH-------------------------------HH
Q 041350          212 NGSLE--------------KFIFSKTNSS--S------HRPLSWEKL-------------------------------KK  238 (344)
Q Consensus       212 ~gsL~--------------~~l~~~~~~~--~------~~~l~~~~~-------------------------------~~  238 (344)
                      |.++.              ..++......  .      ...-.|...                               ..
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86542              1122211100  0      001123211                               01


Q ss_pred             HHHHHHHHHHHHHh----------CCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          239 IAFGVARGVEYLHQ----------GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       239 i~~~ia~~l~yLH~----------~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      +...+..++++|++          .....++|+|+++.|||++.++.+.|+||+.+...
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g  253 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD  253 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence            11223445666652          12478999999999999988888999999988643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.19  E-value=1.7e-05  Score=70.51  Aligned_cols=140  Identities=14%  Similarity=0.156  Sum_probs=92.9

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc---cceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH---FHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.|+.|....+|+... ++..+++|+....  ....+..|...|+.+..   ..+++.+++....+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4588999999999874 5678889987642  35678899999998852   5688999998888889999999998765


Q ss_pred             HH-----------HHhccCCCCC----------------CCCCCHHHHH---HHHH----------------HHHHH-HH
Q 041350          216 EK-----------FIFSKTNSSS----------------HRPLSWEKLK---KIAF----------------GVARG-VE  248 (344)
Q Consensus       216 ~~-----------~l~~~~~~~~----------------~~~l~~~~~~---~i~~----------------~ia~~-l~  248 (344)
                      ..           -|+.......                ...-+|....   ++..                .+... ..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            21           2333221000                0012454321   1111                11111 12


Q ss_pred             HHHh-CCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          249 YLHQ-GCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       249 yLH~-~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 2246799999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.02  E-value=4.3e-05  Score=66.94  Aligned_cols=73  Identities=19%  Similarity=0.250  Sum_probs=53.7

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccc-cchHHHHHHHHHHhhhcc---cceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHH---FHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +.+|.|..+.||+.++.+|+.+.+|+..... .....|..|...|+.+..   --+++.+++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            4589999999999999999999999876432 223467889999988842   2355555542    2378999998765


Q ss_pred             H
Q 041350          215 L  215 (344)
Q Consensus       215 L  215 (344)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=7.8e-05  Score=69.07  Aligned_cols=33  Identities=12%  Similarity=0.258  Sum_probs=29.0

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ...++|+|++|.|||+++++ +.|+||+.+....
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            37899999999999999876 9999999987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.99  E-value=3.1e-05  Score=68.33  Aligned_cols=141  Identities=13%  Similarity=0.052  Sum_probs=77.3

Q ss_pred             ccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEecc-CCCCHH
Q 041350          139 HRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFM-PNGSLE  216 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL~  216 (344)
                      +.|+.|....+|+.     ..+++|+........-+..+|..+++.+...++ .+++++.  .+.-++++||+ ++.+|.
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEECC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccCC
Confidence            56888999999998     568888876432222233568888877754333 4555543  33347899999 665443


Q ss_pred             H------------------HHhccCCCCCCCCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCCCCe
Q 041350          217 K------------------FIFSKTNSSSHRPLS-WEKLKKIAF--------------GVARGVE----YLHQ-GCNQRI  258 (344)
Q Consensus       217 ~------------------~l~~~~~~~~~~~l~-~~~~~~i~~--------------~ia~~l~----yLH~-~~~~~i  258 (344)
                      .                  -++..... .....+ +..+..+..              .+.+.+.    .|.. .....+
T Consensus        97 ~~~~~~~~~~~~~~~~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l  175 (301)
T 3dxq_A           97 PEKFKTRPGSPARAGEAFRKLHGSGAV-FPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA  175 (301)
T ss_dssp             HHHHHHSTTHHHHHHHHHHHHHTSCCC-CSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred             HhhHhhhHHHHHHHHHHHHHHhCCCCC-CCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence            2                  11111100 000011 111111111              0111111    1211 223568


Q ss_pred             eecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          259 LHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       259 vH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      +|+|+.+.||+ .+++.+.++||..+....
T Consensus       176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          176 CHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             ECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            99999999999 566778999999887543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.88  E-value=0.00016  Score=64.46  Aligned_cols=145  Identities=12%  Similarity=0.082  Sum_probs=85.0

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc--eeeEeeE-----EEcCCeEEEEEeccCCC
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGF-----CSEGTRRALVYEFMPNG  213 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~~~g  213 (344)
                      ++ |....||+....+|+.+++|...........+..|..++..+....  +++++..     ...++..+++|+|++|.
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~  112 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  112 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence            55 7778999887666778999998744345567778888888885322  4444443     12245668899999875


Q ss_pred             CHH-----H---------HHhccCC---CCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHh----C
Q 041350          214 SLE-----K---------FIFSKTN---SSSHRPLSWEKL----KKI---------------AFGVARGVEYLHQ----G  253 (344)
Q Consensus       214 sL~-----~---------~l~~~~~---~~~~~~l~~~~~----~~i---------------~~~ia~~l~yLH~----~  253 (344)
                      ++.     .         .++....   ......+++...    ..+               ...+...++.+.+    .
T Consensus       113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  192 (328)
T 1zyl_A          113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  192 (328)
T ss_dssp             ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            432     1         0121110   001112222211    000               1111122333322    1


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       254 ~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      ....++|+|+++.|||++ + .+.|+||+.+....
T Consensus       193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~  225 (328)
T 1zyl_A          193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP  225 (328)
T ss_dssp             SCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred             CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence            236689999999999999 4 89999999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.86  E-value=7.9e-05  Score=67.93  Aligned_cols=145  Identities=15%  Similarity=0.169  Sum_probs=85.7

Q ss_pred             ccccccCcEEEEEEEEe--------CCceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLF--------NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.|..|-...+|+....        ++..+.+|+..........+.+|..+++.+...+ ..++++++.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            34666778889998754        2467888887543334567789999998885333 3566666543    299999


Q ss_pred             cCCCCHHHH-----------------HhccCCCCCCCCC-CHHHHHHHHHHHHH-------------------HHHHHHh
Q 041350          210 MPNGSLEKF-----------------IFSKTNSSSHRPL-SWEKLKKIAFGVAR-------------------GVEYLHQ  252 (344)
Q Consensus       210 ~~~gsL~~~-----------------l~~~~~~~~~~~l-~~~~~~~i~~~ia~-------------------~l~yLH~  252 (344)
                      ++|.+|..-                 |+.........+. -+.++.++..++..                   .+..|.+
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            998655321                 1221111111111 24455555544322                   2333332


Q ss_pred             -----CCCCCeeecCCCCCceEEcCC----CceEEeecCCcccc
Q 041350          253 -----GCNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLC  287 (344)
Q Consensus       253 -----~~~~~ivH~Dik~~Nill~~~----~~~kl~Dfgla~~~  287 (344)
                           .....++|+|+.+.||+++++    +.+.++||..+...
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence                 223568999999999999876    78999999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.76  E-value=0.00017  Score=66.95  Aligned_cols=72  Identities=18%  Similarity=0.277  Sum_probs=50.1

Q ss_pred             ccccccCcEEEEEEEEeC--------CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFN--------GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  209 (344)
                      +.|+.|....||+....+        +..+.+|+.... .....+.+|..+++.+...++ .++++.+.+    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            457888889999997653        467888888432 222567789999998864444 566766543    389999


Q ss_pred             cCCCCH
Q 041350          210 MPNGSL  215 (344)
Q Consensus       210 ~~~gsL  215 (344)
                      ++|.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.74  E-value=0.00022  Score=63.77  Aligned_cols=146  Identities=14%  Similarity=0.064  Sum_probs=76.1

Q ss_pred             cccccCcEE-EEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc--cceeeEeeEEEcCCeEEEEEeccCCCCHH
Q 041350          140 RLGQGGYGS-VFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGTRRALVYEFMPNGSLE  216 (344)
Q Consensus       140 ~lG~G~fG~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~  216 (344)
                      .|+.|+... +|+....+|..+++|......  ..++..|+.+++.+..  -.+.+++.+..+.+  +++||++++.++.
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~  100 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT  100 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence            355554444 667654346677777554322  1234456677766643  23566776644443  6899999877776


Q ss_pred             HHHhccCC--------------------CCCCCCCCHHHHHH--------------------HHHHHHHHHHHHH---hC
Q 041350          217 KFIFSKTN--------------------SSSHRPLSWEKLKK--------------------IAFGVARGVEYLH---QG  253 (344)
Q Consensus       217 ~~l~~~~~--------------------~~~~~~l~~~~~~~--------------------i~~~ia~~l~yLH---~~  253 (344)
                      +.+.....                    ......++......                    ....+...++.|.   ..
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            54422110                    00011122211100                    0011122223331   12


Q ss_pred             CCCCeeecCCCCCceEEcCC----CceEEeecCCcccccC
Q 041350          254 CNQRILHFDIKPHNILLDHN----FQPKISDFGLAKLCSK  289 (344)
Q Consensus       254 ~~~~ivH~Dik~~Nill~~~----~~~kl~Dfgla~~~~~  289 (344)
                      ....++|+|+.+.|||++.+    ..+.|+||+.+.....
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            24679999999999999875    6789999999876544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.71  E-value=0.00053  Score=60.82  Aligned_cols=145  Identities=14%  Similarity=0.138  Sum_probs=82.0

Q ss_pred             cccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccc--eeeEeeE------EEcCCeEEEEEeccC
Q 041350          140 RLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH--IVRLLGF------CSEGTRRALVYEFMP  211 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~~  211 (344)
                      .|+.|....+|+....+| .+++|..... ...+.+..|..++..+...+  +.+++..      ....+..+++++|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            467788889999875555 6888888652 12345667888887775322  3344321      123456789999998


Q ss_pred             CCCHHH--------------HHhccCCC-CCC--CC---CCHHHHHH------------HHHHHHHHHHHHHh----CCC
Q 041350          212 NGSLEK--------------FIFSKTNS-SSH--RP---LSWEKLKK------------IAFGVARGVEYLHQ----GCN  255 (344)
Q Consensus       212 ~gsL~~--------------~l~~~~~~-~~~--~~---l~~~~~~~------------i~~~ia~~l~yLH~----~~~  255 (344)
                      |..+..              .++..... ...  ..   ..|.....            +...+...++++++    ...
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            865421              12221110 000  01   11322111            01124445566653    123


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          256 QRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       256 ~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ..++|+|+++.|||++++..+.|+||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            5799999999999999876668999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.49  E-value=0.00019  Score=65.20  Aligned_cols=73  Identities=14%  Similarity=0.149  Sum_probs=44.4

Q ss_pred             ccccccCcEEEEEEEEeC---------CceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEe
Q 041350          139 HRLGQGGYGSVFRGKLFN---------GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e  208 (344)
                      +.|+.|....+|+....+         +..+++|+.........+...|..+++.+...+ ..++++..  .  -++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            357778888999987543         267888887543222223467888888886444 34666544  2  268999


Q ss_pred             ccCCCCH
Q 041350          209 FMPNGSL  215 (344)
Q Consensus       209 ~~~~gsL  215 (344)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.31  E-value=0.0011  Score=59.39  Aligned_cols=68  Identities=10%  Similarity=0.075  Sum_probs=44.3

Q ss_pred             cccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc---cceeeEeeE------EEcCCeEEEEEeccCC
Q 041350          142 GQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH---FHIVRLLGF------CSEGTRRALVYEFMPN  212 (344)
Q Consensus       142 G~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~------~~~~~~~~lv~e~~~~  212 (344)
                      |.|....||+....+| .+++|+......     ..|+..+..|..   +.+++.+..      ....+..+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444689999976666 899998765432     356666666632   224455432      2345678999999998


Q ss_pred             CCH
Q 041350          213 GSL  215 (344)
Q Consensus       213 gsL  215 (344)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.25  E-value=0.0026  Score=59.44  Aligned_cols=73  Identities=12%  Similarity=0.071  Sum_probs=47.0

Q ss_pred             ccccccCcEEEEEEEEeC-CceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      +.|+.|-...+|+....+ +..+.+|+........-+..+|..+++.+...++ .++++.+. +   .+|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence            457788889999987654 4778888875422222123588888888865444 56777663 2   259999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.49  E-value=0.013  Score=48.49  Aligned_cols=103  Identities=12%  Similarity=0.086  Sum_probs=67.1

Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      -||.+.|....     .++++++++.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|++...+ ..+.       
T Consensus        33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence            48999987654     5899999999999999998776221  1112334457899999999988764 1110       


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKN  340 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p  340 (344)
                             .....+.|||....   ..+.+.=|||+|+++|.-+--..|
T Consensus        98 -------~~~~~~~~pe~~~~---~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -------AGEPPPVAGKLGYS---QCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------------CCSSS---SSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -------ccccCCCChhhccc---cchHHHHHHHHHHHHHHHhhcCCC
Confidence                   11234678887632   456788899999999998854444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.42  E-value=0.012  Score=54.34  Aligned_cols=143  Identities=11%  Similarity=0.180  Sum_probs=84.6

Q ss_pred             cccccCcEEEEEEEEeC--------CceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEecc
Q 041350          140 RLGQGGYGSVFRGKLFN--------GIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYEFM  210 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~  210 (344)
                      .+..|-...+|+....+        +..+.+|+........-+..+|..+++.+...+ ..++++.+.  +  ++|+||+
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~efI  152 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIEEFI  152 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEECC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEEEEe
Confidence            46668888899987553        577888887543222223467888888885333 345555332  2  6899999


Q ss_pred             CCCCHHH-----------------HHhccCC-----CC--CCCCCCHHHHHHHHHHH-------------------HHHH
Q 041350          211 PNGSLEK-----------------FIFSKTN-----SS--SHRPLSWEKLKKIAFGV-------------------ARGV  247 (344)
Q Consensus       211 ~~gsL~~-----------------~l~~~~~-----~~--~~~~l~~~~~~~i~~~i-------------------a~~l  247 (344)
                      +|.+|..                 -|+....     ..  ...+.-+.++..+..++                   ...+
T Consensus       153 ~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e~  232 (424)
T 3mes_A          153 DGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEEI  232 (424)
T ss_dssp             CSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHHH
T ss_pred             CCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHHH
Confidence            9866421                 0111100     00  11222344444443222                   2223


Q ss_pred             HHHHh---------------------CCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          248 EYLHQ---------------------GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       248 ~yLH~---------------------~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      .+|.+                     .....++|+|+.+.||+ ++++.+.++||..|...
T Consensus       233 ~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          233 DQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            33321                     11346899999999999 88889999999988643

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.96  E-value=0.28  Score=44.75  Aligned_cols=31  Identities=26%  Similarity=0.298  Sum_probs=25.8

Q ss_pred             CeeecCCCCCceEE------cCCCceEEeecCCcccc
Q 041350          257 RILHFDIKPHNILL------DHNFQPKISDFGLAKLC  287 (344)
Q Consensus       257 ~ivH~Dik~~Nill------~~~~~~kl~Dfgla~~~  287 (344)
                      .++|+|+.+.|||+      +++..+.++||..|...
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            35799999999999      45677999999998654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.39  E-value=0.013  Score=54.73  Aligned_cols=59  Identities=10%  Similarity=0.133  Sum_probs=18.2

Q ss_pred             hcccccccCcEEEEEEEEeC-CceEEE------EEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEE
Q 041350          137 FKHRLGQGGYGSVFRGKLFN-GIPVAV------KMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCS  198 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~-~~~vav------K~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  198 (344)
                      +.++||   ||+||+|.+.. ..+|||      |..+..   .+....|.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            446677   99999998654 368888      766532   233357889999999999999999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.74  E-value=0.48  Score=38.98  Aligned_cols=82  Identities=12%  Similarity=0.191  Sum_probs=59.7

Q ss_pred             cccceeeEeeEEEcCCeEEEEEeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCC
Q 041350          186 HHFHIVRLLGFCSEGTRRALVYEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIK  264 (344)
Q Consensus       186 ~h~niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik  264 (344)
                      .||+++.. .+-.+.+...+.++.-++ -++.. +         ..++...+++++.+|+...++++.     -+|--++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~  106 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA  106 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence            68888765 455566666666665442 23333 3         347888999999999988766653     4788899


Q ss_pred             CCceEEcCCCceEEeecCC
Q 041350          265 PHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       265 ~~Nill~~~~~~kl~Dfgl  283 (344)
                      |+|++++.++.+++.-.|+
T Consensus       107 P~NL~f~~~~~p~i~~RGi  125 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGL  125 (215)
T ss_dssp             GGGEEECTTSCEEESCCEE
T ss_pred             cceEEEcCCCCEEEEEccC
Confidence            9999999999999987765

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.65  E-value=0.58  Score=38.61  Aligned_cols=82  Identities=16%  Similarity=0.111  Sum_probs=59.1

Q ss_pred             cccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeecCCC
Q 041350          186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE-YLHQGCNQRILHFDIK  264 (344)
Q Consensus       186 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~ivH~Dik  264 (344)
                      .||.+  -...-.+++.+.+.++.-+++.=...+         ..++...+++++.+++.... +++     .-+|--++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~  111 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVC  111 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEe
Confidence            57777  344446677777777765443323333         24788899999999887665 444     45788899


Q ss_pred             CCceEEcCCCceEEeecCC
Q 041350          265 PHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       265 ~~Nill~~~~~~kl~Dfgl  283 (344)
                      |+|++++.++.+++.-.|+
T Consensus       112 P~NL~f~~~~~p~i~hRGi  130 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGV  130 (219)
T ss_dssp             GGGEEECTTCCEEESCCEE
T ss_pred             CceEEEeCCCcEEEEEcCC
Confidence            9999999999999987775

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=89.50  E-value=0.082  Score=31.29  Aligned_cols=6  Identities=33%  Similarity=0.700  Sum_probs=2.1

Q ss_pred             HHHHhh
Q 041350           93 LIYKSR   98 (344)
Q Consensus        93 ~~~~~~   98 (344)
                      ++.|+|
T Consensus        33 ~~~RRR   38 (44)
T 2jwa_A           33 ILIKRR   38 (44)
T ss_dssp             HHHHHH
T ss_pred             hheehh
Confidence            333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=84.20  E-value=0.23  Score=29.39  Aligned_cols=7  Identities=0%  Similarity=0.140  Sum_probs=2.6

Q ss_pred             HHHHHhh
Q 041350           92 FLIYKSR   98 (344)
Q Consensus        92 ~~~~~~~   98 (344)
                      ++++|+|
T Consensus        31 ~~~~RRR   37 (44)
T 2l2t_A           31 AVYVRRK   37 (44)
T ss_dssp             HHHHHTT
T ss_pred             HHHhhhh
Confidence            3333333

>2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=81.24  E-value=2.9  Score=28.26  Aligned_cols=19  Identities=37%  Similarity=0.660  Sum_probs=9.3

Q ss_pred             hhHHHHHHHHHHHHHHHHH
Q 041350           78 GTSIGGIVLFALVIFLIYK   96 (344)
Q Consensus        78 ~~~~~~~~~~~~~~~~~~~   96 (344)
                      +.++++++++.++++++++
T Consensus        15 ~gvi~gilliGllllliwk   33 (79)
T 2knc_B           15 LSVMGAILLIGLAALLIWK   33 (79)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHH
Confidence            3445555555554444444

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=80.38  E-value=0.66  Score=27.47  Aligned_cols=24  Identities=17%  Similarity=0.063  Sum_probs=11.2

Q ss_pred             eeeeeehhhHHHHHHHHHHHHHHH
Q 041350           71 SISLISTGTSIGGIVLFALVIFLI   94 (344)
Q Consensus        71 ~~~~i~~~~~~~~~~~~~~~~~~~   94 (344)
                      .++.-+++.+++.+++++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~   35 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFM   35 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHh
Confidence            456555665544443433333333

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	344
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-50
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-46
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-35
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-60
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQE---FINEVATIGRIHHFHIVR 192
               R+G G +G+V++GK      VAVKML       Q+   F NEV  + +  H +I+ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            +G+ +   + A+V ++    SL   +               KL  IA   A+G++YLH 
Sbjct: 69  FMGYSTAP-QLAIVTQWCEGSSLYHHLHII-----ETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE-LF 311
              + I+H D+K +NI L  +   KI DFGLA + S+           G+  ++APE + 
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
            ++    S++SDVY++G++L E++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELM 203

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-54
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVR 192
           +    LG G  G VF+     +G+ +A K++  E       + I E+  +   +  +IV 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 193 LLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
             G        ++  E M  GSL++ +           +  + L K++  V +G+ YL +
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLK------KAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 253 GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFS 312
               +I+H D+KP NIL++   + K+ DFG++      ++     +  GT  Y++PE   
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQ 176

Query: 313 RNFGEVSYKSDVYSYGMMLLEMV 335
                 S +SD++S G+ L+EM 
Sbjct: 177 G--THYSVQSDIWSMGLSLVEMA 197

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (451), Expect = 4e-54
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)

Query: 121 NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG----QEF 175
           +P +  + +L++I        G G +G+V+  + + N   VA+K + +         Q+ 
Sbjct: 12  DPEKL-FSDLREI--------GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           I EV  + ++ H + ++  G         LV E+    + +     K      +PL   +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVE 116

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           +  +  G  +G+ YLH      ++H D+K  NILL      K+ DFG A + +   S V 
Sbjct: 117 IAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV- 172

Query: 296 LTAARGTAGYIAPE-LFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
                GT  ++APE + + + G+   K DV+S G+  +E+   +
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-54
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 11/209 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K   RLG G +G V+ G       VAVK L+    +   F+ E   + ++ H  +VRL  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             ++     ++ E+M NGSL  F+ +     S   L+  KL  +A  +A G+ ++ +   
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           +  +H D++  NIL+      KI+DFGLA+L   +        A+    + APE    N+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI--NY 184

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
           G  + KSDV+S+G++L E+V   +   P 
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 4e-54
 Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            F   LG G +G V  GK      VA+KM++    +  EFI E   +  + H  +V+L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C++     ++ E+M NG L  ++              ++L ++   V   +EYL     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           ++ LH D+   N L++     K+SDFGL++    D    S   ++    +  PE+     
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMY-- 175

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
            + S KSD++++G+++ E+    K
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK 199

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-54
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
            F   +G G +G V  G   N   VA+K +     + ++FI E   + ++ H  +V+L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C E     LV+EFM +G L  ++ ++         + E L  +   V  G   +     
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEG---MAYLEE 119

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
             ++H D+   N L+  N   K+SDFG+ +    D    S    +    + +PE+F  +F
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVF--SF 176

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
              S KSDV+S+G+++ E+    K
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGK 200

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 7e-53
 Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 38/268 (14%)

Query: 105 ETQLKVEKFL----EDYRTVNPTRYTYKELKKITS---KFKHRLGQGGYGSVFRG----- 152
           E+QL++ +       +Y  V+   Y Y    +      +F   LG G +G V        
Sbjct: 2   ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61

Query: 153 -KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYE 208
            K    I VAVKML  +      +  ++E+  + ++  H +IV LLG C+      L++E
Sbjct: 62  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121

Query: 209 FMPNGSLEKFIFSKTNSSS-----------------HRPLSWEKLKKIAFGVARGVEYLH 251
           +   G L  ++ SK    S                    L++E L   A+ VA+G+E+L 
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
               +  +H D+   N+L+ H    KI DFGLA+    D + V    AR    ++APE  
Sbjct: 182 F---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
               G  + KSDV+SYG++L E+     
Sbjct: 239 FE--GIYTIKSDVWSYGILLWEIFSLGV 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  172 bits (437), Expect = 3e-52
 Identities = 60/235 (25%), Positives = 115/235 (48%), Gaps = 30/235 (12%)

Query: 125 YTYKELKKITSKF-----------KHRLGQGGYGSVFRGKLF----NGIPVAVKML--EH 167
           +T+++  +   +F           +  +G G +G V  G L       I VA+K L   +
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 168 LKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSS 227
            +   ++F++E + +G+  H +++ L G  ++ T   ++ EFM NGSL+ F+        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----- 121

Query: 228 HRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC 287
               +  +L  +  G+A G++YL        +H D+   NIL++ N   K+SDFGL++  
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178

Query: 288 SKDISIVSLTAA---RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
             D S  + T+A   +    + APE     + + +  SDV+SYG+++ E++   +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 7e-52
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 11/204 (5%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           + + +LGQG +G V+ G       VA+K L+    + + F+ E   + ++ H  +V+L  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
             SE     +V E+M  GSL  F+  +T     + L   +L  +A  +A G+ Y+ +   
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
              +H D++  NIL+  N   K++DFGLA+L   +        A+    + APE      
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALY-- 188

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
           G  + KSDV+S+G++L E+    +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGR 212

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 9e-52
 Identities = 50/226 (22%), Positives = 104/226 (46%), Gaps = 24/226 (10%)

Query: 118 RTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-QEF 175
           R +NP  + ++ + ++        G G +G V++ +     +  A K+++       +++
Sbjct: 6   RDLNPEDF-WEIIGEL--------GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 56

Query: 176 INEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEK 235
           + E+  +    H +IV+LL          ++ EF   G+++  +         RPL+  +
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-----ERPLTESQ 111

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           ++ +       + YLH     +I+H D+K  NIL   +   K++DFG++   ++ I    
Sbjct: 112 IQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 166

Query: 296 LTAARGTAGYIAPELF---SRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             +  GT  ++APE+    +       YK+DV+S G+ L+EM    
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 2e-51
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 14/211 (6%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEH---LKGNGQEFINEVATIGRIHHFHIV 191
           +  + +G G YG   + +   +G  +  K L++    +   Q  ++EV  +  + H +IV
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 192 RLLGFCSEGTRRAL--VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           R      + T   L  V E+   G L   I     +   + L  E + ++   +   ++ 
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 250 LHQ--GCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
            H+       +LH D+KP N+ LD     K+ DFGLA++ + D S     A  GT  Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           PE  +R     + KSD++S G +L E+    
Sbjct: 183 PEQMNR--MSYNEKSDIWSLGCLLYELCALM 211

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 3e-51
 Identities = 69/252 (27%), Positives = 110/252 (43%), Gaps = 29/252 (11%)

Query: 116 DYRTVNPTRYTYK---ELKKITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKML- 165
           +Y  ++PT+  Y    E  +    F   LG G +G V     +        + VAVKML 
Sbjct: 3   NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 166 -EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT 223
                   +  ++E+  +  + +H +IV LLG C+ G    ++ E+   G L  F+  K 
Sbjct: 63  PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122

Query: 224 NS------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD 271
           +S                 L  E L   ++ VA+G+ +L     +  +H D+   NILL 
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179

Query: 272 HNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMML 331
           H    KI DFGLA+    D + V    AR    ++APE         +++SDV+SYG+ L
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFL 237

Query: 332 LEMVGCRKNKDP 343
            E+     +  P
Sbjct: 238 WELFSLGSSPYP 249

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (430), Expect = 3e-51
 Identities = 64/228 (28%), Positives = 116/228 (50%), Gaps = 13/228 (5%)

Query: 120 VNPTRYTYK--ELKKITSKFKHRLGQGGYGSVFRGKLFN-GIPVAVKMLEHLKGNGQEFI 176
           ++P+   Y   E+++     KH+LG G YG V+ G      + VAVK L+      +EF+
Sbjct: 2   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 61

Query: 177 NEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
            E A +  I H ++V+LLG C+      ++ EFM  G+L  ++       + + +S   L
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC----NRQEVSAVVL 117

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
             +A  ++  +EYL +   +  +H D+   N L+  N   K++DFGL++L + D +  + 
Sbjct: 118 LYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAH 173

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
             A+    + APE  +    + S KSDV+++G++L E+     +  P 
Sbjct: 174 AGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPG 219

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 6e-51
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           K    +G+G +G V  G    G  VAVK +++     Q F+ E + + ++ H ++V+LLG
Sbjct: 10  KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 196 FCSEG-TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC 254
              E      +V E+M  GSL  ++ S+        L  + L K +  V   +EYL    
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG-- 121

Query: 255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRN 314
               +H D+   N+L+  +   K+SDFGL K  S           +    + APE     
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALRE- 174

Query: 315 FGEVSYKSDVYSYGMMLLEMVGCRK 339
             + S KSDV+S+G++L E+    +
Sbjct: 175 -KKFSTKSDVWSFGILLWEIYSFGR 198

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 7e-51
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIV 191
           KF   +G+G + +V++G      + VA   L   +  K   Q F  E   +  + H +IV
Sbjct: 12  KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71

Query: 192 RLLGFCSEGTRR----ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
           R         +      LV E M +G+L+ ++         + +  + L+     + +G+
Sbjct: 72  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGL 125

Query: 248 EYLHQGCNQRILHFDIKPHNILL-DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYI 306
           ++LH      I+H D+K  NI +       KI D GLA L     +     A  GT  ++
Sbjct: 126 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFM 180

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           APE++     +     DVY++GM +LEM     
Sbjct: 181 APEMYE---EKYDESVDVYAFGMCMLEMATSEY 210

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-50
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGF 196
            +  +G+G +G V+RGK   G  VAVK+    +        E+     + H +I+  +  
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 197 CSEG----TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQ 252
            ++     T+  LV ++  +GSL  ++       +   ++ E + K+A   A G+ +LH 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL-------NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 253 GC-----NQRILHFDIKPHNILLDHNFQPKISDFGLAKLC--SKDISIVSLTAARGTAGY 305
                     I H D+K  NIL+  N    I+D GLA     + D   ++     GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 306 IAPELFSRNF----GEVSYKSDVYSYGMMLLEMVGCRK 339
           +APE+   +      E   ++D+Y+ G++  E+     
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (415), Expect = 2e-49
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 20/208 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHI 190
           +    LG+G +G+V+  +   +   +A+K+L   +        +   EV     + H +I
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +RL G+  + TR  L+ E+ P G++ + +              ++       +A  + Y 
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQK------LSKFDEQRTATYITELANALSYC 122

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H    +R++H DIKP N+LL    + KI+DFG +            T   GT  Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM 175

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
                     K D++S G++  E +  +
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGK 201

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-49
 Identities = 62/226 (27%), Positives = 90/226 (39%), Gaps = 31/226 (13%)

Query: 113 FLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLK 169
           F+ED+                       LG+G YG V           VAVK++  +   
Sbjct: 3   FVEDWD------------------LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV 44

Query: 170 GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHR 229
              +    E+     ++H ++V+  G   EG  + L  E+   G L   I          
Sbjct: 45  DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP------DI 98

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
            +     ++    +  GV YLH      I H DIKP N+LLD     KISDFGLA +   
Sbjct: 99  GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155

Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +     L    GT  Y+APEL  R     +   DV+S G++L  M+
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAML 200

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-49
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 141 LGQGGYGSVFRGKLF---NGIPVAVKML--EHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           LG G +GSV +G        I VA+K+L     K + +E + E   + ++ + +IVRL+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
            C +     LV E    G L KF+  K        +    + ++   V+ G++YL +   
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE--- 127

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYIAPELFSRN 314
           +  +H D+   N+LL +    KISDFGL+K L + D    + +A +    + APE    N
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 185

Query: 315 FGEVSYKSDVYSYGMMLLEMVGCRK 339
           F + S +SDV+SYG+ + E +   +
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 4e-48
 Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 31/230 (13%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
           ++   +G+G +G VF+ +            VAVKML  E       +F  E A +    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKT------------------NSSSHR 229
            +IV+LLG C+ G    L++E+M  G L +F+ S +                  +S    
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
           PLS  +   IA  VA G+ YL +   ++ +H D+   N L+  N   KI+DFGL++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
                +         ++ PE    N    + +SDV++YG++L E+     
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGL 240

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 6e-47
 Identities = 68/234 (29%), Positives = 116/234 (49%), Gaps = 26/234 (11%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKLFNG---IPVAVKMLEHL--KGNGQEFI 176
           PT Y   +   I  KF+  +G+G +G V + ++      +  A+K ++    K + ++F 
Sbjct: 1   PTIYPVLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 177 NEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN----------S 225
            E+  + ++ HH +I+ LLG C       L  E+ P+G+L  F+               +
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK 285
           S+   LS ++L   A  VARG++YL Q   ++ +H D+   NIL+  N+  KI+DFGL++
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
                   V  T  R    ++A E  S N+   +  SDV+SYG++L E+V    
Sbjct: 176 GQEVY---VKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 7e-47
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 140 RLGQGGYGSVFRGKLFN---GIPVAVKMLEHLKGNG---QEFINEVATIGRIHHFHIVRL 193
            LG G +G+V +G          VAVK+L++   +     E + E   + ++ + +IVR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           +G C   +   LV E    G L K++        +R +  + + ++   V+ G++YL + 
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQQ------NRHVKDKNIIELVHQVSMGMKYLEE- 125

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-IVSLTAARGTAGYIAPELFS 312
                +H D+   N+LL      KISDFGL+K    D +   + T  +    + APE  +
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 313 RNFGEVSYKSDVYSYGMMLLEMVGCRK 339
               + S KSDV+S+G+++ E     +
Sbjct: 184 Y--YKFSSKSDVWSFGVLMWEAFSYGQ 208

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-46
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 29/231 (12%)

Query: 111 EKFLEDYRTV----NPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML 165
           E+ LE  R++    +P +  Y   +KI        GQG  G+V+    +  G  VA++ +
Sbjct: 3   EEILEKLRSIVSVGDPKKK-YTRFEKI--------GQGASGTVYTAMDVATGQEVAIRQM 53

Query: 166 EHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTN 224
              +   +E  INE+  +    + +IV  L     G    +V E++  GSL   +     
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---- 109

Query: 225 SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA 284
                 +   ++  +     + +E+LH     +++H DIK  NILL  +   K++DFG  
Sbjct: 110 ---ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
              + + S    +   GT  ++APE+ +R       K D++S G+M +EM+
Sbjct: 164 AQITPEQS--KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMI 210

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (398), Expect = 7e-46
 Identities = 56/249 (22%), Positives = 102/249 (40%), Gaps = 38/249 (15%)

Query: 91  IFLIYKSRESEKEKETQLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVF 150
           +F I+K       +  ++K +  L+ Y                       LG G +G V 
Sbjct: 5   VFDIWKQYYP---QPVEIKHDHVLDHYD------------------IHEELGTGAFGVVH 43

Query: 151 RGK-LFNGIPVAVKMLEHLKGNGQE-FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE 208
           R      G   A K +     + +E    E+ T+  + H  +V L     +     ++YE
Sbjct: 44  RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103

Query: 209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 268
           FM  G L + +  +     H  +S ++  +    V +G+ ++H+      +H D+KP NI
Sbjct: 104 FMSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENI 155

Query: 269 LL--DHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYS 326
           +     + + K+ DFGL        S+   T   GTA + APE+       V Y +D++S
Sbjct: 156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEG--KPVGYYTDMWS 210

Query: 327 YGMMLLEMV 335
            G++   ++
Sbjct: 211 VGVLSYILL 219

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 7e-46
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 19/218 (8%)

Query: 131 KKITSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNGQ--EFINEVATIGR 184
             +   F   +G+G +G V+ G L +     I  AVK L  +   G+  +F+ E   +  
Sbjct: 25  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84

Query: 185 IHHFHIVRLLGFCSEG-TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
             H +++ LLG C        +V  +M +G L  FI ++         + + L      V
Sbjct: 85  FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQV 139

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD--ISIVSLTAARG 301
           A+G   +    +++ +H D+   N +LD  F  K++DFGLA+        S+ + T A+ 
Sbjct: 140 AKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
              ++A E       + + KSDV+S+G++L E++    
Sbjct: 197 PVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGA 232

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 4e-45
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 20/213 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNG----QEFINEVATIGRIHH 187
           +   +LG G +G V RG+        + VAVK L+    +      +FI EV  +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++RL G       + +V E  P GSL   +                L + A  VA G+
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGM 124

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK-LCSKDISIVSLTAARGTAGYI 306
            YL     +R +H D+   N+LL      KI DFGL + L   D   V     +    + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           APE         S+ SD + +G+ L EM    +
Sbjct: 182 APESLKT--RTFSHASDTWMFGVTLWEMFTYGQ 212

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-45
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKL-----FNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHHF 188
           K    LG G +G+V++G          IPVA+K L         +E ++E   +  + + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           H+ RLLG C   T + L+ + MP G L  ++           +  + L      +A+G+ 
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMN 125

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
           YL    ++R++H D+   N+L+      KI+DFGLAKL   +         +    ++A 
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 309 ELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           E         +++SDV+SYG+ + E++    
Sbjct: 183 ESILH--RIYTHQSDVWSYGVTVWELMTFGS 211

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-45
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 18/212 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFNG-----IPVAVKML--EHLKGNGQEFINEVATIGRIHHF 188
             +  +G G +G V++G L        +PVA+K L   + +    +F+ E   +G+  H 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
           +I+RL G  S+     ++ E+M NG+L+KF+  K         S  +L  +  G+A G++
Sbjct: 70  NIIRLEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMK 124

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS-IVSLTAARGTAGYIA 307
           YL    N   +H D+   NIL++ N   K+SDFGL+++   D     + +  +    + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
           PE  S    + +  SDV+S+G+++ E++   +
Sbjct: 182 PEAISY--RKFTSASDVWSFGIVMWEVMTYGE 211

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 6e-45
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 16/205 (7%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE----FINEVATIGRIHHFHI 190
           KF   LG+G + +V   + L      A+K+LE      +        E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           V+L     +  +      +  NG L K+I                 +     +   +EYL
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFYTAEIVSALEYL 124

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H    + I+H D+KP NILL+ +   +I+DFG AK+ S +       +  GTA Y++PEL
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMV 335
            +         SD+++ G ++ ++V
Sbjct: 182 LTE--KSACKSSDLWALGCIIYQLV 204

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-43
 Identities = 49/210 (23%), Positives = 95/210 (45%), Gaps = 18/210 (8%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKGNG--QEFINEVATIGRIHHFH 189
           +    +G+G +G V +G   +     + VA+K  ++   +   ++F+ E  T+ +  H H
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           IV+L+G  +E     ++ E    G L  F+  +        L    L   A+ ++  + Y
Sbjct: 70  IVKLIGVITENPVW-IIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAY 123

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           L     +R +H DI   N+L+  N   K+ DFGL++         + +  +    ++APE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPE 179

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
               NF   +  SDV+ +G+ + E++    
Sbjct: 180 SI--NFRRFTSASDVWMFGVCMWEILMHGV 207

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-43
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 17/216 (7%)

Query: 136 KFKHRLGQGGYGSVFRGKLFN------GIPVAVKML--EHLKGNGQEFINEVATIGRIHH 187
                LGQG +G V+ G             VA+K +          EF+NE + +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIF----SKTNSSSHRPLSWEKLKKIAFGV 243
            H+VRLLG  S+G    ++ E M  G L+ ++     +  N+    P S  K+ ++A  +
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
           A G+ YL      + +H D+   N ++  +F  KI DFG+ +   +              
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
            +++PE      G  +  SDV+S+G++L E+    +
Sbjct: 200 RWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE 233

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-43
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 25/229 (10%)

Query: 136 KFKHRLGQGGYGSVFRG------KLFNGIPVAVKML--EHLKGNGQEFINEVATIGRI-H 186
           K    LG+G +G V         K      VAVKML         +  ++E+  +  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 187 HFHIVRLLGFCSE-GTRRALVYEFMPNGSLEKFIFSKTN----------SSSHRPLSWEK 235
           H ++V LLG C++ G    ++ EF   G+L  ++ SK N                L+ E 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 236 LKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS 295
           L   +F VA+G+E+L     ++ +H D+   NILL      KI DFGLA+   KD   V 
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDPA 344
              AR    ++APE         + +SDV+S+G++L E+     +  P 
Sbjct: 193 KGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPG 239

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 16/214 (7%)

Query: 127 YKELKKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKML--EHLKGNGQEFINEVAT 181
           +K+ + I   +     LG G +  V   +       VA+K +  + L+G      NE+A 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 182 IGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAF 241
           + +I H +IV L      G    L+ + +  G L   I            +     ++ F
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI------VEKGFYTERDASRLIF 114

Query: 242 GVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARG 301
            V   V+YLH                  LD + +  ISDFGL+K+         L+ A G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACG 171

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T GY+APE+ ++     S   D +S G++   ++
Sbjct: 172 TPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILL 203

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-42
 Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 26/225 (11%)

Query: 136 KFKHRLGQGGYGSVFRGKL--------FNGIPVAVKML--EHLKGNGQEFINEVATIGRI 185
                LG+G +G V   +              VAVKML  +  + +  + I+E+  +  I
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75

Query: 186 -HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSK----------TNSSSHRPLSWE 234
             H +I+ LLG C++     ++ E+   G+L +++ ++           + +    LS +
Sbjct: 76  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
            L   A+ VARG+EYL     ++ +H D+   N+L+  +   KI+DFGLA+         
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
             T  R    ++APE         +++SDV+S+G++L E+     
Sbjct: 193 KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGG 235

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  146 bits (370), Expect = 8e-42
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 21/232 (9%)

Query: 111 EKFLED-YRTVNPTRYTYKELKKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLE 166
           +KF ED ++   P     K+   +   +     LG G +G V R      G     K + 
Sbjct: 5   DKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 63

Query: 167 -HLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNS 225
                +     NE++ + ++HH  ++ L     +     L+ EF+  G L   I ++   
Sbjct: 64  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--- 120

Query: 226 SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP--KISDFGL 283
                +S  ++         G++++H+     I+H DIKP NI+ +       KI DFGL
Sbjct: 121 --DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGL 175

Query: 284 AKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           A   + D     +     TA + APE+  R    V + +D+++ G++   ++
Sbjct: 176 ATKLNPD---EIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLL 222

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (364), Expect = 1e-41
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 28/216 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML----------EHLKGNGQEFINEVATIGR 184
           + K  LG+G    V R          AVK++          E ++   +  + EV  + +
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 185 IH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
           +  H +I++L       T   LV++ M  G L  ++      +    LS ++ +KI   +
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL------TEKVTLSEKETRKIMRAL 119

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
              +  LH+     I+H D+KP NILLD +   K++DFG +           L    GT 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173

Query: 304 GYIAPELFS----RNFGEVSYKSDVYSYGMMLLEMV 335
            Y+APE+       N      + D++S G+++  ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 7e-41
 Identities = 42/210 (20%), Positives = 83/210 (39%), Gaps = 18/210 (8%)

Query: 131 KKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH 187
           K++  K+     LG+G +G V R     +      K ++    +      E++ +    H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +I+ L           +++EF+    + + I +         L+  ++      V   +
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEAL 115

Query: 248 EYLHQGCNQRILHFDIKPHNILLDH--NFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
           ++LH      I HFDI+P NI+     +   KI +FG A+         +         Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEY 169

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            APE+       VS  +D++S G ++  ++
Sbjct: 170 YAPEVHQH--DVVSTATDMWSLGTLVYVLL 197

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 5e-40
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 13/212 (6%)

Query: 133 ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG--QEFINEVATIGRIHH 187
           +  ++     +G+G YG V       N + VA+K +   +     Q  + E+  + R  H
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +I+ +       T   +   ++    +   ++        + LS + +    + + RG+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGL 122

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKD-ISIVSLTAARGTAGYI 306
           +Y+H      +LH D+KP N+LL+     KI DFGLA++   D      LT    T  Y 
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 307 APELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           APE+   + G  +   D++S G +L EM+  R
Sbjct: 180 APEIMLNSKG-YTKSIDIWSVGCILAEMLSNR 210

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (356), Expect = 1e-39
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 22/208 (10%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML-------EHLKGNGQEFINEVATIGRIHH 187
                +G+GG+G V+  +    G   A+K L       +  +         ++ +     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
             IV +        + + + + M  G L   +      S H   S   ++  A  +  G+
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGL 120

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIA 307
           E++H    + +++ D+KP NILLD +   +ISD GLA   SK        A+ GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMA 173

Query: 308 PELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           PE+  +        +D +S G ML +++
Sbjct: 174 PEVLQKGVA-YDSSADWFSLGCMLFKLL 200

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  137 bits (347), Expect = 4e-39
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 23/220 (10%)

Query: 131 KKITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE----FINEVATIG 183
             ++ +++    LG GG   V   + L     VAVK+L             F  E     
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 184 RIHHFHIVRLLGFC----SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKI 239
            ++H  IV +          G    +V E++   +L   + +        P++ ++  ++
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEV 116

Query: 240 AFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAA 299
                + + + HQ     I+H D+KP NI++      K+ DFG+A+  +   + V+ TAA
Sbjct: 117 IADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 300 R-GTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
             GTA Y++PE        V  +SDVYS G +L E++   
Sbjct: 174 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGE 211

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 19/206 (9%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLE----HLKGNGQEFINEVATIGR-IHHFH 189
                LG+G +G VF  +        A+K L+     +  + +  + E   +     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 190 IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEY 249
           +  +            V E++  G L   I S             +    A  +  G+++
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS------CHKFDLSRATFYAAEIILGLQF 118

Query: 250 LHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPE 309
           LH    + I++ D+K  NILLD +   KI+DFG+ K      +        GT  YIAPE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPE 173

Query: 310 LFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +      + ++  D +S+G++L EM+
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEML 197

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  131 bits (330), Expect = 1e-36
 Identities = 43/212 (20%), Positives = 80/212 (37%), Gaps = 24/212 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRL 193
           K   R+G+G +G +F G  L N   VA+K     + +  +  +E  T   +     I  +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
             F  EG    LV + +     +            R  S + +   A  +   V+ +H+ 
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLD------LCGRKFSVKTVAMAAKQMLARVQSIHE- 119

Query: 254 CNQRILHFDIKPHNILLDHNFQP-----KISDFGLAKLCSKDIS-----IVSLTAARGTA 303
             + +++ DIKP N L+            + DFG+ K     ++             GTA
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            Y++         E S + D+ + G + +  +
Sbjct: 178 RYMSINTH--LGREQSRRDDLEALGHVFMYFL 207

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 29/222 (13%)

Query: 122 PTRYTYKELKKITSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVA 180
           P   +Y + K I        G G +G V++ KL  +G  VA+K +   K   +    E+ 
Sbjct: 17  PQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 181 TIGRIHHFHIVRLLGFCSEGTRR------ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
            + ++ H +IVRL  F      +       LV +++P          +  S + + L   
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA---RHYSRAKQTLPVI 122

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISI 293
            +K   + + R + Y+H      I H DIKP N+LLD +    K+ DFG AK   +    
Sbjct: 123 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

Query: 294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           VS   +R    Y APEL        +   DV+S G +L E++
Sbjct: 180 VSYICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELL 217

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 4e-36
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 42/241 (17%)

Query: 107 QLKVEKFLEDYRTVNPTRYTYKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML 165
           Q+K    ++DY+              +TS+    LG G  G V +          A+KML
Sbjct: 3   QIKKNAIIDDYK--------------VTSQV---LGLGINGKVLQIFNKRTQEKFALKML 45

Query: 166 EHLKGNGQEFINEVATIGRI-HHFHIVRLLGFC----SEGTRRALVYEFMPNGSLEKFIF 220
           +    +  +   EV    R     HIVR++       +      +V E +  G L   I 
Sbjct: 46  Q----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 101

Query: 221 SKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQP---K 277
            + +    +  +  +  +I   +   ++YLH      I H D+KP N+L          K
Sbjct: 102 DRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 154

Query: 278 ISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGC 337
           ++DFG AK  +   S+ +      T  Y+APE+      +     D++S G+++  ++  
Sbjct: 155 LTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 209

Query: 338 R 338
            
Sbjct: 210 Y 210

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-36
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 141 LGQGGYGSVFRGK-LFNGIPVAVKML------EHLKGNGQEFINEVATIGRIHHFHIVRL 193
           LG+G + +V++ +       VA+K +      E   G  +  + E+  +  + H +I+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 194 LGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG 253
           L      +  +LV++FM                +   L+   +K       +G+EYLHQ 
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIK------DNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 254 CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSR 313
               ILH D+KP+N+LLD N   K++DFGLAK         + T    T  Y APEL   
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL-F 173

Query: 314 NFGEVSYKSDVYSYGMMLLEMV 335
                    D+++ G +L E++
Sbjct: 174 GARMYGVGVDMWAVGCILAELL 195

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (324), Expect = 1e-35
 Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 24/219 (10%)

Query: 132 KITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHF 188
           ++ ++++   ++G G +G ++ G  +  G  VA+K+   +K    +   E      +   
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGG 62

Query: 189 HIVRLLGFC-SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
             +  + +C +EG    +V E +     + F F        R  S + +  +A  +   +
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRI 116

Query: 248 EYLHQGCNQRILHFDIKPHNIL---LDHNFQPKISDFGLAKLCS-----KDISIVSLTAA 299
           EY+H    +  +H D+KP N L           I DFGLAK        + I        
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 300 RGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            GTA Y +         E S + D+ S G +L+      
Sbjct: 174 TGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGS 210

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-35
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 140 RLGQGGYGSVFRGK--LFNGIPVAVKMLEHLKGNG---QEFINEVA---TIGRIHHFHIV 191
            +G+G YG VF+ +     G  VA+K +    G        I EVA    +    H ++V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           RL   C+           +    +++ + +  +      +  E +K + F + RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                R++H D+KP NIL+  + Q K++DFGLA++ S  +++   T+   T  Y APE+ 
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVL 187

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            +     +   D++S G +  EM   +
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRK 212

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  128 bits (322), Expect = 2e-35
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 23/215 (10%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNG---QEFINEVATIG 183
           Y  L+KI        G+G YG V++ +   G   A+K +   K +       I E++ + 
Sbjct: 4   YHGLEKI--------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK 55

Query: 184 RIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            + H +IV+L        R  LV+E +     +     +        L     K     +
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQL 109

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTA 303
             G+ Y H    +R+LH D+KP N+L++   + KI+DFGLA+     +     T    T 
Sbjct: 110 LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTL 164

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            Y AP++      + S   D++S G +  EMV   
Sbjct: 165 WYRAPDVL-MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIV 191
           +   ++G+G YG V++ +    G  VA+K +      +G     I E++ +  ++H +IV
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 192 RLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH 251
           +LL       +  LV+EF+     +       ++S+   +    +K   F + +G+ + H
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFM-----DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 252 QGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELF 311
                R+LH D+KP N+L++     K++DFGLA+     +   +      T  Y APE+ 
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEIL 174

Query: 312 SRNFGEVSYKSDVYSYGMMLLEMV 335
                  S   D++S G +  EMV
Sbjct: 175 LGC-KYYSTAVDIWSLGCIFAEMV 197

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHH 187
           +    LG GG+GSV+ G  + + +PVA+K +E  +        NG     EV  + ++  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 188 FH--IVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
               ++RLL +        L+ E            ++        L  E  +   + V  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLE 121

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVSLTAARGTAG 304
            V +     N  +LH DIK  NIL+D N  + K+ DFG   L    +     T   GT  
Sbjct: 122 AVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174

Query: 305 YIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           Y  PE   R        + V+S G++L +MV   
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 21/209 (10%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHI 190
           +    LG G +G V   +   NG   A+K+L+          +   +E   +  + H  I
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
           +R+ G   +  +  ++ +++  G L   +         +       K  A  V   +EYL
Sbjct: 67  IRMWGTFQDAQQIFMIMDYIEGGELFSLLRK------SQRFPNPVAKFYAAEVCLALEYL 120

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
           H    + I++ D+KP NILLD N   KI+DFG AK               GT  YIAPE+
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMVGCRK 339
            S      +   D +S+G+++ EM+    
Sbjct: 173 VST--KPYNKSIDWWSFGILIYEMLAGYT 199

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-34
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 26/212 (12%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG-------QEFINEVATIGRIHH 187
                LG G +  V + +    G+  A K ++  +          ++   EV+ +  I H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGV 247
            +++ L       T   L+ E +  G L  F+  K        L+ E+  +    +  G 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNG- 125

Query: 248 EYLHQGCNQRILHFDIKPHNILLDHNFQP----KISDFGLAKLCSKDISIVSLTAARGTA 303
             ++   + +I HFD+KP NI+L     P    KI DFGLA                GT 
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 180

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            ++APE+   N+  +  ++D++S G++   ++
Sbjct: 181 EFVAPEIV--NYEPLGLEADMWSIGVITYILL 210

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 18/208 (8%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQE----FINEVATIGRIHHFHI 190
            +   LG+G +G V   +    G   A+K+L       ++     + E   +    H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 191 VRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYL 250
             L        R   V E+   G L   +      S  R  + E+ +     +      L
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEIVSA---L 118

Query: 251 HQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPEL 310
               ++ +++ DIK  N++LD +   KI+DFGL K    D +  ++    GT  Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 311 FSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
                 +     D +  G+++ EM+  R
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGR 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-33
 Identities = 48/224 (21%), Positives = 95/224 (42%), Gaps = 21/224 (9%)

Query: 125 YTYKELKKITSKFKHR------LGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQE 174
           +  +E+ K   + +        +G G YG+V        G  VA+K L      +   + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWE 234
              E+  +  + H +++ LL   +         +F            K     H  L  +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGED 121

Query: 235 KLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV 294
           +++ + + + +G+ Y+H      I+H D+KP N+ ++ + + KI DFGLA+    +    
Sbjct: 122 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---- 174

Query: 295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
            +T    T  Y APE+   N+   +   D++S G ++ EM+  +
Sbjct: 175 -MTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 3e-32
 Identities = 53/247 (21%), Positives = 100/247 (40%), Gaps = 33/247 (13%)

Query: 97  SRESEKEKETQLKVEKFLEDYRTVNPTRYT---YKELKKITSKFKHRLGQGGYGSVFRGK 153
            +ES KE   + K E FL+ + T +        +  +K +        G G +G V   K
Sbjct: 11  EQESVKEFLAKAK-EDFLKKWETPSQNTAQLDQFDRIKTL--------GTGSFGRVMLVK 61

Query: 154 -LFNGIPVAVKMLEHLKGNG----QEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE 208
              +G   A+K+L+  K       +  +NE   +  ++   +V+L     + +   +V E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNI 268
           ++  G +   +            S    +  A  +    EYLH      +++ D+KP N+
Sbjct: 122 YVAGGEMFSHLRR------IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENL 172

Query: 269 LLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYG 328
           L+D     +++DFG AK        +      GT   +APE+        +   D ++ G
Sbjct: 173 LIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIILS--KGYNKAVDWWALG 225

Query: 329 MMLLEMV 335
           +++ EM 
Sbjct: 226 VLIYEMA 232

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (303), Expect = 3e-32
 Identities = 51/236 (21%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 117 YRTVNPTR-YTYKELKKITSKFKHR--------LGQGGYGSVFRGK-LFNGIPVAVKMLE 166
           Y  VN  R   Y + +    ++ ++        LG+G Y  VF    + N   V VK+L+
Sbjct: 10  YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69

Query: 167 HLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR--ALVYEFMPNGSLEKFIFSKT 223
                 ++   E+  +  +    +I+ L     +   R  ALV+E + N   ++      
Sbjct: 70  --PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---- 123

Query: 224 NSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFG 282
                + L+   ++   + + + ++Y H      I+H D+KPHN+++DH + + ++ D+G
Sbjct: 124 -----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWG 175

Query: 283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           LA+                +  +  PEL   ++    Y  D++S G ML  M+  +
Sbjct: 176 LAEFYHPGQEY---NVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRK 227

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-32
 Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 24/214 (11%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIV 191
           +   ++GQG +G VF+ +    G  VA+K +      +G     + E+  +  + H ++V
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 192 RLLGFCSEGTRRA--------LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGV 243
            L+  C               LV++F  +             +     +  ++K++   +
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQML 126

Query: 244 ARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS--KDISIVSLTAARG 301
             G   L+     +ILH D+K  N+L+  +   K++DFGLA+  S  K+      T    
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 302 TAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T  Y  PEL      +     D++  G ++ EM 
Sbjct: 184 TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMW 216

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-31
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 140 RLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATIGRIHHFHIVRLLG 195
           ++G+G YG+VF+ K       VA+K +   +  +G     + E+  +  + H +IVRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 196 FCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCN 255
                 +  LV+EF      + F         +  L  E +K   F + +G+ + H    
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHS--- 119

Query: 256 QRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNF 315
           + +LH D+KP N+L++ N + K+++FGLA+     +     +A   T  Y  P++     
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGA- 176

Query: 316 GEVSYKSDVYSYGMMLLEMVGCRK 339
              S   D++S G +  E+    +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGR 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-27
 Identities = 47/210 (22%), Positives = 83/210 (39%), Gaps = 20/210 (9%)

Query: 136 KFKHRLGQGGYGSVFRGKLF----NGIPVAVKMLEHLKGNG-----QEFINEVATIGRI- 185
           +    LG G YG VF  +       G   A+K+L+           +    E   +  I 
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 186 HHFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVAR 245
               +V L       T+  L+ +++  G L   +      S     +  +++     +  
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHL------SQRERFTEHEVQIYVGEIVL 140

Query: 246 GVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGY 305
            +E+LH+     I++ DIK  NILLD N    ++DFGL+K               GT  Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEY 196

Query: 306 IAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           +AP++            D +S G+++ E++
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 6e-27
 Identities = 42/212 (19%), Positives = 89/212 (41%), Gaps = 16/212 (7%)

Query: 136 KFKHRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLL 194
               +LG G + +V+  K + N   VA+K++   K   +   +E+  + R++     +  
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 195 GFCSEGTRRAL----------VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVA 244
              +    + L          V+  M    L + + +      HR +    +K+I+  + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 245 RGVEYLHQGCNQRILHFDIKPHNILLDHN-FQPKISDFGLAKLCSKDISIVSLTAARGTA 303
            G++Y+H+ C   I+H DIKP N+L++       +    +A L +        T +  T 
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 304 GYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
            Y +PE+           +D++S   ++ E++
Sbjct: 194 EYRSPEVLLG--APWGCGADIWSTACLIFELI 223

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 35/219 (15%)

Query: 127 YKELKKITSKFKHRLGQGGYGSVFRGK-LFNGIPVAVKML---EHLKGNGQEFINEVATI 182
           Y+ LK I        G G  G V           VA+K L      + + +    E+  +
Sbjct: 19  YQNLKPI--------GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 183 GRIHHFHIVRLLGFCS------EGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKL 236
             ++H +I+ LL   +      E     LV E M     +              L  E++
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---------QMELDHERM 121

Query: 237 KKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSL 296
             + + +  G+++LH        H D+KP NI++  +   KI DFGLA+          +
Sbjct: 122 SYLLYQMLCGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MM 175

Query: 297 TAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMV 335
           T    T  Y APE+            D++S G ++ EMV
Sbjct: 176 TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMV 212

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 50/229 (21%), Positives = 100/229 (43%), Gaps = 31/229 (13%)

Query: 125 YTYKELKK----ITSKFK--HRLGQGGYGSVFRGK-LFNGIPVAVKMLEHLKGNG---QE 174
           +  +EL K    +  +++    +G G YGSV        G+ VAVK L     +    + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 175 FINEVATIGRIHHFHIVRLLGFCSEGTRRA-----LVYEFMPNGSLEKFIFSKTNSSSHR 229
              E+  +  + H +++ LL   +            +   +    L   +         +
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQ 116

Query: 230 PLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK 289
            L+ + ++ + + + RG++Y+H      I+H D+KP N+ ++ + + KI DFGLA+    
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173

Query: 290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCR 338
           ++     T    T  Y APE+   N+   +   D++S G ++ E++  R
Sbjct: 174 EM-----TGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 1e-19
 Identities = 30/213 (14%), Positives = 58/213 (27%), Gaps = 47/213 (22%)

Query: 140 RLGQGGYGSVFRGKLFNGIPVAVKMLE-----------HLKGNGQEFINEVATIGRIHHF 188
            +G+G   +VF           VK  +                   F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 189 HIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVE 248
            + +L G           Y +  N  L + I +K        +  E   ++   +   V 
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMILEEVA 117

Query: 249 YLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAP 308
             +    + I+H D+  +N+L+       I DF                 +         
Sbjct: 118 KFYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQ---------------SVEVGEEGWR 158

Query: 309 ELFSRNFGEV--------SYKSDVYSYGMMLLE 333
           E+  R+   +          + D+ S    +L+
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	344
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.38
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.96
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.81
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.7

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-52  Score=363.39  Aligned_cols=198  Identities=30%  Similarity=0.406  Sum_probs=170.9

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||+||+|+. .+|+.||||+++...  ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g   87 (271)
T d1nvra_           8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence            4568899999999999985 468999999997532  3346789999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++..      ...+++..++.++.|+++||+|||+   ++|+||||||+|||+++++++||+|||+|+.......
T Consensus        88 g~L~~~l~~------~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          88 GELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CcHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999843      2469999999999999999999999   9999999999999999999999999999997755433


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........||+.|||||++.+. ..++.++||||+||++|||++|+.||+.
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~  208 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ  208 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence            3334566799999999999764 2346789999999999999999999964

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=360.25  Aligned_cols=196  Identities=30%  Similarity=0.500  Sum_probs=164.5

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.+.||+|+||+||+|...++..||||+++......++|.+|++++++++||||++++|++.+++..++||||+++|+|
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            35678999999999999988888999999987777778999999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..++.++.|+|+||+|||+   ++|+||||||+|||+++++++||+|||+|+........ .
T Consensus        88 ~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          88 SDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             HHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             HHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            99986543     468999999999999999999999   99999999999999999999999999999876554322 2


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .....||+.|+|||++.+.  .++.++|||||||++|||+|++.|+.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~  203 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPY  203 (263)
T ss_dssp             ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCC
Confidence            2345689999999999875  78999999999999999999655553

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=363.15  Aligned_cols=198  Identities=30%  Similarity=0.479  Sum_probs=173.0

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.+.||+|+||+||+|.+.++..||||+++......++|.+|++++++++|||||+++|++.+ +..++||||+++|
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g   92 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG   92 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence            345678899999999999998888899999998777777899999999999999999999998865 4578999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....    ..+++..++.++.||++||+|||+   ++|+||||||+||||++++.+||+|||+|+........
T Consensus        93 ~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          93 SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             BHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             cHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99998854332    358999999999999999999999   99999999999999999999999999999987654322


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                       ......||+.|||||++.+.  .++.++|||||||++|||+||+.|+.
T Consensus       166 -~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~  211 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPY  211 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             -cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCC
Confidence             23456789999999998764  78999999999999999999777654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-51  Score=364.15  Aligned_cols=205  Identities=31%  Similarity=0.512  Sum_probs=179.7

Q ss_pred             HHHHHHHhhcccccccCcEEEEEEEEe-CCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          129 ELKKITSKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       129 ~l~~~~~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      |+....+.+.++||+|+||+||+|+.. +++.||||+++......++|.+|+.+|++++|||||+++|++.+++..++||
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            444444566789999999999999864 5889999999877777889999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++.....    ..+++..++.++.||++||+|||+   ++|+||||||+||||++++++||+|||+|+..
T Consensus        93 E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          93 EFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             ECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             ecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence            99999999999976432    569999999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..+... ......||+.|+|||++.+.  .++.++|||||||++|||++|+.|+.+
T Consensus       166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         166 TGDTYT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             CSSSSE-EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCCce-eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            654332 23445689999999998764  789999999999999999998877643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=359.76  Aligned_cols=197  Identities=31%  Similarity=0.512  Sum_probs=163.3

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.+.||+|+||+||+|+..  ..||||+++..   ....+.|.+|+.+|++++||||++++|++.+ +..++||||+++
T Consensus        11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~   87 (276)
T d1uwha_          11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG   87 (276)
T ss_dssp             CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCE
T ss_pred             EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCC
Confidence            45678999999999999743  36999999743   3344789999999999999999999998765 568999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....     ..+++..+..++.||++||+|||+   ++|+||||||+||||+.++++||+|||+|+.......
T Consensus        88 g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          88 SSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999996543     459999999999999999999999   9999999999999999999999999999987765443


Q ss_pred             ceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ........||+.|||||++... .+.++.++|||||||++|||+||+.||..
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence            3344566799999999998643 23578999999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=352.99  Aligned_cols=194  Identities=26%  Similarity=0.426  Sum_probs=173.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+++.||+|++...    ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            45668899999999999986 46889999998642    33457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..+..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+|+....
T Consensus        88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999654      358999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..    .....||+.|||||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             Cc----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence            32    2456799999999999875  689999999999999999999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=356.74  Aligned_cols=195  Identities=25%  Similarity=0.389  Sum_probs=173.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            34567899999999999984 568999999997543 4457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++..       ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+|+.......
T Consensus       102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999998754       258999999999999999999999   9999999999999999999999999999997754432


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~  218 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCC
Confidence              22456799999999999874  789999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=358.08  Aligned_cols=198  Identities=26%  Similarity=0.400  Sum_probs=171.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            45678899999999999985 46899999999742    34457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999998654      359999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...........||+.|||||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCC
Confidence            4433334456799999999999775  789999999999999999999999964

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-50  Score=359.60  Aligned_cols=209  Identities=29%  Similarity=0.503  Sum_probs=164.4

Q ss_pred             cCHHHHHHHHHhh-----------cccccccCcEEEEEEEEeC-C---ceEEEEEeeccc--cchHHHHHHHHHHhhhcc
Q 041350          125 YTYKELKKITSKF-----------KHRLGQGGYGSVFRGKLFN-G---IPVAVKMLEHLK--GNGQEFINEVATIGRIHH  187 (344)
Q Consensus       125 ~~~~~l~~~~~~~-----------~~~lG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h  187 (344)
                      ++|+++.+++.+|           .+.||+|+||+||+|+... +   ..||||.+....  ...++|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            4555666666555           3579999999999998542 3   358999886532  334689999999999999


Q ss_pred             cceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 041350          188 FHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHN  267 (344)
Q Consensus       188 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~N  267 (344)
                      ||||+++|++.+++..++||||+++|+|.+++....     ..+++.+++.++.|||+||+|||+   ++|+||||||+|
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~N  158 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARN  158 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccce
Confidence            999999999999999999999999999999986433     469999999999999999999999   999999999999


Q ss_pred             eEEcCCCceEEeecCCcccccCCccce---eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          268 ILLDHNFQPKISDFGLAKLCSKDISIV---SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       268 ill~~~~~~kl~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||+.++++||+|||+|+.........   ......||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCC
Confidence            999999999999999999775543221   12234579999999998764  78999999999999999998 8888853

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=348.55  Aligned_cols=192  Identities=28%  Similarity=0.465  Sum_probs=165.9

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc----CCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE----GTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  207 (344)
                      +|.++||+|+||+||+|+.. +++.||+|.+....   ...+.+.+|+++|++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999854 58899999997543   234678999999999999999999999864    35679999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceEEc-CCCceEEeecCCc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQR--ILHFDIKPHNILLD-HNFQPKISDFGLA  284 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~--ivH~Dik~~Nill~-~~~~~kl~Dfgla  284 (344)
                      ||+++|+|.+++...      ..+++..++.++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||+|
T Consensus        92 E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             eCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            999999999999654      358999999999999999999998   66  99999999999996 5889999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +......    .....||+.|||||++.+   .++.++|||||||++|||++|+.||..
T Consensus       163 ~~~~~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         163 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eeccCCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence            8654432    235679999999999865   588999999999999999999999953

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=347.23  Aligned_cols=197  Identities=26%  Similarity=0.455  Sum_probs=176.7

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCCH
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGSL  215 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  215 (344)
                      .+.++||+|+||+||+|+..+++.||||+++......++|.+|+.++++++||||++++|++.+++..++||||+++|+|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            36688999999999999988888999999998777788999999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcccee
Q 041350          216 EKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVS  295 (344)
Q Consensus       216 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  295 (344)
                      .+++....     ..+++..+.+++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++........ .
T Consensus        87 ~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~  157 (258)
T d1k2pa_          87 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S  157 (258)
T ss_dssp             HHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred             HHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence            99986543     458999999999999999999999   99999999999999999999999999999876554322 2


Q ss_pred             eecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          296 LTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       296 ~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .....||+.|+|||++.+.  .++.++||||||+++|||+| |+.||..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~  204 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER  204 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCC
Confidence            3456789999999999865  78999999999999999998 7888864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-51  Score=366.71  Aligned_cols=195  Identities=27%  Similarity=0.413  Sum_probs=170.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.++||+|+||+||+|+. .+|+.||+|+++...  ...+.+.+|+.+|++++|||||++++++.+.++.++||||++
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            34567899999999999985 468999999997532  334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +|+|.+++...      ..+++..+..++.|+++||+|||+  .++|+||||||+|||+++++++||+|||+|+......
T Consensus        88 gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          88 GGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             TEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             CCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            99999999654      358999999999999999999996  1489999999999999999999999999999765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                          .....||+.|||||++.+.  .++.++||||+||++|||++|+.||.+
T Consensus       160 ----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         160 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             ----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             ----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence                2346799999999999875  799999999999999999999999964

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=355.40  Aligned_cols=199  Identities=24%  Similarity=0.429  Sum_probs=172.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc-ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL-KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            34567899999999999985 46889999999754 34457899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++....     ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++++||+|||+|+.......
T Consensus        94 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          94 GAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999986543     469999999999999999999999   9999999999999999999999999999986543321


Q ss_pred             ceeeecccCCcccccccccccc---cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRN---FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......||+.|||||++...   ...++.++|||||||++|||++|+.||..
T Consensus       166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~  217 (288)
T d2jfla1         166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE  217 (288)
T ss_dssp             --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence              12356799999999998432   23678999999999999999999999964

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=354.88  Aligned_cols=203  Identities=27%  Similarity=0.381  Sum_probs=159.7

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEc--CCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSE--GTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  208 (344)
                      +++.+.||+|+||+||+|+. .+|+.||||.++...   ...+.+.+|++++++++||||+++++++.+  +...++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            34568899999999999985 568999999997543   233678999999999999999999999865  456899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGC--NQRILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      |+++|+|.+++.....  ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||+++++.+||+|||+|+.
T Consensus        86 y~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          86 YCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             CCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             cCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999865321  1246999999999999999999999821  13599999999999999999999999999998


Q ss_pred             ccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          287 CSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       287 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...+...  .....||+.|||||++.+.  .++.++|||||||++|||++|+.||+.
T Consensus       164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         164 LNHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence            7654322  2456799999999999764  789999999999999999999999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-49  Score=355.75  Aligned_cols=195  Identities=25%  Similarity=0.368  Sum_probs=170.3

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc----hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN----GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+...++||+|+||+||+|+. .+|+.||||+++.....    .+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            345567899999999999984 56889999999754322    2568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|..++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||+++++++||+|||+|+...
T Consensus        96 ~~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          96 YCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             CCSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999998776432      469999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccceeeecccCCcccccccccccc-cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRN-FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..      ....||+.|||||++.+. .+.++.++|||||||++|||++|+.||..
T Consensus       167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~  216 (309)
T d1u5ra_         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (309)
T ss_dssp             SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence            43      345699999999998642 24688999999999999999999999853

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=357.84  Aligned_cols=206  Identities=31%  Similarity=0.492  Sum_probs=172.5

Q ss_pred             HHHhhcccccccCcEEEEEEEEeC-C-----ceEEEEEeecc--ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeE
Q 041350          133 ITSKFKHRLGQGGYGSVFRGKLFN-G-----IPVAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRR  203 (344)
Q Consensus       133 ~~~~~~~~lG~G~fG~Vy~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  203 (344)
                      ..+.+.+.||+|+||+||+|+... +     ..||+|.+...  ....+.+.+|+.++.++ +|||||+++|++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            344567899999999999998543 2     36999998643  33446899999999999 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNS-----------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPH  266 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~  266 (344)
                      ++||||+++|+|.++|......                 .....+++..++.++.|+++||+|||+   ++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence            9999999999999999764321                 112458999999999999999999999   99999999999


Q ss_pred             ceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          267 NILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       267 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      |||++.++++||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||+| |+.||..
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999977665444444556789999999998764  78999999999999999997 8999853

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=346.98  Aligned_cols=193  Identities=31%  Similarity=0.501  Sum_probs=165.7

Q ss_pred             cccccCcEEEEEEEEe---CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCCC
Q 041350          140 RLGQGGYGSVFRGKLF---NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNGS  214 (344)
Q Consensus       140 ~lG~G~fG~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  214 (344)
                      +||+|+||+||+|...   ++..||||+++...  ...++|.+|+++|++++|||||+++|++.++ ..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCc
Confidence            4999999999999743   35579999997543  3347899999999999999999999998754 5789999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc-
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI-  293 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  293 (344)
                      |.+++....     ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||+|+........ 
T Consensus        95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            999985432     469999999999999999999999   99999999999999999999999999999977554322 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .......||+.|||||++...  .++.++|||||||++|||+| |+.||..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~  215 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK  215 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCC
Confidence            222345689999999998764  78999999999999999998 8999863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=346.22  Aligned_cols=193  Identities=29%  Similarity=0.461  Sum_probs=163.1

Q ss_pred             ccccccCcEEEEEEEEeC---CceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKLFN---GIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      ++||+|+||+||+|...+   ++.||||+++...   ...++|.+|+++|++++|||||+++|+|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            469999999999998643   4679999997432   2246799999999999999999999998654 57899999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      |+|.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            9999999653      359999999999999999999999   9999999999999999999999999999997655433


Q ss_pred             ce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          293 IV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       293 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .. ......||+.|||||++.+.  .++.++|||||||++|||++ |+.||..
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~  213 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG  213 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCC
Confidence            22 22345689999999999764  78999999999999999997 8999853

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-49  Score=353.23  Aligned_cols=195  Identities=29%  Similarity=0.419  Sum_probs=156.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.+.+.||+|+||+||+|+.. +|+.||||++....  ...+.+.+|+.+|++++||||+++++++.+++..++||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            456788999999999999854 68899999997532  233568899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc---CCCceEEeecCCccccc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCS  288 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfgla~~~~  288 (344)
                      +|+|.+++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||+.   +++.+||+|||+|+...
T Consensus        91 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          91 GGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             SCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             CCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999542      469999999999999999999999   9999999999999994   57899999999998765


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence            4322   2346799999999999875  789999999999999999999999964

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-48  Score=349.49  Aligned_cols=193  Identities=28%  Similarity=0.399  Sum_probs=172.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +++.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            34568899999999999985 56899999999742    34457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|..++...      ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999998654      357899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..     ....||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       157 ~~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         157 VT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             CB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cc-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCC
Confidence            32     346799999999999775  688999999999999999999999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=348.70  Aligned_cols=198  Identities=29%  Similarity=0.458  Sum_probs=167.5

Q ss_pred             HHhhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      .+.+.+.||+|+||+||+|+..++..||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g   96 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG   96 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence            356778899999999999998888899999998777777899999999999999999999999865 5578999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISI  293 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  293 (344)
                      +|.+++.....    ..++|.+++.++.||+.||+|||+   ++|+||||||+||||++++++||+|||+|+....... 
T Consensus        97 ~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          97 SLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             BHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             chhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            99999865432    358999999999999999999999   9999999999999999999999999999987654432 


Q ss_pred             eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          294 VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       294 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......||+.|+|||++...  .++.++||||||+++|||++|+.|+.
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             eeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCC
Confidence            223446689999999999764  78999999999999999999777764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=350.57  Aligned_cols=196  Identities=26%  Similarity=0.351  Sum_probs=174.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+|++++||||+++++++.+...+++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            34568899999999999985 56899999999742    34457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +++|+|.+++...      ..+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999654      358999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...  ......||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~  207 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCC
Confidence            322  22456799999999999875  789999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=343.98  Aligned_cols=197  Identities=29%  Similarity=0.518  Sum_probs=161.2

Q ss_pred             hhcccccccCcEEEEEEEEeCC-----ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNG-----IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      .+.+.||+|+||+||+|+..+.     ..||||+++...  ....+|.+|+.++++++|||||+++|++.+....++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            3467899999999999986542     479999997533  233578999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+.+++|.+++....     ..+++.+++.++.|++.||+|||+   ++|+||||||+||||+.++.+||+|||+|+...
T Consensus        90 ~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          90 YMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             CCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999886543     469999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          289 KDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..... .......||+.|||||++.+.  .++.++|||||||++|||++|+.|+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCcc
Confidence            43221 222345689999999998764  78999999999999999999777654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.5e-48  Score=351.65  Aligned_cols=197  Identities=24%  Similarity=0.395  Sum_probs=172.9

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.+.+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++||||+++++++.+++..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            355678899999999999985 568999999997543 334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc--CCCceEEeecCCcccccC
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~--~~~~~kl~Dfgla~~~~~  289 (344)
                      +|+|.+++....     ..+++..+..++.||+.||+|||+   ++|+||||||+|||++  .++.+||+|||+|+....
T Consensus       107 gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         107 GGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             SCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999985332     469999999999999999999999   9999999999999996  467899999999987765


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       179 ~~~---~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         179 KQS---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             TSC---EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccc---cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence            432   2346799999999999875  788999999999999999999999964

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.5e-48  Score=350.60  Aligned_cols=196  Identities=24%  Similarity=0.378  Sum_probs=173.1

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +++.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|++++||||+++++++.+++..++||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            55678999999999999985 569999999997543 3346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc--CCCceEEeecCCcccccCC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD--HNFQPKISDFGLAKLCSKD  290 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~--~~~~~kl~Dfgla~~~~~~  290 (344)
                      |+|.+++...     ...+++.+++.++.||+.||+|||+   .+|+||||||+||||+  .++.+||+|||+|+....+
T Consensus       111 g~L~~~~~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         111 GELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             ChHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999987433     2469999999999999999999999   9999999999999998  6789999999999987655


Q ss_pred             ccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          291 ISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       291 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             Cc---eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            32   2345699999999999875  789999999999999999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=340.49  Aligned_cols=196  Identities=26%  Similarity=0.395  Sum_probs=172.3

Q ss_pred             HHhhcccccccCcEEEEEEEE-eCCceEEEEEeeccc-------cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK-------GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRAL  205 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  205 (344)
                      .+.+.+.||+|+||+||+|+. .+|+.||||+++...       ...+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            345678899999999999985 468999999986421       234789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC----ceEEeec
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF----QPKISDF  281 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~----~~kl~Df  281 (344)
                      ||||+++|+|.+++...      ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        91 v~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          91 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999654      359999999999999999999999   9999999999999998776    4999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+|+.......   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCC
Confidence            99987754422   2345689999999999764  789999999999999999999999964

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-47  Score=346.94  Aligned_cols=193  Identities=22%  Similarity=0.283  Sum_probs=172.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEec
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            45568899999999999985 46999999999642    24457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccC
Q 041350          210 MPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  289 (344)
                      +.+|+|.+++....      .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+|+....
T Consensus       123 ~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         123 VAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             CTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999996543      58999999999999999999999   9999999999999999999999999999997654


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..     ....||+.|||||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       194 ~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCC
Confidence            32     345699999999999875  789999999999999999999999964

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-47  Score=346.59  Aligned_cols=194  Identities=25%  Similarity=0.357  Sum_probs=166.9

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc----cchHHHHH---HHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK----GNGQEFIN---EVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+. .+|+.||||++....    .....+.+   |+.+++.++||||+++++++.+.+..++||
T Consensus         7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm   86 (364)
T d1omwa3           7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL   86 (364)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence            4568899999999999985 468999999996421    22233444   467777788999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++...      ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          87 DLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             CCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999654      358899999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....    .....||+.|||||++.+. ..++.++|||||||++|||++|+.||+.
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~  208 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQ  208 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence            6542    2456799999999998653 3688999999999999999999999964

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-47  Score=339.96  Aligned_cols=196  Identities=24%  Similarity=0.332  Sum_probs=171.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecc----ccchHHHHHHHHHHh-hhcccceeeEeeEEEcCCeEEEEEe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL----KGNGQEFINEVATIG-RIHHFHIVRLLGFCSEGTRRALVYE  208 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e  208 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            34678999999999999985 46899999999742    344567778877765 6899999999999999999999999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....      .+++..++.++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+...
T Consensus        84 y~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          84 YLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             CCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             ecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999996543      58999999999999999999999   999999999999999999999999999998665


Q ss_pred             CCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....  ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||..
T Consensus       155 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         155 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            4322  22456799999999999875  789999999999999999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=339.72  Aligned_cols=196  Identities=20%  Similarity=0.286  Sum_probs=172.6

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPNG  213 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  213 (344)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++........+.+|+++|++++||||+++++++.+++..++||||+++|
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg   86 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence            34568899999999999985 46889999999876655667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC--CceEEeecCCcccccCCc
Q 041350          214 SLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN--FQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       214 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~--~~~kl~Dfgla~~~~~~~  291 (344)
                      +|.+++....     ..+++.++..++.||+.||+|||+   .+|+||||||+|||++.+  ..+||+|||+++......
T Consensus        87 ~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          87 DIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             BHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999995432     369999999999999999999999   999999999999999854  589999999998765443


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .   .....+|+.|+|||.+.+.  .++.++||||+||++|||++|+.||..
T Consensus       159 ~---~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         159 N---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             c---ccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCC
Confidence            2   2345689999999998775  788999999999999999999999964

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=339.71  Aligned_cols=202  Identities=29%  Similarity=0.454  Sum_probs=169.9

Q ss_pred             hhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+.+.||+|+||+||+|+..      +++.||||+++....  ..++|.+|++++++++||||+++++++.+....+++|
T Consensus        16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~   95 (301)
T d1lufa_          16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF   95 (301)
T ss_dssp             EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence            45688999999999999853      357899999975332  2467999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHhccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceE
Q 041350          208 EFMPNGSLEKFIFSKTNS------------------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNIL  269 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nil  269 (344)
                      ||+++|+|.+++......                  .....+++..++.++.|++.||+|||+   ++|+||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceE
Confidence            999999999999754321                  112458999999999999999999999   99999999999999


Q ss_pred             EcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCC-CCC
Q 041350          270 LDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK-NKD  342 (344)
Q Consensus       270 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~-p~~  342 (344)
                      ++.++++||+|||+|+...............||+.|+|||.+.+.  .++.++|||||||++|||++|.. |+.
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999876554433334456789999999999875  79999999999999999999965 554

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=340.48  Aligned_cols=198  Identities=29%  Similarity=0.491  Sum_probs=163.5

Q ss_pred             HhhcccccccCcEEEEEEEEe-CCc----eEEEEEeecc--ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF-NGI----PVAVKMLEHL--KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      +++.+.||+|+||+||+|+.. +|+    .||+|.++..  ....++|.+|++++++++|||||+++|+|.++. .++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEE
Confidence            345688999999999999753 343    5899988643  344578999999999999999999999998754 67888


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+.+|+|.+++....     ..+++..++.++.|||+||+|||+   ++|+||||||+|||++.++++||+|||+|+..
T Consensus        90 e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          90 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             ECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            9999999999886543     468999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      .............||+.|||||++.+.  .++.++|||||||++|||+| |+.|++.
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~  216 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDG  216 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence            655444434456789999999998764  78999999999999999998 6777753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-46  Score=329.24  Aligned_cols=197  Identities=26%  Similarity=0.359  Sum_probs=171.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccc----------hHHHHHHHHHHhhhc-ccceeeEeeEEEcCCe
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN----------GQEFINEVATIGRIH-HFHIVRLLGFCSEGTR  202 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  202 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++.....          .+.+.+|+.++++++ ||||+++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            34568899999999999985 56899999999753211          245889999999997 9999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      .++||||+++|||.+++...      ..+++..++.++.||++||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999653      359999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccc----cCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRN----FGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +++.......   .....||+.|+|||++.+.    ...++.++||||+||++|||++|+.||..
T Consensus       156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~  217 (277)
T d1phka_         156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  217 (277)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence            9998765432   2446799999999998632    23568899999999999999999999964

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=335.71  Aligned_cols=198  Identities=24%  Similarity=0.431  Sum_probs=157.1

Q ss_pred             HHhhcccccccCcEEEEEEEEeC----CceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN----GIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      .+++.+.||+|+||+||+|+...    +..||||.++....  ..+.|.+|+.++++++||||++++|++.+ +..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence            34567889999999999997532    35689998865332  34679999999999999999999999864 5789999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.||++||+|||+   ++|+||||||+||++++++.+||+|||+|+..
T Consensus        87 E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          87 ELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             ECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999886543     468999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~~  343 (344)
                      ...... ......||+.|+|||++.+.  .++.++|||||||++|||++ |+.|++.
T Consensus       159 ~~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~  212 (273)
T d1mp8a_         159 EDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG  212 (273)
T ss_dssp             -------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cCCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCC
Confidence            544322 23455689999999999764  78999999999999999997 7888764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=339.94  Aligned_cols=204  Identities=32%  Similarity=0.489  Sum_probs=161.1

Q ss_pred             HHhhcccccccCcEEEEEEEEe------CCceEEEEEeeccc--cchHHHHHHHHHHhhh-cccceeeEeeEEEcC-CeE
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLK--GNGQEFINEVATIGRI-HHFHIVRLLGFCSEG-TRR  203 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~  203 (344)
                      .+.+.++||+|+||+||+|+..      +++.||||+++...  ...+.+.+|...+.++ +|+||+.+++++.+. ...
T Consensus        14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~   93 (299)
T d1ywna1          14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   93 (299)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred             HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence            4556788999999999999753      34689999997532  3346788899988888 689999999998664 468


Q ss_pred             EEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHN  273 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~  273 (344)
                      ++||||+++|+|.+++......          .....+++..++.++.||++||+|||+   ++|+||||||+||||+++
T Consensus        94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCC
Confidence            9999999999999999754321          123468999999999999999999999   999999999999999999


Q ss_pred             CceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCC-CCC
Q 041350          274 FQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK-NKD  342 (344)
Q Consensus       274 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~-p~~  342 (344)
                      +++||+|||+|+...............||+.|||||++.+.  .++.++|||||||++|||++|.. |+.
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCC
Confidence            99999999999876655444344556799999999999774  78999999999999999998765 553

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=338.58  Aligned_cols=219  Identities=31%  Similarity=0.520  Sum_probs=181.8

Q ss_pred             ccCCcccCH---HHHHHHHHhhcccccccCcEEEEEEEEe------CCceEEEEEeecccc--chHHHHHHHHHHhhh-c
Q 041350          119 TVNPTRYTY---KELKKITSKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKG--NGQEFINEVATIGRI-H  186 (344)
Q Consensus       119 ~~~~~~~~~---~~l~~~~~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~  186 (344)
                      ...|..+++   +|+....+.+.+.||+|+||.||+|+..      +++.||||+++....  ...+|.+|+.+++++ +
T Consensus         6 ~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~   85 (311)
T d1t46a_           6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN   85 (311)
T ss_dssp             CCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCC
T ss_pred             eeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccC
Confidence            344555544   3454555667889999999999999752      356899999975433  345789999999999 6


Q ss_pred             ccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 041350          187 HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFSKTNS------------SSHRPLSWEKLKKIAFGVARGVEYLHQGC  254 (344)
Q Consensus       187 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  254 (344)
                      |||||+++|++.+....++||||+++|+|.+++......            .....+++..+..++.||++||+|||+  
T Consensus        86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--  163 (311)
T d1t46a_          86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--  163 (311)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred             CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--
Confidence            999999999999999999999999999999999765421            123468999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHH
Q 041350          255 NQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEM  334 (344)
Q Consensus       255 ~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~el  334 (344)
                       ++++||||||+|||++.++.+|++|||+++...............||+.|+|||++.+.  .++.++||||||+++|||
T Consensus       164 -~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~el  240 (311)
T d1t46a_         164 -KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWEL  240 (311)
T ss_dssp             -TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHH
T ss_pred             -CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHH
Confidence             99999999999999999999999999999987665444444567799999999999764  789999999999999999


Q ss_pred             HcCCCCCC
Q 041350          335 VGCRKNKD  342 (344)
Q Consensus       335 l~g~~p~~  342 (344)
                      +|++.|+.
T Consensus       241 lt~g~p~~  248 (311)
T d1t46a_         241 FSLGSSPY  248 (311)
T ss_dssp             HTTTCCSS
T ss_pred             HhCCCCCC
Confidence            99666653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=334.58  Aligned_cols=198  Identities=29%  Similarity=0.517  Sum_probs=167.8

Q ss_pred             hhcccccccCcEEEEEEEEeCC----ceEEEEEeeccc--cchHHHHHHHHHHhhhcccceeeEeeEEEc-CCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNG----IPVAVKMLEHLK--GNGQEFINEVATIGRIHHFHIVRLLGFCSE-GTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  208 (344)
                      +|.++||+|+||+||+|++.++    ..||||+++...  ...++|.+|+++|++++||||++++|++.+ +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999986442    368999997532  334679999999999999999999999875 568899999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+++|+|.+++....     ..+++..+++++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       110 ~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             CCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            999999999986543     457889999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....  .......||+.|+|||.+...  .++.++||||||+++|||++|+.|+..
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence            43221  112335689999999998764  789999999999999999998888753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=335.83  Aligned_cols=193  Identities=27%  Similarity=0.348  Sum_probs=163.8

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccccc------hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGN------GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      +.||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999985 46899999998643211      2468899999999999999999999999999999999998


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      ++++..+..      ....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+|+......
T Consensus        84 ~~~~~~~~~------~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          84 TDLEVIIKD------NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEHHHHHTT------CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             chHHhhhhh------cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            887776652      22468899999999999999999999   999999999999999999999999999998765543


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..  .....||+.|+|||++... ..++.++||||+||++|||++|+.||..
T Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         155 RA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             CC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cc--ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence            22  2345799999999998654 3678999999999999999999999853

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=335.32  Aligned_cols=198  Identities=26%  Similarity=0.396  Sum_probs=160.9

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEEEEeccCC
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRALVYEFMPN  212 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  212 (344)
                      +.++||+|+||+||+|+ .+|+.||||+++........+..|+..+.+++||||++++|++.+.+    .+++||||+++
T Consensus         7 l~~~iG~G~fg~Vy~~~-~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECCSSSEEEEEE-ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEE-ECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            46789999999999998 57899999999754333233344556667889999999999997643    67999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG-----CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      |+|.++++..       .++|..++.++.|+|.||+|||+.     ..++|+||||||+||||++++++||+|||+++..
T Consensus        86 g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          86 GSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999642       489999999999999999999962     1369999999999999999999999999999977


Q ss_pred             cCCccce--eeecccCCcccccccccccccC----CCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISIV--SLTAARGTAGYIAPELFSRNFG----EVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......  ......||+.|||||++.+...    .++.++|||||||++|||+||..|+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            5543221  2235679999999999865311    25778999999999999999988763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-46  Score=330.74  Aligned_cols=198  Identities=25%  Similarity=0.352  Sum_probs=162.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc----chHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG----NGQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l  205 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++....    ..+.+.+|++++++++||||+++++++...+    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            45678899999999999985 5689999999975322    2357899999999999999999999986543    4789


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+++++|.+++...      ..+++.+++.++.||++||+|||+   ++|+||||||+|||++.++..+|+|||.++
T Consensus        89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence            99999999999998654      358999999999999999999999   999999999999999999999999999987


Q ss_pred             cccCCcc-ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDIS-IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....... ........||+.|||||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCC
Confidence            6543321 1223456799999999999764  789999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=330.46  Aligned_cols=191  Identities=31%  Similarity=0.512  Sum_probs=158.8

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEcC-CeEEEEEeccCCCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSEG-TRRALVYEFMPNGS  214 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gs  214 (344)
                      .+.+.||+|+||+||+|+. .|..||||+++.. ...++|.+|++++++++||||++++|++.+. +..++||||+++|+
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            4668899999999999985 6889999999754 4457899999999999999999999999654 56899999999999


Q ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCccce
Q 041350          215 LEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDISIV  294 (344)
Q Consensus       215 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  294 (344)
                      |.+++.....    ..+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++......   
T Consensus        88 L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          88 LVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             HHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcCC----CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            9999965432    358999999999999999999999   999999999999999999999999999998765432   


Q ss_pred             eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          295 SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       295 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                        ....+|+.|+|||++.+.  .++.++||||||+++|||+| |+.|++
T Consensus       158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~  202 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYP  202 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence              344688999999999764  78999999999999999998 566654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=336.27  Aligned_cols=188  Identities=27%  Similarity=0.333  Sum_probs=163.1

Q ss_pred             ccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhh-cccceeeEeeEEEc----CCeEEEEEeccCC
Q 041350          139 HRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRI-HHFHIVRLLGFCSE----GTRRALVYEFMPN  212 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~~  212 (344)
                      +.||+|+||+||+|+. .+++.||||+++.    ...+.+|+.++.++ +||||+++++++.+    +...++|||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999985 5689999999964    34677899987665 89999999999865    4678999999999


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC---CCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH---NFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~---~~~~kl~Dfgla~~~~~  289 (344)
                      |+|.+++....    ...+++.+++.++.||+.||+|||+   .+|+||||||+|||+++   ++.+||+|||+|+....
T Consensus        94 g~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          94 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccC
Confidence            99999996532    2469999999999999999999999   99999999999999985   56799999999987665


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ...   .....||+.|||||++.+.  .++.++||||+||++|||++|+.||.
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         167 HNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             CCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred             CCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCC
Confidence            432   2456799999999999875  78999999999999999999999984

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=328.09  Aligned_cols=196  Identities=29%  Similarity=0.415  Sum_probs=158.1

Q ss_pred             hhcccccccCcEEEEEEEEeC--C--ceEEEEEeecc----ccchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLFN--G--IPVAVKMLEHL----KGNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVY  207 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~--~--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  207 (344)
                      ++.+.||+|+||+||+|+...  +  ..||||+++..    ....++|.+|+.+|++++||||++++|++.++ ..++||
T Consensus        11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~   89 (273)
T d1u46a_          11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVT   89 (273)
T ss_dssp             EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheee
Confidence            456789999999999997532  2  37899998743    22346899999999999999999999999764 678999


Q ss_pred             eccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          208 EFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       208 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      ||+++|+|.+++....     ..+++..++.++.|+++||+|||+   ++|+||||||+|||++.++++||+|||+++..
T Consensus        90 e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             ECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999886543     359999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCccce-eeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          288 SKDISIV-SLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       288 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ....... ......||+.|+|||++.+.  .++.++||||||+++|||+| |+.||.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            5543322 22344578899999999875  78999999999999999998 899985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=328.13  Aligned_cols=204  Identities=28%  Similarity=0.439  Sum_probs=168.6

Q ss_pred             HHhhcccccccCcEEEEEEEEeC--------CceEEEEEeecccc--chHHHHHHHHHHhhh-cccceeeEeeEEEcCCe
Q 041350          134 TSKFKHRLGQGGYGSVFRGKLFN--------GIPVAVKMLEHLKG--NGQEFINEVATIGRI-HHFHIVRLLGFCSEGTR  202 (344)
Q Consensus       134 ~~~~~~~lG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  202 (344)
                      .+.+.+.||+|+||+||+|+...        +..||||+++....  ...++.+|...+.++ +|||||+++++|.++..
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            44567889999999999997432        24799999975433  346889999999999 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC
Q 041350          203 RALVYEFMPNGSLEKFIFSKTNS----------SSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH  272 (344)
Q Consensus       203 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~  272 (344)
                      .++||||+++|+|.+++......          .....+++.+++.++.||+.||+|||+   .+|+||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence            99999999999999999755321          123568999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 041350          273 NFQPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVG-CRKNKD  342 (344)
Q Consensus       273 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~-g~~p~~  342 (344)
                      ++.+||+|||+++...............+|+.|+|||.+.+.  .++.++||||||+++|||++ |+.|+.
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            999999999999987665444444556789999999999764  89999999999999999998 576764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=327.79  Aligned_cols=197  Identities=28%  Similarity=0.454  Sum_probs=166.2

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      .+.++||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+++|++++||||+++++++.+++..++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            3457899999999999985 568999999996432   234789999999999999999999999999999999999996


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      + ++.+++....    ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+|+......
T Consensus        85 ~-~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          85 Q-DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             E-EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             C-chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            5 4555553322    2469999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .  ......||+.|+|||.+... ..++.++||||+||++|||++|+.||+.
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             c--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCC
Confidence            2  22345799999999988665 3568899999999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=325.89  Aligned_cols=195  Identities=29%  Similarity=0.387  Sum_probs=165.8

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc-------chHHHHHHHHHHhhhc--ccceeeEeeEEEcCCeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG-------NGQEFINEVATIGRIH--HFHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  204 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++....       ....+.+|+.++++++  ||||+++++++.+.+..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            45678899999999999985 4689999999874321       1234678999999997  899999999999999999


Q ss_pred             EEEeccCC-CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-CCceEEeecC
Q 041350          205 LVYEFMPN-GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-NFQPKISDFG  282 (344)
Q Consensus       205 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-~~~~kl~Dfg  282 (344)
                      +||||+.+ +++.+++...      ..+++..++.++.|++.||+|||+   ++|+||||||+|||++. ++.+||+|||
T Consensus        86 lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence            99999976 6888888543      358999999999999999999999   99999999999999985 5799999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +|+......    .+...||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCC
Confidence            998765432    2456799999999998764 2346789999999999999999999964

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=330.23  Aligned_cols=202  Identities=26%  Similarity=0.443  Sum_probs=171.4

Q ss_pred             HhhcccccccCcEEEEEEEEe------CCceEEEEEeeccccc--hHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKLF------NGIPVAVKMLEHLKGN--GQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  206 (344)
                      ..+.++||+|+||+||+|...      ++..||||+++.....  ...|.+|+.++++++||||++++|++......++|
T Consensus        22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv  101 (308)
T d1p4oa_          22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI  101 (308)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence            346688999999999999753      3578999999754322  24689999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecC
Q 041350          207 YEFMPNGSLEKFIFSKTN----SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFG  282 (344)
Q Consensus       207 ~e~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfg  282 (344)
                      |||+++|+|.+++.....    ......+++..+..++.|+|+||+|||+   ++|+||||||+|||+++++++||+|||
T Consensus       102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecc
Confidence            999999999999864321    1122457999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCC
Q 041350          283 LAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNK  341 (344)
Q Consensus       283 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~  341 (344)
                      +|+...............||+.|+|||.+.+.  .++.++||||||+++|||+||+.|+
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p  235 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQP  235 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCC
Confidence            99977655444444455689999999999775  7889999999999999999986443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-45  Score=325.47  Aligned_cols=196  Identities=27%  Similarity=0.393  Sum_probs=167.5

Q ss_pred             hhcccccccCcEEEEEEEEeCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccCC
Q 041350          136 KFKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      .+.++||+|+||+||+|+..+|+.||||+++...   ...+.+.+|+.+|++++||||+++++++.+.+..++++||+.+
T Consensus         5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence            3457899999999999998889999999996532   3347899999999999999999999999999999999999988


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCcc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDIS  292 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  292 (344)
                      +.+..+...      ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||.|........
T Consensus        85 ~~~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          85 DLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EHHHHHHTS------TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhHHHHHhh------cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            777766532      2569999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          293 IVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       293 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                        ......+++.|+|||.+.+. ..++.++||||+||++|||++|+.||.+
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence              22345689999999998764 4678999999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=329.99  Aligned_cols=199  Identities=31%  Similarity=0.549  Sum_probs=164.7

Q ss_pred             hhcccccccCcEEEEEEEEe-CCc--eEEEEEeecc--ccchHHHHHHHHHHhhh-cccceeeEeeEEEcCCeEEEEEec
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGI--PVAVKMLEHL--KGNGQEFINEVATIGRI-HHFHIVRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  209 (344)
                      ++.+.||+|+||+||+|+.. +|.  .||||.++..  ....++|.+|+++|+++ +||||++++|++.+++..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            35688999999999999854 344  5788887643  33456899999999999 799999999999999999999999


Q ss_pred             cCCCCHHHHHhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEe
Q 041350          210 MPNGSLEKFIFSKTN----------SSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKIS  279 (344)
Q Consensus       210 ~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~  279 (344)
                      +++|+|.++|+....          ......+++..+..++.|||+||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEc
Confidence            999999999975421          1223579999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCC-CCC
Q 041350          280 DFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRK-NKD  342 (344)
Q Consensus       280 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~-p~~  342 (344)
                      |||+|+.......   .....||+.|+|||.+.+.  .++.++|||||||++|||++|.. |+.
T Consensus       170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~  228 (309)
T d1fvra_         170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYC  228 (309)
T ss_dssp             CTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCC
Confidence            9999986543322   2345689999999999764  78999999999999999999776 453

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=321.77  Aligned_cols=196  Identities=31%  Similarity=0.471  Sum_probs=162.5

Q ss_pred             HhhcccccccCcEEEEEEEE-eC-CceEEEEEeeccc---cchHHHHHHHHHHhhh---cccceeeEeeEEEc-----CC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FN-GIPVAVKMLEHLK---GNGQEFINEVATIGRI---HHFHIVRLLGFCSE-----GT  201 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~  201 (344)
                      +++.++||+|+||+||+|+. .+ ++.||||+++...   .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            34567899999999999985 33 6679999986432   2234567788777766   79999999999853     34


Q ss_pred             eEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeec
Q 041350          202 RRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDF  281 (344)
Q Consensus       202 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df  281 (344)
                      ..+++|||++++++.......     ...+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+||
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             eEEEEEEeccCCchhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecch
Confidence            689999999887776554332     2468999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          282 GLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       282 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      |+++.......   .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||+.
T Consensus       161 g~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         161 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhhhhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCC
Confidence            99986554322   2456799999999999775  789999999999999999999999964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=321.05  Aligned_cols=197  Identities=27%  Similarity=0.399  Sum_probs=162.4

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecccc--chHHHHHHHHHHhhhcccceeeEeeEEEcCC----eEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG--NGQEFINEVATIGRIHHFHIVRLLGFCSEGT----RRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  208 (344)
                      .+.++||+|+||+||+|+. .+|+.||||+++....  ..+.+++|+++|++++||||+++++++....    ..+++++
T Consensus        11 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~   90 (345)
T d1pmea_          11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT   90 (345)
T ss_dssp             EEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred             EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE
Confidence            4558899999999999974 5799999999975432  3467899999999999999999999986543    2345556


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCccccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCS  288 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~  288 (344)
                      |+.+|+|.+++..       ..+++..++.++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+...
T Consensus        91 ~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          91 HLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             ECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            6779999999954       258999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccc-eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          289 KDISI-VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       289 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ..... .......||+.|+|||++... ..++.++||||+||++|||++|+.||+.
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCC
Confidence            43221 122456699999999998654 4678899999999999999999999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=319.11  Aligned_cols=199  Identities=24%  Similarity=0.290  Sum_probs=169.8

Q ss_pred             HhhcccccccCcEEEEEEEE----eCCceEEEEEeecc-----ccchHHHHHHHHHHhhhcc-cceeeEeeEEEcCCeEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL----FNGIPVAVKMLEHL-----KGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGTRRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~----~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~  204 (344)
                      +.+.+.||+|+||+||+|+.    .+|+.||||+++..     ....+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            55678999999999999974    24789999998642     2234678899999999977 79999999999999999


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      ++|||+.+|+|.+++....      .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+|
T Consensus       106 ~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999996553      47889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +......... .....|++.|+|||.+......++.++||||+||+||||++|+.||..
T Consensus       177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~  234 (322)
T d1vzoa_         177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  234 (322)
T ss_dssp             EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            8765443322 245679999999999976544678899999999999999999999954

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=316.50  Aligned_cols=198  Identities=24%  Similarity=0.344  Sum_probs=162.7

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeecc---ccchHHHHHHHHHHhhhcccceeeEeeEEEc--------CCeE
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHL---KGNGQEFINEVATIGRIHHFHIVRLLGFCSE--------GTRR  203 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~  203 (344)
                      .+.++||+|+||+||+|+. .+|+.||||++...   ....+++.+|+++|++++||||+++++.+..        ....
T Consensus        13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~   92 (318)
T d3blha1          13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI   92 (318)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence            4567899999999999985 56899999998643   2334788999999999999999999998855        3457


Q ss_pred             EEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCC
Q 041350          204 ALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGL  283 (344)
Q Consensus       204 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgl  283 (344)
                      ++||||++++++..+..      ....+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        93 ~iv~e~~~~~~~~~~~~------~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          93 YLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             EEEEECCCEEHHHHHTC------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCccchhhh------cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence            99999998877765542      23468999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccc--eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          284 AKLCSKDISI--VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       284 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ++........  .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            9876543221  122345699999999998754 3688999999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=320.81  Aligned_cols=195  Identities=27%  Similarity=0.333  Sum_probs=159.9

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccceeeEeeEEEc------CCeEEEEEe
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIVRLLGFCSE------GTRRALVYE  208 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~lv~e  208 (344)
                      +..++||+|+||+||+|+. .+|+.||||+++.....   ..+|+++|++++||||+++++++..      ....++|||
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            3457899999999999986 46899999999754322   3479999999999999999999854      235789999


Q ss_pred             ccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccc
Q 041350          209 FMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLC  287 (344)
Q Consensus       209 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~  287 (344)
                      |++++.+..+.....   ....+++..++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus       100 y~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_         100 YVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             CCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             ccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            998764444332211   12469999999999999999999999   9999999999999999765 8999999999876


Q ss_pred             cCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          288 SKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       288 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....   .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||..
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cCCcc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCC
Confidence            55432   2345799999999987654 3689999999999999999999999853

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.9e-43  Score=310.91  Aligned_cols=196  Identities=23%  Similarity=0.330  Sum_probs=167.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcc-cceeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH-FHIVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||+++... ..+.+.+|++.++.++| +|++.+++++.++...++||||+ +
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~   84 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G   84 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence            45678899999999999985 468999999986532 33467788999999965 89999999999999999999999 7


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcC-----CCceEEeecCCcccc
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDH-----NFQPKISDFGLAKLC  287 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~Dfgla~~~  287 (344)
                      ++|.+++....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        85 ~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          85 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             CCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            89999986543     358999999999999999999999   99999999999999974     578999999999976


Q ss_pred             cCCccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          288 SKDISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       288 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ......     .......||+.|||||++.+.  .++.++||||||+++|||++|+.||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            543221     123345799999999999875  78999999999999999999999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=319.28  Aligned_cols=192  Identities=25%  Similarity=0.381  Sum_probs=159.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEcCC------eEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSEGT------RRA  204 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~  204 (344)
                      +.+.++||+|+||+||+|.. .+|+.||||+++....   ..+.+.+|+++|++++|||||++++++...+      ..+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            34557899999999999985 4689999999975332   2357889999999999999999999997654      579


Q ss_pred             EEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCc
Q 041350          205 LVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLA  284 (344)
Q Consensus       205 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla  284 (344)
                      +||||+ +.+|..++..       ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+|++|||+|
T Consensus       100 lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence            999999 6678877643       359999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          285 KLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       285 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      +......     +...||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             eccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            8765442     456799999999998754 3578899999999999999999999864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=313.18  Aligned_cols=191  Identities=24%  Similarity=0.421  Sum_probs=165.2

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-ccceeeEeeEEEc--CCeEEEEEecc
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-HFHIVRLLGFCSE--GTRRALVYEFM  210 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e~~  210 (344)
                      +.+.++||+|+||+||+|+. .+|+.||||+++.  ...+++.+|+.+|++++ ||||+++++++..  ....++||||+
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~--~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH--HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            45668899999999999985 5689999999975  34578899999999995 9999999999874  45689999999


Q ss_pred             CCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC-ceEEeecCCcccccC
Q 041350          211 PNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF-QPKISDFGLAKLCSK  289 (344)
Q Consensus       211 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~  289 (344)
                      ++++|..+.         ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus       115 ~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         115 NNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             CSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             CCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999997764         458999999999999999999999   9999999999999998654 689999999987655


Q ss_pred             CccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ...   .....+|+.|+|||.+.+. ..++.++||||+||++|||++|+.||..
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCC
Confidence            432   2456689999999998764 3578999999999999999999999854

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=307.91  Aligned_cols=195  Identities=26%  Similarity=0.386  Sum_probs=169.3

Q ss_pred             hhcccccccCcEEEEEEEE-eCCceEEEEEeeccc---cchHHHHHHHHHHhhhcccceeeEeeEEEcCCeEEEEEeccC
Q 041350          136 KFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLK---GNGQEFINEVATIGRIHHFHIVRLLGFCSEGTRRALVYEFMP  211 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  211 (344)
                      ++.++||+|+||+||+|+. .+++.||||+++...   ...+.+.+|+.+++.++||||+++++++.+....++++|++.
T Consensus         5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~   84 (292)
T d1unla_           5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence            4557899999999999985 568899999997533   234788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcccccCCc
Q 041350          212 NGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAKLCSKDI  291 (344)
Q Consensus       212 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  291 (344)
                      +++|..++...      ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.|+......
T Consensus        85 ~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          85 QDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ccccccccccc------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99998887432      468899999999999999999999   999999999999999999999999999998776543


Q ss_pred             cceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          292 SIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       292 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      ..  .....+++.|+|||++... ..++.++||||+||++|||++|+.|+.
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCC
Confidence            22  2344578899999988764 357889999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-42  Score=305.81  Aligned_cols=197  Identities=23%  Similarity=0.276  Sum_probs=162.3

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhcccc-eeeEeeEEEcCCeEEEEEeccCC
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFH-IVRLLGFCSEGTRRALVYEFMPN  212 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~  212 (344)
                      +.+.+.||+|+||+||+|+. .+|+.||||++.... ..+++..|+++++.++|+| |+.+.++..+++..++||||+ +
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence            45678899999999999985 568999999987543 3346889999999998776 555556667888899999999 5


Q ss_pred             CCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEc---CCCceEEeecCCcccccC
Q 041350          213 GSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLD---HNFQPKISDFGLAKLCSK  289 (344)
Q Consensus       213 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~---~~~~~kl~Dfgla~~~~~  289 (344)
                      ++|.+.+....     ..+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+....
T Consensus        87 ~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          87 PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             Cchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            67777664433     468999999999999999999999   9999999999999986   456799999999997754


Q ss_pred             Cccc-----eeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          290 DISI-----VSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       290 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      ....     .......||+.|||||++.+.  .++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccc
Confidence            3221     122455799999999999875  789999999999999999999999954

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=309.43  Aligned_cols=193  Identities=24%  Similarity=0.381  Sum_probs=160.9

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEc-----CCeEEE
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE-----GTRRAL  205 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l  205 (344)
                      +...++||+|+||+||+|+. .+|+.||||+++....   ..+.+.+|+.+|++++||||+++++++..     +...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            34567899999999999984 5699999999975432   23578899999999999999999999863     334567


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      +++|+.+|+|.+++..       ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++.
T Consensus       100 i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             EEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence            7788889999999842       359999999999999999999999   999999999999999999999999999997


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .....     .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||..
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            65433     2345689999999987664 3568899999999999999999999863

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-41  Score=305.90  Aligned_cols=190  Identities=26%  Similarity=0.314  Sum_probs=152.2

Q ss_pred             hhcccccccCcEEEEEEEEe-CCceEEEEEeecccc---chHHHHHHHHHHhhhcccceeeEeeEEEc------CCeEEE
Q 041350          136 KFKHRLGQGGYGSVFRGKLF-NGIPVAVKMLEHLKG---NGQEFINEVATIGRIHHFHIVRLLGFCSE------GTRRAL  205 (344)
Q Consensus       136 ~~~~~lG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~l  205 (344)
                      ++.++||+|+||+||+|... +|+.||||+++....   ..+.+.+|+.++++++||||+++++++..      ....++
T Consensus        20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i   99 (355)
T d2b1pa1          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL   99 (355)
T ss_dssp             EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred             EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence            34578999999999999854 699999999975432   23568899999999999999999999953      468899


Q ss_pred             EEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceEEeecCCcc
Q 041350          206 VYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPKISDFGLAK  285 (344)
Q Consensus       206 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~  285 (344)
                      ||||+.++.+ +.+.        ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||+++
T Consensus       100 v~Ey~~~~l~-~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1         100 VMELMDANLC-QVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEECCSEEHH-HHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEeccchHHH-Hhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhh
Confidence            9999966544 4442        358999999999999999999999   999999999999999999999999999988


Q ss_pred             cccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 041350          286 LCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKD  342 (344)
Q Consensus       286 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~  342 (344)
                      .......   .....+|+.|+|||++.+.  .++.++||||+||+++||++|+.||.
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~  219 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_dssp             ----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCC
Confidence            7654432   2455689999999999775  78999999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-36  Score=276.58  Aligned_cols=197  Identities=25%  Similarity=0.349  Sum_probs=158.0

Q ss_pred             HhhcccccccCcEEEEEEEE-eCCceEEEEEeeccccchHHHHHHHHHHhhhc-----------ccceeeEeeEEEc--C
Q 041350          135 SKFKHRLGQGGYGSVFRGKL-FNGIPVAVKMLEHLKGNGQEFINEVATIGRIH-----------HFHIVRLLGFCSE--G  200 (344)
Q Consensus       135 ~~~~~~lG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~--~  200 (344)
                      +.+.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.++++++           |+||+++++++..  .
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            56678999999999999985 57999999999875555577889999998886           4789999988754  3


Q ss_pred             CeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCC------
Q 041350          201 TRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNF------  274 (344)
Q Consensus       201 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~------  274 (344)
                      ...+++++++..+..........   ....+++..+..++.|+++||+|||+  ..+|+||||||+|||++.++      
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cceeeeeeecccccccccccccc---cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            45667777765554433332222   22568999999999999999999997  37899999999999998655      


Q ss_pred             ceEEeecCCcccccCCccceeeecccCCcccccccccccccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 041350          275 QPKISDFGLAKLCSKDISIVSLTAARGTAGYIAPELFSRNFGEVSYKSDVYSYGMMLLEMVGCRKNKDP  343 (344)
Q Consensus       275 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv~s~Gvvl~ell~g~~p~~~  343 (344)
                      .++++|||.+.......     ....||+.|+|||++...  .++.++||||+||+++||++|+.||.+
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCC
Confidence            38999999998654432     346699999999998764  789999999999999999999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=1.4e-27  Score=197.52  Aligned_cols=162  Identities=17%  Similarity=0.157  Sum_probs=119.5

Q ss_pred             hcccccccCcEEEEEEEEeCCceEEEEEeecccc-------------------chHHHHHHHHHHhhhcccceeeEeeEE
Q 041350          137 FKHRLGQGGYGSVFRGKLFNGIPVAVKMLEHLKG-------------------NGQEFINEVATIGRIHHFHIVRLLGFC  197 (344)
Q Consensus       137 ~~~~lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~~~~~~  197 (344)
                      +.++||+|+||+||+|+..+|+.||||+++....                   ......+|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            5678999999999999988999999998753110                   012345688899999999999887653


Q ss_pred             EcCCeEEEEEeccCCCCHHHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceEEcCCCceE
Q 041350          198 SEGTRRALVYEFMPNGSLEKFIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLHQGCNQRILHFDIKPHNILLDHNFQPK  277 (344)
Q Consensus       198 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ivH~Dik~~Nill~~~~~~k  277 (344)
                      .    .+++|||+++..+.+             ++......++.|++++++|||+   .+|+||||||+|||++++ .++
T Consensus        84 ~----~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          84 G----NAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             T----TEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred             C----CEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence            2    379999998865533             2334466899999999999999   999999999999999965 489


Q ss_pred             EeecCCcccccCCccceeeecccCCccccc------ccccccccCCCCcccchHhHHHHHH
Q 041350          278 ISDFGLAKLCSKDISIVSLTAARGTAGYIA------PELFSRNFGEVSYKSDVYSYGMMLL  332 (344)
Q Consensus       278 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~~~Dv~s~Gvvl~  332 (344)
                      |+|||+|.....+..          ..|..      .|.+.+   .++.++|+||..--++
T Consensus       143 liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         143 IIDFPQSVEVGEEGW----------REILERDVRNIITYFSR---TYRTEKDINSAIDRIL  190 (191)
T ss_dssp             ECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHHH
T ss_pred             EEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcC---CCCCcccHHHHHHHHh
Confidence            999999976543211          11111      122222   5678899999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=1.9e-07  Score=78.79  Aligned_cols=132  Identities=14%  Similarity=0.063  Sum_probs=92.1

Q ss_pred             cCcEEEEEEEEeCCceEEEEEeeccc-cchHHHHHHHHHHhhhc-ccceeeEeeEEEcCCeEEEEEeccCCCCHHHHHhc
Q 041350          144 GGYGSVFRGKLFNGIPVAVKMLEHLK-GNGQEFINEVATIGRIH-HFHIVRLLGFCSEGTRRALVYEFMPNGSLEKFIFS  221 (344)
Q Consensus       144 G~fG~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  221 (344)
                      ++.+.||+.. .++..+.+|+..... .....+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+....
T Consensus        25 ~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            4456899986 456667888876432 33446778888887774 44467888888888899999999999888765421


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 041350          222 KTNSSSHRPLSWEKLKKIAFGVARGVEYLHQG------------------------------------------------  253 (344)
Q Consensus       222 ~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------------  253 (344)
                      .           .....++.++++.++.||+.                                                
T Consensus       104 ~-----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (263)
T d1j7la_         104 E-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD  172 (263)
T ss_dssp             C-----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred             c-----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence            1           11233455556666666631                                                


Q ss_pred             --------CCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          254 --------CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       254 --------~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                              ....++|+|+.|.|||++++...-|+||+.+...
T Consensus       173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                    0123789999999999998776779999988754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.38  E-value=4.7e-07  Score=75.83  Aligned_cols=131  Identities=19%  Similarity=0.104  Sum_probs=86.0

Q ss_pred             ccccC-cEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcc--cceeeEeeEEEcCCeEEEEEeccCCCCHHH
Q 041350          141 LGQGG-YGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHH--FHIVRLLGFCSEGTRRALVYEFMPNGSLEK  217 (344)
Q Consensus       141 lG~G~-fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  217 (344)
                      +..|. -+.||+....++..+.+|.-...  ....+..|...++.+..  -.+.+++++..+++..++||++++|.++.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            44444 36799998777777888876543  33456778888877753  346778888888888999999998876543


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 041350          218 FIFSKTNSSSHRPLSWEKLKKIAFGVARGVEYLH----------------------------------------------  251 (344)
Q Consensus       218 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH----------------------------------------------  251 (344)
                      ..           ....   ..+.++++.|+-||                                              
T Consensus        96 ~~-----------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          96 SH-----------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             SC-----------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cc-----------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            11           1100   11122222222232                                              


Q ss_pred             -----hC----CCCCeeecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          252 -----QG----CNQRILHFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       252 -----~~----~~~~ivH~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                           +.    ....++|+|+.|.|||++++..+-|+||+.+...
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g  206 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  206 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence                 21    1123799999999999998877789999988653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.96  E-value=2.5e-05  Score=69.61  Aligned_cols=75  Identities=15%  Similarity=0.078  Sum_probs=48.1

Q ss_pred             ccccccCcEEEEEEEEeC-CceEEEEEeec----c----ccchHHHHHHHHHHhhhc-c--cceeeEeeEEEcCCeEEEE
Q 041350          139 HRLGQGGYGSVFRGKLFN-GIPVAVKMLEH----L----KGNGQEFINEVATIGRIH-H--FHIVRLLGFCSEGTRRALV  206 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~-~~~vavK~~~~----~----~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv  206 (344)
                      +.||.|....||+.+..+ ++.+.||.-..    .    .........|.+.|+.+. +  ..+++++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999997654 67888986432    1    112234556888887663 2  346666655  34455799


Q ss_pred             EeccCCCCH
Q 041350          207 YEFMPNGSL  215 (344)
Q Consensus       207 ~e~~~~gsL  215 (344)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.81  E-value=7.9e-05  Score=64.42  Aligned_cols=139  Identities=11%  Similarity=0.036  Sum_probs=82.8

Q ss_pred             EEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhccccee--eEee-----EEEcCCeEEEEEeccCCCCHHH--
Q 041350          147 GSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHIV--RLLG-----FCSEGTRRALVYEFMPNGSLEK--  217 (344)
Q Consensus       147 G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~~-----~~~~~~~~~lv~e~~~~gsL~~--  217 (344)
                      -.||+.+..+|..+++|+.+......+++..|...+..|...++.  ..+.     ....++..+.++++++|..+..  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            479999988999999999887666677888999998888643321  1111     2344567889999997643221  


Q ss_pred             ------------HHhcc---CCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCCee
Q 041350          218 ------------FIFSK---TNSSSHRPLSWEK-------------------LKKIAFGVARGVEYLHQ----GCNQRIL  259 (344)
Q Consensus       218 ------------~l~~~---~~~~~~~~l~~~~-------------------~~~i~~~ia~~l~yLH~----~~~~~iv  259 (344)
                                  .++..   .....+..++...                   ...+...+...++.+..    ....+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                        11110   0111111222211                   11111122222333322    2346799


Q ss_pred             ecCCCCCceEEcCCCceEEeecCCcccc
Q 041350          260 HFDIKPHNILLDHNFQPKISDFGLAKLC  287 (344)
Q Consensus       260 H~Dik~~Nill~~~~~~kl~Dfgla~~~  287 (344)
                      |+|+.+.|||++++  ..+.||+-+..-
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             cCCCCcccEEEeCC--ceEEechhcccC
Confidence            99999999999754  458999987643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.26  E-value=0.00059  Score=60.38  Aligned_cols=72  Identities=18%  Similarity=0.277  Sum_probs=49.8

Q ss_pred             ccccccCcEEEEEEEEeCC--------ceEEEEEeeccccchHHHHHHHHHHhhhcccce-eeEeeEEEcCCeEEEEEec
Q 041350          139 HRLGQGGYGSVFRGKLFNG--------IPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI-VRLLGFCSEGTRRALVYEF  209 (344)
Q Consensus       139 ~~lG~G~fG~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~  209 (344)
                      +.|+.|---.+|+....++        ..|.+++... .....+..+|..+++.+.-.++ .++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            4577788889999876543        3466676653 3344566789999998864454 467776643    589999


Q ss_pred             cCCCCH
Q 041350          210 MPNGSL  215 (344)
Q Consensus       210 ~~~gsL  215 (344)
                      +++.+|
T Consensus       123 i~g~~l  128 (395)
T d1nw1a_         123 IPSRPL  128 (395)
T ss_dssp             CCEEEC
T ss_pred             eccccC
Confidence            987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.70  E-value=0.011  Score=49.81  Aligned_cols=144  Identities=14%  Similarity=0.083  Sum_probs=73.4

Q ss_pred             ccccCcEEEEEEEEeCCceEEEEEeeccccchHHHHHHHHHHhhhcccce--eeEee------EEEcCCeEEEEEeccCC
Q 041350          141 LGQGGYGSVFRGKLFNGIPVAVKMLEHLKGNGQEFINEVATIGRIHHFHI--VRLLG------FCSEGTRRALVYEFMPN  212 (344)
Q Consensus       141 lG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~------~~~~~~~~~lv~e~~~~  212 (344)
                      |..|---+.|+.+..+| .+++|+.... ...++...|++++..+...++  ...+-      +.........++.+..+
T Consensus        26 i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g  103 (316)
T d2ppqa1          26 IAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG  103 (316)
T ss_dssp             ECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred             CCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence            55666678899886555 5888988643 233455567777777754322  11111      12234556677777765


Q ss_pred             CCHHH--------------HHhccCCCC---CCCCCCHH------------------HHHHHHHHHHHHHHHHHh-CCCC
Q 041350          213 GSLEK--------------FIFSKTNSS---SHRPLSWE------------------KLKKIAFGVARGVEYLHQ-GCNQ  256 (344)
Q Consensus       213 gsL~~--------------~l~~~~~~~---~~~~l~~~------------------~~~~i~~~ia~~l~yLH~-~~~~  256 (344)
                      .....              .++......   ........                  .....+......+.-.+. ..+.
T Consensus       104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~  183 (316)
T d2ppqa1         104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA  183 (316)
T ss_dssp             BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred             ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence            43221              111110000   00000000                  011111122222222221 3456


Q ss_pred             CeeecCCCCCceEEcCCCceEEeecCCccc
Q 041350          257 RILHFDIKPHNILLDHNFQPKISDFGLAKL  286 (344)
Q Consensus       257 ~ivH~Dik~~Nill~~~~~~kl~Dfgla~~  286 (344)
                      ++||+|+.+.||+++.+...-|.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            899999999999999888778999998753